<SEC-DOCUMENT>0001171843-17-002748.txt : 20170508
<SEC-HEADER>0001171843-17-002748.hdr.sgml : 20170508
<ACCEPTANCE-DATETIME>20170505193217
ACCESSION NUMBER:		0001171843-17-002748
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20170331
FILED AS OF DATE:		20170508
DATE AS OF CHANGE:		20170505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HARVARD BIOSCIENCE INC
		CENTRAL INDEX KEY:			0001123494
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043306140
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33957
		FILM NUMBER:		17819948

	BUSINESS ADDRESS:	
		STREET 1:		84 OCTOBER HILL RD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
		BUSINESS PHONE:		5088938999

	MAIL ADDRESS:	
		STREET 1:		84 OCTOBER HILL ROAD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>f10q_050417.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 18pt; text-align: center; margin: 0pt 0"><B>UNITED STATES </B></P>

<P STYLE="font-size: 18pt; text-align: center; margin: 0pt 0"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><B>WASHINGTON, DC 20549</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 6pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 18pt; text-align: center; margin: 0pt 0"><B>FORM 10-Q </B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 6pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt"><FONT STYLE="font-family: Wingdings; font-size: 12pt"><B>x</B></FONT></TD><TD><FONT STYLE="font-size: 12pt"><B>Quarterly
                                         report pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 </B></FONT></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: center; margin: 9pt 0"><B>For the quarterly period ended March 31, 2017</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt"><FONT STYLE="font-family: Wingdings; font-size: 12pt"><B>&uml;</B></FONT></TD><TD><FONT STYLE="font-size: 12pt"><B>Transition
                                         report pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 </B></FONT></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: center; margin: 9pt 0"><B>For the transition period from <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U> to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Commission file number 001-33957 </B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 6pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 24pt; text-align: center; margin: 0pt 0"><B>HARVARD BIOSCIENCE, INC. </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 6pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>04-3306140</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>(State or Other Jurisdiction
        of</B></FONT></P>
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>Incorporation or Organization)</B></FONT></P>
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD>
    <TD><P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>(IRS Employer</B></FONT></P>
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>Identification No.)</B></FONT></P>
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>84&nbsp;October Hill Road, Holliston, MA</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>01746</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Address of Principal Executive Offices)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>(508) 893-8999 </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>(Registrant&rsquo;s telephone number,
including area code)</B></FONT><B> </B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 6pt; margin-bottom: 6pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Indicate by check mark whether the registrant (1)&nbsp;has filed
all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing
requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;YES&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;&nbsp;NO</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 6pt 0">Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule
405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;YES&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;&nbsp;NO</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0 6pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &ldquo;large accelerated
filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; width: 19%">Large&nbsp;accelerated&nbsp;filer</TD>
    <TD STYLE="text-align: left; width: 45%">&#9744;</TD>
    <TD STYLE="text-align: left; width: 23%">Accelerated&nbsp;filer</TD>
    <TD STYLE="text-align: left; width: 13%">&#9746;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 6pt">Non-accelerated filer</TD>
    <TD NOWRAP STYLE="text-align: left; padding-top: 6pt; padding-bottom: 6pt">&#9744;<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;(Do not check
if a smaller reporting company)</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; padding-top: 6pt; padding-bottom: 6pt">Smaller&nbsp;reporting&nbsp;company</TD>
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 6pt">&#9744;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD NOWRAP STYLE="text-align: left">Emerging growth company</TD>
    <TD STYLE="text-align: left">&#9744;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 6pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;&nbsp;YES&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;NO</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 6pt 0">Indicate the number of shares outstanding of each of the issuer&rsquo;s
classes of common stock, as of the latest practicable date.</P>

<P STYLE="font-size: 10pt; text-indent: 18.35pt; margin: 0pt 0">As of May 2, 2017, there were 34,618,897 shares of common stock,
par value $0.01 per share, outstanding.</P>

<P STYLE="font-size: 10pt; text-indent: 18.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 18.35pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 18.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>HARVARD BIOSCIENCE, INC. </B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>FORM 10-Q</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center">  <FONT STYLE="font-size: 10pt"><B>For the Quarter Ended March 31, 2017</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><A NAME="TableOfContents"></A><B>INDEX </B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="width: 7%">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="width: 88%">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center; width: 4%"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">PART I - FINANCIAL INFORMATION</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_002"><FONT STYLE="font-size: 10pt">Item&nbsp;1.</FONT></A></TD>
    <TD><A HREF="#a_002"><FONT STYLE="font-size: 10pt">Financial Statements</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_003"><FONT STYLE="font-size: 10pt">Consolidated Balance Sheets as of&nbsp;&nbsp;March 31, 2017 and December&nbsp;31, 2016 (unaudited)</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_004"><FONT STYLE="font-size: 10pt">Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2017 and 2016 (unaudited)</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">4</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP><A HREF="#a_005"><FONT STYLE="font-size: 10pt">Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2017 and 2016 (unaudited)</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">5</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_006"><FONT STYLE="font-size: 10pt">Notes to Unaudited Consolidated Financial Statements </FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">6</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_007"><FONT STYLE="font-size: 10pt">Item 2.</FONT></A></TD>
    <TD><A HREF="#a_007"><FONT STYLE="font-size: 10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations </FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">18</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_008"><FONT STYLE="font-size: 10pt">Item 3.</FONT></A></TD>
    <TD><A HREF="#a_008"><FONT STYLE="font-size: 10pt">Quantitative and Qualitative Disclosures about Market Risk </FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">26</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Item 4.</FONT></A></TD>
    <TD><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Controls and Procedures </FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">27</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">PART II - OTHER INFORMATION</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">28</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Item 1.</FONT></A></TD>
    <TD><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Legal Proceedings</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">28</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Item 1A.</FONT></A></TD>
    <TD><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">28</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Item 5.</FONT></A></TD>
    <TD><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Other Information</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">29</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Item 6.</FONT></A></TD>
    <TD><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Exhibits</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">29</FONT></A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">SIGNATURES</FONT></A></TD>
    <TD NOWRAP STYLE="text-align: center"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">31</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><A NAME="a_001"></A><FONT STYLE="font-size: 10pt"><B>PART I. FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B><A NAME="a_002"></A>Item 1.&nbsp;&nbsp;Financial Statements.</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>HARVARD BIOSCIENCE, INC.</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><A NAME="a_003"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED BALANCE SHEETS </B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>(Unaudited, in thousands, except share and per share data) </B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">4,599</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">5,596</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable, net of allowance for doubtful accounts of $559 and $611,</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,479</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,746</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Inventories</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,282</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,955</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other receivables and other assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4,761</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4,175</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Total current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,121</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,472</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Property, plant and equipment, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,268</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,296</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred income tax assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,179</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,157</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Amortizable intangible assets, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,070</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,471</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Goodwill</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">38,398</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">38,032</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Other indefinite lived intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,216</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,209</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">144</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">128</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">107,396</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">107,765</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: left">Liabilities and Stockholders' Equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Current portion, long-term debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,722</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,372</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,835</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,196</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">598</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">223</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,324</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,550</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other liabilities - current</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">478</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">760</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Total current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,056</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,601</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Long-term debt, less current installments</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,931</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,374</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred income tax liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,460</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,417</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other long term liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3,234</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3,177</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Total liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">34,681</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">35,569</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Commitments and contingencies</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Preferred stock, par value $0.01 per share, 5,000,000 shares authorized</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Common stock, par value $0.01 per share, 80,000,000 shares authorized; 42,364,404 and</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">42,186,827 shares issued and 34,618,897 and 34,441,320 shares outstanding, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">418</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">418</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Additional paid-in-capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">215,842</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">215,134</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(117,168</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(116,030</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(15,709</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(16,658</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Treasury stock at cost, 7,745,507 common shares</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(10,668</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(10,668</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total stockholders' equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">72,715</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">72,196</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders' equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">107,396</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">107,765</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">See accompanying notes to unaudited consolidated financial statements.</FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>HARVARD BIOSCIENCE, INC.</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><A NAME="a_004"></A><B>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>(Unaudited, in thousands, except per share data)</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; font-size: 10pt">Revenues</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">24,156</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">26,963</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Cost of revenues (exclusive of items shown separately below)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,657</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">14,018</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Gross profit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">11,499</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,945</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Sales and marketing expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,048</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,102</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">General and administrative expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,206</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,948</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Research and development expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,285</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,425</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Restructuring charges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Amortization of intangible assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">599</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">680</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,138</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13,166</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Operating loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(639</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(221</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Other (expense) income:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Foreign exchange</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(143</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(9</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(162</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(164</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Interest income</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other expense, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(99</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(50</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other expense, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(404</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(222</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss before income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,043</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(443</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Income tax expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">23</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">193</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,066</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(636</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Loss per share:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Basic loss per common share</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.03</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Diluted loss per common share</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.03</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Weighted average common shares:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,579</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,013</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,579</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,013</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Comprehensive loss:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(1,066</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(636</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Foreign currency translation adjustments</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">942</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">616</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Derivatives qualifying as hedges, net of tax:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Gain (loss) on derivative instruments designated and qualifying as cash flow hedges</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(36</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Amounts reclassified from accumulated other comprehensive loss to net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total comprehensive loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(117</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(43</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">See accompanying notes to unaudited consolidated financial statements.</FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>HARVARD BIOSCIENCE, INC.</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><A NAME="a_005"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>(Unaudited, in thousands)</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
&nbsp; &nbsp; &nbsp; &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Net loss</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">(1,066</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">(636</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Stock compensation expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">863</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">754</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 20pt">Depreciation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">306</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">385</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Amortization of catalog costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">(Recovery) provision for allowance for doubtful accounts</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(15</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Amortization of intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">599</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">680</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Amortization of deferred financing costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Deferred income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Changes in operating assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Decrease (increase) in accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">410</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(463</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">(Increase) decrease in inventories</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(300</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">211</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Increase in other receivables and other assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(526</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(463</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Decrease in trade accounts payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(320</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,679</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Decrease in accrued income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(110</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(77</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">(Decrease) increase in accrued expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(571</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,481</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Increase in deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">92</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt">Decrease in other liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(23</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 40pt">Net cash used by operating activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(610</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(726</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows used in investing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Additions to property, plant and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(198</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(201</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Additions to catalog costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(30</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(4</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(228</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(205</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows used in financing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Proceeds from issuance of debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Repayments of debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,113</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,613</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net taxes paid for issuance of common stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(155</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(113</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Net cash used in financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(268</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1,726</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Effect of exchange rate changes on cash</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">109</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">88</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Decrease in cash and cash equivalents</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(997</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,569</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Cash and cash equivalents at the beginning of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">5,596</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">6,744</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at the end of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,599</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,175</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Supplemental disclosures of cash flow information:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Cash paid for interest</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">164</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">194</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Cash paid for income taxes, net of refunds</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">See accompanying notes to unaudited consolidated financial statements.</FONT></P>


<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>HARVARD BIOSCIENCE, INC. </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><A NAME="a_006"></A>NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS </B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Basis of Presentation and Summary of Significant Accounting Policies</B></TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The unaudited consolidated financial statements of Harvard Bioscience,
Inc. and its wholly-owned subsidiaries (collectively, &ldquo;Harvard Bioscience&rdquo; or the &ldquo;Company&rdquo;) as of March
31, 2017 and for the three months ended March 31, 2017 and 2016 have been prepared by the Company pursuant to the rules and regulations
of the Securities and Exchange Commission (&ldquo;SEC&rdquo;). Certain information and footnote disclosures normally included in
financial statements prepared in accordance with U.S. generally accepted accounting principles (&ldquo;U.S. GAAP&rdquo;) have been
condensed or omitted pursuant to such rules and regulations. The December&nbsp;31, 2016 consolidated balance sheet was derived
from audited financial statements, but does not include all disclosures required by U.S. GAAP. However, the Company believes that
the disclosures are adequate to make the information presented not misleading. These unaudited consolidated financial statements
should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&rsquo;s
Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2016, which was filed with the SEC on March 17, 2017.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">In the opinion of management, all adjustments, which include normal
recurring adjustments necessary to present a fair statement of financial position as of March 31, 2017, results of operations and
comprehensive loss and cash flows for the three months ended March 31, 2017 and 2016, as applicable, have been made. The results
of operations for the three months ended March 31, 2017 are not necessarily indicative of the operating results for the full fiscal
year or any future periods.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><B><I>Summary of Significant Accounting Policies</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The accounting policies underlying the accompanying unaudited consolidated
financial statements are those set forth in Note 2 to the consolidated financial statements included in the Company&rsquo;s Annual
Report on Form 10-K for the year ended December&nbsp;31, 2016, which was filed with the SEC on March 17, 2017.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>Recently Issued Accounting Pronouncements</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (ASU) 2014-09, <I>&ldquo;Revenue from Contracts with Customers,&rdquo;</I> a new accounting standard
that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace
most existing revenue recognition guidance within generally accepted accounting principles in the United States. Under this standard,
revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the Company expects to be entitled in exchange for those goods or services. The Company expects to adopt this standard
as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of
its contracts in 2017 concerning any unique customer contract terms or transactions that could have implications to the timing
of revenue recognition under the new guidance. The Company expects this undertaking will be complete in the second half of 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In February 2016, the FASB issued ASU 2016-02, <I>Leases</I>, which
is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet
the assets and liabilities for the rights and obligations created by lease terms of more than 12&nbsp;months. The update is effective
for fiscal years beginning after December 15, 2018. The Company is evaluating the requirements of this guidance and has not yet
determined the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets
and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company&rsquo;s future commitments
under lease obligations are summarized in Note 10.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Recently Adopted Accounting Pronouncements</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In March 2016, the FASB issued ASU 2016-09,&nbsp;Compensation &ndash;
Stock Compensation (Topic 718): <I>Improvements to Employee Share-Based Payment Accounting</I>, which simplifies the accounting
for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities
and classification on the statement of cash flows.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The standard requires an entity to recognize all excess tax benefits
and tax deficiencies as income tax benefit or expense in the income statement as discrete items in the reporting period in which
they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&rsquo;s annual effective tax
rate, applied on a prospective basis. Further, the standard eliminates the requirement to defer the recognition of excess tax benefits
until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with
any valuation allowance, should be recognized on a modified retrospective basis as a cumulative adjustment to retained earnings
as of the date of adoption. Under ASU 2016-09, an entity that applies the treasury stock method in calculating diluted earnings
per share is required to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since such amounts
are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner
as other cash flows related to income taxes on the statement of cash flows, as such excess tax benefits no longer represent financing
activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods
presented.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company adopted ASU 2016-09 as of January 1, 2017. The Company
recorded a cumulative increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding
increase in deferred tax assets related to the prior years&rsquo; unrecognized excess tax benefits. An equal amount of valuation
allowance was also recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in a
net impact of $0. In addition,  tax deficiencies related to vested restricted stock units and canceled stock options during
the first quarter of 2017 have been recognized in the current period&rsquo;s income statement.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">ASU 2016-09 also allows an entity to elect as an accounting policy
either to continue to estimate the total number of awards for which the requisite service period will not be rendered or to account
for forfeitures for service based awards as they occur. An entity that elects to account for forfeitures as they occur should apply
the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earnings as of the date of
adoption. The Company elected as an accounting policy to account for forfeitures for service based awards as they occur, and as
a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings with a corresponding
increase in additional paid in capital related to the prior years&rsquo; stock-based compensation expense as required under the
modified retrospective approach. The tax effect of this adjustment, which included the impact of a valuation allowance was immaterial.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>Accumulated Other Comprehensive Loss</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Changes in each component of accumulated other comprehensive loss,
net of tax are as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">Foreign currency</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">Derivatives</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">translation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">qualifying as</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">Defined benefit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">(in thousands)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">adjustments</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">hedges</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">pension plans</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Total</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-size: 10pt; font-weight: bold">Balance at December 31,&nbsp;&nbsp;2016</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(14,200</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(2,458</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(16,658</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Other comprehensive income before reclassifications</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">942</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">946</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Amounts reclassified from AOCI</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other comprehensive income</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">942</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">7</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">949</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Balance at March 31, 2017</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(13,258</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,458</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(15,709</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>Goodwill and Other Intangible Assets </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Intangible assets consist of the following:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Weighted</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Average</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">March
    31, 2017</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">December
    31, 2016</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Life</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>&nbsp;(a)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="15" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(in thousands)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Amortizable intangible assets:</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">Gross</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">Accumulated
    <BR>
    Amortization</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">Gross</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 10pt">Accumulated
    <BR>
    Amortization</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Existing technology</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">15,287</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(12,020</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">15,082</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(11,710</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">6.8</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;Years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Trade names</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">7,436</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(3,617</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">7,379</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(3,479</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">7.8</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Distribution agreements/customer relationships</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">23,136</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(13,228</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">22,976</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(12,862</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">8.7</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">Patents</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">207</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(131</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">204</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(119</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">1.9</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Total amortizable intangible
    assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">46,066</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(28,996</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">45,641</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(28,170</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Indefinite-lived intangible assets:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Goodwill</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">38,398</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">38,032</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">Other indefinite-lived
    intangible assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">1,216</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">1,209</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">Total goodwill and other
    indefinite-lived intangible assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">39,614</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">39,241</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Total intangible assets,
    gross</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">85,680</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">84,882</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a) Weighted average life as of March 31, 2017.</FONT></P>


<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The change in the carrying amount of goodwill for the three months
ended March 31, 2017 is as follows:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; font-size: 10pt">Balance at December 31, 2016</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right">38,032</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Effect of change in currency translation</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">366</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Balance at March 31, 2017</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">38,398</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Amortization of intangible assets</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Intangible asset amortization expense was $0.6 million and $0.7
million for the three months ended March 31, 2017 and 2016, respectively. Amortization expense of existing amortizable intangible
assets is currently estimated to be $2.4&nbsp;million for the year ending December&nbsp;31, 2017, $2.3 million for the year ending
December 31, 2018, $2.1 million for the year ending December&nbsp;31, 2019, $2.1 million for the year ending December&nbsp;31,
2020 and $2.1 million for the year ending December&nbsp;31, 2021.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>Inventories</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Inventories consist of the following:</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Finished goods</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">9,686</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">9,340</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Work in process</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">900</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">823</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Raw materials</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">9,696</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">9,792</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; text-align: left; padding-left: 10pt">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">20,282</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">19,955</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B>Property, Plant and Equipment</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">As of March 31, 2017 and December 31, 2016, property, plant and equipment
consist of the following:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Land, buildings and leasehold improvements</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">2,117</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">2,095</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Machinery and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,395</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,224</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Computer equipment and software</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,345</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,115</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Furniture and fixtures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,284</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,274</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">Automobiles</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">201</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">196</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,342</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,904</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Less: accumulated depreciation</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,074</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(14,608</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Property, plant and equipment, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,268</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,296</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B>Related Party Transactions</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">As part of the acquisitions of Multi Channel Systems MCS GmbH (MCS)
and Triangle BioSystems, Inc. (TBSI) in 2014, the Company signed lease agreements with the former owners of the acquired companies.
The principals of such former owners of MCS and TBSI were employees of the Company as of March 31, 2017 and 2016. Pursuant to a
lease agreement, the Company incurred rent expense of approximately $58 thousand to the former owners of MCS for both the three
months ended March 31, 2017 and 2016, respectively. The Company incurred rent expense of approximately $11 thousand to the former
owner of TBSI for both the three months ended March 31, 2017 and 2016, respectively.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>Warranties</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Warranties are estimated and accrued at the time revenues are recorded.
A rollforward of the Company&rsquo;s product warranty accrual is as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Beginning</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Additions/</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Ending</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Balance</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Payments</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">(Credits)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Balance</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="15" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-size: 10pt">Year ended December 31, 2016</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">147</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(97</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">143</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">193</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Three months ended March 31, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">193</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">206</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B>Employee Benefit Plans </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">One of the Company&rsquo;s subsidiaries in the United Kingdom, or
UK, Biochrom Limited, maintains contributory, defined benefit pension plans for substantially all of its employees. As of June
30, 2014, these defined benefit pension plans were closed to new employees, as well as closed to the future accrual of benefits
for existing employees. The components of the Company&rsquo;s defined benefit pension expense were as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt">Components of net periodic benefit cost:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Interest cost</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">125</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">168</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Expected return on plan assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(159</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(181</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net amortization loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">87</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">80</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net periodic benefit cost</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">53</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">67</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">For the three months ended March 31, 2017 and 2016, the Company
contributed $0.2&nbsp;million, for both periods, to its defined benefit pension plans. The Company expects to contribute approximately
$0.5 million to its defined benefit pension plans during the remainder of 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company had an underfunded pension liability of approximately
$3.2 million and $3.0 million, as of March 31, 2017 and December 31, 2016, respectively, included in the other long term liabilities
line item in the consolidated balance sheets.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B>Leases </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company has noncancelable operating leases for office and warehouse
space expiring at various dates through 2022 and thereafter. Rent expense, which is recorded on a straight-line basis, is estimated
to be $1.7 million for the year ended December 31, 2017. Rent expense was approximately $0.4 million and $0.5 million for the three
months ended March 31, 2017 and 2016, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Future minimum lease payments for operating leases, with initial
or remaining terms in excess of one year at March 31, 2017, are as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Operating</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Leases</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(in thousands)</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; font-size: 10pt; text-align: left">2018</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">1,610</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">2019</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,618</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">2020</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,421</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">2021</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,098</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">2022</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,098</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; text-align: left">Thereafter</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,836</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net minimum lease payments</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,681</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B>Capital Stock </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Common Stock </I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On February&nbsp;5, 2008, the Company&rsquo;s Board of Directors
adopted a Shareholder Rights Plan and declared a dividend distribution of one preferred stock purchase right for each outstanding
share of the Company&rsquo;s common stock to shareholders of record as of the close of business on February&nbsp;6, 2008. Initially,
these rights will not be exercisable and will trade with the shares of the Company&rsquo;s common stock. Under the Shareholder
Rights Plan, the rights generally will become exercisable if a person becomes an &ldquo;acquiring person&rdquo; by acquiring 20%
or more of the common stock of the Company or if a person commences a tender offer that could result in that person owning 20%
or more of the common stock of the Company. If a person becomes an acquiring person, each holder of a right (other than the acquiring
person) would be entitled to purchase, at the then-current exercise price, such number of shares of preferred stock which are equivalent
to shares of the Company&rsquo;s common stock having a value of twice the exercise price of the right. Unless the Board of Directors
elects to extend such plan, the Shareholder Rights Plan will expire in February 2018. If the Company is acquired in a merger or
other business combination transaction after any such event, each holder of a right would then be entitled to purchase, at the
then-current exercise price, shares of the acquiring company&rsquo;s common stock having a value of twice the exercise price of
the right.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Preferred Stock</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company&rsquo;s Board of Directors has the authority to issue
up to 5.0 million shares of preferred stock and to determine the price privileges and other terms of the shares. The Board of Directors
may exercise this authority without any further approval of stockholders. As of March 31, 2017, the Company had no preferred stock
issued or outstanding.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Employee Stock Purchase Plan (as amended, the &ldquo;ESPP&rdquo;)</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In 2000, the Company approved the ESPP. Under this ESPP, participating
employees can authorize the Company to withhold a portion of their base pay during consecutive six-month payment periods for the
purchase of shares of the Company&rsquo;s common stock. At the conclusion of the period, participating employees can purchase shares
of the Company&rsquo;s common stock at 85% of the lower of the fair market value of the Company&rsquo;s common stock at the beginning
or end of the period. Shares are issued under the ESPP for the six-month periods ending June&nbsp;30 and December&nbsp;31. Under
this plan, 750,000 shares of common stock are authorized for issuance of which 725,239 shares were issued as of March 31, 2017.
There were no shares issued under the ESPP during the three months ended March 31, 2017 and 2016.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Stock Option and Equity Incentive Plans</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Third Amended and Restated 2000 Stock Option and Incentive Plan
(as amended, the &ldquo;Third A&amp;R Plan&rdquo;)</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Second Amendment to the Third A&amp;R Plan (the &ldquo;Amendment&rdquo;)
was adopted by the Board of Directors on April&nbsp;3, 2015. Such Amendment was approved by the stockholders at the Company&rsquo;s
2015 Annual Meeting of Stockholders. Pursuant to the Amendment, the aggregate number of shares authorized for issuance under the
Third A&amp;R Plan was increased by 2,500,000 shares to 17,508,929.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Restricted Stock Units with a Market Condition (the &ldquo;Market
Condition RSU&rsquo;s&rdquo;)</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On August 3, 2015, the Compensation Committee of the Board of Directors
of the Company approved and granted deferred stock awards of Market Condition RSU&rsquo;s to certain members of the Company&rsquo;s
management team under the Third A&amp;R Plan. The vesting of these Market Condition RSU&rsquo;s is cliff-based and linked to the
achievement of a relative total shareholder return of the Company&rsquo;s common stock from August 3, 2015 to the earlier of (i)
August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average
price before each such date). As of March 31, 2017, the target number of these restricted stock units that may be earned is 182,150
shares; the maximum amount is 150% of the target number.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Stock-Based Payment Awards</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The Company accounts for stock-based payment awards in accordance
with the provisions of FASB ASC 718, which requires it to recognize compensation expense for all stock-based payment awards made
to employees and directors including stock options, restricted stock units, Market Condition RSU&rsquo;s and employee stock purchases
related to the&nbsp;ESPP.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The Company adopted ASU 2016-09 as of January 1, 2017. As disclosed
in footnote 2, as a result of this adoption, the Company has elected as an accounting policy to account for forfeitures for service
based awards as they occur, with no adjustment for estimated forfeitures. The Company recognized as of January 1, 2017, a cumulative
effect adjustment of $0.1 million to reduce retained earnings as required under the modified retrospective approach.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">Stock option and restricted stock unit activity under the Company&rsquo;s
Third A&amp;R Plan for the three months ended March 31, 2017 was as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Stock Options</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Restricted Stock Units</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Market Condition RSU's</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Weighted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Stock</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Average</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Restricted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Market</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Options</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Exercise</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Stock Units</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Grant Date</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Condition RSU's</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Grant Date</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Outstanding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Price</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Outstanding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fair Value</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Outstanding</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fair Value</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; font-size: 10pt">Balance at December 31, 2016</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">4,096,818</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">3.94</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">1,072,653</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">3.15</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">182,150</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">4.81</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Granted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.25</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">445,690</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.83</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Exercised</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,709</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.56</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Vested (RSUs)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(251,570</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.28</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Cancelled / forfeited</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(152,212</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right">3.68</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(4,190</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right">3.05</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Balance at March 31, 2017</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,968,897</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">3.94</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,262,583</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">3.01</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">182,150</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">4.81</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The weighted average fair value of the options granted under the
Third A&amp;R Plan during the three months ended March 31, 2017 and 2016 was $1.27 and $1.11, respectively. The following assumptions
were used to estimate the fair value, using the Black-Scholes option pricing model, of stock options granted during the three months
ended March 31, 2017 and 2016:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt">Volatility</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">41.07</TD><TD STYLE="width: 5%; font-size: 10pt; text-align: left">&nbsp;%</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">40.26</TD><TD STYLE="width: 4%; font-size: 10pt; text-align: left">&nbsp;%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Risk-free interest rate</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.89</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.48</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Expected holding period (in years)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.20</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;years</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.36</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dividend yield</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;%</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company used historical volatility to calculate the expected
volatility for each grant as of the grant date. Historical volatility was determined by calculating the mean reversion of the daily
adjusted closing stock price. The risk-free interest rate assumption is based upon observed U.S. Treasury bill interest rates (risk-free)
appropriate for the term of the Company&rsquo;s stock options and Market Condition RSU&rsquo;s. The expected holding period of
stock options represents the period of time options are expected to be outstanding and is based on historical experience. The vesting
period ranges from one to four years and the contractual life is ten years. The correlation coefficient, used to value the Market
Condition RSU&rsquo;s, represents the way in which entities move in relation to the Russell 3000 index as a whole.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Stock-based compensation expense related to stock options, restricted
stock units, Market Condition RSU&rsquo;s and the ESPP for the three months ended March 31, 2017 and 2016 was allocated as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt">Cost of revenues</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">13</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">11</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Sales and marketing</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">133</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">101</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">General and administrative</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">688</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">622</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Research and development</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">29</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total stock-based compensation</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">863</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">754</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company did not capitalize any stock-based compensation.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Earnings per share</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Basic earnings per share is based upon net income divided by the
number of weighted average common shares outstanding during the period. The calculation of diluted earnings per share assumes conversion
of stock options, restricted stock units and Market Condition RSU&rsquo;s into common stock using the treasury method. The weighted
average number of shares used to compute basic and diluted earnings per share consists of the following:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt">Basic</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">34,579,473</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">34,013,352</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt; text-indent: -10pt">Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU's</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,579,473</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">34,013,352</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Excluded from the shares used in calculating the diluted earnings
per common share in the above table are options, restricted stock units and Market Condition RSU&rsquo;s of approximately 5,413,630
and 5,461,017 shares of common stock for the three months ended March 31, 2017 and 2016, respectively, as the impact of these shares
would be anti-dilutive.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>12.</B></TD><TD><B>Long Term Debt</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On August&nbsp;7, 2009, the Company entered into an Amended and
Restated Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and
Bank of America and Brown Brothers Harriman&nbsp;&amp; Co as lenders (as amended, the &ldquo;2009 Credit Agreement&rdquo;). On
March 29, 2013, the Company entered into a Second Amended and Restated Revolving Credit Agreement (as amended, the &ldquo;2013
Credit Agreement&rdquo;) with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&nbsp;&amp; Co, as lenders
that amended and restated the 2009 Credit Agreement. Between September 2011 and March 2016, the Company entered into a series of
amendments that among other things did the following:</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on September 30, 2011, reduced interest rates to the London Interbank Offered Rate plus 3.0%;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on March 29, 2013, converted existing loan advances into a term loan in the principal amount of $15.0 million (the &ldquo;2013 Term Loan&rdquo;), provided a revolving credit facility in the maximum principal amount of $25.0 million (the &ldquo;2013 Revolving Line&rdquo;) and a delayed draw term loan (the &ldquo;2013 DDTL&rdquo;) of up to $15.0 million (all with a maturity date of March 29, 2018);</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on October 31, 2013, reduced the 2013 DDTL from up to $15.0 million to up to $10.0 million;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on April 24, 2015, extended the maturity date of the 2013 Revolving Line to March 29, 2018 and reduced the interest rates on the 2013 Revolving Line, 2013 Term Loan and 2013 DDTL;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on June 30, 2015, amended our quarterly minimum fixed charge coverage financial covenant; and</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on March 9, 2016, amended the principal payment amortization of the 2013 Term Loan and 2013 DDTL to five years, as well as amended our quarterly minimum fixed charge coverage financial covenant.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The maximum amount available under the 2013 Credit Agreement is
$50.0 million as borrowings against the 2013 DDTL in excess of $10.0 million results in a dollar for dollar reduction in the 2013
Revolving Line capacity. The 2013 Revolving Line, 2013 Term Loan and 2013 DDTL each have a maturity date of March&nbsp;29, 2018.
Borrowings under the 2013 Term Loan and the 2013 DDTL accrue interest at a rate based on either the effective London Interbank
Offered Rate (LIBOR) for certain interest periods selected by the Company, or a daily floating rate based on the British Bankers&rsquo;
Association (BBA) LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus
in either case, a margin of 2.75%. Additionally, the 2013 Revolving Line accrues interest at a rate based on either the effective
LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case,
a margin of 2.25%. The Company was required to fix the rate of interest on at least 50% of the 2013 Term Loan and the 2013 DDTL
through the purchase of interest rate swaps.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The loans evidenced by the 2013 Credit Agreement, or the 2013 Loans,
are guaranteed by all of the Company&rsquo;s direct and indirect domestic subsidiaries, and secured by substantially all of the
assets of the Company and the guarantors.&nbsp;The 2013 Loans are subject to restrictive covenants under the 2013 Credit Agreement,
and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis,
including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the 2013 Loans is allowed
by the 2013 Credit Agreement at any time during the terms of the 2013 Loans. The 2013 Loans also contain limitations on the Company&rsquo;s
ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory notes and/or
other consideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017 and December 31, 2016, the Company had net
borrowings of $13.7 million, respectively, outstanding under its 2013 Credit Agreement. The carrying value of the debt approximates
fair value because the interest rate under the obligation approximates market rates of interest available to the Company for similar&nbsp;instruments.&nbsp;As
of March 31, 2017, the Company was in compliance with all financial covenants contained in the 2013 Credit Agreement, was subject
to covenant and working capital borrowing restrictions and had available borrowing capacity under its 2013 Credit Agreement of
$5.2 million.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017, the weighted effective interest rates, net
of the impact of the Company&rsquo;s interest rate swaps, on its 2013 Term Loan, 2013 DDTL and 2013 Revolving Line borrowings were
3.96%, 3.83% and 3.23%, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017 and December 31, 2016, the Company&rsquo;s
borrowings were comprised of:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Long-term debt:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Term loan</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">5,062</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">5,400</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">DDTL</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,125</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,400</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Revolving line</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,550</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,050</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Total unamortized deferred financing costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(84</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(104</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,653</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,746</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Less: current installments</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,800</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,450</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Current unamortized deferred financing costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">78</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">78</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long-term debt</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10,931</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">11,374</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On May 2, 2017, the Company entered into a Third Amended and Restated
Revolving Credit Agreement (as amended, the &ldquo;Credit Agreement&rdquo;) with Bank of America, as agent, and Bank of America
and Brown Brothers Harriman&nbsp;&amp; Co, as lenders that amended and restated the 2013 Credit Agreement. As a result of the Credit
Agreement, the amounts outstanding under the 2013 Credit Agreement with maturities subsequent to March 31, 2018 are classified
as long term. The Credit Agreement was entered into to, among other things, consolidate, combine and restate the outstanding indebtedness,
on the date of the Credit Agreement, into a Term Loan in the principal amount of $14.0 million, and also provide for a $25.0 million
revolving line of credit (the &ldquo;Revolving Line&rdquo;). The Term Loan and the Revolving Line each have a maturity date of
May 1, 2022. Borrowings under the Term Loan accrue interest at a rate based on either the effective LIBOR for certain interest
periods selected by the Company, or a daily floating rate based on the BBA LIBOR as published by Reuters (or other commercially
available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the Revolving Line accrues
interest at a rate based on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating
rate based on the BBA LIBOR, plus in either case, a margin of 2.25%.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Term Loan and loans under the Revolving Line evidenced by the
Credit Agreement, or the Loans, are guaranteed by all of the Company&rsquo;s direct and indirect domestic subsidiaries, and secured
by substantially all of the assets of the Company and the guarantors.&nbsp;The Loans are subject to restrictive covenants under
the Credit Agreement, and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios
on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of
the Loans is allowed by the Credit Agreement at any time during the terms of the Loans. The Loans also contain limitations on the
Company&rsquo;s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory
notes and/or other consideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>13.</B></TD><TD><B>Derivatives</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company uses interest-rate-related derivative instruments to
manage its exposure related to changes in interest rates on its variable-rate debt instruments. The Company does not enter into
derivative instruments for any purpose other than cash flow hedging. The Company does not speculate using derivative instruments.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">By using derivative financial instruments to hedge exposures to
changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the failure of the counterparty
to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty
owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company
owes the counterparty and, therefore, the Company is not exposed to the counterparty&rsquo;s credit risk in those circumstances.
The Company minimizes counterparty credit risk in derivative instruments by entering into transactions with carefully selected
major financial institutions based upon their credit profile.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Market risk is the adverse effect on the value of a derivative instrument
that results from a change in interest rates. The market risk associated with interest-rate contracts is managed by establishing
and monitoring parameters that limit the types and degree of market risk that may be undertaken.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company assesses interest rate risk by continually identifying
and monitoring changes in interest rate exposures that may adversely impact expected future cash flows and by evaluating hedging
opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company&rsquo;s
outstanding or forecasted debt obligations as well as the Company&rsquo;s offsetting hedge positions. The risk management control
systems involve the use of analytical techniques, including cash flow sensitivity analysis, to estimate the expected impact of
changes in interest rates on the Company&rsquo;s future cash flows.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company uses variable-rate London Interbank Offered Rate (LIBOR)
debt to finance its operations. The debt obligations expose the Company to variability in interest payments due to changes in interest
rates. Management believes that it is prudent to limit the variability of a portion of its interest payments. To meet this objective,
management enters into LIBOR based interest rate swap agreements to manage fluctuations in cash flows resulting from changes in
the benchmark interest rate of LIBOR. These swaps change the variable-rate cash flow exposure on the debt obligations to fixed
cash flows. Under the terms of the interest rate swaps, the Company receives LIBOR based variable interest rate payments and makes
fixed interest rate payments, thereby creating the equivalent of fixed-rate debt for the notional amount of its debt hedged. In
accordance with its Credit Agreement, the Company was required to fix the rate of interest on at least 50% of its Term Loan and
the DDTL through the purchase of interest rate swaps. On June 5, 2013, the Company entered into an interest rate swap contract
with an original notional amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in
the effective benchmark interest rate (LIBOR) associated with the Company&rsquo;s Term Loan. On November 29, 2013, the Company
entered into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March
29, 2018 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associated with the DDTL. The notional
amount of the Company&rsquo;s derivative instruments as of March 31, 2017 was $4.5 million. The Term Loan swap contract effectively
converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 0.96% plus
a bank margin of 2.75%. The DDTL swap contract effectively converted specific variable-rate debt into fixed-rate debt and fixed
the LIBOR rate associated with the Term Loan at 0.93% plus a bank margin of 2.75%.The interest rate swaps were designated as cash
flow hedges in accordance with ASC 815, <I>Derivatives and Hedging</I>.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As disclosed in Note 12, on May 2, 2017, the Company entered into
the Credit Agreement to amend its credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman
&amp; Co. as lenders. Immediately after entering into this Credit Agreement, the Company entered into a new interest rate swap
contract with Bank of America with a notional amount of $14.0 million and a maturity date of March 30, 2022 in order to hedge the
risk of changes in the effective benchmark interest rate (LIBOR) associated with the Company&rsquo;s Term Loan. The swap contract
converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 1.86%. The
interest rate swap was designated as a cash flow hedge instrument in accordance with ASC 815 &ldquo;Derivatives and Hedging&rdquo;.
As a result of entering into the new interest rate swap contract, the Company unwound the previous interest rate swap contracts,
and received an immaterial amount in proceeds.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The following table presents the notional amount and fair value
of the Company&rsquo;s derivative instruments as of March 31, 2017 and December 31, 2016.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31, 2017</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">March 31, 2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Notional Amount</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fair Value (a)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold">Derivatives designated as hedging instruments <BR>
under ASC 815</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: left; vertical-align: bottom">Balance sheet classification</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center; vertical-align: bottom">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Interest rate swaps</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 28%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Other liabilities-non current</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,500</TD><TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7</TD><TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31, 2016</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31, 2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Notional Amount</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fair Value (a)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold">Derivatives designated as hedging instruments <BR>
under ASC 815</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: left; vertical-align: bottom">Balance sheet classification</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center; vertical-align: bottom">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Interest rate swaps</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 28%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Other liabilities-non current</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,500</TD><TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a) See Note 14 for the fair value measurements related to these financial instruments.</FONT></P>


<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">All of the Company&rsquo;s derivative instruments are designated
as hedging instruments.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company has structured its interest rate swap agreements to
be 100% effective and as a result, there was no impact to earnings resulting from hedge ineffectiveness. Changes in the fair value
of interest rate swaps designated as hedging instruments that effectively offset the variability of cash flows associated with
variable-rate, long-term debt obligations are reported in accumulated other comprehensive income (&ldquo;AOCI&rdquo;). These amounts
subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in
which the related interest affects earnings. The Company&rsquo;s interest rate swap agreement was deemed to be fully effective
in accordance with ASC 815, and, as such, unrealized gains and losses related to these derivatives were recorded as AOCI.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The following table summarizes the effect of derivatives designated
as cash flow hedging instruments and their classification within comprehensive loss for the three months ended March 31, 2017 and
2016:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold">Derivatives in Hedging Relationships</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount of gain (loss) <BR> recognized in OCI on <BR> derivative (effective portion)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three Months Ended <BR>
March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Interest rate swaps</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">4</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">(36</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The following table summarizes the reclassifications out of accumulated
other comprehensive loss for the three months ended March 31, 2017 and 2016:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold">Details about AOCI Components</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount reclassified from <BR>
AOCI into income <BR>
(effective portion)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three Months <BR>
Ended March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center">Location of amount<BR>
reclassified from AOCI</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">into income (effective portion)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Interest rate swaps</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">3</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">13</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 16%; font-size: 10pt; text-align: center">Interest expense</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017, $7 thousand of deferred losses on derivative
instruments accumulated in AOCI are expected to be reclassified to earnings during the next twelve months. Transactions and events
expected to occur over the next twelve months that will necessitate reclassifying these derivatives&rsquo; losses to earnings include
the repricing of variable-rate debt. There were no cash flow hedges discontinued during 2017 or 2016.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>14.</B></TD><TD><B>Fair Value Measurements</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Fair value measurement is defined as the price that would be received
to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an
orderly transaction between market participants at the measurement date. A fair value hierarchy is established, which prioritizes
the inputs used in measuring fair value into three broad levels as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Level 1&mdash;Quoted prices in active markets for identical assets
or liabilities.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 24.5pt">Level 2&mdash;Inputs, other than the quoted prices in active markets, that
are observable either directly or indirectly.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 24.5pt">Level 3&mdash;Unobservable inputs based on the Company&rsquo;s own assumptions.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The following tables present the fair value hierarchy for those
liabilities measured at fair value on a recurring basis:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="15" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Fair Value as of March 31, 2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">(In thousands)</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Level 1</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid; text-align: center">Level 2</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Level 3</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Total</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left; padding-left: 10pt">Interest rate swap agreements</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">7</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">7</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="15" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Fair Value as of December 31, 2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">(In thousands)</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Level 1</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Level 2</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Level 3</TD><TD STYLE="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Total</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left; padding-left: 10pt">Interest rate swap agreements</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Company uses the market approach technique to value its financial
liabilities. The Company&rsquo;s financial liabilities carried at fair value include derivative instruments used to hedge the Company&rsquo;s
interest rate risks. The fair value of the Company&rsquo;s interest rate swap agreements was based on LIBOR yield curves at the
reporting date.&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>15.</B></TD><TD><B>Income Tax </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Income tax was an expense of approximately $23 thousand and $0.2
million for the three months ended March 31, 2017 and 2016, respectively. The tax expense for the three months ended March 31,
2017 reflects the expense recorded for the three months ended March 31, 2017 associated with the actual results for the three-month
period, as described below.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Discrete items included in the tax expense for the
three months ended March 31, 2017 included changes to reserves for uncertain tax positions and tax deficiencies related
to stock-based compensation. Tax expense for the three months ended March 31, 2016 included foreign currency gains and
losses and the tax impact of the amortization of certain indefinite-lived intangible assets which are amortized for tax
purposes only, against which a valuation allowance is not established.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The effective income tax rate was (2.2%) for the three months ended
March 31, 2017, compared with (43.6%) for the same period in 2016. The tax rates for the three months ended March 31, 2017 and
2016 were based on actual results for the three-month period rather than an effective tax rate estimated for the entire year. In
2017 and 2016 the Company determined that using a year-to-date approach resulted in a better estimate of income tax expense/benefit
based on its forecast of pre-tax income/loss, the mix of taxable income/loss across several jurisdictions with different statutory
tax rates, and the impact of the full valuation allowance against U.S. deferred tax assets.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The difference between the Company&rsquo;s effective tax
rate period over period was primarily attributable to higher pre-tax income at certain individual subsidiaries in 2016
versus 2017, despite an overall pre-tax loss in both periods. In addition, both periods included the tax impact of
amortization of certain indefinite-lived intangibles which are amortized for tax purposes only, against which a
valuation allowance is not established.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&#9;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>16.</B></TD><TD STYLE="text-align: justify"><B>Subsequent Events</B></TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On April 14, 2017, anticipated representatives for the estate of
an individual plaintiff filed a wrongful death complaint with the Suffolk Superior Court, in the County of Suffolk, Massachusetts,
against the Company and other defendants, including Biostage, Inc. (f/k/a Harvard Apparatus Regenerative Technology, Inc.), its
subsidiary that was spun off in 2013, as well as another third party. The complaint seeks payment for an unspecified amount of
damages and alleges that the plaintiff sustained terminal injuries allegedly caused by products, including synthetic trachea scaffolds
and bioreactors, provided by certain of the named defendants and utilized in connection with surgeries performed by third parties
in 2012 and 2013. The litigation is at an early stage and the Company intends to vigorously defend this case. While the Company
believe that such claim is without merit, the Company is unable to predict the ultimate outcome of such litigation.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On May 2, 2017, the Company entered into the Credit Agreement
which restated the 2013 Agreement. See Note 12 for a discussion of the Credit Agreement. Additionally, immediately after
entering into the Credit Agreement, the Company entered into a new interest swap agreement with Bank of America. See Note 13
for a discussion of the interest swap agreement.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"><B><A NAME="a_007"></A>Item&nbsp; 2.</B></TD><TD><B><I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.</I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: -0.85in; margin: 0pt 0 0pt 0.85in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Forward-Looking Statements </B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>This Quarterly Report on Form 10-Q contains statements that are
not statements of historical fact and are forward-looking statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;). The forward-looking statements are
principally, but not exclusively, contained in &ldquo;Item 2: Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations.&rdquo; These statements involve known and unknown risks, uncertainties and other factors that may cause
our actual results, performance or achievements to be materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements
about management&rsquo;s confidence or expectations, and our plans, objectives, expectations and intentions that are not historical
facts. In some cases, you can identify forward-looking statements by terms such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;seek,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;aim,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;projects,&rdquo; &ldquo;predicts,&rdquo; &ldquo;intends,&rdquo; &ldquo;think,&rdquo;
&ldquo;potential,&rdquo; &ldquo;objectives,&rdquo; &ldquo;optimistic,&rdquo; &ldquo;strategy,&rdquo; &ldquo;goals,&rdquo; &ldquo;sees,&rdquo;
&ldquo;new,&rdquo; &ldquo;guidance,&rdquo; &ldquo;future,&rdquo; &ldquo;continue,&rdquo; &ldquo;drive,&rdquo; &ldquo;growth,&rdquo;
&ldquo;long-term,&rdquo; &ldquo;projects,&rdquo; &ldquo;develop,&rdquo; &ldquo;possible,&rdquo; &ldquo;emerging,&rdquo; &ldquo;opportunity,&rdquo;
&ldquo;pursue&rdquo; and similar expressions intended to identify forward-looking statements. These statements reflect our current
views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties,
you should not place undue reliance on these forward-looking statements. Factors that may cause our actual results to differ materially
from those in the forward-looking statements include reductions in customers&rsquo; research budgets or government funding; domestic
and global economic conditions; economic, political and other risks associated with international revenues and operations; currency
exchange rate fluctuations; economic and political conditions generally and those affecting pharmaceutical and biotechnology industries;
the seasonal nature of purchasing in Europe; our failure to expand into foreign countries and international markets; our failure
to realize the expected benefits of facility consolidations; our inability to manage our growth; competition from our competitors;
material weakness in our internal control over financial reporting; ineffective disclosure controls and procedures; failure or
inadequacy of the our information technology structure; impact of difficulties implementing our enterprise resource planning systems;
our failure to identify potential acquisition candidates and successfully close such acquisitions with favorable pricing or integrate
acquired businesses or technologies; unanticipated costs relating to acquisitions and known and unknown costs arising in connection
with our consolidation of business functions and any restructuring initiatives; our inability to effectively sell spectrophotometer
products following the retirement of the GE Healthcare brand; failure of any banking institution in which we deposit our funds
or its failure to provide services; our substantial debt and our ability to meet the financial covenants contained in our credit
facility; our failure to raise or generate capital necessary to implement our acquisition and expansion strategy; the failure of
our spin-off of Biostage, Inc., f/k/a Harvard Apparatus Regenerative Technology, Inc., to qualify as a transaction that is generally
tax-free for U.S. federal income tax purposes; the failure of Biostage to indemnify us for any liabilities associated with Biostage&rsquo;s
business; impact of any impairment of our goodwill or intangible assets; our ability to retain key personnel; failure or inadequacy
or our information technology structure; rising commodity and precious metals costs;&nbsp;&nbsp;our ability to protect our intellectual
property and operate without infringing on others&rsquo; intellectual property; exposure to product and other liability claims;
global stock market volatility, currency exchange rate fluctuations and regulatory changes caused by the United Kingdom&rsquo;s
likely exit from the European Union; plus other factors described under the heading &ldquo;Item 1A. Risk Factors&rdquo; in our
Annual Report on Form 10-K for the year ended December 31, 2016, or described in our other public filings. Our results may also
be affected by factors of which we are not currently aware. We may not update these forward-looking statements, even though our
situation may change in the future, unless we have obligations under the federal securities laws to update and disclose material
developments related to previously disclosed information.</I></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Overview </B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Harvard Bioscience, Inc., a Delaware corporation, is a global developer,
manufacturer and marketer of a broad range of scientific instruments, systems and lab consumables used to advance life science
for basic research, drug discovery, clinical and environmental testing. Our products are sold to thousands of researchers in over
100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific
Inc., VWR, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom,
Germany, Sweden, Spain, France, Canada, and China.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Our Strategy </B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our vision is to be a world leading life science company that excels
in meeting the needs of our customers by providing a wide breadth of innovative products and solutions, while providing exemplary
customer service. Our business strategy is to grow our top-line and bottom-line, and build shareholder value through a commitment
to:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD>commercial excellence;</TD></TR></TABLE>
<P STYLE="font-size: 10pt; text-indent: -16.05pt; margin: 0pt 0 0pt 40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD>new product development;</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 42.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD>strategic acquisitions; and</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD>operational efficiencies.</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Components of Operating Income</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Revenues.</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We generate revenues
by selling apparatus, instruments, devices and consumables through our distributors, direct sales force, websites and catalogs.
Our websites and catalogs serve as the primary sales tools for our Cell and Animal Physiology product line. This product line includes
both proprietary manufactured products and complementary products from various suppliers. Our reputation as a leading producer
in many of our manufactured products creates traffic to our website, enables cross-selling and facilitates the introduction of
new products. We have field sales teams in the U.S., Canada, the United Kingdom, Germany, France, Spain and China. In those regions
where we do not have a direct sales team, we use distributors. Revenues from direct sales to end users represented approximately
67% and 61% of our revenues for the three months ended March 31, 2017 and 2016, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">Products in our Molecular Separation and Analysis product line are
generally sold by distributors, and are typically priced in the range of $5,000-$15,000. They are mainly scientific instruments
like spectrophotometers and plate readers that analyze light to detect and quantify a wide range of molecular and cellular processes,
or apparatus like gel electrophoresis units. We also use distributors for both our catalog products and our higher priced products,
as well as for sales in locations where we do not have subsidiaries or where we have existing distributors in place from acquired
businesses. For the three months ended March 31, 2017 and 2016, approximately 33% and 39% of our total revenues, respectively,
were derived from sales to distributors.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">For the three months ended March 31, 2017 and 2016, approximately
61% of our revenues, for both periods, was derived from products we manufacture, approximately 14% and 16%, respectively, were
derived from complementary products we distribute in order to provide the researcher with a single source for all equipment needed
to conduct a particular experiment, and approximately 25% and 23%, respectively, were derived from distributed products sold under
our brand names.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27.35pt; margin: 0pt 0">For the three months ended March 31, 2017 and 2016, approximately
33% and 38% of our revenues, respectively, were derived from sales made by our non-United States operations. As discussed later
under &ldquo;Selected Results of Operations&rdquo;, the decrease in revenues derived by our non-United States operations is primarily
attributable to currency translation and the sale of our AHN Biotechnologie GmbH subsidiary (AHN).</P>

<P STYLE="font-size: 10pt; text-indent: 27.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">Changes in the relative proportion of our revenue sources between
direct sales and distribution sales are primarily the result of changes in geographic mix.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Cost of revenues.</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues
includes material, labor and manufacturing overhead costs, obsolescence charges, packaging costs, warranty costs, shipping costs
and royalties. Our cost of revenues may vary over time based on the mix of products sold. We sell products that we manufacture
and products that we purchase from third parties. The products that we purchase from third parties typically have a higher cost
of revenues as a percent of revenues because the profit is effectively shared with the original manufacturer. We anticipate that
our manufactured products will continue to have a lower cost of revenues as a percentage of revenues as compared with the cost
of non-manufactured products for the foreseeable future. Additionally, our cost of revenues as a percent of revenues will vary
based on mix of direct to end user sales and distributor sales, mix by product line and mix by geography.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Sales and marketing expenses.</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales
and marketing expense consists primarily of salaries and related expenses for personnel in sales, marketing and customer support
functions. We also incur costs for travel, trade shows, demonstration equipment, public relations and marketing materials, consisting
primarily of the printing and distribution of our catalogs, supplements and the maintenance of our websites. We may from time to
time expand our marketing efforts by employing additional technical marketing specialists in an effort to increase sales of selected
categories of products. We may also from time to time expand our direct sales organizations in an effort to concentrate on key
accounts or promote certain product lines.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>General and administrative expenses.</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
and administrative expense consists primarily of salaries and other related costs for personnel in executive, finance, accounting,
information technology and human resource functions. Other costs include professional fees for legal and accounting services, information
technology infrastructure, facility costs, investor relations, insurance and provision for doubtful accounts.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Research and development expenses.</I>&nbsp;&nbsp;&nbsp; &nbsp;Research
and development expense consists primarily of salaries and related expenses for personnel and spending to develop and enhance our
products. Other research and development expense includes fees for consultants and outside service providers, and material costs
for prototype and test units. We expense research and development costs as incurred. Grants received from governmental entities
related to research projects are accounted for as a reduction in research and development expense over the period of the project.
We believe that investment in product development is a competitive necessity and plan to continue to make these investments in
order to realize the potential of new technologies that we develop, license or acquire for existing markets.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><I>Stock-based compensation expenses.</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based
compensation expense for the three months ended March 31, 2017 and 2016 was $0.9 million and $0.8 million, respectively. The stock-based
compensation expense related to stock options, restricted stock units, restricted stock units with a market condition and the employee
stock purchase plan and was recorded as a component of cost of revenues, sales and marketing expenses, general and administrative
expenses and research and development expenses.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Selected Results of Operations</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Three Months Ended March 31, 2017 compared to Three Months Ended March 31, 2016</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Dollar</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">%</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Change</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Change</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="15" STYLE="font-size: 10pt; text-align: center">(dollars in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt">Revenues</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">24,156</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">26,963</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(2,807</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-10.4</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Cost of revenues</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,657</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,018</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,361</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-9.7</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Gross margin percentage</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47.6</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">N/A</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-0.8</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Sales and marketing expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,048</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,102</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(54</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-1.1</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">General and administrative expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,206</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,948</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(742</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-12.5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Research and development expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,285</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,425</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(140</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-9.8</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Amortization of intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">599</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">680</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(81</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-11.9</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Each reporting period, we face currency exposure that arises from
translating the results of our worldwide operations to the United States dollar at exchange rates that fluctuate from the beginning
of such period. We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the
impact of fluctuations in foreign currency exchange rates. We believe that disclosing this non-GAAP financial information provides
investors with an enhanced understanding of the underlying operations of the business. This non-GAAP financial information is used
by our management to internally evaluate our operating results. The non-GAAP financial information provided below should be considered
in addition to, not as a substitute for, the financial information provided and presented in accordance with accounting principles
generally accepted in the United States, or GAAP and may be different than other companies&rsquo; non-GAAP financial information.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Revenues </I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Revenues for the three months ended March 31, 2017 were $24.2 million,
a decrease of approximately 10.4%, or $2.8 million, compared to revenues of $27.0 million for the three months ended March 31,
2016.&nbsp;&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Excluding the effects of currency translation, primarily from the
weakening of the British Pound against the U.S. dollar, our revenues decreased 7.9% or $2.1 million, from the previous year. The
remainder of the decline in revenues was primarily the result of softness in the European funding environment and slower than expected
NIH budget funding, as well as the loss of approximately $0.7 million in revenues from our AHN subsidiary, following its sale in
October 2016. AHN, located in Nordhausen, Germany, was a manufacturer of liquid handling products.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="5" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Reconciliation of Changes In Revenues Compared to the <BR>
Same Period of the Prior Year</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">For the Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31, 2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left">Change</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; font-size: 10pt; text-align: right">-7.9</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Foreign exchange effect</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-2.5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Total revenue change</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-10.4</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Cost of revenues</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Cost of revenues were $12.7 million for the three months ended March
31, 2017, a decrease of $1.3 million, or 9.7%, compared with $14.0 million for the three months ended March 31, 2016. The decrease
in cost of revenues was primarily due to the decrease in revenues and also included the effect on cost of revenues of the sale
of AHN. Gross profit margin as a percentage of revenues decreased to 47.6% for the three months ended March 31, 2017 compared with
48.0% for 2016. The decrease in gross profit margin was a result of a higher proportion of fixed charges to sales in comparison
to the prior period and also included the effect of foreign currency fluctuation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Sales and marketing expenses</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Sales and marketing expenses were relatively flat, decreasing $0.1
million or 1.1% to $5.0 million for the three months ended March 31, 2017 compared to $5.1 million during the same period in 2016.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>General and administrative expenses</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">General and administrative expenses were $5.2 million for the three
months ended March 31, 2017, a decrease of $0.7 million, or 12.5%, compared with $5.9 million for the three months ended March
31, 2016. The decrease was primarily due to forensic investigation costs incurred during the three months ended March 31, 2016,
partially offset by increased audit remediation costs incurred during the three months ended March 31, 2017.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Research and development expenses </I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Research and development expenses were $1.3 million for the three
months ended March 31, 2017, a decrease of $0.1 million, or 9.8%, compared with $1.4 million for the three months ended March 31,
2016. The decrease in expense was primarily all due to an increase in the amount of research grants earned. Research grants are
accounted for as a reduction in research and development expense over the period of research performed.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Amortization of intangible assets</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Amortization of intangible asset expenses was $0.6 million as compared
to $0.7 million for the three months ended March 31, 2017 and 2016, respectively. The decrease in amortization expense was primarily
due to the effect of some long-lived intangible assets becoming fully amortized towards the end of fiscal year 2016.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Other expense, net</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Other expense, net, was $0.4 million and $0.2 million for the three
months ended March 31, 2017 and 2016, respectively. Included in other expense, net for three months ended March 31, 2017 and 2016
was interest expense of $0.2 million, for both periods. The increase in other expense, net was primarily due to an increase in
foreign exchange losses. Currency exchange rate fluctuations included as a component of net loss resulted in approximately $0.1
million and $9 thousand in currency losses for the three months ended March 31, 2017 and 2016, respectively.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Income taxes </I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Income tax was an expense of approximately $23 thousand and
$0.2 million for the three months ended March 31, 2017 and 2016, respectively. The effective income tax rate was (2.2%) for
the three months ended March 31, 2017 compared with (43.6%) for the same period in 2016. The tax expense for the three months
ended March 31, 2017 reflects the expense recorded for the three months ended March 31, 2017 associated with the actual
results for the three-month period. Discrete items included in the tax expense for the three months ended March 31, 2017
included changes to reserves for uncertain tax positions and tax deficiencies related to stock-based compensation. Tax
expense for the three months ended March 31, 2016 included foreign currency gains and losses and the tax impact of
amortization of certain indefinite-lived intangible assets which are amortized for tax purposes only, against which a valuation
allowance is not established.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">We have operations in the UK and several European countries where
we historically had material current and deferred income tax balances related to those activities.&nbsp; As such, the UK&rsquo;s
2016 decision to withdraw from the European Union or the EU could have a material effect on our current and deferred income taxes.
In March 2017, the UK initiated, through letter submission to the EU, a formal two-year process to officially withdraw its membership.
During this two-year period, the UK and EU member states are expected to negotiate many provisions in the UK bilateral agreements
and tax treaties with EU member states as well as EU rules governing the income tax treatment of deferred intercompany profits.
The final outcome of these negotiations will not be known until both the EU and the UK approve them and the UK enacts the related
changes in its tax laws. EU law will cease to apply in the UK at the end of the two-year process in March 2019, unless the negotiations
are extended. The letter submission in March 2017 is an administrative step required to begin the formal withdrawal process and
is not considered a tax law enactment under ASC 740. Consequently, we plan to adjust our current and deferred taxes when tax law
changes related to UK&rsquo;s withdrawal from the EU are actually enacted and/or when EU law ceases to apply in the UK.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Liquidity and Capital Resources </I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Historically, we have financed our business through cash provided
by operating activities, the issuance of common stock, and bank borrowings. Our liquidity requirements arise primarily from investing
activities, including funding of acquisitions, and other capital expenditures.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017, we held cash and cash equivalents of $4.6
million, compared with $5.6 million at December 31, 2016. As of March 31, 2017 and December 31, 2016, we had $13.7 million of borrowings
outstanding under our credit facility, net of deferred financing costs. Total debt, net of cash and cash equivalents was $9.1 million
at March 31, 2017, compared to $8.1 million at December 31, 2016. In addition, we had an underfunded United Kingdom pension liability
of approximately $3.2 million and $3.0 million at March 31, 2017 and December 31, 2016, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017 and December 31, 2016, cash and cash equivalents
held by our foreign subsidiaries was $3.8 million and $4.5 million, respectively. Funds held by our foreign subsidiaries are not
available for domestic operations unless the funds are repatriated. If we planned to or did repatriate these funds, then United
States federal and state income taxes would have to be recorded on such amounts. Our reinvestment determination is based on the
future operational and capital requirements of our U.S. and non-U.S. operations. As of&nbsp;December 31, 2015, we determined that
the assertion of permanent reinvestment at our foreign subsidiaries in Canada and France was no longer appropriate and we repatriated
approximately $3.2 million during the three months ended March 31, 2016. We did not repatriate any funds during the three months
ended March 31, 2017. Cash balances did not exceed the level required for normal business operations at our subsidiaries in Canada
and France as of March 31, 2017. With no funds available to repatriate, no deferred tax liability was recorded as of that date.
The total tax liability associated with the repatriation of undistributed earnings in Canada and France during the three months
ended March 31, 2016 was approximately $1.7 million, however the liability was entirely offset by the foreign tax credits generated
from the repatriation. We currently have no plans to repatriate any of our undistributed foreign earnings in any other countries
outside of Canada and France. These balances are considered permanently reinvested and will be used for foreign items including
foreign acquisitions, capital investments, pension obligations and operations. It is impracticable to estimate the total tax liability,
if any, which would be created by the future distribution of these earnings.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">We currently intend to retain all of our earnings to finance the
expansion and development of our business and do not anticipate paying any cash dividends to holders of our common stock in the
near future. As a result, capital appreciation, if any, of our common stock will be a stockholder&rsquo;s sole source of gain for
the near future.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; font-size: 10pt">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="9" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Condensed Cash Flow Statements</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="9" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(unaudited)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from operations:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Net loss</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">(1,066</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">(636</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Other adjustments to operating cash flows</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,781</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,891</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Changes in assets and liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1,325</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1,981</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Net cash used in operating activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(610</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(726</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Investing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Additions to property, plant and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(198</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(201</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(30</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(4</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(228</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(205</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Financing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Net repayments of debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(113</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,613</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(155</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(113</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Net cash used in financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(268</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,726</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Effect of exchange rate changes on cash</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">109</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">88</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Decrease in cash and cash equivalents</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(997</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,569</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our operating activities used cash of $0.6 million and $0.7 million
of cash for the three months ended March 31, 2017 and 2016, respectively. Net cash used in operations for both periods was primarily
due to the effect of a net loss and changes in working capital quarter over quarter.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our investing activities used cash of $0.2 million for both the
three months ended March 31, 2017 and 2016. Investing activities during the three months ended March 31, 2017 and 2016 primarily
included cash used for purchases of property, plant and equipment. We spent $0.2 million on capital expenditures during both the
three months ended March 31, 2017 and 2016, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our financing activities have historically consisted of borrowings
and repayments under our revolving credit facility and term loans, payments of debt issuance costs and the issuance of common stock.
During the three months ended March 31, 2017, financing activities used cash of $0.3 million, compared with $1.7 million of cash
used by financing activities for the three months ended March 31, 2016. During the three months ended March 31, 2017, we borrowed
$1.0 million under our credit facility, repaid $1.1 million of debt under our credit facility and term loans and ended the quarter
with $13.7 million of borrowings, net of deferred financing costs of $0.1 million. Net cash paid for tax withholdings from the
issuance of common stock for the three months ended March 31, 2017 were $0.2 million, which related to the vesting of restricted
stock units. During the three months ended March 31, 2016, we borrowed $1.0 million under our credit facility, repaid $2.6 million
of debt under our credit facility and term loans and ended with $17.1 million of borrowings at March 31, 2016, net of deferred
financing costs of $0.1 million. Net cash paid for tax withholdings from the issuance of common stock for the three months ended
March 31, 2016 were $0.1 million, which related to the vesting of restricted stock units.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Borrowing Arrangements</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On August&nbsp;7, 2009, we entered into an Amended and Restated
Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and Bank of
America and Brown Brothers Harriman&nbsp;&amp; Co as lenders (as amended, the &ldquo;2009 Credit Agreement&rdquo;). On March 29,
2013, we entered into a Second Amended and Restated Revolving Credit Agreement (as amended, the &ldquo;2013 Credit Agreement&rdquo;)
with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&nbsp;&amp; Co, as lenders that amended and restated
the 2009 Credit Agreement. Between September 2011 and March 2016, we entered into a series of amendments that among other things
did the following:</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on September 30, 2011, reduced interest rates to the London Interbank Offered Rate plus 3.0%;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on March 29, 2013, converted existing loan advances into a term loan in the principal amount of $15.0 million (the &ldquo;2013 Term Loan&rdquo;), provided a revolving credit facility in the maximum principal amount of $25.0 million (&ldquo;2013 Revolving Line&rdquo;) and a delayed draw term loan (&ldquo;2013 DDTL&rdquo;) of up to $15.0 million (all with a maturity date of March 29, 2018);</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on October 31, 2013, reduced the 2013 DDTL from up to $15.0 million to up to $10.0 million;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on April 24, 2015, extended the maturity date of the 2013 Revolving Line to March 29, 2018 and reduced the interest rates on the 2013 Revolving Line, 2013 Term Loan and 2013 DDTL;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on June 30, 2015, amended our quarterly minimum fixed charge coverage financial covenant; and</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">on March 9, 2016, amended the principal payment amortization of the 2013 Term Loan and 2013 DDTL to five years, as well as amended our quarterly minimum fixed charge coverage financial covenant.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The maximum amount available under the 2013 Credit Agreement is
$50.0 million as borrowings against the 2013 DDTL in excess of $10.0 million results in a dollar for dollar reduction in the 2013
Revolving Line capacity. The 2013 Revolving Line, 2013 Term Loan and 2013 DDTL each have a maturity date of March&nbsp;29, 2018.
Borrowings under the 2013 Term Loan and the 2013 DDTL accrue interest at a rate based on either the effective London Interbank
Offered Rate (LIBOR) for certain interest periods selected by us, or a daily floating rate based on the British Bankers&rsquo;
Association (BBA) LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus
in either case, a margin of 2.75%. Additionally, the 2013 Revolving Line accrues interest at a rate based on either the effective
LIBOR for certain interest periods selected by us, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin
of 2.25%. We were required to fix the rate of interest on at least 50% of the 2013 Term Loan and the 2013 DDTL through the purchase
of interest rate swaps.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The loans evidenced by the 2013 Credit Agreement, or the 2013 Loans,
are guaranteed by all of our direct and indirect domestic subsidiaries, and secured by substantially all of our assets and the
guarantors.&nbsp;The 2013 Loans are subject to restrictive covenants under the 2013 Credit Agreement, and financial covenants that
require us to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage
and minimum working capital. Prepayment of the 2013 Loans is allowed by the 2013 Credit Agreement at any time during the terms
of the 2013 Loans. The 2013 Loans also contain limitations on our ability to incur additional indebtedness and requires lender
approval for acquisitions funded with cash, promissory notes and/or other consideration in excess of $6.0 million and for acquisitions
funded solely with equity in excess of $10.0 million.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">At March 31, 2017, the weighted effective interest rates on the
2013 Term Loan, 2013 DDTL and 2013 Revolving Line borrowings were 3.96%, 3.83% and 3.23%, respectively. The 2013 Credit Agreement
includes covenants relating to income, debt coverage and cash flow, as well as minimum working capital requirements. The 2013 Credit
Agreement also contains limitations on our ability to incur additional indebtedness and requires lender approval for acquisitions
funded with cash, promissory notes and/or other consideration in excess of $6.0 million and for acquisitions funded solely with
equity in excess of $10.0 million. As of March 31, 2017, we were in compliance with all financial covenants contained in the 2013
Credit Agreement; we were subject to covenant and working capital borrowing restrictions, and had available borrowing capacity
under the 2013 Credit Agreement of $5.2 million.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On May 2, 2017, we entered into a Third Amended and Restated Revolving
Credit Agreement (as amended, the &ldquo;Credit Agreement&rdquo;) with Bank of America, as agent, and Bank of America and Brown
Brothers Harriman&nbsp;&amp; Co, as lenders that amended and restated the 2013 Credit Agreement. The Credit Agreement was entered
into to, among other things, consolidate, combine and restate the outstanding indebtedness, on the date of the Credit Agreement,
into a Term Loan in the principal amount of $14.0 million, and also provide for a $25.0 million revolving line of credit (the &ldquo;Revolving
Line&rdquo;). The Term Loan and the Revolving Line each have a maturity date of May 1, 2022. Borrowings under the Term Loan accrue
interest at a rate based on either the effective LIBOR for certain interest periods selected by us, or a daily floating rate based
on the BBA LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus in either
case, a margin of 2.75%. Additionally, the Revolving Line accrues interest at a rate based on either the effective LIBOR for certain
interest periods selected by us, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The Term Loan and loans under the Revolving Line as evidenced by
the Credit Agreement, or the Loans, are guaranteed by all of our direct and indirect domestic subsidiaries, and secured by substantially
all of our assets and the guarantors.&nbsp;The Loans are subject to restrictive covenants under the Credit Agreement, and financial
covenants that require us and our subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum
leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the Loans is allowed by the Credit Agreement
at any time during the terms of the Loans. The Loans also contain limitations on our ability to incur additional indebtedness and
requires lender approval for acquisitions funded with cash, promissory notes and/or other consideration in excess of $6.0 million
and for acquisitions funded solely with equity in excess of $10.0 million.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our forecast of the period of time through which our financial resources
will be adequate to support our operations is a forward-looking statement that involves risks and uncertainties, and actual results
could vary as a result of a number of factors. Based on our current operations and current operating plans, we expect that our
available cash, cash generated from current operations and debt capacity will be sufficient to finance current operations, any
potential future acquisitions and capital expenditures for the next 12 months and beyond. This may involve incurring additional
debt or raising equity capital for our business. Additional capital raising activities will dilute the ownership interests of existing
stockholders to the extent we raise capital by issuing equity securities and we cannot guarantee that we will be successful in
raising additional capital on favorable terms or at all.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Critical Accounting Policies </B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The critical accounting policies underlying the accompanying unaudited
consolidated financial statements are those set forth in Part II, Item 7 included in our Annual Report on Form 10-K for the fiscal
year ended December 31, 2016, which was filed with the SEC on March 17, 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Impact of Foreign Currencies </B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Our international operations in some instances operate in a natural
hedge as we sell our products in many countries and a substantial portion of our revenues, costs and expenses are denominated in
foreign currencies, especially the British pound sterling, the Euro, the Canadian dollar and the Swedish krona.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">During the three months ended March 31, 2017, changes in foreign currency
exchange rates resulted in an unfavorable translation effect on our consolidated revenues and our consolidated net loss. Changes
in foreign currency exchange rates resulted in an unfavorable effect on revenues of approximately $0.7 million and a favorable
effect on expenses of approximately $0.6 million. During the three months ended March 31, 2016, changes in foreign currency exchange
rates resulted in an unfavorable effect on revenues of $0.3 million and a favorable effect on expenses of $0.3 million.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The gain associated with the translation of foreign equity into U.S.
dollars included as a component of comprehensive loss during the three months ended March 31, 2017, was approximately $0.9 million,
compared to a gain of $0.6 million for the three months ended March 31, 2016.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">In addition, currency exchange rate fluctuations included as a component
of net loss resulted in approximately $0.1 million and $9 thousand in currency losses during the three months ended March 31, 2017
and 2016, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Recently Issued Accounting Pronouncements </B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (ASU) 2014-09, <I>&ldquo;Revenue from Contracts with Customers,&rdquo;</I> a new accounting standard
that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace
most existing revenue recognition guidance within generally accepted accounting principles in the United States. Under this standard,
revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which we expect to be entitled in exchange for those goods or services. We expect to adopt this standard as of January 1, 2018
using the modified retrospective approach. We intend to complete a comprehensive assessment of its contracts in 2017 concerning
any unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the
new guidance. We expect this undertaking will be complete in the second half of 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In February 2016, the FASB issued ASU 2016-02, <I>Leases</I>, which
is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet
the assets and liabilities for the rights and obligations created by lease terms of more than 12&nbsp;months. The update is effective
for fiscal years beginning after December 15, 2018. We are evaluating the requirements of this guidance and have not yet determined
the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabilities
will increase upon adoption for right-of-use assets and lease liabilities. Our future commitments under lease obligations are summarized
in Note 10.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"><I>Recently Adopted Accounting Pronouncements</I></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">In March 2016, the FASB issued ASU 2016-09,&nbsp;Compensation &ndash;
Stock Compensation (Topic 718): <I>Improvements to Employee Share-Based Payment Accounting</I>, which simplifies the accounting
for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities
and classification on the statement of cash flows.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The standard requires an entity to recognize all excess tax benefits
and tax deficiencies as income tax benefit or expense in the income statement as discrete items in the reporting period in which
they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&rsquo;s annual effective tax
rate, applied on a prospective basis. Further, the standard eliminates the requirement to defer the recognition of excess tax benefits
until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with
any valuation allowance, should be recognized on a modified retrospective basis as a cumulative adjustment to retained earnings
as of the date of adoption. Under ASU 2016-09, an entity that applies the treasury stock method in calculating diluted earnings
per share is required to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since such amounts
are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner
as other cash flows related to income taxes on the statement of cash flows, as such excess tax benefits no longer represent financing
activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods
presented.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">We adopted ASU 2016-09 as of January 1, 2017. We recorded a cumulative
increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred
tax assets related to the prior years&rsquo; unrecognized excess tax benefits. An equal amount of valuation allowance was also
recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in a net impact of $0.
In addition,  tax deficiencies related to vested restricted stock units and canceled stock options during the first quarter
of 2017 have been recognized in the current period&rsquo;s income statement.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">ASU 2016-09 also allows an entity to elect as an accounting policy
either to continue to estimate the total number of awards for which the requisite service period will not be rendered or to account
for forfeitures for service based awards as they occur. An entity that elects to account for forfeitures as they occur should apply
the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earnings as of the date of
adoption. We elected as an accounting policy to account for forfeitures for service based awards as they occur, and as a result,
we recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings with a corresponding increase in additional
paid in capital related to the prior years as required under the modified retrospective approach. The tax effect of this adjustment,
which included the impact of a valuation allowance was immaterial.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B><A NAME="a_008"></A>Item&nbsp;3.</B></TD><TD><B><I>Quantitative and Qualitative Disclosures about Market Risk.</I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The majority of our manufacturing and testing of products occurs
in our facilities in the United States, Germany, Sweden and Spain. We sell our products globally through our distributors, direct
sales force, websites and catalogs. As a result, our financial results are affected by factors such as changes in foreign currency
exchange rates and weak economic conditions in foreign markets.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">We collect amounts representing a substantial portion of our revenues
and pay amounts representing a substantial portion of our operating expenses in foreign currencies. As a result, changes in currency
exchange rates from time to time may affect our operating results.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">We are exposed to market risk from changes in interest rates primarily
through our financing activities. As of March 31, 2017, we had $13.7 million outstanding under our Credit Agreement, net of deferred
financing costs.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On April 24, 2015, we entered an amendment to our 2013 Credit Agreement
(Third Amendment), which extended the maturity date of the 2013 Revolving Line to March 29, 2018 and reduced the interest rate
to the London Interbank Offered Rate plus 2.25%, 2.75% and 2.75% on the 2013 Revolving Line, 2013 Term Loan and 2013 DDTL, respectively.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Prior to the Third Amendment, borrowings under the 2013 Term Loan
and the 2013 DDTL accrued interest at a rate based on either the effective London Interbank Offered Rate (LIBOR) for certain interest
periods selected by us, or a daily floating rate based on the BBA LIBOR as published by Reuters (or other commercially available
source providing quotations of BBA LIBOR), plus in either case, a margin of 3.0%. Prior to the Third Amendment, the 2013 Revolving
Line accrued interest at a rate based on either the effective LIBOR for certain interest periods selected by us, or a daily floating
rate based on the BBA LIBOR, plus in either case, a margin of 2.5%. We were required to fix the rate of interest on at least 50%
of the 2013 Term Loan and the 2013 DDTL through the purchase of an interest rate swap. The 2013 Term Loan and 2013 DDTL each have
interest payments due at the end of the applicable LIBOR period, or monthly with respect to BBA LIBOR borrowings, and principal
payments are due quarterly. The 2013 Revolving Line has interest payments due at the end of the applicable LIBOR period, or monthly
with respect to BBA LIBOR borrowings. Effective June 5, 2013, we entered into an interest rate swap contract with an original notional
amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark
interest rate (LIBOR) associated with our 2013 Term Loan. The swap contract converted specific variable-rate debt into fixed-rate
debt and fixed LIBOR associated with the 2013 Term Loan at 0.96% plus a bank margin of 3.0%. Effective November 29, 2013, we entered
into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March 29, 2018
in order to hedge the risk of changes in LIBOR associated with a portion of our 2013 DDTL. The swap contract converted specific
variable-rate debt into fixed rate debt and fixed LIBOR associated with half of the 2013 DDTL amount at 0.93% plus a bank margin
of 3.0%. The notional amount of our derivative instruments as of March 31, 2017 was $4.5 million. These swap contracts were associated
with reducing or eliminating interest rate risk and were designated as cash flow hedge instruments in accordance with ASC 815.
We use interest-rate-related derivative instruments to manage our exposure related to changes in interest rates on our variable-rate
debt instruments. We do not enter into derivative instruments for any purpose other than cash flow hedging and we do not speculate
using derivative instruments.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As noted above under the heading &ldquo;Borrowing Arrangements&rdquo;,
on May 2, 2017, we entered into the Credit Agreement to amend our credit facility with Bank of America, as agent, and Bank of America
and Brown Brothers Harriman &amp; Co. as lenders. Immediately after entering into this Credit Agreement, we entered into a new
interest rate swap contract with Bank of America with a notional amount of $14.0 million and a maturity date of March 30, 2022
in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associated with our Term Loan. The swap
contract converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 1.86%.
The interest rate swap was designated as a cash flow hedge instrument in accordance with ASC 815 &ldquo;Derivatives and Hedging&rdquo;.
As a result of entering into the new interest rate swap contract, we unwound the previous interest rate swap contracts, and received
an immaterial amount in proceeds.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">As of March 31, 2017, the weighted effective interest rates, net
of the impact of our interest rate swaps, on our Term Loan , DDTL and Revolving Line borrowings were 3.96%, 3.83% and 3.23%, respectively.
Assuming no other changes which would affect the margin of the interest rate under our 2013 Term Loan, 2013 DDTL and 2013 Revolving
Line, the effect of interest rate fluctuations on outstanding borrowings under our Credit Agreement as of March 31, 2017 over the
next twelve months is quantified and summarized as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold">If compared to the rate as of March 31, 2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest expense <BR>
increase</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; font-size: 10pt; text-align: left">Interest rates increase by 1%</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">66</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Interest rates increase by 2%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">132</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B><A NAME="a_009"></A>Item&nbsp; 4.</B></TD><TD><B><I>Controls and Procedures.</I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted
under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms
and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial
Officer, to allow timely decisions regarding required disclosures.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As required by Rules 13a-15(e) and 15d-15(e)
under the Exchange Act, our management, under the supervision and with the participation of our Chief Executive Officer and Chief
Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures
as of March 31, 2017. Our disclosure controls and procedures are designed to provide reasonable assurance that information required
to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the SEC&rsquo;s rules and forms, and our management necessarily was required to apply its
judgment in evaluating and implementing our disclosure controls and procedures. Based upon the evaluation described above, our
management concluded that our disclosure controls and procedures for the periods covered by this report were not effective, as
of March 31, 2017, because of the material weaknesses in internal control over financial reporting described in Part II, Item 9A
of our Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 17, 2017 (the &ldquo;2016 Form
10-K&rdquo;). Management has concluded that the material weaknesses that were present at December 31, 2016 were also present at
March 31, 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Notwithstanding the assessment that our internal
controls over financial reporting were not effective and that there were material weaknesses as identified in the 2016 Form 10-K,
we believe that our financial statements contained in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31,
2017, fairly present our financial condition, results of operations and cash flows in all material respects.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As previously disclosed in the 2016 Form 10-K,
to remediate the material weaknesses described under the subheading &ldquo;Management&rsquo;s Report on Internal Control Over Financial
Reporting&rdquo; in Item 9A of the 2016 Form 10-K, we plan to implement the remediation initiatives described under the subheading
&ldquo;Remediation Plan&rdquo; in Item 9A of the 2016 Form 10-K and will continue to evaluate the remediation and may in the future
implement additional measures.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We continue to take actions and make progress towards remediating
the material weaknesses related to our internal control over financial reporting, as described above and in our 2016 Form 10-K.
We have taken substantial steps in designing and implementing controls to remediate the material weaknesses in our internal controls
over financial reporting<I>. </I>However, there were no changes in our internal control over financial reporting identified in
connection with the evaluation required by Rules 13a-15 and 15d-15 under the Exchange Act that occurred during the quarter ended
March 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><A NAME="a_010"></A><B>PART II. OTHER INFORMATION</B></P>

<P STYLE="font-size: 10pt; text-indent: -0.85in; margin: 0pt 0 0pt 0.85in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B><A NAME="a_011"></A>Item&nbsp; 1.</B></TD><TD><B><I>Legal Proceedings. </I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On April 14, 2017, anticipated representatives for the estate of
an individual plaintiff filed a wrongful death complaint with the Suffolk Superior Court, in the County of Suffolk, Massachusetts,
against the Company and other defendants, including Biostage, Inc. (f/k/a Harvard Apparatus Regenerative Technology, Inc.), our
former subsidiary that was spun off in 2013, as well as another third party. The complaint seeks payment for an unspecified amount
of damages and alleges that the plaintiff sustained terminal injuries allegedly caused by products, including synthetic trachea
scaffolds and bioreactors, provided by certain of the named defendants and utilized in connection with surgeries performed by third
parties in 2012 and 2013. The litigation is at an early stage and the Company intends to vigorously defend this case and has contacted
its liability insurance carrier to request defense and indemnification of any losses incurred in connection with this lawsuit.
While we believe that such claim is without merit, we are unable to predict the ultimate outcome of such litigation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 55.05pt"><B><A NAME="a_012"></A>Item&nbsp;1A.</B></TD><TD><B><I>Risk Factors. </I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">To our knowledge, and except to the extent additional factual information
disclosed in this Quarterly Report on Form 10-Q relates to such risk factors, there has been no material changes in the risk factors
described in &ldquo;Item 1A. Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended December 31, 2016, which
was filed with the SEC on March 17, 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B><A NAME="a_013"></A>Item&nbsp;5.</B></TD><TD><B>Other Information. </B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Amendment of Material Agreement; and Creation of a Direct Financial
Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">On May 2, 2017, the Company and certain of its subsidiaries
entered into an amendment to the Company&rsquo;s 2013 Credit Agreement with Bank of America, N.A., as agent, and Bank of America,
N.A. and Brown Brothers Harriman &amp; Co., as lenders, as evidenced by that certain Third Amended and Restated Credit Agreement
(the &ldquo;Restated Credit Agreement&rdquo;) and related loan documents, which such Restated Credit Agreement amended certain
terms and conditions of the 2013 Credit Agreement, including among other things, (a) the consolidation, combination and restatement
of the existing term loans and revolving loan balance under the 2013 Credit Agreement into a single term loan in an amount of $14
million (the &ldquo;Term Loan&rdquo;), (b) provision of a revolving credit facility for working capital and acquisitions in an
amount up to $25 million (the &ldquo;Revolving Line&rdquo;), (c) extension of the maturity date for the Term Loan and Revolving
Line to May 1, 2022, and (d) reduction and modification of the interest rate and margins such that the Term Loan and Revolving
Line accrue interest at a rate based on either the effective London Interbank Offered Rate (LIBOR) for certain interest periods
selected by the Company, or a daily floating rate based on LIBOR, plus a margin of 2.75% as to the Term Loan and 2.25% as to the
Revolving Line.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Under the Restated Credit Agreement and related loan documents,
the Term Loan and loans under the Revolving Line, or the Loans, continued to be guaranteed by all of the Company&rsquo;s direct
and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and such guarantors.&nbsp;The
Loans continue to also be subject to restrictive covenants under the Restated Credit Agreement, and financial covenants that require
the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum
fixed charge coverage and minimum working capital. Prepayment of the Loans continues to be allowed by the Credit Agreement at any
time during the terms of the Loans. The Loans also continue to contain limitations on the Company&rsquo;s ability to incur additional
indebtedness and requires lender approval for acquisitions funded with cash, promissory notes and/or other consideration in excess
of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The preceding description of the Restated Credit Agreement is subject
to, and qualified in its entirety by reference to, the Restated Credit Agreement, which is attached as Exhibit 10.1 to this Quarterly
Report on Form 10-Q and is incorporated herein by reference.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-size: 10pt"><B><A NAME="a_014"></A>Item&nbsp;6.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="font-weight: bold; text-align: center; width: 8%">Exhibit <BR>
Index</TD>
    <TD STYLE="width: 92%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left; border-top-color: black; border-top-width: 1pt">10.1</TD>
    <TD STYLE="vertical-align: middle">Third Amended and Restated Credit Agreement dated as of May 1, 2017, by and among Harvard Bioscience, Inc. Bank of America, N.A. and Brown Brothers Harriman &amp; Co.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">31.1</TD>
    <TD STYLE="vertical-align: middle">Certification of Chief Financial Officer of Harvard Bioscience, Inc., pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">31.2</TD>
    <TD STYLE="vertical-align: middle">Certification of Chief Executive Officer of Harvard Bioscience, Inc., pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">32.1*</TD>
    <TD STYLE="vertical-align: middle">Certification of Chief Financial Officer of Harvard Bioscience, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">32.2*</TD>
    <TD STYLE="vertical-align: middle">Certification of Chief Executive Officer of Harvard Bioscience, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.INS</TD>
    <TD STYLE="vertical-align: middle">XBRL Instance Document</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.SCH</TD>
    <TD STYLE="vertical-align: middle">XBRL Taxonomy Extension Schema Document</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.CAL</TD>
    <TD STYLE="vertical-align: middle">XBRL Taxonomy Extension Calculation Linkbase Document</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.LAB</TD>
    <TD STYLE="vertical-align: middle">XBRL Taxonomy Extension Labels Linkbase Document</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.PRE</TD>
    <TD STYLE="vertical-align: middle">XBRL Taxonomy Extension Presentation Linkbase Document</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">101.DEF</TD>
    <TD STYLE="vertical-align: middle">XBRL Taxonomy Extension Definition Linkbase Document</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36px"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">This certification shall not be deemed &ldquo;filed&rdquo; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><A NAME="a_015"></A>SIGNATURES</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by undersigned thereunto duly authorized.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Date: May 5, 2017</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">HARVARD BIOSCIENCE, INC.</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 55%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 30%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 12%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:</TD>
    <TD STYLE="vertical-align: middle; text-align: center; border-bottom: Black 1.1pt solid">/<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">S/&nbsp;&nbsp;&nbsp;&nbsp;JEFFREY A. DUCHEMIN</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: center"><FONT STYLE="font-size: 8pt">Jeffrey A. Duchemin</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: center"><FONT STYLE="font-size: 8pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:</TD>
    <TD STYLE="vertical-align: middle; text-align: center; border-bottom: Black 1.1pt solid">/<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">S/&nbsp;&nbsp;&nbsp;&nbsp;ROBERT E. GAGNON</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: center"><FONT STYLE="font-size: 8pt">Robert E. Gagnon</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: center"><FONT STYLE="font-size: 8pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;<A HREF="#TableOfContents">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><U><A NAME="a_016"></A>INDEX TO EXHIBITS</U></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD><A HREF="exh_101.htm">10.1</A></TD>
    <TD><A HREF="exh_101.htm">Third Amended and Restated Credit Agreement dated as of May 1, 2017, by and among Harvard Bioscience, Inc. Bank of America, N.A. and Brown Brothers Harriman &amp; Co.</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%"><A HREF="exh_311.htm"><FONT STYLE="font-size: 10pt">31.1</FONT></A></TD>
    <TD STYLE="width: 92%"><A HREF="exh_311.htm"><FONT STYLE="font-size: 10pt">Certification of Chief Financial Officer of Harvard Bioscience, Inc., pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</FONT></A></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="exh_312.htm"><FONT STYLE="font-size: 10pt">31.2</FONT></A></TD>
    <TD><A HREF="exh_312.htm"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer of Harvard Bioscience, Inc., pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</FONT></A></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="exh_321.htm"><FONT STYLE="font-size: 10pt">32.1*</FONT></A></TD>
    <TD><A HREF="exh_321.htm"><FONT STYLE="font-size: 10pt">Certification of Chief Financial Officer of Harvard Bioscience, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</FONT></A></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="exh_322.htm"><FONT STYLE="font-size: 10pt">32.2*</FONT></A></TD>
    <TD><A HREF="exh_322.htm"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer of Harvard Bioscience, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101.INS</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">XBRL Instance Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101.SCH</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Schema Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101.CAL</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Calculation Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101.LAB</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Labels Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101.PRE</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Presentation Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">101.DEF</FONT></TD>
    <TD>
        <P STYLE="font-size: 10pt; margin: 0pt 0">XBRL Taxonomy Extension Definition Linkbase Document</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36px"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">This certification shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">- 32 -</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh_101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0; border-top: Black 4.5pt double">Published CUSIP
Number: ____</P>



<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">THIRD AMENDED AND
RESTATED<BR>
CREDIT AGREEMENT</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Dated as of May
1, 2017</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">among</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">HARVARD BIOSCIENCE,
INC.,</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">as the Borrower,</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">BANK OF AMERICA,
N.A.,<BR>
as Administrative Agent and L/C Issuer,</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">BROWN BROTHERS HARRIMAN
&amp; CO.,</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">and</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Each of the Other
Lenders From Time to Time Party Hereto</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in"><U>Section</U></TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt"><U>Page</U></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="width: 90%; text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE I DEFINITIONS AND ACCOUNTING TERMS</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 12pt; padding-bottom: 0pt">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.01&nbsp;&nbsp;&nbsp;Defined Terms</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.02&nbsp;&nbsp;&nbsp;Other Interpretive Provisions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.03&nbsp;&nbsp;&nbsp;Accounting Terms</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.04&nbsp;&nbsp;&nbsp;Rounding</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.05&nbsp;&nbsp;&nbsp;Times of Day</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.06&nbsp;&nbsp;&nbsp;Letter of Credit Amounts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.07&nbsp;&nbsp;&nbsp;Currency Equivalents Generally</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE II the COMMITMENTS and Credit Extensions</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.01&nbsp;&nbsp;&nbsp;The Loans</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.02&nbsp;&nbsp;&nbsp;Borrowings, Conversions and Continuations of Loans</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.03&nbsp;&nbsp;&nbsp;Letters of Credit</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.04&nbsp;&nbsp;&nbsp;Reserved</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.05&nbsp;&nbsp;&nbsp;Prepayments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.06&nbsp;&nbsp;&nbsp;Termination or Reduction of Commitments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.07&nbsp;&nbsp;&nbsp;Repayment of Loans</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.08&nbsp;&nbsp;&nbsp;Interest</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.09&nbsp;&nbsp;&nbsp;Fees</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.10&nbsp;&nbsp;&nbsp;Computation of Interest and Fees</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.11&nbsp;&nbsp;&nbsp;Evidence of Debt</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.12&nbsp;&nbsp;&nbsp;Payments Generally; Administrative Agent&rsquo;s Clawback</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.13&nbsp;&nbsp;&nbsp;Sharing of Payments by Lenders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.14&nbsp;&nbsp;&nbsp;Cash Collateral</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.15&nbsp;&nbsp;&nbsp;Defaulting Lenders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE III TAXES, YIELD PROTECTION AND ILLEGALITY</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.01&nbsp;&nbsp;&nbsp;Taxes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.02&nbsp;&nbsp;&nbsp;Illegality</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.03&nbsp;&nbsp;&nbsp;Inability to Determine Rates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.04&nbsp;&nbsp;&nbsp;Increased Costs; Reserves on Eurodollar Rate Loans</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.05&nbsp;&nbsp;&nbsp;Compensation for Losses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">62</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.06&nbsp;&nbsp;&nbsp;Mitigation Obligations; Replacement of Lenders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.07&nbsp;&nbsp;&nbsp;Survival</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE IV CONDITIONS PRECEDENT TO Credit Extensions</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.01&nbsp;&nbsp;&nbsp;Conditions of Initial Credit Extension</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.02&nbsp;&nbsp;&nbsp;Conditions to all Credit Extensions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">65</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE V REPRESENTATIONS AND WARRANTIES</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.01&nbsp;&nbsp;&nbsp;Existence, Qualification and Power</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.02&nbsp;&nbsp;&nbsp;Authorization; No Contravention</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.03&nbsp;&nbsp;&nbsp;Governmental Authorization; Other Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">5.04&nbsp;&nbsp;&nbsp;Binding Effect</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.05&nbsp;&nbsp;&nbsp;Financial Statements; No Material Adverse Effect</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.06&nbsp;&nbsp;&nbsp;Litigation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.07&nbsp;&nbsp;&nbsp;No Default</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.08&nbsp;&nbsp;&nbsp;Ownership of Property; Liens; Investments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.09&nbsp;&nbsp;&nbsp;Environmental Compliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.10&nbsp;&nbsp;&nbsp;Tax Returns and Payments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.11&nbsp;&nbsp;&nbsp;ERISA Compliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">69</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.12&nbsp;&nbsp;&nbsp;Subsidiaries; Equity Interests; Loan Parties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">69</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.13&nbsp;&nbsp;&nbsp;Margin Regulations; Investment Company Act</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.14&nbsp;&nbsp;&nbsp;Disclosure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.15&nbsp;&nbsp;&nbsp;Compliance with Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.16&nbsp;&nbsp;&nbsp;Intellectual Property; Licenses, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">71</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.17&nbsp;&nbsp;&nbsp;Solvency</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">71</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.18&nbsp;&nbsp;&nbsp;Casualty, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">71</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.19&nbsp;&nbsp;&nbsp;Collateral Documents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">71</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.20&nbsp;&nbsp;&nbsp;Material Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">72</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.21&nbsp;&nbsp;&nbsp;Eligible Receivables</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">72</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.22&nbsp;&nbsp;&nbsp;Eligible Inventory</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">72</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.23&nbsp;&nbsp;&nbsp;Insurance Policies</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">72</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.24&nbsp;&nbsp;&nbsp;Employment and Labor Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">73</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.25&nbsp;&nbsp;&nbsp;OFAC; Anti-Corruption Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">73</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.26&nbsp;&nbsp;&nbsp;EEA Financial Institution</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">73</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.27&nbsp;&nbsp;&nbsp;Restated Obligations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">74</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE VI AFFIRMATIVE COVENANTS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">74</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.01&nbsp;&nbsp;&nbsp;Financial Statements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">74</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.02&nbsp;&nbsp;&nbsp;Certificates; Other Information</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">75</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.03&nbsp;&nbsp;&nbsp;Notices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">78</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.04&nbsp;&nbsp;&nbsp;Payment of Obligations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">79</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.05&nbsp;&nbsp;&nbsp;Preservation of Existence, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">79</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.06&nbsp;&nbsp;&nbsp;Maintenance of Properties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">79</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.07&nbsp;&nbsp;&nbsp;Maintenance of Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">79</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.08&nbsp;&nbsp;&nbsp;Compliance with Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">79</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.09&nbsp;&nbsp;&nbsp;Books and Records</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">80</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.10&nbsp;&nbsp;&nbsp;Inspection Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">80</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.11&nbsp;&nbsp;&nbsp;Use of Proceeds</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">80</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.12&nbsp;&nbsp;&nbsp;Covenant to Guarantee Obligations and Give Security</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">80</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.13&nbsp;&nbsp;&nbsp;Compliance with Environmental Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">84</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.14&nbsp;&nbsp;&nbsp;Reserved</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">84</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.15&nbsp;&nbsp;&nbsp;Further Assurances</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">84</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.16&nbsp;&nbsp;&nbsp;Reserved</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">84</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.17&nbsp;&nbsp;&nbsp;Interest Rate Hedging</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">84</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.18&nbsp;&nbsp;&nbsp;Material Contracts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">85</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.19&nbsp;&nbsp;&nbsp;Cash Collateral Accounts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">85</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.20&nbsp;&nbsp;&nbsp;Anti-Corruption Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">85</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in; width: 90%">ARTICLE VII NEGATIVE COVENANTS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt; width: 10%">85</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.01&nbsp;&nbsp;&nbsp;Liens, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">85</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.02&nbsp;&nbsp;&nbsp;Indebtedness</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">87</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.03&nbsp;&nbsp;&nbsp;Investments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">88</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.04&nbsp;&nbsp;&nbsp;Fundamental Changes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">90</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.05&nbsp;&nbsp;&nbsp;Sale of Assets</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">91</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.06&nbsp;&nbsp;&nbsp;Restricted Payments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">91</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.07&nbsp;&nbsp;&nbsp;Change in Nature of Business</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">91</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.08&nbsp;&nbsp;&nbsp;Transactions with Affiliates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">91</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.09&nbsp;&nbsp;&nbsp;Burdensome Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">92</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.10&nbsp;&nbsp;&nbsp;Use of Proceeds</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">92</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.11&nbsp;&nbsp;&nbsp;Financial Covenants</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">92</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.12&nbsp;&nbsp;&nbsp;Reserved</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">93</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.13&nbsp;&nbsp;&nbsp;Amendments of Organization Documents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">93</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.14&nbsp;&nbsp;&nbsp;Accounting Changes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">93</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.15&nbsp;&nbsp;&nbsp;Prepayments, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">93</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.16&nbsp;&nbsp;&nbsp;Sanctions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">93</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.17&nbsp;&nbsp;&nbsp;Anti-Corruption Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">94</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE VIII EVENTS OF DEFAULT AND REMEDIES</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">94</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.01&nbsp;&nbsp;&nbsp;Events of Default</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">94</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.02&nbsp;&nbsp;&nbsp;Remedies upon Event of Default</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">96</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.03&nbsp;&nbsp;&nbsp;Application of Funds</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">97</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE IX ADMINISTRATIVE AGENT</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">98</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.01&nbsp;&nbsp;&nbsp;Appointment and Authority</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">98</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.02&nbsp;&nbsp;&nbsp;Rights as a Lender</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">99</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.03&nbsp;&nbsp;&nbsp;Exculpatory Provisions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">99</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.04&nbsp;&nbsp;&nbsp;Reliance by Administrative Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">100</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.05&nbsp;&nbsp;&nbsp;Delegation of Duties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">100</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.06&nbsp;&nbsp;&nbsp;Resignation of Administrative Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">100</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.07&nbsp;&nbsp;&nbsp;Non-Reliance on Administrative Agent and Other Lenders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">101</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.08&nbsp;&nbsp;&nbsp;No Other Duties, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">101</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.09&nbsp;&nbsp;&nbsp;Administrative Agent May File Proofs of Claim</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">102</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.10&nbsp;&nbsp;&nbsp;Collateral and Guaranty Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">102</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.11&nbsp;&nbsp;&nbsp;Secured Cash Management Agreements and Secured Hedge Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">103</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE X RESERVED</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">103</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE XI MISCELLANEOUS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">103</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.01&nbsp;&nbsp;&nbsp;Amendments, Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">103</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.02&nbsp;&nbsp;&nbsp;Notices; Effectiveness; Electronic Communications</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">105</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.03&nbsp;&nbsp;&nbsp;No Waiver; Cumulative Remedies; Enforcement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">107</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.04&nbsp;&nbsp;&nbsp;Expenses; Indemnity; Damage Waiver</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">108</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.05&nbsp;&nbsp;&nbsp;Payments Set Aside</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">110</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.06&nbsp;&nbsp;&nbsp;Successors and Assigns</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">110</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.07&nbsp;&nbsp;&nbsp;Treatment of Certain Information; Confidentiality</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">114</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">11.08&nbsp;&nbsp;&nbsp;Right of Setoff</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">115</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.09&nbsp;&nbsp;&nbsp;Interest Rate Limitation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">116</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.10&nbsp;&nbsp;&nbsp;Counterparts; Integration; Effectiveness</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">116</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.11&nbsp;&nbsp;&nbsp;Survival of Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">116</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.12&nbsp;&nbsp;&nbsp;Severability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">116</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.13&nbsp;&nbsp;&nbsp;Replacement of Lenders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">117</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.14&nbsp;&nbsp;&nbsp;Governing Law; Jurisdiction; Etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">117</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.15&nbsp;&nbsp;&nbsp;Waiver of Jury Trial</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">118</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.16&nbsp;&nbsp;&nbsp;No Advisory or Fiduciary Responsibility</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">119</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.17&nbsp;&nbsp;&nbsp;Reserved</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">119</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.18&nbsp;&nbsp;&nbsp;USA PATRIOT Act</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">119</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.19&nbsp;&nbsp;&nbsp;Time of the Essence</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">120</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.20&nbsp;&nbsp;&nbsp;Eligible Contract Participant</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">120</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.21&nbsp;&nbsp;&nbsp;Electronic Execution of Assignments and Certain Other Documents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">120</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.22&nbsp;&nbsp;&nbsp;Acknowledgement and Consent to Bail-In of EEA Financial Institutions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">121</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: 0in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0in">ARTICLE XII ratification</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">121</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">12.01&nbsp;&nbsp;&nbsp;General</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">121</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">12.02&nbsp;&nbsp;&nbsp;Reference to Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">122</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">12.03&nbsp;&nbsp;&nbsp;Entire Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">122</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 90%">SIGNATURES</TD>
    <TD STYLE="width: 10%; text-align: right">S-1</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left">SCHEDULES</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; width: 8%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 88%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">2.01</TD>
    <TD STYLE="vertical-align: middle">Commitments and Applicable Percentages</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.06</TD>
    <TD STYLE="vertical-align: middle">Litigation</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.08(c)</TD>
    <TD STYLE="vertical-align: middle">Owned Real Property</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.08(d)(i)</TD>
    <TD STYLE="vertical-align: middle">Leased Real Property (Lessee)</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.08(d)(ii)</TD>
    <TD STYLE="vertical-align: middle">Leased Real Property (Lessor)</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.08(e)</TD>
    <TD STYLE="vertical-align: middle">Existing Investments</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.08(f)</TD>
    <TD STYLE="vertical-align: middle">Deposit Accounts</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.11</TD>
    <TD STYLE="vertical-align: middle">ERISA</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.13</TD>
    <TD STYLE="vertical-align: middle">Subsidiaries and Other Equity Investments; Loan Parties</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.17</TD>
    <TD STYLE="vertical-align: middle">Intellectual Property Matters</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.23</TD>
    <TD STYLE="vertical-align: middle">Insurance</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">5.24</TD>
    <TD STYLE="vertical-align: middle">Employment and Labor</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">7.01</TD>
    <TD STYLE="vertical-align: middle">Existing Liens</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">7.02</TD>
    <TD STYLE="vertical-align: middle">Existing Indebtedness</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">7.09</TD>
    <TD STYLE="vertical-align: middle">Contractual Obligations</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">11.02</TD>
    <TD STYLE="vertical-align: middle">Administrative Agent&rsquo;s Office, Certain Addresses for Notices</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">EXHIBITS</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 8%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 88%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; vertical-align: middle">Form of</TD></TR>
<TR>
    <TD STYLE="font-weight: bold; font-style: italic; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">A</TD>
    <TD STYLE="vertical-align: middle">Committed Loan Notice</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">B</TD>
    <TD STYLE="vertical-align: middle">Amended and Restated Term Note</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">C</TD>
    <TD STYLE="vertical-align: middle">Third Amended and Restated Revolving Credit Note</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">D</TD>
    <TD STYLE="vertical-align: middle">Compliance Certificate</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">E-1</TD>
    <TD STYLE="vertical-align: middle">Assignment and Assumption</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">E-2</TD>
    <TD STYLE="vertical-align: middle">Administrative Questionnaire</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">F</TD>
    <TD STYLE="vertical-align: middle">Authorization to Share Information</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: middle">G-1 to G-4&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">U.S. Tax Compliance Certificates</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">THIRD AMENDED AND RESTATED CREDIT AGREEMENT</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This THIRD AMENDED AND RESTATED CREDIT AGREEMENT
(&ldquo;<U>Agreement</U>&rdquo;) is entered into as of May 1, 2017, among HARVARD BIOSCIENCE, INC., a Delaware corporation (the
&ldquo;<U>Borrower</U>&rdquo;), BROWN BROTHERS HARRIMAN &amp; CO. and each other lender from time to time party hereto (collectively,
the &ldquo;<U>Lenders</U>&rdquo; and individually, a &ldquo;<U>Lender</U>&rdquo;), and BANK OF AMERICA, N.A., as Administrative
Agent and L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><U>BACKGROUND</U>:</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower, the Administrative Agent and
the Lenders entered into an Amended and Restated Revolving Credit Loan Agreement dated as of August 7, 2009, which was amended
by First Amendment to Amended and Restated Revolving Credit Loan Agreement dated as of September 30, 2011, which was further amended
by Second Amendment to Amended and Restated Revolving Credit Loan Agreement, Limited Consent and Limited Waiver dated as of October
4, 2012; which was further amended by a Second Amended and Restated Credit Agreement dated as of March 29, 2013, which was amended
by that certain First Amendment to Second Amended and Restated Credit Agreement dated as of May 30, 2013; which was further amended
by that certain Second Amendment to Second Amended and Restated Credit Agreement and Waiver dated as of October 31, 2013; which
was further amended by that certain Third Amendment to Second Amended and Restated Credit Agreement dated as of April 24, 2015;
which was further amended by that certain Fourth Amendment to Second Amended and Restated Credit Agreement dated as of June 30,
2015; which was further amended by that certain Fifth Amendment to Second Amended and Restated Credit Agreement dated as of November
5, 2015; and which was further amended by that certain Sixth Amendment to Second Amended and Restated Credit Agreement dated as
of March 9, 2016 (collectively, the &ldquo;<U>Original Credit Agreement</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower, the Guarantors, the Lenders and
the Administrative Agent have agreed to amend the Original Credit Agreement and are entering into this Agreement, among other
things, to consolidate, combine and restate certain outstanding indebtedness into a single term loan and to extend the maturity
date, as provided herein. The Borrower and the Lenders hereby confirm, acknowledge and agree that, as of the date hereof, the
outstanding principal amount of all Term Loans and certain amounts of outstanding Revolving Credit Loans under the Original Credit
Agreement to be consolidated, combined and restated is $14,000,000 (the &ldquo;<U>Restated Obligations</U>&rdquo;). The Lenders
have indicated their willingness to restate the Restated Obligations, and to provide the amendments contained herein, and the
L/C Issuer has indicated its willingness to issue letters of credit, in each case, on the terms and subject to the conditions
set forth herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In consideration of the mutual covenants and
agreements herein contained, the parties hereto covenant and agree as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE I<BR>
DEFINITIONS AND ACCOUNTING TERMS</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defined Terms</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">As used in this Agreement, the following terms
shall have the meanings set forth below:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Adjusted EBITDA</U>&rdquo; means
for any period, EBITDA for such period after adjusting for (a) non-cash stock compensation expense, (b) restructuring charges
related to Permitted Acquisitions contemplated at the time of such Permitted Acquisition and mutually agreed upon by the Borrower
and the Administrative Agent, (c) acquired in-process research and development expense, (d) fair value adjustments resulting from
purchase price allocation related to Permitted Acquisitions and (e) other non-recurring exceptional items of income or expense
mutually agreed upon by the Borrower and the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Administrative Agent</U>&rdquo; means
Bank of America in its capacity as administrative agent under any of the Loan Documents, or any successor administrative agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Administrative Agent&rsquo;s Office</U>&rdquo;
means the Administrative Agent&rsquo;s address and, as appropriate, account as set forth on <U>Schedule 11.02</U>, or such other
address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Administrative Questionnaire</U>&rdquo;
means an Administrative Questionnaire in substantially the form of <U>Exhibit E-2</U> or any other form approved by the Administrative
Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Affiliate</U>&rdquo; means, with
respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled
by or is under common Control with the Person specified.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Agency Fee</U>&rdquo; has the meaning
given such term in <U>Section 2.09(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Aggregate Commitments</U>&rdquo;
means the Commitments of all the Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Aggregate Credit Exposures</U>&rdquo;
means, at any time, in respect of (a)&nbsp;the aggregate amount of the Term Loan outstanding at such time, and (b)&nbsp;the Revolving
Credit Facility, the sum of (i)&nbsp;the unused portion of the Revolving Credit Facility at such time and (ii) the Total Revolving
Credit Outstandings at such time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Agreement</U>&rdquo; means this Credit
Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Applicable Percentage</U>&rdquo;
means (a)&nbsp;in respect of the Term Loan, with respect to any Term Lender at any time, the percentage (carried out to the ninth
decimal place) of the Term Loan represented by the principal amount of such Term Lender&rsquo;s portion of the Term Loan at such
time, and (b)&nbsp;in respect of the Revolving Credit Facility, with respect to any Revolving Credit Lender at any time, the percentage
(carried out to the ninth decimal place) of the Revolving Credit Facility represented by such Revolving Credit Lender&rsquo;s
Revolving Credit Commitment at such time. If the commitment of each Revolving Credit Lender to make Revolving Credit Loans and
the obligation of the L/C Issuer to make L/C Credit Extensions have been terminated pursuant to <U>Section 8.02</U>, or if the
Revolving Credit Commitments have expired, then the Applicable Percentage of each Revolving Credit Lender in respect of the Revolving
Credit Facility shall be determined based on the Applicable Percentage of such Revolving Credit Lender in respect of the Revolving
Credit Facility most recently in effect, giving effect to any subsequent assignments. The initial Applicable Percentage of each
Lender in respect of each Facility is set forth opposite the name of such Lender on <U>Schedule 2.01</U> or in the Assignment
and Assumption pursuant to which such Lender becomes a party hereto, as applicable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Applicable Rate</U>&rdquo; means
(a) in respect of the Term Loan, 2.75% per annum and (b) in respect of the Revolving Credit Facility, 2.25% per annum.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Applicable Revolving Credit Percentage</U>&rdquo;
means with respect to any Revolving Credit Lender at any time, such Revolving Credit Lender&rsquo;s Applicable Percentage in respect
of the Revolving Credit Facility at such time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Appropriate Lender</U>&rdquo; means,
at any time, (a)&nbsp;with respect to the Term Loan or the Revolving Credit Facility, a Lender that has a Commitment with respect
to the Revolving Credit Facility or holds a portion of the Term Loan or a Revolving Credit Loan, respectively, at such time and
(b)&nbsp;with respect to the Letter of Credit Sublimit, (i)&nbsp;the L/C Issuer and (ii)&nbsp;if any Letters of Credit have been
issued pursuant to <U>Section 2.03(a)</U>, the Revolving Credit Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Approved Fund</U>&rdquo; means any
Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity
that administers or manages a Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Assignee Group</U>&rdquo; means two
or more Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Assignment and Assumption</U>&rdquo;
means an assignment and assumption entered into by a Lender and an Eligible Assignee (with the consent of any party whose consent
is required by <U>Section&nbsp;11.06(b)</U>), and accepted by the Administrative Agent, in substantially the form of <U>Exhibit&nbsp;E-1
</U>or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative
Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Attributable Indebtedness</U>&rdquo;
means, on any date, (a) in respect of any Capitalized Lease of any Person, the capitalized amount thereof that would appear on
a balance sheet of such Person prepared as of such date in accordance with GAAP, (b) in respect of any Synthetic Lease Obligation,
the capitalized amount of the remaining lease or similar payments under the relevant lease or other applicable agreement or instrument
that would appear on a balance sheet of such Person prepared as of such date in accordance with GAAP if such lease or other agreement
or instrument were accounted for as a Capitalized Lease and (c) all Synthetic Debt of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Audited Financial Statements</U>&rdquo;
means the audited consolidated balance sheet of the Borrower and its Subsidiaries for the fiscal year ended December 31, 2016,
and the related consolidated statements of income or operations, shareholders&rsquo; equity and cash flows for such fiscal year
of the Borrower and its Subsidiaries, including the notes thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Availability Period</U>&rdquo; means
in respect of the Revolving Credit Facility, the period from and including the Third A&amp;R Effective Date to the earliest of
(i) the Maturity Date with respect to the Revolving Credit Facility, (ii) the date of termination of the Revolving Credit Commitments
pursuant to <U>Section 2.06</U>, and (iii) the date of termination of the commitment of each Revolving Credit Lender to make Revolving
Credit Loans and of the obligation of the L/C Issuer to make L/C Credit Extensions pursuant to <U>Section 8.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Bail-In Action</U>&rdquo; means the
exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an
EEA Financial Institution.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Bail-In Legislation</U>&rdquo; means,
with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council
of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In
Legislation Schedule.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Bank of America</U>&rdquo; means
Bank of America, N.A. and its successors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Books</U>&rdquo; means all of Borrower&rsquo;s
or its Subsidiaries now owned or hereafter acquired books and records (including all of its records indicating, summarizing, or
evidencing its assets (including the Accounts and Inventory) or liabilities, all of Borrower&rsquo;s records relating to its business
operations or financial condition, and all of its goods or General Intangibles related to such information).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Borrower</U>&rdquo; has the meaning
specified in the introductory paragraph hereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Borrower Materials</U>&rdquo; has
the meaning specified in <U>Section 6.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Borrowing</U>&rdquo; shall mean the
making of simultaneous Revolving Credit Loans, having the same Interest Period if a Eurodollar Rate Loan or a LIBOR Daily Floating
Rate Loan, made by each Lender pursuant to <U>Section&nbsp;2.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Business Day</U>&rdquo; means
any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are
in fact closed in, the state where the Administrative Agent&rsquo;s Office is located and, if such day relates to any Eurodollar
Rate Loan, means any such day on which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar
market.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Capital Expenditure</U>&rdquo; shall
mean any payment made directly or indirectly for the purpose of acquiring or constructing fixed assets, real property or equipment
which in accordance with GAAP would be added as a debit to the fixed asset account of the Person making such expenditure, including
without limitation, amounts paid or payable under any conditional sale or other title retention agreement or under any lease or
other periodic payment arrangement which is of such a nature that payment obligations of the lessee or obligor thereunder would
be required by GAAP to be capitalized and shown as liabilities or otherwise appear in the category of property, plant or equipment
or intangibles on the balance sheet of such lessee or obligor but excluding amounts expended in connection with Permitted Acquisitions
(including reasonable capitalized transaction costs related to such Permitted Acquisitions).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Capitalized Leases</U>&rdquo; means
all leases that have been or should be, in accordance with GAAP, recorded as capitalized leases.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cash Collateral Account</U>&rdquo;
means a blocked, non-interest bearing deposit account of one or more of the Loan Parties at Bank of America (or another commercial
bank selected in compliance with <U>Section 6.19</U>) in the name of the Administrative Agent and under the sole dominion and
control of the Administrative Agent, and otherwise established in a manner reasonably satisfactory to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cash Collateralize</U>&rdquo; has
the meaning specified in <U>Section 2.03(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cash Equivalents</U>&rdquo;
shall mean (a) negotiable certificates of deposit, time deposits (including sweep accounts), demand deposits and bankers&rsquo;
acceptances having a maturity of nine months or less and issued by any United States financial institution having capital and surplus
and undivided profits aggregating at least $100,000,000 and rated Prime-1 by Moody&rsquo;s Investors Service, Inc. or A-1 by Standard
&amp; Poor&rsquo;s Ratings Group or issued by the Administrative Agent or any Lender; (b) corporate obligations having a maturity
of nine months or less and rated Prime-1 by Moody&rsquo;s Investors Service, Inc. or A-1 by Standard &amp; Poor&rsquo;s Ratings
Group or issued by the Administrative Agent or any Lender; (c) any direct obligation of the United States of America or any agency
or instrumentality thereof, or of any state or municipality thereof, (i) which has a remaining maturity at the time of purchase
of not more than one year or which is subject to a repurchase agreement with the Administrative Agent or any Lender (or any other
financial institution referred to in clause (a) above) exercisable within one year from the time of purchase and (ii) which, in
the case of obligations of any state or municipality, is rated AA or better by Moody&rsquo;s Investors Services, Inc. or AA or
better by Standard &amp; Poor&rsquo;s Ratings Group; and (d) any mutual fund or other pooled investment vehicle rated AA or better
by Moody&rsquo;s Investors Service, Inc. or AA or better by Standard &amp; Poor&rsquo;s Ratings Group which invests principally
in obligations described above.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cash Management Agreement</U>&rdquo;
means any agreement to provide cash management services, including treasury, depository, overdraft, credit or debit card, electronic
funds transfer, ACH transfer and other cash management arrangements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cash Management Bank</U>&rdquo; means
any Person that, at the time it enters into a Cash Management Agreement, is a Lender or an Affiliate of a Lender, in its capacity
as a party to such Cash Management Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"> &ldquo;<U>CERCLA</U>&rdquo; means the
Comprehensive Environmental Response, Compensation and Liability Act of 1980.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>CERCLIS</U>&rdquo; means the Comprehensive
Environmental Response, Compensation and Liability Information System maintained by the U.S. Environmental Protection Agency.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>CFC</U>&rdquo; means a Person that
is a controlled foreign corporation under Section 957 of the Code.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Change in Law</U>&rdquo; means
the occurrence, after the date of this Agreement, of any of the following: (a) the adoption or taking effect of any law, rule,
regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation
or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive
(whether or not having the force of law) by any Governmental Authority; <U>provided</U> that notwithstanding anything herein to
the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives
thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for
International settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States
regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &ldquo;Change in Law&rdquo;, regardless
of the date enacted, adopted or issued.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Change of Control</U>&rdquo; means
an event or series of events by which:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
&ldquo;person&rdquo; or &ldquo;group&rdquo; (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act
of 1934, but excluding any employee benefit plan of such person or its subsidiaries, and any person or entity acting in its capacity
as trustee, agent or other fiduciary or administrator of any such plan) becomes the &ldquo;beneficial owner&rdquo; (as defined
in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, except that a person or group shall be deemed to have &ldquo;beneficial
ownership&rdquo; of all securities that such person or group has the right to acquire, whether such right is exercisable immediately
or only after the passage of time (such right, an &ldquo;<U>option right</U>&rdquo;)), directly or indirectly, of 35% or more of
the equity securities of the Borrower entitled to vote for members of the board of directors or equivalent governing body of the
Borrower on a fully-diluted basis (and taking into account all such securities that such &ldquo;person&rdquo; or &ldquo;group&rdquo;
has the right to acquire pursuant to any option right); or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;during
any period of 12 consecutive months, a majority of the members of the board of directors or other equivalent governing body of
the Borrower cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day
of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred
to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent
governing body or (iii) whose election or nomination to that board or other equivalent governing body was approved by individuals
referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board
or equivalent governing body; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Person or two or more Persons acting in concert shall have acquired by contract or otherwise, or shall have entered into a contract
or arrangement that, upon consummation thereof, will result in its or their acquisition of the power to exercise, directly or indirectly,
a controlling influence over the management or policies of the Borrower, or control over the equity securities of the Borrower
entitled to vote for members of the board of directors or equivalent governing body of the Borrower on a fully-diluted basis (and
taking into account all such securities that such Person or Persons have the right to acquire pursuant to any option right) representing
35% or more of the combined voting power of such securities.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Code</U>&rdquo; means the Internal
Revenue Code of 1986.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Collateral</U>&rdquo; means all of
the &ldquo;<U>Collateral</U>&rdquo; and &ldquo;<U>Mortgaged Property</U>&rdquo; referred to in the Collateral Documents and all
of the other property that is or is intended under the terms of the Collateral Documents to be subject to Liens in favor of the
Administrative Agent for the benefit of the Secured Parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Collateral Documents</U>&rdquo; means,
collectively, the Security Agreement, the Pledge Agreement, the Intellectual Property Security Agreement, the control agreements,
each of the mortgages, collateral assignments, Security Agreement Supplements, IP Security Agreement Supplements, security agreements,
pledge agreements or other similar agreements delivered to the Administrative Agent pursuant to <U>Section 6.12</U>, and each
of the other agreements, instruments or documents that creates or purports to create a Lien in favor of the Administrative Agent
for the benefit of the Secured Parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Commitment</U>&rdquo; means (a) a
Revolving Credit Commitment, or (b) the amount of the applicable Lender&rsquo;s portion of the Term Loan in relation to the aggregate
amount of the Term Loan outstanding at such time, as the context may require.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Committed Loan Notice</U>&rdquo;
means a notice of (a) a Revolving Credit Borrowing, (b) a conversion of Loans from one Type to the other, or (c) a continuation
of Eurodollar Rate Loans, pursuant to <U>Section&nbsp;2.02(a)</U>, which shall be substantially in the form of <U>Exhibit&nbsp;A
</U>or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic
transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer
of the Borrower.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Commodity Exchange Act</U>&rdquo;
means the Commodity Exchange Act (7 U.S.C. &sect;&nbsp;1 <I>et seq.</I>), as amended from time to time, and any successor statute.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Compliance Certificate</U>&rdquo;
means a certificate substantially in the form of <U>Exhibit&nbsp;D</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Contractual Obligation</U>&rdquo;
means, as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking
to which such Person is a party or by which it or any of its property is bound.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp; &ldquo;<U>Control</U>&rdquo; means the
possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether
through the ability to exercise voting power, by contract or otherwise. &ldquo;<U>Controlling</U>&rdquo; and &ldquo;<U>Controlled</U>&rdquo;
have meanings correlative thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Cost</U>&rdquo; means the calculated
cost of Inventory, as determined from invoices received by Borrower or any of its Subsidiaries, Borrower&rsquo;s or such Subsidiaries&rsquo;
purchase journals or stock ledgers, based upon Borrower&rsquo;s accounting practices, known to Administrative Agent, which practices
are in effect on the date on which this Agreement was executed. &ldquo;Cost&rdquo; does not include any inventory capitalization
costs inclusive of advertising, but may include other charges used in Borrower&rsquo;s determination of cost of goods sold and
bringing goods to market, all within Administrative Agent&rsquo;s reasonable discretion and in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Credit Extension</U>&rdquo; means
each of the following: (a) a Borrowing and (b) an L/C Credit Extension.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Debtor Relief Laws</U>&rdquo; means
the Bankruptcy Code of the United States, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of
creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief Laws of the United States
or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Default</U>&rdquo; means any event
or condition that constitutes an Event of Default or that, with the giving of any notice, the passage of time, or both, would
be an Event of Default.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Default Rate</U>&rdquo; means (a)
when used with respect to Obligations other than Letter of Credit Fees, an interest rate equal to (i) the LIBOR Daily Floating
Rate <U>plus</U> (ii) the Applicable Rate, if any, applicable to LIBOR Daily Floating Rate Loans under the Term Loan <U>plus</U>
(iii) 2% per annum; <U>provided</U>, <U>however</U>, that with respect to a Eurodollar Rate Loan, the Default Rate shall be an
interest rate equal to the interest rate (including any Applicable Rate) otherwise applicable to such Loan <U>plus</U> 2% per
annum and (b) when used with respect to Letter of Credit Fees, a rate equal to the Applicable Rate <U>plus</U> 2% per annum.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Defaulting Lender</U>&rdquo; means,
subject to <U>Section 2.15(b)</U>, any Lender that (a)&nbsp;has failed to (i)&nbsp;fund all or any portion of its Loans within
two (2) Business Days of the date such Loans were required to be funded hereunder unless such Lender notifies the Administrative
Agent and the Borrower in writing that such failure is the result of such Lender&rsquo;s determination that one or more conditions
precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified
in such writing) has not been satisfied, or (ii)&nbsp;pay to the Administrative Agent, the L/C Issuer or any other Lender any
other amount required to be paid by it hereunder (including in respect of its participation in Letters of Credit) within two (2)
Business Days of the date when due, (b)&nbsp;has notified the Borrower, the Administrative Agent or the L/C Issuer in writing
that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless
such writing or public statement relates to such Lender&rsquo;s obligation to fund a Loan hereunder and states that such position
is based on such Lender&rsquo;s determination that a condition precedent to funding (which condition precedent, together with
any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c)&nbsp;has
failed, within three (3) Business Days after written request by the Administrative Agent or the Borrower, to confirm in writing
to the Administrative Agent and the Borrower that it will comply with its prospective funding obligations hereunder (<U>provided
</U>that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation
by the Administrative Agent and the Borrower), or (d)&nbsp;has, or has a direct or indirect parent company that has, (i)&nbsp;become
the subject of a proceeding under any Debtor Relief Law, (ii)&nbsp;had appointed for it a receiver, custodian, conservator, trustee,
administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business
or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such
a capacity, or (iii) become the subject of a Bail-in Action; <U>provided</U> that a Lender shall not be a Defaulting Lender solely
by virtue of the ownership or acquisition of any Equity Interest in that Lender or any direct or indirect parent company thereof
by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the
jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit
such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with
such Lender. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses
(a) through (d) above, and the effective date of such status, shall be conclusive and binding absent manifest error, and such
Lender shall be deemed to be a Defaulting Lender (subject to <U>Section 2.15(b)</U>) as of the date established therefor by the
Administrative Agent in a written notice of such determination, which shall be delivered by the Administrative Agent to the Borrower,
the L/C Issuer and each other Lender promptly following such determination.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Designated Jurisdiction</U>&rdquo;
means any country or territory to the extent that such country or territory itself is the subject of any Sanction (including,
without limitation, Crimea, Cuba, Iran, North Korea, Sudan and Syria).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Disposition</U>&rdquo; or &ldquo;<U>Dispose</U>&rdquo;
means the sale, transfer, license, lease or other disposition (including any sale and leaseback transaction) of any property by
any Person (or the granting of any option or other right to do any of the foregoing), including any sale, assignment, transfer
or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Dollar</U>&rdquo; and &ldquo;<U>$</U>&rdquo;
mean lawful money of the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Domestic Subsidiary</U>&rdquo;
means any Subsidiary that is organized under the laws of any political subdivision of the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>EBITDA</U>&rdquo; means for any period,
Net Income for such period, after restoring thereto amounts deducted for (a) federal and state taxes in respect of income and
profits, (b) Interest Expense and (c) depreciation and amortization, as determined in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp; &ldquo;<U>EEA Financial Institution</U>&rdquo;
means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision
of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described
in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary
of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>EEA Member Country</U>&rdquo; means
any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>EEA Resolution Authority</U>&rdquo;
means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country
(including any delegee) having responsibility for the resolution of any EEA Financial Institution.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eligible Assignee</U>&rdquo; means
any Person that meets the requirements to be an assignee under Section 11.06(b)(iii), (v) and (vi) (subject to such consents,
if any, as may be required under <U>Section 11.06(b)(iii)</U>).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eligible Inventory</U>&rdquo; means
Inventory of the Borrower and its Subsidiaries, the value of which shall be determined by its book value determined in accordance
with GAAP; provided, however, that none of the following classes of Inventory shall be deemed to be Eligible Inventory:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reserved;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
that is obsolete, unusable or otherwise unavailable for sale;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
consisting of promotional, marketing, packaging or shipping materials and supplies;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
that fails to meet all standards imposed by any Governmental Authority having regulatory authority over such Inventory or its use
or sale;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
that is subject to any licensing, patent, royalty, trademark, trade name or copyright agreement with any third party from which
the Borrower or any of its Subsidiaries has received notice of a dispute in respect of any such agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reserved;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
that is not in the possession of or under the sole control of the Borrower or any of its Subsidiaries, unless the applicable third
party has executed a collateral access agreement in favor of the Administrative Agent in form and substance reasonably acceptable
to Administrative Agent;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
consisting of work in progress; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory
with respect to which the representations and warranties set forth herein applicable to Inventory are not correct.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eligible Receivables</U>&rdquo; means
Receivables of the Borrower and its Subsidiaries, the value of which shall be determined by taking into consideration, among other
factors, their book value determined in accordance with GAAP; provided, however, that none of the following classes of Receivables
shall be deemed to be Eligible Receivables:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
that do not arise out of sales of goods or rendering of services in the ordinary course of the Borrower&rsquo;s or the relevant
Subsidiary&rsquo;s business;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
that are otherwise on terms other than those normal or customary in the Borrower&rsquo;s or the relevant Subsidiary&rsquo;s business;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
owing from any Person that is an Affiliate of the Borrower;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
more than 90 days past original invoice date or more than 60&nbsp;days past the date due;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
owing from any Person from which an aggregate amount of more than 20% of the Receivables owing therefrom is more than 60 days past
the date due;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
owing from any Person that (i)&nbsp;has disputed liability for any Receivable owing from such Person or (ii)&nbsp;has otherwise
asserted any claim, demand or liability against the Borrower or any of its Subsidiaries, whether by action, suit, counterclaim
or otherwise; provided that for purposes of subclause (f)(i), such Receivables shall be excluded only to the extent of the amounts
being disputed by such Person at any date of determination;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
owing from any Person that shall take or be the subject of any action or proceeding of a type described in <U>Section&nbsp;8.01(f)</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
(i) owing from any Person that is also a supplier to or creditor of the Borrower or any of its Subsidiaries unless such Person
has waived any right of setoff in a manner acceptable to the Administrative Agent or (ii) representing any manufacturer&rsquo;s
or supplier&rsquo;s credits, discounts, incentive plans or similar arrangements entitling the Borrower or any of its Subsidiaries
to discounts on future purchase therefrom;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reserved;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
arising out of sales on a bill-and-hold, guaranteed sale, sale-or-return, sale on approval or consignment basis or subject to any
right of return, setoff or charge back;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
owing from an account debtor that is an agency, department or instrumentality of the United States or any state thereof unless
the Borrower or its relevant Subsidiary shall have satisfied the requirements of the Assignment of Claims Act of 1940, and any
similar state legislation and the Administrative Agent is satisfied as to the absence of setoffs, counterclaims and other defenses
on the part of such account debtor; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
with respect to which the representations and warranties set forth in herein applicable to Receivables are not correct.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Environmental Laws</U>&rdquo; means
any and all Federal, state, local, and foreign statutes, laws, regulations, ordinances, rules, judgments, orders, decrees, permits,
concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of
the environment or the release of any materials into the environment, including those related to hazardous substances or wastes,
air emissions and discharges to waste or public systems.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Environmental Liability</U>&rdquo;
means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines,
penalties or indemnities), of the Borrower, any other Loan Party or any of their respective Subsidiaries directly or indirectly
resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage,
treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the release or threatened release
of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant to which
liability is assumed or imposed with respect to any of the foregoing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Equity Interests</U>&rdquo; means,
with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all
of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other
ownership or profit interests in) such Person, all of the securities convertible into or exchangeable for shares of capital stock
of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or acquisition from
such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including
partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such shares, warrants, options,
rights or other interests are outstanding on any date of determination.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>ERISA</U>&rdquo; means the Employee
Retirement Income Security Act of 1974.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>ERISA Affiliate</U>&rdquo; means
any trade or business (whether or not incorporated) under common control with the Borrower within the meaning of Section 414(b)
or (c) of the Code (and Sections 414(m) and (o) of the Code for purposes of provisions relating to Section&nbsp;412 of the Code).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>ERISA Event</U>&rdquo; means (a)
a Reportable Event with respect to a Pension Plan; (b) a withdrawal by the Borrower or any ERISA Affiliate from a Pension Plan
subject to Section&nbsp;4063 of ERISA during a plan year in which it was a substantial employer (as defined in Section&nbsp;4001(a)(2)
of ERISA) or a cessation of operations that is treated as such a withdrawal under Section 4062(e) of ERISA; (c) a complete or
partial withdrawal by the Borrower or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan
is in reorganization; (d) the filing of a notice of intent to terminate, the treatment of a Plan amendment as a termination under
Section 4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Pension Plan or Multiemployer Plan;
(e) an event or condition which constitutes grounds under Section 4042 of ERISA for the termination of, or the appointment of
a trustee to administer, any Pension Plan or Multiemployer Plan; or (f) the imposition of any liability under Title IV of ERISA,
other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower or any ERISA Affiliate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>EU Bail-In Legislation Schedule</U>&rdquo;
means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from
time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eurodollar Base Rate</U>&rdquo; has
the meaning specified in the definition of Eurodollar Rate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eurodollar Rate</U>&rdquo; means:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for
any Interest Period with respect to a Eurodollar Rate Loan, the rate per annum equal to the London Interbank Offered Rate (&ldquo;<U>LIBOR</U>&rdquo;)
or a comparable or successor rate, which rate is approved by the Administrative Agent, as published on the applicable Bloomberg
screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent
from time to time) at approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period,
for Dollar deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period; and
if the Eurodollar Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for
any interest calculation with respect to a Base Rate Loan on any date, the rate per annum equal to LIBOR, at or about 11:00 a.m.,
London time determined two Business Days prior to such date for U.S. Dollar deposits with a term of one month commencing that day;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>provided</U> that (i) if the Eurodollar Rate
shall be less than zero, such rate shall be deemed zero for purposes of this Agreement, and (ii) to the extent a comparable or
successor rate is approved by the Administrative Agent in connection herewith, the approved rate shall be applied in a manner consistent
with market practice; <U>provided further</U> that to the extent such market practice is not administratively feasible for the
Administrative Agent, such approval rate shall be applied in a manner as otherwise reasonably determined by the Administrative
Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Eurodollar Rate Loan</U>&rdquo; means
a Loan that bears interest at a rate based on the Eurodollar Rate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"> &ldquo;<U>Eurodollar Reserve Percentage</U>&rdquo;
means, for any day during any Interest Period, the reserve percentage (expressed as a decimal, carried out to five decimal places)
in effect on such day, whether or not applicable to any Lender, under regulations issued from time to time by the FRB for determining
the maximum reserve requirement (including any emergency, supplemental or other marginal reserve requirement) with respect to Eurocurrency
funding (currently referred to as &ldquo;Eurocurrency liabilities&rdquo;). The Eurodollar Rate for each outstanding Eurodollar
Rate Loan shall be adjusted automatically as of the effective date of any change in the Eurodollar Reserve Percentage.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Event of Default</U>&rdquo; has the
meaning specified in <U>Section 8.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Excluded Swap Obligation</U>&rdquo;
means, with respect to any Guarantor, any Swap Obligation if, and to the extent that, all or a portion of the Guaranty of such
Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap Obligation (or any Guaranty thereof)
is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission
(or the application or official interpretation of any thereof) by virtue of such Guarantor&rsquo;s failure for any reason to constitute
an &ldquo;eligible contract participant&rdquo; as defined in the Commodity Exchange Act (determined after giving effect to <U>Section&nbsp;11.20(b)
</U>and any other &ldquo;keepwell, support or other agreement&rdquo; for the benefit of such Guarantor and any and all guarantees
of such Guarantor&rsquo;s Swap Obligations by other Loan Parties) at the time the Guaranty of such Guarantor, or a grant by such
Guarantor of a security interest, becomes effective with respect to such Swap Obligation. If a Swap Obligation arises under a
master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is
attributable to swaps for which such Guaranty or security interest is or becomes excluded in accordance with the first sentence
of this definition.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Excluded Taxes</U>&rdquo; means any
of the following Taxes imposed on or with respect to any Recipient or required to be withheld or deducted from a payment to a
Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in
each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in
the case of any Lender, its Lending Office located in, the jurisdiction imposing such Tax (or any political subdivision thereof)
or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable
to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect
on the date on which (i) such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request
by the Borrower under <U>Section 10.13</U>) or (ii) such Lender changes its Lending Office, except in each case to the extent
that, pursuant to <U>Section 3.01(a)(ii), (a)(iii)</U> or <U>(c)</U>, amounts with respect to such Taxes were payable either to
such Lender&rsquo;s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed
its Lending Office, (c) Taxes attributable to such Recipient&rsquo;s failure to comply with <U>Section 3.01(e)</U> and (d) any
U.S. federal withholding Taxes imposed pursuant to FATCA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Extraordinary Receipt</U>&rdquo;
means any cash received by or paid to or for the account of any Person not in the ordinary course of business, including tax refunds,
pension plan reversions, proceeds of insurance (other than proceeds of business interruption insurance to the extent such proceeds
constitute compensation for lost earnings), condemnation awards (and payments in lieu thereof), indemnity payments and any purchase
price adjustments; <U>provided</U>, <U>however</U>, that an Extraordinary Receipt shall not include cash receipts from proceeds
of insurance, condemnation awards (or payments in lieu thereof) or indemnity payments to the extent that such proceeds, awards
or payments (a) in respect of loss or damage to equipment, fixed assets or real property are applied (or in respect of which expenditures
were previously incurred) to replace or repair the equipment, fixed assets or real property in respect of which such proceeds
were received in accordance with the terms of <U>Section 2.05(b)(v)</U> or (b) are received by any Person in respect of any third
party claim against such Person and applied to pay (or to reimburse such Person for its prior payment of) such claim and the costs
and expenses of such Person with respect thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"> &ldquo;<U>Facility</U>&rdquo; means
the Term Loan or the Revolving Credit Facility, as the context may require.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>FATCA</U>&rdquo; means Sections 1471
through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantially comparable
and not materially more onerous to comply with), any current or future regulations or official interpretations thereof and any
agreements entered into pursuant to Section 1471(b)(1) of the Code, any intergovernmental agreements implementing any of the foregoing,
and any fiscal or regulatory legislation, rules or procedures adopted pursuant to the foregoing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Federal Funds Rate</U>&rdquo; means,
for any day, the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions with members
of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of New York
on the Business Day next succeeding such day; <U>provided</U> that (a) if such day is not a Business Day, the Federal Funds Rate
for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding
Business Day, and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day
shall be the average rate (rounded upward, if necessary, to a whole multiple of 1/100 of 1%) charged to Bank of America on such
day on such transactions as determined by the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Foreign Lender</U>&rdquo;
means any Lender that is organized under the Laws of a jurisdiction other than that in which the Borrower is resident for tax purposes
(including such a Lender when acting in the capacity of the L/C Issuer). For purposes of this definition, the United States, each
State thereof and the District of Columbia shall be deemed to constitute a single jurisdiction. &ldquo;<U>FRB</U>&rdquo; means
the Board of Governors of the Federal Reserve System of the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Fronting Exposure</U>&rdquo; means,
at any time there is a Defaulting Lender that is a Revolving Lender with respect to the L/C Issuer, such Defaulting Lender&rsquo;s
Applicable Percentage of the Outstanding L/C Obligations other than L/C Obligations as to which such Defaulting Lender&rsquo;s
participation obligation has been reallocated to other Revolving Lenders or Cash Collateralized in accordance with the terms hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Fund</U>&rdquo; means any Person
(other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial
loans and similar extensions of credit in the ordinary course of its activities.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Funded Debt</U>&rdquo; means all
Indebtedness to the Lenders, all Indebtedness for borrowed money incurred in connection with Permitted Acquisitions which is not
subordinated to the Indebtedness owing to the Lenders hereunder and all Indebtedness in respect of Capital Leases.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>GAAP</U>&rdquo; means generally accepted
accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board and
the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards
Board or such other principles as may be approved by a significant segment of the accounting profession in the United States,
that are applicable to the circumstances as of the date of determination, consistently applied.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>General Intangible</U>&rdquo; means
all of Borrowers&rsquo; and its Subsidiaries&rsquo; now owned or hereafter acquired right, title, and interest with respect to
&ldquo;general intangibles&rdquo; (as such term is defined from time to time in the Code), and any and all supporting obligations
in respect thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Governmental Authority</U>&rdquo;
means the government of the United States or any other nation, or of any political subdivision thereof, whether state or local,
and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative,
judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national
bodies such as the European Union or the European Central Bank).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Guarantee</U>&rdquo; means, as to
any Person, any (a) any obligation, contingent or otherwise, of such Person guaranteeing or having the economic effect of guaranteeing
any Indebtedness or other obligation payable or performable by another Person (the &ldquo;<U>primary obligor</U>&rdquo;) in any
manner, whether directly or indirectly, and including any obligation of such Person, direct or indirect, (i) to purchase or pay
(or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation, (ii) to purchase or lease property,
securities or services for the purpose of assuring the obligee in respect of such Indebtedness or other obligation of the payment
or performance of such Indebtedness or other obligation, (iii) to maintain working capital, equity capital or any other financial
statement condition or liquidity or level of income or cash flow of the primary obligor so as to enable the primary obligor to
pay such Indebtedness or other obligation, or (iv) entered into for the purpose of assuring in any other manner the obligee in
respect of such Indebtedness or other obligation of the payment or performance thereof or to protect such obligee against loss
in respect thereof (in whole or in part), or (b) any Lien on any assets of such Person securing any Indebtedness or other obligation
of any other Person, whether or not such Indebtedness or other obligation is assumed by such Person (or any right, contingent
or otherwise, of any holder of such Indebtedness to obtain any such Lien). The amount of any Guarantee shall be deemed to be an
amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such
Guarantee is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined
by the guaranteeing Person in good faith. The term &ldquo;<U>Guarantee</U>&rdquo; as a verb has a corresponding meaning.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Guarantors</U>&rdquo; means, collectively,
all direct and indirect Domestic Subsidiaries of the Borrower and each other Subsidiary of the Borrower that shall be required
to execute and deliver a guaranty or guaranty supplement pursuant to <U>Section&nbsp;6.12</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Guaranty</U>&rdquo; means, collectively,
that certain Guaranty dated as of March 29, 2013 by and among Borrower, the Guarantors and the Administrative Agent, together
with each other guaranty and guaranty supplement delivered pursuant to <U>Section&nbsp;6.12</U>, in each case as amended, modified,
supplemented or restated from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Hazardous Materials</U>&rdquo; means
all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including
petroleum or petroleum distillates, asbestos or asbestos-containing materials, polychlorinated biphenyls, radon gas, infectious
or medical wastes and all other substances or wastes of any nature regulated pursuant to any Environmental Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Hedge Bank</U>&rdquo; means any Person
that, at the time it enters into an interest rate Swap Contract required or permitted under <U>Article VI</U> or <U>VII</U>, is
a Lender or an Affiliate of a Lender, in its capacity as a party to such Swap Contract.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Impacted Loans</U>&rdquo; has the
meaning specified in Section 3.03.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Indebtedness</U>&rdquo; shall mean
as applied to any Person, (i) all items (except items of capital or surplus or of retained earnings) which in accordance with
GAAP would be included in determining total liabilities as shown on the liability side of the balance sheet of such Person as
of the date of which Indebtedness is to be determined, including without limitation subordinated debt, if any, and any Capital
Lease, (ii) all indebtedness secured by any mortgage, pledge, lien or conditional sale or other title retention agreement to which
any property or asset owned or held by such Person is subject, whether or not the indebtedness secured thereby shall have been
assumed, and (iii) all indebtedness of others which such Person has directly or indirectly guaranteed, endorsed (otherwise than
for collection or deposit in the ordinary course of business), discounted or sold with recourse or agreed (contingently or otherwise)
to purchase or repurchase or otherwise acquire, or in respect of which such Person has agreed to supply or advance funds (whether
by way of loan, stock purchase, capital contributions or otherwise) or otherwise to become directly or indirectly liable. For
avoidance of doubt, the parties hereby agree that the term Indebtedness shall not include the issuance of any equity interests
by the Borrower and/or any of its Subsidiaries, whether such equity interests constitute common stock or preferred stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Indemnified Taxes</U>&rdquo; means
(a)&nbsp;Taxes other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of
any Loan Party under any Loan Document and (b)&nbsp;to the extent not otherwise described in (a), Other Taxes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Indemnitees</U>&rdquo; has
the meaning specified in <U>Section 11.04(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Information</U>&rdquo; has the meaning
specified in <U>Section 11.07</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Intellectual Property Security Agreement</U>&rdquo;
means that certain Intellectual Property Security Agreement dated as of March 29, 2013 by and among the Borrower, the Administrative
Agent, and the other parties identified as &ldquo;Grantors&rdquo; therein, as amended, modified, supplemented or restated from
time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Interest Charges</U>&rdquo; means,
for any Measurement Period, the sum of (a) all interest, premium payments, debt discount, fees, charges and related expenses in
connection with borrowed money (including capitalized interest) or in connection with the deferred purchase price of assets, in
each case to the extent treated as interest in accordance with GAAP, (b) all interest paid or payable with respect to discontinued
operations and (c) the portion of rent expense under Capitalized Leases that is treated as interest in accordance with GAAP, in
each case, of or by the Borrower and its Subsidiaries on a consolidated basis for the most recently completed Measurement Period.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Interest Expense</U>&rdquo; means
cash Interest Charges paid or payable on Funded Debt.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Interest Payment Date</U>&rdquo;
means, (a) as to any Eurodollar Rate Loan, the last day of each Interest Period applicable to such Loan and the Maturity Date
of the Facility under which such Loan was made; <U>provided</U>, <U>however</U>, that if any Interest Period for a Eurodollar
Rate Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period
shall also be Interest Payment Dates; and (b) as to any LIBOR Daily Floating Rate Loan, the last Business Day of each calendar
month and the Maturity Date of the Facility under which such Loan was made.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Interest Period</U>&rdquo; means,
as to each Eurodollar Rate Loan, the period commencing on the date such Eurodollar Rate Loan is disbursed or converted to or continued
as a Eurodollar Rate Loan and ending on the date one, two or three months thereafter, as selected by the Borrower in its Committed
Loan Notice; <U>provided</U> that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business
Day unless such Business Day falls in another calendar month, in which case such Interest Period shall end on the next preceding
Business Day;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding
day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end
of such Interest Period; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no
Interest Period shall extend beyond the Maturity Date of the Facility under which such Loan was made, unless otherwise consented
to by the Borrower, Lenders and Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Inventory</U>&rdquo; means all Borrower&rsquo;s
and its Subsidiaries now owned or hereafter acquired right, title, and interest with respect to inventory, including goods held
for sale or lease or to be furnished under a contract of service, goods that are leased by Borrower or any of its Subsidiaries
as lessor, goods that are furnished by Borrower or any of its Subsidiaries under a contract of service, and raw materials, work
in process, or materials used or consumed in Borrower&rsquo;s or any of its Subsidiaries&rsquo; business.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Investment</U>&rdquo; means, as to
any Person, any direct or indirect acquisition or investment by such Person, whether by means of (a) the purchase or other acquisition
of Equity Interests of another Person, (b) a loan, advance or capital contribution to, Guarantee or assumption of debt of, or
purchase or other acquisition of any other debt or interest in, another Person, or (c) the purchase or other acquisition (in one
transaction or a series of transactions) of assets of another Person that constitute a business unit or all or a substantial part
of the business of, such Person. For purposes of covenant compliance, the amount of any Investment shall be the amount actually
invested, without adjustment for subsequent increases or decreases in the value of such Investment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>IP Rights</U>&rdquo; has the meaning
specified in <U>Section 5.16</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>IP Security Agreement Supplement</U>&rdquo;
has the meaning specified in the Security Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>IRS</U>&rdquo; means the United States
Internal Revenue Service.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>ISP</U>&rdquo; means, with respect
to any Letter of Credit, the &ldquo;International Standby Practices 1998&rdquo; published by the Institute of International Banking
Law &amp; Practice, Inc. (or such later version thereof as may be in effect at the time of issuance).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Issuer Documents</U>&rdquo; means
with respect to any Letter of Credit, the Letter of Credit Application, and any other document, agreement and instrument entered
into by the L/C Issuer and the Borrower (or any Subsidiary) or in favor of the L/C Issuer and relating to such Letter of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Laws</U>&rdquo; means, collectively,
all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and
administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental
Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed
duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether
or not having the force of law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>L/C Advance</U>&rdquo; means, with
respect to each Revolving Credit Lender, such Lender&rsquo;s funding of its participation in any L/C Borrowing in accordance with
its Applicable Revolving Credit Percentage.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>L/C Borrowing</U>&rdquo; means an
extension of credit resulting from a drawing under any Letter of Credit which has not been reimbursed on the date when made or
refinanced as a Revolving Credit Borrowing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>L/C Credit Extension</U>&rdquo; means,
with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the increase of the amount
thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>L/C Issuer</U>&rdquo; means Bank
of America in its capacity as issuer of Letters of Credit hereunder, or any successor issuer of Letters of Credit hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>L/C Obligations</U>&rdquo; means,
as at any date of determination, the aggregate amount available to be drawn under all outstanding Letters of Credit <U>plus</U>
the aggregate of all Unreimbursed Amounts, including all L/C Borrowings. For purposes of computing the amount available to be
drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with <U>Section 1.06</U>.
For all purposes of this Agreement, if on any date of determination a Letter of Credit has expired by its terms but any amount
may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be
&ldquo;outstanding&rdquo; in the amount so remaining available to be drawn.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Lender</U>&rdquo; has the meaning
specified in the introductory paragraph hereto and, as the context requires.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Lending Office</U>&rdquo; means,
as to any Lender, the office or offices of such Lender described as such in such Lender&rsquo;s Administrative Questionnaire,
or such other office or offices as a Lender may from time to time notify the Borrower and the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Letter of Credit</U>&rdquo; means
any standby letter of credit issued hereunder and, for avoidance of doubt, excludes any commercial, documentary or other types
of letters of credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Letter of Credit Application</U>&rdquo;
means an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by
the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Letter of Credit Expiration Date</U>&rdquo;
means the day that is seven days prior to the Maturity Date then in effect for the Revolving Credit Facility (or, if such day
is not a Business Day, the next preceding Business Day).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Letter of Credit Fee</U>&rdquo;
has the meaning specified in <U>Section 2.03(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Letter of Credit Sublimit</U>&rdquo;
means an amount equal to $3,000,000. The Letter of Credit Sublimit is part of, and not in addition to, the Revolving Credit Facility.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>LIBOR</U>&rdquo; for any Interest
Period with respect to a Eurodollar Rate Loan or a Loan bearing interest at the LIBOR Daily Floating Rate, the rate per annum
equal to the London Interbank Offered Rate or a comparable or successor rate, which rate is approved by the Administrative Agent,
as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as
may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m., London time, two Business Days prior
to the commencement of an Interest Period or the LIBOR Rate, respectively, for Dollar deposits (for delivery on the first day
of such Interest Period or period for such LIBOR Rate) LIBOR with a term equivalent to one (1) month term beginning on that date
which LIBOR is effective for such period</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>LIBOR Daily Floating Rate</U>&rdquo;
means: LIBOR with a term equivalent to one (1) month term beginning on that date which LIBOR is effective for such period provided
that: (i) to the extent a comparable or successor rate is approved by the Administrative Agent in connection herewith, the approved
rate shall be applied in a manner consistent with market practice; <U>provided</U>, <U>further</U> that to the extent such market
practice is not administratively feasible for the Administrative Agent, such approved rate shall be applied in a manner as otherwise
reasonably determined by the Administrative Agent and (ii) if the LIBOR Daily Floating Rate shall be less than zero, such rate
shall be deemed zero for purposes of this Agreement<U>.</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Lien</U>&rdquo; means any mortgage,
pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or other), charge, or preference, priority
or other security interest or preferential arrangement in the nature of a security interest of any kind or nature whatsoever (including
any conditional sale or other title retention agreement, any easement, right of way or other encumbrance on title to real property,
and any financing lease having substantially the same economic effect as any of the foregoing).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Loan</U>&rdquo; means an extension
of credit by a Lender to the Borrower under <U>Article II</U> in the form of a Term Loan or a Revolving Credit Loan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Loan Documents</U>&rdquo; means,
collectively, (a)&nbsp;this Agreement, (b) the Notes, (c) the Guaranty, (d) the Collateral Documents and (e) each Issuer Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Loan Parties</U>&rdquo; means, collectively,
the Borrower and each Guarantor.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>London Banking Day</U>&rdquo; means
any day on which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Material Adverse Effect</U>&rdquo;
shall mean any event, matter or condition which is reasonably likely to have a material adverse effect on (a)&nbsp;the business,
assets, properties, liabilities (actual or contingent), operations or conditions (financial or otherwise) of the Borrower and
its Subsidiaries taken as a whole, (b)&nbsp;the Borrower&rsquo;s or any Guarantor&rsquo;s ability to pay and perform its obligations
under the Loan Documents, (c) the rights and remedies of the Administrative Agent or the Lenders under the Loan Documents, and/or
(d) the Eligible Receivables or the Eligible Inventory.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Material Contract</U>&rdquo; means
the &ldquo;Material Agreements&rdquo; listed on the Borrower&rsquo;s most recent Form 10K filed with the SEC, as supplemented
by the Borrower&rsquo;s Forms 10Q and 8K filed with the SEC thereafter and, with respect to any other Person, each contract to
which such Person is a party involving aggregate consideration payable to or by such Person of $4,000,000 or more in any year
or otherwise if terminated by the counterparty could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Maturity Date</U>&rdquo; means (a)
with respect to the Revolving Credit Facility, May 1, 2022 and (b) with respect to the Term Loan, May 1, 2022; <U>provided</U>,
<U>however</U>, that, in each case, if such date is not a Business Day, the Maturity Date shall be the next preceding Business
Day.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Measurement Period</U>&rdquo; means,
at any date of determination, the most recently completed four fiscal quarters of the Borrower.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Minimum Collateral Amount</U>&rdquo;
means, at any time, (a)&nbsp;with respect to Cash Collateral consisting of cash or deposit account balances provided to reduce
or eliminate Fronting Exposure during any period when a Lender constitutes a Defaulting Lender, an amount equal to 103% of the
Fronting Exposure of the L/C Issuer with respect to Letters of Credit issued and outstanding at such time, (b)&nbsp;with respect
to Cash Collateral consisting of cash or deposit account balances provided in accordance with the provisions of <U>Section 2.14(a)(i)</U>,
<U>(a)(ii)</U>, <U>(a)(iii)</U> or <U>(a)(iv)</U>, an amount equal to 103% of the Outstanding Amount of all L/C Obligations, and
(c)&nbsp;otherwise, an amount determined by the Administrative Agent and the L/C Issuer in their sole discretion.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Moody&rsquo;s</U>&rdquo; means Moody&rsquo;s
Investors Service, Inc. and any successor thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Multiemployer Plan</U>&rdquo; means
any employee benefit plan of the type described in Section&nbsp;4001(a)(3) of ERISA, to which the Borrower or any ERISA Affiliate
makes or is obligated to make contributions, or during the preceding five plan years, has made or been obligated to make contributions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Net Cash Proceeds</U>&rdquo; means:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
respect to any Disposition by the Borrower or any of its Subsidiaries, or any Extraordinary Receipt received or paid to the account
of the Borrower or any of its Subsidiaries, the excess, if any, of (i) the sum of cash and Cash Equivalents received in connection
with such transaction (including any cash or Cash Equivalents received by way of deferred payment pursuant to, or by monetization
of, a note receivable or otherwise, but only as and when so received) over (ii) the sum of (A) the principal amount of any Indebtedness
that is secured by the applicable asset and that is required to be repaid in connection with such transaction (other than Indebtedness
under the Loan Documents), (B) the reasonable and customary out-of-pocket expenses incurred by the Borrower or such Subsidiary
in connection with such transaction and (C) income taxes reasonably estimated to be actually payable within two years of the date
of the relevant transaction as a result of any gain recognized in connection therewith; <U>provided</U> that, if the amount of
any estimated taxes pursuant to subclause (C) exceeds the amount of taxes actually required to be paid in cash in respect of such
Disposition, the aggregate amount of such excess shall constitute Net Cash Proceeds; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
respect to the sale or issuance of any Equity Interest by the Borrower or any of its Subsidiaries, or the incurrence or issuance
of any Indebtedness by the Borrower or any of its Subsidiaries, the excess of (i) the sum of the cash and Cash Equivalents received
in connection with such transaction over (ii) the underwriting discounts and commissions, and other reasonable and customary out-of-pocket
expenses, incurred by the Borrower or such Subsidiary in connection therewith.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Net Income</U>&rdquo; for any period,
shall mean net income (or loss) for such period, determined in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Non-Defaulting Lender</U>&rdquo;
means, at any time, each Lender that is not a Defaulting Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Note</U>&rdquo; means a Term Note
or a Revolving Credit Note, as the context may require.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>NPL</U>&rdquo; means the National
Priorities List under CERCLA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Obligations</U>&rdquo; means all
advances to, and debts, liabilities, obligations, covenants and duties of, any Loan Party arising under any Loan Document or otherwise
with respect to any Loan, Letter of Credit, Secured Cash Management Agreement or Secured Hedge Agreement, in each case whether
direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter
arising and including interest and fees that accrue after the commencement by or against any Loan Party or any Affiliate thereof
of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such
interest and fees are allowed claims in such proceeding; <U>provided</U> that the Obligations shall exclude any Excluded Swap
Obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>OFAC</U>&rdquo; means the Office
of Foreign Assets Control of the United States Department of Treasury.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Organization Documents</U>&rdquo;
means, (a) with respect to any corporation, the certificate or articles of incorporation and the bylaws (or equivalent or comparable
constitutive documents with respect to any non-U.S. jurisdiction); (b) with respect to any limited liability company, the certificate
or articles of formation or organization and operating agreement; and (c) with respect to any partnership, joint venture, trust
or other form of business entity, the partnership, joint venture or other applicable agreement of formation or organization and
any agreement, instrument, filing or notice with respect thereto filed in connection with its formation or organization with the
applicable Governmental Authority in the jurisdiction of its formation or organization and, if applicable, any certificate or
articles of formation or organization of such entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Other Connection Taxes</U>&rdquo;
means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the
jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party
to, performed its obligations under, received payment under, received or perfected a security interest under, engaged in any other
transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Documents).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Other Taxes</U>&rdquo; means all
present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies arising from any
payment made hereunder or under any other Loan Document or from the execution, delivery or enforcement of, or otherwise with respect
to, this Agreement or any other Loan Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Outstanding Amount</U>&rdquo; means
(a) with respect to the Term Loan and Revolving Credit Loans on any date, the aggregate outstanding principal amount thereof after
giving effect to any borrowings and prepayments or repayments of the Term Loan and Revolving Credit Loans, as the case may be,
occurring on such date; and (b) with respect to any L/C Obligations on any date, the amount of such L/C Obligations on such date
after giving effect to any L/C Credit Extension occurring on such date and any other changes in the aggregate amount of the L/C
Obligations as of such date, including as a result of any reimbursements by the Borrower of Unreimbursed Amounts.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Participant</U>&rdquo; has the meaning
specified in <U>Section 11.06(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>PBGC</U>&rdquo; means the Pension
Benefit Guaranty Corporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Pension Plan</U>&rdquo; means any
&ldquo;employee pension benefit plan&rdquo; (as such term is defined in Section 3(2) of ERISA), other than a Multiemployer Plan,
that is subject to Title IV of ERISA and is sponsored or maintained by the Borrower or any ERISA Affiliate or to which the Borrower
or any ERISA Affiliate contributes or has an obligation to contribute, or in the case of a multiple employer or other plan described
in Section 4064(a) of ERISA, has made contributions at any time during the immediately preceding five plan years.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Permitted Acquisition</U>&rdquo;
shall have the meaning specified in <U>Section 7.03(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Permitted Lien</U>&rdquo; shall have
the meaning specified in <U>Section 7.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Person</U>&rdquo; means any natural
person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority
or other entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Plan</U>&rdquo; means any &ldquo;employee
benefit plan&rdquo; (as such term is defined in Section&nbsp;3(3) of ERISA) established by the Borrower or, with respect to any
such plan that is subject to Section 412 of the Code or Title IV of ERISA, any ERISA Affiliate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Platform</U>&rdquo; has the meaning
specified in <U>Section 6.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Pledge Agreement</U>&rdquo; means,
collectively, (a) that certain Stock Pledge Agreement dated as of March 29, 2013 by and between the Borrower and the Administrative
Agent, and (b) that certain Stock Pledge Agreement dated as of March 29, 2013 by and between the Guarantors and the Administrative
Agent, in each case as amended, modified, supplemented or restated from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Pledged Debt</U>&rdquo; has the meaning
specified in the Security Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Pledged Equity</U>&rdquo; has the
meaning specified in the Security Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Public Lender</U>&rdquo; has the
meaning specified in <U>Section 6.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Qualified ECP Guarantor</U>&rdquo;
shall mean, at any time, each Loan Party with total assets exceeding $10,000,000 or that qualifies at such time as an &ldquo;eligible
contract participant&rdquo; under the Commodity Exchange Act and can cause another person to qualify as an &ldquo;eligible contract
participant&rdquo; at such time under &sect;1a(18)(A)(v)(II) of the Commodity Exchange Act.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Receivables</U>&rdquo; means &ldquo;accounts&rdquo;
as such term is defined in the UCC.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Recipient</U>&rdquo; means the Administrative
Agent, any Lender, the L/C Issuer or any other recipient of any payment to be made by or on account of any Obligation of any Loan
Party hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Reduction Amount</U>&rdquo; has the
meaning set forth in <U>Section 2.05(b)(vii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Register</U>&rdquo; has the meaning
specified in <U>Section 11.06(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Related Parties</U>&rdquo; means,
with respect to any Person, such Person&rsquo;s Affiliates and the partners, directors, officers, employees, agents, trustees
and advisors of such Person and of such Person&rsquo;s Affiliates.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Reportable Event</U>&rdquo; means
any of the events set forth in Section 4043(c) of ERISA, other than events for which the 30 day notice period has been waived.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Request for Credit Extension</U>&rdquo;
means (a) with respect to a Borrowing, conversion or continuation of the Term Loan or Revolving Credit Loans, a Committed Loan
Notice and (b) with respect to an L/C Credit Extension, a Letter of Credit Application.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Required Lenders</U>&rdquo; means,
as of any date of determination, if there are two Lenders (with each Lender and its Affiliate constituting one Lender), then both
Lenders, and if more than two Lenders, (a) the Required Revolving Lenders; and (b) the Required Term Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Required Revolving Lenders</U>&rdquo;
means, as of any date of determination, Revolving Credit Lenders holding at least 66-&#8532;% of the sum of the (a)&nbsp;Total
Revolving Credit Outstandings (with the aggregate amount of each Revolving Credit Lender&rsquo;s risk participation and funded
participation in L/C Obligations being deemed &ldquo;held&rdquo; by such Revolving Credit Lender for purposes of this definition)
and (b)&nbsp;aggregate unused Revolving Credit Commitments; <U>provided</U> that the unused Revolving Credit Commitment of, and
the portion of the Total Revolving Credit Outstandings held or deemed held by, any Defaulting Lender shall be excluded for purposes
of making a determination of Required Revolving Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Required Term Lenders</U>&rdquo;
means, as of any date of determination, the Term Lenders holding at least 66-2/3% of the aggregate of the Term Loan outstanding
on such date; <U>provided</U> that the portion of the Term Loan held by any Defaulting Lender shall be excluded for purposes of
making a determination of Required Term Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Responsible Officer</U>&rdquo; means
the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of a Loan Party.
Any document delivered hereunder that is signed by a Responsible Officer of a Loan Party shall be conclusively presumed to have
been authorized by all necessary corporate, partnership and/or other action on the part of such Loan Party and such Responsible
Officer shall be conclusively presumed to have acted on behalf of such Loan Party and, solely for purposes of notices given pursuant
to Article II, any other officer or employee of the applicable Loan Party so designated by any of the foregoing officers in a
notice to the Administrative Agent or any other officer or employee of the applicable Loan Party designated in or pursuant to
an agreement between the applicable Loan Party and the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Restated Obligations</U>&rdquo; is
defined in the preamble hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Restricted Payment</U>&rdquo; means
(i) any cash dividend or other cash distribution or payment, direct or indirect, on or on account of any shares of any class of
stock of the Borrower now or hereafter outstanding or (ii) any redemption, purchase or other acquisition, direct or indirect,
of any shares of any class of stock of the Borrower now or hereafter outstanding or of any warrants, options or rights to purchase
any such stock (including, without limitation, the repurchase of any such stock, warrant, option or right or any refund of the
purchase price thereof in connection with the exercise by the holder thereof of any right of rescission or similar remedies with
respect thereto).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Borrowing</U>&rdquo;
means a borrowing consisting of simultaneous Revolving Credit Loans of the same Type and, in the case of Eurodollar Rate Loans,
having the same Interest Period made by each of the Revolving Credit Lenders pursuant to <U>Section 2.01(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Commitment</U>&rdquo;
means, as to each Revolving Credit Lender, its obligation to (a) make Revolving Credit Loans to the Borrower pursuant to <U>Section
2.01(b)(ii)</U> and (b) purchase participations in L/C Obligations , in an aggregate principal amount at any one time outstanding
not to exceed the amount set forth opposite such Lender&rsquo;s name on <U>Schedule 2.01</U> under the caption &ldquo;Revolving
Credit Commitment&rdquo; or opposite such caption in the Assignment and Assumption pursuant to which such Lender becomes a party
hereto, as applicable, as such amount may be adjusted from time to time in accordance with this Agreement. The aggregate amount
of the Revolving Credit Commitments on the Third A&amp;R Effective Date is $25,000,000, which amount may be reduced from time
to time in accordance with the terms of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Facility</U>&rdquo;
means, at any time, the aggregate amount of the Revolving Credit Lenders&rsquo; Revolving Credit Commitments at such time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Lender</U>&rdquo;
means, at any time, any Lender that has a Revolving Credit Commitment at such time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Loan</U>&rdquo;
has the meaning specified in <U>Section 2.01(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Revolving Credit Note</U>&rdquo;
means a promissory note made by the Borrower in favor of a Revolving Credit Lender evidencing Revolving Credit Loans, as the case
may be, made by such Revolving Credit Lender, substantially in the form of <U>Exhibit&nbsp;C</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>S&amp;P</U>&rdquo; means Standard
&amp; Poor&rsquo;s Financial Services LLC, a subsidiary of The McGraw-Hill Companies, Inc., and any successor thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Sanction(s)</U>&rdquo; means any
sanction administered or enforced by the United States Government (including without limitation, OFAC), the United Nations Security
Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant sanctions authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>SEC</U>&rdquo; means the Securities
and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Secured Cash Management Agreement</U>&rdquo;
means any Cash Management Agreement that is entered into by and between any Loan Party and any Cash Management Bank.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Secured Hedge Agreement</U>&rdquo;
means any interest rate Swap Contract required or permitted under <U>Article VI</U> or <U>VII</U> that is entered into by and
between any Loan Party and any Hedge Bank.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Secured Parties</U>&rdquo; means,
collectively, the Administrative Agent, the Lenders, the L/C Issuer, the Hedge Banks, the Cash Management Banks, each co-agent
or sub-agent appointed by the Administrative Agent from time to time pursuant to <U>Section&nbsp;9.05</U>, and the other Persons
the Obligations owing to which are or are purported to be secured by the Collateral under the terms of the Collateral Documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Security Agreement</U>&rdquo; means,
collectively, (a) that certain Security and Pledge Agreement dated as of March 29, 2013 by and between the Borrower and the Administrative
Agent and (b) that certain Security and Pledge Agreement dated as of March 29, 2013 by and among the Guarantors and the Administrative
Agent, in each case as amended, modified, supplemented or restated from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Security Agreement Supplement</U>&rdquo;
has the meaning specified in the Security Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Solvent</U>&rdquo; and &ldquo;<U>Solvency</U>&rdquo;
mean, with respect to any Person on any date of determination, that on such date (a)&nbsp;the fair value of the property of such
Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, (b)&nbsp;the present
fair salable value of the assets of such Person is not less than the amount that will be required to pay the probable liability
of such Person on its debts as they become absolute and matured, (c)&nbsp;such Person does not intend to, and does not believe
that it will, incur debts or liabilities beyond such Person&rsquo;s ability to pay such debts and liabilities as they mature,
(d)&nbsp;such Person is not engaged in business or a transaction, and is not about to engage in business or a transaction, for
which such Person&rsquo;s property would constitute an unreasonably small capital, and (e) such Person is able to pay its debts
and liabilities, contingent obligations and other commitments as they mature in the ordinary course of business. The amount of
contingent liabilities at any time shall be computed as the amount that, in the light of all the facts and circumstances existing
at such time, represents the amount that can reasonably be expected to become an actual or matured liability.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Specified Loan Party</U>&rdquo; means
any Loan Party that is not an &ldquo;eligible contract participant&rdquo; under the Commodity Exchange Act (determined prior to
giving effect to <U>Section&nbsp;11.20(b)</U>).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Subsidiary</U>&rdquo; of a Person
means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of the
shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other
than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially
owned, or the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both,
by such Person. Unless otherwise specified, all references herein to a &ldquo;<U>Subsidiary</U>&rdquo; or to &ldquo;<U>Subsidiaries</U>&rdquo;
shall refer to a Subsidiary or Subsidiaries of the Borrower.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Swap Contract</U>&rdquo; means (a)
any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity
options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options
or forward bond or forward bond price or forward bond index transactions, interest rate options, forward foreign exchange transactions,
cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions,
currency options, spot contracts, or any other similar transactions or any combination of any of the foregoing (including any
options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement,
and (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of,
or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International
Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules,
a &ldquo;<U>Master Agreement</U>&rdquo;), including any such obligations or liabilities under any Master Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Swap Obligations</U>&rdquo; means
with respect to any Guarantor any obligation to pay or perform under any agreement, contract or transaction that constitutes a
&ldquo;swap&rdquo; within the meaning of Section&nbsp;1a(47) of the Commodity Exchange Act.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Swap Termination Value</U>&rdquo;
means, in respect of any one or more Swap Contracts, after taking into account the effect of any legally enforceable netting agreement
relating to such Swap Contracts, (a) for any date on or after the date such Swap Contracts have been closed out and termination
value(s) determined in accordance therewith, such termination value(s), and (b) for any date prior to the date referenced in clause
(a), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market
or other readily available quotations provided by any recognized dealer in such Swap Contracts (which may include a Lender or
any Affiliate of a Lender).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Synthetic Debt</U>&rdquo; means,
with respect to any Person as of any date of determination thereof, all obligations of such Person in respect of transactions
entered into by such Person that are intended to function primarily as a borrowing of funds but are not otherwise included in
the definition of &ldquo;<U>Indebtedness</U>&rdquo; or as a liability on the consolidated balance sheet of such Person and its
Subsidiaries in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Synthetic Lease Obligation</U>&rdquo;
means the monetary obligation of a Person under (a) a so-called synthetic, off-balance sheet or tax retention lease, or (b) an
agreement for the use or possession of property (including sale and leaseback transactions), in each case, creating obligations
that do not appear on the balance sheet of such Person but which, upon the application of any Debtor Relief Laws to such Person,
would be characterized as the indebtedness of such Person (without regard to accounting treatment).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Taxes</U>&rdquo; means all present
or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other
charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Term Borrowing</U>&rdquo; means a
borrowing consisting of the Term Loan, each portion of which shall be of the same Type and, in the case of Eurodollar Rate Loans,
having the same Interest Period, made by each of the Term&nbsp;Lenders pursuant to <U>Section 2.01(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Term&nbsp;Lender</U>&rdquo; means
any Lender that holds a portion of the Term Loan at a given time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Term Loan</U>&rdquo; means each Lender&rsquo;s
proportionate share of the outstanding aggregate principal amount of the Restated Obligations on the Third A&amp;R Effective Date,
which, on the date hereof, is in an aggregate principal amount of $14,000,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Term&nbsp;Note</U>&rdquo; means an
amended and restated promissory note made by the Borrower in favor of a Term&nbsp;Lender evidencing the portion of the Term Loan
made by such Term&nbsp;Lender, substantially in the form of <U>Exhibit&nbsp;B</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Third A&amp;R Effective Date</U>&rdquo;
means the first date all the conditions precedent in <U>Section 4.01</U> are satisfied or waived in accordance with <U>Section
11.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Threshold Amount</U>&rdquo; means
$500,000, or any lesser amount where a failure to pay or perform is reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Total Funded Debt</U>&rdquo; means
at any date of determination, the aggregate outstanding amount of Funded Debt.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Total Outstandings</U>&rdquo; means
the aggregate Outstanding Amount of all Loans and all L/C Obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Total Revolving Credit Outstandings</U>&rdquo;
means the aggregate Outstanding Amount of all Revolving Credit Loans and L/C Obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Type</U>&rdquo; means, with respect
to a Loan, its character as a LIBOR Daily Floating Rate Loan or a Eurodollar Rate Loan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>UCC</U>&rdquo; means the Uniform
Commercial Code as in effect in The Commonwealth of Massachusetts; <U>provided</U> that, if perfection or the effect of perfection
or non-perfection or the priority of any security interest in any Collateral is governed by the Uniform Commercial Code as in
effect in a jurisdiction other than The Commonwealth of Massachusetts, &ldquo;<U>UCC</U>&rdquo; means the Uniform Commercial Code
as in effect from time to time in such other jurisdiction for purposes of the provisions hereof relating to such perfection, effect
of perfection or non-perfection or priority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Unfunded Pension Liability</U>&rdquo;
means the excess of a Pension Plan&rsquo;s benefit liabilities under Section&nbsp;4001(a)(16) of ERISA, over the current value
of that Pension Plan&rsquo;s assets, determined in accordance with the assumptions used for funding the Pension Plan pursuant
to Section&nbsp;412 of the Code for the applicable plan year.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>United States</U>&rdquo; and &ldquo;<U>U.S.</U>&rdquo;
mean the United States of America.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Unreimbursed Amount</U>&rdquo; has
the meaning specified in <U>Section 2.03(c)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Working Capital</U>&rdquo; means
an amount equal to the sum of (i) one hundred percent (100%) of the Borrower&rsquo;s and its Subsidiaries&rsquo; cash and Cash
Equivalents on deposit, plus (ii) eighty-five percent (85%) of the Borrower&rsquo;s and its Subsidiaries&rsquo; Eligible Receivables
plus (iii) the <U>lesser</U> of (a) an amount equal to forty percent (40%) of the Borrower&rsquo;s and its Subsidiaries&rsquo;
Eligible Inventory and (b) $8,500,000. For purposes of computing Working Capital hereunder after application of the forty percent
(40%) formula as set forth in clause (ii) above, the Borrower shall not include more than $4,250,000 of Eligible Inventory maintained
at any one warehouse, distribution center or other real property leased by the Borrower or any Subsidiary in the calculation thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&ldquo;<U>Write-Down and Conversion Powers</U>&rdquo;
means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from
time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described
in the EU Bail-In Legislation Schedule.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Interpretive Provisions</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">With reference to this Agreement and each other
Loan Document, unless otherwise specified herein or in such other Loan Document:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever the
context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words &ldquo;include,&rdquo;
&ldquo;includes&rdquo; and &ldquo;including&rdquo; shall be deemed to be followed by the phrase &ldquo;without limitation.&rdquo;
The word &ldquo;will&rdquo; shall be construed to have the same meaning and effect as the word &ldquo;shall.&rdquo; Unless the
context requires otherwise, (i) any definition of or reference to any agreement, instrument or other document (including any Organization
Document) shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented
or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein or in any
other Loan Document), (ii) any reference herein to any Person shall be construed to include such Person&rsquo;s successors and
assigns, (iii) the words &ldquo;herein,&rdquo; &ldquo;hereof&rdquo; and &ldquo;hereunder,&rdquo; and words of similar import when
used in any Loan Document, shall be construed to refer to such Loan Document in its entirety and not to any particular provision
thereof, (iv) all references in a Loan Document to Articles, Sections, Preliminary Statements, Exhibits and Schedules shall be
construed to refer to Articles and Sections of, and Preliminary Statements, Exhibits and Schedules to, the Loan Document in which
such references appear, (v) any reference to any law shall include all statutory and regulatory provisions consolidating, amending,
replacing or interpreting such law and any reference to any law or regulation shall, unless otherwise specified, refer to such
law or regulation as amended, modified or supplemented from time to time, and (vi) the words &ldquo;<U>asset</U>&rdquo; and &ldquo;<U>property</U>&rdquo;
shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties,
including cash, securities, accounts and contract rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the computation of periods of time from a specified date to a later specified date, the word &ldquo;<U>from</U>&rdquo;
means &ldquo;<U>from and including</U>;&rdquo; the words &ldquo;<U>to</U>&rdquo; and &ldquo;<U>until</U>&rdquo; each mean &ldquo;<U>to
but excluding</U>;&rdquo; and the word &ldquo;<U>through</U>&rdquo; means &ldquo;<U>to and including</U>.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section headings herein and in the other Loan Documents are included for convenience of reference only and shall not affect
the interpretation of this Agreement or any other Loan Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accounting Terms</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Generally</U>. All accounting terms not specifically or completely defined herein shall be construed in conformity with,
and all financial data (including financial ratios and other financial calculations) required to be submitted pursuant to this
Agreement shall be prepared in conformity with, GAAP applied on a consistent basis, as in effect from time to time, applied in
a manner consistent with that used in preparing the Audited Financial Statements, <U>except</U> as otherwise specifically prescribed
herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Changes in GAAP</U>. If at any time any change in GAAP would affect the computation of any financial ratio or requirement
set forth in any Loan Document, and either the Borrower or the Required Lenders shall so request, the Administrative Agent, the
Lenders and the Borrower shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof
in light of such change in GAAP (subject to the approval of the Required Lenders); <U>provided</U> that, until so amended, (i)
such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii)&nbsp;the
Borrower shall provide to the Administrative Agent and the Lenders financial statements and other documents required under this
Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement
made before and after giving effect to such change in GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rounding</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any financial ratios required to be maintained
by the Borrower pursuant to this Agreement shall be calculated by dividing the appropriate component by the other component, carrying
the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down
to the nearest number (with a rounding-up if there is no nearest number).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Times of Day</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise specified, all references
herein to times of day shall be references to Eastern time (daylight or standard, as applicable).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Letter of Credit Amounts</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise specified herein, the amount
of a Letter of Credit at any time shall be deemed to be the stated amount of such Letter of Credit in effect at such time; <U>provided</U>,
<U>however</U>, that with respect to any Letter of Credit that, by its terms or the terms of any Issuer Document related thereto,
provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed
to be the maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum
stated amount is in effect at such time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">1.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Currency Equivalents Generally</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any amount specified in this Agreement (other
than in <U>Articles II</U>, <U>IX</U> and <U>X</U>) or any of the other Loan Documents to be in Dollars shall also include the
equivalent of such amount in any currency other than Dollars, such equivalent amount thereof in the applicable currency to be
determined by the Administrative Agent at such time on the basis of the Spot Rate (as defined below) for the purchase of such
currency with Dollars. For purposes of this <U>Section&nbsp;1.07</U>, the &ldquo;<U>Spot Rate</U>&rdquo; for a currency means
the rate determined by the Administrative Agent to be the rate quoted by the Person acting in such capacity as the spot rate for
the purchase by such Person of such currency with another currency through its principal foreign exchange trading office at approximately
11:00 a.m. on the date two Business Days prior to the date of such determination; <U>provided</U> that the Administrative Agent
may obtain such spot rate from another financial institution designated by the Administrative Agent if the Person acting in such
capacity does not have as of the date of determination a spot buying rate for any such currency.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE II<BR>
the COMMITMENTS and Credit Extensions</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Loans</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Term Borrowing</U>. Subject to the terms and conditions set forth herein, each Term&nbsp;Lender severally agrees
to consolidate, combine and restate the Restated Obligations in a single loan on the Third A&amp;R Effective Date in an aggregate
principal amount not to exceed $14,000,000. The Borrower and each Lender hereby acknowledge, confirm and agree that such consolidation,
combination and restatement shall be effected by a cashless settlement. Any portion of the Term Loan which is repaid or prepaid
may not be reborrowed. The Term Loan may be a LIBOR Daily Floating Rate Loan or a Eurodollar Rate Loan, as further provided herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Revolving Credit Borrowings</U>. Subject to the terms and conditions set forth herein, each Revolving Credit Lender
severally agrees to make loans (each such loan, a &ldquo;<U>Revolving Credit Loan</U>&rdquo;) to the Borrower from time to time,
on any Business Day during the Availability Period for the Revolving Credit Facility, in an aggregate amount not to exceed at any
time outstanding the amount of such Lender&rsquo;s Revolving Credit Commitment; <U>provided</U> that, after giving effect to any
Revolving Credit Borrowing, (i) the Total Revolving Credit Outstandings, shall not exceed the Revolving Credit Facility and (ii)
the aggregate Outstanding Amount of the Revolving Credit Loans of any Lender, <U>plus</U> such Revolving Credit Lender&rsquo;s
Applicable Revolving Credit Percentage of the Outstanding Amount of all L/C Obligations, shall not exceed such Revolving Credit
Lender&rsquo;s Revolving Credit Commitment. Within the limits of each Revolving Credit Lender&rsquo;s Revolving Credit Commitment,
and subject to the other terms and conditions hereof, including, without limitation, any voluntary or automatic reduction thereof,
as provided under <U>Section 2.06</U>, the Borrower may borrow under this <U>Section 2.01(b)</U>, prepay under <U>Section 2.05</U>,
and reborrow under this <U>Section 2.01(b)</U>. Revolving Credit Loans may be LIBOR Daily Floating Rate Loans or Eurodollar Rate
Loans, as further provided herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Borrowings, Conversions and Continuations of Loans</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Term Borrowing, each Revolving Credit Borrowing, each conversion of the Term Loan or Revolving Credit Loans from one
Type to the other, and each continuation of Eurodollar Rate Loans shall be made upon the Borrower&rsquo;s irrevocable notice to
the Administrative Agent, which may be given by (A)&nbsp;telephone, or (B)&nbsp;a Committed Loan Notice; provided that any telephone
notice must be confirmed immediately by delivery to the Administrative Agent of a Committed Loan Notice. Each such Committed Loan
Notice must be received by the Administrative Agent not later than 11:00 a.m. (i) three Business Days prior to the requested date
of any Borrowing of, conversion to or continuation of Eurodollar Rate Loans or of any conversion of Eurodollar Rate Loans to LIBOR
Daily Floating Rate Loans, and (ii) on the requested date of any Borrowing of LIBOR Daily Floating Rate Loans; <U>provided</U>,
<U>however</U>, that if the Borrower wishes to request Eurodollar Rate Loans having an Interest Period other than one, two, three
or six months in duration as provided in the definition of &ldquo;Interest Period,&rdquo; the applicable notice must be received
by the Administrative Agent not later than 11:00 a.m. four Business Days prior to the requested date of such Borrowing, conversion
or continuation, whereupon the Administrative Agent shall give prompt notice to the Appropriate Lenders of such request and determine
whether the requested Interest Period is acceptable to all of them. Not later than 11:00 a.m., three Business Days before the requested
date of such Borrowing, conversion or continuation, the Administrative Agent shall notify the Borrower (which notice may be by
telephone) whether or not the requested Interest Period has been consented to by all the Lenders. Each Borrowing of, conversion
to or continuation of Eurodollar Rate Loans shall be in a principal amount of $1,000,000 or a whole multiple of $100,000 in excess
thereof. Except as provided in <U>Sections&nbsp;2.03(c)</U>, each Borrowing of or conversion to LIBOR Daily Floating Rate Loans
shall be in a principal amount of $500,000 or a whole multiple of $100,000 in excess thereof. Each Committed Loan Notice shall
specify (i)&nbsp;whether the Borrower is requesting a Term Borrowing, a Revolving Credit Borrowing, a conversion of the Term Loan
or Revolving Credit Loans from one Type to the other, or a continuation of Eurodollar Rate Loans, (ii) the requested date of the
Borrowing, conversion or continuation, as the case may be (which shall be a Business Day), (iii) the principal amount of Loans
to be borrowed, converted or continued, (iv) the Type of Loans to be borrowed or to which the existing Term Loan or Revolving Credit
Loans are to be converted, and (v) if applicable, the duration of the Interest Period with respect thereto. If the Borrower fails
to specify a Type of Loan in a Committed Loan Notice or if the Borrower fails to give a timely notice requesting a conversion or
continuation, then the applicable Term Loan or Revolving Credit Loans shall be made as, or converted to, LIBOR Daily Floating Rate
Loans. Any such automatic conversion to LIBOR Daily Floating Rate Loans shall be effective as of the last day of the Interest Period
then in effect with respect to the applicable Eurodollar Rate Loans. If the Borrower requests a Borrowing of, conversion to, or
continuation of Eurodollar Rate Loans in any such Committed Loan Notice, but fails to specify an Interest Period, it will be deemed
to have specified an Interest Period of one month.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following receipt of a Committed Loan Notice, the Administrative Agent shall promptly notify each Lender of the amount of
its Applicable Percentage under the applicable Facility of the applicable Term Loan or Revolving Credit Loans, and if no timely
notice of a conversion or continuation is provided by the Borrower, the Administrative Agent shall notify each Lender of the details
of any automatic conversion to LIBOR Daily Floating Rate Loans described in <U>Section 2.02(a)</U>. In the case of a Term&nbsp;Borrowing
or a Revolving Credit Borrowing, each Appropriate Lender shall make the amount of its Loan available to the Administrative Agent
in immediately available funds at the Administrative Agent&rsquo;s Office not later than 1:00 p.m. on the Business Day specified
in the applicable Committed Loan Notice. Upon satisfaction of the applicable conditions set forth in <U>Section 4.02</U> (and,
if such Borrowing is the initial Credit Extension, <U>Section 4.01</U>), the Administrative Agent shall make all funds so received
available to the Borrower in like funds as received by the Administrative Agent either by (i) crediting the account of the Borrower
on the books of Bank of America with the amount of such funds or (ii) wire transfer of such funds, in each case in accordance with
instructions provided to (and reasonably acceptable to) the Administrative Agent by the Borrower; <U>provided</U>, <U>however</U>,
that if, on the date a Committed Loan Notice with respect to a Revolving Credit Borrowing is given by the Borrower, there are L/C
Borrowings outstanding, then the proceeds of such Revolving Credit Borrowing, <U>first</U>, shall be applied to the payment in
full of any such L/C Borrowings, and <U>second</U>, shall be made available to the Borrower as provided above.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided herein, a Eurodollar Rate Loan may be continued or converted only on the last day of an Interest
Period for such Eurodollar Rate Loan. During the existence of a Default, no Loans may be requested as, converted to or continued
as Eurodollar Rate Loans without the consent of the Required Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent shall promptly notify the Borrower and the Lenders of the interest rate applicable to any Interest
Period for Eurodollar Rate Loans upon determination of such interest rate. At any time that LIBOR Daily Floating Rate Loans are
outstanding, the Administrative Agent shall notify the Borrower and the Lenders of any change in Bank of America&rsquo;s prime
rate used in determining the LIBOR Daily Floating Rate promptly following the public announcement of such change.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>After giving effect to all Borrowings, all conversions of Loans from one Type to the other, and all continuations of Loans
as the same Type, there shall not be more than five Interest Periods in effect in respect of the Term Loan, and the Revolving Credit
Facility.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Letters of Credit</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Letter of Credit Commitment</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the terms and conditions set forth herein, (A) the L/C Issuer agrees, in reliance upon the agreements of the
Revolving Credit Lenders set forth in this <U>Section 2.03</U>, (1) from time to time on any Business Day during the period from
the Third A&amp;R Effective Date until the Letter of Credit Expiration Date, to issue Letters of Credit for the account of the
Borrower, and to amend Letters of Credit previously issued by it, in accordance with <U>Section 2.03(b)</U>, and (2) to honor drawings
under the Letters of Credit; and (B) the Revolving Credit Lenders severally agree to participate in Letters of Credit issued for
the account of the Borrower and any drawings thereunder; <U>provided</U> that after giving effect to any L/C Credit Extension with
respect to any Letter of Credit, (x) the Total Revolving Credit Outstandings, shall not exceed the Revolving Credit Facility, (y)
the aggregate Outstanding Amount of the Revolving Credit Loans of any Revolving Credit Lender, <U>plus</U> such Lender&rsquo;s
Applicable Revolving Credit Percentage of the Outstanding Amount of all L/C Obligations shall not exceed such Lender&rsquo;s Revolving
Credit Commitment, and (z) the Outstanding Amount of the L/C Obligations shall not exceed the Letter of Credit Sublimit. Each request
by the Borrower for the issuance or amendment of a Letter of Credit shall be deemed to be a representation by the Borrower that
the L/C Credit Extension so requested complies with the conditions set forth in the proviso to the preceding sentence. Within the
foregoing limits, and subject to the terms and conditions hereof, the Borrower&rsquo;s ability to obtain Letters of Credit shall
be fully revolving, and accordingly the Borrower may, during the foregoing period, obtain Letters of Credit to replace Letters
of Credit that have expired or that have been drawn upon and reimbursed.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The L/C Issuer shall not issue any Letter of Credit if:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(A)<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
expiry date of such requested Letter of Credit would occur more than twelve months after the date of issuance, unless the Required
Revolving Lenders have approved such expiry date; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
expiry date of such requested Letter of Credit would occur after the Letter of Credit Expiration Date, unless all the Revolving
Credit Lenders have approved such expiry date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The L/C Issuer shall not be under any obligation to issue any Letter of Credit if:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain the L/C
Issuer from issuing such Letter of Credit, or any Law applicable to the L/C Issuer or any request or directive (whether or not
having the force of law) from any Governmental Authority with jurisdiction over the L/C Issuer shall prohibit, or request that
the L/C Issuer refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose
upon the L/C Issuer with respect to such Letter of Credit any restriction, reserve or capital requirement (for which the L/C Issuer
is not otherwise compensated hereunder) not in effect on the Third A&amp;R Effective Date, or shall impose upon the L/C Issuer
any unreimbursed loss, cost or expense which was not applicable on the Third A&amp;R Effective Date and which the L/C Issuer in
good faith deems material to it;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
issuance of such Letter of Credit would violate one or more policies of the L/C Issuer applicable to letters of credit generally;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as otherwise agreed by the Administrative Agent and the L/C Issuer, such Letter of Credit is in an initial stated amount less than
$100,000, in the case of a commercial Letter of Credit, or $500,000, in the case of a standby Letter of Credit;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
Letter of Credit is to be denominated in a currency other than Dollars; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(E)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
default of any Lender&rsquo;s obligations to fund under <U>Section 2.03(c)</U> exists or any Lender is at such time a Defaulting
Lender hereunder, unless the L/C Issuer has entered into satisfactory arrangements with the Borrower or such Lender to eliminate
the L/C Issuer&rsquo;s risk with respect to such Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The L/C Issuer shall not amend any Letter of Credit if the L/C Issuer would not be permitted at such time to issue such
Letter of Credit in its amended form under the terms hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The L/C Issuer shall be under no obligation to amend any Letter of Credit if (A) the L/C Issuer would have no obligation
at such time to issue such Letter of Credit in its amended form under the terms hereof, or (B) the beneficiary of such Letter of
Credit does not accept the proposed amendment to such Letter of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The L/C Issuer shall act on behalf of the Revolving Credit Lenders with respect to any Letters of Credit issued by it and
the documents associated therewith, and the L/C Issuer shall have all of the benefits and immunities (A)&nbsp;provided to the Administrative
Agent in <U>Article IX</U> with respect to any acts taken or omissions suffered by the L/C Issuer in connection with Letters of
Credit issued by it or proposed to be issued by it and Issuer Documents pertaining to such Letters of Credit as fully as if the
term &ldquo;Administrative Agent&rdquo; as used in <U>Article IX</U> included the L/C Issuer with respect to such acts or omissions,
and (B) as additionally provided herein with respect to the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Procedures for Issuance and Amendment of Letters of Credit</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Letter of Credit shall be issued or amended, as the case may be, upon the request of the Borrower delivered to the
L/C Issuer (with a copy to the Administrative Agent) in the form of a Letter of Credit Application, appropriately completed and
signed by a Responsible Officer of the Borrower. Such Letter of Credit Application must be received by the L/C Issuer and the Administrative
Agent not later than 11:00 a.m. at least two Business Days (or such later date and time as the Administrative Agent and the L/C
Issuer may agree in a particular instance in their sole discretion) prior to the proposed issuance date or date of amendment, as
the case may be. In the case of a request for an initial issuance of a Letter of Credit, such Letter of Credit Application shall
specify in form and detail satisfactory to the L/C Issuer: (A) the proposed issuance date of the requested Letter of Credit (which
shall be a Business Day); (B) the amount thereof; (C) the expiry date thereof; (D) the name and address of the beneficiary thereof;
(E) the documents to be presented by such beneficiary in case of any drawing thereunder; (F) the full text of any certificate to
be presented by such beneficiary in case of any drawing thereunder; (G) the purpose and nature of the requested Letter of Credit;
and (H) such other matters as the L/C Issuer may require. In the case of a request for an amendment of any outstanding Letter of
Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the L/C Issuer (1) the Letter of Credit
to be amended; (2) the proposed date of amendment thereof (which shall be a Business Day); (3) the nature of the proposed amendment;
and (4) such other matters as the L/C Issuer may require. Additionally, the Borrower shall furnish to the L/C Issuer and the Administrative
Agent such other documents and information pertaining to such requested Letter of Credit issuance or amendment, including any Issuer
Documents, as the L/C Issuer or the Administrative Agent may require.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Promptly after receipt of any Letter of Credit Application, the L/C Issuer will confirm with the Administrative Agent (by
telephone or in writing) that the Administrative Agent has received a copy of such Letter of Credit Application from the Borrower
and, if not, the L/C Issuer will provide the Administrative Agent with a copy thereof. Unless the L/C Issuer has received written
notice from any Revolving Credit Lender, the Administrative Agent or any Loan Party, at least one Business Day prior to the requested
date of issuance or amendment of the applicable Letter of Credit, that one or more applicable conditions contained in <U>Article
IV</U> shall not then be satisfied, then, subject to the terms and conditions hereof, the L/C Issuer shall, on the requested date,
issue a Letter of Credit for the account of the Borrower or enter into the applicable amendment, as the case may be, in each case
in accordance with the L/C Issuer&rsquo;s usual and customary business practices. Immediately upon the issuance of each Letter
of Credit, each Revolving Credit Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from
the L/C Issuer a risk participation in such Letter of Credit in an amount equal to the product of such Revolving Credit Lender&rsquo;s
Applicable Revolving Credit Percentage <U>times</U> the amount of such Letter of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Promptly after its delivery of any Letter of Credit or any amendment to a Letter of Credit to an advising bank with respect
thereto or to the beneficiary thereof, the L/C Issuer will also deliver to the Borrower and the Administrative Agent a true and
complete copy of such Letter of Credit or amendment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Drawings and Reimbursements; Funding of Participations</U>. (i) Upon receipt from the beneficiary of any Letter of Credit
of any notice of a drawing under such Letter of Credit, the L/C Issuer shall notify the Borrower and the Administrative Agent thereof.
Not later than 11:00 a.m. on the date of any payment by the L/C Issuer under a Letter of Credit (each such date, an &ldquo;<U>Honor
Date</U>&rdquo;), the Borrower shall reimburse the L/C Issuer through the Administrative Agent in an amount equal to the amount
of such drawing. If the Borrower fails to so reimburse the L/C Issuer by such time, the Administrative Agent shall promptly notify
each Revolving Credit Lender of the Honor Date, the amount of the unreimbursed drawing (the &ldquo;<U>Unreimbursed Amount</U>&rdquo;),
and the amount of such Revolving Credit Lender&rsquo;s Applicable Revolving Credit Percentage thereof. In such event, the Borrower
shall be deemed to have requested a Revolving Credit Borrowing of LIBOR Daily Floating Rate Loans to be disbursed on the Honor
Date in an amount equal to the Unreimbursed Amount, without regard to the minimum and multiples specified in <U>Section 2.02</U>
for the principal amount of LIBOR Daily Floating Rate Loans, but subject to the amount of the unutilized portion of the Revolving
Credit Commitments and the conditions set forth in <U>Section 4.02</U> (other than the delivery of a Committed Loan Notice). Any
notice given by the L/C Issuer or the Administrative Agent pursuant to this <U>Section 2.03(c)(i)</U> may be given by telephone
if immediately confirmed in writing; <U>provided</U> that the lack of such an immediate confirmation shall not affect the conclusiveness
or binding effect of such notice.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Revolving Credit Lender shall upon any notice pursuant to <U>Section&nbsp;2.03(c)(i)</U> make funds available to the
Administrative Agent for the account of the L/C Issuer at the Administrative Agent&rsquo;s Office in an amount equal to its Applicable
Revolving Credit Percentage of the Unreimbursed Amount not later than 1:00 p.m. on the Business Day specified in such notice by
the Administrative Agent, whereupon, subject to the provisions of <U>Section 2.03(c)(iii)</U>, each Revolving Credit Lender that
so makes funds available shall be deemed to have made a LIBOR Daily Floating Rate Loan to the Borrower in such amount. The Administrative
Agent shall remit the funds so received to the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to any Unreimbursed Amount that is not fully refinanced by a Revolving Credit Borrowing of LIBOR Daily Floating
Rate Loans because the conditions set forth in <U>Section&nbsp;4.02</U> cannot be satisfied or for any other reason, the Borrower
shall be deemed to have incurred from the L/C Issuer an L/C Borrowing in the amount of the Unreimbursed Amount that is not so refinanced,
which L/C Borrowing shall be due and payable on demand (together with interest) and shall bear interest at the Default Rate. In
such event, each Revolving Credit Lender&rsquo;s payment to the Administrative Agent for the account of the L/C Issuer pursuant
to <U>Section 2.03(c)(ii)</U> shall be deemed payment in respect of its participation in such L/C Borrowing and shall constitute
an L/C Advance from such Lender in satisfaction of its participation obligation under this <U>Section 2.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Until each Revolving Credit Lender funds its Revolving Credit Loan or L/C Advance pursuant to this <U>Section 2.03(c)</U>
to reimburse the L/C Issuer for any amount drawn under any Letter of Credit, interest in respect of such Lender&rsquo;s Applicable
Revolving Credit Percentage of such amount shall be solely for the account of the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Revolving Credit Lender&rsquo;s obligation to make Revolving Credit Loans or L/C Advances to reimburse the L/C Issuer
for amounts drawn under Letters of Credit, as contemplated by this <U>Section 2.03(c)</U>, shall be absolute and unconditional
and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which
such Lender may have against the L/C Issuer, the Borrower or any other Person for any reason whatsoever; (B) the occurrence or
continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing; <U>provided</U>,
<U>however</U>, that each Revolving Credit Lender&rsquo;s obligation to make Revolving Credit Loans pursuant to this <U>Section
2.03(c)</U> is subject to the conditions set forth in <U>Section 4.02</U> (other than delivery by the Borrower of a Committed Loan
Notice ). No such making of an L/C Advance shall relieve or otherwise impair the obligation of the Borrower to reimburse the L/C
Issuer for the amount of any payment made by the L/C Issuer under any Letter of Credit, together with interest as provided herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any Revolving Credit Lender fails to make available to the Administrative Agent for the account of the L/C Issuer any
amount required to be paid by such Lender pursuant to the foregoing provisions of this <U>Section 2.03(c)</U> by the time specified
in <U>Section 2.03(c)(ii)</U>, the L/C Issuer shall be entitled to recover from such Lender (acting through the Administrative
Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which
such payment is immediately available to the L/C Issuer at a rate per annum equal to the greater of the Federal Funds Rate and
a rate determined by the L/C Issuer in accordance with banking industry rules on interbank compensation, plus any administrative,
processing or similar fees customarily charged by the L/C Issuer in connection with the foregoing. If such Lender pays such amount
(with interest and fees as aforesaid), the amount so paid shall constitute such Lender&rsquo;s Committed Loan included in the relevant
Committed Borrowing or L/C Advance in respect of the relevant L/C Borrowing, as the case may be. A certificate of the L/C Issuer
submitted to any Revolving Credit Lender (through the Administrative Agent) with respect to any amounts owing under this <U>Section&nbsp;2.03(c)(vi)</U>
shall be conclusive absent manifest error.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Repayment of Participations</U>. (i) At any time after the L/C Issuer has made a payment under any Letter of Credit and
has received from any Revolving Credit Lender such Lender&rsquo;s L/C Advance in respect of such payment in accordance with <U>Section
2.03(c)</U>, if the Administrative Agent receives for the account of the L/C Issuer any payment in respect of the related Unreimbursed
Amount or interest thereon (whether directly from the Borrower or otherwise, including proceeds of Cash Collateral applied thereto
by the Administrative Agent), the Administrative Agent will distribute to such Lender its Applicable Revolving Credit Percentage
thereof in the same funds as those received by the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any payment received by the Administrative Agent for the account of the L/C Issuer pursuant to <U>Section 2.03(c)(i)</U>
is required to be returned under any of the circumstances described in <U>Section 11.05</U> (including pursuant to any settlement
entered into by the L/C Issuer in its discretion), each Revolving Credit Lender shall pay to the Administrative Agent for the account
of the L/C Issuer its Applicable Revolving Credit Percentage thereof on demand of the Administrative Agent, <U>plus</U> interest
thereon from the date of such demand to the date such amount is returned by such Lender, at a rate per annum equal to the Federal
Funds Rate from time to time in effect. The obligations of the Lenders under this clause shall survive the payment in full of the
Obligations and the termination of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Obligations Absolute</U>. The obligation of the Borrower to reimburse the L/C Issuer for each drawing under each Letter
of Credit and to repay each L/C Borrowing shall be absolute, unconditional and irrevocable, and shall be paid strictly in accordance
with the terms of this Agreement under all circumstances, including the following:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any lack of validity or enforceability of such Letter of Credit, this Agreement, or any other Loan Document;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the existence of any claim, counterclaim, setoff, defense or other right that the Borrower or any Subsidiary may have at
any time against any beneficiary or any transferee of such Letter of Credit (or any Person for whom any such beneficiary or any
such transferee may be acting), the L/C Issuer or any other Person, whether in connection with this Agreement, the transactions
contemplated hereby or by such Letter of Credit or any agreement or instrument relating thereto, or any unrelated transaction;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any draft, demand, certificate or other document presented under such Letter of Credit proving to be forged, fraudulent,
invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect; or any loss or delay
in the transmission or otherwise of any document required in order to make a drawing under such Letter of Credit;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any payment by the L/C Issuer under such Letter of Credit against presentation of a draft or certificate that does not strictly
comply with the terms of such Letter of Credit; or any payment made by the L/C Issuer under such Letter of Credit to any Person
purporting to be a trustee in bankruptcy, debtor-in-possession, assignee for the benefit of creditors, liquidator, receiver or
other representative of or successor to any beneficiary or any transferee of such Letter of Credit, including any arising in connection
with any proceeding under any Debtor Relief Law; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other circumstance or happening whatsoever, whether or not similar to any of the foregoing, including any other circumstance
that might otherwise constitute a defense available to, or a discharge of, the Borrower or any of its Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower shall promptly examine a copy
of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with
the Borrower&rsquo;s instructions or other irregularity, the Borrower will immediately notify the L/C Issuer. The Borrower shall
be conclusively deemed to have waived any such claim against the L/C Issuer and its correspondents unless such notice is given
as aforesaid.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Role of L/C Issuer</U>. Each Lender and the Borrower agree that, in paying any drawing under a Letter of Credit, the
L/C Issuer shall not have any responsibility to obtain any document (other than any sight draft, certificates and documents expressly
required by the Letter of Credit) or to ascertain or inquire as to the validity or accuracy of any such document or the authority
of the Person executing or delivering any such document. None of the L/C Issuer, the Administrative Agent, any of their respective
Related Parties nor any correspondent, participant or assignee of the L/C Issuer shall be liable to any Lender for (i) any action
taken or omitted in connection herewith at the request or with the approval of the Revolving Credit Lenders or the Required Revolving
Lenders, as applicable; (ii) any action taken or omitted in the absence of gross negligence or willful misconduct; or (iii) the
due execution, effectiveness, validity or enforceability of any document or instrument related to any Letter of Credit or Issuer
Document. The Borrower hereby assumes all risks of the acts or omissions of any beneficiary or transferee with respect to its use
of any Letter of Credit; <U>provided</U>, <U>however</U>, that this assumption is not intended to, and shall not, preclude the
Borrower&rsquo;s pursuing such rights and remedies as it may have against the beneficiary or transferee at law or under any other
agreement. None of the L/C Issuer, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant
or assignee of the L/C Issuer shall be liable or responsible for any of the matters described in clauses (i) through (v) of <U>Section
2.03(e)</U>; <U>provided</U>, <U>however</U>, that anything in such clauses to the contrary notwithstanding, the Borrower may have
a claim against the L/C Issuer, and the L/C Issuer may be liable to the Borrower, to the extent, but only to the extent, of any
direct, as opposed to consequential or exemplary, damages suffered by the Borrower which the Borrower proves were caused by the
L/C Issuer&rsquo;s willful misconduct or gross negligence or the L/C Issuer&rsquo;s willful failure to pay under any Letter of
Credit after the presentation to it by the beneficiary of a sight draft and certificate(s) strictly complying with the terms and
conditions of a Letter of Credit. In furtherance and not in limitation of the foregoing, the L/C Issuer may accept documents that
appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information
to the contrary, and the L/C Issuer shall not be responsible for the validity or sufficiency of any instrument transferring or
assigning or purporting to transfer or assign a Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole
or in part, which may prove to be invalid or ineffective for any reason.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cash Collateral</U>. Upon the request of the Administrative Agent, (i) if the L/C Issuer has honored any full or partial
drawing request under any Letter of Credit and such drawing has resulted in an L/C Borrowing shall within three (3) Business Days,
or (ii) if, as of the Letter of Credit Expiration Date, any L/C Obligation for any reason remains outstanding, the Borrower shall,
immediately, Cash Collateralize the then Outstanding Amount of all L/C Obligations. <U>Sections 2.05</U> and <U>8.02(c) </U>set
forth certain additional requirements to deliver Cash Collateral hereunder. For purposes of this <U>Section 2.03</U>, <U>Section
2.05</U> and <U>Section 8.02(c)</U>, &ldquo;<U>Cash Collateralize</U>&rdquo; means to pledge and deposit with or deliver to the
Administrative Agent, for the benefit of the L/C Issuer and the Lenders, as collateral for the L/C Obligations, cash or deposit
account balances pursuant to documentation in form and substance satisfactory to the Administrative Agent and the L/C Issuer (which
documents are hereby consented to by the Lenders) in the Minimum Collateral Amount. Derivatives of such term have corresponding
meanings. The Borrower hereby grants to the Administrative Agent, for the benefit of the L/C Issuer and the Lenders, a security
interest in all such cash, deposit accounts and all balances therein and all proceeds of the foregoing. Cash Collateral shall be
maintained in blocked, non-interest bearing deposit accounts at Bank of America. If at any time the Administrative Agent determines
that any funds held as Cash Collateral are subject to any right or claim of any Person other than the Administrative Agent or that
the total amount of such funds is less than the aggregate Outstanding Amount of all L/C Obligations, the Borrower will, forthwith
upon demand by the Administrative Agent, pay to the Administrative Agent, as additional funds to be deposited as Cash Collateral,
an amount equal to the excess of (x)&nbsp;such aggregate Outstanding Amount over (y)&nbsp;the total amount of funds, if any, then
held as Cash Collateral that the Administrative Agent determines to be free and clear of any such right and claim. Upon the drawing
of any Letter of Credit for which funds are on deposit as Cash Collateral, such funds shall be applied, to the extent permitted
under applicable Laws, to reimburse the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Applicability of ISP and UCP</U>. Unless otherwise expressly agreed by the L/C Issuer and the Borrower when a Letter
of Credit is issued, (i) the rules of the ISP shall apply to each standby Letter of Credit, and (ii) the rules of the Uniform Customs
and Practice for Documentary Credits, as most recently published by the International Chamber of Commerce at the time of issuance
shall apply to each commercial Letter of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Letter of Credit Fees</U>. The Borrower shall pay to the Administrative Agent for the account of each Revolving Credit
Lender in accordance with its Applicable Revolving Credit Percentage a Letter of Credit fee (the &ldquo;<U>Letter of Credit Fee</U>&rdquo;)
for each Letter of Credit equal to 2.50% per annum <U>times</U> the daily amount available to be drawn under such Letter of Credit.
For purposes of computing the daily amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit
shall be determined in accordance with <U>Section 1.06</U>. Letter of Credit Fees shall be (i) due and payable on the first Business
Day after the end of each March, June, September and December, commencing with the first such date to occur after the issuance
of such Letter of Credit, on the Letter of Credit Expiration Date and thereafter on demand and (ii) computed on a quarterly basis
in arrears. Notwithstanding anything to the contrary contained herein, upon the request of the Required Revolving Lenders, while
any Event of Default exists, all Letter of Credit Fees shall accrue at the Default Rate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fronting Fee and Documentary and Processing Charges Payable to L/C Issuer</U>. The Borrower shall pay directly to the
L/C Issuer for its own account a fronting fee with respect to each Letter of Credit, at one-eighth of one percent (0.125%) per
annum, computed on the daily amount available to be drawn under such Letter of Credit on a quarterly basis in arrears. Such fronting
fee shall be due and payable on the tenth Business Day after the end of each March, June, September and December in respect of
the most recently-ended quarterly period (or portion thereof, in the case of the first payment), commencing with the first such
date to occur after the issuance of such Letter of Credit, on the Letter of Credit Expiration Date and thereafter on demand. For
purposes of computing the daily amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall
be determined in accordance with <U>Section 1.06</U>. In addition, the Borrower shall pay directly to the L/C Issuer for its own
account the customary issuance, presentation, amendment and other processing fees, and other standard costs and charges, of the
L/C Issuer relating to letters of credit as from time to time in effect. Such customary fees and standard costs and charges are
due and payable on demand and are nonrefundable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(k)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conflict with Issuer Documents</U>. In the event of any conflict between the terms hereof and the terms of any Issuer
Document, the terms hereof shall control.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayments</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Optional</U>. Subject to the last sentence of this <U>Section 2.05(a)(i)</U>, the Borrower may, upon delivery of a notice
to the Administrative Agent, at any time or from time to time voluntarily prepay the Term Loan and Revolving Credit Loans in whole
or in part without premium or penalty; <U>provided</U> that (A) such notice must be received by the Administrative Agent not later
than 11:00 a.m. (1) three Business Days prior to any date of prepayment of Eurodollar Rate Loans and (2) on the date of prepayment
of LIBOR Daily Floating Rate Loans; (B) any prepayment of Eurodollar Rate Loans shall be in a principal amount of $500,000 or a
whole multiple of $100,000 in excess thereof; and (C) any prepayment of LIBOR Daily Floating Rate Loans shall be in a principal
amount of $500,000 or a whole multiple of $100,000 in excess thereof or, in each case, if less, the entire principal amount thereof
then outstanding. Each such notice shall specify the date and amount of such prepayment and the Type(s) of Loans to be prepaid
and, if Eurodollar Rate Loans are to be prepaid, the Interest Period(s) of such Loans. The Administrative Agent will promptly notify
each Lender of its receipt of each such notice, and of the amount of such Lender&rsquo;s ratable portion of such prepayment (based
on such Lender&rsquo;s Applicable Percentage in respect of the relevant Facility). If such notice is given by the Borrower, the
Borrower shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified
therein. Any prepayment of a Eurodollar Rate Loan shall be accompanied by all accrued interest on the amount prepaid, together
with any additional amounts required pursuant to <U>Section 3.05</U>. Each prepayment of the outstanding Term Loan pursuant to
this <U>Section 2.05(a)</U> shall be applied to the principal repayment installments of the Term Loan in inverse order of maturity,
and each such prepayment shall be paid to the Lenders in accordance with their respective Applicable Percentages in respect of
each of the relevant Facilities.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Mandatory</U>. (i) If the Borrower or any of its Subsidiaries Disposes of any property (other than any Disposition of
any property permitted by <U>Section 7.05(a)</U>, or <U>(b)</U>) which results in the realization by such Person of Net Cash Proceeds,
the Borrower shall prepay an aggregate principal amount of Loans equal to 100% of such Net Cash Proceeds within five (5) Business
Days upon receipt thereof by such Person (such prepayments to be applied as set forth in clauses (vi) and (ix) below); <U>provided</U>,
<U>however</U>, that, with respect to any Net Cash Proceeds realized under a Disposition described in this <U>Section 2.05(b)(i)</U>,
such Net Cash Proceeds will be deposited in an account of a Loan Party with the Administrative Agent and, at the election of the
Borrower (as notified by the Borrower to the Administrative Agent on or prior to the date of such Disposition), and so long as
no Default or Event of Default shall have occurred and be continuing, the Borrower or such Subsidiary may reinvest all or any portion
of such Net Cash Proceeds in operating assets so long as within 180 days after the receipt of such Net Cash Proceeds, such purchase
shall have been consummated (as certified by the Borrower in writing to the Administrative Agent); and <U>provided further</U>,
however, that any Net Cash Proceeds not subject to such definitive agreement or so reinvested shall be immediately applied to the
prepayment of the Loans as set forth in this <U>Section 2.05(b)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the sale or issuance by the Borrower or any of its Subsidiaries of any of its Equity Interests (other than the issuance
of common stock upon the exercise of stock options held by employees and directors of the Borrower), the Borrower shall prepay
an aggregate principal amount of Loans equal to 100% of all Net Cash Proceeds received therefrom immediately upon receipt thereof
by the Borrower or such Subsidiary (such prepayments to be applied as set forth in clauses (vi) and (ix) below).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the incurrence or issuance by the Borrower or any of its Subsidiaries of any Indebtedness (other than Indebtedness
expressly permitted to be incurred or issued pursuant to <U>Section 7.02</U>), the Borrower shall prepay an aggregate principal
amount of Loans equal to 100% of all Net Cash Proceeds received therefrom immediately upon receipt thereof by the Borrower or such
Subsidiary (such prepayments to be applied as set forth in clauses (vi) and (ix) below).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon any Extraordinary Receipt above an aggregate amount of $1,500,000 during any fiscal year, received by or paid to or
for the account of the Borrower or any of its Subsidiaries, and not otherwise included in clause (ii), (iii) or (iv) of this <U>Section
2.05(b)</U>, the Borrower shall prepay an aggregate principal amount of Loans equal to 100% of all Net Cash Proceeds received therefrom
within five (5) Business Days upon receipt thereof by the Borrower or such Subsidiary (such prepayments to be applied as set forth
in clauses (vi) and (ix) below); <U>provided</U>, <U>however</U>, that with respect to any proceeds of insurance, condemnation
awards (or payments in lieu thereof) or indemnity payments, at the election of the Borrower (as notified by the Borrower to the
Administrative Agent on or prior to the date of receipt of such insurance proceeds, condemnation awards or indemnity payments),
and so long as no Default or Event of Default shall have occurred and be continuing, the Borrower or such Subsidiary may apply
within 180 days after the receipt of such cash proceeds to replace or repair the equipment, fixed assets or real property in respect
of which such cash proceeds were received; and <U>provided</U>, <U>further</U>, <U>however</U>, that any cash proceeds not so applied
shall be immediately applied to the prepayment of the Loans as set forth in this <U>Section&nbsp;2.05(b)(v)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each prepayment of Loans pursuant to the foregoing provisions of this <U>Section 2.05(b)</U> shall be applied, <U>first</U>,
to the Term Loan and to the principal repayment installments thereof in inverse order of maturity and, <U>second</U>, to the Revolving
Credit Facility in the manner set forth in clause (ix) of this <U>Section 2.05(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If as of the last day of any fiscal quarter the aggregate outstanding principal amount of the Revolving Credit Loans exceeds
the Borrower&rsquo;s Working Capital, the Borrower will within five&nbsp;(5) Business Days repay the Revolving Credit Notes, without
penalty or premium (other than the amounts due under <U>Section 2.4</U> or <U>Section 2.5</U>, if applicable), in an amount necessary
to cause the outstanding principal amount of the Revolving Credit Loans not to exceed the Borrower&rsquo;s Working Capital as of
the last day of such fiscal quarter.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prepayments of the Revolving Credit Facility made pursuant to this <U>Section 2.05(b)</U>, <U>first</U>, shall be applied
ratably to the L/C Borrowings, <U>second</U>, shall be applied to the outstanding Revolving Credit Loans and, <U>third</U>, shall
be used to Cash Collateralize the remaining L/C Obligations; and, in the case of prepayments of the Revolving Credit Facility required
pursuant to clause (i), (ii), (iii), (iv) or (v) of this <U>Section 2.05(b)</U>, the amount remaining, if any, after the prepayment
in full of all L/C Borrowings and Revolving Credit Loans outstanding at such time and the Cash Collateralization of the remaining
L/C Obligations in full (the sum of such prepayment amounts, cash collateralization amounts and remaining amount being, collectively,
the &ldquo;<U>Reduction Amount</U>&rdquo;) may be retained by the Borrower for use in the ordinary course of its business, and
the Revolving Credit Facility shall be automatically and permanently reduced by the Reduction Amount as set forth in <U>Section&nbsp;2.06(b)(iii)</U>.
Upon the drawing of any Letter of Credit that has been Cash Collateralized, the funds held as Cash Collateral shall be applied
(without any further action by or notice to or from the Borrower or any other Loan Party) to reimburse the L/C Issuer or the Revolving
Credit Lenders, as applicable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination or Reduction of Commitments</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Optional</U>. The Borrower may, upon notice to the Administrative Agent, terminate the Revolving Credit Facility, the
Letter of Credit Sublimit, or from time to time permanently reduce the Revolving Credit Facility or the Letter of Credit Sublimit;
<U>provided</U> that (i) any such notice shall be received by the Administrative Agent not later than 11:00 a.m. five Business
Days prior to the date of termination or reduction, (ii) any such partial reduction shall be in an aggregate amount of $5,000,000
or any whole multiple of $250,000 in excess thereof and (iii) the Borrower shall not terminate or reduce (A) the Revolving Credit
Facility if, after giving effect thereto and to any concurrent prepayments hereunder, the Total Revolving Credit Outstandings would
exceed the Revolving Credit Facility, or (B) the Letter of Credit Sublimit if, after giving effect thereto, the Outstanding Amount
of L/C Obligations not fully Cash Collateralized hereunder would exceed the Letter of Credit Sublimit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Mandatory</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Revolving Credit Facility shall be automatically and permanently reduced both (x) on each date on which the prepayment
of Revolving Credit Loans outstanding thereunder is required to be made pursuant to <U>Section 2.05(b)(i)</U>, <U>(ii)</U>, <U>(iii)</U>,
<U>(iv)</U> or <U>(v)</U> by an amount equal to the applicable Reduction Amount.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If after giving effect to any reduction or termination of Revolving Credit Commitments under this <U>Section 2.06</U>, the
Letter of Credit Sublimit exceeds the Revolving Credit Facility at such time, or the Letter of Credit Sublimit, as the case may
be, shall be automatically reduced by the amount of such excess.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Application of Commitment Reductions; Payment of Fees</U>. The Administrative Agent will promptly notify the Lenders
of any termination or reduction of the Letter of Credit Sublimit or the Revolving Credit Commitment under this <U>Section&nbsp;2.06</U>.
Upon any reduction of the Revolving Credit Commitments, the Revolving Credit Commitment of each Revolving Credit Lender shall be
reduced by such Lender&rsquo;s Applicable Revolving Credit Percentage of such reduction amount. All fees in respect of the Revolving
Credit Facility accrued until the effective date of any termination of the Revolving Credit Facility shall be paid on the effective
date of such termination.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Repayment of Loans</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Term Loan</U>. The Borrower shall repay to the Term Lenders, Seven Hundred Thousand Dollars ($700,000) on the last Business
Day of each calendar quarter commencing with a payment on June&nbsp;30, 2017 and on the last Business Day of each calendar quarter
thereafter (which amounts shall be reduced as a result of the application of prepayments in accordance with Section 2.05(b)(v));
<U>provided</U>, however, that the final principal payment of the Term Loan shall be made on the Maturity Date for the Term Loan
and in any event shall be in an amount equal to the aggregate principal amount of the Term Loan outstanding on such date. The Term
Loan may not be reborrowed.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Revolving Credit Loans</U>. The Borrower shall repay to the Revolving Credit Lenders on the Maturity Date for the Revolving
Credit Facility the aggregate principal amount of all Revolving Credit Loans outstanding on such date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interest</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provisions of <U>Section 2.08(b)</U>, (i) each Eurodollar Rate Loan shall bear interest on the outstanding
principal amount thereof for each Interest Period at a rate per annum equal to the Eurodollar Rate for such Interest Period <U>plus</U>
the Applicable Rate for the Term Loan or the Revolving Credit Facility, as applicable; and (ii) each LIBOR Daily Floating Rate
Loan for the Term Loan or the Revolving Credit Facility, as applicable, shall bear interest on the outstanding principal amount
thereof from the applicable borrowing date at a rate per annum equal to the LIBOR Daily Floating Rate <U>plus</U> the Applicable
Rate for the Term Loan or the Revolving Credit Facility, as applicable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) If any amount of principal of any Loan is not paid when due (without regard to any applicable grace periods), whether
at stated maturity, by acceleration or otherwise, such amount shall thereafter bear interest at a fluctuating interest rate per
annum at all times equal to the Default Rate to the fullest extent permitted by applicable Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any amount (other than principal of any Loan) payable by the Borrower under any Loan Document is not paid when due (without
regard to any applicable grace periods), whether at stated maturity, by acceleration or otherwise, then upon the request of the
Required Lenders such amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the
Default Rate to the fullest extent permitted by applicable Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the request of the Required Lenders, while any Event of Default exists, the Borrower shall pay interest on the principal
amount of all outstanding Obligations hereunder at a fluctuating interest rate per annum at all times equal to the Default Rate
to the fullest extent permitted by applicable Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be due and payable upon
demand.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Interest on each Loan shall be due and payable in arrears on each Interest Payment Date applicable thereto and at such other
times as may be specified herein. Interest hereunder shall be due and payable in accordance with the terms hereof before and after
judgment, and before and after the commencement of any proceeding under any Debtor Relief Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower hereby authorizes the Administrative Agent to debit any account of the Borrower with the Administrative Agent
for the payment of all interest and fees hereunder on or after the date such payments of interest and principal are due.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fees</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In addition to certain fees described in <U>Sections
2.03(i) and (j)</U>:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Commitment Fee</U>. The Borrower shall pay to the Administrative Agent for the account of each Revolving Credit Lender
in accordance with its Applicable Revolving Credit Percentage, a commitment fee equal to one-half of one percent (0.50%) per annum
times the actual daily amount by which the Revolving Credit Facility exceeds the sum of (i) the Outstanding Amount of Revolving
Credit Loans and (ii) the Outstanding Amount of L/C Obligations. The commitment fee shall accrue at all times during the Availability
Period, including at any time during which one or more of the conditions in <U>Article IV</U> is not met, and shall be due and
payable quarterly in arrears on the last Business Day of each March, June, September and December, commencing with the first such
date to occur after the Third A&amp;R Effective Date, and, in the case of the commitment fee with respect to the Revolving Credit
Facility, on the last day of the Availability Period for the Revolving Credit Facility. The commitment fee shall be calculated
quarterly in arrears.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agency Fees</U>. The Borrower shall pay to the Administrative Agent (for its own account) on the Third A&amp;R Effective
Date and on each anniversary thereafter until the Maturity Date with respect to the Term Loan, an annual fee of Ten Thousand Dollars
($10,000) which shall be fully earned and payable on the Third A&amp;R Effective Date and on each anniversary of the Third A&amp;R
Effective Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Computation of Interest and Fees</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All computations of fees and interest shall
be made on the basis of a 360-day year and actual days elapsed (which results in more fees or interest, as applicable, being paid
than if computed on the basis of a 365-day year). Interest shall accrue on each Loan for the day on which the Loan is made, and
shall not accrue on a Loan, or any portion thereof, for the day on which the Loan or such portion is paid, <U>provided</U> that
any Loan that is repaid on the same day on which it is made shall, subject to <U>Section 2.12(a)</U>, bear interest for one day.
Each determination by the Administrative Agent of an interest rate or fee hereunder shall be conclusive and binding for all purposes,
absent manifest error.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Evidence of Debt</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Credit Extensions made by each Lender shall be evidenced by one or more accounts or records maintained by such Lender
and by the Administrative Agent in the ordinary course of business. The accounts or records maintained by the Administrative Agent
and each Lender shall be conclusive absent manifest error of the amount of the Credit Extensions made by the Lenders to the Borrower
and the interest and payments thereon. Any failure to so record or any error in doing so shall not, however, limit or otherwise
affect the obligation of the Borrower hereunder to pay any amount owing with respect to the Obligations. In the event of any conflict
between the accounts and records maintained by any Lender and the accounts and records of the Administrative Agent in respect of
such matters, the accounts and records of the Administrative Agent shall control in the absence of manifest error. Upon the request
of any Lender made through the Administrative Agent, the Borrower shall execute and deliver to such Lender (through the Administrative
Agent) a Note, which shall evidence such Lender&rsquo;s Loans in addition to such accounts or records. Each Lender may attach schedules
to its Note and endorse thereon the date, Type (if applicable), amount and maturity of its Loans and payments with respect thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In addition to the accounts and records referred to in <U>Section 2.11(a)</U>, each Lender and the Administrative Agent
shall maintain in accordance with its usual practice accounts or records evidencing the purchases and sales by such Lender of participations
in Letters of Credit. In the event of any conflict between the accounts and records maintained by the Administrative Agent and
the accounts and records of any Lender in respect of such matters, the accounts and records of the Administrative Agent shall control
in the absence of manifest error.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payments Generally; Administrative Agent&rsquo;s Clawback</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U>. All payments to be made by the Borrower shall be made without condition or deduction for any counterclaim,
defense, recoupment or setoff. Except as otherwise expressly provided herein, all payments by the Borrower hereunder shall be made
to the Administrative Agent, for the account of the respective Lenders to which such payment is owed, at the Administrative Agent&rsquo;s
Office in Dollars and in immediately available funds not later than 2:00 p.m. on the date specified herein. The Administrative
Agent will promptly distribute to each Lender its Applicable Percentage in respect of the relevant Facility (or other applicable
share as provided herein) of such payment in like funds as received by wire transfer to such Lender&rsquo;s Lending Office. All
payments received by the Administrative Agent after 2:00 p.m. shall be deemed received on the next succeeding Business Day and
any applicable interest or fee shall continue to accrue. If any payment to be made by the Borrower shall come due on a day other
than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected on
computing interest or fees, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i)&nbsp;&nbsp; <U>Funding by Lenders; Presumption by Administrative Agent</U>. Unless the Administrative Agent shall have received
notice from a Lender prior to the proposed date of any Borrowing of Eurodollar Rate Loans (or, in the case of any Borrowing of
LIBOR Daily Floating Rate Loans, prior to 12:00 noon on the date of such Borrowing) that such Lender will not make available to
the Administrative Agent such Lender&rsquo;s share of such Borrowing, the Administrative Agent may assume that such Lender has
made such share available on such date in accordance with <U>Section 2.02</U> (or, in the case of a Borrowing of LIBOR Daily Floating
Rate Loans, that such Lender has made such share available in accordance with and at the time required by <U>Section 2.02</U>)
and may, in reliance upon such assumption, make available to the Borrower a corresponding amount. In such event, if a Lender has
not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the
Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount in immediately available
funds with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding
the date of payment to the Administrative Agent, at (A) in the case of a payment to be made by such Lender, the greater of the
Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation,
plus any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing,
and (B) in the case of a payment to be made by the Borrower, the interest rate applicable to LIBOR Daily Floating Rate Loans. If
the Borrower and such Lender shall pay such interest to the Administrative Agent for the same or an overlapping period, the Administrative
Agent shall promptly remit to the Borrower the amount of such interest paid by the Borrower for such period. If such Lender pays
its share of the applicable Borrowing to the Administrative Agent, then the amount so paid shall constitute such Lender&rsquo;s
Loan included in such Borrowing. Any payment by the Borrower shall be without prejudice to any claim the Borrower may have against
a Lender that shall have failed to make such payment to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)<FONT STYLE="font-size: 10pt">&nbsp;
</FONT><U>Payments by Borrower; Presumptions by Administrative Agent</U>. Unless the Administrative Agent shall have received notice
from the Borrower prior to the time at which any payment is due to the Administrative Agent for the account of the Lenders or the
L/C Issuer hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made
such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Appropriate Lenders
or the L/C Issuer, as the case may be, the amount due. In such event, if the Borrower has not in fact made such payment, then each
of the Appropriate Lenders or the L/C Issuer, as the case may be, severally agrees to repay to the Administrative Agent forthwith
on demand the amount so distributed to such Lender or the L/C Issuer, in immediately available funds with interest thereon, for
each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative
Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry
rules on interbank compensation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A notice of the Administrative Agent to any
Lender or the Borrower with respect to any amount owing under this subsection (b) shall be conclusive, absent manifest error.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Failure to Satisfy Conditions Precedent</U>. If any Lender makes available to the Administrative Agent funds for any
Loan to be made by such Lender as provided in the foregoing provisions of this <U>Article II</U>, and such funds are not made available
to the Borrower by the Administrative Agent because the conditions to the applicable Credit Extension set forth in <U>Article IV</U>
are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds
as received from such Lender) to such Lender, without interest.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Obligations of Lenders Several</U>. The obligations of the Lenders hereunder to make the Term Loan and Revolving Credit
Loans, to fund participations in Letters of Credit and to make payments pursuant to <U>Section 11.04(c)</U> are several and not
joint. The failure of any Lender to make any Loan, to fund any such participation or to make any payment under <U>Section 11.04(c)</U>
on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no
Lender shall be responsible for the failure of any other Lender to so make its Loan, to purchase its participation or to make its
payment under <U>Section 11.04(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Funding Source</U>. Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular
place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any
particular place or manner.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insufficient Funds</U>. If at any time insufficient funds are received by and available to the Administrative Agent to
pay fully all amounts of principal, L/C Borrowings, interest and fees then due hereunder, such funds shall be applied (i) <U>first</U>,
toward payment of interest and fees then due hereunder, ratably among the parties entitled thereto in accordance with the amounts
of interest and fees then due to such parties, and (ii) <U>second</U>, toward payment of principal and L/C Borrowings then due
hereunder, ratably among the parties entitled thereto in accordance with the amounts of principal and L/C Borrowings then due to
such parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sharing of Payments by Lenders</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If any Lender shall, by exercising any right
of setoff or counterclaim or otherwise, obtain payment in respect of (a) Obligations in respect of any the Facilities due and
payable to such Lender hereunder and under the other Loan Documents at such time in excess of its ratable share (according to
the proportion of (i) the amount of such Obligations due and payable to such Lender at such time to (ii) the aggregate amount
of the Obligations in respect of the Facilities due and payable to all Lenders hereunder and under the other Loan Documents at
such time) of payments on account of the Obligations in respect of the Facilities due and payable to all Lenders hereunder and
under the other Loan Documents at such time obtained by all the Lenders at such time or (b) Obligations in respect of any of the
Facilities owing (but not due and payable) to such Lender hereunder and under the other Loan Documents at such time in excess
of its ratable share (according to the proportion of (i) the amount of such Obligations owing (but not due and payable) to such
Lender at such time to (ii) the aggregate amount of the Obligations in respect of the Facilities owing (but not due and payable)
to all Lenders hereunder and under the other Loan Parties at such time) of payment on account of the Obligations in respect of
the Facilities owing (but not due and payable) to all Lenders hereunder and under the other Loan Documents at such time obtained
by all of the Lenders at such time then the Lender receiving such greater proportion shall (a) notify the Administrative Agent
of such fact, and (b) purchase (for cash at face value) participations in the Loans and subparticipations in L/C Obligations of
the other Lenders, or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared
by the Lenders ratably in accordance with the aggregate amount of Obligations in respect of the Facilities then due and payable
to the Lenders or owing (but not due and payable) to the Lenders, as the case may be, <U>provided</U> that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
any such participations or subparticipations are purchased and all or any portion of the payment giving rise thereto is recovered,
such participations or subparticipations shall be rescinded and the purchase price restored to the extent of such recovery, without
interest; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
provisions of this Section shall not be construed to apply to (A) any payment made by the Borrower pursuant to and in accordance
with the express terms of this Agreement or (B) any payment obtained by a Lender as consideration for the assignment of or sale
of a participation in any of its Loans or subparticipations in L/C Obligations to any assignee or participant, other than to the
Borrower or any Subsidiary thereof (as to which the provisions of this Section shall apply).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower consents to the foregoing and
agrees, to the extent it may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the
foregoing arrangements may exercise against the Borrower rights of setoff and counterclaim with respect to such participation
as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cash Collateral</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Credit Support Events</U>. If (i)&nbsp;the L/C Issuer has honored any full or partial drawing request under any
Letter of Credit and such drawing has resulted in an L/C Borrowing, (ii)&nbsp;as of the Letter of Credit Expiration Date, any L/C
Obligation for any reason remains outstanding, (iii)&nbsp;the Borrower shall be required to provide Cash Collateral pursuant to
<U>Section 2.05</U> or <U>8.02(c)</U>, or (iv)&nbsp;there shall exist a Defaulting Lender, the Borrower shall immediately (in the
case of clause (iii) above) or within one&nbsp;(1) Business Day (in all other cases) following any request by the Administrative
Agent or the L/C Issuer, provide Cash Collateral in an amount not less than the applicable Minimum Collateral Amount (determined
in the case of Cash Collateral provided pursuant to clause (iv) above, after giving effect to <U>Section 2.15(a)(iv)</U> and any
Cash Collateral provided by the Defaulting Lender).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Grant of Security Interest</U>. The Borrower, and to the extent provided by any Defaulting Lender, such Defaulting Lender,
hereby grants to (and subjects to the control of) the Administrative Agent, for the benefit of the Administrative Agent, the L/C
Issuer and the Lenders, and agrees to maintain, a first priority security interest in all such cash, deposit accounts and all balances
therein, and all other property so provided as collateral pursuant hereto, and in all proceeds of the foregoing, all as security
for the obligations to which such Cash Collateral may be applied pursuant to <U>Section 2.14(b)</U>. If at any time the Administrative
Agent determines that Cash Collateral is subject to any right or claim of any Person other than the Administrative Agent or the
L/C Issuer as herein provided, or that the total amount of such Cash Collateral is less than the Minimum Collateral Amount, the
Borrower will, promptly upon demand by the Administrative Agent, pay or provide to the Administrative Agent additional Cash Collateral
in an amount sufficient to eliminate such deficiency. All Cash Collateral (other than credit support not constituting funds subject
to deposit) shall be maintained in blocked, non-interest bearing deposit accounts at Bank of America. The Borrower shall pay on
demand therefor from time to time all customary account opening, activity and other administrative fees and charges in connection
with the maintenance and disbursement of Cash Collateral.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Application</U>. Notwithstanding anything to the contrary contained in this Agreement, Cash Collateral provided under
any of this <U>Section 2.14</U> or <U>Sections 2.03</U>, <U>2.15</U> or <U>8.02</U> in respect of Letters of Credit shall be held
and applied to the satisfaction of the specific L/C Obligations, obligations to fund participations therein (including, as to Cash
Collateral provided by a Revolving Credit Lender that is a Defaulting Lender, any interest accrued on such obligation) and other
obligations for which the Cash Collateral was so provided, prior to any other application of such property as may be provided for
herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Release</U>. Cash Collateral (or the appropriate portion thereof) provided to reduce Fronting Exposure or other obligations
shall be released promptly following (i)&nbsp;the elimination of the applicable Fronting Exposure or other obligations giving rise
thereto (including by the termination of Defaulting Lender status of the applicable Revolving Credit Lender or, as appropriate,
its assignee following compliance with <U>Section&nbsp;11.06(b)</U>) or (ii)&nbsp;the determination by the Administrative Agent
and the L/C Issuer that there exists excess Cash Collateral; <U>provided</U>, <U>however</U>, (A)&nbsp;any such release shall be
without prejudice to, and any disbursement or other transfer of Cash Collateral shall be and remain subject to, any other Lien
conferred under the Loan Documents and the other applicable provisions of the Loan Documents, and (B)&nbsp;the Person providing
Cash Collateral and the L/C Issuer may agree that Cash Collateral shall not be released but instead held to support future anticipated
Fronting Exposure or other obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defaulting Lenders</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustments</U>. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting
Lender, then, until such time as that Lender is no longer a Defaulting Lender, to the extent permitted by applicable Law:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waivers and Amendments</U>. Such Defaulting Lender&rsquo;s right to approve or disapprove any amendment, waiver or consent
with respect to this Agreement shall be restricted as set forth in the definition of &ldquo;Required Lenders&rdquo; and <U>Section
11.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defaulting Lender Waterfall</U>. Any payment of principal, interest, fees or other amounts received by the Administrative
Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to <U>Article VIII</U> or
otherwise) or received by the Administrative Agent from a Defaulting Lender pursuant to <U>Section 11.08</U> shall be applied at
such time or times as may be determined by the Administrative Agent as follows: <U>first</U>, to the payment of any amounts owing
by such Defaulting Lender to the Administrative Agent hereunder; <U>second</U>, to the payment on a pro rata basis of any amounts
owing by such Defaulting Lender to the L/C Issuer hereunder; <U>third</U>, to Cash Collateralize the L/C Issuer&rsquo;s Fronting
Exposure with respect to such Defaulting Lender in accordance with <U>Section 2.14</U>; <U>fourth</U>, as the Borrower may request
(so long as no Default or Event of Default exists), to the funding of any Loan in respect of which such Defaulting Lender has failed
to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent; <U>fifth</U>, if so determined
by the Administrative Agent and the Borrower, to be held in a deposit account and released pro rata in order to (A)&nbsp;satisfy
such Defaulting Lender&rsquo;s potential future funding obligations with respect to Loans under this Agreement and (B)&nbsp;Cash
Collateralize the L/C Issuer&rsquo;s future Fronting Exposure with respect to such Defaulting Lender with respect to future Letters
of Credit issued under this Agreement, in accordance with <U>Section&nbsp;2.14</U>; <U>sixth</U>, to the payment of any amounts
owing to the Lenders or the L/C Issuer as a result of any judgment of a court of competent jurisdiction obtained by any Lender,
the L/C Issuer or the Swingline Lender against such Defaulting Lender as a result of such Defaulting Lender&rsquo;s breach of its
obligations under this Agreement; <U>seventh</U>, so long as no Default or Event of Default exists, to the payment of any amounts
owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting
Lender as a result of such Defaulting Lender&rsquo;s breach of its obligations under this Agreement; and <U>eighth</U>, to such
Defaulting Lender or as otherwise as may be required under the Loan Documents in connection with any Lien conferred thereunder
or directed by a court of competent jurisdiction; <U>provided</U> that if (1) such payment is a payment of the principal amount
of any Loans or L/C Borrowings in respect of which such Defaulting Lender has not fully funded its appropriate share, and (2) such
Loans were made or the related Letters of Credit were issued at a time when the conditions set forth in <U>Section&nbsp;4.02</U>
were satisfied or waived, such payment shall be applied solely to pay the Loans of, and L/C Obligations owed to, all Non-Defaulting
Lenders on a pro rata basis prior to being applied to the payment of any Loans of, or L/C Obligations owed to, such Defaulting
Lender until such time as all Loans and funded and unfunded participations in L/C Obligations are held by the Lenders pro rata
in accordance with the Commitments hereunder without giving effect to <U>Section 2.15(a)(v)</U>. Any payments, prepayments or other
amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post
Cash Collateral pursuant to this <U>Section 2.15(a)(ii)</U> shall be deemed paid to and redirected by such Defaulting Lender, and
each Lender irrevocably consents hereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Fees</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(A)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fees</U>. No Defaulting Lender shall be entitled to receive any fee payable under <U>Section 2.09(a)</U> for any period
during which that Lender is a Defaulting Lender (and the Borrower shall not be required to pay any such fee that otherwise would
have been required to have been paid to that Defaulting Lender).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(B)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Letter of Credit Fees</U>. Each Defaulting Lender shall be entitled to receive Letter of Credit Fees for any period during
which that Lender is a Defaulting Lender only to the extent allocable to its Applicable Revolving Percentage of the stated amount
of Letters of Credit for which it has provided Cash Collateral pursuant to <U>Section 2.14</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(C)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defaulting Lender Fees</U>. With respect to any Letter of Credit Fee not required to be paid to any Defaulting Lender
pursuant to clause (B) above, the Borrower shall (1) pay to each Non-Defaulting Lender that portion of any such fee otherwise payable
to such Defaulting Lender with respect to such Defaulting Lender&rsquo;s participation in L/C Obligations that has been reallocated
to such Non-Defaulting Lender pursuant to clause (iv) below, (2) pay to the L/C Issuer the amount of any such fee otherwise payable
to such Defaulting Lender to the extent allocable to such L/C Issuer&rsquo;s Fronting Exposure to such Defaulting Lender, and (3)
not be required to pay the remaining amount of any such fee.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reallocation of Applicable Revolving Percentages to Reduce Fronting Exposure</U>. All or any part of such Defaulting
Lender&rsquo;s participation in L/C Obligations and Swingline Loans shall be reallocated among the Non-Defaulting Lenders in accordance
with their respective Applicable Revolving Percentages (calculated without regard to such Defaulting Lender&rsquo;s Commitment)
but only to the extent that (A)&nbsp;the conditions set forth in <U>Section 4.02</U> are satisfied at the time of such reallocation
(and, unless the Borrower shall have otherwise notified the Administrative Agent at such time, the Borrower shall be deemed to
have represented and warranted that such conditions are satisfied at such time), and (B)&nbsp;such reallocation does not cause
the aggregate Revolving Exposure of any Non-Defaulting Lender to exceed such Non-Defaulting Lender&rsquo;s Revolving Commitment.
No reallocation hereunder shall constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender
arising from that Lender having become a Defaulting Lender, including any claim of a Non-Defaulting Lender as a result of such
Non-Defaulting Lender&rsquo;s increased exposure following such reallocation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cash Collateral</U>. If the reallocation described in clause (a)(iv) above cannot, or can only partially, be effected,
the Borrower shall, without prejudice to any right or remedy available to it hereunder or under applicable Law, Cash Collateralize
the L/C Issuer&rsquo;s Fronting Exposure in accordance with the procedures set forth in <U>Section 2.14</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defaulting Lender Cure</U>. If the Borrower, the Administrative Agent and the L/C Issuer agree in writing that a Lender
is no longer a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date
specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any Cash
Collateral), that Lender will, to the extent applicable, purchase at par that portion of outstanding Loans of the other Lenders
or take such other actions as the Administrative Agent may determine to be necessary to cause the Loans and funded and unfunded
participations in Letters of Credit to be held on a pro rata basis by the Lenders in accordance with their Applicable Percentages
(without giving effect to <U>Section 2.15(a)(iv)</U>), whereupon such Lender will cease to be a Defaulting Lender; <U>provided</U>
that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrower while
that Lender was a Defaulting Lender; and <U>provided, further</U>, that except to the extent otherwise expressly agreed by the
affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any
party hereunder arising from that Lender&rsquo;s having been a Defaulting Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE III<BR>
TAXES, YIELD PROTECTION AND ILLEGALITY</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payments Free of Taxes; Obligation to Withhold; Payments on Account of Taxes</U>. (i) Any and all payments by or on account
of any obligation of the Borrower hereunder or under any other Loan Document shall to the extent permitted by applicable Laws be
made free and clear of and without reduction or withholding for any Taxes. If, however, applicable Laws require the Borrower or
the Administrative Agent to withhold or deduct any Tax, such Tax shall be withheld or deducted in accordance with such Laws as
determined by the Borrower or the Administrative Agent, as the case may be, upon the basis of the information and documentation
to be delivered pursuant to subsection (e) below.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Borrower or the Administrative Agent shall be required by the Code to withhold or deduct any Taxes, including both
United States Federal backup withholding and withholding taxes, from any payment, then (A) the Administrative Agent shall withhold
or make such deductions as are determined by the Administrative Agent to be required based upon the information and documentation
it has received pursuant to subsection (e) below, (B) the Administrative Agent shall timely pay the full amount withheld or deducted
to the relevant Governmental Authority in accordance with the Code, and (C) to the extent that the withholding or deduction is
made on account of Indemnified Taxes or Other Taxes, the sum payable by the Borrower shall be increased as necessary so that after
any required withholding or the making of all required deductions (including deductions applicable to additional sums payable under
this Section) the Administrative Agent, Lender or L/C Issuer, as the case may be, receives an amount equal to the sum it would
have received had no such withholding or deduction been made.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of Other Taxes by the Borrower</U>. Without limiting the provisions of subsection (a) above, the Borrower shall
timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Indemnifications</U>. (i) Without limiting the provisions of subsection (a) or (b) above, the Borrower shall, and
does hereby indemnify the Administrative Agent, each Lender and the L/C Issuer, and shall make payment in respect thereof within
10 days after demand therefor, for the full amount of any Indemnified Taxes or Other Taxes (including Indemnified Taxes or Other
Taxes imposed or asserted on or attributable to amounts payable under this Section) withheld or deducted by the Borrower or the
Administrative Agent or paid by the Administrative Agent, such Lender or the L/C Issuer, as the case may be, and any penalties,
interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes
were correctly or legally imposed or asserted by the relevant Governmental Authority. The Borrower shall also, and does hereby,
indemnify the Administrative Agent, and shall make payment in respect thereof within 10 days after demand therefor, for any amount
which a Lender or the L/C Issuer for any reason fails to pay indefeasibly to the Administrative Agent as required by clause (ii)
of this subsection. A certificate as to the amount of any such payment or liability delivered to the Borrower by a Lender or the
L/C Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender
or the L/C Issuer, shall be conclusive absent manifest error.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the provisions of subsection (a) or (b) above, each Lender and the L/C Issuer shall, and does hereby, indemnify
the Borrower and the Administrative Agent, and shall make payment in respect thereof within 10 days after demand therefor, against
any and all Taxes and any and all related losses, claims, liabilities, penalties, interest and expenses (including the fees, charges
and disbursements of any counsel for the Borrower or the Administrative Agent) incurred by or asserted against the Borrower or
the Administrative Agent by any Governmental Authority as a result of the failure by such Lender or the L/C Issuer, as the case
may be, to deliver, or as a result of the inaccuracy, inadequacy or deficiency of, any documentation required to be delivered by
such Lender or the L/C Issuer, as the case may be, to the Borrower or the Administrative Agent pursuant to subsection (e). Each
Lender and the L/C Issuer hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing
to such Lender or the L/C Issuer, as the case may be, under this Agreement or any other Loan Document against any amount due to
the Administrative Agent under this clause (ii). The agreements in this clause (ii) shall survive the resignation and/or replacement
of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender or the L/C Issuer, the termination of
the Aggregate Commitments and the repayment, satisfaction or discharge of all other Obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Evidence of Payments</U>. Upon request by the Borrower or the Administrative Agent, as the case may be, after any payment
of Taxes by the Borrower or the Administrative Agent to a Governmental Authority as provided in this <U>Section 3.01</U>, the Borrower
shall deliver to the Administrative Agent or the Administrative Agent shall deliver to the Borrower, as the case may be, the original
or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of any return required by
Laws to report such payment or other evidence of such payment reasonably satisfactory to the Borrower or the Administrative Agent,
as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Status of Lenders; Tax Documentation</U>. (i) Each Lender shall deliver to the Borrower and to the Administrative Agent,
at the time or times prescribed by applicable Laws or when reasonably requested by the Borrower or the Administrative Agent, such
properly completed and executed documentation prescribed by applicable Laws or by the taxing authorities of any jurisdiction and
such other reasonably requested information as will permit the Borrower or the Administrative Agent, as the case may be, to determine
(A) whether or not payments made hereunder or under any other Loan Document are subject to Taxes, (B) if applicable, the required
rate of withholding or deduction, and (C) such Lender&rsquo;s entitlement to any available exemption from, or reduction of, applicable
Taxes in respect of all payments to be made to such Lender by the Borrower pursuant to this Agreement or otherwise to establish
such Lender&rsquo;s status for withholding tax purposes in the applicable jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the generality of the foregoing, if the Borrower is resident for tax purposes in the United States,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(A)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Lender that is a &ldquo;United States person&rdquo; within the meaning of Section 7701(a)(30) of the Code shall deliver
to the Borrower and the Administrative Agent executed originals of Internal Revenue Service Form W-9 or such other documentation
or information prescribed by applicable Laws or reasonably requested by the Borrower or the Administrative Agent as will enable
the Borrower or the Administrative Agent, as the case may be, to determine whether or not such Lender is subject to backup withholding
or information reporting requirements; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(B)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each Foreign Lender that is entitled under the Code or any applicable treaty to an exemption from or reduction of withholding
tax with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower and the Administrative Agent
(in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes
a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent, but
only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(I)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>executed originals of Internal Revenue Service Form W-BENE (or W-8BEN, as applicable) claiming eligibility for benefits
of an income tax treaty to which the United States is a party,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(II)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>executed originals of Internal Revenue Service Form W-8ECI,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(III)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>executed originals of Internal Revenue Service Form W-8IMY and all required supporting documentation,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(IV)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under section 881(c) of the
Code, (x) a certificate to the effect that such Foreign Lender is not (A) a &ldquo;bank&rdquo; within the meaning of section 881(c)(3)(A)
of the Code, (B) a &ldquo;10 percent shareholder&rdquo; of the Borrower within the meaning of section 881(c)(3)(B) of the Code,
or (C) a &ldquo;controlled foreign corporation&rdquo; described in section 881(c)(3)(C) of the Code and (y) executed originals
of Internal Revenue Service Form W-BENE (or W-8BEN, as applicable),</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(V)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to the extent a Foreign Lender is not the beneficial owner, executed copies of IRS Form W-8IMY, accompanied by IRS Form
W-SECT, IRS Form W-8BENE (or W-8BEN, as applicable), a U.S. Tax Compliance Certificate substantially in the form of <U>Exhibit
G-2</U> or <U>Exhibit G-3</U>, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; <U>provided</U>
that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the
portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of <U>Exhibit
G-4</U> on behalf of each such direct and indirect partner; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">(VI)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>executed originals of any other form prescribed by applicable Laws as a basis for claiming exemption from or a reduction
in United States Federal withholding tax together with such supplementary documentation as may be prescribed by applicable Laws
to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Lender shall promptly:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(A)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>notify the Borrower and the Administrative Agent of any change in circumstances which would modify or render invalid any
claimed exemption or reduction; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(B)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>take such steps as shall not be materially disadvantageous to it, in the reasonable judgment of such Lender, and as may
be reasonably necessary (including the re-designation of its Lending Office) to avoid any requirement of applicable Laws of any
jurisdiction that the Borrower or the Administrative Agent make any withholding or deduction for taxes from amounts payable to
such Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(C)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA
if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section
1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time
or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation
prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation
reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent
to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&rsquo;s obligations
under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (C), &ldquo;FATCA&rdquo;
shall include any amendments made to FATCA after the date of this Agreement. For purposes of determining withholding Taxes imposed
under FATCA, from and after the Third A&amp;R Effective Date, the Borrower and the Administrative Agent shall treat (and the Lenders
hereby authorize the Administrative Agent to treat) this Agreement as not qualifying as a &ldquo;grandfathered obligation&rdquo;
within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Treatment of Certain Refunds</U>. Unless required by applicable Laws, at no time shall the Administrative Agent have
any obligation to file for or otherwise pursue on behalf of a Lender or the L/C Issuer, or have any obligation to pay to any Lender
or the L/C Issuer, any refund of Taxes withheld or deducted from funds paid for the account of such Lender or the L/C Issuer, as
the case may be. If the Administrative Agent, any Lender or the L/C Issuer determines, in its sole discretion, that it has received
a refund of any Taxes or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower
has paid additional amounts pursuant to this Section, it shall pay to the Borrower an amount equal to such refund (but only to
the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes
or Other Taxes giving rise to such refund), net of all out-of-pocket expenses incurred by the Administrative Agent, such Lender
or the L/C Issuer, as the case may be, and without interest (other than any interest paid by the relevant Governmental Authority
with respect to such refund), <U>provided</U> that the Borrower, upon the request of the Administrative Agent, such Lender or the
L/C Issuer, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the
relevant Governmental Authority) to the Administrative Agent, such Lender or the L/C Issuer in the event the Administrative Agent,
such Lender or the L/C Issuer is required to repay such refund to such Governmental Authority. This subsection shall not be construed
to require the Administrative Agent, any Lender or the L/C Issuer to make available its tax returns (or any other information relating
to its taxes that it deems confidential) to the Borrower or any other Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Illegality</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If any Lender determines that any Law has made
it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office
to make, maintain or fund Eurodollar Rate Loans, or to determine or charge interest rates based upon the Eurodollar Rate, or any
Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits
of, Dollars in the London interbank market, then, on notice thereof by such Lender to the Borrower through the Administrative
Agent, any obligation of such Lender to make or continue Eurodollar Rate Loans or to convert LIBOR Daily Floating Rate Loans to
Eurodollar Rate Loans shall be suspended until such Lender notifies the Administrative Agent and the Borrower that the circumstances
giving rise to such determination no longer exist. Upon receipt of such notice, the Borrower shall, upon demand from such Lender
(with a copy to the Administrative Agent), prepay or, if applicable, convert all Eurodollar Rate Loans of such Lender to LIBOR
Daily Floating Rate Loans, either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain
such Eurodollar Rate Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurodollar Rate
Loans. Upon any such prepayment or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inability to Determine Rates</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If in connection with any request for a Eurodollar
Rate Loan or a conversion to or continuation thereof, (a)&nbsp;the Required Lenders determine that (i) Dollar deposits are not
being offered to banks in the London interbank Eurodollar market for the applicable amount and Interest Period of such Eurodollar
Rate Loan (in each case with respect to clause (a)(i), &ldquo;<U>Impacted Loans</U>&rdquo;), (ii)&nbsp;adequate and reasonable
means do not exist for determining the Eurodollar Rate for any requested Interest Period with respect to a proposed Eurodollar
Rate Loan or in connection with an existing or proposed LIBOR Daily Floating Rate Loan, or (iii)&nbsp;for any reason the Eurodollar
Rate for any requested Interest Period with respect to a proposed Eurodollar Rate Loan does not adequately and fairly reflect
the cost to such Lenders of funding such Eurodollar Rate Loan, the Administrative Agent will promptly so notify the Borrower and
each Lender. Thereafter, the obligation of the Lenders to make or maintain Eurodollar Rate Loans shall be suspended (to the extent
of the affected Eurodollar Rate Loans or Interest Periods). Upon receipt of such notice, the Borrower may revoke any pending request
for a Borrowing of, conversion to or continuation of Eurodollar Rate Loans (to the extent of the affected Eurodollar Rate Loans
or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a Borrowing at the rate
so determined by the Administrative Agent in accordance with the terms hereof in the amount specified therein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding the foregoing, if the Required
Lenders have made the determination described in clause (a) (i) of this section, the Administrative Agent, in consultation with
the Borrower and the affected Lenders, may establish an alternative interest rate for the Impacted Loans, in which case, such
alternative rate of interest shall apply with respect to the Impacted Loans until (1) the Administrative Agent revokes the notice
delivered with respect to the Impacted Loans under clause (a) of the first sentence of this section, (2) the Administrative Agent
or the Required Lenders notify the Administrative Agent and the Borrower that such alternative interest rate does not adequately
and fairly reflect the cost to such Lenders of funding the Impacted Loans, or (3) any Lender determines that any Law has made
it unlawful, or that any Governmental Authority has asserted that it is unlawful, for such Lender or its applicable Lending Office
to make, maintain or fund Loans whose interest is determined by reference to such alternative rate of interest or to determine
or charge interest rates based upon such rate or any Governmental Authority has imposed material restrictions on the authority
of such Lender to do any of the foregoing and provides the Administrative Agent and the Borrower written notice thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Increased Costs; Reserves on Eurodollar Rate Loans</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Increased Costs Generally</U>. If any Change in Law shall:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement
against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (except any reserve
requirement reflected in the Eurodollar Rate) or the L/C Issuer;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>subject any Lender or the L/C Issuer to any tax of any kind whatsoever with respect to this Agreement, any Letter of Credit,
any participation in a Letter of Credit or any Eurodollar Rate Loan made by it, or change the basis of taxation of payments to
such Lender or the L/C Issuer in respect thereof (except for Indemnified Taxes or Other Taxes covered by <U>Section 3.01</U> and
the imposition of, or any change in the rate of, any Excluded Tax payable by such Lender or the L/C Issuer); or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>impose on any Lender or the L/C Issuer or the London interbank market any other condition, cost or expense affecting this
Agreement or Eurodollar Rate Loans made by such Lender or any Letter of Credit or participation therein;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">and the result of any of the foregoing shall be
to increase the cost to such Lender of making or maintaining any Eurodollar Rate Loan (or of maintaining its obligation to make
any such Loan), or to increase the cost to such Lender or the L/C Issuer of participating in, issuing or maintaining any Letter
of Credit (or of maintaining its obligation to participate in or to issue any Letter of Credit), or to reduce the amount of any
sum received or receivable by such Lender or the L/C Issuer hereunder (whether of principal, interest or any other amount) then,
upon request of such Lender or the L/C Issuer, the Borrower will pay to such Lender or the L/C Issuer, as the case may be, such
additional amount or amounts as will compensate such Lender or the L/C Issuer, as the case may be, for such additional costs incurred
or reduction suffered.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Capital Requirements</U>. If any Lender or the L/C Issuer determines that any Change in Law affecting such Lender or
the L/C Issuer or any Lending Office of such Lender or such Lender&rsquo;s or the L/C Issuer&rsquo;s holding company, if any, regarding
capital requirements has or would have the effect of reducing the rate of return on such Lender&rsquo;s or the L/C Issuer&rsquo;s
capital or on the capital of such Lender&rsquo;s or the L/C Issuer&rsquo;s holding company, if any, as a consequence of this Agreement,
the Commitments of such Lender or the Loans made by, or participations in Letters of Credit held by, such Lender, or the Letters
of Credit issued by the L/C Issuer, to a level below that which such Lender or the L/C Issuer or such Lender&rsquo;s or the L/C
Issuer&rsquo;s holding company could have achieved but for such Change in Law (taking into consideration such Lender&rsquo;s or
the L/C Issuer&rsquo;s policies and the policies of such Lender&rsquo;s or the L/C Issuer&rsquo;s holding company with respect
to capital adequacy), then from time to time the Borrower will pay to such Lender or the L/C Issuer, as the case may be, such additional
amount or amounts as will compensate such Lender or the L/C Issuer or such Lender&rsquo;s or the L/C Issuer&rsquo;s holding company
for any such reduction suffered.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificates for Reimbursement</U>. A certificate of a Lender or the L/C Issuer setting forth the amount or amounts necessary
to compensate such Lender or the L/C Issuer or its holding company, as the case may be, as specified in subsection (a) or (b) of
this Section and delivered to the Borrower shall be conclusive absent manifest error. The Borrower shall pay such Lender or the
L/C Issuer, as the case may be, the amount shown as due on any such certificate within 10 days after receipt thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delay in Requests</U>. Failure or delay on the part of any Lender or the L/C Issuer to demand compensation pursuant to
the foregoing provisions of this Section shall not constitute a waiver of such Lender&rsquo;s or the L/C Issuer&rsquo;s right to
demand such compensation, <U>provided</U> that the Borrower shall not be required to compensate a Lender or the L/C Issuer pursuant
to the foregoing provisions of this Section for any increased costs incurred or reductions suffered more than nine months prior
to the date that such Lender or the L/C Issuer, as the case may be, notifies the Borrower of the Change in Law giving rise to such
increased costs or reductions and of such Lender&rsquo;s or the L/C Issuer&rsquo;s intention to claim compensation therefor (except
that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period referred
to above shall be extended to include the period of retroactive effect thereof).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation for Losses</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Upon demand of any Lender (with a copy to the
Administrative Agent) from time to time, the Borrower shall promptly compensate such Lender for and hold such Lender harmless
from any loss, cost or expense incurred by it as a result of:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any continuation, conversion, payment or prepayment of any Loan other than a LIBOR Daily Floating Rate Loan on a day other
than the last day of the Interest Period for such Loan (whether voluntary, mandatory, automatic, by reason of acceleration, or
otherwise);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any failure by the Borrower (for a reason other than the failure of such Lender to make a Loan) to prepay, borrow, continue
or convert any Loan other than a LIBOR Daily Floating Rate Loan on the date or in the amount notified by the Borrower; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any assignment of a Eurodollar Rate Loan on a day other than the last day of the Interest Period therefor as a result of
a request by the Borrower pursuant to <U>Section&nbsp;11.13</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">including any loss of anticipated profits and
any loss or expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees payable
to terminate the deposits from which such funds were obtained. The Borrower shall also pay any customary administrative fees charged
by such Lender in connection with the foregoing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">For purposes of calculating amounts payable by
the Borrower to the Lenders under this <U>Section&nbsp;3.05</U>, each Lender shall be deemed to have funded each Eurodollar Rate
Loan made by it at the Eurodollar Rate for such Loan by a matching deposit or other borrowing in the London interbank eurodollar
market for a comparable amount and for a comparable period, whether or not such Eurodollar Rate Loan was in fact so funded.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Mitigation Obligations; Replacement of Lenders</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Designation of a Different Lending Office</U>. If any Lender requests compensation under <U>Section 3.04</U>, or the
Borrower is required to pay any additional amount to any Lender, the L/C Issuer, or any Governmental Authority for the account
of any Lender or the L/C Issuer pursuant to <U>Section 3.01</U>, or if any Lender gives a notice pursuant to <U>Section 3.02</U>,
then such Lender or the L/C Issuer shall, as applicable, use reasonable efforts to designate a different Lending Office for funding
or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates,
if, in the judgment of such Lender or the L/C Issuer, such designation or assignment (i) would eliminate or reduce amounts payable
pursuant to <U>Section 3.01</U> or <U>3.04</U>, as the case may be, in the future, or eliminate the need for the notice pursuant
to <U>Section 3.02</U>, as applicable, and (ii) in each case, would not subject such Lender or the L/C Issuer, as the case may
be, to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender or the L/C Issuer, as the case
may be. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender or the L/C Issuer in connection
with any such designation or assignment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Replacement of Lenders</U>. If any Lender requests compensation under <U>Section 3.04</U>, or if the Borrower is required
to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to <U>Section 3.01</U>,
the Borrower may replace such Lender in accordance with <U>Section 11.13</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Survival</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All of the Borrower&rsquo;s obligations under
this <U>Article III</U> shall survive termination of the Aggregate Commitments, repayment of all other Obligations hereunder,
and resignation of the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE IV<BR>
CONDITIONS PRECEDENT TO Credit Extensions</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conditions of Initial Credit Extension</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The obligation of the L/C Issuer and each Lender
to enter into this Agreement is subject to satisfaction of the following conditions precedent:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent&rsquo;s receipt of the following, each of which shall be originals or telecopies (followed promptly
by originals) unless otherwise specified, each properly executed by a Responsible Officer of the signing Loan Party, each dated
the Third A&amp;R Effective Date (or, in the case of certificates of governmental officials, a recent date before the Third A&amp;R
Effective Date) and each in form and substance satisfactory to the Administrative Agent and each of the Lenders:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>executed counterparts of this Agreement and the Guaranty, sufficient in number for distribution to the Administrative Agent,
each Lender and the Borrower;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a Note executed by the Borrower in favor of each Lender requesting a Note;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>confirmation of security agreements, in form and substance reasonably acceptable to the Lenders;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such certificates of resolutions or other action, incumbency certificates and/or other certificates of Responsible Officers
of each Loan Party as the Administrative Agent may require evidencing the identity, authority and capacity of each Responsible
Officer thereof authorized to act as a Responsible Officer in connection with this Agreement and the other Loan Documents to which
such Loan Party is a party or is to be a party;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such documents and certifications as the Administrative Agent may reasonably require to evidence that each Loan Party is
duly organized or formed, and that the Borrower is validly existing, in good standing and qualified to engage in business in each
jurisdiction where its ownership, lease or operation of properties or the conduct of its business requires such qualification,
except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a favorable opinion of Burns &amp; Levinson LLP, counsel to the Loan Parties, addressed to the Administrative Agent and
each Lender, as the Required Lenders may reasonably request;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a certificate signed by a Responsible Officer of the Borrower certifying (A) that the conditions specified in <U>Sections
4.02(a)</U> and <U>(b)</U> have been satisfied, and (B) that there has been no event or circumstance since the date of the Audited
Financial Statements that has had or could be reasonably expected to have, either individually or in the aggregate, a Material
Adverse Effect since December 31, 2016;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>certificates attesting to the Solvency of each Loan Party from its chief financial officer;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>[Reserved];</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no Default or Event of Default shall have occurred and be continuing; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such other assurances, certificates, documents, consents or opinions as the Administrative Agent, the L/C Issuer or any
Lender reasonably may require.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) All fees required to be paid to the Administrative Agent on or before the Third A&amp;R Effective Date shall have been
paid, including, without limitation, the Agency Fee, and (ii) all fees required to be paid to the Lenders on or before the Third
A&amp;R Effective Date shall have been paid.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Unless waived by the Administrative Agent, the Borrower shall have paid all fees, charges and disbursements of counsel to
the Administrative Agent (directly to such counsel if requested by the Administrative Agent) to the extent invoiced prior to or
on the Third A&amp;R Effective Date, plus such additional amounts of such fees, charges and disbursements as shall constitute its
reasonable estimate of such fees, charges and disbursements incurred or to be incurred by it through the closing proceedings (<U>provided</U>
that such estimate shall not thereafter preclude a final settling of accounts between the Borrower and the Administrative Agent).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Without limiting the generality of the provisions
of the last paragraph of <U>Section 9.03</U>, for purposes of determining compliance with the conditions specified in this <U>Section
4.01</U>, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied
with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender
unless the Administrative Agent shall have received notice from such Lender prior to the proposed Third A&amp;R Effective Date
specifying its objection thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conditions to all Credit Extensions</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The obligation of each Lender to honor any
Request for Credit Extension (other than a Committed Loan Notice requesting only a conversion of Loans to the other Type, or a
continuation of Eurodollar Rate Loans) is subject to the following conditions precedent:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The representations and warranties of the Borrower contained in <U>Article V</U> or any other Loan Document, or which are
contained in any document furnished at any time under or in connection herewith or therewith, shall be true and correct in all
material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are
already qualified or modified by materiality) on and as of the date of such Credit Extension, except to the extent that such representations
and warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date in all
material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are
already qualified or modified by materiality), and except that for purposes of this <U>Section 4.02</U>, the representations and
warranties contained in <U>Sections 5.05(a)</U> and <U>(b)</U> shall be deemed to refer to the most recent statements furnished
pursuant to <U>Sections 6.01(a)</U> and <U>(b)</U>, respectively.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Default or Event of Default shall exist, or would result from such proposed Credit Extension or from the application
of the proceeds thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent and, if applicable, or the L/C Issuer shall have received a Request for Credit Extension in accordance
with the requirements hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Request for Credit Extension (other than
a Committed Loan Notice requesting only a conversion of Loans to the other Type or a continuation of Eurodollar Rate Loans) submitted
by the Borrower shall be deemed to be a representation and warranty that the conditions specified in <U>Sections 4.02(a) and (b)
</U>have been satisfied on and as of the date of the applicable Credit Extension.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE V<BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower represents and warrants to the
Administrative Agent and the Lenders (and such representations are re-made by the Borrower each time the Borrower submits a quarterly
Compliance Certificate pursuant to <U>Section 6.02</U>) that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Existence, Qualification and Power</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Loan Party and each of its Subsidiaries
(a) is duly organized or formed, validly existing and, as applicable, in good standing under the Laws of the jurisdiction of its
incorporation or organization, (b) has all requisite power and authority and all requisite governmental licenses, authorizations,
consents and approvals to (i) own or lease its assets and carry on its business and (ii) execute, deliver and perform its obligations
under the Loan Documents to which it is a party and consummate the Transaction, and (c) is duly qualified and is licensed and,
as applicable, in good standing under the Laws of each jurisdiction where its ownership, lease or operation of properties or the
conduct of its business requires such qualification or license; except in each case referred to in clause (b)(i) or (c), to the
extent that failure to do so could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorization; No Contravention</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The execution, delivery and performance by
each Loan Party of each Loan Document to which such Person is a party have been duly authorized by all necessary corporate or
other organizational action, and do not and will not (a) contravene the terms of any of such Person&rsquo;s Organization Documents;
(b) conflict with or result in any breach or contravention of, or the creation of any Lien under, or require any payment to be
made under (i) any Contractual Obligation to which such Person is a party or affecting such Person or the properties of such Person
or any of its Subsidiaries or (ii) any order, injunction, writ or decree of any Governmental Authority or any arbitral award to
which such Person or its property is subject; or (c) violate any Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governmental Authorization; Other Consents</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No approval, consent, exemption, authorization,
or other action by, or notice to, or filing with, any Governmental Authority or any other Person is necessary or required in connection
with (a) the execution, delivery or performance by, or enforcement against, any Loan Party of this Agreement or any other Loan
Document, (b)&nbsp;the grant by any Loan Party of the Liens granted by it pursuant to the Collateral Documents, (c)&nbsp;the perfection
or maintenance of the Liens created under the Collateral Documents (including the first priority nature thereof) or (d)&nbsp;the
exercise by the Administrative Agent or any Lender of its rights under the Loan Documents or the remedies in respect of the Collateral
pursuant to the Collateral Documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Binding Effect</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement has been, and each other Loan
Document, when delivered hereunder, will have been, duly executed and delivered by each Loan Party that is party thereto. This
Agreement constitutes, and each other Loan Document when so delivered will constitute, a legal, valid and binding obligation of
such Loan Party, enforceable against each Loan Party that is party thereto in accordance with its terms.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements; No Material Adverse Effect</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Audited Financial Statements (i) were prepared in accordance with GAAP consistently applied throughout the period covered
thereby, except as otherwise expressly noted therein; (ii) fairly present in all material respects the financial condition of the
Borrower and its Subsidiaries as of the date thereof and their results of operations for the period covered thereby in accordance
with GAAP consistently applied throughout the period covered thereby, except as otherwise expressly noted therein; and (iii) show
all material indebtedness and other liabilities, direct or contingent, of the Borrower and its Subsidiaries as of the date thereof,
including liabilities for taxes, material commitments and Indebtedness.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since the date of the Audited Financial Statements, there has been no event or circumstance, either individually or in the
aggregate, that has had or could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Litigation</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Except as set forth on <U>Schedule 5.06</U>
attached hereto, there is no action, proceeding or investigation pending or threatened (or any basis therefor known to the Borrower)
(i) which questions the validity of this Agreement, the Notes, the Loan Documents, or the other documents executed in connection
herewith or therewith, or any action taken or to be taken pursuant hereto or thereto, or (ii) which if adversely determined against
the Borrower, would result in liability of the Borrower in an amount which exceeds $250,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Default</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Neither the Borrower nor any Subsidiary thereof
is in default under or with respect to, or a party to, any Contractual Obligation that could, either individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Ownership of Property; Liens; Investments</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower and each of its Subsidiaries has good record and marketable title in fee simple to, or valid leasehold interests
in, all real property necessary or used in the ordinary conduct of its business, except for such defects in title as could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The property of the Borrower and each of its Subsidiaries is subject to no Liens, other than Permitted Liens.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule&nbsp;5.08(c)</U> sets forth a complete and accurate list of all real property owned by the Borrower and each
of its Subsidiaries, showing as of the date hereof the street address, county or other relevant jurisdiction, state, record owner
and book and fair value thereof. Each Loan Party and each of its Subsidiaries has good and marketable title to the real property
owned by the Borrower or such Subsidiary, free and clear of all Liens, other than Permitted Liens.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i)&nbsp;&nbsp;&#9;<U>Schedule&nbsp;5.08(d)(i) sets forth a complete and accurate list of all leases</U> of real property under which
the Borrower or any Subsidiary of the Borrower is the lessee, showing as of the date hereof the street address, county or other
relevant jurisdiction, state, lessor, lessee, expiration date and annual rental cost thereof. Each such lease is the legal, valid
and binding obligation of the lessor thereof, enforceable in accordance with its terms.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;&nbsp;&nbsp;&nbsp;(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT><U>Schedule 5.08(d)(ii)</U> sets forth a complete and accurate list of all leases of real property under which any Loan
Party or any Subsidiary of the Borrower is the lessor, showing as of the date hereof the street address, county or other relevant
jurisdiction, state, lessor, lessee, expiration date and annual rental cost thereof. Each such lease is the legal, valid and binding
obligation of the lessee thereof, enforceable in accordance with its terms.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule&nbsp;5.08(e)</U> sets forth a complete and accurate list of all Investments held by the Borrower or any Subsidiary
of the Borrower on the date hereof, showing as of the date hereof the amount, obligor or issuer and maturity, if any, thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 5.08(f)</U> sets forth a list of all banks and other financial institutions and depositories at which the Borrowers
and/or any Domestic Subsidiary maintains (or has caused to be maintained) or will maintain deposit accounts, operating accounts,
or other accounts of any kind or nature into which funds of the Borrower or any Domestic Subsidiary are from time to time deposited
and correctly identifies the name and address of each depository, the name in which each account is held, the purpose of the account
and the complete account number.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Compliance</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">With respect to existing Environmental Laws
and claims alleging potential liability or responsibility for violation of any Environmental Law, Borrower has reasonably concluded
that such Environmental Laws and claims could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Returns and Payments</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower and its Subsidiaries have filed
all tax returns required by law to be filed and have paid all taxes, assessments and other governmental charges levied upon any
of their respective properties, assets, income or franchises, other than those (i) not yet delinquent, (ii) not material in aggregate
amount, (iii) being or about to be contested as provided in subsection 5.4 and/or (iv) not reasonably likely to have a Material
Adverse Effect. The charges, accruals and reserves on the books of the Borrower and its Subsidiaries in respect of their respective
taxes are adequate in the opinion of the Borrower, and the Borrower knows of no unpaid assessment for additional taxes or of any
basis therefor other than those which in the aggregate, are not reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>ERISA Compliance</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 5.11</U> sets forth a true, correct and complete list of all material employee benefit plans and arrangements
of the Borrower and its Subsidiaries, including, without limitation, all pension profit sharing or similar plans providing for
a program of deferred compensation to any employee or any plan, subject to the provisions of ERISA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Plan is in compliance in all material respects with the applicable provisions of ERISA, the Code and other Federal
or state Laws. Each Plan that is intended to qualify under Section 401(a) of the Code has received a favorable determination letter
from the IRS or an application for such a letter is currently being processed by the IRS with respect thereto and, to the best
knowledge of the Borrower, nothing has occurred which would prevent, or cause the loss of, such qualification. The Borrower and
each ERISA Affiliate have made all required contributions to each Plan subject to Section 412 of the Code, and no application for
a funding waiver or an extension of any amortization period pursuant to Section 412 of the Code has been made with respect to any
Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no pending or, to the best knowledge of the Borrower, threatened claims, actions or lawsuits, or action by any
Governmental Authority, with respect to any Plan that could reasonably be expected to have a Material Adverse Effect. There has
been no prohibited transaction or violation of the fiduciary responsibility rules with respect to any Plan that has resulted or
could reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) No ERISA Event has occurred or is reasonably expected to occur; (ii)&nbsp;no Pension Plan has any Unfunded Pension Liability;
(iii) neither the Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability under Title IV of
ERISA with respect to any Pension Plan (other than premiums due and not delinquent under Section 4007 of ERISA); (iv) neither the
Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability (and no event has occurred which,
with the giving of notice under Section 4219 of ERISA, would result in such liability) under Section 4201 or 4243 of ERISA with
respect to a Multiemployer Plan; and (v) neither the Borrower nor any ERISA Affiliate has engaged in a transaction that could be
subject to Section 4069 or 4212(c) of ERISA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Subsidiaries; Equity Interests; Loan Parties</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower has no Subsidiaries other than
those specifically disclosed in Part (a) of <U>Schedule 5.12</U>, and all of the outstanding Equity Interests in such Subsidiaries
have been validly issued, are fully paid and non-assessable and are owned by a Loan Party in the amounts specified on Part (a)
of <U>Schedule&nbsp;5.12</U> free and clear of all Liens except those created under the Collateral Documents or Permitted Liens.
The Borrower has no equity investments in any other corporation or entity other than those specifically disclosed in Part (b)
of <U>Schedule 5.12</U>. Set forth on Part (d) of <U>Schedule 5.12</U> is a complete and accurate list of all Loan Parties, showing
as of the Third A&amp;R Effective Date (as to each Loan Party) the jurisdiction of its incorporation, the address of its principal
place of business and its U.S. taxpayer identification number or, in the case of any Foreign Subsidiary that does not have a U.S.
taxpayer identification number, its unique identification number issued to it by the jurisdiction of its incorporation. The copy
of the charter of each Loan Party and each amendment thereto provided pursuant to <U>Section 4.01(a)</U> is a true and correct
copy of each such document, each of which is valid and in full force and effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Margin Regulations; Investment Company Act</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower is not engaged and will not engage, principally or as one of its important activities, in the business of purchasing
or carrying margin stock or margin securities (within the meaning of Regulation U and Regulation T issued by the FRB), or extending
credit for the purpose of purchasing or carrying margin stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Borrower, any Person Controlling the Borrower, or any Subsidiary is or is required to be registered as an &ldquo;investment
company&rdquo; under the Investment Company Act of 1940.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclosure</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower has disclosed to the Administrative
Agent and the Lenders all agreements, instruments and corporate or other restrictions to which it or any of its Subsidiaries is
subject, and all other matters known to it, that, individually or in the aggregate, could reasonably be expected to result in
a Material Adverse Effect. No report, financial statement, certificate or other information furnished (whether in writing or orally)
by or on behalf of any Loan Party to the Administrative Agent or any Lender in connection with the transactions contemplated hereby
and the negotiation of this Agreement or delivered hereunder or under any other Loan Document (in each case as modified or supplemented
by other information so furnished) contains any material misstatement of fact or omits to state any material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that,
with respect to projected financial information, the Borrower represents only that such information was prepared in good faith
based upon assumptions believed to be reasonable at the time and the Borrower makes no representation about information of a general
economic nature and general information about the industry of the Borrower or any of its Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Loan Party and each Subsidiary thereof
is in compliance in all material respects with the requirements of all Laws and all orders, writs, injunctions and decrees applicable
to it or to its properties, except in such instances in which (a) such requirement of Law or order, writ, injunction or decree
is being contested in good faith by appropriate proceedings diligently conducted or (b) the failure to comply therewith, either
individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Intellectual Property; Licenses, Etc</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower and each of its Subsidiaries own,
or possess the right to use, all of the trademarks, service marks, trade names, copyrights, patents, patent rights, franchises,
licenses and other intellectual property rights (collectively, &ldquo;<U>IP Rights</U>&rdquo;) that are reasonably necessary for
the operation of their respective businesses, without conflict with the rights of any other Person. <U>Schedule 5.16</U> sets
forth a complete and accurate list of: (a)&nbsp;all registered copyrights owned by the Borrower or any Subsidiary, all applications
for registration of copyrights owned by the Borrower or any Subsidiary, and all other Copyrights owned by the Borrower or any
Subsidiary and material or reasonably necessary to the conduct of the business of the Borrower or any Subsidiary; (b)&nbsp;all
registered patents owned by the Borrower or any Subsidiary and all applications for patents owned by the Borrower or any Subsidiary;
(c)&nbsp;all registered trademarks owned by the Borrower or any Subsidiary, all applications for registration of trademarks owned
by the Borrower or any Subsidiary, and all other trademarks owned by the Borrower or any Subsidiary and material or reasonably
necessary to the conduct of the business of the Borrower or any Subsidiary, and (d)&nbsp;all intellectual property licenses entered
into by the Borrower or any Subsidiary pursuant to which (x)&nbsp;the Borrower or any Subsidiary has provided any license or other
rights in intellectual property owned or controlled by the Borrower or any Subsidiary to any other Person or (y)&nbsp;any Person
has granted to the Borrower or any Subsidiary any license or other rights in intellectual property owned or controlled by such
Person that is material to the business of the Borrower or any Subsidiary. To the best knowledge of the Borrower, no slogan or
other advertising device, product, process, method, substance, part or other material now employed, or now contemplated to be
employed, by the Borrower or any of its Subsidiaries infringes upon any rights held by any other Person. No claim or litigation
regarding any of the foregoing is pending or, to the best knowledge of the Borrower, threatened, which, either individually or
in the aggregate, could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Solvency</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower is, individually and together
with its Subsidiaries on a consolidated basis, Solvent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Casualty, Etc</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Neither the businesses nor the properties of
the Borrower or any of its Subsidiaries are affected by any fire, explosion, accident, strike, lockout or other labor dispute,
drought, storm, hail, earthquake, embargo, act of God or of the public enemy or other casualty (whether or not covered by insurance)
that, either individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.75in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Collateral Documents</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The provisions of the Collateral Documents
are effective to create in favor of the Administrative Agent for the benefit of the Secured Parties a legal, valid and enforceable
first priority Lien (subject to Liens permitted by <U>Section 7.01</U>) on all right, title and interest of the respective Loan
Parties in the Collateral described therein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Material Agreements</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower&rsquo;s most recent form 10-K
filed with the SEC, as supplemented by the Borrower&rsquo;s forms 10-Q and 8-K filed with the SEC thereafter, accurately and completely
lists each material agreement and instrument required to be disclosed therein, including but not limited to any material leases,
employment agreements or other agreements with management of the Borrower or any Subsidiary, stockholder agreements and all other
material agreements required to be disclosed therein. Each of the Borrower and its Subsidiaries (as applicable) and, to the best
of the Borrower&rsquo;s knowledge, all third parties to such material agreements, are in material compliance with the terms thereof,
and no default or event of default by the Borrower or, to the Borrower&rsquo;s knowledge, any other party thereto, exists thereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.21<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Eligible Receivables</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Eligible Receivables included the calculation
of minimum Working Capital are bona fide existing payment obligations of Account Debtors created by the sale or lease and delivery
of Inventory or the rendition of services to such Account Debtors in the ordinary course of Borrower&rsquo;s and/or its Subsidiaries&rsquo;
business, owed to Borrower and/or such Subsidiaries without defenses, disputes, offsets, counterclaims, or rights of return or
cancellation (other than normal return policies) known to the Borrower or such Subsidiary. As to each Receivable that is identified
by Borrower as an Eligible Receivables in a Compliance Certificate submitted to Administrative Agent, such Account is not excluded
as ineligible by virtue of one or more of the excluding criteria set forth in the definition of Eligible Receivables, other than
subsection (f) which is qualified to the Borrower&rsquo;s knowledge.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.22<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Eligible Inventory</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All Eligible Inventory included in the calculation
of minimum Working Capital is of good and merchantable quality. As to each item of Inventory that is identified by Borrower as
Eligible Inventory in a Compliance Certificate submitted to Administrative Agent, such Inventory is located at one of the locations
set forth on <U>Schedule 5.08</U> or at such other location identified in writing by Borrower to Administrative Agent, or is in
transit from one such location to another such location and is not otherwise excluded as ineligible by virtue of one or more of
the excluding criteria set forth in the definition of Eligible Inventory.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.23<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance Policies</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The properties of the Borrower and its Subsidiaries
are insured with financially sound and reputable insurance companies not Affiliates of the Borrower, in such amounts, with such
deductibles and covering such risks as are customarily carried by companies engaged in similar businesses and owning similar properties
in localities where the Borrower or the applicable Subsidiary operates. <U>Schedule 5.23</U> lists all material insurance policies
of any kind or nature by or on behalf of the Borrower, as well as a summary of the principal terms of such insurance. All such
insurance policies, together with any insurance policies obtained by the Borrower after the Third A&amp;R Effective Date are or
will be in full force and effect and provide coverage of such risks and in such amounts as is customarily maintained for businesses
of the scope and size of the Borrower..</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.24<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employment and Labor Agreements</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Schedule 5.24</U> accurately and completely
describes each employment agreement, agreement for the payment of defined compensation, severance or so-called change in control
agreement covering executive officers of the Borrower, as well as all collective bargaining agreements or other labor agreements
covering any employees of the Borrower or its Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.25<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>OFAC; Anti-Corruption Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Loan Party, nor, to the knowledge of the Loan Parties, any director, officer, employee, agent, affiliate or representative
thereof, is an individual or entity that is, or is owned or controlled by any individual or entity that is (i) currently the subject
or target of any Sanctions, (ii) included on OFAC&rsquo;s List of Specially Designated Nationals, HMT&rsquo;s Consolidated List
of Financial Sanctions Targets and the Investment Ban List, or any similar list enforced by any other relevant sanctions authority,
or (iii) located, organized or resident in a Designated Jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Loan Parties and, to the knowledge of the Borrower, their respective directors, officers, employees, and agents are,
and have been in compliance with all applicable laws, rules, regulations and orders regarding Sanctions, and have conducted their
businesses in compliance with applicable anti-corruption Laws and have instituted and maintained policies and procedures designed
to promote and achieve compliance with such Laws. The Borrower will not, directly or, to the Borrower&rsquo;s knowledge, indirectly,
use the proceeds of the Loans, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner
or other Person to fund any activities or business of or with any Person, or in any country or territory, that, at the time of
such funding, is, or whose government is, the subject of Sanctions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Borrower or any of its Subsidiaries nor, to the knowledge of the Borrower, any director, officer, employee or
agent of the Borrower or any of its Subsidiaries has taken any action, directly or indirectly, that would result in a material
violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the
&ldquo;<U>FCPA</U>&rdquo;) or any other applicable anti-corruption law. No part of the proceeds of the Loans will be used, directly
or to the Borrower&rsquo;s knowledge, indirectly, for any payment to any governmental official or employee, political party, official
of a political party, candidate for political office, or anyone else acting in an official capacity in violation of the FCPA or
any other anti-corruption law. The Borrower and its Subsidiaries are in compliance, in all material respects, with the Act and
all other applicable anti-money laundering and counter-terrorist financing laws and regulations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.26<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>EEA Financial Institution</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No Loan Party is an EEA Financial Institution.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.27<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restated Obligations</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Loan Parties confirm, acknowledge, and
agree that the aggregate outstanding principal amount of Restated Obligations as of the date hereof is $14,000,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE VI<BR>
AFFIRMATIVE COVENANTS</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">So long as any Lender shall have any Commitment
hereunder, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied, or any Letter of Credit shall remain outstanding,
the Borrower shall, and shall (except in the case of the covenants set forth in <U>Sections 6.01</U>, <U>6.02</U>, <U>6.03</U>
and <U>6.11</U>) cause each Subsidiary to:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Deliver to the Administrative Agent and each
Lender, in form and detail satisfactory to the Administrative Agent and the Required Lenders:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as soon as available, but in any event within 120 days after the end of each fiscal year of the Borrower (commencing with
the fiscal year ended December 31, 2016), a consolidated balance sheet of the Borrower and its Subsidiaries as at the end of such
fiscal year, and the related consolidated statements of income or operations, changes in shareholders&rsquo; equity, and cash flows
for such fiscal year, setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable
detail and prepared in accordance with GAAP, such consolidated statements to be audited and accompanied by a report and opinion
of an independent certified public accountant of nationally recognized standing reasonably acceptable to the Required Lenders,
which report and opinion shall be prepared in accordance with generally accepted auditing standards and shall not be subject to
any &ldquo;going concern&rdquo; or like qualification or exception or any qualification or exception as to the scope of such audit,
and such consolidating statements to be certified by the chief executive officer, chief financial officer, treasurer or controller
of the Borrower to the effect that such statements are fairly stated in all material respects when considered in relation to the
consolidated financial statements of the Borrower and its Subsidiaries;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as soon as available, but in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal
year of the Borrower (commencing with the fiscal quarter ended December 31, 2016), and within 60 days after the end of the fourth
fiscal quarter, a consolidated and consolidating balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal
quarter, and the related consolidated and consolidating statements of income or operations, changes in shareholders&rsquo; equity,
and cash flows for such fiscal quarter and for the portion of the Borrower&rsquo;s fiscal year then ended, setting forth in each
case in comparative form the figures for the corresponding fiscal quarter of the previous fiscal year and the corresponding portion
of the previous fiscal year, all in reasonable detail, such consolidated statements to be certified by the chief executive officer,
chief financial officer, treasurer or controller of the Borrower as fairly presenting the financial condition, results of operations,
shareholders&rsquo; equity and cash flows of the Borrower and its Subsidiaries in accordance with GAAP, subject only to normal
year-end audit adjustments and the absence of footnotes and such consolidating statements to be certified by the chief executive
officer, chief financial officer, treasurer or controller of the Borrower to the effect that such statements are fairly stated
in all material respects when considered in relation to the consolidated financial statements of the Borrower and its Subsidiaries;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>on or before January 30 of each fiscal year of the Borrower, a budget of the Borrower and its Subsidiaries on a consolidated
basis for the then current fiscal year, including forecasts prepared by management of the Borrower, in form satisfactory to the
Administrative Agent and the Required Lenders, of consolidated balance sheets and statements of income or operations and cash flows
of the Borrower and its Subsidiaries on a quarterly basis for the immediately following fiscal year (including the fiscal year
in which the Maturity Date for the Term Loans occurs).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As soon as available, but in any event within forty-five (45) days after the end of each quarterly accounting period in
each fiscal year of the Borrower and within sixty (60) days after the end of the fourth fiscal quarter, (i) quarterly summary accounts
receivable aging report, in such form as Administrative Agent may from time to time reasonably require and (ii) reports detailing
such other information as Administrative Agent may from time to time reasonably require. All of the reports listed in forgoing
clauses (i) and (ii) shall be in reasonable detail and current through at least the close of business for the immediately preceding
quarter and certified by the Chief Executive Officer or the Chief Financial Officer or such other officer of the Borrower as may
be acceptable in the sole discretion of Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">As to any information contained in materials furnished
pursuant to <U>Section 6.02(d)</U>, the Borrower shall not be separately required to furnish such information under <U>Section
6.01(a)</U> or <U>(b)</U> above, but the foregoing shall not be in derogation of the obligation of the Borrower to furnish the
information and materials described in <U>Sections 6.01(a)</U> and <U>(b)</U> above at the times specified therein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificates; Other Information</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Deliver to the Administrative Agent and each
Lender, in form and detail satisfactory to the Administrative Agent and the Required Lenders:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>concurrently with the delivery of the financial statements referred to in <U>Sections&nbsp;6.01(a)</U> and <U>(b)</U>, (i)
a duly completed Compliance Certificate signed by the chief executive officer, chief financial officer, treasurer or controller
of the Borrower, and in the event of any change in generally accepted accounting principles used in the preparation of such financial
statements, the Borrower shall also provide, if necessary for the determination of compliance with <U>Section 7.11</U>, a statement
of reconciliation conforming such financial statements to GAAP and (ii) a copy of management&rsquo;s discussion and analysis with
respect to such financial statements;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly after any request by the Administrative Agent or any Lender, copies of any detailed audit reports, management letters
or recommendations submitted to the board of directors (or the audit committee of the board of directors) of any Loan Party by
independent accountants in connection with the accounts or books of any Loan Party or any of its Subsidiaries, or any audit of
any of them;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly after the same are available, copies of each annual report, proxy or financial statement or other report or communication
sent to the stockholders of the Borrower, and copies of all annual, regular, periodic and special reports and registration statements
which the Borrower may file or be required to file with the SEC under Section&nbsp;13 or 15(d) of the Securities Exchange Act of
1934, or with any national securities exchange, and in any case not otherwise required to be delivered to the Administrative Agent
pursuant hereto;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly after the furnishing thereof, copies of any statement or report furnished to any holder of debt securities of any
Loan Party or of any of its Subsidiaries pursuant to the terms of any indenture, loan or credit or similar agreement and not otherwise
required to be furnished to the Lenders pursuant to <U>Section 6.01</U> or any other clause of this <U>Section&nbsp;6.02</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as soon as available, but in any event within 30 days after the end of each fiscal year of the Borrower, a report summarizing
the insurance coverage (specifying type, amount and carrier) in effect for each Loan Party and its Subsidiaries and containing
such additional information as the Administrative Agent, or any Lender through the Administrative Agent, may reasonably specify;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly, and in any event within five Business Days after receipt thereof by any Loan Party or any Subsidiary thereof,
copies of each notice or other correspondence received from the SEC (or comparable agency in any applicable non-U.S. jurisdiction)
concerning any investigation or possible investigation or other inquiry by such agency regarding financial or other operational
results of any Loan Party or any Subsidiary thereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>reserved;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly after the assertion or occurrence thereof, notice of any action or proceeding against or of any noncompliance by
any Loan Party or any of its Subsidiaries with any Environmental Law or Environmental Permit that could reasonably be expected
to have a Material Adverse Effect;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as soon as available, but in any event within 30 days after the end of each fiscal year of the Borrower, an update supplementing
<U>Schedules&nbsp;5.08(c), 5.08(d)(i), 5.08(d)(ii), 5.08(e) and 5.16</U>, containing the information included in such Schedules
as may be necessary for such Schedules to be true, accurate and complete in accordance with the applicable representation and warranty
hereunder as if made as of the last day of the fiscal year of the Borrower, each such report to be signed by a Responsible Officer
of the Borrower and each such update to be in substance reasonably satisfactory to the Administrative Agent;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promptly, such additional information regarding the business, financial, legal or corporate affairs of any Loan Party or
any Subsidiary thereof, or compliance with the terms of the Loan Documents, as the Administrative Agent or any Lender may from
time to time reasonably request.; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(k)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within five (5) Business Days of request by Agent, a fully executed Authorization to Share Insurance Information in the
form of <U>Exhibit F</U> attached hereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Documents required to be delivered pursuant
to <U>Section 6.01(a)</U> or <U>(b)</U> or <U>Section&nbsp;6.02(d)</U> (to the extent any such documents are included in materials
otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the
date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower&rsquo;s website on the Internet
at the website address listed on <U>Schedule 11.02</U>; or (ii) on which such documents are posted on the Borrower&rsquo;s behalf
on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial,
third-party website or whether sponsored by the Administrative Agent); <U>provided</U> that: (i) the Borrower shall deliver paper
copies of such documents to the Administrative Agent or any Lender that requests the Borrower to deliver such paper copies until
a written request to cease delivering paper copies is given by the Administrative Agent or such Lender and (ii) the Borrower shall
notify the Administrative Agent and each Lender (by telecopier or electronic mail) of the posting of any such documents and provide
to the Administrative Agent by electronic mail electronic versions (<U>i.e.</U>, soft copies) of such documents. Notwithstanding
anything contained herein, in every instance the Borrower shall be required to provide paper copies of the Compliance Certificates
required by <U>Section 6.02(b)</U> to the Administrative Agent. Except for such Compliance Certificates, the Administrative Agent
shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and in any event shall
have no responsibility to monitor compliance by the Borrower with any such request for delivery, and each Lender shall be solely
responsible for requesting delivery to it or maintaining its copies of such documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Borrower hereby acknowledges that (a) the
Administrative Agent will make available to the Lenders and the L/C Issuer materials and/or information provided by or on behalf
of the Borrower hereunder (collectively, &ldquo;<U>Borrower Materials</U>&rdquo;) by posting the Borrower Materials on IntraLinks
or another similar electronic system (the &ldquo;<U>Platform</U>&rdquo;) and (b) certain of the Lenders (each, a &ldquo;<U>Public
Lender</U>&rdquo;) may have personnel who do not wish to receive material non-public information with respect to the Borrower
or its Affiliates, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related
activities with respect to such Persons&rsquo; securities. The Borrower hereby agrees that so long as the Borrower is the issuer
of any outstanding debt or equity securities that are registered or issued pursuant to a private offering or is actively contemplating
issuing any such securities it will use commercially reasonable efforts to identify that portion of the Borrower Materials that
may be distributed to the Public Lenders and that (w) all such Borrower Materials shall be clearly and conspicuously marked &ldquo;PUBLIC&rdquo;
which, at a minimum, shall mean that the word &ldquo;PUBLIC&rdquo; shall appear prominently on the first page thereof; (x) by
marking Borrower Materials &ldquo;PUBLIC,&rdquo; the Borrower shall be deemed to have authorized the Administrative Agent, the
L/C Issuer and the Lenders to treat such Borrower Materials as not containing any material non-public information (although it
may be sensitive and proprietary) with respect to the Borrower or its securities for purposes of United States Federal and state
securities laws (<U>provided</U>, <U>however</U>, that to the extent such Borrower Materials constitute Information, they shall
be treated as set forth in <U>Section 11.07</U>); (y) all Borrower Materials marked &ldquo;PUBLIC&rdquo; are permitted to be made
available through a portion of the Platform designated &ldquo;Public Side Information;&rdquo; and (z) the Administrative Agent
shall be entitled to treat any Borrower Materials that are not marked &ldquo;PUBLIC&rdquo; as being suitable only for posting
on a portion of the Platform not designated &ldquo;Public Side Information.&rdquo; Notwithstanding the foregoing, the Borrower
shall be under no Obligation to mark any Borrower Materials &ldquo;PUBLIC&rdquo;.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Promptly notify the Administrative Agent and each
Lender:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of the occurrence of any Default;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of any matter that has resulted or could reasonably be expected to result in a Material Adverse Effect, including (i) breach
or non-performance of, or any default under, a Contractual Obligation of the Borrower or any Subsidiary; (ii) any dispute, litigation,
investigation, proceeding or suspension between the Borrower or any Subsidiary and any Governmental Authority; or (iii) the commencement
of, or any material development in, any litigation or proceeding affecting the Borrower or any Subsidiary, including pursuant to
any applicable Environmental Laws;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of the occurrence of any ERISA Event;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of any material change in accounting policies or financial reporting practices by any Loan Party or any Subsidiary thereof;
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of the (i) occurrence of any Disposition of property or assets for which the Borrower is required to make a mandatory prepayment
pursuant to <U>Section&nbsp;2.05(b)(ii)</U>, (ii) occurrence of any sale of capital stock or other Equity Interests for which the
Borrower is required to make a mandatory prepayment pursuant to <U>Section&nbsp;2.05(b)(iii)</U>, (iii) incurrence or issuance
of any Indebtedness for which the Borrower is required to make a mandatory prepayment pursuant to <U>Section 2.05(b)(iv)</U>, and
(iv) receipt of any Extraordinary Receipt for which the Borrower is required to make a mandatory prepayment pursuant to <U>Section
2.0(b)(v)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each notice pursuant to <U>Section 6.03</U>
(other than <U>Section 6.03(e)</U> or <U>(f)</U>) shall be accompanied by a statement of a Responsible Officer of the Borrower
setting forth details of the occurrence referred to therein and stating what action the Borrower has taken and proposes to take
with respect thereto. Each notice pursuant to <U>Section 6.03(a)</U> shall describe with particularity any and all provisions
of this Agreement and any other Loan Document that have been breached.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of Obligations</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Pay and discharge as the same shall become
due and payable, all its obligations and liabilities, including (a) all tax liabilities, assessments and governmental charges
or levies upon it or its properties or assets, unless the same are being contested in good faith by appropriate proceedings diligently
conducted and adequate reserves in accordance with GAAP are being maintained by the Borrower or such Subsidiary; (b) all lawful
claims which, if unpaid, would by law become a Lien upon its property; and (c) all Indebtedness, as and when due and payable,
but subject to any applicable grace periods and subordination provisions contained in any instrument or agreement evidencing such
Indebtedness.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Preservation of Existence, Etc</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Preserve, renew and maintain in full force and effect its legal existence and good standing under the Laws of the jurisdiction
of its organization except in a transaction permitted by <U>Section 7.04</U> or <U>7.05</U>; (b) take all reasonable action to
maintain all rights, privileges, permits, licenses and franchises necessary or desirable in the normal conduct of its business,
except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect; and (c) preserve
or renew all of its registered patents, trademarks, trade names and service marks, the non-preservation of which could reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Maintenance of Properties</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Maintain, preserve and protect all of its material properties and equipment necessary in the operation of its business in
good working order and condition, ordinary wear and tear excepted; and (b) make all necessary repairs thereto and renewals and
replacements thereof except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Maintenance of Insurance</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Maintain with financially sound and reputable
insurance companies not Affiliates of the Borrower, insurance with respect to its properties and business against loss or damage
of the kinds customarily insured against by Persons engaged in the same or similar business, of such types and in such amounts
as are customarily carried under similar circumstances by such other Persons.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Comply in all material respects with the requirements
of all Laws and all orders, writs, injunctions and decrees applicable to it or to its business or property, except in such instances
in which (a) such requirement of Law or order, writ, injunction or decree is being contested in good faith by appropriate proceedings
diligently conducted; or (b) the failure to comply therewith could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Books and Records</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Maintain proper Books, in which full, true
and correct entries in conformity with GAAP consistently applied shall be made of all financial transactions and matters involving
the assets and business of the Borrower or such Subsidiary, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inspection Rights</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Permit representatives and independent contractors
of the Administrative Agent and each Lender to visit and inspect any of its properties, to examine its corporate, financial and
operating records, and make copies thereof or abstracts therefrom, and to discuss its affairs, finances and accounts with its
directors, officers, and independent public accountants, all at the expense of the Borrower and at such reasonable times during
normal business hours and as often as may be reasonably desired, upon reasonable advance notice to the Borrower; <U>provided</U>,
<U>however</U>, that when an Event of Default exists the Administrative Agent or any Lender (or any of their respective representatives
or independent contractors) may do any of the foregoing at the expense of the Borrower at any time during normal business hours
and without advance notice; <U>provided</U>, <U>further</U>, that so long as no occurrence of a Default or Event of Default has
occurred and is continuing, the Borrower shall only be responsible for the expenses relating to such inspections once per calendar
year.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Use the proceeds of the Revolving Credit Loans
for working capital, Permitted Acquisitions and general corporate purposes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Covenant to Guarantee Obligations and Give Security</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the formation or acquisition of any new direct or indirect Subsidiary (other than any CFC or a Subsidiary that is held
directly or indirectly by a CFC) by any Loan Party, then the Borrower shall, at the Borrower&rsquo;s expense:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 10&nbsp;days after such formation or acquisition, cause such Subsidiary, and cause each direct and indirect parent
of such Subsidiary (if it has not already done so), to duly execute and deliver to the Administrative Agent a guaranty or guaranty
supplement, in form and substance reasonably satisfactory to the Administrative Agent, guaranteeing the other Loan Parties&rsquo;
obligations under the Loan Documents,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 10 days after such formation or acquisition, furnish to the Administrative Agent a description of the real and personal
properties of such Subsidiary, in detail reasonably satisfactory to the Administrative Agent,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 30 days after such formation or acquisition, cause such Subsidiary and each direct and indirect parent of such Subsidiary
(if it has not already done so) to duly execute and deliver to the Administrative Agent deeds of trust, trust deeds, deeds to secure
debt, mortgages, leasehold mortgages, leasehold deeds of trust, Security Agreement Supplements, IP Security Agreement Supplements
and other security and pledge agreements, as specified by and in form and substance satisfactory to the Administrative Agent (including
delivery of all Pledged Interests in and of such Subsidiary, and other instruments of the type specified in <U>Section 4.01(a)(iii)</U>),
securing payment of all the Obligations of such Subsidiary or such parent, as the case may be, under the Loan Documents and constituting
Liens on all such real and personal properties,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 30 days after such formation or acquisition, cause such Subsidiary and each direct and indirect parent of such Subsidiary
(if it has not already done so) to take whatever action (including the recording of mortgages, the filing of Uniform Commercial
Code financing statements, the giving of notices and the endorsement of notices on title documents) may be reasonably necessary
or advisable in the opinion of the Administrative Agent to vest in the Administrative Agent (or in any representative of the Administrative
Agent designated by it) valid and subsisting Liens on the properties purported to be subject to the deeds of trust, trust deeds,
deeds to secure debt, mortgages, leasehold mortgages, leasehold deeds of trust, Security Agreement Supplements, IP Security Agreement
Supplements and security and pledge agreements delivered pursuant to this <U>Section&nbsp;6.12</U>,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 60 days after such formation or acquisition, deliver to the Administrative Agent, upon the request of the Administrative
Agent in its sole discretion, a signed copy of a favorable opinion, addressed to the Administrative Agent and the other Secured
Parties, of counsel for the Loan Parties reasonably acceptable to the Administrative Agent as to the matters contained in clauses&nbsp;(i),
(iii) and (iv) above, and as to such other matters as the Administrative Agent may reasonably request, and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as promptly as practicable after such formation or acquisition, deliver, upon the request of the Administrative Agent in
its sole discretion, to the Administrative Agent with respect to each parcel of real property owned or held by the entity that
is the subject of such formation or acquisition title reports, surveys and engineering, soils and other reports, and environmental
assessment reports, each in scope, form and substance reasonably satisfactory to the Administrative Agent, <U>provided</U>, <U>however</U><I>,</I>
that to the extent that any Loan Party or any of its Subsidiaries shall have otherwise received any of the foregoing items with
respect to such real property, such items shall, promptly after the receipt thereof, be delivered to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the acquisition of any property by any Loan Party, if such property, in the judgment of the Administrative Agent, shall
not already be subject to a perfected first priority security interest in favor of the Administrative Agent for the benefit of
the Secured Parties, then the Borrower shall, at the Borrower&rsquo;s expense:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 10 days after such acquisition, furnish to the Administrative Agent a description of the property so acquired in
detail reasonably satisfactory to the Administrative Agent,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 15 days after the Administrative Agent delivers to the Borrower the appropriate form which may be delivered on the
date of or following such acquisition, cause the applicable Loan Party to duly execute and deliver to the Administrative Agent
deeds of trust, trust deeds, deeds to secure debt, mortgages, leasehold mortgages, leasehold deeds of trust, Security Agreement
Supplements, IP Security Agreement Supplements and other security and pledge agreements, as specified by and in form and substance
satisfactory to the Administrative Agent, securing payment of all the Obligations of the applicable Loan Party under the Loan Documents
and constituting Liens on all such properties,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 30 days after such acquisition, cause the applicable Loan Party to take whatever action (including the recording
of mortgages, the filing of Uniform Commercial Code financing statements, the giving of notices and the endorsement of notices
on title documents) may be reasonably necessary or advisable in the opinion of the Administrative Agent to vest in the Administrative
Agent (or in any representative of the Administrative Agent designated by it) valid and subsisting Liens on such property, enforceable
against all third parties,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 60 days after such acquisition, deliver to the Administrative Agent, upon the request of the Administrative Agent
in its sole discretion, a signed copy of a favorable opinion, addressed to the Administrative Agent and the other Secured Parties,
of counsel for the Loan Parties reasonably acceptable to the Administrative Agent as to the matters contained in clauses&nbsp;(ii)
and (iii) above and as to such other matters as the Administrative Agent may reasonably request, and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as promptly as practicable after any acquisition of a real property, deliver, upon the request of the Administrative Agent
in its sole discretion, to the Administrative Agent with respect to such real property title reports, surveys and engineering,
soils and other reports, and environmental assessment reports, each in scope, form and substance reasonably satisfactory to the
Administrative Agent, <U>provided</U>, <U>however</U>, that to the extent that any Loan Party or any of its Subsidiaries shall
have otherwise received any of the foregoing items with respect to such real property, such items shall, promptly after the receipt
thereof, be delivered to the Administrative Agent,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the request of the Administrative Agent following the occurrence and during the continuance of a Default, the Borrower
shall, at the Borrower&rsquo;s expense:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 10 days after such request, furnish to the Administrative Agent a description of the real and personal properties
of the Loan Parties and their respective Subsidiaries in detail satisfactory to the Administrative Agent,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 15 days after such request, duly execute and deliver, and cause each Loan Party (other than any CFC or a Subsidiary
that is held directly or indirectly by a CFC) of the Borrower (if it has not already done so) to duly execute and deliver, to the
Administrative Agent deeds of trust, trust deeds, deeds to secure debt, mortgages, leasehold mortgages, leasehold deeds of trust,
Security Agreement Supplements, IP Security Agreement Supplements and other security and pledge agreements, as specified by and
in form and substance satisfactory to the Administrative Agent (including delivery of all Pledged Equity and Pledged Debt in and
of such Subsidiary, and other instruments of the type specified in <U>Section 4.01(a)(iii))</U>, securing payment of all the Obligations
of the applicable Loan Party under the Loan Documents and constituting Liens on all such properties,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 30 days after such request, take, and cause each Loan Party (other than any CFC or a Subsidiary that is held directly
or indirectly by a CFC) of the Borrower to take, whatever action (including the recording of mortgages, the filing of Uniform Commercial
Code financing statements, the giving of notices and the endorsement of notices on title documents) may be necessary or advisable
in the opinion of the Administrative Agent to vest in the Administrative Agent (or in any representative of the Administrative
Agent designated by it) valid and subsisting Liens on the properties purported to be subject to the deeds of trust, trust deeds,
deeds to secure debt, mortgages, leasehold mortgages, leasehold deeds of trust, Security Agreement Supplements, IP Security Agreement
Supplements and security and pledge agreements delivered pursuant to this <U>Section&nbsp;6.12</U>, enforceable against all third
parties in accordance with their terms,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>within 60 days after such request, deliver to the Administrative Agent, upon the request of the Administrative Agent in
its sole discretion, a signed copy of a favorable opinion, addressed to the Administrative Agent and the other Secured Parties,
of counsel for the Loan Parties acceptable to the Administrative Agent as to the matters contained in clauses&nbsp;(ii) and (iii)
above, and as to such other matters as the Administrative Agent may reasonably request, and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as promptly as practicable after such request, deliver, upon the request of the Administrative Agent in its sole discretion,
to the Administrative Agent with respect to each parcel of real property owned or held by the Borrower and its Subsidiaries, title
reports, surveys and engineering, soils and other reports, and environmental assessment reports, each in scope, form and substance
satisfactory to the Administrative Agent, <U>provided</U>, <U>however</U><I>,</I> that to the extent that any Loan Party or any
of its Subsidiaries shall have otherwise received any of the foregoing items with respect to such real property, such items shall,
promptly after the receipt thereof, be delivered to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At any time upon request of the Administrative Agent, promptly execute and deliver any and all further instruments and documents
and take all such other action as the Administrative Agent may deem necessary or desirable in obtaining the full benefits of, or
(as applicable) in perfecting and preserving the Liens of, such guaranties, deeds of trust, trust deeds, deeds to secure debt,
mortgages, leasehold mortgages, leasehold deeds of trust, Security Agreement Supplements, IP Security Agreement Supplements and
other security and pledge agreements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Environmental Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Comply, in all material respects, with all
applicable Environmental Laws and Environmental Permits; obtain and renew all Environmental Permits necessary for its operations
and properties; and to the extent required by any applicable Environmental Laws, conduct any investigation, study, sampling and
testing, and undertake any cleanup, removal, remedial or other action necessary to remove and clean up all Hazardous Materials
from any of its properties, in accordance with the requirements of all Environmental Laws; <U>provided</U>, <U>however</U>, that
neither the Borrower nor any of its Subsidiaries shall be required to undertake any such cleanup, removal, remedial or other action
to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves
are being maintained with respect to such circumstances in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Further Assurances</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Promptly upon request by the Administrative
Agent, or any Lender through the Administrative Agent, (a) correct any material defect or error that may be discovered in any
Loan Document or in the execution, acknowledgment, filing or recordation thereof, (b) do, execute, acknowledge, deliver, record,
re-record, file, re-file, register and re-register any and all such further acts, deeds, certificates, assurances and other instruments
as the Administrative Agent, or any Lender through the Administrative Agent, may reasonably require from time to time in order
to (i) carry out more effectively the purposes of the Loan Documents, (ii) to the fullest extent permitted by applicable law,
subject any Loan Party&rsquo;s or any of its Subsidiaries&rsquo; properties, assets, rights or interests to the Liens now or hereafter
intended to be covered by any of the Collateral Documents, (iii) perfect and maintain the validity, effectiveness and priority
of any of the Collateral Documents and any of the Liens intended to be created thereunder and (iv) assure, convey, grant, assign,
transfer, preserve, protect and confirm more effectively unto the Secured Parties the rights granted or now or hereafter intended
to be granted to the Secured Parties under any Loan Document or under any other instrument executed in connection with any Loan
Document to which any Loan Party or any of its Subsidiaries is or is to be a party, and cause each of its Subsidiaries to do so
and (c) deliver a collateral access agreement to the Administrative Agent, in form and substance reasonably satisfactory to it,
for any headquarters location where books and records are kept or any other U.S. location where Collateral (including, without
limitation, Inventory) having an aggregate fair market value of $1,000,000 or more is located.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Material Contracts</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Perform and observe all the terms and provisions
of each Material Contract to be performed or observed by it, maintain each such Material Contract in full force and effect, enforce
each such Material Contract in accordance with its terms, take all such action to such end as may be from time to time requested
by the Administrative Agent and, upon request of the Administrative Agent, and cause each of its Subsidiaries to do so, except,
in any case, where the failure to do so, either individually or in the aggregate, could not reasonably be expected to have a Material
Adverse Effect.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cash Collateral Accounts</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Maintain, and cause each of the other Loan
Parties to maintain, all Cash Collateral Accounts with Bank of America or another commercial bank located in the United States
reasonably acceptable to the Administrative Agent, which, if reasonably requested by the Administrative Agent, deliver an accepted
assignment of such accounts to the Administrative Agent for the benefit of the Secured Parties pursuant to the terms of the Security
Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Anti-Corruption Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Conduct its business in compliance with the
United States Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010, and other similar anti-corruption legislation in
other jurisdictions, and maintain policies and procedures designed to promote and achieve compliance with such laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE VII<BR>
NEGATIVE COVENANTS</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">So long as any Lender shall have any Commitment
hereunder, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied, or any Letter of Credit shall remain outstanding,
the Borrower shall not, nor shall it permit any Subsidiary to, directly or indirectly:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Liens, Etc</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Create, incur, assume or suffer to exist, any
mortgage, lien, charge or encumbrance on, or security interest in, or pledge of, or conditional sale or other title retention
agreement (including any Capital Lease) with respect to, any real or personal property (tangible or intangible, now existing or
hereafter acquired)(each being a &ldquo;<U>Lien</U>&rdquo;), including but not limited to the Accounts and Inventory, nor will
the Borrower nor any Subsidiary make the foregoing negative covenant in favor of any other Person except the following (each being
a &ldquo;<U>Permitted Lien</U>&rdquo;):</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens for taxes not yet delinquent or being contested in good faith; mechanics&rsquo;, workmen&rsquo;s, materialmen&rsquo;s
or other like liens arising in the ordinary course of business in respect of obligations which are not yet due or which are being
contested in good faith (as to which adequate reserves have been established on the Borrower&rsquo;s books to the extent required
by GAAP) and which were not incurred in connection with the purchase of property, borrowing of money or the obtaining of credit
and which do not detract from the value of the properties or assets of the Borrower and its Subsidiaries or affect the use thereof
in the operation of their business;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The existing Liens referred to in <U>Schedule 7.01</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Purchase money mortgages, liens and other security interests, including Capital Leases, created in respect of property acquired
by the Borrower and/or any of its Subsidiaries after the date hereof or existing in respect of property so acquired prior to the
date hereof, <U>provided</U> that (i) each such lien shall at all times be confined solely to the item of property so acquired,
and (ii) the aggregate principal amount of indebtedness secured by all such liens shall at no time exceed $1,000,000;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business which,
in the aggregate, do not materially detract from the value of the property subject thereto or interfere with the ordinary conduct
of the businesses of the Borrower;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens arising solely by virtue of any contractual, statutory or common law provision relating to banker&rsquo;s liens, rights
of set-off or similar rights and remedies as to deposit accounts or other funds maintained with any financial institution;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens in connection with operating leases and granted to secure obligations with respect to &ldquo;off balance sheet&rdquo;
or &ldquo;synthetic&rdquo; leases (<U>i.e</U>., leases where for tax purposes the lessee is treated as the owner of the leased
property but for GAAP purposes the lease is treated as an operating lease and the lessor is treated as the owner of the leased
property);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens consisting of security deposits securing the Borrower&rsquo;s and/or any Subsidiary&rsquo;s obligations under real
property leases;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any Lien securing Indebtedness to the Lenders;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Deposits or pledges made in connection with, or to secure payment of, worker&rsquo;s compensation, unemployment insurance,
old age pensions or social security;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens arising by operation of law or under rental agreements made in the ordinary course of business to secure landlords,
lessors or renters under leases and confined to the premises or property rented;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(k)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens acquired in connection with the consummation of Permitted Acquisitions subject to <U>Section 7.02(g)</U>; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(l)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liens in favor of any bank or other financial institution solely against the Borrower&rsquo;s and/or any Subsidiary&rsquo;s
deposit account(s) with such bank or other financial institution securing such bank&rsquo;s or other financial institution&rsquo;s
obligation to guarantee the Borrower&rsquo;s and/or its Subsidiaries&rsquo; promissory notes issued in connection with a Permitted
Acquisition.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indebtedness</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Create, incur, assume or become or remain liable
in respect of any Indebtedness, except:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indebtedness to the Lenders hereunder;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liabilities of the Borrower and/or its Subsidiaries (other than for borrowed money) incurred in the ordinary course of its
business and in accordance with customary trade practices;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Existing Indebtedness, together with all accrued and unpaid interest thereon, of the Borrower and/or any Subsidiary referred
to in <U>Schedule 7.02</U> attached hereto, and refinancings thereof in an amount not more than the greater of (i) the respective
unpaid principal amounts thereof or (ii) the respective principal amounts available to be drawn thereunder on the date hereof,
in each case as specified in such schedule, together with all accrued and unpaid interest thereon;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indebtedness of the Borrower and/or any Subsidiary secured as permitted by, and subject to the proviso to, subparagraph
(c) of <U>Section 7.02</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Unsecured Indebtedness incurred or assumed in connection with (i) any Permitted Acquisition consummated pursuant to <U>Section
7.03(g)(A)</U> hereof in an amount not to exceed seventy-five percent (75%) of the purchase price of such Permitted Acquisition
(excluding as Indebtedness incurred or assumed for the purpose of this computation, any promissory notes issued in connection with
and included in the payment of the purchase price of any such Permitted Acquisition) and (ii) any Permitted Acquisition consummated
pursuant to <U>Section&nbsp;7.03(g)(B)</U> hereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indebtedness in respect of promissory notes issued in connection with any Permitted Acquisition and secured as permitted
by <U>Section 7.02</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Other secured Indebtedness incurred or assumed in connection with any Permitted Acquisition consummated pursuant to (i)
<U>Section 7.3(g)(A)</U> in an aggregate principal amount at any time outstanding not to exceed $500,000 and (ii) <U>Section 7.03(g)</U>
hereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Other unsecured Indebtedness not to exceed $100,000; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indebtedness in respect of (i) taxes, assessments, governmental charges or levies and claims for labor, materials and supplies
to the extent that payment thereof shall not at the time be required to be made or is being contested, (ii) judgments or awards
which have been in force for less than the applicable appeal period so long as execution is not levied thereunder or in respect
of which the Borrower or any Subsidiary shall in good faith be prosecuting an appeal or proceedings for review in a manner reasonably
satisfactory to the Administrative Agent and in respect of which a stay of execution shall have been obtained pending such appeal
or review and for which adequate reserves have been established in accordance with, and to the extent required by, GAAP, and (iii)
endorsements made in connection with the deposit of items for credit or collection in the ordinary course of business.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Investments</U>. Make or hold any Investments, except:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Investments held by the Borrower and its Subsidiaries in the form of Cash Equivalents;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>advances to officers, directors and employees of the Borrower and Subsidiaries in an aggregate amount not to exceed $500,000
at any time outstanding, for travel, entertainment, relocation and analogous ordinary business purposes;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Investments by the Borrower and its Subsidiaries in their respective Subsidiaries outstanding on the date hereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Investments consisting of extensions of credit in the nature of accounts receivable or notes receivable arising from the
grant of trade credit in the ordinary course of business, and Investments received in satisfaction or partial satisfaction thereof
from financially troubled account debtors to the extent reasonably necessary in order to prevent or limit loss;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Guarantees permitted by <U>Section 7.02</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Investments existing on the date hereof (other than those referred to in <U>Section 7.03(c)(i)</U>) and set forth on <U>Schedule
5.08(e)</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>acquire or enter into any agreement (other than purchases of equipment or inventory from any Person in the ordinary course
of business) requiring the acquisition of all, or substantially all, of the assets or stock or other equity interests of any Person
provided such acquisition (whether by acquisition, merger or otherwise) is to be consummated by (i) the Borrower or (ii) a Domestic
Subsidiary, <U>provided</U>, that such Domestic Subsidiary is or becomes a Loan Party provided each of the following conditions
precedent has been satisfied:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">(A) (1) The purchase price paid by the
Borrower and/or its Subsidiaries in connection with Permitted Acquisitions consummated under this <U>Section 7.03(g)(A)</U> is
payable (i) solely in shares of capital stock of the Borrower in an amount not to exceed $10,000,000 in connection with any single
Permitted Acquisition (such capital stock valuation shall be the closing price of the Borrower&rsquo;s common stock on the NASDAQ
National Market on the date such transaction is approved by the Borrower&rsquo;s board of directors), (ii) solely in cash, (iii)
solely by issuance of one or more promissory notes or (iv) some combination of the foregoing, <U>provided</U>, <U>however</U>,
that except in the case of clause (i) above, the amount of cash consideration <U>plus</U> promissory notes <U>plus</U> shares of
capital stock of the Borrower does not exceed $6,000,000 in connection with any single Permitted Acquisition;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the Borrower notifies the Administrative
Agent in writing of all proposed Permitted Acquisitions under this <U>Section&nbsp;7.03(g)(A)</U> no less than thirty (30) days
prior to the anticipated closing date; and (3) the Borrower notifies the Administrative Agent as soon as practicable following
any material changes in the business terms or projected impact of any Permitted Acquisition which has previously been disclosed
to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
in connection with Permitted Acquisitions consummated in accordance with <U>Section&nbsp;7.03(g)(A)</U>, the Borrower and/or its
Subsidiaries will only enter into agreements to acquire, and shall only be permitted to acquire, all or substantially all of the
assets or stock or other equity interests of any Person (whether by acquisition, merger or otherwise) with the prior written consent
of the Required Lenders to be provided in their reasonable discretion and subject to satisfaction of each of the following conditions:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 93 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Lenders shall have received written notice of such acquisition and the basic terms thereof, as soon as reasonably practicable,
but in any event not less than thirty (30) days prior to the anticipated consummation of the acquisition;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The assets to be acquired are employed or, if such acquisition is structured as purchase of stock or other equity interests,
the Person so acquired conducts its business in an industry which is the same as that of the Borrower and the Required Lenders
are satisfied as to the foregoing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the time of consummation of such acquisition, no Default and no Event of Default exists, or would be caused by such consummation
and the Lenders are satisfied as to the foregoing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At least five (5) Business Days prior to the consummation of any such acquisition, the Borrower shall have delivered to
the Lenders a certificate, signed by the Chief Executive Officer or Chief Financial Officer of the Borrower, certifying that the
Borrower has conducted or caused to be conducted all due diligence deemed reasonably necessary for the proposed acquisition, and
that the results of such due diligence are deemed satisfactory by the officer of the Borrower executing such certificate;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The acquisition is not hostile and has been approved by the governing body of the Person being acquired or of the Person
whose assets are being acquired;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No less than thirty (30) days prior to the anticipated consummation of the acquisition, the Borrower shall deliver to the
Lenders, among such other financial information and reports as may be required by the Lenders, revised financial projections, income
statements and balance sheets setting forth the effect of the acquisition and demonstrating to the satisfaction of the Required
Lenders (in their sole discretion) that the Borrower will, on a going forward basis, be in compliance with all covenants (including
the financial covenants contained herein) set forth in this Agreement, and further demonstrating that the proposed acquisition
will, prior to the end of the second fiscal quarter of the Borrower immediately succeeding the fiscal quarter during which any
such acquisition is consummated, increase the Borrower&rsquo;s Adjusted EBITDA, after giving effect to all additional interest
and Indebtedness related to such acquisition (including any Indebtedness incurred under this Agreement), as well as the relevant
income statement effects deemed applicable by the Required Lenders and all adjustments to historical performance approved by the
Required Lenders, all in the Required Lenders&rsquo; sole discretion; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent (at the direction of the Required Lenders) shall not have issued notice to the Borrower that, in
the Required Lenders&rsquo; reasonable discretion, it or they have determined that a proposed acquisition is not a Permitted Acquisition,
any such notice to be delivered to the Borrower within 15 days of the last to occur of (x) receipt of written notice from the Borrower
required by paragraph (a) of this <U>Section&nbsp;7.03(g)(B)</U> and such notice to set forth, in reasonable detail, the basic
for such determination by the Lenders and (y) the last of the materials required to be delivered under <U>Section 7.03(g)(B)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 94 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each acquisition consummated in accordance
with the provisions of <U>Section 7.03(g)(A)</U> and <U>Section 7.03(g)(B)</U> shall be referred to as a &ldquo;<U>Permitted Acquisition</U>&rdquo;.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>other Investments not to exceed $500,000 in the aggregate in any fiscal year;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(1) Investments in Loan Parties in the form of capital contributions, dividends or intercompany loans, and (2) Investments
in the form of capital contributions, dividends or intercompany loans in Subsidiaries that are not Loan Parties up to an aggregate
amount outstanding at any time not to exceed $2,500,000, so long as the same are reasonably advisable or necessary;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indemnification agreements in connection with contractual arrangements entered into in the ordinary course of business.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fundamental Changes</U>. Merge, dissolve, liquidate, consolidate with or into another Person, or Dispose of (whether
in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired)
to or in favor of any Person, except that, so long as no Default exists or would result therefrom:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Subsidiary may merge with (i) the Borrower, <U>provided</U> that the Borrower shall be the continuing or surviving Person,
or (ii) any one or more other Subsidiaries, <U>provided</U> that when any Loan Party is merging with another Subsidiary, such Loan
Party shall be the continuing or surviving Person;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Loan Party may Dispose of all or substantially all of its assets (upon voluntary liquidation or otherwise) to the Borrower
or to another Loan Party; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Subsidiary that is not a Loan Party may dispose of all or substantially all its assets (including any Disposition that
is in the nature of a liquidation) to (i) another Subsidiary that is not a Loan Party or (ii) to a Loan Party.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sale of Assets</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Sell, lease or otherwise dispose of any of
its properties or assets, <U>except</U> for (a) sales, leases or other dispositions in the ordinary course of business, (b) sales,
leases or other dispositions of obsolete or unusable property or assets (it being understood that customer lists, contracts, inventory
and accounts receivable are excluded from this exception), (c) sales, leases or other dispositions of duplicative property or
other assets acquired in connection with Permitted Acquisitions, and (d) sales, leases and other dispositions of other property
and assets in an aggregate amount not to exceed $2,000,000 per fiscal year for the Borrower and all of its Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 95 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restricted Payments</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Declare or make, directly or indirectly, any
Restricted Payment, or incur any obligation (contingent or otherwise) to do so, or issue or sell any Equity Interests or accept
any capital contributions, except that, so long as no Default or Event of Default shall have occurred and be continuing at the
time of any action described below or would result therefrom:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each Subsidiary may make Restricted Payments to the Borrower, any Subsidiaries of the Borrower that are Guarantors and any
other Person that owns a direct Equity Interest in such Subsidiary, ratably according to their respective holdings of the type
of Equity Interest in respect of which such Restricted Payment is being made;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Borrower and each Subsidiary may declare and make dividend payments or other distributions payable solely in the common
stock or other common Equity Interests of such Person; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except to the extent the Net Cash Proceeds thereof are required to be applied to the prepayment of the Loans pursuant to
<U>Section&nbsp;2.05(b)(iii)</U>, the Borrower and each Subsidiary may purchase, redeem or otherwise acquire its common Equity
Interests with the proceeds received from the substantially concurrent issue of new common Equity Interests.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Change in Nature of Business</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Engage in any material line of business substantially
different from those lines of business conducted by the Borrower and its Subsidiaries on the date hereof or any business substantially
related or incidental thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transactions with Affiliates</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Enter into any transaction of any kind with
any Affiliate of the Borrower, whether or not in the ordinary course of business, other than on fair and reasonable terms substantially
as favorable to the Borrower or such Subsidiary as would be obtainable by the Borrower or such Subsidiary at the time in a comparable
arm&rsquo;s length transaction with a Person other than an Affiliate; <U>provided</U> that the foregoing restriction shall not
apply to transactions between or among the Loan Parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Burdensome Agreements</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Enter into or permit to exist any Contractual
Obligation (other than this Agreement or any other Loan Document) that (a) limits the ability (i) of any Subsidiary to make Restricted
Payments to the Borrower or any Guarantor or to otherwise transfer property to or invest in the Borrower or any Guarantor, except
for any agreement in effect (A) on the date hereof and set forth on <U>Schedule 7.09</U> or (B) at the time any Subsidiary becomes
a Subsidiary of the Borrower, so long as such agreement was not entered into solely in contemplation of such Person becoming a
Subsidiary of the Borrower, (ii) of any Subsidiary to Guarantee the Indebtedness of the Borrower or (iii) of the Borrower or any
Subsidiary to create, incur, assume or suffer to exist Liens on property of such Person; <U>provided</U>, <U>however</U>, that
this clause (iii) shall not prohibit any negative pledge incurred or provided in favor of any holder of Indebtedness permitted
under <U>Section 7.02(i)</U> solely to the extent any such negative pledge relates to the property financed by or the subject
of such Indebtedness; or (b) requires the grant of a Lien to secure an obligation of such Person if a Lien is granted to secure
another obligation of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Use the proceeds of any Credit Extension, whether
directly or indirectly, and whether immediately, incidentally or ultimately, to purchase or carry margin stock (within the meaning
of Regulation U of the FRB) or to extend credit to others for the purpose of purchasing or carrying margin stock or to refund
indebtedness originally incurred for such purpose.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Covenants</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Maximum Leverage Ratio</U>. As of the last day of any fiscal quarter, the ratio of (i) Total Funded Debt of the Borrower
and its Subsidiaries as of the last day of such fiscal quarter, to (ii) the Borrower&rsquo;s and its Subsidiaries&rsquo; consolidated
Adjusted EBITDA for the period of four consecutive fiscal quarters ending on the last day of such fiscal quarter to be more than
2.50:1.00.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Minimum Fixed Charge Coverage Ratio</U>. As of the last day of any fiscal quarter, commencing with the fiscal quarter
ending on March 31, 2017, and the last day of each fiscal quarter thereafter, the ratio of (i) consolidated Adjusted EBITDA of
the Borrower and its Subsidiaries for the four-quarter period ending on the last day of such fiscal quarter, minus, (x) aggregate
cash capital expenditures, minus (y) cash taxes paid, each of (x) and (y) for the four-quarter period ending on the last day such
fiscal quarter, to (ii) the current portion of Funded Debt other than the Total Revolving Credit Outstandings, as of the last day
of such fiscal quarter, plus (without duplication) Interest Expense during such trailing four (4) fiscal quarters, to be less than
1.25:1.00.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Minimum Working Capital</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the last day of any fiscal quarter, permit their Working Capital to be less than the aggregate outstanding principal balance
of the sum of (i) the aggregate outstanding principal amount of the Term Loan <U>plus</U> (ii) the aggregate outstanding amount
of the Revolving Credit Loans;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
any Subsidiary whose Eligible Receivables and Eligible Inventory exceed $1,000,000 in the calculation of minimum Working Capital
pursuant to <U>Section 7.3</U> hereof, the Administrative Agent shall have received the following with respect to such Subsidiary:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;satisfactory
lien, tax and judgment searches confirming the absence of any liens, claims, charges or encumbrances of any nature on any Accounts
of such Subsidiary; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 97 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;certified
copies of the charter documents and by-laws of each such Subsidiary, together with certificates of appropriate governmental authorities
as to the corporate good standing of such Subsidiaries (to the extent such documents and certificates are available in the applicable
jurisdiction).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments of Organization Documents</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Amend any of its Organization Documents in
any material respect in a manner that is adverse to the rights or remedies of the Administrative Agent or the Lenders, without
the prior written consent of the Administrative Agent (not to be unreasonably withheld).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accounting Changes</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Make any change in (a)&nbsp;accounting policies
or reporting practices, except as required by GAAP, or (b)&nbsp;fiscal year.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayments, Etc. of Indebtedness</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Prepay, redeem, purchase, defease or otherwise
satisfy prior to the scheduled maturity thereof in any manner, or make any payment in violation of any subordination terms of,
any Indebtedness, except (a)&nbsp;the prepayment of the Credit Extensions in accordance with the terms of this Agreement and (b)&nbsp;regularly
scheduled or required repayments or redemptions of Indebtedness set forth in <U>Schedule 7.02</U> and refinancings and refundings
of such Indebtedness in compliance with <U>Section 7.02(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sanctions</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Directly or indirectly, use the proceeds of
any Credit Extension, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or
other individual or entity, to fund any activities of or business with any individual or entity, or in any Designated Jurisdiction,
that, at the time of such funding, is the subject of Sanctions, or in any other manner that will result in a violation by any
individual or entity (including any individual or entity participating in the transaction, whether as Lender, Arranger, Administrative
Agent, L/C Issuer, or otherwise) of Sanctions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Anti-Corruption Laws</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Directly or indirectly use the proceeds of
any Credit Extension for any purpose which would breach the United States Foreign Corrupt Practices Act of 1977, the UK Bribery
Act 2010, and other similar anti-corruption legislation in other jurisdictions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 98 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE VIII<BR>
EVENTS OF DEFAULT AND REMEDIES</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Events of Default</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any of the following shall constitute an Event
of Default:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Payment</U>. The Borrower or any other Loan Party fails to (i) pay when and as required to be paid herein, any amount
of principal of any Loan or any L/C Obligation or deposit any funds as Cash Collateral in respect of L/C Obligations, or (ii) pay
within three days after the same becomes due, any interest on any Loan or on any L/C Obligation, or any fee due hereunder, or (iii)
pay within five days after the same becomes due, any other amount payable hereunder or under any other Loan Document; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Specific Covenants</U>. (i) The Borrower fails to perform or observe any term, covenant or agreement contained in any
of <U>Section 6.01</U>, <U>6.02</U>, <U>6.03</U>, <U>6.05</U>, <U>6.10</U>, <U>6.11</U>, <U>6.12</U>, <U>6.14</U>, <U>6.17</U>,
<U>6.18</U> or <U>Article VII</U>, (ii) any of the Guarantors fails to perform or observe any term, covenant or agreement contained
in the Guaranty or (iii) any of the Loan Parties fails to perform or observe any term, covenant or agreement contained in <U>Section
4</U> of the Security Agreement; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Defaults</U>. Any Loan Party fails to perform or observe any other covenant or agreement (not specified in <U>Section
8.01(a)</U> or <U>(b)</U> above) contained in any Loan Document on its part to be performed or observed and such failure continues
for 30 days; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. Any representation, warranty, certification or statement of fact made or deemed made
by or on behalf of the Borrower or any other Loan Party herein, in any other Loan Document, or in any document delivered in connection
herewith or therewith shall be incorrect or misleading when made or deemed made; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cross-Default</U>. (i) Any Loan Party or any Subsidiary thereof (A) fails to make any payment when due after giving effect
to any applicable grace period (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect
of any Indebtedness or Guarantee (other than Indebtedness hereunder and Indebtedness under Swap Contracts) having an aggregate
principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined
or syndicated credit arrangement) of more than the Threshold Amount, or (B) fails to observe or perform any other agreement or
condition relating to any such Indebtedness or Guarantee or contained in any instrument or agreement evidencing, securing or relating
thereto, after giving effect to any applicable grace period, or any other event occurs, the effect of which default or other event
is to cause, or to permit the holder or holders of such Indebtedness or the beneficiary or beneficiaries of such Guarantee (or
a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, with the giving of notice if
required, such Indebtedness to be demanded or to become due or to be repurchased, prepaid, defeased or redeemed (automatically
or otherwise), or an offer to repurchase, prepay, defease or redeem such Indebtedness to be made, prior to its stated maturity,
or such Guarantee to become payable or cash collateral in respect thereof to be demanded; or (ii) there occurs under any Swap Contract
an Early Termination Date (as defined in such Swap Contract) resulting from (A) any event of default under such Swap Contract as
to which a Loan Party or any Subsidiary thereof is the Defaulting Party (as defined in such Swap Contract) or (B) any Termination
Event (as so defined) under such Swap Contract as to which a Loan Party or any Subsidiary thereof is an Affected Party (as so defined)
and, in either event, the Swap Termination Value owed by such Loan Party or such Subsidiary as a result thereof is greater than
the Threshold Amount; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 99 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insolvency Proceedings, Etc</U>. Any Loan Party or any Subsidiary thereof institutes or consents to the institution of
any proceeding under any Debtor Relief Law, or makes an assignment for the benefit of creditors; or applies for or consents to
the appointment of any receiver, trustee, custodian, conservator, liquidator, rehabilitator or similar officer for it or for all
or any material part of its property; or any receiver, trustee, custodian, conservator, liquidator, rehabilitator or similar officer
is appointed without the application or consent of such Person and the appointment continues undischarged or unstayed for 60 calendar
days; or any proceeding under any Debtor Relief Law relating to any such Person or to all or any material part of its property
is instituted without the consent of such Person and continues undismissed or unstayed for 60 calendar days, or an order for relief
is entered in any such proceeding; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inability to Pay Debts; Attachment</U>. (i) Any Loan Party or any Subsidiary thereof becomes unable or admits in writing
its inability or fails generally to pay its debts as they become due, or (ii) any writ or warrant of attachment or execution or
similar process is issued or levied against all or any material part of the property of any such Person and is not released, vacated
or fully bonded within 30 days after its issue or levy; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Judgments</U>. There is entered against any Loan Party or any Subsidiary thereof (i) one or more final judgments or orders
that have, or could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect and, in either
case, (A) enforcement proceedings are commenced by any creditor upon such judgment or order, or (B) there is a period of 60 consecutive
days during which a stay of enforcement of such judgment, by reason of a pending appeal or otherwise, is not in effect or such
judgment has not been discharged; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>ERISA</U>. (i) An ERISA Event occurs with respect to a Pension Plan or Multiemployer Plan which has resulted or could
reasonably be expected to result in liability of the Borrower under Title&nbsp;IV of ERISA to the Pension Plan, Multiemployer Plan
or the PBGC in an aggregate amount in excess of the Threshold Amount, or (ii) the Borrower or any ERISA Affiliate fails to pay
when due, after the expiration of any applicable grace period, any installment payment with respect to its withdrawal liability
under Section 4201 of ERISA under a Multiemployer Plan in an aggregate amount in excess of the Threshold Amount; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 100 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Invalidity of Loan Documents</U>. Any provision of any Loan Document, at any time after its execution and delivery and
for any reason other than as expressly permitted hereunder or thereunder or satisfaction in full of all the Obligations, ceases
to be in full force and effect; or any Loan Party or any other Person contests in any manner the validity or enforceability of
any provision of any Loan Document; or any Loan Party denies that it has any or further liability or obligation under any provision
of any Loan Document, or purports to revoke, terminate or rescind any provision of any Loan Document; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(k)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Change of Control</U>. There occurs any Change of Control; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(l)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Collateral Documents</U>. Any Collateral Document after delivery thereof pursuant to <U>Section&nbsp;4.01</U> or <U>6.12</U>
shall for any reason (other than pursuant to the terms thereof) cease to create a valid and perfected first priority Lien (subject
to Liens permitted by <U>Section 7.01</U>) on the Collateral purported to be covered thereby, other than if such failure of perfection
is due to the Administrative Agent&rsquo;s failure to file properly or properly file any applicable continuations; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(m)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower is enjoined, restrained, or in any material way prevented by the order of any Governmental Authority from conducting
all, or any material part of, its business and such order is not stayed or revoked within five (5) days.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Remedies upon Event of Default</U>. If any Event of Default occurs and is continuing, the Administrative Agent shall,
at the request of, or may, with the consent of, the Required Lenders, take any or all of the following actions:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare the commitment of each Lender to make Loans and any obligation of the L/C Issuer to make L/C Credit Extensions to
be terminated, whereupon such commitments and obligation shall be terminated;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare the unpaid principal amount of all outstanding Loans, all interest accrued and unpaid thereon, and all other amounts
owing or payable hereunder or under any other Loan Document to be immediately due and payable, without presentment, demand, protest
or other notice of any kind, all of which are hereby expressly waived by the Borrower;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>require that the Borrower Cash Collateralize the L/C Obligations (in an amount equal to the then Outstanding Amount thereof);
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>exercise on behalf of itself, the Lenders and the L/C Issuer all rights and remedies available to it, the Lenders and the
L/C Issuer under the Loan Documents;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><U>provided</U>, <U>however</U>, that upon the
occurrence of an actual or deemed entry of an order for relief with respect to the Borrower under the Bankruptcy Code of the United
States, the obligation of each Lender to make Loans and any obligation of the L/C Issuer to make L/C Credit Extensions shall automatically
terminate, the unpaid principal amount of all outstanding Loans and all interest and other amounts as aforesaid shall automatically
become due and payable, and the obligation of the Borrower to Cash Collateralize the L/C Obligations as aforesaid shall automatically
become effective, in each case without further act of the Administrative Agent or any Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 101 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Application of Funds</U>. After the exercise of remedies provided for in <U>Section 8.02</U> (or after the Loans have
automatically become immediately due and payable and the L/C Obligations have automatically been required to be Cash Collateralized
as set forth in the proviso to <U>Section 8.02</U>), any amounts received on account of the Obligations shall be applied by the
Administrative Agent in the following order:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>First</U>, to payment of that portion of the Obligations constituting fees, indemnities, expenses and other amounts (including
fees, charges and disbursements of counsel to the Administrative Agent and amounts payable under <U>Article III</U>) payable to
the Administrative Agent in its capacity as such;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Second</U>, to payment of that portion of the Obligations constituting fees, indemnities and other amounts (other than
principal, interest and Letter of Credit Fees) payable to the Lenders and the L/C Issuer (including fees, charges and disbursements
of counsel to the respective Lenders and the L/C Issuer arising under the Loan Documents and amounts payable under <U>Article III</U>),
ratably among them in proportion to the respective amounts described in this clause <U>Second</U> payable to them;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Third</U>, to payment of that portion of the Obligations constituting accrued and unpaid Letter of Credit Fees and interest
on the Loans, L/C Borrowings and other Obligations arising under the Loan Documents, ratably among the Lenders and the L/C Issuer
in proportion to the respective amounts described in this clause <U>Third</U> payable to them;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Fourth</U>, to payment of that portion of the Obligations constituting unpaid principal of the Loans, L/C Borrowings
and Obligations then owing under Secured Hedge Agreements and Secured Cash Management Agreements, ratably among the Lenders, the
L/C Issuer, the Hedge Banks and the Cash Management Banks in proportion to the respective amounts described in this clause <U>Fourth</U>
held by them;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Fifth</U>, to the Administrative Agent for the account of the L/C Issuer, to Cash Collateralize that portion of L/C Obligations
comprised of the aggregate undrawn amount of Letters of Credit; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><U>Last</U>, the balance, if any, after all of the Obligations have been indefeasibly paid in full, to the Borrower or as
otherwise required by Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Subject to <U>Section 2.03(c)</U>, amounts used
to Cash Collateralize the aggregate undrawn amount of Letters of Credit pursuant to clause <U>Fifth</U> above shall be applied
to satisfy drawings under such Letters of Credit as they occur. If any amount remains on deposit as Cash Collateral after all Letters
of Credit have either been fully drawn or expired, such remaining amount shall be applied to the other Obligations, if any, in
the order set forth above.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Notwithstanding the foregoing, Obligations arising
under Secured Cash Management Agreements and Secured Hedge Agreements shall be excluded from the application described above if
the Administrative Agent has not received written notice thereof, together with such supporting documentation as the Administrative
Agent may request, from the applicable Cash Management Bank or Hedge Bank, as the case may be. Each Cash Management Bank or Hedge
Bank not a party to the Credit Agreement that has given the notice contemplated by the preceding sentence shall, by such notice,
be deemed to have acknowledged and accepted the appointment of the Administrative Agent pursuant to the terms of <U>Article IX</U>
hereof for itself and its Affiliates as if a &ldquo;Lender&rdquo; party hereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE IX<BR>
ADMINISTRATIVE AGENT</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Appointment and Authority</U>. (a) Each of the Lenders and the L/C Issuer hereby irrevocably appoints Bank of America
to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative
Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms
hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this Article are
solely for the benefit of the Administrative Agent, the Lenders and the L/C Issuer, and neither the Borrower nor any other Loan
Party shall have rights as a third party beneficiary of any of such provisions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent shall also act as the &ldquo;<U>collateral agent</U>&rdquo; under the Loan Documents, and each
of the Lenders (including in its capacities as a potential Hedge Bank and a potential Cash Management Bank) and the L/C Issuer
hereby irrevocably appoints and authorizes the Administrative Agent to act as the agent of such Lender and the L/C Issuer for purposes
of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the Obligations,
together with such powers and discretion as are reasonably incidental thereto. In this connection, the Administrative Agent, as
&ldquo;collateral agent&rdquo; and any co-agents, sub-agents and attorneys-in-fact appointed by the Administrative Agent pursuant
to <U>Section 9.05</U> for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the
Collateral Documents, or for exercising any rights and remedies thereunder at the direction of the Administrative Agent, shall
be entitled to the benefits of all provisions of this <U>Article IX</U> and <U>Article XI</U> (including <U>Section&nbsp;11.04(c)</U>,
as though such co-agents, sub-agents and attorneys-in-fact were the &ldquo;collateral agent&rdquo; under the Loan Documents) as
if set forth in full herein with respect thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>It is understood and agreed that the use of the term &ldquo;agent&rdquo; herein or in any other Loan Documents (or any similar
term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations
arising under agency doctrine of any applicable Law. Instead such term is used as a matter of market custom, and is intended to
create or reflect only an administrative relationship between contracting parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rights as a Lender</U>. The Person serving as the Administrative Agent hereunder shall have the same rights and powers
in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the
term &ldquo;Lender&rdquo; or &ldquo;Lenders&rdquo; shall, unless otherwise expressly indicated or unless the context otherwise
requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates
may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage
in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative
Agent hereunder and without any duty to account therefor to the Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 103 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exculpatory Provisions</U>. The Administrative Agent shall not have any duties or obligations except those expressly
set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights
and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as
directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for
herein or in the other Loan Documents), <U>provided</U> that the Administrative Agent shall not be required to take any action
that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any
Loan Document or applicable law; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not
be liable for the failure to disclose, any information relating to the Borrower or any of its Affiliates that is communicated to
or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request
of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent
shall believe in good faith shall be necessary, under the circumstances as provided in <U>Sections 11.01</U> and <U>8.02</U>) or
(ii) in the absence of its own gross negligence or willful misconduct. The Administrative Agent shall be deemed not to have knowledge
of any Default unless and until notice describing such Default is given to the Administrative Agent by the Borrower, a Lender or
the L/C Issuer.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty
or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate,
report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii)&nbsp;the performance or
observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any
Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other
agreement, instrument or document, or the creation, perfection or priority of any Lien purported to be created by the Collateral
Documents, (v) the value or the sufficiency of any Collateral, or (vi) the satisfaction of any condition set forth in <U>Article
IV</U> or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reliance by Administrative Agent</U>. The Administrative Agent shall be entitled to rely upon, and shall not incur any
liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including
any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been
signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to
it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying
thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance of a Letter of Credit,
that by its terms must be fulfilled to the satisfaction of a Lender or the L/C Issuer, the Administrative Agent may presume that
such condition is satisfactory to such Lender or the L/C Issuer unless the Administrative Agent shall have received notice to the
contrary from such Lender or the L/C Issuer prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative
Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected
by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants
or experts.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delegation of Duties</U>. The Administrative Agent may perform any and all of its duties and exercise its rights and
powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent.
The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or
through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the
Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection
with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resignation of Administrative Agent</U>. The Administrative Agent may at any time give notice of its resignation to the
Lenders, the L/C Issuer and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right,
in consultation with the Borrower, to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate
of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders
and shall have accepted such appointment within 30&nbsp;days after the retiring Administrative Agent gives notice of its resignation,
then the retiring Administrative Agent may on behalf of the Lenders and the L/C Issuer, appoint a successor Administrative Agent
meeting the qualifications set forth above; <U>provided</U> that if the Administrative Agent shall notify the Borrower and the
Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance
with such notice and (a)&nbsp;the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and
under the other Loan Documents (except that in the case of any collateral security held by the Administrative Agent on behalf of
the Lenders or the L/C Issuer under any of the Loan Documents, the retiring Administrative Agent shall continue to hold such collateral
security until such time as a successor Administrative Agent is appointed) and (b)&nbsp;all payments, communications and determinations
provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender and the L/C Issuer directly,
until such time as the Required Lenders appoint a successor Administrative Agent as provided for above in this Section. Upon the
acceptance of a successor&rsquo;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested
with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent, and the retiring Administrative
Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged
therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the
same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the retiring Administrative
Agent&rsquo;s resignation hereunder and under the other Loan Documents, the provisions of this Article and <U>Section&nbsp;11.04</U>
shall continue in effect for the benefit of such retiring Administrative Agent, its sub-agents and their respective Related Parties
in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative
Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any resignation by Bank of America as Administrative
Agent pursuant to this Section shall also constitute its resignation as L/C Issuer. Upon the acceptance of a successor&rsquo;s
appointment as Administrative Agent hereunder, (i) such successor shall succeed to and become vested with all of the rights, powers,
privileges and duties of the retiring L/C Issuer, (ii) the retiring L/C Issuer shall be discharged from all of their respective
duties and obligations hereunder or under the other Loan Documents, and (iii) the successor L/C Issuer shall issue letters of
credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements
satisfactory to the retiring L/C Issuer to effectively assume the obligations of the retiring L/C Issuer with respect to such
Letters of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Reliance on Administrative Agent and Other Lenders</U>. Each Lender and the L/C Issuer acknowledges that it has,
independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based
on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement.
Each Lender and the L/C Issuer also acknowledges that it will, independently and without reliance upon the Administrative Agent
or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem
appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan
Document or any related agreement or any document furnished hereunder or thereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Other Duties, Etc</U>. Anything herein to the contrary notwithstanding, none of the Bookrunners listed on the cover
page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in
its capacity, as applicable, as the Administrative Agent, a Lender or the L/C Issuer hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Administrative Agent May File Proofs of Claim</U>. In case of the pendency of any proceeding under any Debtor Relief
Law or any other judicial proceeding relative to any Loan Party, the Administrative Agent (irrespective of whether the principal
of any Loan or L/C Obligation shall then be due and payable as herein expressed or by declaration or otherwise and irrespective
of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention
in such proceeding or otherwise</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 106 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans, L/C
Obligations and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable
in order to have the claims of the Lenders, the L/C Issuer and the Administrative Agent (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Lenders, the L/C Issuer and the Administrative Agent and their respective
agents and counsel and all other amounts due the Lenders, the L/C Issuer and the Administrative Agent under <U>Sections 2.03(i)</U>
and <U>(j)</U>, <U>2.09</U> and <U>11.04</U>) allowed in such judicial proceeding; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">and any custodian, receiver, assignee, trustee,
liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender and the
L/C Issuer to make such payments to the Administrative Agent and, if the Administrative Agent shall consent to the making of such
payments directly to the Lenders and the L/C Issuer, to pay to the Administrative Agent any amount due for the reasonable compensation,
expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative
Agent under <U>Sections&nbsp;2.09</U> and <U>11.04</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Nothing contained herein shall be deemed to
authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender or the L/C Issuer any
plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or the L/C
Issuer to authorize the Administrative Agent to vote in respect of the claim of any Lender or the L/C Issuer or in any such proceeding.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Collateral and Guaranty Matters</U>. Each of the Lenders (including in its capacities as a potential Cash Management
Bank and a potential Hedge Bank) and the L/C Issuer irrevocably authorize the Administrative Agent, at its option and in its discretion,</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to release any Lien on any property granted to or held by the Administrative Agent under any Loan Document (i) upon termination
of the Aggregate Commitments and payment in full of all Obligations (other than (A) contingent indemnification obligations and
(B) obligations and liabilities under Secured Cash Management Agreements and Secured Hedge Agreements as to which arrangements
satisfactory to the applicable Cash Management Bank of Hedge Bank shall have been made) and the expiration or termination of all
Letters of Credit (other than Letters of Credit as to which other arrangements satisfactory to the Administrative Agent and the
L/C Issuer shall have been made), (ii) that is sold or to be sold as part of or in connection with any sale permitted hereunder
or under any other Loan Document, or (iii) if approved, authorized or ratified in writing in accordance with <U>Section 11.01</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to release any Guarantor from its obligations under the Guaranty if such Person ceases to be a Subsidiary as a result of
a transaction permitted hereunder; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 107 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to subordinate any Lien on any property granted to or held by the Administrative Agent under any Loan Document to the holder
of any Lien on such property that is permitted by <U>Section 7.01(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Upon request by the Administrative Agent at
any time, the Required Lenders will confirm in writing the Administrative Agent&rsquo;s authority to release or subordinate its
interest in particular types or items of property, or to release any Guarantor from its obligations under the Guaranty pursuant
to this <U>Section 9.10</U>. In each case as specified in this <U>Section 9.10</U>, the Administrative Agent will, at the Borrower&rsquo;s
expense, execute and deliver to the applicable Loan Party such documents as such Loan Party may reasonably request to evidence
the release of such item of Collateral from the assignment and security interest granted under the Collateral Documents or to
subordinate its interest in such item, or to release such Guarantor from its obligations under the Guaranty, in each case in accordance
with the terms of the Loan Documents and this <U>Section 9.10</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Secured Cash Management Agreements and Secured Hedge Agreements</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No Cash Management Bank or Hedge Bank that
obtains the benefits of <U>Section 8.03</U>, any Guaranty or any Collateral by virtue of the provisions hereof or of any Guaranty
or any Collateral Document shall have any right to notice of any action or to consent to, direct or object to any action hereunder
or under any other Loan Document or otherwise in respect of the Collateral (including the release or impairment of any Collateral)
other than in its capacity as a Lender and, in such case, only to the extent expressly provided in the Loan Documents. Notwithstanding
any other provision of this <U>Article IX</U> to the contrary, the Administrative Agent shall not be required to verify the payment
of, or that other satisfactory arrangements have been made with respect to, Obligations arising under Secured Cash Management
Agreements and Secured Hedge Agreements unless the Administrative Agent has received written notice of such Obligations, together
with such supporting documentation as the Administrative Agent may request, from the applicable Cash Management Bank or Hedge
Bank, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE X<BR>
RESERVED</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE XI<BR>
MISCELLANEOUS</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments, Etc</U>. No amendment or waiver of any provision of this Agreement or any other Loan Document, and no consent
to any departure by the Borrower or any other Loan Party therefrom, shall be effective unless in writing signed by the Required
Lenders and the Borrower or the applicable Loan Party, as the case may be, and acknowledged by the Administrative Agent, and each
such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given; <U>provided</U>,
<U>however</U>, that no such amendment, waiver or consent shall:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>waive any condition set forth in <U>Section 4.01</U> (other than <U>Section 4.01(b)(i) </U>or <U>(c)</U>), or, in the case
of the initial Credit Extension, <U>Section&nbsp;4.02</U>, without the written consent of each Lender;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 108 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>extend or increase the Commitment of any Lender (or reinstate any Commitment terminated pursuant to <U>Section 8.02</U>)
without the written consent of such Lender;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>postpone any date fixed by this Agreement or any other Loan Document for (i) any payment (excluding mandatory prepayments)
of principal, interest, fees or other amounts due to the Lenders (or any of them) hereunder or under such other Loan Document without
the written consent of each Lender entitled to such payment or (ii) any scheduled reduction of any Facility hereunder or under
any other Loan Document without the written consent of each Appropriate Lender;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>reduce the principal of, or the rate of interest specified herein on, any Loan or L/C Borrowing, or (subject to clause (iv)(v)
of the second proviso to this <U>Section 11.01</U>) any fees or other amounts payable hereunder or under any other Loan Document,
or change the manner of computation of any financial ratio (including any change in any applicable defined term) used in determining
the Applicable Rate that would result in a reduction of any interest rate on any Loan or any fee payable hereunder without the
written consent of each Lender entitled to such amount; <U>provided</U>, <U>however</U>, that only the consent of the Required
Lenders shall be necessary (i) to amend the definition of &ldquo;Default Rate&rdquo; or to waive any obligation of the Borrower
to pay interest or Letter of Credit Fees at the Default Rate or (ii) to amend any financial covenant hereunder (or any defined
term used therein) even if the effect of such amendment would be to reduce the rate of interest on any Loan or L/C Borrowing or
to reduce any fee payable hereunder;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>change (i) <U>Section 8.03</U> in a manner that would alter the pro rata sharing of payments required thereby without the
written consent of each Lender or (ii) the order of application of any reduction in the Commitments or any prepayment of Loans
among the Facilities from the application thereof set forth in the applicable provisions of <U>Section&nbsp;2.05(b)</U> or <U>2.06(b)</U>,
respectively, in any manner that materially and adversely affects the Lenders under a Facility without the written consent of (i)&nbsp;if
such Facility is the Term Loan, the Required Term Lenders and (ii)&nbsp;if such Facility is the Revolving Credit Facility, the
Required Revolving Lenders;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>change (i) any provision of this <U>Section 11.01</U> or the definition of &ldquo;Required Lenders&rdquo; or any other provision
hereof specifying the number or percentage of Lenders required to amend, waive or otherwise modify any rights hereunder or make
any determination or grant any consent hereunder (other than the definitions specified in clause (ii) of this <U>Section 11.01(g)</U>),
without the written consent of each Lender or (ii) the definition of &ldquo;Required Revolving Lenders,&rdquo; or &ldquo;Required
Term Lenders,&rdquo; without the written consent of each Lender under the applicable Facility;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>release all or substantially all of the Collateral in any transaction or series of related transactions, without the written
consent of each Lender;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>release all or substantially all of the value of the Guaranty, without the written consent of each Lender, except to the
extent the release of any Subsidiary from the Guaranty is permitted pursuant to <U>Section 9.10</U> (in which case such release
may be made by the Administrative Agent acting alone); or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 109 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>impose any greater restriction on the ability of any Lender under a Facility to assign any of its rights or obligations
hereunder without the written consent of (i) if such Facility is the Term Loan, the Required Term Lenders and (ii) if such Facility
is the Revolving Credit Facility, the Required Revolving Lenders;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">and <U>provided</U>, <U>further</U>, that no amendment,
waiver or consent shall, unless in writing and signed by the L/C Issuer in addition to the Lenders required above, affect the rights
or duties of the L/C Issuer under this Agreement or any Issuer Document relating to any Letter of Credit issued or to be issued
by it and no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Lenders
required above, affect the rights or duties of the Administrative Agent under this Agreement or any other Loan Document may be
amended, or rights or privileges thereunder waived, in a writing executed only by the parties thereto. Notwithstanding anything
to the contrary herein, no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder,
except that the Commitment of such Lender may not be increased or extended without the consent of such Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices; Effectiveness; Electronic Communications</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices Generally</U>. Except in the case of notices and other communications expressly permitted to be given by telephone
(and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing
and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopier as follows,
and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable
telephone number, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if to the Borrower, the Administrative Agent or the L/C Issuer, to the address, telecopier number, electronic mail address
or telephone number specified for such Person on <U>Schedule 11.02</U>; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if to any other Lender, to the address, telecopier number, electronic mail address or telephone number specified in its
Administrative Questionnaire.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Notices and other communications sent by hand
or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received; notices
and other communications sent by telecopier shall be deemed to have been given when sent (except that, if not given during normal
business hours for the recipient, shall be deemed to have been given at the opening of business on the next business day for the
recipient). Notices and other communications delivered through electronic communications to the extent provided in subsection (b)
below shall be effective as provided in such subsection (b).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Electronic Communications</U>. Notices and other communications to the Lenders and the L/C Issuer hereunder may be delivered
or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved by
the Administrative Agent, <U>provided</U> that the foregoing shall not apply to notices to any Lender or the L/C Issuer pursuant
to <U>Article II</U> if such Lender or the L/C Issuer, as applicable, has notified the Administrative Agent that it is incapable
of receiving notices under such Article by electronic communication. The Administrative Agent or the Borrower may, in its discretion,
agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by
it, <U>provided</U> that approval of such procedures may be limited to particular notices or communications.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 110 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless the Administrative Agent otherwise prescribes,
(i)&nbsp;notices and other communications sent to an e-mail address shall be deemed received upon the sender&rsquo;s receipt of
an acknowledgement from the intended recipient (such as by the &ldquo;return receipt requested&rdquo; function, as available,
return e-mail or other written acknowledgement), <U>provided</U> that if such notice or other communication is not sent during
the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business
on the next business day for the recipient, and (ii)&nbsp;notices or communications posted to an Internet or intranet website
shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing
clause&nbsp;(i) of notification that such notice or communication is available and identifying the website address therefor.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Platform</U>. THE PLATFORM IS PROVIDED &ldquo;AS IS&rdquo; AND &ldquo;AS AVAILABLE.&rdquo; THE AGENT PARTIES (AS
DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY
DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY,
INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM
FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no
event shall the Administrative Agent or any of its Related Parties (collectively, the &ldquo;<U>Agent Parties</U>&rdquo;) have
any liability to the Borrower, any Lender, the L/C Issuer or any other Person for losses, claims, damages, liabilities or expenses
of any kind (whether in tort, contract or otherwise) arising out of the Borrower&rsquo;s or the Administrative Agent&rsquo;s transmission
of Borrower Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are
determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence
or willful misconduct of such Agent Party; <U>provided</U>, <U>however</U>, that in no event shall any Agent Party have any liability
to the Borrower, any Lender, the L/C Issuer or any other Person for indirect, special, incidental, consequential or punitive damages
(as opposed to direct or actual damages).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 111 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Change of Address, Etc</U>. The Borrower, the Administrative Agent and the L/C Issuer may change its address, telecopier
or telephone number for notices and other communications hereunder by notice to the other parties hereto. Each other Lender may
change its address, telecopier or telephone number for notices and other communications hereunder by notice to the Borrower, the
Administrative Agent and the L/C Issuer. In addition, each Lender agrees to notify the Administrative Agent from time to time to
ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number
and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such
Lender. Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all
times have selected the &ldquo;Private Side Information&rdquo; or similar designation on the content declaration screen of the
Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&rsquo;s compliance procedures
and applicable Law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are
not made available through the &ldquo;Public Side Information&rdquo; portion of the Platform and that may contain material non-public
information with respect to the Borrower or its securities for purposes of United States Federal or state securities laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reliance by Administrative Agent, L/C Issuer and Lenders</U>. The Administrative Agent, the L/C Issuer and the Lenders
shall be entitled to rely and act upon any notices (including telephonic Committed Loan Notices) purportedly given by or on behalf
of the Borrower even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed
by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation
thereof. The Borrower shall indemnify the Administrative Agent, the L/C Issuer, each Lender and the Related Parties of each of
them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given
by or on behalf of the Borrower. All telephonic notices to and other telephonic communications with the Administrative Agent may
be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Waiver; Cumulative Remedies; Enforcement</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No failure by any Lender, the L/C Issuer or
the Administrative Agent to exercise, and no delay by any such Person in exercising, any right, remedy, power or privilege hereunder
or under any other Loan Document shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy,
power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power
or privilege. The rights, remedies, powers and privileges herein provided, and provided under each other Loan Document, are cumulative
and not exclusive of any rights, remedies, powers and privileges provided by law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding anything to the contrary contained
herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents
against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with
such enforcement shall be instituted and maintained exclusively by, the Administrative Agent in accordance with <U>Section 8.02
</U>for the benefit of all the Lenders and the L/C Issuer; <U>provided</U>, <U>however</U>, that the foregoing shall not prohibit
(a) the Administrative Agent from exercising on its own behalf the rights and remedies that inure to its benefit (solely in its
capacity as Administrative Agent) hereunder and under the other Loan Documents, (b) the L/C Issuer from exercising the rights
and remedies that inure to its benefit (solely in its capacity as L/C Issuer) hereunder and under the other Loan Documents, (c)
any Lender from exercising setoff rights in accordance with <U>Section 11.08</U> (subject to the terms of <U>Section 2.13</U>),
or (d) any Lender from filing proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding
relative to any Loan Party under any Debtor Relief Law; and <U>provided</U>, <U>further</U>, that if at any time there is no Person
acting as Administrative Agent hereunder and under the other Loan Documents, then (i) the Required Lenders shall have the rights
otherwise ascribed to the Administrative Agent pursuant to <U>Section 8.02</U> and (ii) in addition to the matters set forth in
clauses (b), (c) and (d) of the preceding proviso and subject to <U>Section 2.13</U>, any Lender may, with the consent of the
Required Lenders, enforce any rights and remedies available to it and as authorized by the Required Lenders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 112 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expenses; Indemnity; Damage Waiver</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Costs and Expenses</U>. The Borrower shall pay (i)&nbsp;all reasonable out-of-pocket expenses incurred by the Administrative
Agent and its Affiliates (including the reasonable fees, charges and disbursements of counsel for the Administrative Agent), in
connection with the syndication of the credit facilities provided for herein, the preparation, negotiation, execution, delivery
and administration of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions
hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii)&nbsp;all reasonable
out-of-pocket expenses incurred by the L/C Issuer in connection with the issuance, amendment, renewal or extension of any Letter
of Credit or any demand for payment thereunder and (iii)&nbsp;all out-of-pocket expenses incurred by the Administrative Agent,
any Lender or the L/C Issuer (including the fees, charges and disbursements of any counsel for the Administrative Agent, any Lender
or the L/C Issuer, in connection with the enforcement or protection of its rights) (A) in connection with this Agreement and the
other Loan Documents, including its rights under this Section, or (B) in connection with Loans made or Letters of Credit issued
hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such
Loans or Letters of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification by the Borrower</U>. The Borrower shall indemnify the Administrative Agent (and any sub-agent thereof),
each Lender and the L/C Issuer, and each Related Party of any of the foregoing Persons (each such Person being called an &ldquo;<U>Indemnitee</U>&rdquo;)
against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including
the fees, charges and disbursements of any counsel for any Indemnitee, incurred by any Indemnitee or asserted against any Indemnitee
by any third party or by the Borrower or any other Loan Party arising out of, in connection with, or as a result of (i)&nbsp;the
execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby,
the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the transactions
contemplated hereby or thereby, or, in the case of the Administrative Agent (and any sub-agent thereof) and its Related Parties
only, the administration of this Agreement and the other Loan Documents, (ii)&nbsp;any Loan or Letter of Credit or the use or proposed
use of the proceeds therefrom (including any refusal by the L/C Issuer to honor a demand for payment under a Letter of Credit if
the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii)&nbsp;any
actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by the Borrower or any of
its Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of its Subsidiaries, or (iv)&nbsp;any
actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract,
tort or any other theory, whether brought by a third party or by the Borrower or any other Loan Party, and regardless of whether
any Indemnitee is a party thereto; <U>provided</U> that such indemnity shall not, as to any Indemnitee, be available to the extent
that such losses, claims, damages, liabilities or related expenses (x)&nbsp;are determined by a court of competent jurisdiction
by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or (y)&nbsp;result
from a claim brought by the Borrower or any other Loan Party against an Indemnitee for breach in bad faith of such Indemnitee&rsquo;s
obligations hereunder or under any other Loan Document, if the Borrower or such Loan Party has obtained a final and nonappealable
judgment in its favor on such claim as determined by a court of competent jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 113 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reimbursement by Lenders</U>. To the extent that the Borrower for any reason fails to indefeasibly pay any amount required
under subsection&nbsp;(a) or&nbsp;(b) of this Section to be paid by it to the Administrative Agent (or any sub-agent thereof),
the L/C Issuer or any Related Party of any of the foregoing, each Lender severally agrees to pay to the Administrative Agent (or
any such sub-agent), the L/C Issuer or such Related Party, as the case may be, such Lender&rsquo;s Applicable Percentage (determined
as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount, <U>provided</U>
that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred
by or asserted against the Administrative Agent (or any such sub-agent) or the L/C Issuer in its capacity as such, or against any
Related Party of any of the foregoing acting for the Administrative Agent (or any such sub-agent) or L/C Issuer in connection with
such capacity. The obligations of the Lenders under this subsection&nbsp;(c) are subject to the provisions of <U>Section&nbsp;2.12(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Consequential Damages, Etc</U>. To the fullest extent permitted by applicable law and even if advised of the
possibility thereof, the Borrower shall not assert, and hereby waives, any claim against any Indemnitee, on any theory of liability,
for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection
with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions
contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee referred to in subsection
(b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed
to such unintended recipients by such Indemnitee through telecommunications, electronic or other information transmission systems
in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby other than for
direct or actual damages resulting from the gross negligence or willful misconduct of such Indemnitee as determined by a final
and nonappealable judgment of a court of competent jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 114 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payments</U>. All amounts due under this Section shall be payable not later than ten Business Days after demand therefor.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Survival</U>. The agreements in this Section shall survive the resignation of the Administrative Agent and the L/C Issuer,
the replacement of any Lender, the termination of the Aggregate Commitments and the repayment, satisfaction or discharge of all
the other Obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payments Set Aside</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">To the extent that any payment by or on behalf
of the Borrower is made to the Administrative Agent, the L/C Issuer or any Lender, or the Administrative Agent, the L/C Issuer
or any Lender exercises its right of setoff, and such payment or the proceeds of such setoff or any part thereof is subsequently
invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into
by the Administrative Agent, the L/C Issuer or such Lender in its discretion) to be repaid to a trustee, receiver or any other
party, in connection with any proceeding under any Debtor Relief Law or otherwise, then (a) to the extent of such recovery, the
obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such setoff had not occurred, and (b) each Lender and the L/C Issuer severally agrees to pay to the
Administrative Agent upon demand its applicable share (without duplication) of any amount so recovered from or repaid by the Administrative
Agent, <U>plus</U> interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to
the Federal Funds Rate from time to time in effect. The obligations of the Lenders and the L/C Issuer under clause (b) of the
preceding sentence shall survive the payment in full of the Obligations and the termination of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns Generally</U>. The provisions of this Agreement shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and assigns permitted hereby, except that the Borrower may not assign or
otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and
each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee
in accordance with the provisions of <U>Section 11.06(b)</U>, (ii) by way of participation in accordance with the provisions of
<U>Section 11.06(d)</U>, or (iii) by way of pledge or assignment of a security interest subject to the restrictions of <U>Section
11.06(f)</U> (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement,
expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors
and assigns permitted hereby, Participants to the extent provided in subsection (d) of this Section and, to the extent expressly
contemplated hereby, the Related Parties of each of the Administrative Agent, the L/C Issuer and the Lenders) any legal or equitable
right, remedy or claim under or by reason of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 115 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignments by Lenders</U>. Any Lender may at any time assign to one or more assignees all or a portion of its rights
and obligations under this Agreement (including all or a portion of its Commitment(s) and the Loans (including for purposes of
this <U>Section 11.06(b)</U>, participations in L/C Obligations) at the time owing to it); <U>provided</U> that any such assignment
shall be subject to the following conditions:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Minimum Amounts</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(A)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of an assignment of the entire remaining amount of the assigning Lender&rsquo;s Commitment under any Facility
and the Loans at the time owing to it under such Facility or in the case of an assignment to a Lender, an Affiliate of a Lender
or an Approved Fund, no minimum amount need be assigned; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(B)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this
purpose includes Loans outstanding thereunder) or, if the Commitment is not then in effect, the principal outstanding balance of
the Loans of the assigning Lender subject to each such assignment, determined as of the date the Assignment and Assumption with
respect to such assignment is delivered to the Administrative Agent or, if &ldquo;Trade Date&rdquo; is specified in the Assignment
and Assumption, as of the Trade Date, shall not be less than $5,000,000, in the case of any assignment in respect of the Revolving
Credit Facility, or $1,000,000, in the case of any assignment in respect of the Term Loan, unless each of the Administrative Agent
and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be
unreasonably withheld or delayed); <U>provided</U>, <U>however</U>, that concurrent assignments to members of an Assignee Group
and concurrent assignments from members of an Assignee Group to a single Eligible Assignee (or to an Eligible Assignee and members
of its Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has been
met;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proportionate Amounts</U>. Each partial assignment shall be made as an assignment of a proportionate part of all the
assigning Lender&rsquo;s rights and obligations under this Agreement with respect to the Loans or the Commitment assigned, except
that this clause (ii) shall not prohibit any Lender from assigning all or a portion of its rights and obligations among separate
Facilities on a non-pro rata basis;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Required Consents</U>. No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B)
of this Section and, in addition:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(A)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (1) an Event
of Default has occurred and is continuing at the time of such assignment or (2) such assignment is to a Lender, an Affiliate of
a Lender or an Approved Fund; <U>provided</U> that the Borrower shall be deemed to have consented to any such assignment unless
it shall object thereto by written notice to the Administrative Agent within five (5) Business Days after having received notice
thereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 116 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(B)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required for
assignments in respect of (1) the Term Loan or any Revolving Credit Commitment if such assignment is to a Person that is not a
Lender with a Commitment in respect of the Term Loan or Revolving Credit Facility, an Affiliate of such Lender or an Approved Fund
with respect to such Lender or (2) the Term Loan to a Person that is not a Lender, an Affiliate of a Lender or an Approved Fund;
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">(C)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the consent of the L/C Issuer (such consent not to be unreasonably withheld or delayed) shall be required for any assignment
that increases the obligation of the assignee to participate in exposure under one or more Letters of Credit (whether or not then
outstanding).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignment and Assumption</U>. The parties to each assignment shall execute and deliver to the Administrative Agent an
Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500; <U>provided</U>, <U>however</U>,
that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any
assignment. The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Assignment to Borrower</U>. No such assignment shall be made to the Borrower or any of the Borrower&rsquo;s Affiliates
or Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Assignment to Natural Persons</U>. No such assignment shall be made to a natural person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Subject to acceptance and recording thereof by
the Administrative Agent pursuant to subsection&nbsp;(c) of this Section, from and after the effective date specified in each Assignment
and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such
Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder
shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement
(and, in the case of an Assignment and Assumption covering all of the assigning Lender&rsquo;s rights and obligations under this
Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of <U>Sections 3.01</U>,
<U>3.04</U>, <U>3.05</U> and <U>11.04</U> with respect to facts and circumstances occurring prior to the effective date of such
assignment. Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender. Any assignment
or transfer by a Lender of rights or obligations under this Agreement that does not comply with this subsection shall be treated
for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with <U>Section
11.06(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 117 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Register</U>. The Administrative Agent, acting solely for this purpose as an agent of the Borrower, shall maintain at
the Administrative Agent&rsquo;s Office a copy of each Assignment and Assumption delivered to it and a register for the recordation
of the names and addresses of the Lenders, and the Commitments of, and principal amounts of the Loans and L/C Obligations owing
to, each Lender pursuant to the terms hereof from time to time (the &ldquo;<U>Register</U>&rdquo;). The entries in the Register
shall be conclusive, and the Borrower, the Administrative Agent and the Lenders may treat each Person whose name is recorded in
the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the
contrary. The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to
time upon reasonable prior notice.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Participations</U>. Any Lender may at any time, without the consent of, or notice to, the Borrower or the Administrative
Agent, sell participations to any Person (other than a natural person or the Borrower or any of the Borrower&rsquo;s Affiliates
or Subsidiaries) (each, a &ldquo;<U>Participant</U>&rdquo;) in all or a portion of such Lender&rsquo;s rights and/or obligations
under this Agreement (including all or a portion of its Commitment and/or the Loans (including such Lender&rsquo;s participations
in L/C Obligations) owing to it); <U>provided</U> that (i)&nbsp;such Lender&rsquo;s obligations under this Agreement shall remain
unchanged, (ii)&nbsp;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations
and (iii)&nbsp;the Borrower, the Administrative Agent, the Lenders and the L/C Issuer shall continue to deal solely and directly
with such Lender in connection with such Lender&rsquo;s rights and obligations under this Agreement. Any agreement or instrument
pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this
Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; <U>provided</U> that such agreement
or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or
other modification described in the first proviso to <U>Section 11.01</U> that affects such Participant. Subject to <U>subsection
(e)</U> of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of <U>Sections&nbsp;3.01</U>,
<U>3.04</U> and <U>3.05</U> to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to <U>Section
11.06(b)</U>. To the extent permitted by law, each Participant also shall be entitled to the benefits of <U>Section&nbsp;11.08</U>
as though it were a Lender, <U>provided</U> such Participant agrees to be subject to <U>Section 2.13</U> as though it were a Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Limitations upon Participant Rights</U>. A Participant shall not be entitled to receive any greater payment under <U>Section
3.01</U> or <U>3.04</U> than the applicable Lender would have been entitled to receive with respect to the participation sold to
such Participant, unless the sale of the participation to such Participant is made with the Borrower&rsquo;s prior written consent.
A Participant that would be a Foreign Lender if it were a Lender shall not be entitled to the benefits of <U>Section&nbsp;3.01</U>
unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of the
Borrower, to comply with <U>Section 3.01(e)</U> as though it were a Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 118 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Pledges</U>. Any Lender may at any time pledge or assign a security interest in all or any portion of its rights
under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment
to secure obligations to a Federal Reserve Bank; <U>provided</U> that no such pledge or assignment shall release such Lender from
any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resignation as L/C Issuer after Assignment</U>. Notwithstanding anything to the contrary contained herein, if at any
time Bank of America assigns all of its Revolving Credit Commitment and Revolving Credit Loans pursuant to <U>Section 11.06(b)</U>,
Bank of America may, upon 30 days&rsquo; notice to the Borrower and the Lenders, resign as L/C Issuer. In the event of any such
resignation as L/C Issuer, the Borrower shall be entitled to appoint from among the Lenders a successor L/C Issuer hereunder; <U>provided</U>,
<U>however</U>, that no failure by the Borrower to appoint any such successor shall affect the resignation of Bank of America as
L/C Issuer. If Bank of America resigns as L/C Issuer, it shall retain all the rights, powers, privileges and duties of the L/C
Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its resignation as L/C Issuer and
all L/C Obligations with respect thereto (including the right to require the Lenders to make LIBOR Daily Floating Rate Loans or
fund risk participations in Unreimbursed Amounts pursuant to <U>Section 2.03(c)</U>). Upon the appointment of a successor L/C Issuer,
(a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring L/C
Issuer, and (b) the successor L/C Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding
at the time of such succession or make other arrangements satisfactory to Bank of America to effectively assume the obligations
of Bank of America with respect to such Letters of Credit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Treatment of Certain Information; Confidentiality</U>. Each of the Administrative Agent, the Lenders and the L/C Issuer
agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a)&nbsp;to
its Affiliates and to its and its Affiliates&rsquo; respective partners, directors, officers, employees, agents, trustees, advisors
and representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential
nature of such Information and instructed to keep such Information confidential), (b)&nbsp;to the extent requested by any regulatory
authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of
Insurance Commissioners), (c)&nbsp;to the extent required by applicable laws or regulations or by any subpoena or similar legal
process, (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document
or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder,
(f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee of or Participant
in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual
or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations,
(g) with the consent of the Borrower or (h)&nbsp;to the extent such Information (i)&nbsp;becomes publicly available other than
as a result of a breach of this Section or (ii)&nbsp;becomes available to the Administrative Agent, any Lender, the L/C Issuer
or any of their respective Affiliates on a nonconfidential basis from a source other than the Borrower.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 119 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">For purposes of this Section, &ldquo;<U>Information</U>&rdquo;
means all information received from any Loan Party or any Subsidiary thereof relating to any Loan Party or any Subsidiary thereof
or their respective businesses, other than any such information that is available to the Administrative Agent, any Lender or the
L/C Issuer on a nonconfidential basis prior to disclosure by any Loan Party or any Subsidiary thereof, <U>provided</U> that, in
the case of information received from a Loan Party or any such Subsidiary after the date hereof, such information is clearly identified
at the time of delivery as confidential. Any Person required to maintain the confidentiality of Information as provided in this
Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care
to maintain the confidentiality of such Information as such Person would accord to its own confidential information.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each of the Administrative Agent, the Lenders
and the L/C Issuer acknowledges that (a) the Information may include material non-public information concerning the Borrower or
a Subsidiary, as the case may be, (b) it has developed compliance procedures regarding the use of material non-public information
and (c) it will handle such material non-public information in accordance with applicable Law, including United States Federal
and state securities Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Right of Setoff</U>. If an Event of Default shall have occurred and be continuing, each Lender, the L/C Issuer and each
of their respective Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable
law, to set off and apply any and all deposits (general or special, time or demand, provisional or final, in whatever currency)
at any time held and other obligations (in whatever currency) at any time owing by such Lender, the L/C Issuer or any such Affiliate
to or for the credit or the account of the Borrower against any and all of the obligations of the Borrower now or hereafter existing
under this Agreement or any other Loan Document to such Lender or the L/C Issuer, irrespective of whether or not such Lender or
the L/C Issuer shall have made any demand under this Agreement or any other Loan Document and although such obligations of the
Borrower may be contingent or unmatured or are owed to a branch or office of such Lender or the L/C Issuer different from the branch
or office holding such deposit or obligated on such indebtedness. The rights of each Lender, the L/C Issuer and their respective
Affiliates under this Section are in addition to other rights and remedies (including other rights of setoff) that such Lender,
the L/C Issuer or their respective Affiliates may have. Each Lender and the L/C Issuer agrees to notify the Borrower and the Administrative
Agent promptly after any such setoff and application, <U>provided</U> that the failure to give such notice shall not affect the
validity of such setoff and application.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interest Rate Limitation</U>. Notwithstanding anything to the contrary contained in any Loan Document, the interest paid
or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable
Law (the &ldquo;<U>Maximum Rate</U>&rdquo;). If the Administrative Agent or any Lender shall receive interest in an amount that
exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal,
refunded to the Borrower. In determining whether the interest contracted for, charged, or received by the Administrative Agent
or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable Law, (a) characterize any payment
that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof,
and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated
term of the Obligations hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 120 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts; Integration; Effectiveness</U>. This Agreement and each of the other Loan Documents may be executed in
counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of
which when taken together shall constitute a single contract. This Agreement, the other Loan Documents, and any separate letter
agreements with respect to fees payable to the Administrative Agent or the L/C Issuer, constitute the entire contract among the
parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written,
relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall
have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that,
when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature
page of this Agreement or any other Loan Document, or any certificate delivered thereunder, by fax transmission or email transmission
(e.g., &ldquo;pdf&rdquo; or &ldquo;tif&rdquo;) shall be effective as delivery of a manually executed counterpart of this Agreement
or such other Loan Document or certificate. Without limiting the foregoing, to the extent a manually executed counterpart is not
specifically required to be delivered under the terms of any Loan Document, upon the request of any party, such fax transmission
or e-mail transmission shall be promptly followed by such manually executed counterpart.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Survival of Representations and Warranties</U>. All representations and warranties made hereunder and in any other Loan
Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution
and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent
and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding
that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Credit Extension,
and shall continue in full force and effect as long as any Loan or any other Obligation hereunder shall remain unpaid or unsatisfied
or any Letter of Credit shall remain outstanding.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable,
(a) the legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall
not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid
or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal,
invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Replacement of Lenders</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If any Lender requests compensation under <U>Section
3.04</U>, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account
of any Lender pursuant to <U>Section 3.01</U>, or if any Lender is a Defaulting Lender, then the Borrower may, at its sole expense
and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse
(in accordance with and subject to the restrictions contained in, and consents required by, <U>Section 11.06</U>), all of its
interests, rights and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such obligations
(which assignee may be another Lender, if a Lender accepts such assignment), <U>provided</U> that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 121 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Borrower shall have paid to the Administrative Agent the assignment fee specified in <U>Section 11.06(b)</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such Lender shall have received payment of an amount equal to the outstanding principal of its Loans and L/C Advances, accrued
interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any
amounts under <U>Section 3.05</U>) from the assignee (to the extent of such outstanding principal and accrued interest and fees)
or the Borrower (in the case of all other amounts);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of any such assignment resulting from a claim for compensation under <U>Section 3.04</U> or payments required
to be made pursuant to <U>Section&nbsp;3.01</U>, such assignment will result in a reduction in such compensation or payments thereafter;
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such assignment does not conflict with applicable Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A Lender shall not be required to make any
such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling
the Borrower to require such assignment and delegation cease to apply.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law; Jurisdiction; Etc</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>GOVERNING LAW</U>. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE COMMONWEALTH
OF MASSACHUSETTS.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>SUBMISSION TO JURISDICTION</U>. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF
AND ITS PROPERTY, TO THE NONEXCLUSIVE JURISDICTION OF THE COURTS OF THE COMMONWEALTH OF MASSACHUSETTS SITTING IN SUFFOLK COUNTY
AND OF THE UNITED STATES DISTRICT COURT OF THE DISTRICT OF MASSACHUSETTS, AND ANY APPELLATE COURT FROM ANY THEREOF, IN ANY ACTION
OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY
JUDGMENT, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR
PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL
COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE
ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR IN
ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT, ANY LENDER OR THE L/C ISSUER MAY OTHERWISE HAVE TO
BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST THE BORROWER OR ANY OTHER LOAN PARTY
OR THEIR RESPECTIVE PROPERTIES IN THE COURTS OF ANY JURISDICTION.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 122 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>WAIVER OF VENUE</U>. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH&nbsp;(B) OF THIS
SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF
AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>SERVICE OF PROCESS</U>. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES
IN <U>SECTION&nbsp;11.02</U>. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER
MANNER PERMITTED BY APPLICABLE LAW</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Jury Trial</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR
INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR
THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT
OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER
INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Advisory or Fiduciary Responsibility</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In connection with all aspects of each transaction
contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document),
the Borrower acknowledges and agrees that: (i) (A) the arranging and other services regarding this Agreement provided by the Administrative
Agent are arm&rsquo;s-length commercial transactions between the Borrower and its Affiliates, on the one hand, and the Administrative
Agent, on the other hand, (B) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent
it has deemed appropriate, and (C) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions
of the transactions contemplated hereby and by the other Loan Documents; (ii) (A) the Administrative Agent is and has been acting
solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be
acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates, or any other Person and (B) the Administrative
Agent has no obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those
obligations expressly set forth herein and in the other Loan Documents; and (iii) the Administrative Agent and its respective
Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its
Affiliates, and the Administrative Agent has no obligation to disclose any of such interests to the Borrower or its Affiliates.
To the fullest extent permitted by law, the Borrower hereby waives and releases any claims that it may have against the Administrative
Agent with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction
contemplated hereby.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 123 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reserved</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>USA PATRIOT Act</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Lender that is subject to the Act (as
hereinafter defined) and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that
pursuant to the requirements of the USA <FONT STYLE="text-transform: uppercase">Patriot A</FONT>ct (Title III of Pub. L. 107-56
(signed into law October 26, 2001)) (the &ldquo;<U>Act</U>&rdquo;), it is required to obtain, verify and record information that
identifies each Loan Party, which information includes the name and address of each Loan Party and other information that will
allow such Lender or the Administrative Agent, as applicable, to identify each Loan Party in accordance with the Act. The Borrower
shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information
that the Administrative Agent or such Lender requests in order to comply with its ongoing obligations under applicable &ldquo;know
your customer&rdquo; an anti-money laundering rules and regulations, including the Act.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Time of the Essence</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Time is of the essence of the Loan Documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Eligible Contract Participant</U>. (a) Notwithstanding anything in the Loan Documents to the contrary, a Loan Party shall
not be deemed to be a guarantor of any Obligations arising out of or in connection with any Hedging Agreements if such Loan Party
is not an &ldquo;<U>Eligible Contract Participant</U>&rdquo; (as defined in &sect;&nbsp;1(a)(18) of the Commodity Exchange Act
and the applicable rules issued by the Commodity Futures Trading Commission and/or the SEC (collectively, and as now or hereafter
in effect, the &ldquo;ECP Rules&rdquo;)) to the extent that the providing of such guaranty by such Loan Party would violate the
ECP Rules or any other applicable law or regulation. This paragraph shall not affect any Obligations not arising out of or in connection
with any Hedging Agreements, nor shall it affect any Obligations arising out of or in connection with any Hedging Agreements to
the extent such Loan Party qualifies as an &ldquo;<U>Eligible Contract Participant</U>&rdquo; (so defined).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 124 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Loan Party that is a Qualified ECP Guarantor at the time the Guaranty, in each case, by any Specified Loan Party, becomes
effective with respect to any Swap Obligation, hereby jointly and severally, absolutely, unconditionally and irrevocably undertakes
to provide such funds or other support to each Specified Loan Party with respect to such Swap Obligation as may be needed by such
Specified Loan Party from time to time to honor all of its obligations under its Guaranty and the other Loan Documents in respect
of such Swap Obligation (but, in each case, only up to the maximum amount of such liability that can be hereby incurred without
rendering such Qualified ECP Guarantor&rsquo;s obligations and undertakings under this Section 11.20(b) voidable under applicable
law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations and undertakings
of each Qualified ECP Guarantor under this Section shall remain in full force and effect until the Obligations have been indefeasibly
paid and performed in full. Each Qualified ECP Guarantor intends this Section to constitute, and this Section shall be deemed to
constitute, a guarantee of the obligations of, and a &ldquo;keepwell, support, or other agreement&rdquo; for the benefit of, each
Specified Loan Party for all purposes of the Commodity Exchange Act.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.21<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Electronic Execution of Assignments and Certain Other Documents</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The words &ldquo;execution,&rdquo; &ldquo;execute,&rdquo;
&ldquo;signed,&rdquo; &ldquo;signature,&rdquo; and words of like import in or related to any document to be signed in connection
with this Agreement and the transactions contemplated hereby (including without limitation Assignment and Assumptions, amendments
or other Committed Loan Notices, waivers and consents) shall be deemed to include electronic signatures, the electronic matching
of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records
in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature
or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law,
including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and
Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that notwithstanding anything
contained herein to the contrary the Administrative Agent is under no obligation to agree to accept electronic signatures in any
form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it; provided,
further, without limiting the foregoing, upon the request of the Administrative Agent, any electronic signature shall be promptly
followed by such manually executed counterparts.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.22<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Acknowledgement and Consent to Bail-In of EEA Financial Institutions</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding anything to the contrary in
any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges
that any liability of any Lender that is an EEA Financial Institution arising under any Loan Document, to the extent such liability
is unsecured, may be subject to the write-down and conversion powers of an EEA Resolution Authority and agrees and consents to,
and acknowledges and agrees to be bound by:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 125 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder
which may be payable to it by any Lender that is an EEA Financial Institution; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the effects of any Bail-in Action on any such liability, including, if applicable:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a reduction in full or in part or cancellation of any such liability;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial
Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such
shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under
this Agreement or any other Loan Document; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">the variation of the terms of such liability in
connection with the exercise of the write-down and conversion powers of any EEA Resolution Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">ARTICLE XII<BR>
ratification</P>

<P STYLE="font-size: 10pt; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">IN ADDITION, TO INDUCE THE LENDERS AND THE
ADMINISTRATIVE AGENT TO AGREE TO THE TERMS OF THIS AGREEMENT, THE BORROWER REPRESENTS AND WARRANTS THAT AS OF THE DATE OF ITS
EXECUTION OF THIS AGREEMENT THERE ARE NO CLAIMS OR OFFSETS AGAINST OR RIGHTS OF RECOUPMENT WITH RESPECT TO OR DEFENSES OR COUNTERCLAIMS
TO ITS OBLIGATIONS UNDER THE LOAN DOCUMENTS (INCLUDING WITHOUT LIMITATION, UNDER THE ORIGINAL CREDIT AGREEMENT, OR AGAINST ANY
PRIOR AGENT) AND IN ACCORDANCE THEREWITH IT:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver</U>. WAIVES ANY AND ALL SUCH CLAIMS, OFFSETS, RIGHTS OF RECOUPMENT, DEFENSES OR COUNTERCLAIMS, ARISING PRIOR TO
THE DATE OF ITS EXECUTION OF THIS AGREEMENT AND</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Release</U>. RELEASES AND DISCHARGES THE LENDERS AND THE ADMINISTRATIVE AGENT AND ALL PRIOR AGENTS AND THEIR OFFICERS,
DIRECTORS, EMPLOYEES, AGENTS AND AFFILIATES (COLLECTIVELY THE &ldquo;RELEASED PARTIES&rdquo;) FROM ANY AND ALL LIABILITIES, CLAIMS,
CAUSES OF ACTION, IN LAW OR EQUITY, WHICH THE BORROWER OR ANY LOAN PARTY OR ANY OF THEIR SUBSIDIARIES MAY HAVE AGAINST ANY RELEASED
PARTY ARISING PRIOR TO THE DATE HEREOF IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 126 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reference to Agreement</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each of the Loan Documents, including the Original
Credit Agreement, the Notes and any and all other agreements, documents, or instruments now or hereafter executed and delivered
pursuant to the terms hereof or pursuant to the terms of the Original Credit Agreement, as amended hereby, are hereby amended
so that any reference in such Loan Documents to the Original Credit Agreement shall mean a reference to the Original Credit Agreement,
and as further amended hereby.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement</U></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement embodies the entire agreement
among the parties hereto with respect to the subject matter thereof, and supersedes any and all prior representations and understandings,
whether written or oral, relating to this amendment. There are no oral agreements among the parties hereto with respect to the
subject matter hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">[ <I>The remainder of this page is intentionally
left blank</I>. ]</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">[<I>Signature page follows</I>]</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 127 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"><I>IN WITNESS WHEREOF, </I>the parties hereto
have caused this Agreement to be duly executed as of the date first above written.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left">HARVARD BIOSCIENCE, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 30%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ Robert Gagnon</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left">Name: Robert Gagnon</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left">Title:&nbsp;&nbsp;&nbsp;Chief Financial Officer</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 128; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left"><FONT STYLE="text-transform: uppercase">bank of america, n.a., as</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Administrative Agent</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ Denise Jones</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Name:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">Denise Jones</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Title:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">Vice President </TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle"><FONT STYLE="text-transform: uppercase">bank of america, n.a., as a Lender and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle">L/C Issuer</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">/s/ Peter McCarthy</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Name:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">Peter McCarthy</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Title:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">SVP</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 130 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left"><FONT STYLE="text-transform: uppercase">brown brothers harriman &amp; co.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">/s/ Daniel G. Head, Jr.</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Name:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">Daniel G. Head, Jr.</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Title:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">SVP</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 131 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Schedule 2.01</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Commitments and Applicable Percentages</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 37%; border: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Lender</U></TD>
    <TD STYLE="width: 40%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Revolving Credit Commitment</U></TD>
    <TD STYLE="width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Applicable <BR>
Percentage</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">Bank of America, N.A.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">$17,500,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">70.000000000%</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">Brown Brothers Harriman &amp; Co.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">$7,500,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">30.000000000%</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in"><B>$25,000,000.00</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in"><B>100.000000000%</B></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 37%; border: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Lender</U></TD>
    <TD STYLE="width: 40%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Term Commitment</U></TD>
    <TD STYLE="width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in; text-decoration: underline"><U>Applicable <BR>
Percentage</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">Bank of America, N.A.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">$9,800,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">70.000000000%</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">Brown Brothers Harriman &amp; Co.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">$4,200,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in">30.000000000%</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in"><B>$14,000,000.00</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 0in"><B>100.000000000%</B></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 132 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT A</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">FORM OF COMMITTED LOAN NOTICE</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">Date: ___________, _____</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">To:&#9;Bank of America, N.A., as Administrative
Agent</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is made to that certain Third Amended
and Restated Credit Agreement, dated as of April [__], 2017, (as amended, restated, extended, supplemented or otherwise modified
in writing from time to time, the &ldquo;<U>Agreement</U>;&rdquo; the terms defined therein being used herein as therein defined),
among Harvard Bioscience, Inc., a Delaware corporation, (the &ldquo;<U>Borrower</U>&rdquo;), the Lenders from time to time party
thereto, and Bank of America, N.A., as Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned hereby requests (select one):</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">On __________________ (a Business Day):</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A Revolving Credit Borrowing (if requesting
a Revolving Credit Borrowing, item 5 below must be completed) in the amount of $______________.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A Term Borrowing (for initial advance only)
in the amount of $________________.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A Borrowing of Eurodollar Rate Loans in the
amount of $_______________.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in">[_] A Borrowing of LIBOR Daily Floating
Rate Loans in the amount of $______________.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A conversion of Term Loans from [_____________]
to [________________]</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A conversion of Revolving Credit Loans from
[_____________] to</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">[________________]</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">[_] A continuation of Eurodollar Rate Loans:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">&#9;[_] Continuation under the Revolving Credit
Facility</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0 0pt 20pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">&#9;[_] Continuation under the Term Facility</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">1.&#9;On _____________________&#9;(a Business Day).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">2.&#9;In the amount of $&#9;________________________</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 133 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -117pt; margin: 0pt 0 0pt 225pt">3.&#9;Comprised of &#9;_________________________________________<BR>
[Type of Loan requested]</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -117pt; margin: 0pt 0 0pt 225pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">4.&#9;For Eurodollar Rate Loans: with an Interest
Period of <U>&#9;</U>____ months.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
Revolving Credit Loans: The Revolving Credit Borrowing requested herein complies with the proviso to the first sentence of <U>Section
2.01(b)</U> of the Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Borrower hereby represents and warrants that
the conditions specified in <U>Section 4.02</U> of the Agreement shall be satisfied on and as of the date of the proposed Borrowing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle">HARVARD BIOSCIENCE, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Name:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT B</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">[FORM OF] AMENDED AND RESTATED
TERM NOTE</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 71%">$[________].00</TD>
    <TD NOWRAP STYLE="width: 12%">Initial Issuance Date:&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 14%; text-align: right">March
29, 2013</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Restated:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: right">April [__], 2017</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">FOR VALUE RECEIVED, the undersigned (the &ldquo;<U>Borrower</U>&rdquo;),
hereby promises to pay to [_______________] or registered assigns (the &ldquo;<U>Lender</U>&rdquo;), in accordance with the provisions
of the Agreement (as hereinafter defined), the principal amount of the Term Loan from time to time made by the Lender to the Borrower
under that certain Third Amended and Restated Credit Agreement, dated as of April [__], 2017 (as amended, restated, extended, supplemented
or otherwise modified in writing from time to time, the &ldquo;<U>Agreement</U>;&rdquo; the terms defined therein being used herein
as therein defined), among the Borrower, the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative
Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Borrower promises to pay interest on the unpaid
principal amount of each Term Loan from the date of such Loan until such principal amount is paid in full, at such interest rates
and at such times as provided in the Agreement. All payments of principal and interest shall be made to the Administrative Agent
for the account of the Lender in Dollars in immediately available funds at the Administrative Agent&rsquo;s Office. If any amount
is not paid in full when due hereunder, such unpaid amount shall bear interest, to be paid upon demand, from the due date thereof
until the date of actual payment (and before as well as after judgment) computed at the per annum rate set forth in the Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This Amended and Restated Term Note (the &ldquo;<U>Note</U>&rdquo;)
is one of the Term Notes referred to in the Agreement, is entitled to the benefits thereof and may be prepaid in whole or in part
subject to the terms and conditions provided therein. This Amended and Restated Term Note is also entitled to the benefits of the
Guaranty. Upon the occurrence and continuation of one or more of the Events of Default specified in the Agreement, all amounts
then remaining unpaid on this Amended and Restated Term Note shall become, or may be declared to be, immediately due and payable
all as provided in the Agreement. Term Loans made by the Lender shall be evidenced by one or more loan accounts or records maintained
by the Lender in the ordinary course of business. The Lender may also attach schedules to this Term Note and endorse thereon the
date, amount and maturity of its Amended and Restated Term Loans and payments with respect thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This Amended and Restated Term Note amends, restates
and supersedes, but does not, and is not intended to and shall not extinguish or cancel the indebtedness (including, but not limited
to, all accrued but unpaid interest thereon) evidenced by the Term Note dated March 29, 2013 (the &ldquo;<U>Original Note</U>&rdquo;)
made by the Borrower, jointly and severally, in favor of the Lender. This Amended and Restated Term Note is not a novation or discharge
of the terms and provisions of the Borrower under the Original Note or under any Loan Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Borrower, for itself, its successors and assigns,
hereby waives diligence, presentment, protest and demand and notice of protest, demand, dishonor and non-payment of this Amended
and Restated Term Note.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 135 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">THIS NOTE IS SIGNED AS A SEALED INSTRUMENT AND
SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle">HARVARD BIOSCIENCE, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Name:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 136 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">LOANS AND PAYMENTS WITH RESPECT THERETO</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Type of <BR>
Loan Made</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Amount of <BR>
Loan Made</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">End of <BR>
Interest <BR>
Period</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Amount of <BR>
Principal or <BR>
Interest Paid <BR>
This Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Outstanding<BR>
 Principal <BR>
Balance This <BR>
Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Notation <BR>
Made By</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 137 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT C</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">[FORM OF] THIRD AMENDED AND
RESTATED REVOLVING CREDIT NOTE</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 71%">$[________].00</TD>
    <TD NOWRAP STYLE="width: 12%">Initial Issuance Date:&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 14%; text-align: right">November 21, 2003</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Restated:&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">August 7, 2009</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Restated:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: right">March 29, 2013</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Restated:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: right">April [__], 2017</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">FOR VALUE RECEIVED, the undersigned (the &ldquo;<U>Borrower</U>&rdquo;),
hereby promises to pay to [______________] or registered assigns (the &ldquo;<U>Lender</U>&rdquo;), in accordance with the provisions
of the Agreement (as hereinafter defined), the principal amount of each Revolving Credit Loan from time to time made by the Lender
to the Borrower under that certain Third Amended and Restated Credit Agreement, dated as of April [__], 2017 (as amended, restated,
extended, supplemented or otherwise modified in writing from time to time, the &ldquo;<U>Agreement</U>;&rdquo; the terms defined
therein being used herein as therein defined), among the Borrower, the Lenders from time to time party thereto, and Bank of America,
N.A., as Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Borrower promises to pay interest on the unpaid
principal amount of each Revolving Credit Loan from the date of such Loan until such principal amount is paid in full, at such
interest rates and at such times as provided in the Agreement. All payments of principal and interest shall be made to the Administrative
Agent for the account of the Lender in Dollars in immediately available funds at the Administrative Agent&rsquo;s Office. If any
amount is not paid in full when due hereunder, such unpaid amount shall bear interest, to be paid upon demand, from the due date
thereof until the date of actual payment (and before as well as after judgment) computed at the per annum rate set forth in the
Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This Third Amended and Restated Revolving Credit
Note (the &ldquo;<U>Note</U>&rdquo;) is one of the Revolving Credit Notes referred to in the Agreement, is entitled to the benefits
thereof and may be prepaid in whole or in part subject to the terms and conditions provided therein. This Third Amended and Restated
Revolving Credit Note is also entitled to the benefits of the Guaranty. Upon the occurrence and continuation of one or more of
the Events of Default specified in the Agreement, all amounts then remaining unpaid on this Third Amended and Restated Revolving
Credit Note shall become, or may be declared to be, immediately due and payable all as provided in the Agreement. Revolving Credit
Loans made by the Lender shall be evidenced by one or more loan accounts or records maintained by the Lender in the ordinary course
of business. The Lender may also attach schedules to this Third Amended and Restated Revolving Credit Note and endorse thereon
the date, amount and maturity of its Revolving Credit Loans and payments with respect thereto.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This Third Amended and Restated Revolving Credit
Note amends, restates and supersedes, but does not, and is not intended to and shall not extinguish or cancel the indebtedness
(including, but not limited to, all accrued but unpaid interest thereon) evidenced by the Revolving Credit Note dated November
21, 2003, as amended and restated by that certain Amended and Restated Revolving Credit Note dated August 7, 2009, as amended and
restated by that certain Second Amended and Restated Revolving Credit Note dated March 29, 2013 (the &ldquo;<U>Original Note</U>&rdquo;)
made by the Borrower, jointly and severally, in favor of the Lender. This Third Amended and Restated Revolving Promissory Note
is not a novation or discharge of the terms and provisions of the Borrower under the Original Note or under any Loan Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 138 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Borrower, for itself, its successors and assigns,
hereby waives diligence, presentment, protest and demand and notice of protest, demand, dishonor and non-payment of this Third
Amended and Restated Revolving Credit Note.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 139 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">THIS NOTE IS SIGNED AS A SEALED INSTRUMENT AND
SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle">HARVARD BIOSCIENCE, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Name:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 140 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">LOANS AND PAYMENTS WITH RESPECT THERETO</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Type of <BR>
Loan Made</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Amount of <BR>
Loan Made</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">End of <BR>
Interest <BR>
Period</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Amount of <BR>
Principal or <BR>
Interest Paid <BR>
This Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Outstanding<BR>
 Principal <BR>
Balance This <BR>
Date</TD>
    <TD STYLE="text-align: center; width: 5%; vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom">Notation <BR>
Made By</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 141 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT D</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">FORM OF COMPLIANCE CERTIFICATE</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">Financial Statement Date: ________, ____</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">To:&#9;Bank of America, N.A., as Administrative
Agent</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is made to that certain Third Amended
and Restated Credit Agreement, dated as of April&nbsp;[__], 2017 (as amended, restated, extended, supplemented or otherwise modified
in writing from time to time, the &ldquo;<U>Agreement</U>;&rdquo; the terms defined therein being used herein as therein defined),
among Harvard Bioscience, Inc., a Delaware corporation (the &ldquo;<U>Borrower</U>&rdquo;), the Lenders from time to time party
thereto, and Bank of America, N.A., as Administrative Agent.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned Responsible Officer hereby certifies
as of the date hereof that he/she is the ___________________________________ of the Borrower, and that, as such, he/she is authorized
to execute and deliver this Certificate to the Administrative Agent on the behalf of the Borrower, and that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>[Use following paragraph 1 for fiscal year-end
financial statements]</I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Borrower has delivered (i) the year-end audited financial statements required by <U>Section 6.01(a)</U> of the Agreement for the
fiscal year of the Borrower ended as of the above date, together with the report and opinion of an independent certified public
accountant required by such section and (ii) the consolidating balance sheet of the Borrower and its Subsidiaries as at the end
of such fiscal year and the related consolidating statements of income or operations, shareholders&rsquo; equity and cash flows
for such fiscal year. Such consolidating statements are fairly stated in all material respects when considered in relation to the
consolidated financial statements of the Borrower and its Subsidiaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>[Use following paragraph 1 for fiscal quarter-end
financial statements]</I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Borrower has delivered the unaudited financial statements required by <U>Section 6.01(b)</U> of the Agreement for the fiscal quarter
of the Borrower ended as of the above date and the related consolidated and consolidating statements of income or operations, changes
in shareholders&rsquo; equity, and cash flows for such fiscal quarter. Such consolidated financial statements fairly present in
all material respects the financial condition, results of operations and cash flows of the Borrower and its Subsidiaries in accordance
with GAAP as at such date and for such period, subject only to normal year-end audit adjustments and the absence of footnotes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned has reviewed and is familiar with the terms of the Agreement and has made, or has caused to be made under his/her supervision,
a detailed review of the transactions and condition (financial or otherwise) of the Borrower during the accounting period covered
by such financial statements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 142 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
review of the activities of the Borrower during such fiscal period has been made under the supervision of the undersigned with
a view to determining whether during such fiscal period the Borrower performed and observed all its Obligations under the Loan
Documents, and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>[select one:]</I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">to the knowledge of the undersigned, during such
fiscal period the Borrower performed and observed each covenant and condition of the Loan Documents applicable to it, and no Default
has occurred and is continuing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>--or--</I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">to the knowledge of the undersigned, the following
covenants or conditions have not been performed or observed and the following is a list of each such Default that has occurred
and is continuing and its nature and status:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Borrower contained in <U>Article V</U> of the Agreement and all representations and warranties
of any Guarantees that are contained in any document furnished at any time under or in connection with the Loan Documents, are
true and correct and for all representations and warranties which are not by their terms qualified by &ldquo;materiality&rdquo;,
in all material respects on and as of the date hereof, except to the extent that such representations and warranties specifically
refer to an earlier date, in which case they are true and correct as of such earlier date, and except that for purposes of this
Compliance Certificate, the representations and warranties contained in subsections (a) and (b) of <U>Section 5.05</U> of the Agreement
shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of <U>Section 6.01</U>
of the Agreement, including the statements in connection with which this Compliance Certificate is delivered.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
financial covenant analyses and information set forth on <U>Schedules 1</U> and <U>2</U> attached hereto are true and accurate
on and as of the date of this Certificate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"><I>IN WITNESS WHEREOF,</I> the undersigned has
executed this Certificate as of ______________<U>&#9;</U>, _____________<U>&#9;</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle">HARVARD BIOSCIENCE, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">By:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Name:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 143 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT E-1</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">FORM OF ASSIGNMENT AND ASSUMPTION</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This Assignment and Assumption (this &ldquo;<U>Assignment
and Assumption</U>&rdquo;) is dated as of the Effective Date set forth below and is entered into by and between the Assignor identified
in item&nbsp;1 below (the &ldquo;<U>Assignor</U>&rdquo;) and the Assignee identified in item 2 below (the &ldquo;<U>Assignee</U>&rdquo;).
Capitalized terms used but not defined herein shall have the meanings given to them in the Third Amended and Restated Credit Agreement
identified below (the &ldquo;<U>Credit Agreement</U>&rdquo;), receipt of a copy of which is hereby acknowledged by the Assignee.
The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference
and made a part of this Assignment and Assumption as if set forth herein in full.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">For an agreed consideration, the Assignor hereby
irrevocably sells and assigns to the Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject
to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date inserted by the
Administrative Agent as contemplated below (i) all of the Assignor&rsquo;s rights and obligations in its capacity as a Lender under
the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to the amount and
percentage interest identified below of all of such outstanding rights and obligations of the Assignor under the respective facilities
identified below and (ii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and
any other right of the Assignor (in its capacity as a Lender) against any Person, whether known or unknown, arising under or in
connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed
thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims,
malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned
pursuant to clause (i) above (the rights and obligations sold and assigned by the Assignor to the Assignee pursuant to clauses
(i) and (ii) above being referred to herein collectively as the &ldquo;<U>Assigned Interest</U>&rdquo;). Each such sale and assignment
is without recourse to the Assignor and, except as expressly provided in this Assignment and Assumption, without representation
or warranty by the Assignor.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; text-align: left; width: 5%">1.</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; width: 10%"><U>Assignor[s]<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></U></TD>
    <TD STYLE="vertical-align: middle; text-align: justify; width: 85%">________________________________________________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">________________________________________________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">2.</TD>
    <TD STYLE="vertical-align: middle; text-align: justify"><U>Assignee[s]<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></U></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">________________________________________________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">________________________________________________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">[for each Assignee, indicate [Affiliate][Approved Fund] of [<FONT STYLE="font-size: 10pt; font-weight: normal"><I>identify Lender</I><FONT STYLE="font-style: normal">]]</FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">3.</TD>
    <TD STYLE="vertical-align: middle; text-align: justify"><U>Borrower(s)<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></U></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">______________________________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">4.</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left"><U>Administrative Agent</U><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:
    Bank of America, N.A., as the Administrative Agent under the Credit Agreement</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left">5.</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left"><U>Credit Agreement</U><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:
    Third Amended and Restated Credit Agreement, dated as of April&nbsp;[__], 2017, among the Borrower, the Lenders from time
    to time party thereto, and Bank of America, N.A., as Administrative Agent</FONT></TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 144 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%; text-align: left">6.</TD><TD STYLE="text-align: justify">Assigned Interest:</TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center; width: 13%">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 23%">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 15%">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 12%">Aggregate</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 12%">Amount of</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 13%">Percentage</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 12%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Amount of</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Commitment/Loans</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Assigned of</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Facility</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Commitment/Loans</TD>
    <TD STYLE="text-decoration: underline; border-right: Black 1pt solid; text-align: center">Assigned</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">Commitment/</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">CUSIP</TD></TR>
<TR>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center">Assignor[s]</TD>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; text-align: center">Assignee[s]</TD>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; text-align: center">Assigned</TD>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; text-align: center">for all Lenders</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; text-align: center">Loans</TD>
    <TD STYLE="text-decoration: underline; vertical-align: middle; border-right: Black 1pt solid; text-align: center">&nbsp;Number</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$________________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$_________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$________________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$_________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$________________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$_________</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">____________%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%; text-align: left">[7.</TD><TD STYLE="text-align: justify">Trade Date:&#9;__________________]</TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Effective Date: __________________, 20__ [TO BE
INSERTED BY ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.]</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The terms set forth in this Assignment and Assumption are hereby
agreed to:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; vertical-align: middle; text-align: left">ASSIGNOR</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">[NAME OF ASSIGNOR]</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 51%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; width: 30%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 16%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Title:</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; vertical-align: middle; text-align: left">ASSIGNEE</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">[NAME OF ASSIGNEE]</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Title:</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Consented to and Accepted:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">BANK OF AMERICA, N.A., as<BR>
Administrative Agent</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">By:&#9;_________________________________<BR>
&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 145 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B><I>ANNEX 1 TO ASSIGNMENT AND ASSUMPTION</I></B></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">[___________________]</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">STANDARD TERMS AND CONDITIONS
FOR</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">ASSIGNMENT AND ASSUMPTION</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignor</U>.
The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned Interest, (ii) the Assigned
Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken
all action necessary, to execute and deliver this Assignment and Assumption and to consummate the transactions contemplated hereby;
and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with
the Credit Agreement or any other Loan Document, (ii) the execution, legality, validity, enforceability, genuineness, sufficiency
or value of the Loan Documents or any collateral thereunder, (iii) the financial condition of the Borrower, any of its Subsidiaries
or Affiliates or any other Person obligated in respect of any Loan Document or (iv) the performance or observance by the Borrower,
any of its Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Loan Document.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignee</U>.
The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action necessary, to execute
and deliver this Assignment and Assumption and to consummate the transactions contemplated hereby and to become a Lender under
the Credit Agreement, (ii) it meets all the requirements to be an assignee under <U>Section&nbsp;15.1(b)(iii)</U>, <U>(v)</U> and
<U>(vi)</U> of the Credit Agreement (subject to such consents, if any, as may be required under <U>Section&nbsp;15.1(b)(iii)</U>
of the Credit Agreement), (iii) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement
as a Lender thereunder and, to the extent of [the][the relevant] Assigned Interest, shall have the obligations of a Lender thereunder,
(iv) it is sophisticated with respect to decisions to acquire assets of the type represented by [the][such] Assigned Interest and
either it, or the Person exercising discretion in making its decision to acquire [the][such] Assigned Interest, is experienced
in acquiring assets of such type, (v) it has received a copy of the Credit Agreement, and has received or has been accorded the
opportunity to receive copies of the most recent financial statements delivered pursuant to Section&nbsp;5.1 thereof, as applicable,
and such other documents and information as it deems appropriate to make its own credit analysis and decision to enter into this
Assignment and Assumption and to purchase [the][such] Assigned Interest, (vi) it has, independently and without reliance upon the
Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own
credit analysis and decision to enter into this Assignment and Assumption and to purchase the Assigned Interest, and (vii) if it
is a Foreign Lender, attached hereto is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement,
duly completed and executed by the Assignee; and (b) agrees that (i) it will, independently and without reliance upon the Administrative
Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at the time,
continue to make its own credit decisions in taking or not taking action under the Loan Documents, and (ii) it will perform in
accordance with their terms all of the obligations which by the terms of the Loan Documents are required to be performed by it
as a Lender.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 146 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments</U>.
From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including
payments of principal, interest, fees and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective
Date and to the Assignee for amounts which have accrued from and after the Effective Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Provisions</U>. This Assignment and Assumption shall be binding upon, and inure to the benefit of, the parties hereto and their
respective successors and assigns. This Assignment and Assumption may be executed in any number of counterparts, which together
shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment and Assumption by telecopy
shall be effective as delivery of a manually executed counterpart of this Assignment and Assumption. This Assignment and Assumption
shall be governed by, and construed in accordance with, the law of the State of the Commonwealth of Massachusetts.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 147 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT E-2</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>FORM OF ADMINISTRATIVE QUESTIONNAIRE</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #3333FF"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: #3333FF"><B>Borrower
                                         or Deal Name </B></FONT><B>___________________________________________________________________</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
<B>E-mail this document with your commitment letter to: __<U>Renee Marion</U>___________________________________</B></FONT></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">E-mail address of recipient: ____<U>renee.marion@baml.com</U>_____________________________________</P>






<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #3333FF"><B>2. Legal Name of Lender of Record for
Signature Page</B></FONT>: _________________________________________________________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left; padding-left: 10pt">Markit Entity Identifier (MEI) #&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" NOWRAP STYLE="vertical-align: middle; text-align: left; padding-left: 10pt">Fund Manager Name (if applicable)&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="padding-left: 10pt">Legal Address from Tax Document of Lender of Record:</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; width: 5%; padding-left: 10pt">Country&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 16%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 79%; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; padding-left: 10pt">Address&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
</TABLE>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 7%; padding-left: 10pt">City&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 28%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 11%">State/Province</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 32%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 6%">Country</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 16%; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>


<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #3333FF"><B></B></FONT></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="5" STYLE="color: #3333FF; font-weight: bold; vertical-align: middle; text-align: left">3.&nbsp;&nbsp;Domestic Funding Address:</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="color: #3333FF; font-weight: bold; vertical-align: middle; text-align: left">4. Eurodollar Funding Address:</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Street Address&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Street Address&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" NOWRAP STYLE="vertical-align: middle; text-align: left">Suite/ Mail Code</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="vertical-align: middle; text-align: left">Suite/ Mail Code&nbsp;&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle; width: 3%">City&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 6%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 12%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 6%">State&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 17%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; width: 4%">City</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 9%; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 7%">State&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 29%; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Postal Code</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;Country</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Postal Code</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Country</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1.1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #3333FF"><B></B></FONT></P>

<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><B>5. Credit Contact Information:</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>Syndicate level
information (which may contain material non-public information about the Borrower and its related parties or their respective
securities will be made available to the Credit Contact(s).&nbsp; The Credit Contacts identified must be able to receive such
information in accordance with his/her institution's compliance procedures and applicable laws, including Federal and State securities
laws.</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="2" STYLE="color: red; font-weight: bold; vertical-align: middle">Primary Credit Contact:</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="width: 13%">First Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; width: 87%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Middle Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Last Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Street Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Suite/Mail Code</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>City</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>State</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Postal Code</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Country</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Office Telephone #</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Office Facsimile #</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD NOWRAP>Work E-Mail Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 148 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: middle; width: 13%">IntraLinks/SyndTrak</TD>
    <TD STYLE="vertical-align: bottom; width: 87%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>E-Mail Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="color: red; font-weight: bold; vertical-align: middle">Secondary Credit Contact:</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>First Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Middle Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Last Name</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Street Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Suite/Mail Code</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>City</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>State</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Postal Code</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Country</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Office Telephone #</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>Office Facsimile #</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD NOWRAP>Work E-Mail Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: middle">IntraLinks/SyndTrak</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>E-Mail Address</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>


<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="4" STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle; text-align: left">Primary Operations Contact:</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle; text-align: left">Secondary Operations Contact:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">First</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">MI __</TD>
    <TD STYLE="width: 8%">Last</TD>
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">First</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">MI __</TD>
    <TD STYLE="width: 8%">Last</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Street Address</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">Street Address</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 15%">Suite/Mail Code</TD>
    <TD STYLE="font-size: 10pt; width: 38%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 12%">Suite/Mail Code</TD>
    <TD STYLE="font-size: 10pt; width: 35%; border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">City</TD>
    <TD STYLE="width: 19%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">State</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">City</TD>
    <TD STYLE="width: 19%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">State</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 8%">Postal Code</TD>
    <TD STYLE="font-size: 10pt; width: 16%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 8%">Country</TD>
    <TD STYLE="font-size: 10pt; width: 21%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 10%">Postal Code</TD>
    <TD STYLE="font-size: 10pt; width: 15%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 8%">Country</TD>
    <TD STYLE="font-size: 10pt; width: 14%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 8%"><FONT STYLE="font-size: 10pt">Telephone</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 9%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 8%"><FONT STYLE="font-size: 10pt">Facsimilie</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 28%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 9%"><FONT STYLE="font-size: 10pt">Telephone</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 13%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 7%"><FONT STYLE="font-size: 10pt">Facsimilie</FONT></TD>
    <TD STYLE="width: 18%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 13%">E-Mail Address</TD>
    <TD STYLE="font-size: 10pt; width: 40%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 14%">E-Mail Address</TD>
    <TD STYLE="font-size: 10pt; width: 33%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt">IntraLinks/SyndTrak E-Mail</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">IntraLinks/SyndTrak E-Mail</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 7%">Address</TD>
    <TD STYLE="font-size: 10pt; width: 49%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 7%">Address</TD>
    <TD STYLE="font-size: 10pt; width: 37%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: red"><B><I>Does Secondary Operations Contact
need copy of notices? </I></B></FONT>___YES ___ NO&#9;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>


<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="4" STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle; text-align: left">Letter of Credit Contact:&#9;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle; text-align: left">Draft
    Documentation Contact or Legal Counsel:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">First</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">MI __</TD>
    <TD STYLE="width: 8%">Last</TD>
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">First</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%">MI __</TD>
    <TD STYLE="width: 8%">Last</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>Title</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Street Address</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">Street Address</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 149 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 15%">Suite/Mail Code</TD>
    <TD STYLE="font-size: 10pt; width: 38%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 12%">Suite/Mail Code</TD>
    <TD STYLE="font-size: 10pt; width: 35%; border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">City</TD>
    <TD STYLE="width: 19%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">State</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">City</TD>
    <TD STYLE="width: 19%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 6%">State</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 8%">Postal Code</TD>
    <TD STYLE="font-size: 10pt; width: 16%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 8%">Country</TD>
    <TD STYLE="font-size: 10pt; width: 21%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 10%">Postal Code</TD>
    <TD STYLE="font-size: 10pt; width: 15%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 8%">Country</TD>
    <TD STYLE="font-size: 10pt; width: 14%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 8%"><FONT STYLE="font-size: 10pt">Telephone</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 9%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 8%"><FONT STYLE="font-size: 10pt">Facsimilie</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 28%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 9%"><FONT STYLE="font-size: 10pt">Telephone</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 13%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 7%"><FONT STYLE="font-size: 10pt">Facsimilie</FONT></TD>
    <TD STYLE="width: 18%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 13%">E-Mail Address</TD>
    <TD STYLE="font-size: 10pt; width: 40%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 14%">E-Mail Address</TD>
    <TD STYLE="font-size: 10pt; width: 33%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><B>6. Lender&rsquo;s Fed Wire Payment Instructions:</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Pay to:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Bank Name</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 24%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>ABA #</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>City</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>State</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Account #</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD NOWRAP>Account Name</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Attention</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><B>7. Lender&rsquo;s Standby Letter of Credit, Commercial
Letter of Credit, and Bankers&rsquo; Acceptance Fed Wire Payment Instructions (if applicable): </B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Pay to:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Bank Name</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 24%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 150 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 8%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 24%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>ABA #</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>City</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>State</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Account #</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD NOWRAP>Account Name</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Attention</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 80pt">Can the Lender&rsquo;s Fed Wire Payment Instructions in Section 6 be used? ___YES ___
NO</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 80pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 80pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 80pt">&nbsp;</P>



<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B></B></P>

<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><B>8. Lender&rsquo;s Organizational Structure and Tax
Status</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>Please refer to the enclosed withholding tax instructions below
and then complete this section accordingly:</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B></B></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="5" STYLE="vertical-align: middle; text-align: left">Lender Taxpayer Identification Number (TIN):</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 0.5pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 0.5pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; width: 9%">&nbsp;-</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; width: 9%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; width: 12%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt; width: 14%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt; width: 12%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; width: 13%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 41.2pt 0pt 0">Tax Withholding Form Delivered to Bank of America (check
applicable one):</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 41.2pt 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="font-weight: bold; vertical-align: bottom; border-bottom: Black 0.5pt solid; width: 8%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; width: 12%">W-9</TD>
    <TD STYLE="font-weight: bold; vertical-align: bottom; border-bottom: Black 0.5pt solid; width: 8%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: bottom; width: 12%">W-8BEN</TD>
    <TD STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle; border-bottom: Black 0.5pt solid; width: 9%"><U>&nbsp;</U></TD>
    <TD STYLE="font-weight: bold; vertical-align: bottom; width: 12%">W-8ECI</TD>
    <TD STYLE="font-weight: bold; vertical-align: bottom; border-bottom: Black 0.5pt solid; width: 8%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: left; width: 12%">W-8EXP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: bottom; border-bottom: Black 0.5pt solid; width: 8%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; width: 11%">W-8IMY</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 41.2pt 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 41.2pt 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B><U>Tax Contact:</U>&#9; </B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">First <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U> MI __Last ______________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Title <U>&#9; &#9; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Street Address <U>&#9; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Suite/ Mail Code &#9;___________________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">City _____________ State &#9;______________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Postal Code Country ________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Telephone ___________ Facsimile ____________</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">E-Mail Address <U>&#9; &#9; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>NON&ndash;U.S. LENDER INSTITUTIONS</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 151 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: blue">1. Corporations:</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">If your institution is incorporated outside of the United States for
U.S. federal income tax purposes, and is the beneficial owner of the interest and other income it receives, you must complete one
of the following three tax forms, as applicable to your institution: a.) Form W-8BEN (Certificate of Foreign Status of Beneficial
Owner), b.) Form W-8ECI (Income Effectively Connected to a U.S. Trade or Business), or c.) Form W-8EXP (Certificate of Foreign
Government or Governmental Agency).</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">A U.S. taxpayer identification number is required for any institution
submitting a Form W-8 ECI. It is also required on Form W-8BEN for certain institutions claiming the benefits of a tax treaty with
the U.S. Please refer to the instructions when completing the form applicable to your institution. In addition, please be advised
that U.S. tax regulations do not permit the acceptance of faxed forms. <B>An original tax form must be submitted.</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: blue">2. Flow-Through Entities</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">If your institution is organized outside the U.S., and is classified
for U.S. federal income tax purposes as either a Partnership, Trust, Qualified or Non-Qualified Intermediary, or other non-U.S.
flow-through entity, an original Form</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">W-8IMY (Certificate of Foreign Intermediary, Foreign Flow-Through Entity,
or Certain U.S. branches for United States Tax Withholding) must be completed by the intermediary together with a withholding statement.
Flow-through entities other than Qualified Intermediaries are required to include tax forms for each of the underlying beneficial
owners.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Please refer to the instructions when completing this form. In addition,
please be advised that U.S. tax regulations do not permit the acceptance of faxed forms. <B>Original tax form(s) must be submitted</B>.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B>U.S. LENDER INSTITUTIONS:</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">If your institution is incorporated or organized within the United
States, you must complete and return Form W-9 (Request for Taxpayer Identification Number and Certification). <B>Please be advised
that we require an original form W-9</B>.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0"><B><I>Pursuant to the language contained in the tax section of the
Credit Agreement, the applicable tax form for your institution must be completed and returned on or prior to the date on which
your institution becomes a lender under this Credit Agreement. Failure to provide the proper tax form when requested will subject
your institution to U.S. tax withholding.</I></B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<HR SIZE="2" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><B>9. Bank of America&rsquo;s Payment Instructions:</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><I>&nbsp;</I></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="width: 9%">Pay to:</TD>
    <TD STYLE="width: 91%">Bank of America, N.A.</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">ABA # 026009593</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">New York, NY</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Account #</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Attn: Corporate Credit Services&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">Ref:&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><I></I></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0; color: #3333FF"><I>&nbsp;</I>&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 152 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT F</I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">[FORM OF] AUTHORIZATION TO SHARE
INSURANCE</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left">TO:</TD><TD STYLE="text-align: justify">Insurance Agent</TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in">RE:</TD><TD STYLE="text-align: justify">Third Amended and Restated Credit Agreement, dated as of April [__], 2017, by and among Harvard
Bioscience, Inc., a Delaware corporation, the Lenders from time to time party thereto, and Bank of America, N.A., as Agent (as
amended, modified, extended, restated, replaced, or supplemented from time to time, the &ldquo;<U>Credit Agreement</U>&rdquo;;
capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Credit Agreement)</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left">DATE:</TD><TD STYLE="text-align: justify">[Date]</TD>
</TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; width: 25%">Grantor:</TD>
    <TD STYLE="width: 75%">[Insert Applicable Loan Party Name] (the &ldquo;<U>Grantor</U>&rdquo;)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline">Administrative Agent:</TD>
    <TD>Bank of America, N.A., as Administrative Agent for the Secured Parties, I.S.A.O.A., A.T.I.M.A. * (the &ldquo;<U>Administrative
    Agent</U>&rdquo;)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Attn:&nbsp;&nbsp;MAC Legal Collateral Administration</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Mail Code CA4-702-02-25</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>2001 Clayton Road, 2nd Floor</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Concord, CA 94520</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline">Policy Number:</TD>
    <TD>[Insert Applicable Policy Number]</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline">Insurance Company/Agent:</TD>
    <TD>[Insert Applicable Insurance Company/Agent] (the &ldquo;<U>Insurance Agent</U>&rdquo;)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline">Insurance Company Address:</TD>
    <TD>[Insert Insurance Company&rsquo;s Address]</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-decoration: underline">Insurance Company Telephone No.:</TD>
    <TD>[Insert Insurance Company&rsquo;s Telephone No.]</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline">Insurance Company Fax No.:</TD>
    <TD>[Insert Insurance Company&rsquo;s Fax No.]</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Grantor hereby authorizes the Insurance
Agent to send evidence of all insurance to the Agent, as may be requested by the Agent, together with requested insurance policies,
certificates of insurance, declarations and endorsements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">_______________________________________</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">* <FONT STYLE="font-size: 10pt">I.S.A.O.A. stands for &ldquo;its successors and/or assigns.&rdquo; A.T.I.M.A.
stands for &ldquo;as their interest may appear.&rdquo;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 153 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Delivery of an executed counterpart of a signature
page of this Certificate by fax transmission or other electronic mail transmission (e.g. &ldquo;pdf&rdquo; or &ldquo;tif&rdquo;)
shall be effective as delivery of a manually executed counterpart of this Certificate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 154 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left"><FONT STYLE="text-transform: uppercase">[GRANTOR NAME],</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">a [Jurisdiction and Type of Organization]</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 20%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Name:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">Title:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 155 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0"><I>EXHIBIT G-1 </I></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>[Form
of] U.S. TAX COMPLIANCE CERTIFICATE</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">(For Foreign Lenders That Are Not Partnerships
For U.S. Federal Income Tax Purposes)</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is hereby made to the Third Amended
and Restated Credit Agreement dated as of April [__], 2017 (as amended, supplemented or otherwise modified from time to time, the
&ldquo;<U>Credit Agreement</U>&rdquo;), among Harvard Bioscience, Inc<B>.</B>, a Delaware corporation (&ldquo;the <U>Borrower</U>&rdquo;),
the Lenders from time to time party thereto, and Bank of America, N.A., as administrative agent (the &ldquo;<U>Administrative Agent</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Pursuant to the provisions of <U>Section 3.01(c)</U>
of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record and beneficial owner of the Loan(s) (as
well as any Note(s) evidencing such Loan(s)) in respect of which it is providing this certificate, (ii) it is not a bank within
the meaning of Section 881(c)(3)(A) of the Code, (iii) it is not a ten percent shareholder of the Borrower within the meaning of
Section 871(h)(3)(B) of the Code and (iv) it is not a controlled foreign corporation related to the Borrower as described in Section
881(c)(3)(C) of the Code.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned has furnished the Administrative
Agent and the Borrower with a certificate of its non-U.S. Person status on IRS Form W-8BENE (or W-8BEN, as applicable). By executing
this certificate, the undersigned agrees that (1) if the information provided on this certificate changes, the undersigned shall
promptly so inform the Borrower and the Administrative Agent, and (2) the undersigned shall have at all times furnished the Borrower
and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which
each payment is to be made to the undersigned, or in either of the two calendar years preceding such payments.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise defined herein, terms defined
in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify"><B>[NAME OF LENDER]</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">By:&nbsp;&nbsp;_______________________&#9;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 97%; text-indent: 0in; text-align: justify">Name:&nbsp;&nbsp;________________________</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">Title:&nbsp;&nbsp;________________________</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Date: ________ __, 20<B>[ ]</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 156 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B><I>EXHIBIT G-2</I></B></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>[Form
of] U.S. TAX COMPLIANCE CERTIFICATE</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">(For Foreign Participants That Are Not Partnerships
For U.S. Federal Income Tax Purposes)</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is hereby made to the Third Amended
and Restated Credit Agreement dated as of April [__], 2017 (as amended, supplemented or otherwise modified from time to time, the
&ldquo;<U>Credit Agreement</U>&rdquo;), among Harvard Bioscience, Inc., a Delaware corporation (&ldquo;the <U>Borrower</U>&rdquo;),
the Lenders from time to time party thereto, and Bank of America, N.A., as administrative agent (the &ldquo;<U>Administrative Agent</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Pursuant to the provisions of <U>Section 3.01(c)</U>
of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record and beneficial owner of the participation
in respect of which it is providing this certificate, (ii) it is not a bank within the meaning of Section 881(c)(3)(A) of the Code,
(iii) it is not a ten percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code, and (iv) it is
not a controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of the Code.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned has furnished its participating
Lender with a certificate of its non-U.S. Person status on IRS Form W-8BENE (or W-8BEN, as applicable). By executing this certificate,
the undersigned agrees that (1) if the information provided on this certificate changes, the undersigned shall promptly so inform
such Lender in writing, and (2) the undersigned shall have at all times furnished such Lender with a properly completed and currently
effective certificate in either the calendar year in which each payment is to be made to the undersigned, or in either of the two
calendar years preceding such payments.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise defined herein, terms defined
in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify"><B>[NAME OF PARTICIPANT]</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">By:&nbsp;&nbsp;_______________________&#9;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 97%; text-indent: 0in; text-align: justify">Name:&nbsp;&nbsp;________________________</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">Title:&nbsp;&nbsp;________________________</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Date: ________ __, 20<B>[ ]</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 157 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B><I>EXHIBIT G-3</I></B></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>[Form
of] U.S. TAX COMPLIANCE CERTIFICATE</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">(For Foreign Participants That Are Partnerships
For U.S. Federal Income Tax Purposes)</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is hereby made to the Third Amended
and Restated Credit Agreement dated as of April [__], 2017 (as amended, supplemented or otherwise modified from time to time, the
&ldquo;<U>Credit Agreement</U>&rdquo;), among Harvard Bioscience, Inc., a Delaware corporation (&ldquo;the <U>Borrower</U>&rdquo;),
the Lenders from time to time party thereto, and Bank of America, N.A., as administrative agent (the &ldquo;<U>Administrative Agent</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Pursuant to the provisions of <U>Section 3.01(c)</U>
of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record owner of the participation in respect
of which it is providing this certificate, (ii) its direct or indirect partners/members are the sole beneficial owners of such
participation, (iii) with respect such participation, neither the undersigned nor any of its direct or indirect partners/members
is a bank extending credit pursuant to a loan agreement entered into in the ordinary course of its trade or business within the
meaning of Section 881(c)(3)(A) of the Code, (iv) none of its direct or indirect partners/members is a ten percent shareholder
of the Borrower within the meaning of Section 871(h)(3)(B) of the Code and (v) none of its direct or indirect partners/members
is a controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of the Code.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned has furnished its participating
Lender with IRS Form W-8IMY accompanied by one of the following forms from each of its partners/members that is claiming the portfolio
interest exemption: (i) an IRS Form W-8BENE (or W-8BEN, as applicable) or (ii) an IRS Form W-8IMY accompanied by an IRS Form W-8BENE
(or W-8BEN, as applicable) from each of such partner&rsquo;s/member&rsquo;s beneficial owners that is claiming the portfolio interest
exemption. By executing this certificate, the undersigned agrees that (1) if the information provided on this certificate changes,
the undersigned shall promptly so inform such Lender and (2) the undersigned shall have at all times furnished such Lender with
a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the
undersigned, or in either of the two calendar years preceding such payments.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise defined herein, terms defined
in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify"><B>[NAME OF PARTICIPANT]</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">By:&nbsp;&nbsp;_______________________&#9;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 97%; text-indent: 0in; text-align: justify">Name:&nbsp;&nbsp;________________________</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">Title:&nbsp;&nbsp;________________________</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Date: ________ __, 20<B>[ ]</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 158 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B><I>EXHIBIT G-4</I></B></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>[FORM
OF] U.S. TAX COMPLIANCE CERTIFICATE</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">(For Foreign Lenders That Are Partnerships For
U.S. Federal Income Tax Purposes)</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Reference is hereby made to the Third Amended
and Restated Credit Agreement dated as of April [__], 2017 (as amended, supplemented or otherwise modified from time to time, the
&ldquo;<U>Credit Agreement</U>&rdquo;), among Harvard Bioscience, Inc<B>.</B>, a Delaware corporation (&ldquo;the <U>Borrower</U>&rdquo;),
the Lenders from time to time party thereto, and Bank of America, N.A., as administrative agent (the &ldquo;<U>Administrative Agent</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Pursuant to the provisions of <U>Section 3.01(c)</U>
of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record owner of the Loan(s) (as well as any Note(s)
evidencing such Loan(s)) in respect of which it is providing this certificate, (ii) its direct or indirect partners/members are
the sole beneficial owners of such Loan(s) (as well as any Note(s) evidencing such Loan(s)), (iii) with respect to the extension
of credit pursuant to this Credit Agreement or any other Loan Document, neither the undersigned nor any of its direct or indirect
partners/members is a bank extending credit pursuant to a loan agreement entered into in the ordinary course of its trade or business
within the meaning of Section 881(c)(3)(A) of the Code, (iv) none of its direct or indirect partners/members is a ten percent shareholder
of the Borrower within the meaning of Section 871(h)(3)(B) of the Code and (v) none of its direct or indirect partners/members
is a controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of the Code.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The undersigned has furnished the Administrative
Agent and the Borrower with IRS Form W-8IMY accompanied by one of the following forms from each of its partners/members that is
claiming the portfolio interest exemption: (i) an IRS Form W-8BENE (or W-8BEN, as applicable) or (ii) an IRS Form W-8IMY accompanied
by an IRS Form W-8BENE (or W-8BEN, as applicable) from each of such partner&rsquo;s/member&rsquo;s beneficial owners that is claiming
the portfolio interest exemption. By executing this certificate, the undersigned agrees that (1) if the information provided on
this certificate changes, the undersigned shall promptly so inform the Borrower and the Administrative Agent, and (2) the undersigned
shall have at all times furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate
in either the calendar year in which each payment is to be made to the undersigned, or in either of the two calendar years preceding
such payments.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise defined herein, terms defined
in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify"><B>[NAME OF LENDER]</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">By:&nbsp;&nbsp;_______________________&#9;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 97%; text-indent: 0in; text-align: justify">Name:&nbsp;&nbsp;________________________</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">Title:&nbsp;&nbsp;________________________</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Date: ________ __, 20<B>[ ]</B></P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exh_311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT&nbsp;31.1 </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Certification</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">I, Robert E. Gagnon, certify that:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">1. I have reviewed this Quarterly Report on Form 10-Q of Harvard Bioscience, Inc.;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">a. Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">b. Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">c. Evaluated the effectiveness of the registrant&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">d. Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">a. All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">b. Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Date: May 5, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ ROBERT E. GAGNON</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Robert E. Gagnon</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exh_312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT&nbsp;31.2 </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Certification </B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">I, Jeffrey A. Duchemin, certify that:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">1. I have reviewed this Quarterly Report on Form 10-Q of Harvard Bioscience, Inc.;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">a. Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">b. Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">c. Evaluated the effectiveness of the registrant&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">d. Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">a. All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">b. Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 175.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 175.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Date: May 5, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ JEFFREY A. DUCHEMIN</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"> Jeffrey A. Duchemin </FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 175.5pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exh_321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT&nbsp;32.1 </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>CERTIFICATION OF PERIODIC FINANCIAL REPORT </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>PURSUANT TO 18 U.S.C. SECTION&nbsp;1350</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The undersigned officer of Harvard Bioscience, Inc. (the &ldquo;Company&rdquo;)
hereby certifies to his knowledge that the Company&rsquo;s Quarterly Report on Form 10-Q for the quarterly period ended March 31,
2017 (the &ldquo;Report&rdquo;) to which this certification is being furnished as an exhibit, as filed with the Securities and
Exchange Commission on the date hereof, fully complies with the requirements of Section&nbsp;13(a) or 15(d), as applicable, of
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and that the information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company. This certification
is provided solely pursuant to 18 U.S.C. Section&nbsp;1350 and Item&nbsp;601(b)(32) of Regulation S-K (&ldquo;Item 601(b)(32)&rdquo;)
promulgated under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and the Exchange Act. In accordance
with clause (ii)&nbsp;of Item&nbsp;601(b)(32), this certification (A)&nbsp;shall not be deemed &ldquo;filed&rdquo; for purposes
of Section&nbsp;18 of the Exchange Act, or otherwise subject to the liability of that section, and (B)&nbsp;shall not be deemed
to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Date: May 5, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ ROBERT E. GAGNON</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Robert E. Gagnon</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>exh_322.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT&nbsp;32.2 </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>CERTIFICATION OF PERIODIC FINANCIAL REPORT </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>PURSUANT TO 18 U.S.C. SECTION&nbsp;1350</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">The undersigned officer of Harvard Bioscience, Inc. (the &ldquo;Company&rdquo;)
hereby certifies to his knowledge that the Company&rsquo;s Quarterly Report on Form 10-Q for the quarterly period ended March 31,
2017 (the &ldquo;Report&rdquo;) to which this certification is being furnished as an exhibit, as filed with the Securities and
Exchange Commission on the date hereof, fully complies with the requirements of Section&nbsp;13(a) or 15(d), as applicable, of
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and that the information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company. This certification
is provided solely pursuant to 18 U.S.C. Section&nbsp;1350 and Item&nbsp;601(b)(32) of Regulation S-K (&ldquo;Item 601(b)(32)&rdquo;)
promulgated under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and the Exchange Act. In accordance
with clause (ii)&nbsp;of Item&nbsp;601(b)(32), this certification (A)&nbsp;shall not be deemed &ldquo;filed&rdquo; for purposes
of Section&nbsp;18 of the Exchange Act, or otherwise subject to the liability of that section, and (B)&nbsp;shall not be deemed
to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.</P>

<P STYLE="font-size: 10pt; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Date: May 5, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.1pt solid">/s/ JEFFREY A. DUCHEMIN</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Jeffrey A. Duchemin </FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer </FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>hbio-20170331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6-->
<!-- XBRL 2.1 & Dimensional Validation Status: Passed -->
<!-- XSD Content Model Validation Status: Passed -->
<!-- CDM/Internal Validation Status: Passed -->
<!-- EFM Validation Status: Not Performed -->
<!-- Formula Linkbase Validation Status: Not Performed -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:hbio="http://www.harvardbioscience.com/20170331" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xsi:schemaLocation="http://www.harvardbioscience.com/20170331 hbio-20170331.xsd http://www.xbrl.org/dtr/type/non-numeric http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd http://www.xbrl.org/dtr/type/numeric http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd http://www.xbrl.org/2009/role/negated http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd http://fasb.org/us-gaap/2016-01-31 http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd http://www.xbrl.org/2006/ref http://www.xbrl.org/2006/ref-2006-02-27.xsd http://fasb.org/us-types/2016-01-31 http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd http://fasb.org/us-roles/2016-01-31 http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd http://xbrl.sec.gov/country/2016-01-31 http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd">
  <link:schemaRef xlink:href="hbio-20170331.xsd" xlink:type="simple"></link:schemaRef>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Aug07_2009_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-08-07</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar29_2013_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-03-28</xbrli:startDate>
      <xbrli:endDate>2013-03-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-03-28</xbrli:startDate>
      <xbrli:endDate>2013-03-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-03-28</xbrli:startDate>
      <xbrli:endDate>2013-03-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Aug06_2009_TO_Aug07_2009_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-08-06</xbrli:startDate>
      <xbrli:endDate>2009-08-07</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct30_2013_TO_Oct31_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-10-30</xbrli:startDate>
      <xbrli:endDate>2013-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct30_2013_TO_Oct31_2013_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-10-30</xbrli:startDate>
      <xbrli:endDate>2013-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jun05_2013_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Nov30_2013_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_May02_2017_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-05-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_AutomobilesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Dec31_2016_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2015_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2016_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_AutomobilesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Apr03_2015_Entity_0001123494">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-04-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-04-23</xbrli:startDate>
      <xbrli:endDate>2015-04-24</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-04-23</xbrli:startDate>
      <xbrli:endDate>2015-04-24</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">hbio:DelayedDrawdownTermLoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-04-23</xbrli:startDate>
      <xbrli:endDate>2015-04-24</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hbio:MarketConditionRestrictedStockUnitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hbio:MarketConditionRestrictedStockUnitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hbio:MarketConditionRestrictedStockUnitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_MultiChannelSystemsMcsGmbhMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hbio:MultiChannelSystemsMcsGmbhMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_TriangleBiosystemsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hbio:TriangleBiosystemsIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_MultiChannelSystemsMcsGmbhMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hbio:MultiChannelSystemsMcsGmbhMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_TriangleBiosystemsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hbio:TriangleBiosystemsIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-05-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-01</xbrli:startDate>
      <xbrli:endDate>2017-05-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-01</xbrli:startDate>
      <xbrli:endDate>2017-05-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="hbio:CreditAgreementAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-05-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_May02_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-05-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_May01_2017_TO_May02_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-01</xbrli:startDate>
      <xbrli:endDate>2017-05-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="myUSDPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="ID_0" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod id="ID_1" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">152212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice id="ID_2" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ID_3" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">3968897</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 id="ID_4" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.94</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="ID_5" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">2.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ID_6" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">1262583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="ID_7" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">251570</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ID_8" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="ID_9" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">4190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="ID_10" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_11" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">2.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <hbio:LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold id="ID_12" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">6000000</hbio:LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold>
  <hbio:LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold id="ID_13" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">10000000</hbio:LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold>
  <hbio:PreviousApprovedCreditFacility id="ID_14" contextRef="AS_OF_Aug07_2009_Entity_0001123494" unitRef="USD" decimals="-5">20000000</hbio:PreviousApprovedCreditFacility>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="ID_15" contextRef="AS_OF_Mar29_2013_Entity_0001123494" unitRef="USD" decimals="-5">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <hbio:DdtlThresholdForDollarForDollarReductionInRevolvingLine id="ID_16" contextRef="AS_OF_Mar29_2013_Entity_0001123494" unitRef="USD" decimals="-5">10000000</hbio:DdtlThresholdForDollarForDollarReductionInRevolvingLine>
  <us-gaap:SecuredDebt id="ID_17" contextRef="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-5">15000000</us-gaap:SecuredDebt>
  <us-gaap:SecuredDebt id="ID_18" contextRef="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="USD" decimals="-5">25000000</us-gaap:SecuredDebt>
  <us-gaap:SecuredDebt id="ID_19" contextRef="AS_OF_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="USD" decimals="-5">15000000</us-gaap:SecuredDebt>
  <hbio:Maturitydates id="ID_20" contextRef="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">2018-03-29</hbio:Maturitydates>
  <hbio:Maturitydates id="ID_21" contextRef="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">2018-03-29</hbio:Maturitydates>
  <hbio:Maturitydates id="ID_22" contextRef="FROM_Mar28_2013_TO_Mar29_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember">2018-03-29</hbio:Maturitydates>
  <hbio:InterestRateInExcessOfLiborOnCreditFacility id="ID_23" contextRef="FROM_Aug06_2009_TO_Aug07_2009_Entity_0001123494" unitRef="pure" decimals="2">0.03</hbio:InterestRateInExcessOfLiborOnCreditFacility>
  <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd id="ID_24" contextRef="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="4">0.0396</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
  <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd id="ID_25" contextRef="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="pure" decimals="4">0.0383</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
  <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd id="ID_26" contextRef="AS_OF_Mar31_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="pure" decimals="4">0.0323</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity id="ID_27" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">5200000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod id="ID_28" contextRef="FROM_Oct30_2013_TO_Oct31_2013_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="USD" decimals="-5">10000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
  <hbio:TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity id="ID_29" contextRef="FROM_Oct30_2013_TO_Oct31_2013_Entity_0001123494" unitRef="USD" decimals="-5">5000000</hbio:TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity>
  <us-gaap:DerivativeAssetNotionalAmount id="ID_30" contextRef="AS_OF_Jun05_2013_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-5">15000000</us-gaap:DerivativeAssetNotionalAmount>
  <us-gaap:DerivativeAssetNotionalAmount id="ID_31" contextRef="AS_OF_Nov30_2013_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="USD" decimals="-5">5000000</us-gaap:DerivativeAssetNotionalAmount>
  <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred id="ID_32" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">7000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
  <hbio:LiborFixedRate id="ID_33" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="4">0.0096</hbio:LiborFixedRate>
  <hbio:LiborFixedRate id="ID_34" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="pure" decimals="4">0.0093</hbio:LiborFixedRate>
  <hbio:DerivativeInterestRateSwapEffectivePercentage id="ID_35" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="2">1</hbio:DerivativeInterestRateSwapEffectivePercentage>
  <us-gaap:Assets id="ID_36" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">107765000</us-gaap:Assets>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="ID_37" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1209000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:OtherAssetsCurrent id="ID_38" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4175000</us-gaap:OtherAssetsCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent id="ID_39" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1157000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent id="ID_40" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">611000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="ID_41" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="ID_42" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">80000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="ID_43" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">42186827</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="ID_44" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">34441320</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:TreasuryStockShares id="ID_45" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">7745507</us-gaap:TreasuryStockShares>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_46" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="ID_47" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:AssetsCurrent id="ID_48" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">45472000</us-gaap:AssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent id="ID_49" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">128000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:SecuredDebtCurrent id="ID_50" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">2372000</us-gaap:SecuredDebtCurrent>
  <us-gaap:DeferredRevenueCurrent id="ID_51" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">500000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:AccruedIncomeTaxesCurrent id="ID_52" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">223000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="ID_53" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4550000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="ID_54" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">760000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="ID_55" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">14601000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtNoncurrent id="ID_56" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">11374000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent id="ID_57" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">6417000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:OtherAccruedLiabilitiesNoncurrent id="ID_58" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">3177000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="ID_59" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">35569000</us-gaap:Liabilities>
  <us-gaap:PreferredStockValue id="ID_60" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue id="ID_61" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">418000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_62" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">215134000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_63" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-116030000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TreasuryStockCarryingBasis id="ID_64" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">10668000</us-gaap:TreasuryStockCarryingBasis>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_65" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">107765000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:OtherAssetsCurrent id="ID_66" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4761000</us-gaap:OtherAssetsCurrent>
  <us-gaap:AssetsCurrent id="ID_67" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">45121000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_68" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4268000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DeferredTaxAssetsNetNoncurrent id="ID_69" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1179000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="ID_70" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1216000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:OtherAssetsNoncurrent id="ID_71" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">144000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets id="ID_72" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">107396000</us-gaap:Assets>
  <us-gaap:DeferredRevenueCurrent id="ID_73" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">598000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:AccruedIncomeTaxesCurrent id="ID_74" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">99000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="ID_75" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4324000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="ID_76" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">478000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="ID_77" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">14056000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtNoncurrent id="ID_78" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">10931000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent id="ID_79" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">6460000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:OtherAccruedLiabilitiesNoncurrent id="ID_80" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">3234000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="ID_81" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">34681000</us-gaap:Liabilities>
  <us-gaap:PreferredStockValue id="ID_82" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue id="ID_83" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">418000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_84" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">215842000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_85" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-117168000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TreasuryStockCarryingBasis id="ID_86" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">10668000</us-gaap:TreasuryStockCarryingBasis>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_87" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">107396000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent id="ID_88" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">559000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:CommonStockSharesIssued id="ID_89" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">42364404</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="ID_90" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">34618897</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SecuredDebt id="ID_91" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">13746000</us-gaap:SecuredDebt>
  <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral id="ID_92" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">7000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
  <invest:DerivativeNotionalAmount id="ID_93" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">5500000</invest:DerivativeNotionalAmount>
  <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral id="ID_94" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
  <us-gaap:DerivativeLiabilities id="ID_95" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="ID_96" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">7000</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="ID_97" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="ID_98" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="ID_99" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="ID_100" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">0</us-gaap:DerivativeLiabilities>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_101" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">5596000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_102" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4599000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:StockholdersEquity id="ID_103" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">72196000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="ID_104" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">72715000</us-gaap:StockholdersEquity>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_105" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-3">-14200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_106" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-3">-13258000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <dei:TradingSymbol id="ID_107" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">HBIO</dei:TradingSymbol>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_108" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4296000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PreferredStockSharesAuthorized id="ID_109" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="ID_110" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">80000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:TreasuryStockShares id="ID_111" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">7745507</us-gaap:TreasuryStockShares>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="ID_112" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_113" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <dei:EntityCommonStockSharesOutstanding id="ID_114" contextRef="AS_OF_May02_2017_Entity_0001123494" unitRef="shares" decimals="INF">34618897</dei:EntityCommonStockSharesOutstanding>
  <dei:DocumentType id="ID_115" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">10-Q</dei:DocumentType>
  <dei:DocumentFiscalYearFocus id="ID_116" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">2017</dei:DocumentFiscalYearFocus>
  <dei:EntityCurrentReportingStatus id="ID_117" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory id="ID_118" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="ID_119" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">HARVARD BIOSCIENCE INC</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers id="ID_120" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer id="ID_121" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">No</dei:EntityWellKnownSeasonedIssuer>
  <us-gaap:SellingAndMarketingExpense id="ID_122" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">5048000</us-gaap:SellingAndMarketingExpense>
  <us-gaap:SellingAndMarketingExpense id="ID_123" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">5102000</us-gaap:SellingAndMarketingExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="ID_124" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">5206000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="ID_125" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">5948000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ID_126" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1285000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ID_127" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1425000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RestructuringCharges id="ID_128" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges id="ID_129" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">11000</us-gaap:RestructuringCharges>
  <us-gaap:AmortizationOfIntangibleAssets id="ID_130" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">599000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="ID_131" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">680000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="ID_132" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-143000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="ID_133" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-9000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:InterestExpense id="ID_134" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">162000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="ID_135" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">164000</us-gaap:InterestExpense>
  <us-gaap:OtherInterestAndDividendIncome id="ID_136" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:OtherInterestAndDividendIncome>
  <us-gaap:OtherInterestAndDividendIncome id="ID_137" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1000</us-gaap:OtherInterestAndDividendIncome>
  <us-gaap:OtherNonoperatingIncomeExpense id="ID_138" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-99000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="ID_139" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-50000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:StockOptionPlanExpense id="ID_140" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">863000</us-gaap:StockOptionPlanExpense>
  <us-gaap:Depreciation id="ID_141" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">306000</us-gaap:Depreciation>
  <hbio:AmortizationOfCatalogCosts id="ID_142" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">9000</hbio:AmortizationOfCatalogCosts>
  <us-gaap:ProvisionForDoubtfulAccounts id="ID_143" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-15000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:AmortizationOfFinancingCosts id="ID_144" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">19000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_145" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="ID_146" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-410000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInInventories id="ID_147" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">300000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="ID_148" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">526000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsPayableTrade id="ID_149" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-320000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_150" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-110000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="ID_151" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-571000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="ID_152" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">92000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="ID_153" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_154" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-610000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PropertyPlantAndEquipmentAdditions id="ID_155" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">198000</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_156" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">228000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfSecuredDebt id="ID_157" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_158" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1113000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_159" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-155000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_160" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-268000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_161" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">109000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_162" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-997000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:InterestPaid id="ID_163" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">164000</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid id="ID_164" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">333000</us-gaap:IncomeTaxesPaid>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock id="ID_165" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:center;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;HARVARD BIOSCIENCE, INC. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:center;margin-top:4.5pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;1.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:27pt;' &gt;Basis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' &gt;The unaudited consolidated financial statements of Harvard Bioscience, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Inc. and its wholly-owned subsidiaries (collectively, &amp;#8220;Harvard Bioscience&amp;#8221; or the &amp;#8220;Company&amp;#8221;) as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; have been prepared by the Company pursuant to the rules &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) have been cond&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ensed or omitted pursuant to such rules and regulations. The December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. However, the Company believes tha&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;t the disclosures are adequate to make the information presented not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&amp;#8217;s Annu&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;al Report on Form 10-K for the fiscal year ended December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, which was filed with the SEC on &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 17, 2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' &gt;In the opinion of management, all adjustments, which include normal recurring adjustments necessary to present a fair statement o&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;f financial position as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, results of operations and comprehensive loss &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;and cash flows for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, a&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s applicable, have been made. The results of o&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;perations for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; are not necessarily indicative of the operating results for the full fiscal year or any future periods.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:27pt;' &gt;Summary of Significant Accounting Policies&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' &gt;The accounting policies underlying the accompanying unaudited consolidated financial statements are those set forth in Note 2 to the consolidated financial statements included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, which was filed with the SEC on March 17, 2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock id="ID_166" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Foreign currency&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Derivatives&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;translation  &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;qualifying as&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Defined benefit&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:middle;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;hedges&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;pension plans&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance at December 31,  2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(14,200)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,458)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(16,658)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:25.5pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other comprehensive income before reclassifications&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;942&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;946&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Amounts reclassified from AOCI&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other comprehensive income &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;942&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;949&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(13,258)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,458)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(15,709)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock id="ID_167" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Weighted &lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Life&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt; (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='11' rowspan='1' style='width:247.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:247.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Amortizable intangible assets:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Existing technology&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;15,287&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(12,020)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;15,082&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(11,710)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;6.8&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Trade names&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,436&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3,617)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,379&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3,479)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7.8&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Distribution agreements/customer relationships&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;23,136&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(13,228)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;22,976&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(12,862)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8.7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Patents&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;207&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(131)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;204&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(119)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.9&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total amortizable intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;46,066&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(28,996)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;45,641&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(28,170)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Indefinite-lived intangible assets:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,398&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,032&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other indefinite-lived intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,216&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,209&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total goodwill and other indefinite-lived intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;39,614&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;39,241&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total intangible assets, gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;85,680&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;84,882&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td colspan='15' rowspan='1' style='width:496.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:496.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(a) Weighted average life as of March 31, 2017.&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfGoodwillTextBlock id="ID_168" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,032&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Effect of change in currency translation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;366&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,398&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock id="ID_169" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:153pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Finished goods&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,686&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,340&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Work in process&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;900&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;823&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Raw materials&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,696&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,792&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;20,282&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;19,955&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:InventoryFinishedGoods id="ID_170" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">9686000</us-gaap:InventoryFinishedGoods>
  <us-gaap:InventoryWorkInProcess id="ID_171" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">900000</us-gaap:InventoryWorkInProcess>
  <us-gaap:InventoryRawMaterials id="ID_172" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">9696000</us-gaap:InventoryRawMaterials>
  <hbio:ScheduleOfPropertyPlantAndEquipmentTableTextBlock id="ID_173" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:150pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:150pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Land, buildings and leasehold improvements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2,117&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,395&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,224&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Computer equipment and software&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,345&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,115&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,284&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,274&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Automobiles&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;201&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;196&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;19,342&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;18,904&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Less: accumulated depreciation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(15,074)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(14,608)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Property, plant and equipment, net&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,268&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,296&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hbio:ScheduleOfPropertyPlantAndEquipmentTableTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_174" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">19342000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="ID_175" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">15074000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_176" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember" unitRef="USD" decimals="-3">2117000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_177" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="-3">7395000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_178" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">8345000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_179" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="-3">1284000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_180" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">201000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="ID_181" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;7&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Related Party Transactions&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' &gt;As part of the acquisitions of Multi Channel Systems MCS GmbH (MCS)&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and Triangle BioSystems, Inc. (TBSI) in 2014, the Company signed lease agreements with the former owners of the acquired companies.  The principals of such former owners of MCS and TBSI were employees of the Com&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;pany&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Pursuant to a lease agreement&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the Company incurred rent &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;expense of approximately $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;58&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; thousand to the former owners of MCS for&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; both&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; T&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;he Company incurr&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ed rent &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;expense of approximately $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;11&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; thousand to the former owner of TBSI for both&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock id="ID_182" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Beginning&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Additions/&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Ending&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Payments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;(Credits)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='10' rowspan='1' style='width:246pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:246pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:6.75pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Year ended December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;147&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(97)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;143&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;193&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:6.45pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Three months ended March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;193&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;206&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="ID_183" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Operating &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Leases&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,610&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,618&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2020&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2021&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,098&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2022&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,098&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Thereafter&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,836&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net minimum lease payments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,681&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="ID_184" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1610000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="ID_185" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1618000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="ID_186" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1421000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="ID_187" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1098000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="ID_188" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1098000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="ID_189" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">1836000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="ID_190" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">8681000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <hbio:ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock id="ID_191" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock Options&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Restricted Stock Units&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:144pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:144pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Market Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Weighted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Restricted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Market&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Options&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Exercise &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock Units&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Grant Date&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Grant Date&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt; Price&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,096,818&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.94&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,072,653&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.15&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;182,150&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4.81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;30,000&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.25&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;445,690&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2.83&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Exercised&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(5,709)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2.56&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Vested (RSUs)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(251,570)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.28&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Cancelled / forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(152,212)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.68&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(4,190)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.05&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3,968,897&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.94&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,262,583&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.01&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;182,150&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4.81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hbio:ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock>
  <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock id="ID_192" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:129.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:129.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Basic &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,579,473&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,013,352&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,579,473&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,013,352&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ID_193" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Cost of revenues&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Sales and marketing&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;133&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;General and administrative&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;622&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Research and development&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;20&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;863&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock id="ID_194" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:138pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:138pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Long-term debt:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Term loan&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,062&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,400&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     DDTL&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,125&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,400&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Revolving line&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,550&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,050&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Total unamortized deferred financing costs&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(84)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(104)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total debt&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13,653&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13,746&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Less: current installments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,800)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,450)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Current unamortized deferred financing costs&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;78&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;78&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;10,931&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;11,374&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock id="ID_195" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Notional Amount&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:27pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives designated as hedging instruments under ASC 815&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance sheet classification&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other liabilities-non current&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,500&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Notional Amount&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:27pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives designated as hedging instruments under ASC 815&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance sheet classification&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other liabilities-non current&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,500&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='8' rowspan='1' style='width:530.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:530.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(a) See Note 14 for the fair value measurements related to these financial instruments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
  <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock id="ID_196" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:55.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives in Hedging Relationships&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Amount of gain (loss) recognized in OCI on derivative (effective portion) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:31.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(36)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="ID_197" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Fair Value as of March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 1&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 2&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swap agreements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Fair Value as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 1&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 2&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swap agreements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="ID_198" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">2400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="ID_199" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">2300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="ID_200" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">2100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour id="ID_201" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">2100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive id="ID_202" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">2100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <dei:CurrentFiscalYearEndDate id="ID_203" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax id="ID_204" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">942000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax id="ID_205" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">616000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="ID_206" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="ID_207" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-36000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax id="ID_208" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-3000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax id="ID_209" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-13000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ID_210" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-117000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ID_211" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-43000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_212" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember" unitRef="USD" decimals="-3">-131000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <hbio:TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill id="ID_213" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">39614000</hbio:TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill>
  <hbio:TotalIntangibleAssets id="ID_214" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">85680000</hbio:TotalIntangibleAssets>
  <us-gaap:DefinedBenefitPlanInterestCost id="ID_215" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">125000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets id="ID_216" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">159000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses id="ID_217" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-87000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost id="ID_218" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">53000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:StandardProductWarrantyAccrual id="ID_219" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">206000</us-gaap:StandardProductWarrantyAccrual>
  <us-gaap:StandardProductWarrantyAccrual id="ID_220" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">193000</us-gaap:StandardProductWarrantyAccrual>
  <us-gaap:StandardProductWarrantyAccrualPayments id="ID_221" contextRef="FROM_Jan01_2016_TO_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">97000</us-gaap:StandardProductWarrantyAccrualPayments>
  <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued id="ID_222" contextRef="FROM_Jan01_2016_TO_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">143000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_223" contextRef="AS_OF_Dec31_2015_Entity_0001123494" unitRef="USD" decimals="-3">6744000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_224" contextRef="AS_OF_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4175000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dei:EntityCentralIndexKey id="ID_225" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">0001123494</dei:EntityCentralIndexKey>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="ID_226" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-3">942000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ID_227" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-3">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="ID_228" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-3">942000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ID_229" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-3000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:SecuredDebt id="ID_230" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">13653000</us-gaap:SecuredDebt>
  <invest:DerivativeNotionalAmount id="ID_231" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">4500000</invest:DerivativeNotionalAmount>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_232" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">18904000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="ID_233" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">14608000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_234" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember" unitRef="USD" decimals="-3">2095000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_235" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="-3">7224000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_236" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">8115000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_237" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="-3">1274000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="ID_238" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">196000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:InventoryFinishedGoods id="ID_239" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">9340000</us-gaap:InventoryFinishedGoods>
  <us-gaap:InventoryWorkInProcess id="ID_240" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">823000</us-gaap:InventoryWorkInProcess>
  <us-gaap:InventoryRawMaterials id="ID_241" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">9792000</us-gaap:InventoryRawMaterials>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_242" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">46066000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_243" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-28996000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_244" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="USD" decimals="-3">15287000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_245" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="USD" decimals="-3">-12020000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_246" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" unitRef="USD" decimals="-3">7436000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_247" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">23136000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_248" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember" unitRef="USD" decimals="-3">207000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_249" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" unitRef="USD" decimals="-3">-3617000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_250" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">-13228000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_251" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember" unitRef="USD" decimals="-3">-119000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <hbio:TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill id="ID_252" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">39241000</hbio:TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill>
  <hbio:TotalIntangibleAssets id="ID_253" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">84882000</hbio:TotalIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="ID_254" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">P6Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="ID_255" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">P7Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="ID_256" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">P8Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="ID_257" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember">P1Y10M25D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:StandardProductWarrantyAccrual id="ID_258" contextRef="AS_OF_Dec31_2015_Entity_0001123494" unitRef="USD" decimals="-3">147000</us-gaap:StandardProductWarrantyAccrual>
  <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock id="ID_259" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Components of net periodic benefit cost:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest cost&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;125&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;168&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(159)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(181)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net amortization loss&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;87&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net periodic benefit cost&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;53&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;67&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="ID_260" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">445690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="ID_261" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">34579473</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="ID_262" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="shares" decimals="INF">34013352</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="ID_263" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="ID_264" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="shares" decimals="INF">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="ID_265" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">34579473</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="ID_266" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="shares" decimals="INF">34013352</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <hbio:IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan id="ID_267" contextRef="AS_OF_Apr03_2015_Entity_0001123494" unitRef="shares" decimals="INF">2500000</hbio:IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="ID_268" contextRef="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="pure" decimals="4">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="ID_269" contextRef="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="4">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="ID_270" contextRef="FROM_Apr23_2015_TO_Apr24_2015_Entity_0001123494_hbio_CreditAgreementAxis_hbio_DelayedDrawdownTermLoanMember" unitRef="pure" decimals="4">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="ID_271" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="ID_272" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ID_273" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="shares" decimals="INF">182150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ID_274" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="myUSDPerShare" decimals="2">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ID_275" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="myUSDPerShare" decimals="2">4.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="ID_276" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:165pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:165pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:79.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:79.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:80.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:80.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Volatility&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;41.07&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;40.26&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.89&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.48&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Expected holding period (in years)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5.20&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;years&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5.36&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_277" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">45641000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_278" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-28170000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_279" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="USD" decimals="-3">15082000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_280" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="USD" decimals="-3">-11710000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_281" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" unitRef="USD" decimals="-3">7379000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_282" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">22976000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="ID_283" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember" unitRef="USD" decimals="-3">204000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_284" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" unitRef="USD" decimals="-3">-3479000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="ID_285" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">-12862000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ID_286" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">4096818</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ID_287" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="shares" decimals="INF">1072653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ID_288" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ID_289" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="shares" decimals="INF">182150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ID_290" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="myUSDPerShare" decimals="2">4.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="ID_291" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="ID_292" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_AwardTypeAxis_hbio_MarketConditionRestrictedStockUnitMember" unitRef="myUSDPerShare" decimals="2">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted id="ID_293" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Recently Issued Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' &gt;&amp;#8220;Revenue from Contracts with Customers,&amp;#8221;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in th&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;e United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or servi&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ces. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactio&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ns that could have implications to the timing of revenue recognition under the new guidance. The Company expects this undertaking will be complete in the second half of 2017.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;In February 2016, the FASB issued ASU 2016-02, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' &gt;Leases&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, which is intended to impr&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ove financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12&amp;#160;months. The update is effective for fiscal year&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s beginning after December 15, 2018. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;The Company is evaluating the requirements of this guidance and has not yet determined the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabili&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;ties will increase upon adoption for right-of-use assets and lease liabilities. The Company&amp;#8217;s future commitments under lease obligations are summarized in Note 10.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;In March 2016, the FASB issued ASU 2016-09,&amp;#160;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Compensation &amp;#8211; Stock Compensation (Topic 718): &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' &gt;Improvements to Employee Share-Based Payment Accounting&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, which simplifies the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity o&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;r liabilities and classification on the statement of cash flows. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The standard requires an entity to recognize all excess tax benefits and tax deficiencies as income tax benefit or expense in the income statement as discrete items in the reporting period &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;in which they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&amp;#8217;s annual effective tax rate, applied on a prospective basis. Further, the standard eliminates the requirement to defer the recognition of excess t&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ax benefits until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with any valuation allowance, should be recognized on a modified retrospective basis as a cumulative adjustment to retain&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ed earnings as of the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;date of adoption. Under ASU &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016-09, an entity that applies the treasury stock method in calculating diluted earnings per share is required to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; such amounts are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner as other cash flows related to income taxes on the statement of cash flows, as such excess tax benefits no longer&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; represent financing activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods presented. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;The Company adopted ASU 2016-09 as of January 1, 2017. The Company  recorded a cumulative&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred tax assets related to the prior years&amp;#8217; unrecognized excess tax benefits. An equal amount of valuation allowance was also &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in a net impact of $0. In addition, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;tax deficiencies related to vested restricted stock units and canceled stock options during the first quarter&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of 2017 have been recognized in the current period&amp;#8217;s income statement.  &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;ASU &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016-09 also allows an entity to elect as an accounting policy either to continue to estimate the total number of awards for which the requisite service period will not be rende&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;red or to account for forfeitures for service based awards as they occur. An entity that elects to account for forfeitures as they occur should apply the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earn&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ings as of the date of adoption. The Company elected as an accounting policy to account for forfeitures for service based awards as they &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;occur, and as a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; with a corresponding increase in additional paid in capital related to the prior years&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;&amp;#8217; stock-based compensation expense&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; as required under the modified retrospective approach. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; The tax effect of this adjustment, which included the impact of a valuation al&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;lowance was immaterial. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
  <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock id="ID_294" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:39pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Details about AOCI Components&lt;/font&gt;&lt;/td&gt;&lt;td colspan='6' rowspan='1' style='width:118.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Amount reclassified from AOCI into income (effective portion)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Location of amount&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:40.2pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;reclassified from AOCI&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;into income (effective portion)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='6' rowspan='1' style='width:118.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest expense&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="ID_295" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;15.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Income Tax &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;Income tax was an expense of approximately $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;23&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; thousand and $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;0.2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; million for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;, respectively. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;The tax expense for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; reflects the expense recorded for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;associated with the actual results for the three-month period, as described below.  &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;Discrete items included in the tax expense for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; included changes to reserves for unc&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;ertain tax positions and t&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;ax deficiencies related to stock-based compensation. Tax expense for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; included foreign currency gains and losses and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;the tax impact of the&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;amortiza&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;tion of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;certain &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;indefinite-lived intangible assets&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; which are amortized for tax purposes only, against which a valuation allowance is not established&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;background-color:#FFFF00;margin-left:24.5pt;color:#000000;' &gt;   &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;The effective income tax rate was &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2.2%)&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;, compared with &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(43.6%)&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; for the same period in &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;.  The tax rates for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; were based on actual results for the three-month period rather than an effective tax rate estimated fo&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;r the entire year.  &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;In 2017 and 2016 t&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;he Company determined that using a year-to-date approach resulted in a better estimate of income tax expense&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;/benefit&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; based on its forecast of pre-tax income&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;/loss&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;, the mix of&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; taxable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; income&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;/loss&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; across several jurisdict&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;ions with different statutory tax rates, and the impact of the full valuation allowance against U.S. deferred tax assets.        &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;The difference between the Company&amp;#8217;s effective tax rate period over period was primarily attributable to &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;higher pre-tax incom&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;e&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; at certain individual subsidiaries&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; in 2016 versus 2017,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; despite an overall pre-tax loss in both periods. In addition, both periods included the tax impact of amortization of certain indefinite-lived intangibles which are amortized for tax purposes only, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;against which a valuation allowance is not established.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:StandardProductWarrantyAccrualPayments id="ID_296" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">3000</us-gaap:StandardProductWarrantyAccrualPayments>
  <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued id="ID_297" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">16000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:DefinedBenefitPlanInterestCost id="ID_298" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">168000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets id="ID_299" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">181000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses id="ID_300" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-80000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost id="ID_301" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">67000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear id="ID_302" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">500000</us-gaap:DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer id="ID_303" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-5">200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer id="ID_304" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent id="ID_305" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">3200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent id="ID_306" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-5">3000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_307" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">5413630</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_308" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="shares" decimals="INF">5461017</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="ID_309" contextRef="AS_OF_Apr03_2015_Entity_0001123494" unitRef="shares" decimals="INF">17508929</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <hbio:WeightedAverageEstimatedBlackScholesValueOfOptionGrants id="ID_310" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">1.27</hbio:WeightedAverageEstimatedBlackScholesValueOfOptionGrants>
  <hbio:WeightedAverageEstimatedBlackScholesValueOfOptionGrants id="ID_311" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">1.11</hbio:WeightedAverageEstimatedBlackScholesValueOfOptionGrants>
  <us-gaap:DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion id="ID_312" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">4000</us-gaap:DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion>
  <us-gaap:DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion id="ID_313" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">-36000</us-gaap:DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion>
  <dei:DocumentPeriodEndDate id="ID_314" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">2017-03-31</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag id="ID_315" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">false</dei:AmendmentFlag>
  <dei:DocumentFiscalPeriodFocus id="ID_316" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">Q1</dei:DocumentFiscalPeriodFocus>
  <hbio:EstimatedRentalExpensesCurrentYear id="ID_317" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="INF">1700000</hbio:EstimatedRentalExpensesCurrentYear>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_318" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-5">500000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_319" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">400000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_320" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_MultiChannelSystemsMcsGmbhMember" unitRef="USD" decimals="-3">58000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_321" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_TriangleBiosystemsIncMember" unitRef="USD" decimals="-3">11000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_322" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_MultiChannelSystemsMcsGmbhMember" unitRef="USD" decimals="-3">58000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="ID_323" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_BusinessAcquisitionAxis_hbio_TriangleBiosystemsIncMember" unitRef="USD" decimals="-3">11000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="ID_324" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="pure" decimals="3">-0.436</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="ID_325" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="3">-0.022</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <hbio:MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed id="ID_326" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="2">0.5</hbio:MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed>
  <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion id="ID_327" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">3000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
  <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion id="ID_328" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_InterestRateSwapMember" unitRef="USD" decimals="-3">13000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="ID_329" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="4">0.4107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="ID_330" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="4">0.0189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="ID_331" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="pure" decimals="4">0.4026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="ID_332" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="pure" decimals="4">0.0148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ID_333" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="4">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ID_334" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="pure" decimals="4">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="ID_335" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="ID_336" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494">P5Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensation id="ID_337" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">863000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_338" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="USD" decimals="-3">13000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_339" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">29000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_340" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-3">133000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_341" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">688000</us-gaap:ShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="ID_342" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">-5709</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <hbio:PercentageOfOutstandingCommonStock id="ID_343" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="pure" decimals="2">0.2</hbio:PercentageOfOutstandingCommonStock>
  <hbio:EmployeeStockPurchasePlanSharesAuthorized id="ID_344" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">750000</hbio:EmployeeStockPurchasePlanSharesAuthorized>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="ID_345" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="shares" decimals="INF">725239</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <hbio:AdditionsToCatalogCosts id="ID_346" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">30000</hbio:AdditionsToCatalogCosts>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="ID_347" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 id="ID_348" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">3.94</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:Revenues id="ID_349" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">24156000</us-gaap:Revenues>
  <us-gaap:CostOfGoodsAndServicesSold id="ID_350" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">12657000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:GrossProfit id="ID_351" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">11499000</us-gaap:GrossProfit>
  <us-gaap:OperatingExpenses id="ID_352" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">12138000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="ID_353" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-639000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense id="ID_354" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-404000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_355" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-1043000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_356" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">23000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss id="ID_357" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-1066000</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareDiluted id="ID_358" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">-0.03</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareBasic id="ID_359" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">-0.03</us-gaap:EarningsPerShareBasic>
  <us-gaap:Revenues id="ID_360" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">26963000</us-gaap:Revenues>
  <us-gaap:CostOfGoodsAndServicesSold id="ID_361" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">14018000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:GrossProfit id="ID_362" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">12945000</us-gaap:GrossProfit>
  <us-gaap:OperatingExpenses id="ID_363" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">13166000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="ID_364" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-221000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense id="ID_365" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-222000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_366" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-443000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_367" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">193000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss id="ID_368" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-636000</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareDiluted id="ID_369" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">-0.02</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareBasic id="ID_370" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="myUSDPerShare" decimals="2">-0.02</us-gaap:EarningsPerShareBasic>
  <us-gaap:ComprehensiveIncomeNoteTextBlock id="ID_371" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;3.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Accumulated Other Comprehensive Loss&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Changes in each component of accumulated other comprehensive loss, net of tax are as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Foreign currency&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Derivatives&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;translation  &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;qualifying as&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Defined benefit&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:middle;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;hedges&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;pension plans&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance at December 31,  2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(14,200)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,458)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(16,658)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:25.5pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other comprehensive income before reclassifications&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;942&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;946&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Amounts reclassified from AOCI&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other comprehensive income &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;942&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;949&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:82.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(13,258)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,458)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(15,709)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <us-gaap:InventoryDisclosureTextBlock id="ID_372" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;5&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Inventories&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Inventories consist of the following:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:153pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Finished goods&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,686&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,340&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Work in process&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;900&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;823&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Raw materials&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,696&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;9,792&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;20,282&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;19,955&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:StockOptionPlanExpense id="ID_373" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">754000</us-gaap:StockOptionPlanExpense>
  <us-gaap:Depreciation id="ID_374" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">385000</us-gaap:Depreciation>
  <hbio:AmortizationOfCatalogCosts id="ID_375" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">3000</hbio:AmortizationOfCatalogCosts>
  <us-gaap:ProvisionForDoubtfulAccounts id="ID_376" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">37000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:AmortizationOfFinancingCosts id="ID_377" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">28000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_378" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="ID_379" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">463000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInInventories id="ID_380" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-211000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="ID_381" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">463000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsPayableTrade id="ID_382" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-2679000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_383" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-77000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="ID_384" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1481000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="ID_385" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">32000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="ID_386" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-23000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_387" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-726000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PropertyPlantAndEquipmentAdditions id="ID_388" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">201000</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_389" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">205000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfSecuredDebt id="ID_390" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">1000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_391" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">2613000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_392" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-113000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_393" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-1726000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_394" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">88000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_395" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-2569000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:InterestPaid id="ID_396" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">194000</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid id="ID_397" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">171000</us-gaap:IncomeTaxesPaid>
  <hbio:AdditionsToCatalogCosts id="ID_398" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4000</hbio:AdditionsToCatalogCosts>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="ID_399" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;6&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Property&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;, Plant and Equipment&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Calibri;font-size:11pt;margin-left:0pt;' &gt;	&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, p&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;roperty, plant and equipment &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;consist of the following:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:150pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:150pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Land, buildings and leasehold improvements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2,117&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,395&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,224&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Computer equipment and software&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,345&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,115&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,284&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,274&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Automobiles&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;201&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;196&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;19,342&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;18,904&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Less: accumulated depreciation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(15,074)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(14,608)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Property, plant and equipment, net&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,268&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,296&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:ProductWarrantyDisclosureTextBlock id="ID_400" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;8&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Warranties&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Warranties are estimated and accrued at the time revenues are recorded.  &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;A rollforward of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;the Company&amp;#8217;s product warranty accrual&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; is as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Beginning&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Additions/&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Ending&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Payments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;(Credits)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='10' rowspan='1' style='width:246pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:246pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:6.75pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Year ended December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;147&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(97)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;143&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;193&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:6.45pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Three months ended March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;193&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;206&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
  <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock id="ID_401" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;10&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Leases &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company has noncancelable operating leases for office and warehouse space expiring at various dates through &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2022 and&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; thereafter. Rent expense, which is recorded on a straight-line basis, is estimated to &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;be &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;$&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;1.7&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; for the year&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; ended &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.  Rent expense was approximately $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.4&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million and $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.5&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Future minimum lease payments for operating leases, with initial or r&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;emaining terms in excess of one year at &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;are as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Operating &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Leases&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,610&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,618&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2020&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2021&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,098&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2022&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,098&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Thereafter&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,836&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net minimum lease payments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:67.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8,681&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock id="ID_402" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;9&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Employee Benefit Plans &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;One&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;the Company&amp;#8217;s &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;subs&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;idiaries in the United Kingdom, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;or UK, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Biochrom Limited, maintain&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;contributory, defined benefit &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;pension plans for substantially all of its&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; employees. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;As of June 30, 2014, these defined benefit pension plans wer&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;e&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; closed to new employees,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; as well as closed to the future accrual of benefits for existing employees. The components of the Company&amp;#8217;s defined benefit pension expense were as follows:&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:109.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Components of net periodic benefit cost:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest cost&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;125&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;168&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(159)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(181)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net amortization loss&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;87&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Net periodic benefit cost&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;53&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;67&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;For &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the Company contributed $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;&amp;#160;million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; for both periods&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; to its defined benefit pension plans. The Company expects to contribute &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;approximately &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;$&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.5&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;to its defined benefit pension plans during the remainder of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;T&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;he Company had an underfunded pension liability of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;approximately $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;3.2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;$&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;3.0&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;a&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;in&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;cluded in the other &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;long term &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;liabilities line item in the consolidated balance&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; sheets&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock id="ID_403" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;11&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Capital Stock &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Common Stock &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;On February&amp;#160;5, 2008, the Company&amp;#8217;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; Board of Directors adopted a Shareholder Rights Plan and declared a dividend distribution of one preferred stock purchase right for each outstanding share of the Company&amp;#8217;s common stock to shareholders of record as of the close of business on February&amp;#160;6, 2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;008. Initially, these rights will not be exercisable and will trade with the shares of the Company&amp;#8217;s common stock. Under the Shareholder Rights Plan, the rights generally will become exercisable if a person becomes a&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;n &amp;#8220;acquiring person&amp;#8221; by acquiring 20% or&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; more of the common stock of the Company or if a person commences a tender offer that could result in that person owning 20% or more of the common stock of the Company. If a person becomes an acquiring person, each holder of a right (other than the acquiri&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ng person) would be entitled to purchase, at the then-current exercise price, such number of shares of preferred stock which are equivalent to shares of the Company&amp;#8217;s common stock having a value of twice the exercise price of the right.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Unless the Board of Directors elects to extend such plan, the Shareholder Rights Plan will expire in February 2018.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; If the Company is a&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;cquired in a merger or other business combination transaction after any such event, each holder of a right would then be entitled to purchase, at the then-current exercise price, shares of the acquiring company&amp;#8217;s common stock having a value of twice the ex&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ercise price of the right.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Preferred Stock&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; Company&amp;#8217;s Board of Directors &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;has the authority to issue up to 5.0 million shares of preferred stock and to determine the price privileges and other terms of the shares. The Board of Directors may exercise th&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;is authority without any further approval of stockholders. As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the Company had no preferred stock issued or outstanding&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Employee Stock Purchase Plan (as amended, the &amp;#8220;ESPP&amp;#8221;)&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;In 2000, the Company approved &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;the ESPP&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. Under thi&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ESPP&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, participating employees can authorize the Company to withhold a portion of their base pay during consecutive six-month payment periods for the purchase of shares of the Company&amp;#8217;s common stock. At the conclusion of the period, participating employee&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s can purchase shares of the Company&amp;#8217;s common stock at 85% of the lower of the fair market value of the Company&amp;#8217;s common stock at the beginning or end of the period. Shares are iss&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ued under the ESPP for the six-month periods ending June&amp;#160;30 and December&amp;#160;31.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; Under this plan, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;750,000&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; shares of common stock are authorized for issuance of which &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;725,239&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; shares were issue&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;d as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;There were no shares issued under the ESPP during the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:27pt;' &gt;Stock Option and Equity Incentive Plans&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Third Amended and Restated 2000 Stock Option and Incentive Plan (as amended, the &amp;#8220;Third A&amp;amp;R Plan&amp;#8221;)&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Second Amendment to the Third A&amp;amp;R Plan (the &amp;#8220;Amendment&amp;#8221;) was adopted by the Board of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Directors on April&amp;#160;3, 2015. Such Amendment was approved by the stockholders at the Company&amp;#8217;s 2015 Annual Meeting&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of Stockholders&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.  Pursuant to the Amendment, the aggregate number of shares authorized for issuance under the Third A&amp;amp;R Plan was increased by 2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;,500,000 shares to 17,508,929.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Restricted Stock Units with a Market Condition (the &amp;#8220;Market Condition RSU&amp;#8217;s&amp;#8221;)&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;On August 3, 2015, the Compensation Committee of the Board of Directors of the Company approved and granted deferred stock awards of Market Condi&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;tion RSU&amp;#8217;s to certain members of the Company&amp;#8217;s management team under the Third A&amp;amp;R Plan.  The vesting of these Market Condition RSU&amp;#8217;s is cliff-based and linked to the achievement of a relative total shareholder return of the Company&amp;#8217;s common stock from Aug&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ust 3, 2015 to the earlier of (i) August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average price before each such date). As &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, t&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;he target number of thes&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;e restricted stock units that may be earned is 182,150 shares; the maximum amount is 150% of the target number.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Stock-Based Payment Awards&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' &gt;The Company accounts for stock-based payment awards in accordance with the provisions of FASB ASC 718, which requir&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;es it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, Market Condition RSU&amp;#8217;s and employee stock purchases related to the&amp;#160;ESPP.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;color:#000000;' &gt;The Company adopted ASU 20&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;16-09 as of January 1, 2017. As disclosed in footnote 2, as a result of this adoption, the Company has elected as an accounting policy to account for forfeitures for service based awards as they occur, with no adjustment for estimated forfeitures. The Comp&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;any recognized as of January 1, 2017, a cumulative effect adjustment of $0.1 million to reduce retained earnings as required under the modified retrospective approach. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' &gt;Stock option and restricted stock unit activity under the Company&amp;#8217;s Third A&amp;amp;R Plan for&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; was as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock Options&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Restricted Stock Units&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:144pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:144pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Market Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Weighted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Restricted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Market&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Options&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Exercise &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Stock Units&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Grant Date&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Grant Date&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt; Price&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,096,818&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.94&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,072,653&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.15&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;182,150&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4.81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;30,000&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.25&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;445,690&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2.83&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Exercised&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(5,709)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;2.56&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Vested (RSUs)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(251,570)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.28&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Cancelled / forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(152,212)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.68&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(4,190)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.05&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3,968,897&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.94&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,262,583&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3.01&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:78pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;182,150&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4.81&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;weighted average fair value of the options granted under the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Third A&amp;amp;R&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; Plan during the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; was $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;1.27&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;1.11&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;The following assumptions were used to esti&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;mate the fair value&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, using the Black-Scholes option pricing model,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of stock options granted during the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:165pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:165pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:79.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:79.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:80.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:80.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Volatility&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;41.07&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;40.26&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.89&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.48&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Expected holding period (in years)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5.20&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;years&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5.36&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&lt;td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company used historical volatility to calculate the expected volatility &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;for each grant as of the grant date&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Historical volatility was determined by calculating the mean reversion of the daily adjusted closing stock price. The risk-free interest rate &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;assumption is based upon observed U.S. Treasury bill interest rates (risk-free) appropriate for the term of the Company&amp;#8217;s stock options and Market Condition RSU&amp;#8217;s. The expected holding period of stock options represents the period of time options are expec&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ted to be outstanding and is based on historical experience. The vesting period ranges from one to four years and the contractual life is ten years. The correlation coefficient, used to value the Market Condition RSU&amp;#8217;s, represents the way in which entities&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; move in relation to the Russell 3000 index as a whole.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Stock-&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;based c&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;om&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;pensation expense related to&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; stock options, restricted stock units&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, Market Condition RSU&amp;#8217;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ESPP&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; was alloca&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ted as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Cost of revenues&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Sales and marketing&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;133&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;101&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;General and administrative&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;622&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Research and development&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;20&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;863&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company did not capitalize any stock-based compensation.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Earnings per share&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Basic earnings per share is based upon net income divided by the number of&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; weighted average common shares outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options, restricted stock units and Market Condition RSU&amp;#8217;s into common stock using the treasury method. The weighted av&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;erage number of shares used to compute basic and diluted earnings per share consists of the following:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:129.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:129.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:9.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Basic &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,579,473&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,013,352&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU&amp;#39;s&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,579,473&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;34,013,352&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Excluded from the shares used in calculating the diluted earnings per common share in the above table are options, restricted stock units and Market Condition RSU&amp;#8217;s of approximately &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;5,413,630&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;5,461,017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; shares of common stock for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively, as the impact of these shares would be ant&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;i&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-dilutive.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
  <us-gaap:LongTermDebtTextBlock id="ID_404" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;12.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;Long Term Debt&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;On August&amp;#160;7, 2009, the Company entered into an Amended and Restated Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&amp;#160;&amp;amp;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; Co as lenders (as amended, the &amp;#8220;2009 Credit Agreement&amp;#8221;). On March 29, 2013, the Company entered into a Second Amended and Restated Revolving Credit Agreement (as amended, the &amp;#8220;2013 Credit Agreement&amp;#8221;) with Bank of America, as agent, and Bank of America and&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; Brown Brothers Harriman&amp;#160;&amp;amp; Co, as lenders that amended and restated the 2009 Credit Agreement. Between September 2011 and March 2016, the Company entered into a series of amendments that among other things did the following:&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on September 30, 2011, red&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;uced interest rates to the London Interbank Offered Rate plus 3.0%;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on March 29, 2013, converted existing loan advances into a term loan in the principal amount of $15.0 million (the &amp;#8220;2013 Term Loan&amp;#8221;), provided a revolving credit facility in the maxim&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;um principal amount of $25.0 million (the &amp;#8220;2013 Revolving Line&amp;#8221;) and a delayed draw term loan (the &amp;#8220;2013 DDTL&amp;#8221;) of up to $15.0 million (all with a maturity date of March 29, 2018);&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on October 31, 2013, reduced the 2013 DDTL from up to $15.0 million to&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; up to $10.0 million;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on April 24, 2015, extended the maturity date of the 2013 Revolving Line to March 29, 2018 and reduced the interest rates on the 2013 Revolving Line, 2013 Term Loan and 2013 DDTL;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on June 30, 2015, amended our quarterly mini&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;mum fixed charge coverage financial covenant; and&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' &gt;&amp;#61623;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' &gt;on March 9, 2016, amended the principal payment amortization of the 2013 Term Loan and 2013 DDTL to five years, as well as amended our quarterly minimum fixed charge coverage financial covenant.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The maximum amount available under the 2013 Credit Agreement is $50.0 million as borrowings against the 2013 DDTL in excess of $10.0 million results in a dollar for dollar reduction in the 2013 Revolving Line capacity. The 2013 Revolving Line, 2013 Term Lo&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;an and 2013 DDTL each have a maturity date of March&amp;#160;29, 2018. Borrowings under the 2013 Term Loan and the 2013 DDTL accrue interest at a rate based on either the effective London Interbank Offered Rate (LIBOR) for certain interest periods selected by the C&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ompany, or a daily floating rate based on the British Bankers&amp;#8217; Association (BBA) LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the 2013 Revolv&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ing Line accrues interest at a rate based on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%. The Company was required to fix the rate &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;of interest on at least 50% of the 2013 Term Loan and the 2013 DDTL through the purchase of interest rate swaps.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;The loans evidenced by the 2013 Credit Agreement, or the 2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Loans, are guaranteed by all of the Company&amp;#8217;s direct and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and the guarantors.&amp;#160;The 2013 Loans are subject to restrictive covenants under the 2013 Credit Agreement, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the 2013 Loans is all&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;owed by the 2013 Credit Agreement at any time during the terms of the 2013 Loans. The 2013 Loans also contain limitations on the Company&amp;#8217;s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory n&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;otes and/or other consideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the C&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ompany had net borrowings of $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;13.7&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;respectively, outstanding under its &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Credit Agreement. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;T&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;he &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;carrying value of the debt approximates fair value because the interest rate under the obligation approximates market rates of interest available to the Company for similar&amp;#160;instruments.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the Company was in compliance with all financial covenants contained in the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Credit A&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;greement,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; was subject to &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;covenant and w&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;orking capital borrowing restriction&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and had &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;available borrowing capacity&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; under its &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Credit &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Agre&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ement &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;of $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;5.2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;    &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the weighted effective interest rates&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, net of the impact of the Company&amp;#8217;s interest rate swaps, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;on &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;its 2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Term Loan, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;DDTL and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2013 &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Revolving Line borrowings were &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;3.96%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;3.83%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;3.23%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, the Company&amp;#8217;s borrowings were comprised of:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='3' rowspan='1' style='width:138pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:138pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Long-term debt:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Term loan&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,062&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,400&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     DDTL&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,125&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,400&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Revolving line&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,550&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,050&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Total unamortized deferred financing costs&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(84)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(104)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total debt&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13,653&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13,746&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Less: current installments&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,800)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(2,450)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;     Current unamortized deferred financing costs&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;78&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;78&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;10,931&lt;/font&gt;&lt;/td&gt;&lt;td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;11,374&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;On May 2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, 2017, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;the Company entered into a Third Amended and Restated Revolving Credit Agreement (as amended, the &amp;#8220;Credit Agreement&amp;#8221;) with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&amp;#160;&amp;amp;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; Co, as lenders that amended and restated the 2013 Credit Agreement. As a result of the Credit Agreement, the amounts outstanding under the 2013 Credit Agreement with maturities subsequent to March 31, 2018 are classified as long term. The Credit Agreement&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt; was entered into to, among other things, consolidate, combine and restate the outstanding indebtedness, on the date of the Credit Agreement, into a Term Loan in the principal amount of $14.0 million, and also provide for a $25.0 million revolving line of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;credit (the &amp;#8220;Revolving Line&amp;#8221;).  The Term Loan and the Revolving Line each have a maturity date of May 1, 2022.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Borrowings under the Term Loan accrue interest at a rate based on either the effective &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;LIBOR&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; for certain interest periods selected by the Company&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, or a daily floating rate based on the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;BBA&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; LIBOR as published by Reu&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ters (or other commercially available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the Revolving Line accrues interest at a rate based &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%.&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' &gt;The Term Loan and loans under the Revolving Line evidenced by the Credit Agreemen&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;t, or the Loans, are guaranteed by all of the Company&amp;#8217;s direct and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and the guarantors.&amp;#160;The Loans are subject to restrictive covenants under the Credit Agreement, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the Loans is allowed &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;by the Credit Agreement at any time during the terms of the Loans. The Loans also contain limitations on the Company&amp;#8217;s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory notes and/or other co&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;nsideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock id="ID_405" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;13&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;Derivatives&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company uses interest&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-related derivative instruments to manage its exposure related to changes in interest rates on its variable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate debt instruments. The Company does not enter into derivative instruments for any purpose other &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;than cash flow hedging. The Company does not speculate using derivative instruments.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;By using derivative financial instruments to hedge exposures to changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the f&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ailure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative co&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ntract is negative, the Company owes the counterparty and, therefore, the Company is not exposed to the counterparty&amp;#8217;s credit risk in those circumstances. The Company minimizes counterparty credit risk in derivative instruments by entering into transaction&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s with carefully selected major financial institutions based upon their credit profile.  &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Market risk is the adverse effect on the value of a derivative instrument that results from a change in interest rates. The market risk associated with interest&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rat&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;e contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company assesses interest rate risk by continually identifying and monitoring changes in interest rate exposures th&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;at may adversely impact expected future cash flows and by evaluating hedging opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company&amp;#8217;s outstanding or forecasted debt obligations as&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; well as the Company&amp;#8217;s offsetting hedge positions. The risk management control systems involve the use of analytical techniques, including cash flow sensitivity analysis, to estimate the expected impact of changes in interest rates on the Company&amp;#8217;s future &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;cash flows.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company uses variable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate London Interbank Offered Rate (LIBOR) debt to finance its operations. The debt obligations expose the Company to variability in interest payments due to changes in interest rates. Management believes that it is p&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;rudent to limit the variability of a portion of its interest payments. To meet this objective, management enters into LIBOR based interest rate swap agreements to manage fluctuations in cash flows resulting from changes in the benchmark interest rate of LI&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;BOR. These swaps change the variable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate cash flow exposure on the debt obligations to fixed cash flows.  Under the terms of the interest rate swaps, the Company receives LIBOR based variable interest rate payments and makes fixed interest rate payments, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;thereby creating the equivalent of fixed-rate debt for the notional amount of its debt hedged.  In accordance with its Credit Agreement, the Company was required to fix the rate of interest on at least 50% of its Term Loan and the DDTL through the purchase&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of interest rate swaps. On June 5, 2013, the Company entered into an interest rate swap contract with an original notional amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark inter&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;est rate (LIBOR) associated with the Company&amp;#8217;s Term Loan. On November 29, 2013, the Company entered into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March 29, 2018 in order to hedge the risk &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;of changes in the effective benchmark interest rate (LIBOR) associated with the DDTL. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;The notional amount of the Company&amp;#8217;s derivative instruments as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; w&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;as $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;4.5&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; The Term Loan swap &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;contract &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;effectively &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;convert&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ed specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.96%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; plus a ba&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;nk margin of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.75%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;The DDTL swap contract &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;effectively &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;converted specific variable-rate debt into fixed-r&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ate debt and fixed the LIBOR rate associated with the Term Loan at &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.93%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; plus a bank margin of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.75%&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.The interest rate swap&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;were designated as &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;cash flow hedge&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; in accordance with ASC 815, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' &gt;Derivatives and Hedging&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;As disclos&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ed in Note 12, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;on May &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, 2017, the&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; Company entered into the Credit Agreement to amend its credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman &amp;amp; Co. as lenders. I&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;mmediately after entering into this Credit Agreemen&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;t&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;,  the Company entered into a new interest rate swap contract with Bank of America with a notional amount of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;$14.0 million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and a maturity date of March 30, 2022 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associa&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ted with the Company&amp;#8217;s Term Loan. The swap contract converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Loan at 1.86%. The interest&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; rate swap was designated as a cash flow hedge instrument in accorda&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;nce with ASC 815 &amp;#8220;Derivatives and Hedging&amp;#8221;. As a result of entering into the new interest rate swap &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;contract, the Company unwound the previous interest rate swap contracts, and received an immaterial amount in proceeds.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The following table presents &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;the&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; no&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;tional amount and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;fair value&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of the Company&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;&amp;#8217;&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; derivative &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;instrument&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s as of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Notional Amount&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:27pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives designated as hedging instruments under ASC 815&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance sheet classification&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other liabilities-non current&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4,500&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Notional Amount&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Fair Value (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:27pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives designated as hedging instruments under ASC 815&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Balance sheet classification&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:12.75pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other liabilities-non current&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;5,500&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='8' rowspan='1' style='width:530.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:530.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(a) See Note 14 for the fair value measurements related to these financial instruments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;All of the Company&amp;#8217;s derivative instruments are designated as hedging instruments.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company has structured its interest rate swap agreements&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; to be 100% effective and as a result, there was no impact to earnings resulting from hedge ineffectiveness.  Changes in the fair value of interest rate swaps designated as hedging instruments that effectively offset the variability of cash flows associate&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;d with variable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate, long&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-term debt obligations are reported in accumulated other comprehensive income (&amp;#8220;AOCI&amp;#8221;). These amounts subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;which the related interest affects earnings.  The Company&amp;#8217;s interest rate swap agreement was deemed to be fully effective in accordance with ASC 815, and, as such, unrealized gains and losses related to these derivatives were recorded as AOCI.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The followi&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ng table summarizes the effect of derivatives designated as cash flow hedging instruments &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;and their classification within comprehensive loss for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:55.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Derivatives in Hedging Relationships&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Amount of gain (loss) recognized in OCI on derivative (effective portion) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:31.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;4 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(36)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The following table summarizes the reclassifications out of accumulated other comprehensive loss for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:39pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Details about AOCI Components&lt;/font&gt;&lt;/td&gt;&lt;td colspan='6' rowspan='1' style='width:118.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Amount reclassified from AOCI into income (effective portion)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Location of amount&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:40.2pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='5' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;reclassified from AOCI&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;into income (effective portion)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:15pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='6' rowspan='1' style='width:118.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swaps&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;3 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;13 &lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest expense&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;As of &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;7&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; thousand&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; of deferred&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; losses on derivative instruments accumulated in AOCI are expected to be reclassified to earnings during the next &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;twelve&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; months. Transactions and events expected to occur over the next twelve months that will necessitate reclassifying these derivatives&amp;#8217; losses to earnings include the repricing of variable&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;-rate debt. There were no cash flow hedges discontinued during &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; or &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="ID_406" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;14&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;Fair Value Measurements&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Fair value measurement is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;market participants at the measurement date. A fair value hierarchy is established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Level 1&amp;#8212;Quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Level 2&amp;#8212;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Level 3&amp;#8212;Unobservable inputs based on the Company&amp;#8217;s own assumptions.&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The following table&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s present&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; the fair value hierarchy for those liabili&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;ties measured at fair value on a recurring basis:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Fair Value as of March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 1&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 2&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swap agreements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Fair Value as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:14.4pt;' &gt;&lt;td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 1&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 2&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Level 3&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Interest rate swap agreements&lt;/font&gt;&lt;/td&gt;&lt;td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;The Company uses the market approach technique to value its financial liabilities.  The Company&amp;#8217;s financial liabilities carried at fair value include derivative instruments used to hedge the Company&amp;#8217;s interest rate risks. The fair value of the Company&amp;#8217;s &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;interest rate swap agreement&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; was based on LIBOR yield curves at the reporting date.&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock id="ID_407" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;4&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;. &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	Goodwill and Other Intangible Assets&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Intangible assets consist of the following:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Weighted &lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' &gt;December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt;Life&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' &gt; (a)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td colspan='11' rowspan='1' style='width:247.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:247.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Amortizable intangible assets:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Existing technology&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;15,287&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(12,020)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;15,082&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(11,710)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;6.8&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Trade names&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,436&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3,617)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7,379&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(3,479)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;7.8&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Distribution agreements/customer relationships&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;23,136&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(13,228)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;22,976&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(12,862)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;8.7&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Patents&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;207&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(131)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;204&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(119)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1.9&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total amortizable intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;46,066&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(28,996)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;45,641&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(28,170)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Indefinite-lived intangible assets:&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,398&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,032&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Other indefinite-lived intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,216&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;1,209&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:26.4pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total goodwill and other indefinite-lived intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;39,614&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;39,241&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Total intangible assets, gross&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;85,680&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;84,882&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td colspan='15' rowspan='1' style='width:496.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:496.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(a) Weighted average life as of March 31, 2017.&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' &gt;The change&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; in the carrying amount of goodwill for the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; is as follows:&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;table style='border-collapse:collapse;' &gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,032&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.2pt;' &gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Effect of change in currency translation&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;366&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style='height:13.8pt;' &gt;&lt;td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;Balance at March 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;38,398&lt;/font&gt;&lt;/td&gt;&lt;td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' &gt;&lt;font style='font-family:Arial;font-size:10pt;color:#000000;' &gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='line-height:20pt;' /&gt;&lt;div&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' &gt;Amortization of intangible assets&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;Intangible asset amortization expense was $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.6&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million and $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;0.7&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; for&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; the &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;three months ended&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;March 31,&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2016&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, respectively.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;Amortization expense of existing amortizable intangible assets is currently estimated to be&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.4&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;&amp;#160;million for the year ending December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2017&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.3&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million for the year ending December 31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2018&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.1&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million for the year ending December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2019&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.1&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million for the year ending Dece&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;mber&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2020&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; and $&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2.1&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; million for the year ending December&amp;#160;31, &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;2021&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:ShareBasedCompensation id="ID_408" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="USD" decimals="-3">11000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_409" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">20000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_410" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-3">101000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_411" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">622000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ID_412" contextRef="FROM_Jan01_2016_TO_Mar31_2016_Entity_0001123494" unitRef="USD" decimals="-3">754000</us-gaap:ShareBasedCompensation>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_413" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">-16658000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_414" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">-15709000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:GoodwillForeignCurrencyTranslationGainLoss id="ID_415" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">366000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="ID_416" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">949000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="ID_417" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">946000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:SubsequentEventsTextBlock id="ID_418" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494">&lt;div&gt;&lt;p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' &gt;1&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;6&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;	&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' &gt;Subsequent Events&lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;On April 14, 2017, anticipated representatives for the estate of an individual plaintiff filed a wrongful death complaint with the Suffolk Superior Court, in the County of Suffolk, Massachusetts, against the Company and other &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;defendants, including Biostage, Inc. (f/k/a Harvard Apparatus Regenerative Technology, Inc.), its subsidiary that was spun off in 2013, as well as another third party.  The complaint seeks payment for an unspecified amount of damages and alleges that the p&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;laintiff sustained terminal injuries allegedly caused by products, including synthetic trachea scaffolds and bioreactors, provided by certain of the named defendants and utilized in connection with surgeries performed by third parties in 2012 and 2013.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; The&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt; litigation is at an early s&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;tage and the Company intends to vigorously defend this case.  While the Company believe that such claim is without merit, the Company is unable to predict the ultimate outcome of such litigation. &lt;/font&gt;&lt;/p&gt;&lt;p style='text-align:left;line-height:12pt;' &gt;&lt;/p&gt;&lt;p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' &gt;&lt;font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' &gt;On May 2&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;, 2017, the Company en&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;tered into &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;color:#000000;' &gt;the Credit Agreement which restated the 2013 Agreement.  See Note 12 for a discussion of the Credit Agreement.&lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;  Additionally, immediately after entering into the Credit Agreement, the Company entered into a new interest swap agreement with Bank &lt;/font&gt;&lt;font style='font-family:Times New Roman;font-size:10pt;' &gt;of America. See Note 13 for a discussion of the interest swap agreement&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:AccountsReceivableNetCurrent id="ID_419" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">15746000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet id="ID_420" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">19955000</us-gaap:InventoryNet>
  <us-gaap:AccountsReceivableNetCurrent id="ID_421" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">15479000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet id="ID_422" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">20282000</us-gaap:InventoryNet>
  <us-gaap:Goodwill id="ID_423" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">38398000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="ID_424" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">38032000</us-gaap:Goodwill>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="ID_425" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">17471000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="ID_426" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">17070000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:AccountsPayableCurrent id="ID_427" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">6196000</us-gaap:AccountsPayableCurrent>
  <us-gaap:SecuredDebtCurrent id="ID_428" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">2722000</us-gaap:SecuredDebtCurrent>
  <us-gaap:AccountsPayableCurrent id="ID_429" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">5835000</us-gaap:AccountsPayableCurrent>
  <us-gaap:SecuredDebt id="ID_430" contextRef="AS_OF_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-6">14000000</us-gaap:SecuredDebt>
  <hbio:Maturitydates id="ID_431" contextRef="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember">2022-05-01</hbio:Maturitydates>
  <hbio:Maturitydates id="ID_432" contextRef="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember">2022-05-01</hbio:Maturitydates>
  <us-gaap:SecuredDebt id="ID_433" contextRef="AS_OF_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="USD" decimals="-6">25000000</us-gaap:SecuredDebt>
  <hbio:LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold id="ID_434" contextRef="AS_OF_May02_2017_Entity_0001123494" unitRef="USD" decimals="-6">6000000</hbio:LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold>
  <hbio:LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold id="ID_435" contextRef="AS_OF_May02_2017_Entity_0001123494" unitRef="USD" decimals="-6">10000000</hbio:LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="ID_436" contextRef="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="pure" decimals="4">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="ID_437" contextRef="FROM_May01_2017_TO_May02_2017_Entity_0001123494_hbio_CreditAgreementAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="4">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DerivativeAssetNotionalAmount id="ID_438" contextRef="AS_OF_May02_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-2">14000000</us-gaap:DerivativeAssetNotionalAmount>
  <hbio:LiborFixedRate id="ID_439" contextRef="FROM_May01_2017_TO_May02_2017_Entity_0001123494_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="4">0.0186</hbio:LiborFixedRate>
  <us-gaap:LongTermLoansPayable id="ID_440" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">5400000</us-gaap:LongTermLoansPayable>
  <hbio:DelayedDrawdownTermLoan id="ID_441" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4400000</hbio:DelayedDrawdownTermLoan>
  <hbio:RevolvingCreditFacility id="ID_442" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">4050000</hbio:RevolvingCreditFacility>
  <us-gaap:DeferredFinanceCostsNet id="ID_443" contextRef="AS_OF_Dec31_2016_Entity_0001123494" unitRef="USD" decimals="-3">104000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:LongTermLoansPayable id="ID_444" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">5062000</us-gaap:LongTermLoansPayable>
  <hbio:DelayedDrawdownTermLoan id="ID_445" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4125000</hbio:DelayedDrawdownTermLoan>
  <hbio:RevolvingCreditFacility id="ID_446" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">4550000</hbio:RevolvingCreditFacility>
  <us-gaap:DeferredFinanceCostsNet id="ID_447" contextRef="AS_OF_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-3">84000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:CumulativeEffectOnRetainedEarningsBeforeTax1 id="ID_448" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="USD" decimals="-5">100000</us-gaap:CumulativeEffectOnRetainedEarningsBeforeTax1>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="ID_449" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-3">4000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ID_450" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-3">-3000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="ID_451" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-3">7000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="ID_452" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-3">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ID_453" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-3">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="ID_454" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-3">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_455" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-3">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_456" contextRef="AS_OF_Dec31_2016_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-3">-2458000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_457" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-3">7000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_458" contextRef="AS_OF_Mar31_2017_Entity_0001123494_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-3">-2458000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue id="ID_459" contextRef="FROM_Jan01_2017_TO_Mar31_2017_Entity_0001123494" unitRef="myUSDPerShare" decimals="INF">3.28</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>hbio-20170331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6 Using Fujitsu -->
<!-- Validation status: Passed -->
<schema targetNamespace="http://www.harvardbioscience.com/20170331" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:hbio="http://www.harvardbioscience.com/20170331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
    <annotation>
        <appinfo>
            <link:linkbaseRef xlink:type="simple" xlink:href="hbio-20170331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
            <link:linkbaseRef xlink:type="simple" xlink:href="hbio-20170331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
            <link:linkbaseRef xlink:type="simple" xlink:href="hbio-20170331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
            <link:linkbaseRef xlink:type="simple" xlink:href="hbio-20170331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
            <link:roleType roleURI="http://www.harvardbioscience.com/role/StatementsOfOperations" id="ELRID_StatementsOfOperations">
                <link:definition>000400 - Statement - Statements of Operations</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition" id="ELRID_StatementsOfFinancialPosition">
                <link:definition>000200 - Statement - Statements of Financial Position</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/StatementsOfFinancialPositionParentheticals" id="ELRID_StatementsOfFinancialPositionParentheticals">
                <link:definition>000300 - Statement - Statements of Financial Position (Parentheticals)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows" id="ELRID_StatementsOfCashFlows">
                <link:definition>000600 - Statement - Statements of Cash Flows</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCosts" id="ELRID_RestructuringAndOtherExitCosts">
                <link:definition>010100 - Disclosure - Restructuring and Other Exit Costs</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Warranties" id="ELRID_Warranties">
                <link:definition>010230 - Disclosure - Warranties</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Inventories" id="ELRID_Inventories">
                <link:definition>010050 - Disclosure - Inventories</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Acquisitions" id="ELRID_Acquisitions">
                <link:definition>010070 - Disclosure - Acquisitions</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssets" id="ELRID_GoodwillAndOtherIntangibleAssets">
                <link:definition>010045 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/IncomeTaxes" id="ELRID_IncomeTaxes">
                <link:definition>010160 - Disclosure - Income Taxes</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SegmentReporting" id="ELRID_SegmentReporting">
                <link:definition>010210 - Disclosure - Segment Reporting</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails2" id="ELRID_LongTermDebtDetails2">
                <link:definition>400160 - Disclosure - Long Term Debt (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStock" id="ELRID_CapitalStock">
                <link:definition>010190 - Disclosure - Capital Stock</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlans" id="ELRID_EmployeeBenefitPlans">
                <link:definition>010170 - Disclosure - Employee Benefit Plans</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Leases" id="ELRID_Leases">
                <link:definition>010140 - Disclosure - Leases</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Organiziation" id="ELRID_Organiziation">
                <link:definition>010000 - Disclosure - Organiziation</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Concentrations" id="ELRID_Concentrations">
                <link:definition>010030 - Disclosure - Concentrations</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipment" id="ELRID_PropertyPlantAndEquipment">
                <link:definition>010060 - Disclosure - Property, Plant and Equipment</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccruedExpenses" id="ELRID_AccruedExpenses">
                <link:definition>010150 - Disclosure - Accrued Expenses</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CommitmentsAndContingentLiabilities" id="ELRID_CommitmentsAndContingentLiabilities">
                <link:definition>010180 - Disclosure - Commitments and Contingent Liabilities</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebts" id="ELRID_AllowanceForDoubtfulDebts">
                <link:definition>010220 - Disclosure - Allowance for Doubtful Debts</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunaudited" id="ELRID_QuarterlyFinancialInformationunaudited">
                <link:definition>010240 - Disclosure - Quarterly Financial Information (unaudited)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="ELRID_SummaryOfSignificantAccountingPoliciesPolicies">
                <link:definition>200000 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables" id="ELRID_GoodwillAndOtherIntangibleAssetsTables">
                <link:definition>300015 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/InventoriesTables" id="ELRID_InventoriesTables">
                <link:definition>300020 - Disclosure - Inventories (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsTables" id="ELRID_RestructuringAndOtherExitCostsTables">
                <link:definition>300070 - Disclosure - Restructuring and Other Exit Costs (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AcquisitionsTables" id="ELRID_AcquisitionsTables">
                <link:definition>300040 - Disclosure - Acquisitions (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/WarrantiesTables" id="ELRID_WarrantiesTables">
                <link:definition>300180 - Disclosure - Warranties (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables" id="ELRID_EmployeeBenefitPlansTables">
                <link:definition>300140 - Disclosure - Employee Benefit Plans (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LeasesTables" id="ELRID_LeasesTables">
                <link:definition>300110 - Disclosure - Leases (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStockTables" id="ELRID_CapitalStockTables">
                <link:definition>300150 - Disclosure - Capital Stock (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationTables" id="ELRID_SegmentAndRelatedInformationTables">
                <link:definition>300160 - Disclosure - Segment and Related Information (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsNarrativesDetails" id="ELRID_GoodwillAndOtherIntangibleAssetsNarrativesDetails">
                <link:definition>400031 - Disclosure - Goodwill and Other Intangible Assets (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1" id="ELRID_GoodwillAndOtherIntangibleAssetsDetails1">
                <link:definition>400032 - Disclosure - Goodwill and Other Intangible Assets (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/InventoriesDetails1" id="ELRID_InventoriesDetails1">
                <link:definition>400040 - Disclosure - Inventories (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails" id="ELRID_RestructuringAndOtherExitCotsNarrativesDetails">
                <link:definition>400120 - Disclosure - Restructuring and Other Exit Cots (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1" id="ELRID_RestructuringAndOtherExitCostsDetails1">
                <link:definition>400130 - Disclosure - Restructuring and Other Exit Costs (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AcquisitionsNarrativesDetails" id="ELRID_AcquisitionsNarrativesDetails">
                <link:definition>400060 - Disclosure - Acquisitions (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AcquisitionsDetails1" id="ELRID_AcquisitionsDetails1">
                <link:definition>400070 - Disclosure - Acquisitions (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/WarrantiesDetails1" id="ELRID_WarrantiesDetails1">
                <link:definition>400400 - Disclosure - Warranties (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails2" id="ELRID_EmployeeBenefitPlansDetails2">
                <link:definition>400290 - Disclosure - Employee Benefit Plans (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansNarrativesDetails" id="ELRID_EmployeeBenefitPlansNarrativesDetails">
                <link:definition>400270 - Disclosure - Employee Benefit Plans (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1" id="ELRID_EmployeeBenefitPlansDetails1">
                <link:definition>400280 - Disclosure - Employee Benefit Plans (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LeasesNarrativesDetails" id="ELRID_LeasesNarrativesDetails">
                <link:definition>400210 - Disclosure - Leases (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LeasesDetails1" id="ELRID_LeasesDetails1">
                <link:definition>400210 - Disclosure - Leases (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails" id="ELRID_CapitalStockNarrativesDetails">
                <link:definition>400320 - Disclosure - Capital Stock (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails1" id="ELRID_CapitalStockDetails1">
                <link:definition>400330 - Disclosure - Capital Stock (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails" id="ELRID_LongTermDebtNarrativesDetails">
                <link:definition>400140 - Disclosure - Long Term Debt (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails" id="ELRID_IncomeTaxNarrativesDetails">
                <link:definition>400240 - Disclosure - Income Tax (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationNarrativesDetails" id="ELRID_SegmentAndRelatedInformationNarrativesDetails">
                <link:definition>500000 - Disclosure - Segment and Related Information (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" id="ELRID_BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
                <link:definition>010010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RecentlyIssuedAccountingPronouncements" id="ELRID_RecentlyIssuedAccountingPronouncements">
                <link:definition>010020 - Disclosure - Recently Issued Accounting Pronouncements</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LongTermDebt" id="ELRID_LongTermDebt">
                <link:definition>010110 - Disclosure - Long Term Debt</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails2" id="ELRID_CapitalStockDetails2">
                <link:definition>400340 - Disclosure - Capital Stock (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails2" id="ELRID_GoodwillAndOtherIntangibleAssetsDetails2">
                <link:definition>400033 - Disclosure - Goodwill and Other Intangible Assets (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentTables" id="ELRID_PropertyPlantAndEquipmentTables">
                <link:definition>300030 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LongTermDebtTables" id="ELRID_LongTermDebtTables">
                <link:definition>300080 - Disclosure - Long Term Debt (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccruedExpensesTables" id="ELRID_AccruedExpensesTables">
                <link:definition>300120 - Disclosure - Accrued Expenses (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/IncomeTaxesTables" id="ELRID_IncomeTaxesTables">
                <link:definition>300130 - Disclosure - Income Taxes (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsTables" id="ELRID_AllowanceForDoubtfulDebtsTables">
                <link:definition>300170 - Disclosure - Allowance for Doubtful Debts (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunauditedTables" id="ELRID_QuarterlyFinancialInformationunauditedTables">
                <link:definition>300190 - Disclosure - Quarterly Financial Information (unaudited) (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/ConcentrationsNarrativesDetails" id="ELRID_ConcentrationsNarrativesDetails">
                <link:definition>400010 - Disclosure - Concentrations (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1" id="ELRID_PropertyPlantAndEquipmentDetails1">
                <link:definition>400050 - Disclosure - Property, Plant and Equipment (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccruedExpensesDetails1" id="ELRID_AccruedExpensesDetails1">
                <link:definition>400230 - Disclosure - Accrued Expenses (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails1" id="ELRID_IncomeTaxDetails1">
                <link:definition>400250 - Disclosure - Income Tax (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails2" id="ELRID_IncomeTaxDetails2">
                <link:definition>400260 - Disclosure - Income Tax (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails3" id="ELRID_EmployeeBenefitPlansDetails3">
                <link:definition>400300 - Disclosure - Employee Benefit Plans (Details 3)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails4" id="ELRID_EmployeeBenefitPlansDetails4">
                <link:definition>400310 - Disclosure - Employee Benefit Plans (Details 4)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails3" id="ELRID_CapitalStockDetails3">
                <link:definition>400350 - Disclosure - Capital Stock (Details 3)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1" id="ELRID_SegmentAndRelatedInformationDetails1">
                <link:definition>500010 - Disclosure - Segment and Related Information (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsDetails1" id="ELRID_AllowanceForDoubtfulDebtsDetails1">
                <link:definition>400390 - Disclosure - Allowance for doubtful debts (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/StatementOfComprehensiveIncomeParentheticals" id="ELRID_StatementOfComprehensiveIncomeParentheticals">
                <link:definition>000510 - Statement - Statement of Comprehensive Income (Parentheticals)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1" id="ELRID_SummaryOfSignificantAccountingPolicyDetails1">
                <link:definition>400000 - Disclosure - Summary of Significant Accounting Policy (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/Derivatives" id="ELRID_Derivatives">
                <link:definition>010120 - Disclosure - Derivatives</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DerivativeTables" id="ELRID_DerivativeTables">
                <link:definition>300090 - Disclosure - Derivative (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DerivativeNarrativesDetails" id="ELRID_DerivativeNarrativesDetails">
                <link:definition>400170 - Disclosure - Derivative (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DerivativeDetails1" id="ELRID_DerivativeDetails1">
                <link:definition>400180 - Disclosure - Derivative (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DerivativeDetails2" id="ELRID_DerivativeDetails2">
                <link:definition>400190 - Disclosure - Derivative (Details 2)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/FairValueMeasurements" id="ELRID_FairValueMeasurements">
                <link:definition>010130 - Disclosure - Fair Value Measurements</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/FairValueMeasurementsTables" id="ELRID_FairValueMeasurementsTables">
                <link:definition>300100 - Disclosure - Fair Value Measurements (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/FairValueMeasurementsDetails" id="ELRID_FairValueMeasurementsDetails">
                <link:definition>400200 - Disclosure - Fair Value Measurements (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RelatedPartyTransactions" id="ELRID_RelatedPartyTransactions">
                <link:definition>010200 - Disclosure - Related Party Transactions</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncome" id="ELRID_AccumulatedOtherComprehensiveIncome">
                <link:definition>010040 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeTables" id="ELRID_DisclosureAccumulatedOtherComprehensiveIncomeTables">
                <link:definition>300010 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails" id="ELRID_AccumulatedOtherComprehensiveIncomeDetails">
                <link:definition>400020 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails1" id="ELRID_LongTermDebtDetails1">
                <link:definition>400150 - Disclosure - Long Term Debt (Details 1)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails" id="ELRID_RelatedPartyTransactionsNarrativesDetails">
                <link:definition>400360 - Disclosure - Related Party Transactions (Narratives) (Details)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPoliciesTables" id="ELRID_SummaryOfSignificantAccountingPoliciesTables">
                <link:definition>300000 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/DocumentAndEntityInformation" id="ELRID_DocumentAndEntityInformation">
                <link:definition>000100 - Document - Document and Entity Information</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
            <link:roleType roleURI="http://www.harvardbioscience.com/role/SubsequentEvents" id="ELRID_SubsequentEvents">
                <link:definition>010250 - Disclosure - Subsequent Events</link:definition>
                <link:usedOn>link:presentationLink</link:usedOn>
                <link:usedOn>link:calculationLink</link:usedOn>
                <link:usedOn>link:definitionLink</link:usedOn>
            </link:roleType>
        </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element name="AmortizationOfCatalogCosts" id="hbio_AmortizationOfCatalogCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="AdditionsToCatalogCosts" id="hbio_AdditionsToCatalogCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="NonCashRestructuringCharge" id="hbio_NonCashRestructuringCharge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="OrganizationDisclosureAbstract" id="hbio_OrganizationDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="OrganizationDisclosureTextBlock" id="hbio_OrganizationDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="ConcentrationsDisclosureAbstract" id="hbio_ConcentrationsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="AccruedExpensesDisclosureTextBlock" id="hbio_AccruedExpensesDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="AllowanceForDoubtfulDebtsDisclosureAbstract" id="hbio_AllowanceForDoubtfulDebtsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="AllowanceForDoubtfulDebtsDisclosureTextBlock" id="hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock" id="hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" id="hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="TotalIntangibleAssets" id="hbio_TotalIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="DateOfStockRepurchaseProgramAuthorized" id="hbio_DateOfStockRepurchaseProgramAuthorized" type="invest:dateStringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TreasuryStockAcquiredUnderStockRepurchaseProgram" id="hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" id="hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="EmployeeStockPurchasePlanSharesAuthorized" id="hbio_EmployeeStockPurchasePlanSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" id="hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" type="invest:dateStringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" id="hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" id="hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="FungibleSharesIssuanceRatio" id="hbio_FungibleSharesIssuanceRatio" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="StockOptionsAndRestrictedStockUnitsIssued" id="hbio_StockOptionsAndRestrictedStockUnitsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="FungibleShareAdjustmentForRestrictedStockUnitsGranted" id="hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" id="hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="EstimatedRentalExpensesCurrentYear" id="hbio_EstimatedRentalExpensesCurrentYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" id="hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" id="hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="InterestRateInExcessOfLiborOnCreditFacility" id="hbio_InterestRateInExcessOfLiborOnCreditFacility" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold" id="hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold" id="hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="StockOptionsAndRestrictedStockUnitsCancelled" id="hbio_StockOptionsAndRestrictedStockUnitsCancelled" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="FungibleShareAdjustmentForRestrictedStockUnitsCancelled" id="hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="FixedAssetsWriteOffMember" id="hbio_FixedAssetsWriteOffMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="OtherCostsMember" id="hbio_OtherCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlan2016ConsolidatedMember" id="hbio_RestructuringPlan2016ConsolidatedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlan2015ConsolidatedMember" id="hbio_RestructuringPlan2015ConsolidatedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="AhnBiotechnologieGmbhAcquisitionMember" id="hbio_AhnBiotechnologieGmbhAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ModularSfcAcquisitionMember" id="hbio_ModularSfcAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" id="hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="ComprehensiveIncomeLossPolicyTextBlock" id="hbio_ComprehensiveIncomeLossPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="ImpairmentOfLongLivedAssetsPolicyTextBlock" id="hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="ScheduleOfPropertyPlantAndEquipmentTableTextBlock" id="hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="NetAssetsByGeographicAreaTableTextBlock" id="hbio_NetAssetsByGeographicAreaTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TotalAccruedExpenses" id="hbio_TotalAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="NetOperatingLossCarryforwardFederalAndState" id="hbio_NetOperatingLossCarryforwardFederalAndState" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="NetOperatingLossCarryforwardForeign" id="hbio_NetOperatingLossCarryforwardForeign" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="NetOperatingLossCarryforwardsSubjectToAnnualLimitation" id="hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="NetOperatingLossCarryforwardsAnnualLimitation" id="hbio_NetOperatingLossCarryforwardsAnnualLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="UndistributedForeignEarnings" id="hbio_UndistributedForeignEarnings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="CashInForeignSubsidiaries" id="hbio_CashInForeignSubsidiaries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="CashHeldInForeignSubsidiariesUsedForAcquisitions" id="hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements" id="hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" id="hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" id="hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" id="hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" id="hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="RestOfTheWorldMember" id="hbio_RestOfTheWorldMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="CmaAcquisitionMember" id="hbio_CmaAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" id="hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" id="hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" id="hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" id="hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsEightCentsToFourDollarsSeventeenCentsMember" id="hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" id="hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" id="hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" id="hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" id="hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" id="hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="InventoryImpairmentMember" id="hbio_InventoryImpairmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlan2014ConsolidatedPlansAMember" id="hbio_RestructuringPlan2014ConsolidatedPlansAMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="IncomeTaxDisclosureLineItems" id="hbio_IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" id="hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="CashInForeignSubsidiariesUsedForAcquisitionsAxis" id="hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TypesOfAcquisitionsDomain" id="hbio_TypesOfAcquisitionsDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="PercentageOfOutstandingCommonStock" id="hbio_PercentageOfOutstandingCommonStock" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" id="hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="RestrictedStockUnitsOutstandingForIssuanceOfAwards" id="hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="IncentiveStockOptionsGrantedToDate" id="hbio_IncentiveStockOptionsGrantedToDate" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="NonQualifiedStockOptionsGrantedToDate" id="hbio_NonQualifiedStockOptionsGrantedToDate" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="CommonStockMarketValuePerShareOnReportingDate" id="hbio_CommonStockMarketValuePerShareOnReportingDate" type="num:perShareItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="InTheMoneyStockOptionsExercisableAtTheReportingDate" id="hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="AnnualizedEstimatedForfeitureRate" id="hbio_AnnualizedEstimatedForfeitureRate" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanPurchasesDuringYear" id="hbio_DefinedBenefitPlanPurchasesDuringYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanUnrealizedLossGain" id="hbio_DefinedBenefitPlanUnrealizedLossGain" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="NumberOfCustomersWithBenchmarkContribution" id="hbio_NumberOfCustomersWithBenchmarkContribution" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="NumberOfCustomersWithBenchmarkContributionExceptOne" id="hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlan2010PlanBMember" id="hbio_RestructuringPlan2010PlanBMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="DeferredIncomeTaxesAmount" id="hbio_DeferredIncomeTaxesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="ServiceCostForDefinedBenefitPlan" id="hbio_ServiceCostForDefinedBenefitPlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="FairValueImpairmentOfPensionAssets" id="hbio_FairValueImpairmentOfPensionAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="DeferredIncomeTaxReclassificationFromCurrentToNonCurrent" id="hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="DeferredIncomeTaxesOnPensionLiabilities" id="hbio_DeferredIncomeTaxesOnPensionLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="WeightedAverageEstimatedBlackScholesValueOfOptionGrants" id="hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants" type="num:perShareItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionContingentConsiderationAtFairValue1" id="hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionCostOfAcquiredEntity1Abstract" id="hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" id="hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" id="hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" id="hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" id="hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" id="hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" id="hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="SegmentReportingInformationNetAssets1" id="hbio_SegmentReportingInformationNetAssets1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" id="hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="LiborFixedRate" id="hbio_LiborFixedRate" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DelayedDrawdownTermLoanMember" id="hbio_DelayedDrawdownTermLoanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlan2013Member" id="hbio_RestructuringPlan2013Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" id="hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" id="hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFourtyFiveCentsMember" id="hbio_TwoDollarsFourtyFiveCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFiftySixCentsMember" id="hbio_TwoDollarsFiftySixCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" id="hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ThreeDollarsSixtyFourCentsMember" id="hbio_ThreeDollarsSixtyFourCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" id="hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsFourCentsMember" id="hbio_FourDollarsFourCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" id="hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" id="hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" id="hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlanDecember2013Member" id="hbio_RestructuringPlanDecember2013Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TransferOfCashAndCashEquivalentsToHART" id="hbio_TransferOfCashAndCashEquivalentsToHART" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="CreditAgreementLineItems" id="hbio_CreditAgreementLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="PreviousApprovedCreditFacility" id="hbio_PreviousApprovedCreditFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="CreditAgreementTable" id="hbio_CreditAgreementTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="CreditAgreementAxis" id="hbio_CreditAgreementAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="CreditAgreementDomain" id="hbio_CreditAgreementDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="Maturitydates" id="hbio_Maturitydates" type="xbrli:dateItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="SecuredDebtInterestRateAtPeriodEnd" id="hbio_SecuredDebtInterestRateAtPeriodEnd" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="DdtlThresholdForDollarForDollarReductionInRevolvingLine" id="hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="DiscontinuedOperationsMember" id="hbio_DiscontinuedOperationsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="SubleaseInitialTerm" id="hbio_SubleaseInitialTerm" type="invest:dateStringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="SubleaseExtendedTerm" id="hbio_SubleaseExtendedTerm" type="xbrli:dateItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="IncrementalOptionsGrantedDueToHartSpinoff" id="hbio_IncrementalOptionsGrantedDueToHartSpinoff" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="IncrementalUnitsGrantedDueToHartSpinoff" id="hbio_IncrementalUnitsGrantedDueToHartSpinoff" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" id="hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="DerivativeInterestRateSwapEffectivePercentage" id="hbio_DerivativeInterestRateSwapEffectivePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TransitionServicesChargedToSpinnee" id="hbio_TransitionServicesChargedToSpinnee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage" id="hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanAveragePensionPlanLiability" id="hbio_DefinedBenefitPlanAveragePensionPlanLiability" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue" id="hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage" id="hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanAverageRemainingWorkLifetime" id="hbio_DefinedBenefitPlanAverageRemainingWorkLifetime" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue" id="hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="StockIssuedDuringPeriodGrossStockOptionsExercised" id="hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="DistributionRevenuesFromSpinnee" id="hbio_DistributionRevenuesFromSpinnee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="ExpansionAreaOfRealEstateProperty" id="hbio_ExpansionAreaOfRealEstateProperty" type="num:areaItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="MultiChannelSystemsMcsGmbhMember" id="hbio_MultiChannelSystemsMcsGmbhMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TriangleBiosystemsIncMember" id="hbio_TriangleBiosystemsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="HekaElektronikMember" id="hbio_HekaElektronikMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ValuationAllowancesAndReservesCurrencyTranslation" id="hbio_ValuationAllowancesAndReservesCurrencyTranslation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
    <element name="RestructuringPlan2014Member" id="hbio_RestructuringPlan2014Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" id="hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" id="hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" id="hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="WarrantyOther" id="hbio_WarrantyOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="RestructuringPlanQ12015Member" id="hbio_RestructuringPlanQ12015Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="MarketConditionRestrictedStockUnitMember" id="hbio_MarketConditionRestrictedStockUnitMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlanQ22015Member" id="hbio_RestructuringPlanQ22015Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" id="hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" id="hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" id="hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" id="hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="RestructuringPlanQ42015Member" id="hbio_RestructuringPlanQ42015Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TaxLiabilityOnForeignEarningsRepatriated" id="hbio_TaxLiabilityOnForeignEarningsRepatriated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="NetImpactOfForeignRateChanges" id="hbio_NetImpactOfForeignRateChanges" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="DeferredTaxAssetsTaxCreditsOnRepatriation" id="hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
    <element name="DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets" id="hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets" id="hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="DeferredTaxLiabilitiesOnRepatriation" id="hbio_DeferredTaxLiabilitiesOnRepatriation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets" id="hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" id="hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="IncomeTaxReconciliationForeignTaxCreditsDeduction" id="hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="IncomeTaxReconciliationLossOnSubsidiaryStockSale" id="hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="IncomeTaxRateReconciliationDeductionsStockOptions" id="hbio_IncomeTaxRateReconciliationDeductionsStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
    <element name="OperatingLossCarryforwardsExpirationYear" id="hbio_OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditCarryforwardsExpirationYear" id="hbio_TaxCreditCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditExpire2017Member" id="hbio_TaxCreditExpire2017Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditExpire2020Member" id="hbio_TaxCreditExpire2020Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditExpirationAxis" id="hbio_TaxCreditExpirationAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditExpirationDomain" id="hbio_TaxCreditExpirationDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="TaxCreditExpire2022Member" id="hbio_TaxCreditExpire2022Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="Documentandentityinformationabstract" id="hbio_Documentandentityinformationabstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="NonAffiliateShareHolding" id="hbio_NonAffiliateShareHolding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
    <element name="DeferredFinancingCostsMember" id="hbio_DeferredFinancingCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
    <element name="DelayedDrawdownTermLoan" id="hbio_DelayedDrawdownTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
    <element name="RevolvingCreditFacility" id="hbio_RevolvingCreditFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>hbio-20170331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6 Using Fujitsu -->
<!-- Validation status: Passed -->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/instance http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccruedExpensesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccruedExpensesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccumulatedOtherComprehensiveIncomeDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/InventoriesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_InventoriesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LeasesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LeasesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_PropertyPlantAndEquipmentDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementsOfOperations" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfOperations" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfCashFlows" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfFinancialPosition" />
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementsOfOperations">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_71" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_72" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetIncomeLoss_71" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefit_72" order="23.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_73" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_74" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetIncomeLoss_73" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_74" order="22.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_111" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="Locator_us-gaap_OperatingIncomeLoss_112" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_111" xlink:to="Locator_us-gaap_OperatingIncomeLoss_112" order="14.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="Locator_us-gaap_OperatingIncomeLoss_75" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="Locator_us-gaap_GrossProfit_76" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingIncomeLoss_75" xlink:to="Locator_us-gaap_GrossProfit_76" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="Locator_us-gaap_GrossProfit_79" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="Locator_us-gaap_Revenues_80" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_GrossProfit_79" xlink:to="Locator_us-gaap_Revenues_80" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="Locator_us-gaap_GrossProfit_81" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="Locator_us-gaap_CostOfGoodsAndServicesSold_82" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_GrossProfit_81" xlink:to="Locator_us-gaap_CostOfGoodsAndServicesSold_82" order="2.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="Locator_us-gaap_OperatingIncomeLoss_77" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_78" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingIncomeLoss_77" xlink:to="Locator_us-gaap_OperatingExpenses_78" order="13.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_83" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="Locator_us-gaap_SellingAndMarketingExpense_84" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_83" xlink:to="Locator_us-gaap_SellingAndMarketingExpense_84" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_85" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="Locator_us-gaap_GeneralAndAdministrativeExpense_86" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_85" xlink:to="Locator_us-gaap_GeneralAndAdministrativeExpense_86" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_87" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpense_88" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_87" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpense_88" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_89" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_90" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_89" xlink:to="Locator_us-gaap_RestructuringCharges_90" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_91" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="Locator_us-gaap_AmortizationOfIntangibleAssets_92" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_91" xlink:to="Locator_us-gaap_AmortizationOfIntangibleAssets_92" order="8.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_93" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="Locator_us-gaap_OtherGeneralExpense_94" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_93" xlink:to="Locator_us-gaap_OtherGeneralExpense_94" order="12.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_95" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="Locator_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_96" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_95" xlink:to="Locator_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_96" order="9.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_97" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="Locator_us-gaap_AssetImpairmentCharges_98" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_97" xlink:to="Locator_us-gaap_AssetImpairmentCharges_98" order="10.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_99" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="Locator_us-gaap_GainLossOnSaleOfBusiness_100" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingExpenses_99" xlink:to="Locator_us-gaap_GainLossOnSaleOfBusiness_100" order="11.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_113" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_114" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_113" xlink:to="Locator_us-gaap_NonoperatingIncomeExpense_114" order="21.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_101" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_102" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NonoperatingIncomeExpense_101" xlink:to="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_102" order="16.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_103" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="Locator_us-gaap_InterestExpense_104" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NonoperatingIncomeExpense_103" xlink:to="Locator_us-gaap_InterestExpense_104" order="18.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_105" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInterestAndDividendIncome" xlink:label="Locator_us-gaap_OtherInterestAndDividendIncome_106" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NonoperatingIncomeExpense_105" xlink:to="Locator_us-gaap_OtherInterestAndDividendIncome_106" order="19.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_107" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="Locator_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_108" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NonoperatingIncomeExpense_107" xlink:to="Locator_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_108" order="17.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_109" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpense_110" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NonoperatingIncomeExpense_109" xlink:to="Locator_us-gaap_OtherNonoperatingIncomeExpense_110" order="20.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_129" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_130" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTax_129" xlink:to="Locator_us-gaap_NetIncomeLoss_130" order="24.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_131" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_132" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTax_131" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_132" order="36.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_133" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_134" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTax_133" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_134" order="38.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_135" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_136" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTax_135" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_136" order="39.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_137" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTax_137" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138" order="40.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_221" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_222" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_221" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentNet_222" order="10.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_223" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="Locator_us-gaap_DeferredTaxAssetsNetNoncurrent_224" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_223" xlink:to="Locator_us-gaap_DeferredTaxAssetsNetNoncurrent_224" order="11.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_225" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsNet_226" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_225" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsNet_226" order="12.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_227" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_228" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_227" xlink:to="Locator_us-gaap_Goodwill_228" order="13.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_229" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_230" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_229" xlink:to="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_230" order="14.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_231" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="Locator_us-gaap_OtherAssetsNoncurrent_232" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_231" xlink:to="Locator_us-gaap_OtherAssetsNoncurrent_232" order="15.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_233" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_234" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Assets_233" xlink:to="Locator_us-gaap_AssetsCurrent_234" order="9.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_235" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_236" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_235" xlink:to="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_236" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_237" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="Locator_us-gaap_AccountsReceivableNetCurrent_238" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_237" xlink:to="Locator_us-gaap_AccountsReceivableNetCurrent_238" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_239" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_240" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_239" xlink:to="Locator_us-gaap_InventoryNet_240" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_241" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="Locator_us-gaap_DeferredTaxAssetsNetCurrent_242" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_241" xlink:to="Locator_us-gaap_DeferredTaxAssetsNetCurrent_242" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_243" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="Locator_us-gaap_OtherAssetsCurrent_244" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_243" xlink:to="Locator_us-gaap_OtherAssetsCurrent_244" order="8.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_245" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="Locator_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_246" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_AssetsCurrent_245" xlink:to="Locator_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_246" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquity_247" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_248" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquity_247" xlink:to="Locator_us-gaap_Liabilities_248" order="31.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_251" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_252" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Liabilities_251" xlink:to="Locator_us-gaap_LiabilitiesCurrent_252" order="27.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_259" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="Locator_us-gaap_OtherLiabilitiesCurrent_260" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_259" xlink:to="Locator_us-gaap_OtherLiabilitiesCurrent_260" order="26.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_261" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="Locator_us-gaap_SecuredDebtCurrent_262" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_261" xlink:to="Locator_us-gaap_SecuredDebtCurrent_262" order="19.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_263" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="Locator_us-gaap_NotesPayableCurrent_264" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_263" xlink:to="Locator_us-gaap_NotesPayableCurrent_264" order="21.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_265" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="Locator_us-gaap_AccountsPayableCurrent_266" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_265" xlink:to="Locator_us-gaap_AccountsPayableCurrent_266" order="20.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_267" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="Locator_us-gaap_DeferredRevenueCurrent_268" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_267" xlink:to="Locator_us-gaap_DeferredRevenueCurrent_268" order="22.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_269" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="Locator_us-gaap_AccruedIncomeTaxesCurrent_270" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_269" xlink:to="Locator_us-gaap_AccruedIncomeTaxesCurrent_270" order="23.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_271" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesCurrent" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesCurrent_272" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_271" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesCurrent_272" order="24.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_273" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrent_274" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesCurrent_273" xlink:to="Locator_us-gaap_AccruedLiabilitiesCurrent_274" order="25.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_253" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_254" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Liabilities_253" xlink:to="Locator_us-gaap_LongTermDebtNoncurrent_254" order="28.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_255" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesNoncurrent_256" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Liabilities_255" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesNoncurrent_256" order="29.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_257" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="Locator_us-gaap_OtherAccruedLiabilitiesNoncurrent_258" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_Liabilities_257" xlink:to="Locator_us-gaap_OtherAccruedLiabilitiesNoncurrent_258" order="30.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquity_249" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_250" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquity_249" xlink:to="Locator_us-gaap_StockholdersEquity_250" order="40.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_275" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="Locator_us-gaap_PreferredStockValue_276" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_275" xlink:to="Locator_us-gaap_PreferredStockValue_276" order="34.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_277" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="Locator_us-gaap_CommonStockValue_278" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_277" xlink:to="Locator_us-gaap_CommonStockValue_278" order="35.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_279" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="Locator_us-gaap_AdditionalPaidInCapitalCommonStock_280" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_279" xlink:to="Locator_us-gaap_AdditionalPaidInCapitalCommonStock_280" order="36.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_281" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="Locator_us-gaap_RetainedEarningsAccumulatedDeficit_282" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_281" xlink:to="Locator_us-gaap_RetainedEarningsAccumulatedDeficit_282" order="37.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_283" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="Locator_us-gaap_TreasuryStockCarryingBasis_284" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_283" xlink:to="Locator_us-gaap_TreasuryStockCarryingBasis_284" order="39.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_285" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_286" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_StockholdersEquity_285" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_286" order="38.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_399" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="Locator_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_400" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_399" xlink:to="Locator_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_400" order="42.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_401" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_402" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_401" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_402" order="41.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_407" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="Locator_us-gaap_ProceedsFromIssuanceOfSecuredDebt_408" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_407" xlink:to="Locator_us-gaap_ProceedsFromIssuanceOfSecuredDebt_408" order="36.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_409" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="Locator_us-gaap_RepaymentsOfLongTermDebt_410" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_409" xlink:to="Locator_us-gaap_RepaymentsOfLongTermDebt_410" order="35.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_411" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_412" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_411" xlink:to="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_412" order="37.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_413" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="Locator_us-gaap_ProceedsFromIssuanceOfCommonStock_414" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_413" xlink:to="Locator_us-gaap_ProceedsFromIssuanceOfCommonStock_414" order="40.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_415" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="Locator_us-gaap_RepaymentsOfShortTermDebt_416" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_415" xlink:to="Locator_us-gaap_RepaymentsOfShortTermDebt_416" order="34.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_417" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferOfCashAndCashEquivalentsToHART" xlink:label="Locator_hbio_TransferOfCashAndCashEquivalentsToHART_418" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_417" xlink:to="Locator_hbio_TransferOfCashAndCashEquivalentsToHART_418" order="38.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_419" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="Locator_us-gaap_PaymentsOfDebtIssuanceCosts_420" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_419" xlink:to="Locator_us-gaap_PaymentsOfDebtIssuanceCosts_420" order="39.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_403" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_404" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_403" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_404" order="32.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_421" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAdditions_422" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_421" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentAdditions_422" order="27.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_423" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionsToCatalogCosts" xlink:label="Locator_hbio_AdditionsToCatalogCosts_424" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_423" xlink:to="Locator_hbio_AdditionsToCatalogCosts_424" order="28.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_425" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_426" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_425" xlink:to="Locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_426" order="30.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_427" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_428" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_427" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_428" order="31.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_429" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="Locator_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_430" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_429" xlink:to="Locator_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_430" order="29.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_405" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_406" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_405" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_406" order="25.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_431" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_432" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_431" xlink:to="Locator_us-gaap_NetIncomeLoss_432" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_433" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="Locator_us-gaap_StockOptionPlanExpense_434" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_433" xlink:to="Locator_us-gaap_StockOptionPlanExpense_434" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_435" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="Locator_us-gaap_Depreciation_436" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_435" xlink:to="Locator_us-gaap_Depreciation_436" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_437" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_438" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_437" xlink:to="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_438" order="8.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_439" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="Locator_us-gaap_GainLossOnDispositionOfAssets_440" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_439" xlink:to="Locator_us-gaap_GainLossOnDispositionOfAssets_440" order="9.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_441" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonCashRestructuringCharge" xlink:label="Locator_hbio_NonCashRestructuringCharge_442" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_441" xlink:to="Locator_hbio_NonCashRestructuringCharge_442" order="10.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_443" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AmortizationOfCatalogCosts" xlink:label="Locator_hbio_AmortizationOfCatalogCosts_444" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_443" xlink:to="Locator_hbio_AmortizationOfCatalogCosts_444" order="11.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_445" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="Locator_us-gaap_ProvisionForDoubtfulAccounts_446" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_445" xlink:to="Locator_us-gaap_ProvisionForDoubtfulAccounts_446" order="12.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_447" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="Locator_us-gaap_AmortizationOfIntangibleAssets_448" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_447" xlink:to="Locator_us-gaap_AmortizationOfIntangibleAssets_448" order="13.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_449" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="Locator_us-gaap_AmortizationOfFinancingCosts_450" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_449" xlink:to="Locator_us-gaap_AmortizationOfFinancingCosts_450" order="14.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_451" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_DeferredIncomeTaxExpenseBenefit_452" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_451" xlink:to="Locator_us-gaap_DeferredIncomeTaxExpenseBenefit_452" order="15.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_453" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccountsReceivable_454" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_453" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccountsReceivable_454" order="17.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_455" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="Locator_us-gaap_IncreaseDecreaseInInventories_456" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_455" xlink:to="Locator_us-gaap_IncreaseDecreaseInInventories_456" order="18.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_457" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="Locator_us-gaap_IncreaseDecreaseInOtherReceivables_458" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_457" xlink:to="Locator_us-gaap_IncreaseDecreaseInOtherReceivables_458" order="19.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_459" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade_460" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_459" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade_460" order="20.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_461" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_462" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_461" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_462" order="21.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_463" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccruedLiabilities_464" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_463" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccruedLiabilities_464" order="22.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_465" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="Locator_us-gaap_IncreaseDecreaseInDeferredRevenue_466" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_465" xlink:to="Locator_us-gaap_IncreaseDecreaseInDeferredRevenue_466" order="23.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_467" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="Locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_468" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_467" xlink:to="Locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_468" order="24.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_469" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="Locator_us-gaap_AssetImpairmentCharges_470" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_469" xlink:to="Locator_us-gaap_AssetImpairmentCharges_470" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_471" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="Locator_us-gaap_GainLossOnSaleOfBusiness_472" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_471" xlink:to="Locator_us-gaap_GainLossOnSaleOfBusiness_472" order="7.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_499" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_500" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebt_499" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_500" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_501" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_502" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebt_501" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_502" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_503" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_504" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebt_503" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_504" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_505" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_506" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebt_505" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_506" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_507" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_508" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebt_507" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_508" order="5.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="Locator_hbio_TotalIntangibleAssets_655" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_656" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalIntangibleAssets_655" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_656" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="Locator_hbio_TotalIntangibleAssets_657" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_658" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalIntangibleAssets_657" xlink:to="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_658" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_659" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_660" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_659" xlink:to="Locator_us-gaap_Goodwill_660" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_661" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_662" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_661" xlink:to="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_662" order="6.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/InventoriesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_705" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="Locator_us-gaap_InventoryFinishedGoods_706" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_InventoryNet_705" xlink:to="Locator_us-gaap_InventoryFinishedGoods_706" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_707" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="Locator_us-gaap_InventoryWorkInProcess_708" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_InventoryNet_707" xlink:to="Locator_us-gaap_InventoryWorkInProcess_708" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_709" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="Locator_us-gaap_InventoryRawMaterials_710" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_InventoryNet_709" xlink:to="Locator_us-gaap_InventoryRawMaterials_710" order="3.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsDetails1">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_969" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_970" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_969" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_970" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_973" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_974" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_973" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_974" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_975" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_976" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_975" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_976" order="3.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_971" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_972" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_971" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_972" order="9.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_977" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_978" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_977" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_978" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_979" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_980" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_979" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_980" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_981" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_982" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_981" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_982" order="8.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1219" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesOnPensionLiabilities" xlink:label="Locator_hbio_DeferredIncomeTaxesOnPensionLiabilities_1220" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1219" xlink:to="Locator_hbio_DeferredIncomeTaxesOnPensionLiabilities_1220" order="22.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1221" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:label="Locator_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_1222" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1221" xlink:to="Locator_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_1222" order="23.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1223" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanServiceCost_1224" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1223" xlink:to="Locator_us-gaap_DefinedBenefitPlanServiceCost_1224" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1225" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanInterestCost_1226" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1225" xlink:to="Locator_us-gaap_DefinedBenefitPlanInterestCost_1226" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1227" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1228" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1227" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1228" order="3.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1229" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1230" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1229" xlink:to="Locator_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1230" order="4.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1231" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="Locator_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1232" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1231" xlink:to="Locator_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1232" order="5.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LeasesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1261" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1262" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1261" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1262" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1263" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1264" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1263" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1264" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1265" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1266" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1265" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1266" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1267" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1268" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1267" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1268" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1269" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1270" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1269" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1270" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1271" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1272" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1271" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1272" order="6.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_2015" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentGross_2016" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentNet_2015" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentGross_2016" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_2017" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2018" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentNet_2017" xlink:to="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2018" order="3.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccruedExpensesDetails1">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2073" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="Locator_us-gaap_EmployeeRelatedLiabilitiesCurrent_2074" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalAccruedExpenses_2073" xlink:to="Locator_us-gaap_EmployeeRelatedLiabilitiesCurrent_2074" order="1.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2075" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="Locator_us-gaap_AccruedProfessionalFeesCurrent_2076" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalAccruedExpenses_2075" xlink:to="Locator_us-gaap_AccruedProfessionalFeesCurrent_2076" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2077" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="Locator_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2078" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalAccruedExpenses_2077" xlink:to="Locator_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2078" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2079" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="Locator_us-gaap_OtherAccruedLiabilitiesCurrent_2080" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalAccruedExpenses_2079" xlink:to="Locator_us-gaap_OtherAccruedLiabilitiesCurrent_2080" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2081" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="Locator_us-gaap_RestructuringReserveCurrent_2082" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_TotalAccruedExpenses_2081" xlink:to="Locator_us-gaap_RestructuringReserveCurrent_2082" order="3.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_2147" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2148" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefit_2147" xlink:to="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2148" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2151" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentForeignTaxExpenseBenefit_2152" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2151" xlink:to="Locator_us-gaap_CurrentForeignTaxExpenseBenefit_2152" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2153" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="Locator_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2154" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2153" xlink:to="Locator_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2154" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_2149" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="Locator_hbio_DeferredIncomeTaxesAmount_2150" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefit_2149" xlink:to="Locator_hbio_DeferredIncomeTaxesAmount_2150" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="Locator_hbio_DeferredIncomeTaxesAmount_2155" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="Locator_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2156" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_DeferredIncomeTaxesAmount_2155" xlink:to="Locator_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2156" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="Locator_hbio_DeferredIncomeTaxesAmount_2157" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2158" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_hbio_DeferredIncomeTaxesAmount_2157" xlink:to="Locator_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2158" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2143" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2144" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2143" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2144" order="26.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2145" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2146" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2145" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2146" order="27.0" weight="1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="Locator_us-gaap_DeferredTaxAssetsNet_2235" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2236" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsNet_2235" xlink:to="Locator_us-gaap_DeferredTaxAssetsGross_2236" order="12.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2215" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2216" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2215" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2216" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2217" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="Locator_us-gaap_DeferredTaxAssetsInventory_2218" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2217" xlink:to="Locator_us-gaap_DeferredTaxAssetsInventory_2218" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2219" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" xlink:label="Locator_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_2220" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2219" xlink:to="Locator_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_2220" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2221" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2222" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2221" xlink:to="Locator_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2222" order="5.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2223" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_2224" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2223" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_2224" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2225" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_2226" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2225" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_2226" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2227" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_2228" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2227" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_2228" order="8.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2229" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" xlink:label="Locator_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_2230" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2229" xlink:to="Locator_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_2230" order="9.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2231" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2232" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2231" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2232" order="10.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2233" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_2234" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsGross_2233" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_2234" order="11.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="Locator_us-gaap_DeferredTaxAssetsNet_2237" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="Locator_us-gaap_DeferredTaxAssetsValuationAllowance_2238" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_DeferredTaxAssetsNet_2237" xlink:to="Locator_us-gaap_DeferredTaxAssetsValuationAllowance_2238" order="13.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2865" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2866" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2865" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2866" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2867" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2868" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2867" xlink:to="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2868" order="4.0" weight="-1" />
    </calculationLink>
    <calculationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2923" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2924" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebtNoncurrent_2923" xlink:to="Locator_us-gaap_SecuredDebt_2924" order="6.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2929" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="Locator_us-gaap_LongTermLoansPayable_2930" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_SecuredDebt_2929" xlink:to="Locator_us-gaap_LongTermLoansPayable_2930" order="2.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2931" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoan" xlink:label="Locator_hbio_DelayedDrawdownTermLoan_2932" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_SecuredDebt_2931" xlink:to="Locator_hbio_DelayedDrawdownTermLoan_2932" order="3.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2933" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsNet_2934" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_SecuredDebt_2933" xlink:to="Locator_us-gaap_DeferredFinanceCostsNet_2934" order="5.0" weight="-1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2935" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RevolvingCreditFacility" xlink:label="Locator_hbio_RevolvingCreditFacility_2936" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_SecuredDebt_2935" xlink:to="Locator_hbio_RevolvingCreditFacility_2936" order="4.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2925" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="Locator_us-gaap_SecuredDebtCurrent_2926" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebtNoncurrent_2925" xlink:to="Locator_us-gaap_SecuredDebtCurrent_2926" order="7.0" weight="1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2927" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2928" />
        <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Locator_us-gaap_LongTermDebtNoncurrent_2927" xlink:to="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2928" order="8.0" weight="-1" />
    </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>hbio-20170331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6 Using Fujitsu -->
<!-- Validation status: Passed -->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/instance http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccumulatedOtherComprehensiveIncomeDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails3" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails3" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/ConcentrationsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_ConcentrationsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails3" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails3" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails4" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails4" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_FairValueMeasurementsDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_PropertyPlantAndEquipmentDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RelatedPartyTransactionsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCostsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCotsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SegmentAndRelatedInformationDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SummaryOfSignificantAccountingPolicyDetails1" />
    <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
    <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
    <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
    <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
    <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_665" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_666" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_665" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_666" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_681" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_682" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_681" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_682" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_667" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="Locator_us-gaap_DevelopedTechnologyRightsMember_668" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_667" xlink:to="Locator_us-gaap_DevelopedTechnologyRightsMember_668" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_669" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_670" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_669" xlink:to="Locator_us-gaap_TradeNamesMember_670" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_671" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_672" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_671" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_672" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_673" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember" xlink:label="Locator_us-gaap_PatentsMember_674" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_673" xlink:to="Locator_us-gaap_PatentsMember_674" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_675" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_676" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_675" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_676" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_677" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_678" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_677" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_678" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_643" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_644" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_643" xlink:to="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_644" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_664" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_664" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_679" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_680" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_679" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_680" order="3.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_747" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_748" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_747" xlink:to="Locator_us-gaap_RestructuringCharges_748" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_749" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:label="Locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_750" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_749" xlink:to="Locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_750" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_715" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_716" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_715" xlink:to="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_716" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_719" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_720" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_719" xlink:to="Locator_us-gaap_RestructuringCostAndReserveAxis_720" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_723" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_724" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RestructuringCostAndReserveAxis_723" xlink:to="Locator_us-gaap_TypeOfRestructuringDomain_724" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_725" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="Locator_us-gaap_EmployeeSeveranceMember_726" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_725" xlink:to="Locator_us-gaap_EmployeeSeveranceMember_726" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_727" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="Locator_hbio_FixedAssetsWriteOffMember_728" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_727" xlink:to="Locator_hbio_FixedAssetsWriteOffMember_728" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_729" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="Locator_hbio_OtherCostsMember_730" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_729" xlink:to="Locator_hbio_OtherCostsMember_730" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_731" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="Locator_hbio_InventoryImpairmentMember_732" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_731" xlink:to="Locator_hbio_InventoryImpairmentMember_732" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_721" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_722" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_721" xlink:to="Locator_us-gaap_RestructuringPlanAxis_722" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_733" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_734" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RestructuringPlanAxis_733" xlink:to="Locator_us-gaap_RestructuringPlanDomain_734" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_735" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2016ConsolidatedMember_736" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_735" xlink:to="Locator_hbio_RestructuringPlan2016ConsolidatedMember_736" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_737" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2015ConsolidatedMember_738" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_737" xlink:to="Locator_hbio_RestructuringPlan2015ConsolidatedMember_738" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_739" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_740" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_739" xlink:to="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_740" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_741" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="Locator_hbio_RestructuringPlan2010PlanBMember_742" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_741" xlink:to="Locator_hbio_RestructuringPlan2010PlanBMember_742" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_743" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="Locator_hbio_RestructuringPlan2013Member_744" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_743" xlink:to="Locator_hbio_RestructuringPlan2013Member_744" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_745" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="Locator_hbio_RestructuringPlanDecember2013Member_746" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_745" xlink:to="Locator_hbio_RestructuringPlanDecember2013Member_746" order="6.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_783" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_784" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_783" xlink:to="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_784" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_799" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_800" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_799" xlink:to="Locator_us-gaap_RestructuringCostAndReserveAxis_800" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_803" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_804" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RestructuringCostAndReserveAxis_803" xlink:to="Locator_us-gaap_TypeOfRestructuringDomain_804" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_849" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_850" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_RestructuringCostAndReserveAxis_849" xlink:to="Locator_us-gaap_TypeOfRestructuringDomain_850" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_805" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="Locator_us-gaap_EmployeeSeveranceMember_806" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_805" xlink:to="Locator_us-gaap_EmployeeSeveranceMember_806" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_807" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="Locator_hbio_FixedAssetsWriteOffMember_808" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_807" xlink:to="Locator_hbio_FixedAssetsWriteOffMember_808" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_809" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="Locator_hbio_OtherCostsMember_810" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_809" xlink:to="Locator_hbio_OtherCostsMember_810" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_811" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="Locator_hbio_InventoryImpairmentMember_812" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_811" xlink:to="Locator_hbio_InventoryImpairmentMember_812" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_801" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_802" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_801" xlink:to="Locator_us-gaap_RestructuringPlanAxis_802" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_813" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_814" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RestructuringPlanAxis_813" xlink:to="Locator_us-gaap_RestructuringPlanDomain_814" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_847" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_848" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_RestructuringPlanAxis_847" xlink:to="Locator_us-gaap_RestructuringPlanDomain_848" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_815" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2016ConsolidatedMember_816" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_815" xlink:to="Locator_hbio_RestructuringPlan2016ConsolidatedMember_816" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_817" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2015ConsolidatedMember_818" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_817" xlink:to="Locator_hbio_RestructuringPlan2015ConsolidatedMember_818" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_819" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_820" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_819" xlink:to="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_820" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_821" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="Locator_hbio_RestructuringPlan2010PlanBMember_822" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_821" xlink:to="Locator_hbio_RestructuringPlan2010PlanBMember_822" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_823" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="Locator_hbio_RestructuringPlan2013Member_824" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_823" xlink:to="Locator_hbio_RestructuringPlan2013Member_824" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_825" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="Locator_hbio_RestructuringPlanDecember2013Member_826" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_825" xlink:to="Locator_hbio_RestructuringPlanDecember2013Member_826" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_827" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014Member" xlink:label="Locator_hbio_RestructuringPlan2014Member_828" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_827" xlink:to="Locator_hbio_RestructuringPlan2014Member_828" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_829" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ12015Member" xlink:label="Locator_hbio_RestructuringPlanQ12015Member_830" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_829" xlink:to="Locator_hbio_RestructuringPlanQ12015Member_830" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_831" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ22015Member" xlink:label="Locator_hbio_RestructuringPlanQ22015Member_832" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_831" xlink:to="Locator_hbio_RestructuringPlanQ22015Member_832" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_833" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ42015Member" xlink:label="Locator_hbio_RestructuringPlanQ42015Member_834" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringPlanDomain_833" xlink:to="Locator_hbio_RestructuringPlanQ42015Member_834" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_835" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_836" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_835" xlink:to="Locator_us-gaap_RestructuringReserveRollForward_836" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_837" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="Locator_us-gaap_RestructuringReserve_838" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_837" xlink:to="Locator_us-gaap_RestructuringReserve_838" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_839" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_840" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_839" xlink:to="Locator_us-gaap_RestructuringCharges_840" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_841" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="Locator_us-gaap_PaymentsForRestructuring_842" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_841" xlink:to="Locator_us-gaap_PaymentsForRestructuring_842" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_843" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1" xlink:label="Locator_us-gaap_RestructuringReserveAccrualAdjustment1_844" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_843" xlink:to="Locator_us-gaap_RestructuringReserveAccrualAdjustment1_844" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_845" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment" xlink:label="Locator_us-gaap_RestructuringReserveTranslationAdjustment_846" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_845" xlink:to="Locator_us-gaap_RestructuringReserveTranslationAdjustment_846" order="5.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_913" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="Locator_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_914" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_913" xlink:to="Locator_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_914" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_915" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesGross_916" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_915" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesGross_916" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_917" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" xlink:label="Locator_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_918" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_917" xlink:to="Locator_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_918" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_919" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="Locator_us-gaap_NumberOfBusinessesAcquired_920" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_919" xlink:to="Locator_us-gaap_NumberOfBusinessesAcquired_920" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_921" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease" xlink:label="Locator_us-gaap_GoodwillOtherIncreaseDecrease_922" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_921" xlink:to="Locator_us-gaap_GoodwillOtherIncreaseDecrease_922" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_899" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_900" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_899" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_900" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_903" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_904" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_903" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_904" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_905" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_906" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_905" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_906" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_907" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_908" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_907" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_908" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_909" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="Locator_hbio_ModularSfcAcquisitionMember_910" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_909" xlink:to="Locator_hbio_ModularSfcAcquisitionMember_910" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_911" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_912" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_911" xlink:to="Locator_hbio_CmaAcquisitionMember_912" order="3.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1019" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_1020" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1019" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_1020" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1021" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_1022" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1021" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_1022" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1023" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_1024" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1023" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_1024" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1025" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1026" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1025" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1026" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1027" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_1028" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1027" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_1028" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1029" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_1030" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1029" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_1030" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1031" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_1032" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1031" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_1032" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1033" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_1034" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1033" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_1034" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1035" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_1036" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_1035" xlink:to="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_1036" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1037" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1038" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1037" xlink:to="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1038" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1039" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesGross_1040" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1039" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesGross_1040" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1041" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" xlink:label="Locator_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_1042" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_1041" xlink:to="Locator_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_1042" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1043" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="Locator_us-gaap_BusinessAcquisitionsProFormaRevenue_1044" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1043" xlink:to="Locator_us-gaap_BusinessAcquisitionsProFormaRevenue_1044" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1045" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="Locator_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1046" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_1045" xlink:to="Locator_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1046" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_949" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_950" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_949" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_950" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_985" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_986" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_985" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_986" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_989" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_990" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_989" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_990" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_991" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnpatentedTechnologyMember" xlink:label="Locator_us-gaap_UnpatentedTechnologyMember_992" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_991" xlink:to="Locator_us-gaap_UnpatentedTechnologyMember_992" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_997" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentedTechnologyMember" xlink:label="Locator_us-gaap_PatentedTechnologyMember_998" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_997" xlink:to="Locator_us-gaap_PatentedTechnologyMember_998" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_999" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="Locator_us-gaap_NoncompeteAgreementsMember_1000" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_999" xlink:to="Locator_us-gaap_NoncompeteAgreementsMember_1000" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_995" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_996" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_995" xlink:to="Locator_us-gaap_TradeNamesMember_996" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_993" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_994" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_993" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_994" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_987" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="Locator_us-gaap_SubsequentEventTypeAxis_988" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_987" xlink:to="Locator_us-gaap_SubsequentEventTypeAxis_988" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="Locator_us-gaap_SubsequentEventTypeAxis_1015" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="Locator_us-gaap_SubsequentEventTypeDomain_1016" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_SubsequentEventTypeAxis_1015" xlink:to="Locator_us-gaap_SubsequentEventTypeDomain_1016" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="Locator_us-gaap_SubsequentEventTypeAxis_1047" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="Locator_us-gaap_SubsequentEventTypeDomain_1048" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_SubsequentEventTypeAxis_1047" xlink:to="Locator_us-gaap_SubsequentEventTypeDomain_1048" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="Locator_us-gaap_SubsequentEventTypeDomain_1017" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="Locator_us-gaap_SubsequentEventMember_1018" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SubsequentEventTypeDomain_1017" xlink:to="Locator_us-gaap_SubsequentEventMember_1018" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_983" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_984" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_983" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_984" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_1001" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1002" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_1001" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1002" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_1049" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1050" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_1049" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1050" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1003" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1004" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1003" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1004" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1005" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="Locator_hbio_ModularSfcAcquisitionMember_1006" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1005" xlink:to="Locator_hbio_ModularSfcAcquisitionMember_1006" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1007" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_1008" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1007" xlink:to="Locator_hbio_CmaAcquisitionMember_1008" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1009" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1010" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1009" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1010" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1011" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="Locator_hbio_TriangleBiosystemsIncMember_1012" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1011" xlink:to="Locator_hbio_TriangleBiosystemsIncMember_1012" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1013" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_1014" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1013" xlink:to="Locator_hbio_HekaElektronikMember_1014" order="6.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_1359" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1360" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RangeAxis_1359" xlink:to="Locator_us-gaap_RangeMember_1360" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1363" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="Locator_us-gaap_MaximumMember_1364" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RangeMember_1363" xlink:to="Locator_us-gaap_MaximumMember_1364" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1361" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="Locator_us-gaap_MinimumMember_1362" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RangeMember_1361" xlink:to="Locator_us-gaap_MinimumMember_1362" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1369" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfStockRepurchaseProgramAuthorized" xlink:label="Locator_hbio_DateOfStockRepurchaseProgramAuthorized_1370" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1369" xlink:to="Locator_hbio_DateOfStockRepurchaseProgramAuthorized_1370" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1371" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="Locator_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1372" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1371" xlink:to="Locator_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1372" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1373" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="Locator_us-gaap_StockRepurchaseProgramPeriodInForce1_1374" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1373" xlink:to="Locator_us-gaap_StockRepurchaseProgramPeriodInForce1_1374" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1375" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="Locator_us-gaap_TreasuryStockSharesAcquired_1376" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1375" xlink:to="Locator_us-gaap_TreasuryStockSharesAcquired_1376" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1377" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_1378" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1377" xlink:to="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_1378" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1379" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram" xlink:label="Locator_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_1380" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1379" xlink:to="Locator_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_1380" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1381" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" xlink:label="Locator_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_1382" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1381" xlink:to="Locator_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_1382" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1383" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_1384" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1383" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_1384" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1385" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EmployeeStockPurchasePlanSharesAuthorized" xlink:label="Locator_hbio_EmployeeStockPurchasePlanSharesAuthorized_1386" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1385" xlink:to="Locator_hbio_EmployeeStockPurchasePlanSharesAuthorized_1386" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1387" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1388" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1387" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1388" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1389" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" xlink:label="Locator_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_1390" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1389" xlink:to="Locator_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_1390" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1391" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1392" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1391" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1392" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1395" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_1396" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1395" xlink:to="Locator_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_1396" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1397" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleSharesIssuanceRatio" xlink:label="Locator_hbio_FungibleSharesIssuanceRatio_1398" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1397" xlink:to="Locator_hbio_FungibleSharesIssuanceRatio_1398" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1401" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1402" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1401" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1402" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1403" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="Locator_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_1404" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1403" xlink:to="Locator_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_1404" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1405" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="Locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1406" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1405" xlink:to="Locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1406" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1407" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1408" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1407" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1408" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1409" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PercentageOfOutstandingCommonStock" xlink:label="Locator_hbio_PercentageOfOutstandingCommonStock_1410" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1409" xlink:to="Locator_hbio_PercentageOfOutstandingCommonStock_1410" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1411" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" xlink:label="Locator_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_1412" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1411" xlink:to="Locator_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_1412" order="22.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1413" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares" xlink:label="Locator_us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares_1414" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1413" xlink:to="Locator_us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares_1414" order="23.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1415" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards" xlink:label="Locator_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_1416" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1415" xlink:to="Locator_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_1416" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1417" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncentiveStockOptionsGrantedToDate" xlink:label="Locator_hbio_IncentiveStockOptionsGrantedToDate_1418" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1417" xlink:to="Locator_hbio_IncentiveStockOptionsGrantedToDate_1418" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1419" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonQualifiedStockOptionsGrantedToDate" xlink:label="Locator_hbio_NonQualifiedStockOptionsGrantedToDate_1420" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1419" xlink:to="Locator_hbio_NonQualifiedStockOptionsGrantedToDate_1420" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1421" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CommonStockMarketValuePerShareOnReportingDate" xlink:label="Locator_hbio_CommonStockMarketValuePerShareOnReportingDate_1422" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1421" xlink:to="Locator_hbio_CommonStockMarketValuePerShareOnReportingDate_1422" order="27.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1423" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1424" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1423" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1424" order="28.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1425" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate" xlink:label="Locator_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_1426" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1425" xlink:to="Locator_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_1426" order="29.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1427" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1428" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1427" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1428" order="30.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1429" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1430" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1429" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1430" order="31.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1431" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AnnualizedEstimatedForfeitureRate" xlink:label="Locator_hbio_AnnualizedEstimatedForfeitureRate_1432" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1431" xlink:to="Locator_hbio_AnnualizedEstimatedForfeitureRate_1432" order="32.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1433" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants" xlink:label="Locator_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_1434" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1433" xlink:to="Locator_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_1434" order="33.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1435" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalOptionsGrantedDueToHartSpinoff" xlink:label="Locator_hbio_IncrementalOptionsGrantedDueToHartSpinoff_1436" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1435" xlink:to="Locator_hbio_IncrementalOptionsGrantedDueToHartSpinoff_1436" order="34.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1437" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalUnitsGrantedDueToHartSpinoff" xlink:label="Locator_hbio_IncrementalUnitsGrantedDueToHartSpinoff_1438" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1437" xlink:to="Locator_hbio_IncrementalUnitsGrantedDueToHartSpinoff_1438" order="35.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1441" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1442" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1441" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1442" order="37.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1444" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1444" order="38.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1445" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1" xlink:label="Locator_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_1446" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1445" xlink:to="Locator_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_1446" order="39.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1351" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1352" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1351" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1352" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1355" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_1356" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1355" xlink:to="Locator_us-gaap_RangeAxis_1356" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1357" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1358" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1357" xlink:to="Locator_us-gaap_AwardTypeAxis_1358" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1365" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1366" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_AwardTypeAxis_1365" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1366" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1447" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1448" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_AwardTypeAxis_1447" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1448" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1367" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="Locator_hbio_MarketConditionRestrictedStockUnitMember_1368" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1367" xlink:to="Locator_hbio_MarketConditionRestrictedStockUnitMember_1368" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1393" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1394" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1393" xlink:to="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1394" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1399" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1400" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1399" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1400" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1439" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="Locator_us-gaap_PreferredStockSharesAuthorized_1440" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1439" xlink:to="Locator_us-gaap_PreferredStockSharesAuthorized_1440" order="36.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1531" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1532" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1531" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1532" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1545" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1546" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1545" xlink:to="Locator_us-gaap_AwardTypeAxis_1546" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1547" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1548" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_AwardTypeAxis_1547" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1548" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1549" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="Locator_hbio_MarketConditionRestrictedStockUnitMember_1550" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1549" xlink:to="Locator_hbio_MarketConditionRestrictedStockUnitMember_1550" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1551" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1552" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1551" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1552" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1555" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1556" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1555" xlink:to="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1556" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1557" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1558" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1557" xlink:to="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1558" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1559" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsIssued" xlink:label="Locator_hbio_StockOptionsAndRestrictedStockUnitsIssued_1560" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1559" xlink:to="Locator_hbio_StockOptionsAndRestrictedStockUnitsIssued_1560" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1561" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1562" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1561" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1562" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1563" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1564" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1563" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1564" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1565" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted" xlink:label="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_1566" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1565" xlink:to="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_1566" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1567" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1568" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1567" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1568" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1569" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="Locator_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1570" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1569" xlink:to="Locator_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1570" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1571" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1572" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1571" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1572" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1573" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1574" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1573" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1574" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1575" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1576" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1575" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1576" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1577" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1578" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1577" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1578" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1579" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1580" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1579" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1580" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1581" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1582" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1581" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1582" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1583" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1584" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1583" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1584" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1585" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1586" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1585" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1586" order="23.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1587" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1588" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1587" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1588" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1589" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1590" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1589" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1590" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1591" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1592" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1591" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1592" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1593" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1594" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1593" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1594" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1595" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1596" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1595" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1596" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1597" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" xlink:label="Locator_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_1598" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1597" xlink:to="Locator_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_1598" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1599" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" xlink:label="Locator_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_1600" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1599" xlink:to="Locator_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_1600" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1601" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1602" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1601" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1602" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1603" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1604" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1603" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1604" order="27.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1605" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsCancelled" xlink:label="Locator_hbio_StockOptionsAndRestrictedStockUnitsCancelled_1606" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1605" xlink:to="Locator_hbio_StockOptionsAndRestrictedStockUnitsCancelled_1606" order="28.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1607" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1608" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1607" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1608" order="29.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1609" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1610" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1609" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1610" order="30.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1611" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled" xlink:label="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_1612" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1611" xlink:to="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_1612" order="31.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1613" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="Locator_us-gaap_PreferredStockSharesAuthorized_1614" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1613" xlink:to="Locator_us-gaap_PreferredStockSharesAuthorized_1614" order="32.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1615" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" xlink:label="Locator_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_1616" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1615" xlink:to="Locator_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_1616" order="33.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1553" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1554" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1553" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1554" order="2.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_1665" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_1666" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_CreditAgreementTable_1665" xlink:to="Locator_hbio_CreditAgreementAxis_1666" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_1667" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1668" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_hbio_CreditAgreementAxis_1667" xlink:to="Locator_hbio_CreditAgreementDomain_1668" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_1707" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1708" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_hbio_CreditAgreementAxis_1707" xlink:to="Locator_hbio_CreditAgreementDomain_1708" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1671" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_1672" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_1671" xlink:to="Locator_us-gaap_SecuredDebtMember_1672" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1673" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_1674" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_1673" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_1674" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1669" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="Locator_us-gaap_RevolvingCreditFacilityMember_1670" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_1669" xlink:to="Locator_us-gaap_RevolvingCreditFacilityMember_1670" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1657" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_1658" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_hbio_CreditAgreementLineItems_1657" xlink:to="Locator_hbio_CreditAgreementTable_1658" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1675" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PreviousApprovedCreditFacility" xlink:label="Locator_hbio_PreviousApprovedCreditFacility_1676" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1675" xlink:to="Locator_hbio_PreviousApprovedCreditFacility_1676" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1677" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_1678" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1677" xlink:to="Locator_us-gaap_SecuredDebt_1678" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1679" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="Locator_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1680" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1679" xlink:to="Locator_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1680" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1681" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Maturitydates" xlink:label="Locator_hbio_Maturitydates_1682" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1681" xlink:to="Locator_hbio_Maturitydates_1682" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1683" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1684" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1683" xlink:to="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1684" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1685" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_1686" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1685" xlink:to="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_1686" order="6.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1687" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="Locator_us-gaap_LineOfCredit_1688" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1687" xlink:to="Locator_us-gaap_LineOfCredit_1688" order="7.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1689" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="Locator_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1690" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1689" xlink:to="Locator_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1690" order="8.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1691" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InterestRateInExcessOfLiborOnCreditFacility" xlink:label="Locator_hbio_InterestRateInExcessOfLiborOnCreditFacility_1692" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1691" xlink:to="Locator_hbio_InterestRateInExcessOfLiborOnCreditFacility_1692" order="9.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1693" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SecuredDebtInterestRateAtPeriodEnd" xlink:label="Locator_hbio_SecuredDebtInterestRateAtPeriodEnd_1694" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1693" xlink:to="Locator_hbio_SecuredDebtInterestRateAtPeriodEnd_1694" order="10.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1695" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="Locator_hbio_LiborFixedRate_1696" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1695" xlink:to="Locator_hbio_LiborFixedRate_1696" order="11.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1697" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="Locator_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_1698" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1697" xlink:to="Locator_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_1698" order="12.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1699" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="Locator_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1700" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1699" xlink:to="Locator_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1700" order="13.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1701" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" xlink:label="Locator_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_1702" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1701" xlink:to="Locator_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_1702" order="14.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1703" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" xlink:label="Locator_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_1704" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1703" xlink:to="Locator_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_1704" order="15.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1705" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="Locator_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1706" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementLineItems_1705" xlink:to="Locator_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1706" order="16.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1801" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1802" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_1801" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_1802" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1803" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1804" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1803" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1804" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1773" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1774" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1773" xlink:to="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1774" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1775" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="Locator_hbio_TaxCreditExpirationAxis_1776" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1775" xlink:to="Locator_hbio_TaxCreditExpirationAxis_1776" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="Locator_hbio_TaxCreditExpirationAxis_1805" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1806" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_hbio_TaxCreditExpirationAxis_1805" xlink:to="Locator_hbio_TaxCreditExpirationDomain_1806" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="Locator_hbio_TaxCreditExpirationAxis_1827" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1828" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_hbio_TaxCreditExpirationAxis_1827" xlink:to="Locator_hbio_TaxCreditExpirationDomain_1828" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1807" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2017Member" xlink:label="Locator_hbio_TaxCreditExpire2017Member_1808" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1807" xlink:to="Locator_hbio_TaxCreditExpire2017Member_1808" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1809" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2020Member" xlink:label="Locator_hbio_TaxCreditExpire2020Member_1810" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1809" xlink:to="Locator_hbio_TaxCreditExpire2020Member_1810" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1811" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2022Member" xlink:label="Locator_hbio_TaxCreditExpire2022Member_1812" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1811" xlink:to="Locator_hbio_TaxCreditExpire2022Member_1812" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1777" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1778" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1777" xlink:to="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1778" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1783" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1784" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1783" xlink:to="Locator_hbio_TypesOfAcquisitionsDomain_1784" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1829" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1830" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1829" xlink:to="Locator_hbio_TypesOfAcquisitionsDomain_1830" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1785" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_1786" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1785" xlink:to="Locator_hbio_CmaAcquisitionMember_1786" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1787" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1788" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1787" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1788" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1789" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1790" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1789" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1790" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1791" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_1792" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1791" xlink:to="Locator_hbio_HekaElektronikMember_1792" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1779" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="Locator_us-gaap_IncomeTaxAuthorityAxis_1780" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1779" xlink:to="Locator_us-gaap_IncomeTaxAuthorityAxis_1780" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="Locator_us-gaap_IncomeTaxAuthorityAxis_1793" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1794" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_IncomeTaxAuthorityAxis_1793" xlink:to="Locator_us-gaap_IncomeTaxAuthorityDomain_1794" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="Locator_us-gaap_IncomeTaxAuthorityAxis_1831" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1832" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_IncomeTaxAuthorityAxis_1831" xlink:to="Locator_us-gaap_IncomeTaxAuthorityDomain_1832" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1795" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="Locator_us-gaap_DomesticCountryMember_1796" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1795" xlink:to="Locator_us-gaap_DomesticCountryMember_1796" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1797" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="Locator_us-gaap_StateAndLocalJurisdictionMember_1798" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1797" xlink:to="Locator_us-gaap_StateAndLocalJurisdictionMember_1798" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1799" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="Locator_us-gaap_ForeignCountryMember_1800" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1799" xlink:to="Locator_us-gaap_ForeignCountryMember_1800" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1781" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1782" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1781" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_1782" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1813" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions" xlink:label="Locator_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_1814" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1813" xlink:to="Locator_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_1814" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1815" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxRateReconciliationDeductionsStockOptions" xlink:label="Locator_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_1816" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1815" xlink:to="Locator_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_1816" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1817" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="Locator_us-gaap_OperatingLossCarryforwards_1818" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1817" xlink:to="Locator_us-gaap_OperatingLossCarryforwards_1818" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1819" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OperatingLossCarryforwardsExpirationYear" xlink:label="Locator_hbio_OperatingLossCarryforwardsExpirationYear_1820" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1819" xlink:to="Locator_hbio_OperatingLossCarryforwardsExpirationYear_1820" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1821" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="Locator_us-gaap_TaxCreditCarryforwardAmount_1822" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1821" xlink:to="Locator_us-gaap_TaxCreditCarryforwardAmount_1822" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1823" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditCarryforwardsExpirationYear" xlink:label="Locator_hbio_TaxCreditCarryforwardsExpirationYear_1824" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1823" xlink:to="Locator_hbio_TaxCreditCarryforwardsExpirationYear_1824" order="6.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1825" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_1826" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1825" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_1826" order="7.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1897" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1898" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_1897" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_1898" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1911" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1912" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_1911" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_1912" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1899" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="Locator_us-gaap_CostOfSalesMember_1900" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1899" xlink:to="Locator_us-gaap_CostOfSalesMember_1900" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1901" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1902" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1901" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1902" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1903" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="Locator_us-gaap_SellingAndMarketingExpenseMember_1904" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1903" xlink:to="Locator_us-gaap_SellingAndMarketingExpenseMember_1904" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1905" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="Locator_us-gaap_GeneralAndAdministrativeExpenseMember_1906" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1905" xlink:to="Locator_us-gaap_GeneralAndAdministrativeExpenseMember_1906" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1907" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DiscontinuedOperationsMember" xlink:label="Locator_hbio_DiscontinuedOperationsMember_1908" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1907" xlink:to="Locator_hbio_DiscontinuedOperationsMember_1908" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1889" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1890" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1889" xlink:to="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1890" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1895" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1896" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1895" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_1896" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1909" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="Locator_us-gaap_ShareBasedCompensation_1910" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1909" xlink:to="Locator_us-gaap_ShareBasedCompensation_1910" order="1.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/ConcentrationsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1973" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="Locator_us-gaap_ConcentrationRiskTable_1974" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1973" xlink:to="Locator_us-gaap_ConcentrationRiskTable_1974" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="Locator_us-gaap_ConcentrationRiskTable_1977" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1978" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ConcentrationRiskTable_1977" xlink:to="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1978" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1979" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1980" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1979" xlink:to="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1980" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1993" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1994" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1993" xlink:to="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1994" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1981" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNetMember" xlink:label="Locator_us-gaap_SalesRevenueGoodsNetMember_1982" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1981" xlink:to="Locator_us-gaap_SalesRevenueGoodsNetMember_1982" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1983" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="Locator_us-gaap_AccountsReceivableMember_1984" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_1983" xlink:to="Locator_us-gaap_AccountsReceivableMember_1984" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1985" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCustomer" xlink:label="Locator_us-gaap_ConcentrationRiskCustomer_1986" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1985" xlink:to="Locator_us-gaap_ConcentrationRiskCustomer_1986" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1987" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContribution" xlink:label="Locator_hbio_NumberOfCustomersWithBenchmarkContribution_1988" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1987" xlink:to="Locator_hbio_NumberOfCustomersWithBenchmarkContribution_1988" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1989" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="Locator_us-gaap_ConcentrationRiskPercentage1_1990" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1989" xlink:to="Locator_us-gaap_ConcentrationRiskPercentage1_1990" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1991" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" xlink:label="Locator_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_1992" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1991" xlink:to="Locator_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_1992" order="4.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2035" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentGross_2036" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2035" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentGross_2036" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2037" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2038" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2037" xlink:to="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2038" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2039" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_2040" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2039" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentNet_2040" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2011" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2012" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2011" xlink:to="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2012" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2019" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2020" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2019" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2020" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2021" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2022" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2021" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2022" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2041" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2042" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2041" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2042" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2033" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:label="Locator_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2034" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2033" xlink:to="Locator_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2034" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2023" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="Locator_us-gaap_LandBuildingsAndImprovementsMember_2024" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2023" xlink:to="Locator_us-gaap_LandBuildingsAndImprovementsMember_2024" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2025" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="Locator_us-gaap_MachineryAndEquipmentMember_2026" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2025" xlink:to="Locator_us-gaap_MachineryAndEquipmentMember_2026" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2027" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="Locator_us-gaap_ComputerEquipmentMember_2028" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2027" xlink:to="Locator_us-gaap_ComputerEquipmentMember_2028" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2029" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="Locator_us-gaap_FurnitureAndFixturesMember_2030" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2029" xlink:to="Locator_us-gaap_FurnitureAndFixturesMember_2030" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2031" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="Locator_us-gaap_AutomobilesMember_2032" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2031" xlink:to="Locator_us-gaap_AutomobilesMember_2032" order="5.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails3">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2271" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2272" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2271" xlink:to="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2272" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2243" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2244" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2243" xlink:to="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2244" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2247" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2248" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2247" xlink:to="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2248" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2251" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2252" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2251" xlink:to="Locator_us-gaap_PlanAssetCategoriesDomain_2252" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2273" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2274" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2273" xlink:to="Locator_us-gaap_PlanAssetCategoriesDomain_2274" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2253" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="Locator_us-gaap_EquitySecuritiesMember_2254" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2253" xlink:to="Locator_us-gaap_EquitySecuritiesMember_2254" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2255" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="Locator_us-gaap_DebtSecuritiesMember_2256" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2255" xlink:to="Locator_us-gaap_DebtSecuritiesMember_2256" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2257" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="Locator_us-gaap_CashAndCashEquivalentsMember_2258" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2257" xlink:to="Locator_us-gaap_CashAndCashEquivalentsMember_2258" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2259" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="Locator_us-gaap_OtherAssetsMember_2260" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2259" xlink:to="Locator_us-gaap_OtherAssetsMember_2260" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2249" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2250" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2249" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2250" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2261" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2262" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2261" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2262" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2275" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2276" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2275" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2276" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2263" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="Locator_us-gaap_FairValueInputsLevel1Member_2264" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2263" xlink:to="Locator_us-gaap_FairValueInputsLevel1Member_2264" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2265" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="Locator_us-gaap_FairValueInputsLevel2Member_2266" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2265" xlink:to="Locator_us-gaap_FairValueInputsLevel2Member_2266" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2267" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2268" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2267" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2268" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2269" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2270" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2269" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2270" order="1.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails4">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2311" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2312" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2311" xlink:to="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2312" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2315" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2316" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2315" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2316" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2317" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2318" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2317" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2318" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2319" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2320" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2319" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2320" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2321" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2322" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2321" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2322" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2323" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanPurchasesDuringYear" xlink:label="Locator_hbio_DefinedBenefitPlanPurchasesDuringYear_2324" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2323" xlink:to="Locator_hbio_DefinedBenefitPlanPurchasesDuringYear_2324" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2325" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanUnrealizedLossGain" xlink:label="Locator_hbio_DefinedBenefitPlanUnrealizedLossGain_2326" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2325" xlink:to="Locator_hbio_DefinedBenefitPlanUnrealizedLossGain_2326" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2327" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2328" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2327" xlink:to="Locator_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2328" order="4.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails3">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2353" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2354" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2353" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2354" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2357" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2358" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2357" xlink:to="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2358" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2359" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2360" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2359" xlink:to="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2360" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2431" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2432" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2431" xlink:to="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2432" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2361" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" xlink:label="Locator_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_2362" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2361" xlink:to="Locator_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_2362" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2363" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" xlink:label="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_2364" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2363" xlink:to="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_2364" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2365" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" xlink:label="Locator_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_2366" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2365" xlink:to="Locator_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_2366" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2367" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_2368" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2367" xlink:to="Locator_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_2368" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2369" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember" xlink:label="Locator_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_2370" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2369" xlink:to="Locator_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_2370" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2371" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" xlink:label="Locator_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_2372" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2371" xlink:to="Locator_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_2372" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2373" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" xlink:label="Locator_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_2374" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2373" xlink:to="Locator_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_2374" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2375" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" xlink:label="Locator_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_2376" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2375" xlink:to="Locator_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_2376" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2377" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" xlink:label="Locator_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_2378" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2377" xlink:to="Locator_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_2378" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2379" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="Locator_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_2380" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2379" xlink:to="Locator_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_2380" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2381" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="Locator_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_2382" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2381" xlink:to="Locator_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_2382" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2383" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" xlink:label="Locator_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_2384" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2383" xlink:to="Locator_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_2384" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2385" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFourtyFiveCentsMember" xlink:label="Locator_hbio_TwoDollarsFourtyFiveCentsMember_2386" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2385" xlink:to="Locator_hbio_TwoDollarsFourtyFiveCentsMember_2386" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2387" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftySixCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftySixCentsMember_2388" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2387" xlink:to="Locator_hbio_TwoDollarsFiftySixCentsMember_2388" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2389" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_2390" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2389" xlink:to="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_2390" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2391" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyFourCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyFourCentsMember_2392" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2391" xlink:to="Locator_hbio_ThreeDollarsSixtyFourCentsMember_2392" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2393" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_2394" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2393" xlink:to="Locator_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_2394" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2395" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFourCentsMember" xlink:label="Locator_hbio_FourDollarsFourCentsMember_2396" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2395" xlink:to="Locator_hbio_FourDollarsFourCentsMember_2396" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2397" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" xlink:label="Locator_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_2398" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2397" xlink:to="Locator_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_2398" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2399" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="Locator_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_2400" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2399" xlink:to="Locator_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_2400" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2401" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" xlink:label="Locator_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_2402" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2401" xlink:to="Locator_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_2402" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2403" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" xlink:label="Locator_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_2404" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2403" xlink:to="Locator_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_2404" order="22.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2405" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="Locator_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_2406" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2405" xlink:to="Locator_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_2406" order="23.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2407" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" xlink:label="Locator_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_2408" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2407" xlink:to="Locator_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_2408" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2409" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" xlink:label="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_2410" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2409" xlink:to="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_2410" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2411" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_2412" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2411" xlink:to="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_2412" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2413" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_2414" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2413" xlink:to="Locator_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_2414" order="27.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2415" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2416" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2415" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2416" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2417" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2418" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2417" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2418" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2419" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2420" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2419" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2420" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2421" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2422" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2421" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2422" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2423" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2424" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2423" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2424" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2425" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2426" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2425" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2426" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2427" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2428" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2427" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2428" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2429" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2430" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2429" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2430" order="8.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2499" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2500" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2499" xlink:to="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2500" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2503" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="Locator_us-gaap_StatementGeographicalAxis_2504" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2503" xlink:to="Locator_us-gaap_StatementGeographicalAxis_2504" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="Locator_us-gaap_StatementGeographicalAxis_2505" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2506" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_StatementGeographicalAxis_2505" xlink:to="Locator_us-gaap_SegmentGeographicalDomain_2506" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="Locator_us-gaap_StatementGeographicalAxis_2523" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2524" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_StatementGeographicalAxis_2523" xlink:to="Locator_us-gaap_SegmentGeographicalDomain_2524" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2507" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="Locator_country_US_2508" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2507" xlink:to="Locator_country_US_2508" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2509" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_DE" xlink:label="Locator_country_DE_2510" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2509" xlink:to="Locator_country_DE_2510" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2511" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_GB" xlink:label="Locator_country_GB_2512" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2511" xlink:to="Locator_country_GB_2512" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2513" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestOfTheWorldMember" xlink:label="Locator_hbio_RestOfTheWorldMember_2514" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2513" xlink:to="Locator_hbio_RestOfTheWorldMember_2514" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2515" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="Locator_us-gaap_IntersegmentEliminationMember_2516" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2515" xlink:to="Locator_us-gaap_IntersegmentEliminationMember_2516" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2517" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="Locator_us-gaap_Revenues_2518" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2517" xlink:to="Locator_us-gaap_Revenues_2518" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2519" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SegmentReportingInformationNetAssets1" xlink:label="Locator_hbio_SegmentReportingInformationNetAssets1_2520" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2519" xlink:to="Locator_hbio_SegmentReportingInformationNetAssets1_2520" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2521" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="Locator_us-gaap_NoncurrentAssets_2522" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2521" xlink:to="Locator_us-gaap_NoncurrentAssets_2522" order="3.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2579" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2580" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2579" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2580" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2581" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="Locator_us-gaap_DevelopedTechnologyRightsMember_2582" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2581" xlink:to="Locator_us-gaap_DevelopedTechnologyRightsMember_2582" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2583" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_2584" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2583" xlink:to="Locator_us-gaap_TradeNamesMember_2584" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2585" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DistributionRightsMember" xlink:label="Locator_us-gaap_DistributionRightsMember_2586" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2585" xlink:to="Locator_us-gaap_DistributionRightsMember_2586" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2587" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_2588" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2587" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_2588" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2589" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember" xlink:label="Locator_us-gaap_PatentsMember_2590" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2589" xlink:to="Locator_us-gaap_PatentsMember_2590" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2557" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2558" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2557" xlink:to="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2558" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2571" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2572" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2571" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2572" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2573" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2574" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2573" xlink:to="Locator_us-gaap_RangeAxis_2574" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2591" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2592" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_RangeAxis_2591" xlink:to="Locator_us-gaap_RangeMember_2592" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2613" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2614" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_RangeAxis_2613" xlink:to="Locator_us-gaap_RangeMember_2614" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2593" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="Locator_us-gaap_MaximumMember_2594" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RangeMember_2593" xlink:to="Locator_us-gaap_MaximumMember_2594" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2595" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="Locator_us-gaap_MinimumMember_2596" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_RangeMember_2595" xlink:to="Locator_us-gaap_MinimumMember_2596" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2609" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2610" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2609" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2610" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2561" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2562" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2561" xlink:to="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2562" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2575" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2576" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2575" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2576" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2597" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2598" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2597" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2598" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2599" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="Locator_us-gaap_LandBuildingsAndImprovementsMember_2600" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2599" xlink:to="Locator_us-gaap_LandBuildingsAndImprovementsMember_2600" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2601" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="Locator_us-gaap_MachineryAndEquipmentMember_2602" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2601" xlink:to="Locator_us-gaap_MachineryAndEquipmentMember_2602" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2603" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="Locator_us-gaap_ComputerEquipmentMember_2604" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2603" xlink:to="Locator_us-gaap_ComputerEquipmentMember_2604" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2605" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="Locator_us-gaap_FurnitureAndFixturesMember_2606" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2605" xlink:to="Locator_us-gaap_FurnitureAndFixturesMember_2606" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2607" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="Locator_us-gaap_AutomobilesMember_2608" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2607" xlink:to="Locator_us-gaap_AutomobilesMember_2608" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2577" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2578" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2577" xlink:to="Locator_us-gaap_RangeAxis_2578" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2611" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentUsefulLife_2612" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2611" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentUsefulLife_2612" order="1.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2679" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2680" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2679" xlink:to="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2680" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2683" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="Locator_us-gaap_DerivativeInstrumentRiskAxis_2684" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2683" xlink:to="Locator_us-gaap_DerivativeInstrumentRiskAxis_2684" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="Locator_us-gaap_DerivativeInstrumentRiskAxis_2685" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2686" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_DerivativeInstrumentRiskAxis_2685" xlink:to="Locator_us-gaap_DerivativeContractTypeDomain_2686" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="Locator_us-gaap_DerivativeInstrumentRiskAxis_2703" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2704" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_DerivativeInstrumentRiskAxis_2703" xlink:to="Locator_us-gaap_DerivativeContractTypeDomain_2704" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2687" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_2688" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeContractTypeDomain_2687" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_2688" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2689" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_2690" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeContractTypeDomain_2689" xlink:to="Locator_us-gaap_SecuredDebtMember_2690" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2691" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_2692" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2691" xlink:to="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_2692" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2693" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="Locator_us-gaap_DerivativeAssetNotionalAmount_2694" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2693" xlink:to="Locator_us-gaap_DerivativeAssetNotionalAmount_2694" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2695" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="Locator_hbio_LiborFixedRate_2696" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2695" xlink:to="Locator_hbio_LiborFixedRate_2696" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2697" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_2698" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2697" xlink:to="Locator_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_2698" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2699" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2700" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2699" xlink:to="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2700" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2701" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DerivativeInterestRateSwapEffectivePercentage" xlink:label="Locator_hbio_DerivativeInterestRateSwapEffectivePercentage_2702" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2701" xlink:to="Locator_hbio_DerivativeInterestRateSwapEffectivePercentage_2702" order="6.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2727" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2728" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2727" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2728" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2741" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2742" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2741" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2742" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2729" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2730" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2729" xlink:to="Locator_us-gaap_InterestRateSwapMember_2730" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2719" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2720" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DerivativesFairValueLineItems_2719" xlink:to="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2720" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2723" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="Locator_us-gaap_BalanceSheetLocationAxis_2724" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2723" xlink:to="Locator_us-gaap_BalanceSheetLocationAxis_2724" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="Locator_us-gaap_BalanceSheetLocationAxis_2731" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="Locator_us-gaap_BalanceSheetLocationDomain_2732" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_BalanceSheetLocationAxis_2731" xlink:to="Locator_us-gaap_BalanceSheetLocationDomain_2732" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="Locator_us-gaap_BalanceSheetLocationAxis_2739" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="Locator_us-gaap_BalanceSheetLocationDomain_2740" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_BalanceSheetLocationAxis_2739" xlink:to="Locator_us-gaap_BalanceSheetLocationDomain_2740" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="Locator_us-gaap_BalanceSheetLocationDomain_2733" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="Locator_us-gaap_OtherLiabilitiesMember_2734" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BalanceSheetLocationDomain_2733" xlink:to="Locator_us-gaap_OtherLiabilitiesMember_2734" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2725" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2726" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2725" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2726" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2735" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="Locator_invest_DerivativeNotionalAmount_2736" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativesFairValueLineItems_2735" xlink:to="Locator_invest_DerivativeNotionalAmount_2736" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2737" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="Locator_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_2738" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativesFairValueLineItems_2737" xlink:to="Locator_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_2738" order="2.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2761" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2762" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2761" xlink:to="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2762" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2765" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2766" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2765" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2766" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2769" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2770" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2769" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2770" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2771" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2772" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2771" xlink:to="Locator_us-gaap_InterestRateSwapMember_2772" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2767" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_2768" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2767" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_2768" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_2773" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_2774" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_2773" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_2774" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_2775" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="Locator_us-gaap_InterestExpenseMember_2776" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_2775" xlink:to="Locator_us-gaap_InterestExpenseMember_2776" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2777" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion" xlink:label="Locator_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion_2778" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2777" xlink:to="Locator_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion_2778" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2779" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:label="Locator_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_2780" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2779" xlink:to="Locator_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_2780" order="2.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/FairValueMeasurementsDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2812" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2812" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2813" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="Locator_us-gaap_FairValueInputsLevel1Member_2814" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2813" xlink:to="Locator_us-gaap_FairValueInputsLevel1Member_2814" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2815" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="Locator_us-gaap_FairValueInputsLevel2Member_2816" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2815" xlink:to="Locator_us-gaap_FairValueInputsLevel2Member_2816" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2817" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2818" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2817" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2818" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2819" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2820" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2819" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2820" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2821" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2822" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2821" xlink:to="Locator_us-gaap_InterestRateSwapMember_2822" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2803" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2804" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2803" xlink:to="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2804" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2807" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2808" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2807" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2808" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2809" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2810" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2809" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2810" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2823" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="Locator_us-gaap_DerivativeLiabilities_2824" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2823" xlink:to="Locator_us-gaap_DerivativeLiabilities_2824" order="1.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2861" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2862" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2861" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2862" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2869" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="Locator_us-gaap_StatementEquityComponentsAxis_2870" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2869" xlink:to="Locator_us-gaap_StatementEquityComponentsAxis_2870" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="Locator_us-gaap_StatementEquityComponentsAxis_2871" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2872" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_StatementEquityComponentsAxis_2871" xlink:to="Locator_us-gaap_EquityComponentDomain_2872" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="Locator_us-gaap_StatementEquityComponentsAxis_2887" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2888" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="Locator_us-gaap_StatementEquityComponentsAxis_2887" xlink:to="Locator_us-gaap_EquityComponentDomain_2888" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2873" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="Locator_us-gaap_AccumulatedTranslationAdjustmentMember_2874" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_EquityComponentDomain_2873" xlink:to="Locator_us-gaap_AccumulatedTranslationAdjustmentMember_2874" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2875" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="Locator_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2876" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_EquityComponentDomain_2875" xlink:to="Locator_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2876" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2877" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="Locator_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2878" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_EquityComponentDomain_2877" xlink:to="Locator_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2878" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2879" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2880" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2879" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2880" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2881" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2882" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2881" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2882" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2883" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2884" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2883" xlink:to="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2884" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2885" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2886" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2885" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2886" order="4.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2917" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_2918" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2917" xlink:to="Locator_hbio_CreditAgreementTable_2918" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_2937" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_2938" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_hbio_CreditAgreementTable_2937" xlink:to="Locator_hbio_CreditAgreementAxis_2938" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_2939" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2940" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_hbio_CreditAgreementAxis_2939" xlink:to="Locator_hbio_CreditAgreementDomain_2940" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2941" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_2942" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_2941" xlink:to="Locator_us-gaap_SecuredDebtMember_2942" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2943" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_2944" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_2943" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_2944" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2945" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="Locator_us-gaap_RevolvingCreditFacilityMember_2946" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_2945" xlink:to="Locator_us-gaap_RevolvingCreditFacilityMember_2946" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2947" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFinancingCostsMember" xlink:label="Locator_hbio_DeferredFinancingCostsMember_2948" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_hbio_CreditAgreementDomain_2947" xlink:to="Locator_hbio_DeferredFinancingCostsMember_2948" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2949" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="Locator_us-gaap_LongTermLoansPayable_2950" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2949" xlink:to="Locator_us-gaap_LongTermLoansPayable_2950" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2951" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoan" xlink:label="Locator_hbio_DelayedDrawdownTermLoan_2952" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2951" xlink:to="Locator_hbio_DelayedDrawdownTermLoan_2952" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2953" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RevolvingCreditFacility" xlink:label="Locator_hbio_RevolvingCreditFacility_2954" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2953" xlink:to="Locator_hbio_RevolvingCreditFacility_2954" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2955" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsNet_2956" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2955" xlink:to="Locator_us-gaap_DeferredFinanceCostsNet_2956" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2957" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2958" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2957" xlink:to="Locator_us-gaap_SecuredDebt_2958" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2959" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="Locator_us-gaap_SecuredDebtCurrent_2960" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2959" xlink:to="Locator_us-gaap_SecuredDebtCurrent_2960" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2961" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2962" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2961" xlink:to="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2962" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2963" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2964" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2963" xlink:to="Locator_us-gaap_LongTermDebtNoncurrent_2964" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2965" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="Locator_us-gaap_UnamortizedDebtIssuanceExpense_2966" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_LongTermDebtNoncurrent_2965" xlink:to="Locator_us-gaap_UnamortizedDebtIssuanceExpense_2966" order="1.0" />
    </definitionLink>
    <definitionLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_2989" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2990" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_2989" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2990" order="-1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2993" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_2994" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2993" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_2994" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_2995" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2996" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_2995" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2996" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2997" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_2998" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2997" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_2998" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2999" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="Locator_hbio_TriangleBiosystemsIncMember_3000" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_2999" xlink:to="Locator_hbio_TriangleBiosystemsIncMember_3000" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3001" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_3002" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3001" xlink:to="Locator_hbio_HekaElektronikMember_3002" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_3003" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="Locator_us-gaap_OperatingLeasesRentExpenseNet_3004" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_3003" xlink:to="Locator_us-gaap_OperatingLeasesRentExpenseNet_3004" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_3005" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="Locator_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_3006" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_3005" xlink:to="Locator_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_3006" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_3007" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransitionServicesChargedToSpinnee" xlink:label="Locator_hbio_TransitionServicesChargedToSpinnee_3008" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_3007" xlink:to="Locator_hbio_TransitionServicesChargedToSpinnee_3008" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_3009" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DistributionRevenuesFromSpinnee" xlink:label="Locator_hbio_DistributionRevenuesFromSpinnee_3010" />
        <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_3009" xlink:to="Locator_hbio_DistributionRevenuesFromSpinnee_3010" order="4.0" />
    </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>hbio-20170331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6 Using Fujitsu -->
<!-- Validation status: Passed -->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/instance http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
    <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="element1" />
        <label xlink:type="resource" xlink:label="label1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_invest_DerivativeNotionalAmount_en-US">Notional Amount of Interest Rate Derivatives</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1" xlink:to="label1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="element2" />
        <label xlink:type="resource" xlink:label="label2" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_AmendmentDescription_en-US">Amendment description</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element2" xlink:to="label2" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="element3" />
        <label xlink:type="resource" xlink:label="label3" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_AmendmentFlag_en-US">Amendment flag</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element3" xlink:to="label3" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="element4" />
        <label xlink:type="resource" xlink:label="label4" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_CurrentFiscalYearEndDate_en-US">Current fiscal year end date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element4" xlink:to="label4" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="element5" />
        <label xlink:type="resource" xlink:label="label5" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_DocumentPeriodEndDate_en-US">Document period end date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element5" xlink:to="label5" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="element6" />
        <label xlink:type="resource" xlink:label="label6" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_TradingSymbol_en-US">Trading Symbol</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element6" xlink:to="label6" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="element7" />
        <label xlink:type="resource" xlink:label="label7" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityWellKnownSeasonedIssuer_en-US">Entity well known seasoned issuer</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element7" xlink:to="label7" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="element8" />
        <label xlink:type="resource" xlink:label="label8" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityVoluntaryFilers_en-US">Entity voluntary filers</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element8" xlink:to="label8" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="element9" />
        <label xlink:type="resource" xlink:label="label9" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityCurrentReportingStatus_en-US">Entity current reporting status</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element9" xlink:to="label9" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="element10" />
        <label xlink:type="resource" xlink:label="label10" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityFilerCategory_en-US">Entity filer category</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element10" xlink:to="label10" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="element11" />
        <label xlink:type="resource" xlink:label="label11" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityPublicFloat_en-US">Entity public float</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element11" xlink:to="label11" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="element12" />
        <label xlink:type="resource" xlink:label="label12" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityRegistrantName_en-US">Entity registrant name</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element12" xlink:to="label12" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="element13" />
        <label xlink:type="resource" xlink:label="label13" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityCentralIndexKey_en-US">Entity central index key</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element13" xlink:to="label13" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="element14" />
        <label xlink:type="resource" xlink:label="label14" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_EntityCommonStockSharesOutstanding_en-US">Entity common stock shares outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element14" xlink:to="label14" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="element15" />
        <label xlink:type="resource" xlink:label="label15" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_DocumentFiscalYearFocus_en-US">Document Fiscal Year Focus</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element15" xlink:to="label15" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="element16" />
        <label xlink:type="resource" xlink:label="label16" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_DocumentFiscalPeriodFocus_en-US">Document Period Focus</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element16" xlink:to="label16" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="element17" />
        <label xlink:type="resource" xlink:label="label17" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_dei_DocumentType_en-US">Document Type</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element17" xlink:to="label17" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="element18" />
        <label xlink:type="resource" xlink:label="label18" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AreaOfRealEstateProperty_en-US">Square Footage of Real Estate Property</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element18" xlink:to="label18" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="element19" />
        <label xlink:type="resource" xlink:label="label19" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AwardTypeAxis_en-US">Award Type [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element19" xlink:to="label19" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="element20" />
        <label xlink:type="resource" xlink:label="label20" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AutomobilesMember_en-US">Automobiles [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element20" xlink:to="label20" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="element21" />
        <label xlink:type="resource" xlink:label="label21" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccountingPoliciesAbstract_en-US">Summary of Significant Accounting Policies [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element21" xlink:to="label21" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="element22" />
        <label xlink:type="resource" xlink:label="label22" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccountsReceivableMember_en-US">Accounts Receivable [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element22" xlink:to="label22" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="element23" />
        <label xlink:type="resource" xlink:label="label23" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccountsPayableCurrent_en-US">Accounts payable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element23" xlink:to="label23" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="element24" />
        <label xlink:type="resource" xlink:label="label24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AccountsPayableCurrent_en-US">Accounts payable and accrued expeneses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element24" xlink:to="label24" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="element25" />
        <label xlink:type="resource" xlink:label="label25" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccountsReceivableNetCurrent_en-US">Accounts receivable, net of allowance for doubtful accounts of $559 and $611, respectively</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element25" xlink:to="label25" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="element26" />
        <label xlink:type="resource" xlink:label="label26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AccountsReceivableNetCurrent_en-US">Accounts receivable, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element26" xlink:to="label26" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="element27" />
        <label xlink:type="resource" xlink:label="label27" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrentAbstract_en-US">Accrued Liabilities Current [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element27" xlink:to="label27" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="element28" />
        <label xlink:type="resource" xlink:label="label28" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccruedProfessionalFeesCurrent_en-US">Accrued Professional Fees Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element28" xlink:to="label28" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="element29" />
        <label xlink:type="resource" xlink:label="label29" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent_en-US">Accrued expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element29" xlink:to="label29" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="element30" />
        <label xlink:type="resource" xlink:label="label30" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccruedIncomeTaxesCurrent_en-US">Accrued income taxes payable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element30" xlink:to="label30" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="element31" />
        <label xlink:type="resource" xlink:label="label31" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_en-US">Accumulated Other Comprehensive Income (Loss) [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element31" xlink:to="label31" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="element32" />
        <label xlink:type="resource" xlink:label="label32" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element32" xlink:to="label32" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="element33" />
        <label xlink:type="resource" xlink:label="label33" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element33" xlink:to="label33" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="element34" />
        <label xlink:type="resource" xlink:label="label34" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element34" xlink:to="label34" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="element35" />
        <label xlink:type="resource" xlink:label="label35" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_en-US">Accumulated Defined Benefit Plans Adjustment [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element35" xlink:to="label35" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="element36" />
        <label xlink:type="resource" xlink:label="label36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_en-US">Defined benefit pension plans</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element36" xlink:to="label36" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="element37" />
        <label xlink:type="resource" xlink:label="label37" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedTranslationAdjustmentMember_en-US">Foreign currency translation adjustment [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element37" xlink:to="label37" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="element38" />
        <label xlink:type="resource" xlink:label="label38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AccumulatedTranslationAdjustmentMember_en-US">Foreign currency translation adjustments</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element38" xlink:to="label38" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="element39" />
        <label xlink:type="resource" xlink:label="label39" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_en-US">Accumulated Other Comprehensive Income [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element39" xlink:to="label39" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="element40" />
        <label xlink:type="resource" xlink:label="label40" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element40" xlink:to="label40" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="element41" />
        <label xlink:type="resource" xlink:label="label41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_en-US">Derivatives qualifying as hedges</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element41" xlink:to="label41" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="element42" />
        <label xlink:type="resource" xlink:label="label42" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_en-US">Accumulated other comprehensive loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element42" xlink:to="label42" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="element43" />
        <label xlink:type="resource" xlink:label="label43" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_en-US">Opening Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element43" xlink:to="label43" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="element44" />
        <label xlink:type="resource" xlink:label="label44" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_en-US">Closing Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element44" xlink:to="label44" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="element45" />
        <label xlink:type="resource" xlink:label="label45" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalCommonStock_en-US">Additional paid-in-capital</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element45" xlink:to="label45" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="element46" />
        <label xlink:type="resource" xlink:label="label46" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_en-US">Adjustments to reconcile net income to net cash provided by operating activities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element46" xlink:to="label46" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="element47" />
        <label xlink:type="resource" xlink:label="label47" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AdvertisingCostsPolicyTextBlock_en-US">Catalog Costs [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element47" xlink:to="label47" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="element48" />
        <label xlink:type="resource" xlink:label="label48" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_en-US">Allowance for doubtful accounts</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element48" xlink:to="label48" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="element49" />
        <label xlink:type="resource" xlink:label="label49" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AmortizationOfFinancingCosts_en-US">Amortization of deferred financing costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element49" xlink:to="label49" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="element50" />
        <label xlink:type="resource" xlink:label="label50" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AmortizationOfIntangibleAssets_en-US">Amortization of intangible assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element50" xlink:to="label50" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="element51" />
        <label xlink:type="resource" xlink:label="label51" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element51" xlink:to="label51" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="element52" />
        <label xlink:type="resource" xlink:label="label52" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AssetImpairmentCharges_en-US">Asset Impairment Charges</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element52" xlink:to="label52" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="element53" />
        <label xlink:type="resource" xlink:label="label53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_AssetImpairmentCharges_en-US">Impairment charges</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element53" xlink:to="label53" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="element54" />
        <label xlink:type="resource" xlink:label="label54" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Assets_en-US">Total Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element54" xlink:to="label54" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="element55" />
        <label xlink:type="resource" xlink:label="label55" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_Assets_en-US">Total Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element55" xlink:to="label55" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="element56" />
        <label xlink:type="resource" xlink:label="label56" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AssetsAbstract_en-US">Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element56" xlink:to="label56" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="element57" />
        <label xlink:type="resource" xlink:label="label57" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_en-US">Assets Held For Sale Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element57" xlink:to="label57" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="element58" />
        <label xlink:type="resource" xlink:label="label58" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract_en-US">Current Assets:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element58" xlink:to="label58" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="element59" />
        <label xlink:type="resource" xlink:label="label59" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_AssetsCurrent_en-US">Total current assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element59" xlink:to="label59" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="element60" />
        <label xlink:type="resource" xlink:label="label60" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_AssetsCurrent_en-US">Total current assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element60" xlink:to="label60" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="element61" />
        <label xlink:type="resource" xlink:label="label61" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BalanceSheetLocationAxis_en-US">Balance Sheet Location [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element61" xlink:to="label61" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="element62" />
        <label xlink:type="resource" xlink:label="label62" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BalanceSheetLocationDomain_en-US">Balance Sheet Location [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element62" xlink:to="label62" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="element63" />
        <label xlink:type="resource" xlink:label="label63" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAxis_en-US">Business Acquisition [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element63" xlink:to="label63" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="element64" />
        <label xlink:type="resource" xlink:label="label64" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_en-US">Business Acquisition, Effective Date of Acquisition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element64" xlink:to="label64" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="element65" />
        <label xlink:type="resource" xlink:label="label65" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_en-US">Changes in fair value of acquisition contingencies</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element65" xlink:to="label65" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="element66" />
        <label xlink:type="resource" xlink:label="label66" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_en-US">Gain on acquisition contingencies</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element66" xlink:to="label66" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="element67" />
        <label xlink:type="resource" xlink:label="label67" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAcquireeDomain_en-US">Business Acquisition, Acquiree [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element67" xlink:to="label67" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="element68" />
        <label xlink:type="resource" xlink:label="label68" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionsProFormaRevenue_en-US">Business Acquisitions Pro Forma Revenue</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element68" xlink:to="label68" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="element69" />
        <label xlink:type="resource" xlink:label="label69" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessCombinationsAbstract_en-US">Business Combinations [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element69" xlink:to="label69" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="element70" />
        <label xlink:type="resource" xlink:label="label70" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_en-US">Business Acquisitions Pro Forma Net Income Loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element70" xlink:to="label70" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="element71" />
        <label xlink:type="resource" xlink:label="label71" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionLineItems_en-US">Business Acquisition [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element71" xlink:to="label71" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="element72" />
        <label xlink:type="resource" xlink:label="label72" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessCombinationDisclosureTextBlock_en-US">Acquisitions Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element72" xlink:to="label72" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="element73" />
        <label xlink:type="resource" xlink:label="label73" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_BusinessCombinationDescriptionAbstract_en-US">Acquisition Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element73" xlink:to="label73" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="element74" />
        <label xlink:type="resource" xlink:label="label74" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_CashAndCashEquivalentsAtCarryingValue_en-US">Cash and cash equivalents at the begining of period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element74" xlink:to="label74" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="element75" />
        <label xlink:type="resource" xlink:label="label75" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_en-US">Cash and cash equivalents</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element75" xlink:to="label75" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="element76" />
        <label xlink:type="resource" xlink:label="label76" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_CashAndCashEquivalentsAtCarryingValue_en-US">Cash and cash equivalents at the end of period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element76" xlink:to="label76" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="element77" />
        <label xlink:type="resource" xlink:label="label77" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_en-US">Cash and Cash Equivalents [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element77" xlink:to="label77" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="element78" />
        <label xlink:type="resource" xlink:label="label78" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_en-US">Increase in cash and cash equivalents</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element78" xlink:to="label78" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="element79" />
        <label xlink:type="resource" xlink:label="label79" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_en-US">Increase in cash and cash equivalents</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element79" xlink:to="label79" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="element80" />
        <label xlink:type="resource" xlink:label="label80" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsMember_en-US">Cash and Cash Equivalents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element80" xlink:to="label80" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="element81" />
        <label xlink:type="resource" xlink:label="label81" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_en-US">Commitments and Contingencies Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element81" xlink:to="label81" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="element82" />
        <label xlink:type="resource" xlink:label="label82" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies_en-US">Commitments and contingencies</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element82" xlink:to="label82" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="element83" />
        <label xlink:type="resource" xlink:label="label83" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_en-US">Commitments and Contingencies Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element83" xlink:to="label83" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="element84" />
        <label xlink:type="resource" xlink:label="label84" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_en-US">Common Stock- Shares Issued</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element84" xlink:to="label84" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="element85" />
        <label xlink:type="resource" xlink:label="label85" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized_en-US">Common Stock- Shares Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element85" xlink:to="label85" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="element86" />
        <label xlink:type="resource" xlink:label="label86" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommonStockValue_en-US">Common stock, par value $0.01 per share, 80,000,000 shares authorized; 42,364,404 and 42,186,827 shares issued and 34,618,897 and 34,441,320 shares outstanding, respectively</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element86" xlink:to="label86" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="element87" />
        <label xlink:type="resource" xlink:label="label87" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare_en-US">Common stock par value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element87" xlink:to="label87" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="element88" />
        <label xlink:type="resource" xlink:label="label88" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_en-US">Common Stock- Shares Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element88" xlink:to="label88" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="element89" />
        <label xlink:type="resource" xlink:label="label89" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_en-US">Components Of Deferred Tax Assets And Liabilities [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element89" xlink:to="label89" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="element90" />
        <label xlink:type="resource" xlink:label="label90" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_en-US">Comprehensive Income Net of Tax [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element90" xlink:to="label90" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="element91" />
        <label xlink:type="resource" xlink:label="label91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_en-US">Comprehensive loss:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element91" xlink:to="label91" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="element92" />
        <label xlink:type="resource" xlink:label="label92" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNoteTextBlock_en-US">Accumulated Other Comprehensive Income Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element92" xlink:to="label92" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="element93" />
        <label xlink:type="resource" xlink:label="label93" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax_en-US">Total Comprehensive Income (Loss), Net of Tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element93" xlink:to="label93" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="element94" />
        <label xlink:type="resource" xlink:label="label94" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_ComprehensiveIncomeNetOfTax_en-US">Total Comprehensive Income (Loss), Net of Tax, total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element94" xlink:to="label94" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="element95" />
        <label xlink:type="resource" xlink:label="label95" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember_en-US">Computer Equipment [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element95" xlink:to="label95" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="element96" />
        <label xlink:type="resource" xlink:label="label96" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskByBenchmarkAxis_en-US">Concentration Risk by Benchmark [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element96" xlink:to="label96" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="element97" />
        <label xlink:type="resource" xlink:label="label97" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskDisclosureTextBlock_en-US">Concentrations Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element97" xlink:to="label97" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="element98" />
        <label xlink:type="resource" xlink:label="label98" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskLineItems_en-US">Concentration Risk [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element98" xlink:to="label98" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="element99" />
        <label xlink:type="resource" xlink:label="label99" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskBenchmarkDomain_en-US">Concentration Risk Benchmark [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element99" xlink:to="label99" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="element100" />
        <label xlink:type="resource" xlink:label="label100" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskTable_en-US">Concentration Risk [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element100" xlink:to="label100" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:label="element101" />
        <label xlink:type="resource" xlink:label="label101" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_en-US">Concentrations [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element101" xlink:to="label101" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCustomer" xlink:label="element102" />
        <label xlink:type="resource" xlink:label="label102" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskCustomer_en-US">Concentration Risk, Customer</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element102" xlink:to="label102" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="element103" />
        <label xlink:type="resource" xlink:label="label103" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskPercentage1_en-US">Concentration Risk, Percentage</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element103" xlink:to="label103" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="element104" />
        <label xlink:type="resource" xlink:label="label104" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ConsolidationPolicyTextBlock_en-US">Principles of Consolidation [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element104" xlink:to="label104" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="element105" />
        <label xlink:type="resource" xlink:label="label105" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CostOfGoodsAndServicesSold_en-US">Cost of revenues (exclusive of items shown separately below)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element105" xlink:to="label105" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="element106" />
        <label xlink:type="resource" xlink:label="label106" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CostOfSalesMember_en-US">Cost of Sales [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element106" xlink:to="label106" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1" xlink:label="element107" />
        <label xlink:type="resource" xlink:label="label107" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_en-US">Cumulative Effect On Retained Earnings Before Tax1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element107" xlink:to="label107" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1" xlink:label="element108" />
        <label xlink:type="resource" xlink:label="label108" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_en-US">Cumulative effect adjustment to retained earnings</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element108" xlink:to="label108" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="element109" />
        <label xlink:type="resource" xlink:label="label109" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CurrentIncomeTaxExpenseBenefit_en-US">Current Income Tax Expense (Benefit) From Continuing Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element109" xlink:to="label109" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="element110" />
        <label xlink:type="resource" xlink:label="label110" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_CurrentIncomeTaxExpenseBenefit_en-US">Current Income Tax Expense (Benefit), Total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element110" xlink:to="label110" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="element111" />
        <label xlink:type="resource" xlink:label="label111" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CurrentForeignTaxExpenseBenefit_en-US">Current Foreign Income Tax Expense (benefit) From Continuing Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element111" xlink:to="label111" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="element112" />
        <label xlink:type="resource" xlink:label="label112" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_CustomerRelationshipsMember_en-US">Customer Relationships [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element112" xlink:to="label112" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="element113" />
        <label xlink:type="resource" xlink:label="label113" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DebtInstrumentLineItems_en-US">Debt Instrument [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element113" xlink:to="label113" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="element114" />
        <label xlink:type="resource" xlink:label="label114" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DebtInstrumentLineItems_en-US">Debt Instrument</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element114" xlink:to="label114" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="element115" />
        <label xlink:type="resource" xlink:label="label115" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_en-US">Debt Instrument, Description Of Variable Rate Basis</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element115" xlink:to="label115" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="element116" />
        <label xlink:type="resource" xlink:label="label116" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_en-US">Basis Spread Over LIBOR</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element116" xlink:to="label116" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="element117" />
        <label xlink:type="resource" xlink:label="label117" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DebtSecuritiesMember_en-US">Debt Securities [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element117" xlink:to="label117" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="element118" />
        <label xlink:type="resource" xlink:label="label118" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_en-US">Deferred Tax Assets Property Plant And Equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element118" xlink:to="label118" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="element119" />
        <label xlink:type="resource" xlink:label="label119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_en-US">Property, plant and equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element119" xlink:to="label119" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="element120" />
        <label xlink:type="resource" xlink:label="label120" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_en-US">Deferred Compensation Arrangement with Individual, Maximum Contractual Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element120" xlink:to="label120" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="element121" />
        <label xlink:type="resource" xlink:label="label121" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredFinanceCostsCurrentNet_en-US">Deferred Finance Costs Current Net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element121" xlink:to="label121" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="element122" />
        <label xlink:type="resource" xlink:label="label122" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DeferredFinanceCostsCurrentNet_en-US">Current unamortized deferred financing costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element122" xlink:to="label122" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="element123" />
        <label xlink:type="resource" xlink:label="label123" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredFinanceCostsNet_en-US">DeferredFinanceCostsNet</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element123" xlink:to="label123" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="element124" />
        <label xlink:type="resource" xlink:label="label124" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xml:lang="en-US" id="NegatedTerse_us-gaap_DeferredFinanceCostsNet_en-US">Total unamortized deferred financing costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element124" xlink:to="label124" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="element125" />
        <label xlink:type="resource" xlink:label="label125" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_en-US">Deferred Foreign Income Tax Expense (Benefit)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element125" xlink:to="label125" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="element126" />
        <label xlink:type="resource" xlink:label="label126" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredRevenueCurrent_en-US">Deferred revenue</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element126" xlink:to="label126" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="element127" />
        <label xlink:type="resource" xlink:label="label127" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredIncomeTaxExpenseBenefit_en-US">Deferrred Income Taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element127" xlink:to="label127" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="element128" />
        <label xlink:type="resource" xlink:label="label128" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_DeferredIncomeTaxExpenseBenefit_en-US">Deferrred Income Taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element128" xlink:to="label128" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="element129" />
        <label xlink:type="resource" xlink:label="label129" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNet_en-US">Deferred Tax Assets, Net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element129" xlink:to="label129" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="element130" />
        <label xlink:type="resource" xlink:label="label130" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_DeferredTaxAssetsNet_en-US">Deferred tax assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element130" xlink:to="label130" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="element131" />
        <label xlink:type="resource" xlink:label="label131" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsInventory_en-US">Deferred Tax Assets, Inventory</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element131" xlink:to="label131" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="element132" />
        <label xlink:type="resource" xlink:label="label132" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsInventory_en-US">Inventory</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element132" xlink:to="label132" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="element133" />
        <label xlink:type="resource" xlink:label="label133" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsGross_en-US">Deferred Tax Assets, Gross</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element133" xlink:to="label133" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="element134" />
        <label xlink:type="resource" xlink:label="label134" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_DeferredTaxAssetsGross_en-US">Total gross deferred assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element134" xlink:to="label134" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="element135" />
        <label xlink:type="resource" xlink:label="label135" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsLiabilitiesNet_en-US">Net Deferred Tax Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element135" xlink:to="label135" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="element136" />
        <label xlink:type="resource" xlink:label="label136" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNetNoncurrent_en-US">Deferred income tax assets - non-current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element136" xlink:to="label136" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="element137" />
        <label xlink:type="resource" xlink:label="label137" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNetCurrent_en-US">Deferred income tax assets - current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element137" xlink:to="label137" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="element138" />
        <label xlink:type="resource" xlink:label="label138" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_en-US">Deferred Tax Assets, Accounts Receivable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element138" xlink:to="label138" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="element139" />
        <label xlink:type="resource" xlink:label="label139" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_en-US">Accounts receivable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element139" xlink:to="label139" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="element140" />
        <label xlink:type="resource" xlink:label="label140" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element140" xlink:to="label140" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="element141" />
        <label xlink:type="resource" xlink:label="label141" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_en-US">Stock compensation expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element141" xlink:to="label141" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:label="element142" />
        <label xlink:type="resource" xlink:label="label142" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_en-US">Deferred Tax Assets, Pension Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element142" xlink:to="label142" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:label="element143" />
        <label xlink:type="resource" xlink:label="label143" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_en-US">Pension liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element143" xlink:to="label143" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:label="element144" />
        <label xlink:type="resource" xlink:label="label144" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Contingencies</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element144" xlink:to="label144" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:label="element145" />
        <label xlink:type="resource" xlink:label="label145" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_en-US">Contingent consideration</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element145" xlink:to="label145" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="element146" />
        <label xlink:type="resource" xlink:label="label146" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_en-US">Deferred Tax Assets, Accrued Expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element146" xlink:to="label146" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="element147" />
        <label xlink:type="resource" xlink:label="label147" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_en-US">Accrued expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element147" xlink:to="label147" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="element148" />
        <label xlink:type="resource" xlink:label="label148" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_en-US">Deferred Tax Assets, Other Accrued Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element148" xlink:to="label148" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="element149" />
        <label xlink:type="resource" xlink:label="label149" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_en-US">Other assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element149" xlink:to="label149" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="element150" />
        <label xlink:type="resource" xlink:label="label150" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilities_en-US">Total Deferred Tax Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element150" xlink:to="label150" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="element151" />
        <label xlink:type="resource" xlink:label="label151" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_en-US">Deferred Tax Liabilities, Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element151" xlink:to="label151" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="element152" />
        <label xlink:type="resource" xlink:label="label152" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesAbstract_en-US">Deferred Tax Liabilities [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element152" xlink:to="label152" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="element153" />
        <label xlink:type="resource" xlink:label="label153" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DeferredTaxLiabilitiesAbstract_en-US">Deferred tax liabilities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element153" xlink:to="label153" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="element154" />
        <label xlink:type="resource" xlink:label="label154" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesNoncurrent_en-US">Deferred income tax liabilities - non-current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element154" xlink:to="label154" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="element155" />
        <label xlink:type="resource" xlink:label="label155" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_en-US">Deferred Tax Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element155" xlink:to="label155" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="element156" />
        <label xlink:type="resource" xlink:label="label156" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesOther_en-US">Deferred Tax Liabilities, Other</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element156" xlink:to="label156" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesCurrent" xlink:label="element157" />
        <label xlink:type="resource" xlink:label="label157" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesCurrent_en-US">Deferred income tax liabilities - current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element157" xlink:to="label157" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="element158" />
        <label xlink:type="resource" xlink:label="label158" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_en-US">Deferred Tax Liabilities, Property, Plant and Equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element158" xlink:to="label158" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="element159" />
        <label xlink:type="resource" xlink:label="label159" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_en-US">Deferred Tax Assets, Valuation Allowance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element159" xlink:to="label159" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="element160" />
        <label xlink:type="resource" xlink:label="label160" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DeferredTaxAssetsValuationAllowance_en-US">Less: valuation allowance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element160" xlink:to="label160" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="element161" />
        <label xlink:type="resource" xlink:label="label161" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Year One</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element161" xlink:to="label161" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData" xlink:label="element162" />
        <label xlink:type="resource" xlink:label="label162" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData_en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Support, Methodology and Source Data</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element162" xlink:to="label162" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="element163" />
        <label xlink:type="resource" xlink:label="label163" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Year Three</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element163" xlink:to="label163" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear" xlink:label="element164" />
        <label xlink:type="resource" xlink:label="label164" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear_en-US">Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element164" xlink:to="label164" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="element165" />
        <label xlink:type="resource" xlink:label="label165" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Year Two</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element165" xlink:to="label165" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="element166" />
        <label xlink:type="resource" xlink:label="label166" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_en-US">Net Amortization Loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element166" xlink:to="label166" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="element167" />
        <label xlink:type="resource" xlink:label="label167" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_en-US">Net Amortization Loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element167" xlink:to="label167" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear" xlink:label="element168" />
        <label xlink:type="resource" xlink:label="label168" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear_en-US">Expected employer contribution in current remaining fiscal year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element168" xlink:to="label168" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="element169" />
        <label xlink:type="resource" xlink:label="label169" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_en-US">Defined Benefit Plan, Actual Return on Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element169" xlink:to="label169" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="element170" />
        <label xlink:type="resource" xlink:label="label170" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Five Fiscal Years Thereafter</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element170" xlink:to="label170" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="element171" />
        <label xlink:type="resource" xlink:label="label171" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanActuarialGainLoss_en-US">Defined Benefit Plan, Actuarial Net (Gains) Losses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element171" xlink:to="label171" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="element172" />
        <label xlink:type="resource" xlink:label="label172" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_en-US">Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element172" xlink:to="label172" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportBondIndices" xlink:label="element173" />
        <label xlink:type="resource" xlink:label="label173" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportBondIndices_en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Support, Bond Indices</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element173" xlink:to="label173" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="element174" />
        <label xlink:type="resource" xlink:label="label174" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Year Five</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element174" xlink:to="label174" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="element175" />
        <label xlink:type="resource" xlink:label="label175" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_en-US">Defined Benefit Plan, Amounts Recognized in Balance Sheet</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element175" xlink:to="label175" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="element176" />
        <label xlink:type="resource" xlink:label="label176" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_en-US">Defined Benefit Plan, Amounts Recognized in Balance Sheet</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element176" xlink:to="label176" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:label="element177" />
        <label xlink:type="resource" xlink:label="label177" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_en-US">Defined Benefit Plan, Accumulated Benefit Obligation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element177" xlink:to="label177" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="element178" />
        <label xlink:type="resource" xlink:label="label178" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanDisclosureLineItems_en-US">Defined Benefit Plan Disclosure [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element178" xlink:to="label178" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="element179" />
        <label xlink:type="resource" xlink:label="label179" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_en-US">Defined Benefit Plan, Expected Future Benefit Payments in Year Four</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element179" xlink:to="label179" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="element180" />
        <label xlink:type="resource" xlink:label="label180" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element180" xlink:to="label180" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="element181" />
        <label xlink:type="resource" xlink:label="label181" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element181" xlink:to="label181" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="element182" />
        <label xlink:type="resource" xlink:label="label182" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element182" xlink:to="label182" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="element183" />
        <label xlink:type="resource" xlink:label="label183" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_en-US">Defined Benefit Plan, Fair Value of Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element183" xlink:to="label183" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="element184" />
        <label xlink:type="resource" xlink:label="label184" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_en-US">Defined Benefit Plan, Fair Value of Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element184" xlink:to="label184" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="element185" />
        <label xlink:type="resource" xlink:label="label185" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_en-US">Defined Benefit Plan, Fair Value of Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element185" xlink:to="label185" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="element186" />
        <label xlink:type="resource" xlink:label="label186" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_DefinedBenefitPlanBenefitObligation_en-US">Defined Benefit Plan, Benefit Obligation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element186" xlink:to="label186" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="element187" />
        <label xlink:type="resource" xlink:label="label187" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_DefinedBenefitPlanBenefitObligation_en-US">Defined Benefit Plan, Benefit Obligation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element187" xlink:to="label187" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="element188" />
        <label xlink:type="resource" xlink:label="label188" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanBenefitObligation_en-US">Defined Benefit Plan, Benefit Obligation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element188" xlink:to="label188" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="element189" />
        <label xlink:type="resource" xlink:label="label189" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_en-US">Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element189" xlink:to="label189" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="element190" />
        <label xlink:type="resource" xlink:label="label190" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element190" xlink:to="label190" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="element191" />
        <label xlink:type="resource" xlink:label="label191" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_en-US">Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Benefit Obligation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element191" xlink:to="label191" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:label="element192" />
        <label xlink:type="resource" xlink:label="label192" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_en-US">Defined Benefit Plan, Funded Status of Plan [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element192" xlink:to="label192" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByPlanParticipants" xlink:label="element193" />
        <label xlink:type="resource" xlink:label="label193" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanContributionsByPlanParticipants_en-US">Defined Benefit Plan, Contributions by Plan Participants</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element193" xlink:to="label193" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="element194" />
        <label xlink:type="resource" xlink:label="label194" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_en-US">Expected Return on Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element194" xlink:to="label194" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="element195" />
        <label xlink:type="resource" xlink:label="label195" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_en-US">Expected Return on Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element195" xlink:to="label195" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="element196" />
        <label xlink:type="resource" xlink:label="label196" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanInterestCost_en-US">Interest Cost</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element196" xlink:to="label196" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="element197" />
        <label xlink:type="resource" xlink:label="label197" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_en-US">Defined Benefit Plan Funded Status Of Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element197" xlink:to="label197" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:label="element198" />
        <label xlink:type="resource" xlink:label="label198" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_en-US">Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element198" xlink:to="label198" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="element199" />
        <label xlink:type="resource" xlink:label="label199" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanContributionsByEmployer_en-US">Defined Benefit Plan Payments In Current Fiscal Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element199" xlink:to="label199" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="element200" />
        <label xlink:type="resource" xlink:label="label200" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanBenefitsPaid_en-US">Defined Benefit Plan, Benefits Paid</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element200" xlink:to="label200" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="element201" />
        <label xlink:type="resource" xlink:label="label201" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element201" xlink:to="label201" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="element202" />
        <label xlink:type="resource" xlink:label="label202" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element202" xlink:to="label202" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="element203" />
        <label xlink:type="resource" xlink:label="label203" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_en-US">Net Periodic Benefit Cost, Total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element203" xlink:to="label203" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="element204" />
        <label xlink:type="resource" xlink:label="label204" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_en-US">Net Periodic Benefit Cost, Total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element204" xlink:to="label204" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="element205" />
        <label xlink:type="resource" xlink:label="label205" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_en-US">Curtailment Gain</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element205" xlink:to="label205" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="element206" />
        <label xlink:type="resource" xlink:label="label206" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_en-US">Curtailment Gain</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element206" xlink:to="label206" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="element207" />
        <label xlink:type="resource" xlink:label="label207" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_en-US">Defined Benefit Plan, Settlements, Plan Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element207" xlink:to="label207" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:label="element208" />
        <label xlink:type="resource" xlink:label="label208" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_en-US">Pension Defined Benefit Plans, Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element208" xlink:to="label208" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:label="element209" />
        <label xlink:type="resource" xlink:label="label209" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_en-US">Pension Defined Benefit Plans, Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element209" xlink:to="label209" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="element210" />
        <label xlink:type="resource" xlink:label="label210" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_en-US">Defined Benefit Plan by Plan Asset Categories [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element210" xlink:to="label210" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="element211" />
        <label xlink:type="resource" xlink:label="label211" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element211" xlink:to="label211" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="element212" />
        <label xlink:type="resource" xlink:label="label212" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_en-US">Defined Benefit Plan, Actual Plan Asset Allocations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element212" xlink:to="label212" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="element213" />
        <label xlink:type="resource" xlink:label="label213" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanCostRecognized_en-US">Defined Contribution Plan Payments In Current Fiscal Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element213" xlink:to="label213" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="element214" />
        <label xlink:type="resource" xlink:label="label214" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DefinedBenefitPlanServiceCost_en-US">Service Cost</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element214" xlink:to="label214" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="element215" />
        <label xlink:type="resource" xlink:label="label215" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Depreciation_en-US">Depreciation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element215" xlink:to="label215" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="element216" />
        <label xlink:type="resource" xlink:label="label216" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentRiskAxis_en-US">Derivative Instrument Risk [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element216" xlink:to="label216" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="element217" />
        <label xlink:type="resource" xlink:label="label217" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_en-US">Deferred losses on derivative instruments accumulated in AOCI expected to be reclassified to earnings</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element217" xlink:to="label217" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="element218" />
        <label xlink:type="resource" xlink:label="label218" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element218" xlink:to="label218" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="element219" />
        <label xlink:type="resource" xlink:label="label219" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_en-US">Derivative Instruments And Hedging Activities Disclosure [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element219" xlink:to="label219" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="element220" />
        <label xlink:type="resource" xlink:label="label220" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element220" xlink:to="label220" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="element221" />
        <label xlink:type="resource" xlink:label="label221" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element221" xlink:to="label221" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="element222" />
        <label xlink:type="resource" xlink:label="label222" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeAssetNotionalAmount_en-US">Notional Amount of Interest Rate Swaps</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element222" xlink:to="label222" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="element223" />
        <label xlink:type="resource" xlink:label="label223" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeLiabilities_en-US">Derivative Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element223" xlink:to="label223" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="element224" />
        <label xlink:type="resource" xlink:label="label224" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_en-US">Derivative Liability, Fair Value, Net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element224" xlink:to="label224" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion" xlink:label="element225" />
        <label xlink:type="resource" xlink:label="label225" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion_en-US">Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element225" xlink:to="label225" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="element226" />
        <label xlink:type="resource" xlink:label="label226" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsGainLossLineItems_en-US">Derivative Instruments, Gain (Loss) [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element226" xlink:to="label226" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="element227" />
        <label xlink:type="resource" xlink:label="label227" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeContractTypeDomain_en-US">Derivative Contract Type [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element227" xlink:to="label227" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:label="element228" />
        <label xlink:type="resource" xlink:label="label228" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element228" xlink:to="label228" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="element229" />
        <label xlink:type="resource" xlink:label="label229" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element229" xlink:to="label229" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="element230" />
        <label xlink:type="resource" xlink:label="label230" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativesFairValueLineItems_en-US">Derivatives, Fair Value [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element230" xlink:to="label230" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="element231" />
        <label xlink:type="resource" xlink:label="label231" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DerivativesPolicyTextBlock_en-US">Derivatives [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element231" xlink:to="label231" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="element232" />
        <label xlink:type="resource" xlink:label="label232" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_en-US">Recently Issued Accounting Pronouncements Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element232" xlink:to="label232" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="element233" />
        <label xlink:type="resource" xlink:label="label233" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DevelopedTechnologyRightsMember_en-US">Developed Technology Rights [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element233" xlink:to="label233" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:label="element234" />
        <label xlink:type="resource" xlink:label="label234" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_en-US">Assets Held For Sale [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element234" xlink:to="label234" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DistributionRightsMember" xlink:label="element235" />
        <label xlink:type="resource" xlink:label="label235" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DistributionRightsMember_en-US">Distribution Agreements [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element235" xlink:to="label235" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="element236" />
        <label xlink:type="resource" xlink:label="label236" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_DomesticCountryMember_en-US">Domestic Country [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element236" xlink:to="label236" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="element237" />
        <label xlink:type="resource" xlink:label="label237" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_DomesticCountryMember_en-US">Federal</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element237" xlink:to="label237" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="element238" />
        <label xlink:type="resource" xlink:label="label238" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock_en-US">Earnings Per Share [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element238" xlink:to="label238" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="element239" />
        <label xlink:type="resource" xlink:label="label239" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasic_en-US">Basic earnings per common share</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element239" xlink:to="label239" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="element240" />
        <label xlink:type="resource" xlink:label="label240" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EarningsPerShareDiluted_en-US">Diluted Earnings Per Common Share</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element240" xlink:to="label240" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="element241" />
        <label xlink:type="resource" xlink:label="label241" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EarningsPerShareAbstract_en-US">Earnings (loss) per share:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element241" xlink:to="label241" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="element242" />
        <label xlink:type="resource" xlink:label="label242" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_en-US">Effect of exchange rate changes on cash</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element242" xlink:to="label242" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="element243" />
        <label xlink:type="resource" xlink:label="label243" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_en-US">US Federal Income Tax Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element243" xlink:to="label243" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="element244" />
        <label xlink:type="resource" xlink:label="label244" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_en-US">Effective Income Tax Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element244" xlink:to="label244" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="element245" />
        <label xlink:type="resource" xlink:label="label245" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element245" xlink:to="label245" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="element246" />
        <label xlink:type="resource" xlink:label="label246" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeRelatedLiabilitiesCurrent_en-US">Employee Related Liabilities Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element246" xlink:to="label246" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="element247" />
        <label xlink:type="resource" xlink:label="label247" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element247" xlink:to="label247" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="element248" />
        <label xlink:type="resource" xlink:label="label248" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeSeveranceMember_en-US">Employee Severance [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element248" xlink:to="label248" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="element249" />
        <label xlink:type="resource" xlink:label="label249" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element249" xlink:to="label249" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="element250" />
        <label xlink:type="resource" xlink:label="label250" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element250" xlink:to="label250" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="element251" />
        <label xlink:type="resource" xlink:label="label251" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EquityComponentDomain_en-US">Equity Component [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element251" xlink:to="label251" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="element252" />
        <label xlink:type="resource" xlink:label="label252" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_EquitySecuritiesMember_en-US">Equity Securities [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element252" xlink:to="label252" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="element253" />
        <label xlink:type="resource" xlink:label="label253" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueByFairValueHierarchyLevelAxis_en-US">Fair Value By Fair Value Hierarchy Level [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element253" xlink:to="label253" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="element254" />
        <label xlink:type="resource" xlink:label="label254" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresAbstract_en-US">Fair Value Disclosures [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element254" xlink:to="label254" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="element255" />
        <label xlink:type="resource" xlink:label="label255" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element255" xlink:to="label255" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="element256" />
        <label xlink:type="resource" xlink:label="label256" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element256" xlink:to="label256" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="element257" />
        <label xlink:type="resource" xlink:label="label257" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element257" xlink:to="label257" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="element258" />
        <label xlink:type="resource" xlink:label="label258" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresTextBlock_en-US">Fair Value Disclosures [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element258" xlink:to="label258" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="element259" />
        <label xlink:type="resource" xlink:label="label259" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueOfFinancialInstrumentsPolicy_en-US">Fair Value of Financial Instruments [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element259" xlink:to="label259" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="element260" />
        <label xlink:type="resource" xlink:label="label260" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel3Member_en-US">Fair Value, Inputs, Level 3 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element260" xlink:to="label260" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="element261" />
        <label xlink:type="resource" xlink:label="label261" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel1Member_en-US">Fair Value, Inputs, Level 1 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element261" xlink:to="label261" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="element262" />
        <label xlink:type="resource" xlink:label="label262" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel2Member_en-US">Fair Value, Inputs, Level 2 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element262" xlink:to="label262" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="element263" />
        <label xlink:type="resource" xlink:label="label263" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element263" xlink:to="label263" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="element264" />
        <label xlink:type="resource" xlink:label="label264" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element264" xlink:to="label264" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="element265" />
        <label xlink:type="resource" xlink:label="label265" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_en-US">Estimated Amortization Expense Year 2</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element265" xlink:to="label265" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="element266" />
        <label xlink:type="resource" xlink:label="label266" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsNet_en-US">Amortizable intangible assets, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element266" xlink:to="label266" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="element267" />
        <label xlink:type="resource" xlink:label="label267" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_FiniteLivedIntangibleAssetsNet_en-US">Amortizable intangibles, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element267" xlink:to="label267" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="element268" />
        <label xlink:type="resource" xlink:label="label268" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element268" xlink:to="label268" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="element269" />
        <label xlink:type="resource" xlink:label="label269" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_en-US">Estimated Amortization Expense Next Twelve Months</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element269" xlink:to="label269" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="element270" />
        <label xlink:type="resource" xlink:label="label270" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsLineItems_en-US">Finite-Lived Intangible Assets [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element270" xlink:to="label270" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="element271" />
        <label xlink:type="resource" xlink:label="label271" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsGross_en-US">Finite-Lived Intangible Assets, Gross</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element271" xlink:to="label271" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="element272" />
        <label xlink:type="resource" xlink:label="label272" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife_en-US">Finite-Lived Intangible Assets, Weighted Average Useful Life</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element272" xlink:to="label272" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="element273" />
        <label xlink:type="resource" xlink:label="label273" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element273" xlink:to="label273" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="element274" />
        <label xlink:type="resource" xlink:label="label274" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_en-US">Estimated Amortization Expense Year 5</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element274" xlink:to="label274" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="element275" />
        <label xlink:type="resource" xlink:label="label275" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_en-US">Estimated Amortization Expense Year 4</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element275" xlink:to="label275" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="element276" />
        <label xlink:type="resource" xlink:label="label276" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_en-US">Estimated Amortization Expense Year 3</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element276" xlink:to="label276" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="element277" />
        <label xlink:type="resource" xlink:label="label277" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_en-US">Foreign Currency Transaction [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element277" xlink:to="label277" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="element278" />
        <label xlink:type="resource" xlink:label="label278" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_en-US">Foreign exchange</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element278" xlink:to="label278" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="element279" />
        <label xlink:type="resource" xlink:label="label279" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ForeignCountryMember_en-US">Foreign Country [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element279" xlink:to="label279" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="element280" />
        <label xlink:type="resource" xlink:label="label280" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_ForeignCountryMember_en-US">Foreign tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element280" xlink:to="label280" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignEarningsRepatriated" xlink:label="element281" />
        <label xlink:type="resource" xlink:label="label281" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ForeignEarningsRepatriated_en-US">Foreign Earnings Repatriated</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element281" xlink:to="label281" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="element282" />
        <label xlink:type="resource" xlink:label="label282" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_FurnitureAndFixturesMember_en-US">Furniture and Fixtures [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element282" xlink:to="label282" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="element283" />
        <label xlink:type="resource" xlink:label="label283" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfBusiness_en-US">Gain Loss On Sale Of Business</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element283" xlink:to="label283" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="element284" />
        <label xlink:type="resource" xlink:label="label284" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_GainLossOnSaleOfBusiness_en-US">Loss on sale of AHN</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element284" xlink:to="label284" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="element285" />
        <label xlink:type="resource" xlink:label="label285" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GainLossOnDispositionOfAssets_en-US">(Gain) loss on sales of fixed assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element285" xlink:to="label285" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="element286" />
        <label xlink:type="resource" xlink:label="label286" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_GainLossOnDispositionOfAssets_en-US">(Gain) loss on sales of fixed assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element286" xlink:to="label286" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="element287" />
        <label xlink:type="resource" xlink:label="label287" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_en-US">Gain on sale of assets, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element287" xlink:to="label287" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="element288" />
        <label xlink:type="resource" xlink:label="label288" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_en-US">Gain on sale of assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element288" xlink:to="label288" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="element289" />
        <label xlink:type="resource" xlink:label="label289" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense_en-US">General and administrative expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element289" xlink:to="label289" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="element290" />
        <label xlink:type="resource" xlink:label="label290" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpenseMember_en-US">General and Administrative Expense [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element290" xlink:to="label290" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="element291" />
        <label xlink:type="resource" xlink:label="label291" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_en-US">Employee Benefit Plans Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element291" xlink:to="label291" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="element292" />
        <label xlink:type="resource" xlink:label="label292" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_en-US">Goodwill Written Off Related To Sale Of Business Unit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element292" xlink:to="label292" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="element293" />
        <label xlink:type="resource" xlink:label="label293" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_en-US">Adjustment to goodwill for AHN disposition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element293" xlink:to="label293" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="element294" />
        <label xlink:type="resource" xlink:label="label294" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillPurchaseAccountingAdjustments_en-US">Goodwill Purchase Accounting Adjustments</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element294" xlink:to="label294" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="element295" />
        <label xlink:type="resource" xlink:label="label295" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_GoodwillPurchaseAccountingAdjustments_en-US">Adjustment to purchase price allocation of prior year acquisition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element295" xlink:to="label295" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="element296" />
        <label xlink:type="resource" xlink:label="label296" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_Goodwill_en-US">Goodwill, Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element296" xlink:to="label296" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="element297" />
        <label xlink:type="resource" xlink:label="label297" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_Goodwill_en-US">Goodwill, Ending Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element297" xlink:to="label297" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="element298" />
        <label xlink:type="resource" xlink:label="label298" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Goodwill_en-US">Goodwill</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element298" xlink:to="label298" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="element299" />
        <label xlink:type="resource" xlink:label="label299" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_en-US">Foreign currency translation adjustments related to goodwill balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element299" xlink:to="label299" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="element300" />
        <label xlink:type="resource" xlink:label="label300" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_en-US">Effect of change in currency transaltion</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element300" xlink:to="label300" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="element301" />
        <label xlink:type="resource" xlink:label="label301" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_en-US">Goodwill and Other Intangible Assets [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element301" xlink:to="label301" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease" xlink:label="element302" />
        <label xlink:type="resource" xlink:label="label302" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillOtherIncreaseDecrease_en-US">Goodwill Other Changes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element302" xlink:to="label302" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="element303" />
        <label xlink:type="resource" xlink:label="label303" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_en-US">Goodwill And Other Intangible Assets Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element303" xlink:to="label303" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="element304" />
        <label xlink:type="resource" xlink:label="label304" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillAcquiredDuringPeriod_en-US">Acquired during the period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element304" xlink:to="label304" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="element305" />
        <label xlink:type="resource" xlink:label="label305" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_en-US">Goodwill And Other Intangible Assets Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element305" xlink:to="label305" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="element306" />
        <label xlink:type="resource" xlink:label="label306" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_GrossProfit_en-US">Gross profit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element306" xlink:to="label306" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="element307" />
        <label xlink:type="resource" xlink:label="label307" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_GrossProfit_en-US">Gross profit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element307" xlink:to="label307" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="element308" />
        <label xlink:type="resource" xlink:label="label308" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IntersegmentEliminationMember_en-US">Total [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element308" xlink:to="label308" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="element309" />
        <label xlink:type="resource" xlink:label="label309" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureAbstract_en-US">Income Tax [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element309" xlink:to="label309" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="element310" />
        <label xlink:type="resource" xlink:label="label310" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_en-US">Discontinued operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element310" xlink:to="label310" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="element311" />
        <label xlink:type="resource" xlink:label="label311" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_en-US">Basic earnings per common share from continuing operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element311" xlink:to="label311" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="element312" />
        <label xlink:type="resource" xlink:label="label312" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeStatementLocationAxis_en-US">Income Statement Location [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element312" xlink:to="label312" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="element313" />
        <label xlink:type="resource" xlink:label="label313" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_en-US">Income from continuing operations, Foreign</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element313" xlink:to="label313" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="element314" />
        <label xlink:type="resource" xlink:label="label314" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_en-US">Loss before income taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element314" xlink:to="label314" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="element315" />
        <label xlink:type="resource" xlink:label="label315" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_en-US">(Loss) income before income taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element315" xlink:to="label315" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="element316" />
        <label xlink:type="resource" xlink:label="label316" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeStatementLocationDomain_en-US">Income Statement Location [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element316" xlink:to="label316" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="element317" />
        <label xlink:type="resource" xlink:label="label317" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_en-US">Operating Income (Loss) [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element317" xlink:to="label317" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="element318" />
        <label xlink:type="resource" xlink:label="label318" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxAuthorityAxis_en-US">Income Tax Authority [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element318" xlink:to="label318" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="element319" />
        <label xlink:type="resource" xlink:label="label319" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_en-US">Discontinued operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element319" xlink:to="label319" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="element320" />
        <label xlink:type="resource" xlink:label="label320" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_en-US">Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element320" xlink:to="label320" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="element321" />
        <label xlink:type="resource" xlink:label="label321" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_en-US">Income From Continuing Operations, Domestic</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element321" xlink:to="label321" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="element322" />
        <label xlink:type="resource" xlink:label="label322" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_en-US">Diluted earnings per common share from continuing operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element322" xlink:to="label322" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="element323" />
        <label xlink:type="resource" xlink:label="label323" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxAuthorityDomain_en-US">Income Tax Authority [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element323" xlink:to="label323" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="element324" />
        <label xlink:type="resource" xlink:label="label324" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock_en-US">Income Taxes Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element324" xlink:to="label324" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="element325" />
        <label xlink:type="resource" xlink:label="label325" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit_en-US">Income tax expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element325" xlink:to="label325" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="element326" />
        <label xlink:type="resource" xlink:label="label326" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_IncomeTaxExpenseBenefit_en-US">Income Tax Expense, Total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element326" xlink:to="label326" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="element327" />
        <label xlink:type="resource" xlink:label="label327" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeStatementAbstract_en-US">CONSOLIDATED STATEMENTS OF OPERATIONS</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element327" xlink:to="label327" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="element328" />
        <label xlink:type="resource" xlink:label="label328" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_en-US">Computed "Expected" Income Tax Expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element328" xlink:to="label328" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="element329" />
        <label xlink:type="resource" xlink:label="label329" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_en-US">Computed "expected" income tax (benefit) expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element329" xlink:to="label329" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="element330" />
        <label xlink:type="resource" xlink:label="label330" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_en-US">Income Tax Expense (benefit) Attributable To Income From Continuing Operations [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element330" xlink:to="label330" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="element331" />
        <label xlink:type="resource" xlink:label="label331" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_en-US">Effective Tax Rate Reconciliation [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element331" xlink:to="label331" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:label="element332" />
        <label xlink:type="resource" xlink:label="label332" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_en-US">Increase (Decrease) In Income Taxes Resulting From Impact Of Discontinued Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element332" xlink:to="label332" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="element333" />
        <label xlink:type="resource" xlink:label="label333" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_en-US">Increase (Decrease) In Income Taxes Resulting From Adjustment Of Prior Year Tax Accruals</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element333" xlink:to="label333" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="element334" />
        <label xlink:type="resource" xlink:label="label334" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_en-US">Impact of change to prior year tax accruals</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element334" xlink:to="label334" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="element335" />
        <label xlink:type="resource" xlink:label="label335" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_en-US">Increase (Decrease) In Income Taxes Resulting From Change In Valuation Allowance Allocated To Income Tax Expense Benefit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element335" xlink:to="label335" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="element336" />
        <label xlink:type="resource" xlink:label="label336" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_en-US">Change in valuation allowance allocated to income tax expense (benefit)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element336" xlink:to="label336" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:label="element337" />
        <label xlink:type="resource" xlink:label="label337" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_en-US">Income Tax Reconciliation Repatriation Of Foreign Earnings</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element337" xlink:to="label337" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:label="element338" />
        <label xlink:type="resource" xlink:label="label338" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_en-US">U.S. tax on actual and deemed dividends from foreign subsidiaries</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element338" xlink:to="label338" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="element339" />
        <label xlink:type="resource" xlink:label="label339" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_en-US">Income Tax Reconciliation, Nondeductible Expense, Share-based Compensation Cost</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element339" xlink:to="label339" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="element340" />
        <label xlink:type="resource" xlink:label="label340" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_en-US">Non-deductible stock compensation expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element340" xlink:to="label340" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="element341" />
        <label xlink:type="resource" xlink:label="label341" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationOtherAdjustments_en-US">Increase (Decrease) In Income Taxes Resulting From Other</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element341" xlink:to="label341" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="element342" />
        <label xlink:type="resource" xlink:label="label342" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationOtherAdjustments_en-US">Other</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element342" xlink:to="label342" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="element343" />
        <label xlink:type="resource" xlink:label="label343" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_en-US">Increase (Decrease) In Income Taxes Resulting From Foreign Tax Rate Differential</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element343" xlink:to="label343" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="element344" />
        <label xlink:type="resource" xlink:label="label344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_en-US">Foreign tax rate differential</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element344" xlink:to="label344" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="element345" />
        <label xlink:type="resource" xlink:label="label345" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationTaxCredits_en-US">Income Tax Reconciliation, Tax Credits</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element345" xlink:to="label345" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="element346" />
        <label xlink:type="resource" xlink:label="label346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationTaxCredits_en-US">Tax credits</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element346" xlink:to="label346" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="element347" />
        <label xlink:type="resource" xlink:label="label347" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxPolicyTextBlock_en-US">Income Taxes [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element347" xlink:to="label347" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="element348" />
        <label xlink:type="resource" xlink:label="label348" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_en-US">Increase (Decrease) In Income Taxes Resulting From State Income Taxes, Net Of Federal Income Tax Benefit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element348" xlink:to="label348" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="element349" />
        <label xlink:type="resource" xlink:label="label349" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_en-US">State income taxes, net of federal income tax benefit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element349" xlink:to="label349" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="element350" />
        <label xlink:type="resource" xlink:label="label350" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncomeTaxesPaid_en-US">Cash paid for income taxes, net of refunds</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element350" xlink:to="label350" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="element351" />
        <label xlink:type="resource" xlink:label="label351" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_en-US">(Decrease) increase in accrued income taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element351" xlink:to="label351" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="element352" />
        <label xlink:type="resource" xlink:label="label352" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsReceivable_en-US">(Increase) decrease in accounts receivable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element352" xlink:to="label352" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="element353" />
        <label xlink:type="resource" xlink:label="label353" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_IncreaseDecreaseInAccountsReceivable_en-US">(Increase) decrease in accounts receivable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element353" xlink:to="label353" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="element354" />
        <label xlink:type="resource" xlink:label="label354" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayableTrade_en-US">Increase in trade accounts payable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element354" xlink:to="label354" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="element355" />
        <label xlink:type="resource" xlink:label="label355" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccruedLiabilities_en-US">Increase in accrued expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element355" xlink:to="label355" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="element356" />
        <label xlink:type="resource" xlink:label="label356" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInInventories_en-US">Increase in inventories</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element356" xlink:to="label356" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="element357" />
        <label xlink:type="resource" xlink:label="label357" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_IncreaseDecreaseInInventories_en-US">Increase in inventories</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element357" xlink:to="label357" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="element358" />
        <label xlink:type="resource" xlink:label="label358" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDeferredRevenue_en-US">(Decrease) increase in deferred revenue</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element358" xlink:to="label358" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="element359" />
        <label xlink:type="resource" xlink:label="label359" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_en-US">Changes in operating assets and liabilities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element359" xlink:to="label359" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="element360" />
        <label xlink:type="resource" xlink:label="label360" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherReceivables_en-US">Increase in other receivables and other assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element360" xlink:to="label360" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="element361" />
        <label xlink:type="resource" xlink:label="label361" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_IncreaseDecreaseInOtherReceivables_en-US">Increase in other receivables and other assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element361" xlink:to="label361" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="element362" />
        <label xlink:type="resource" xlink:label="label362" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_en-US">Increase (decrease) in other liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element362" xlink:to="label362" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="element363" />
        <label xlink:type="resource" xlink:label="label363" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_en-US">Other indefinite lived intangible assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element363" xlink:to="label363" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="element364" />
        <label xlink:type="resource" xlink:label="label364" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsFiniteLivedPolicy_en-US">Intangible Assets Finite Lived [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element364" xlink:to="label364" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="element365" />
        <label xlink:type="resource" xlink:label="label365" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_InterestExpense_en-US">Interest expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element365" xlink:to="label365" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="element366" />
        <label xlink:type="resource" xlink:label="label366" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InterestExpense_en-US">Interest expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element366" xlink:to="label366" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="element367" />
        <label xlink:type="resource" xlink:label="label367" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InterestPaid_en-US">Cash paid for interest</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element367" xlink:to="label367" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="element368" />
        <label xlink:type="resource" xlink:label="label368" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InterestExpenseMember_en-US">Interest Expense [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element368" xlink:to="label368" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="element369" />
        <label xlink:type="resource" xlink:label="label369" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InterestRateSwapMember_en-US">Derivatives qualifying as hedges [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element369" xlink:to="label369" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="element370" />
        <label xlink:type="resource" xlink:label="label370" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryPolicyTextBlock_en-US">Inventories [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element370" xlink:to="label370" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="element371" />
        <label xlink:type="resource" xlink:label="label371" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryNet_en-US">Inventories</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element371" xlink:to="label371" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="element372" />
        <label xlink:type="resource" xlink:label="label372" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_InventoryNet_en-US">Total Inventories, Net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element372" xlink:to="label372" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="element373" />
        <label xlink:type="resource" xlink:label="label373" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryFinishedGoods_en-US">Finished Goods</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element373" xlink:to="label373" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="element374" />
        <label xlink:type="resource" xlink:label="label374" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryDisclosureTextBlock_en-US">Inventories Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element374" xlink:to="label374" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="element375" />
        <label xlink:type="resource" xlink:label="label375" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryDisclosureAbstract_en-US">Inventories Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element375" xlink:to="label375" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="element376" />
        <label xlink:type="resource" xlink:label="label376" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryWorkInProcess_en-US">Work in Process</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element376" xlink:to="label376" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="element377" />
        <label xlink:type="resource" xlink:label="label377" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_InventoryRawMaterials_en-US">Raw Materials</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element377" xlink:to="label377" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="element378" />
        <label xlink:type="resource" xlink:label="label378" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LandBuildingsAndImprovementsMember_en-US">Land, Buildings and Improvements [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element378" xlink:to="label378" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="element379" />
        <label xlink:type="resource" xlink:label="label379" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LeaseExpirationDate1_en-US">Lease Expiration Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element379" xlink:to="label379" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="element380" />
        <label xlink:type="resource" xlink:label="label380" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LeasesAbstract_en-US">Leases Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element380" xlink:to="label380" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="element381" />
        <label xlink:type="resource" xlink:label="label381" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Liabilities_en-US">Total liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element381" xlink:to="label381" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="element382" />
        <label xlink:type="resource" xlink:label="label382" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_Liabilities_en-US">Total liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element382" xlink:to="label382" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="element383" />
        <label xlink:type="resource" xlink:label="label383" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity_en-US">Total liabilities and stockholders' equity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element383" xlink:to="label383" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="element384" />
        <label xlink:type="resource" xlink:label="label384" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_LiabilitiesAndStockholdersEquity_en-US">Total liabilities and stockholders' equity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element384" xlink:to="label384" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="element385" />
        <label xlink:type="resource" xlink:label="label385" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_en-US">Liabilities and Stockholders' Equity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element385" xlink:to="label385" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="element386" />
        <label xlink:type="resource" xlink:label="label386" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LiabilitiesFairValueDisclosureAbstract_en-US">Liabilities Fair Value Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element386" xlink:to="label386" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="element387" />
        <label xlink:type="resource" xlink:label="label387" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent_en-US">Total current liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element387" xlink:to="label387" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="element388" />
        <label xlink:type="resource" xlink:label="label388" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_LiabilitiesCurrent_en-US">Total current liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element388" xlink:to="label388" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="element389" />
        <label xlink:type="resource" xlink:label="label389" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract_en-US">Current liabilities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element389" xlink:to="label389" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="element390" />
        <label xlink:type="resource" xlink:label="label390" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_LiabilitiesCurrentAbstract_en-US">Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element390" xlink:to="label390" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="element391" />
        <label xlink:type="resource" xlink:label="label391" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LineOfCredit_en-US">Line of Credit Facility, Amount Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element391" xlink:to="label391" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="element392" />
        <label xlink:type="resource" xlink:label="label392" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_en-US">Maximum Borrowings Available Under The Current Credit Agreement</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element392" xlink:to="label392" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="element393" />
        <label xlink:type="resource" xlink:label="label393" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_en-US">Revolving line</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element393" xlink:to="label393" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="element394" />
        <label xlink:type="resource" xlink:label="label394" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_en-US">Interest Rate As Of Reporting Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element394" xlink:to="label394" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="element395" />
        <label xlink:type="resource" xlink:label="label395" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_en-US">Line of Credit Facility, Maximum Borrowing Capacity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element395" xlink:to="label395" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="element396" />
        <label xlink:type="resource" xlink:label="label396" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_en-US">Line of Credit Facility, Remaining Borrowing Capacity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element396" xlink:to="label396" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="element397" />
        <label xlink:type="resource" xlink:label="label397" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebt_en-US">Long-term Debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element397" xlink:to="label397" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="element398" />
        <label xlink:type="resource" xlink:label="label398" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_LongTermDebt_en-US">Long-term Debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element398" xlink:to="label398" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="element399" />
        <label xlink:type="resource" xlink:label="label399" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtAbstract_en-US">Long Term Debt Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element399" xlink:to="label399" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="element400" />
        <label xlink:type="resource" xlink:label="label400" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtTextBlock_en-US">Long Term Debt Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element400" xlink:to="label400" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="element401" />
        <label xlink:type="resource" xlink:label="label401" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_en-US">Debt repayments of principal in Year Three</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element401" xlink:to="label401" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="element402" />
        <label xlink:type="resource" xlink:label="label402" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtNoncurrent_en-US">Long-term debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element402" xlink:to="label402" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="element403" />
        <label xlink:type="resource" xlink:label="label403" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_LongTermDebtNoncurrent_en-US">Long-term debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element403" xlink:to="label403" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="element404" />
        <label xlink:type="resource" xlink:label="label404" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_en-US">Debt repayments of principal in Year Two</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element404" xlink:to="label404" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="element405" />
        <label xlink:type="resource" xlink:label="label405" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_en-US">Debt repayments of principal in Year Four</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element405" xlink:to="label405" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="element406" />
        <label xlink:type="resource" xlink:label="label406" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_en-US">Debt repayments of principal in Year Five</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element406" xlink:to="label406" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="element407" />
        <label xlink:type="resource" xlink:label="label407" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermLoansPayable_en-US">Term Loan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element407" xlink:to="label407" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="element408" />
        <label xlink:type="resource" xlink:label="label408" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_en-US">Debt repayments of principal in the next twelve months</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element408" xlink:to="label408" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="element409" />
        <label xlink:type="resource" xlink:label="label409" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MachineryAndEquipmentMember_en-US">Machinery and Equipment [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element409" xlink:to="label409" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="element410" />
        <label xlink:type="resource" xlink:label="label410" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_MachineryAndEquipmentMember_en-US">Machinery and Equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element410" xlink:to="label410" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="element411" />
        <label xlink:type="resource" xlink:label="label411" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_en-US">Major Types of Debt and Equity Securities [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element411" xlink:to="label411" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="element412" />
        <label xlink:type="resource" xlink:label="label412" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_en-US">Major Types of Debt and Equity Securities [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element412" xlink:to="label412" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="element413" />
        <label xlink:type="resource" xlink:label="label413" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MaximumMember_en-US">Maximum [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element413" xlink:to="label413" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="element414" />
        <label xlink:type="resource" xlink:label="label414" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MinimumMember_en-US">Minimum [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element414" xlink:to="label414" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="element415" />
        <label xlink:type="resource" xlink:label="label415" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_MovementInValuationAllowancesAndReservesRollForward_en-US">Movement in Valuation Allowances and Reserves Roll Forward [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element415" xlink:to="label415" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="element416" />
        <label xlink:type="resource" xlink:label="label416" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NoncurrentAssets_en-US">Long-lived assets, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element416" xlink:to="label416" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="element417" />
        <label xlink:type="resource" xlink:label="label417" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivities_en-US">Net cash provided by operating activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element417" xlink:to="label417" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="element418" />
        <label xlink:type="resource" xlink:label="label418" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_NetCashProvidedByUsedInOperatingActivities_en-US">Net cash provided by operating activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element418" xlink:to="label418" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="element419" />
        <label xlink:type="resource" xlink:label="label419" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_en-US">Cash flows provided by (used in) financing activities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element419" xlink:to="label419" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="element420" />
        <label xlink:type="resource" xlink:label="label420" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivities_en-US">Net cash used in investing activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element420" xlink:to="label420" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="element421" />
        <label xlink:type="resource" xlink:label="label421" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xml:lang="en-US" id="NegatedTotal_us-gaap_NetCashProvidedByUsedInInvestingActivities_en-US">Net cash used in investing activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element421" xlink:to="label421" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="element422" />
        <label xlink:type="resource" xlink:label="label422" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_en-US">Cash flows (used in) provided by investing activities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element422" xlink:to="label422" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="element423" />
        <label xlink:type="resource" xlink:label="label423" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_en-US">Cash flows from operating activities:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element423" xlink:to="label423" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="element424" />
        <label xlink:type="resource" xlink:label="label424" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_NetIncomeLoss_en-US">Net loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element424" xlink:to="label424" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="element425" />
        <label xlink:type="resource" xlink:label="label425" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_en-US">Net income (loss)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element425" xlink:to="label425" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="element426" />
        <label xlink:type="resource" xlink:label="label426" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_NetIncomeLoss_en-US">Net loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element426" xlink:to="label426" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="element427" />
        <label xlink:type="resource" xlink:label="label427" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivities_en-US">Net cash (used in) provided by financing activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element427" xlink:to="label427" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="element428" />
        <label xlink:type="resource" xlink:label="label428" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_NetCashProvidedByUsedInFinancingActivities_en-US">Net cash (used in) provided by financing activities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element428" xlink:to="label428" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="element429" />
        <label xlink:type="resource" xlink:label="label429" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NoncompeteAgreementsMember_en-US">Non compete Agreements [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element429" xlink:to="label429" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="element430" />
        <label xlink:type="resource" xlink:label="label430" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NonoperatingIncomeExpense_en-US">Other expense, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element430" xlink:to="label430" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="element431" />
        <label xlink:type="resource" xlink:label="label431" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_NonoperatingIncomeExpense_en-US">Other expense, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element431" xlink:to="label431" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="element432" />
        <label xlink:type="resource" xlink:label="label432" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NotesPayableCurrent_en-US">Notes payable</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element432" xlink:to="label432" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="element433" />
        <label xlink:type="resource" xlink:label="label433" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_NumberOfBusinessesAcquired_en-US">Number of businesses acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element433" xlink:to="label433" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="element434" />
        <label xlink:type="resource" xlink:label="label434" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_en-US">Operating Leases, Total Future Minimum Payments Due</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element434" xlink:to="label434" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="element435" />
        <label xlink:type="resource" xlink:label="label435" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_en-US">Operating Leases, Total Future Minimum Payments Due</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element435" xlink:to="label435" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="element436" />
        <label xlink:type="resource" xlink:label="label436" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_en-US">2018</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element436" xlink:to="label436" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="element437" />
        <label xlink:type="resource" xlink:label="label437" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingExpenses_en-US">Total operating expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element437" xlink:to="label437" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="element438" />
        <label xlink:type="resource" xlink:label="label438" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_OperatingExpenses_en-US">Total operating expenses, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element438" xlink:to="label438" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="element439" />
        <label xlink:type="resource" xlink:label="label439" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_en-US">Leases Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element439" xlink:to="label439" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="element440" />
        <label xlink:type="resource" xlink:label="label440" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_en-US">2017</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element440" xlink:to="label440" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="element441" />
        <label xlink:type="resource" xlink:label="label441" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_en-US">HART Sublease Rent</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element441" xlink:to="label441" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="element442" />
        <label xlink:type="resource" xlink:label="label442" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_en-US">Thereafter</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element442" xlink:to="label442" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="element443" />
        <label xlink:type="resource" xlink:label="label443" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesRentExpenseNet_en-US">Operating Leases, Rent Expense, Net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element443" xlink:to="label443" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="element444" />
        <label xlink:type="resource" xlink:label="label444" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLossCarryforwards_en-US">Operating Loss Carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element444" xlink:to="label444" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="element445" />
        <label xlink:type="resource" xlink:label="label445" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_OperatingLossCarryforwards_en-US">Operating loss carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element445" xlink:to="label445" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="element446" />
        <label xlink:type="resource" xlink:label="label446" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_en-US">2019</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element446" xlink:to="label446" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="element447" />
        <label xlink:type="resource" xlink:label="label447" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss_en-US">Operating income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element447" xlink:to="label447" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="element448" />
        <label xlink:type="resource" xlink:label="label448" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_OperatingIncomeLoss_en-US">Operating (loss) income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element448" xlink:to="label448" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="element449" />
        <label xlink:type="resource" xlink:label="label449" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_en-US">2020</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element449" xlink:to="label449" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="element450" />
        <label xlink:type="resource" xlink:label="label450" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_en-US">2021</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element450" xlink:to="label450" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="element451" />
        <label xlink:type="resource" xlink:label="label451" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_en-US">Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element451" xlink:to="label451" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="element452" />
        <label xlink:type="resource" xlink:label="label452" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_en-US">Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element452" xlink:to="label452" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="element453" />
        <label xlink:type="resource" xlink:label="label453" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_en-US">Amounts reclassified from accumulated other comprehensive income to net income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element453" xlink:to="label453" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="element454" />
        <label xlink:type="resource" xlink:label="label454" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_en-US">Derivatives Reclassification Adjustment from AOCI, net tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element454" xlink:to="label454" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="element455" />
        <label xlink:type="resource" xlink:label="label455" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_en-US">Amounts reclassified from accumulated other comprehensive loss to net loss</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element455" xlink:to="label455" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="element456" />
        <label xlink:type="resource" xlink:label="label456" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_en-US">Other Comprehensive Income (Loss), Net of Tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element456" xlink:to="label456" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="element457" />
        <label xlink:type="resource" xlink:label="label457" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_OtherComprehensiveIncomeLossNetOfTax_en-US">Other Comprehensive Income (Loss), Net of Tax, total</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element457" xlink:to="label457" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:label="element458" />
        <label xlink:type="resource" xlink:label="label458" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_en-US">Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, Tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element458" xlink:to="label458" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="element459" />
        <label xlink:type="resource" xlink:label="label459" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_en-US">Other Comprehensive Income (Loss) before Reclassifications</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element459" xlink:to="label459" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="element460" />
        <label xlink:type="resource" xlink:label="label460" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_en-US">Unrealized losses on pension benefit obligation, net of tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element460" xlink:to="label460" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="element461" />
        <label xlink:type="resource" xlink:label="label461" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_en-US">Unrealized losses on pension benefit obligation, net of tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element461" xlink:to="label461" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="element462" />
        <label xlink:type="resource" xlink:label="label462" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherAccruedLiabilitiesNoncurrent_en-US">Other liabilities- non current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element462" xlink:to="label462" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="element463" />
        <label xlink:type="resource" xlink:label="label463" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherAssetsCurrent_en-US">Other receivables and other assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element463" xlink:to="label463" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:label="element464" />
        <label xlink:type="resource" xlink:label="label464" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, Tax</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element464" xlink:to="label464" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="element465" />
        <label xlink:type="resource" xlink:label="label465" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherAssetsNoncurrent_en-US">Other assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element465" xlink:to="label465" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="element466" />
        <label xlink:type="resource" xlink:label="label466" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_en-US">Loss on derivative instruments designated and qualifying as cash flow hedges</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element466" xlink:to="label466" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="element467" />
        <label xlink:type="resource" xlink:label="label467" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_en-US">Gain (loss) on derivative instruments designated and qualifying as cash flow hedges</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element467" xlink:to="label467" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="element468" />
        <label xlink:type="resource" xlink:label="label468" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_en-US">Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element468" xlink:to="label468" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="element469" />
        <label xlink:type="resource" xlink:label="label469" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_en-US">Derivatives qualifying as hedges, net of tax:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element469" xlink:to="label469" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="element470" />
        <label xlink:type="resource" xlink:label="label470" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_en-US">Foreign currency translation adjustments</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element470" xlink:to="label470" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="element471" />
        <label xlink:type="resource" xlink:label="label471" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherGeneralExpense_en-US">HART transaction costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element471" xlink:to="label471" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInterestAndDividendIncome" xlink:label="element472" />
        <label xlink:type="resource" xlink:label="label472" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherInterestAndDividendIncome_en-US">Interest income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element472" xlink:to="label472" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="element473" />
        <label xlink:type="resource" xlink:label="label473" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncomeExpenseAbstract_en-US">Other income (expense):</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element473" xlink:to="label473" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="element474" />
        <label xlink:type="resource" xlink:label="label474" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncomeExpense_en-US">Other income (expense), net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element474" xlink:to="label474" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="element475" />
        <label xlink:type="resource" xlink:label="label475" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesCurrent_en-US">Other liabilities - current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element475" xlink:to="label475" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="element476" />
        <label xlink:type="resource" xlink:label="label476" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element476" xlink:to="label476" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="element477" />
        <label xlink:type="resource" xlink:label="label477" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherAssetsMember_en-US">Other Assets [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element477" xlink:to="label477" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="element478" />
        <label xlink:type="resource" xlink:label="label478" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherAccruedLiabilitiesCurrent_en-US">Other Accrued Liabilities Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element478" xlink:to="label478" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="element479" />
        <label xlink:type="resource" xlink:label="label479" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesMember_en-US">Other liabilities-non current [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element479" xlink:to="label479" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="element480" />
        <label xlink:type="resource" xlink:label="label480" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element480" xlink:to="label480" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract" xlink:label="element481" />
        <label xlink:type="resource" xlink:label="label481" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_en-US">Recently Issued Accounting Pronouncements [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element481" xlink:to="label481" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentedTechnologyMember" xlink:label="element482" />
        <label xlink:type="resource" xlink:label="label482" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PatentedTechnologyMember_en-US">Patented Technology [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element482" xlink:to="label482" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember" xlink:label="element483" />
        <label xlink:type="resource" xlink:label="label483" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PatentsMember_en-US">Patents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element483" xlink:to="label483" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="element484" />
        <label xlink:type="resource" xlink:label="label484" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireBusinessesGross_en-US">Cash Paid for Acquisition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element484" xlink:to="label484" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="element485" />
        <label xlink:type="resource" xlink:label="label485" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_PaymentsToAcquireBusinessesGross_en-US">Cash Paid for Acquisition</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element485" xlink:to="label485" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="element486" />
        <label xlink:type="resource" xlink:label="label486" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PaymentsOfDebtIssuanceCosts_en-US">Payments of debt issuance costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element486" xlink:to="label486" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="element487" />
        <label xlink:type="resource" xlink:label="label487" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_PaymentsOfDebtIssuanceCosts_en-US">Payments of debt issuance costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element487" xlink:to="label487" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="element488" />
        <label xlink:type="resource" xlink:label="label488" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PaymentsForRestructuring_en-US">Restructuring Reserve, Settled with Cash</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element488" xlink:to="label488" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="element489" />
        <label xlink:type="resource" xlink:label="label489" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_en-US">Acquisitions, net of cash acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element489" xlink:to="label489" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="element490" />
        <label xlink:type="resource" xlink:label="label490" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_en-US">Acquisitions, net of cash acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element490" xlink:to="label490" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="element491" />
        <label xlink:type="resource" xlink:label="label491" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_en-US">Defined Benefit Plans Liabilities Noncurrent</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element491" xlink:to="label491" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="element492" />
        <label xlink:type="resource" xlink:label="label492" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_en-US">Employee Benefit Plans Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element492" xlink:to="label492" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="element493" />
        <label xlink:type="resource" xlink:label="label493" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PlanAssetCategoriesDomain_en-US">Plan Asset Categories [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element493" xlink:to="label493" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="element494" />
        <label xlink:type="resource" xlink:label="label494" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized_en-US">Preferred Stock - Shares Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element494" xlink:to="label494" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="element495" />
        <label xlink:type="resource" xlink:label="label495" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PreferredStockParOrStatedValuePerShare_en-US">Preferred Stock Par value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element495" xlink:to="label495" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="element496" />
        <label xlink:type="resource" xlink:label="label496" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PreferredStockValue_en-US">Preferred stock, par value $0.01 per share, 5,000,000 shares authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element496" xlink:to="label496" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="element497" />
        <label xlink:type="resource" xlink:label="label497" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_en-US">Net proceeds from issuance of debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element497" xlink:to="label497" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="element498" />
        <label xlink:type="resource" xlink:label="label498" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_en-US">Proceeds From Divestiture Of Businesses Net Of Cash Divested</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element498" xlink:to="label498" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="element499" />
        <label xlink:type="resource" xlink:label="label499" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_en-US">Dispositions, net of cash</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element499" xlink:to="label499" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="element500" />
        <label xlink:type="resource" xlink:label="label500" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_en-US">Net proceeds from issuance of common stock</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element500" xlink:to="label500" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="element501" />
        <label xlink:type="resource" xlink:label="label501" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_en-US">Proceeds from sales of property, plant and equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element501" xlink:to="label501" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:label="element502" />
        <label xlink:type="resource" xlink:label="label502" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProductWarrantiesDisclosuresAbstract_en-US">Warranties Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element502" xlink:to="label502" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock" xlink:label="element503" />
        <label xlink:type="resource" xlink:label="label503" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProductWarrantyDisclosureTextBlock_en-US">Warranties Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element503" xlink:to="label503" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="element504" />
        <label xlink:type="resource" xlink:label="label504" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProductWarrantyAccrualClassifiedCurrent_en-US">Product Warranty Accrual Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element504" xlink:to="label504" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="element505" />
        <label xlink:type="resource" xlink:label="label505" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentUsefulLife_en-US">Property, Plant and Equipment useful life</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element505" xlink:to="label505" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="element506" />
        <label xlink:type="resource" xlink:label="label506" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTypeDomain_en-US">Property, Plant and Equipment, Type [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element506" xlink:to="label506" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="element507" />
        <label xlink:type="resource" xlink:label="label507" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_en-US">Property, Plant and Equipment [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element507" xlink:to="label507" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="element508" />
        <label xlink:type="resource" xlink:label="label508" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentAbstract_en-US">Property, Plant and Equipment Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element508" xlink:to="label508" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="element509" />
        <label xlink:type="resource" xlink:label="label509" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentAdditions_en-US">Additions to property, plant and equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element509" xlink:to="label509" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="element510" />
        <label xlink:type="resource" xlink:label="label510" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_PropertyPlantAndEquipmentAdditions_en-US">Additions to property, plant and equipment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element510" xlink:to="label510" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="element511" />
        <label xlink:type="resource" xlink:label="label511" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_en-US">Property, plant and equipment, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element511" xlink:to="label511" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="element512" />
        <label xlink:type="resource" xlink:label="label512" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_PropertyPlantAndEquipmentNet_en-US">Property, plant and equipment, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element512" xlink:to="label512" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="element513" />
        <label xlink:type="resource" xlink:label="label513" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentLineItems_en-US">Property, Plant and Equipment [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element513" xlink:to="label513" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="element514" />
        <label xlink:type="resource" xlink:label="label514" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross_en-US">Property, Plant and Equipment, Gross</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element514" xlink:to="label514" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="element515" />
        <label xlink:type="resource" xlink:label="label515" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis_en-US">Property, Plant and Equipment by Type [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element515" xlink:to="label515" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="element516" />
        <label xlink:type="resource" xlink:label="label516" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element516" xlink:to="label516" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="element517" />
        <label xlink:type="resource" xlink:label="label517" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ProvisionForDoubtfulAccounts_en-US">Provision for allowance for doubtful accounts</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element517" xlink:to="label517" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="element518" />
        <label xlink:type="resource" xlink:label="label518" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialDataAbstract_en-US">Quarterly Financial Data [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element518" xlink:to="label518" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="element519" />
        <label xlink:type="resource" xlink:label="label519" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialInformationTextBlock_en-US">Quarterly Financial Information (unaudited) Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element519" xlink:to="label519" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="element520" />
        <label xlink:type="resource" xlink:label="label520" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_en-US">Quarterly Financial Information Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element520" xlink:to="label520" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="element521" />
        <label xlink:type="resource" xlink:label="label521" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RangeAxis_en-US">Range [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element521" xlink:to="label521" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="element522" />
        <label xlink:type="resource" xlink:label="label522" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RangeMember_en-US">Range [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element522" xlink:to="label522" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="element523" />
        <label xlink:type="resource" xlink:label="label523" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ReceivablesPolicyTextBlock_en-US">Allowance for Doubtful Accounts [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element523" xlink:to="label523" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="element524" />
        <label xlink:type="resource" xlink:label="label524" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_en-US">Reclassification from Accumulated Other Comprehensive Income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element524" xlink:to="label524" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="element525" />
        <label xlink:type="resource" xlink:label="label525" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_en-US">Reclassification from Accumulated Other Comprehensive Income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element525" xlink:to="label525" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="element526" />
        <label xlink:type="resource" xlink:label="label526" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_en-US">Reclassification from Accumulated Other Comprehensive Income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element526" xlink:to="label526" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="element527" />
        <label xlink:type="resource" xlink:label="label527" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xml:lang="en-US" id="NegatedTotal_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_en-US">Reclassification from Accumulated Other Comprehensive Income</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element527" xlink:to="label527" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="element528" />
        <label xlink:type="resource" xlink:label="label528" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element528" xlink:to="label528" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Reclassifications" xlink:label="element529" />
        <label xlink:type="resource" xlink:label="label529" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Reclassifications_en-US">Reclassifications [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element529" xlink:to="label529" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="element530" />
        <label xlink:type="resource" xlink:label="label530" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_en-US">Reconciliation Of Uncertain Tax Liabilities [abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element530" xlink:to="label530" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="element531" />
        <label xlink:type="resource" xlink:label="label531" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_en-US">Related Party Transactions Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element531" xlink:to="label531" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="element532" />
        <label xlink:type="resource" xlink:label="label532" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsAbstract_en-US">Related Party Transactions [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element532" xlink:to="label532" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="element533" />
        <label xlink:type="resource" xlink:label="label533" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RepaymentsOfLongTermDebt_en-US">Repayments of debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element533" xlink:to="label533" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="element534" />
        <label xlink:type="resource" xlink:label="label534" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_RepaymentsOfLongTermDebt_en-US">Repayments of debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element534" xlink:to="label534" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="element535" />
        <label xlink:type="resource" xlink:label="label535" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RepaymentsOfShortTermDebt_en-US">Repayments of short-term debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element535" xlink:to="label535" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="element536" />
        <label xlink:type="resource" xlink:label="label536" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_RepaymentsOfShortTermDebt_en-US">Repayments of short-term debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element536" xlink:to="label536" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="element537" />
        <label xlink:type="resource" xlink:label="label537" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense_en-US">Research and development expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element537" xlink:to="label537" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="element538" />
        <label xlink:type="resource" xlink:label="label538" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpenseMember_en-US">Research and Development Expense [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element538" xlink:to="label538" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="element539" />
        <label xlink:type="resource" xlink:label="label539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_ResearchAndDevelopmentExpenseMember_en-US">Research and development</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element539" xlink:to="label539" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment" xlink:label="element540" />
        <label xlink:type="resource" xlink:label="label540" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringReserveTranslationAdjustment_en-US">Restructuring Reserve, Translation Adjustment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element540" xlink:to="label540" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:label="element541" />
        <label xlink:type="resource" xlink:label="label541" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_en-US">Restructuring number of positions eliminated, percent</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element541" xlink:to="label541" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="element542" />
        <label xlink:type="resource" xlink:label="label542" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringCharges_en-US">Restructuring charges (credits)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element542" xlink:to="label542" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="element543" />
        <label xlink:type="resource" xlink:label="label543" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringReserve_en-US">Restructuring Reserve</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element543" xlink:to="label543" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="element544" />
        <label xlink:type="resource" xlink:label="label544" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_RestructuringReserve_en-US">Restructuring Reserve, Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element544" xlink:to="label544" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="element545" />
        <label xlink:type="resource" xlink:label="label545" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_RestructuringReserve_en-US">Restructuring Reserve, Ending Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element545" xlink:to="label545" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="element546" />
        <label xlink:type="resource" xlink:label="label546" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringReserveCurrent_en-US">Accrued Severance Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element546" xlink:to="label546" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="element547" />
        <label xlink:type="resource" xlink:label="label547" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringPlanDomain_en-US">Restructuring Plan [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element547" xlink:to="label547" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="element548" />
        <label xlink:type="resource" xlink:label="label548" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringPlanAxis_en-US">Restructuring Plan [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element548" xlink:to="label548" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1" xlink:label="element549" />
        <label xlink:type="resource" xlink:label="label549" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringReserveAccrualAdjustment1_en-US">Restructuring Reserve, Accrual Adjustment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element549" xlink:to="label549" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="element550" />
        <label xlink:type="resource" xlink:label="label550" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedActivitiesAbstract_en-US">Restructuring and Related Activities [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element550" xlink:to="label550" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="element551" />
        <label xlink:type="resource" xlink:label="label551" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringReserveRollForward_en-US">Restructuring Reserve [Roll Forward]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element551" xlink:to="label551" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="element552" />
        <label xlink:type="resource" xlink:label="label552" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringCostAndReserveAxis_en-US">Restructuring Cost and Reserve [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element552" xlink:to="label552" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="element553" />
        <label xlink:type="resource" xlink:label="label553" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringCostAndReserveLineItems_en-US">Restructuring Cost and Reserve [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element553" xlink:to="label553" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="element554" />
        <label xlink:type="resource" xlink:label="label554" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_en-US">Restructuring And Other Exit Costs Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element554" xlink:to="label554" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="element555" />
        <label xlink:type="resource" xlink:label="label555" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit_en-US">Accumulated deficit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element555" xlink:to="label555" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="element556" />
        <label xlink:type="resource" xlink:label="label556" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RevenueRecognitionPolicyTextBlock_en-US">Revenue Recognition [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element556" xlink:to="label556" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="element557" />
        <label xlink:type="resource" xlink:label="label557" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_Revenues_en-US">Revenues</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element557" xlink:to="label557" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="element558" />
        <label xlink:type="resource" xlink:label="label558" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_RevolvingCreditFacilityMember_en-US">Revolving Credit Facility [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element558" xlink:to="label558" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="element559" />
        <label xlink:type="resource" xlink:label="label559" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_RevolvingCreditFacilityMember_en-US">Revolving line</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element559" xlink:to="label559" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="element560" />
        <label xlink:type="resource" xlink:label="label560" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_en-US">Capital Stock Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element560" xlink:to="label560" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="element561" />
        <label xlink:type="resource" xlink:label="label561" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element561" xlink:to="label561" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="element562" />
        <label xlink:type="resource" xlink:label="label562" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element562" xlink:to="label562" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="element563" />
        <label xlink:type="resource" xlink:label="label563" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element563" xlink:to="label563" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="element564" />
        <label xlink:type="resource" xlink:label="label564" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_en-US">Fair Value Assumptions, Expected Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element564" xlink:to="label564" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="element565" />
        <label xlink:type="resource" xlink:label="label565" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element565" xlink:to="label565" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="element566" />
        <label xlink:type="resource" xlink:label="label566" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_en-US">Begining Balance Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element566" xlink:to="label566" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="element567" />
        <label xlink:type="resource" xlink:label="label567" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_en-US">Closing Balance Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element567" xlink:to="label567" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="element568" />
        <label xlink:type="resource" xlink:label="label568" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element568" xlink:to="label568" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="element569" />
        <label xlink:type="resource" xlink:label="label569" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_en-US">Weighted Average Fair Value of Vested Restricted Stock</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element569" xlink:to="label569" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="element570" />
        <label xlink:type="resource" xlink:label="label570" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SegmentsGeographicalAreasAbstract_en-US">Segments, Geographical Areas [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element570" xlink:to="label570" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNetMember" xlink:label="element571" />
        <label xlink:type="resource" xlink:label="label571" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SalesRevenueGoodsNetMember_en-US">Sales Revenue, Goods, Net [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element571" xlink:to="label571" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="element572" />
        <label xlink:type="resource" xlink:label="label572" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_en-US">Schedule of Inventory [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element572" xlink:to="label572" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="element573" />
        <label xlink:type="resource" xlink:label="label573" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_en-US">Schedule of effect of derivative instruments on the consolidated statements of operations [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element573" xlink:to="label573" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="element574" />
        <label xlink:type="resource" xlink:label="label574" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element574" xlink:to="label574" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="element575" />
        <label xlink:type="resource" xlink:label="label575" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_en-US">Schedule of Assumptions Used [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element575" xlink:to="label575" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="element576" />
        <label xlink:type="resource" xlink:label="label576" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_en-US">Accumulated Other Comprehensive Income [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element576" xlink:to="label576" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="element577" />
        <label xlink:type="resource" xlink:label="label577" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element577" xlink:to="label577" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="element578" />
        <label xlink:type="resource" xlink:label="label578" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element578" xlink:to="label578" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="element579" />
        <label xlink:type="resource" xlink:label="label579" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element579" xlink:to="label579" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="element580" />
        <label xlink:type="resource" xlink:label="label580" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfDebtTableTextBlock_en-US">Schedule of Debt [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element580" xlink:to="label580" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:label="element581" />
        <label xlink:type="resource" xlink:label="label581" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element581" xlink:to="label581" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="element582" />
        <label xlink:type="resource" xlink:label="label582" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element582" xlink:to="label582" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="element583" />
        <label xlink:type="resource" xlink:label="label583" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_en-US">Schedule of Cash Flow Hedges Included in AOCI [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element583" xlink:to="label583" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:label="element584" />
        <label xlink:type="resource" xlink:label="label584" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element584" xlink:to="label584" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="element585" />
        <label xlink:type="resource" xlink:label="label585" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element585" xlink:to="label585" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="element586" />
        <label xlink:type="resource" xlink:label="label586" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_en-US">Table Of Assumptions [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element586" xlink:to="label586" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="element587" />
        <label xlink:type="resource" xlink:label="label587" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element587" xlink:to="label587" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="element588" />
        <label xlink:type="resource" xlink:label="label588" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element588" xlink:to="label588" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="element589" />
        <label xlink:type="resource" xlink:label="label589" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_en-US">Schedule of Credit Losses for Financing Receivables, Current [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element589" xlink:to="label589" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:label="element590" />
        <label xlink:type="resource" xlink:label="label590" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_en-US">Schedule Of Costs Of Retirement Plans [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element590" xlink:to="label590" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="element591" />
        <label xlink:type="resource" xlink:label="label591" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_en-US">Schedule of Nonvested Share Activity [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element591" xlink:to="label591" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="element592" />
        <label xlink:type="resource" xlink:label="label592" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_en-US">Warranty Rollforward Disclosure [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element592" xlink:to="label592" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="element593" />
        <label xlink:type="resource" xlink:label="label593" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_en-US">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element593" xlink:to="label593" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="element594" />
        <label xlink:type="resource" xlink:label="label594" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_en-US">Schedule of Allocation of Plan Assets [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element594" xlink:to="label594" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:label="element595" />
        <label xlink:type="resource" xlink:label="label595" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_en-US">Schedule of Net Funded Status [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element595" xlink:to="label595" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="element596" />
        <label xlink:type="resource" xlink:label="label596" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_en-US">Basic and Diluted Shares [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element596" xlink:to="label596" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="element597" />
        <label xlink:type="resource" xlink:label="label597" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_en-US">Schedule of Quarterly Financial Information [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element597" xlink:to="label597" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="element598" />
        <label xlink:type="resource" xlink:label="label598" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element598" xlink:to="label598" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="element599" />
        <label xlink:type="resource" xlink:label="label599" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element599" xlink:to="label599" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:label="element600" />
        <label xlink:type="resource" xlink:label="label600" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element600" xlink:to="label600" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="element601" />
        <label xlink:type="resource" xlink:label="label601" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element601" xlink:to="label601" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="element602" />
        <label xlink:type="resource" xlink:label="label602" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element602" xlink:to="label602" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="element603" />
        <label xlink:type="resource" xlink:label="label603" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_en-US">Schedule of Business Acquisitions , Contingent Consideration [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element603" xlink:to="label603" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="element604" />
        <label xlink:type="resource" xlink:label="label604" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_en-US">Schedule of Business Acquisitions [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element604" xlink:to="label604" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="element605" />
        <label xlink:type="resource" xlink:label="label605" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_en-US">Schedule of Business Acquisitions, by Acquisition [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element605" xlink:to="label605" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="element606" />
        <label xlink:type="resource" xlink:label="label606" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_en-US">Schedule of Defined Benefit Plans Disclosures [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element606" xlink:to="label606" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:label="element607" />
        <label xlink:type="resource" xlink:label="label607" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element607" xlink:to="label607" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="element608" />
        <label xlink:type="resource" xlink:label="label608" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfGoodwillTextBlock_en-US">Goodwill Rollforward [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element608" xlink:to="label608" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="element609" />
        <label xlink:type="resource" xlink:label="label609" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_en-US">Stock Based Compensation Expense Activity By Function [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element609" xlink:to="label609" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="element610" />
        <label xlink:type="resource" xlink:label="label610" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element610" xlink:to="label610" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="element611" />
        <label xlink:type="resource" xlink:label="label611" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_en-US">Schedule of Property, Plant and Equipment [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element611" xlink:to="label611" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="element612" />
        <label xlink:type="resource" xlink:label="label612" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element612" xlink:to="label612" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="element613" />
        <label xlink:type="resource" xlink:label="label613" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_en-US">Segment and Related Information [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element613" xlink:to="label613" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="element614" />
        <label xlink:type="resource" xlink:label="label614" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_en-US">Schedule of Restructuring and Related Costs [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element614" xlink:to="label614" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="element615" />
        <label xlink:type="resource" xlink:label="label615" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element615" xlink:to="label615" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="element616" />
        <label xlink:type="resource" xlink:label="label616" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_en-US">Schedule of Summary of Outstanding and Exercisable Options [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element616" xlink:to="label616" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="element617" />
        <label xlink:type="resource" xlink:label="label617" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_en-US">Restructuring Plan Table [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element617" xlink:to="label617" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:label="element618" />
        <label xlink:type="resource" xlink:label="label618" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element618" xlink:to="label618" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="element619" />
        <label xlink:type="resource" xlink:label="label619" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element619" xlink:to="label619" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="element620" />
        <label xlink:type="resource" xlink:label="label620" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SecuredDebtCurrent_en-US">Current portion, long-term debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element620" xlink:to="label620" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="element621" />
        <label xlink:type="resource" xlink:label="label621" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_SecuredDebtCurrent_en-US">Less: current installments</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element621" xlink:to="label621" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="element622" />
        <label xlink:type="resource" xlink:label="label622" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SecuredDebt_en-US">Secured Debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element622" xlink:to="label622" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="element623" />
        <label xlink:type="resource" xlink:label="label623" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_SecuredDebt_en-US">Total Debt</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element623" xlink:to="label623" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="element624" />
        <label xlink:type="resource" xlink:label="label624" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SecuredDebtMember_en-US">Term Loan [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element624" xlink:to="label624" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="element625" />
        <label xlink:type="resource" xlink:label="label625" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_SecuredDebtMember_en-US">Term Loan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element625" xlink:to="label625" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="element626" />
        <label xlink:type="resource" xlink:label="label626" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SegmentReportingDisclosureTextBlock_en-US">Segment Reporting Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element626" xlink:to="label626" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="element627" />
        <label xlink:type="resource" xlink:label="label627" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_en-US">Segment and Related Information Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element627" xlink:to="label627" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="element628" />
        <label xlink:type="resource" xlink:label="label628" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SegmentReportingInformationLineItems_en-US">Segment Reporting Information [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element628" xlink:to="label628" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="element629" />
        <label xlink:type="resource" xlink:label="label629" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SegmentGeographicalDomain_en-US">Segment, Geographical [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element629" xlink:to="label629" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="element630" />
        <label xlink:type="resource" xlink:label="label630" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SellingAndMarketingExpense_en-US">Sales and marketing expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element630" xlink:to="label630" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="element631" />
        <label xlink:type="resource" xlink:label="label631" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SellingAndMarketingExpenseMember_en-US">Selling and Marketing Expense [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element631" xlink:to="label631" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="element632" />
        <label xlink:type="resource" xlink:label="label632" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation_en-US">Share-based Compensation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element632" xlink:to="label632" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="element633" />
        <label xlink:type="resource" xlink:label="label633" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_en-US">Options, Grants in Period, Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element633" xlink:to="label633" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="element634" />
        <label xlink:type="resource" xlink:label="label634" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element634" xlink:to="label634" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="element635" />
        <label xlink:type="resource" xlink:label="label635" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period, Maximum</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element635" xlink:to="label635" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="element636" />
        <label xlink:type="resource" xlink:label="label636" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_en-US">Options, Exercises in Period, Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element636" xlink:to="label636" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="element637" />
        <label xlink:type="resource" xlink:label="label637" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_en-US">Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element637" xlink:to="label637" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="element638" />
        <label xlink:type="resource" xlink:label="label638" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_en-US">Accelerated Share Based Compensation Expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element638" xlink:to="label638" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="element639" />
        <label xlink:type="resource" xlink:label="label639" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element639" xlink:to="label639" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="element640" />
        <label xlink:type="resource" xlink:label="label640" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_en-US">Options, Grants in Period, Gross</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element640" xlink:to="label640" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="element641" />
        <label xlink:type="resource" xlink:label="label641" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_en-US">Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element641" xlink:to="label641" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="element642" />
        <label xlink:type="resource" xlink:label="label642" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_en-US">Opening Balance Stock Options Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element642" xlink:to="label642" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="element643" />
        <label xlink:type="resource" xlink:label="label643" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_en-US">Closing Balance Stock Options Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element643" xlink:to="label643" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="element644" />
        <label xlink:type="resource" xlink:label="label644" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_en-US">Equity Instruments Other than Options, Grants in Period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element644" xlink:to="label644" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="element645" />
        <label xlink:type="resource" xlink:label="label645" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element645" xlink:to="label645" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="element646" />
        <label xlink:type="resource" xlink:label="label646" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element646" xlink:to="label646" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="element647" />
        <label xlink:type="resource" xlink:label="label647" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_en-US">Begining Balance Grant Date Fair Value Of Restricted Stock Units</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element647" xlink:to="label647" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="element648" />
        <label xlink:type="resource" xlink:label="label648" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_en-US">Closing Balance Grant Date Fair Value Of Restricted Stock Units</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element648" xlink:to="label648" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="element649" />
        <label xlink:type="resource" xlink:label="label649" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element649" xlink:to="label649" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="element650" />
        <label xlink:type="resource" xlink:label="label650" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_en-US">Begining Balance Restricted Stock Units Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element650" xlink:to="label650" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="element651" />
        <label xlink:type="resource" xlink:label="label651" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_en-US">Closing Balance Restricted Stock Units Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element651" xlink:to="label651" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="element652" />
        <label xlink:type="resource" xlink:label="label652" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element652" xlink:to="label652" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="element653" />
        <label xlink:type="resource" xlink:label="label653" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element653" xlink:to="label653" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="element654" />
        <label xlink:type="resource" xlink:label="label654" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_en-US">Fair Value Assumptions, Risk Free Interest Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element654" xlink:to="label654" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="element655" />
        <label xlink:type="resource" xlink:label="label655" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element655" xlink:to="label655" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="element656" />
        <label xlink:type="resource" xlink:label="label656" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element656" xlink:to="label656" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="element657" />
        <label xlink:type="resource" xlink:label="label657" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_en-US">Equity Instruments Other than Options, Vested in Period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element657" xlink:to="label657" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="element658" />
        <label xlink:type="resource" xlink:label="label658" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_en-US">Options, Forfeitures and Expirations in Period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element658" xlink:to="label658" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="element659" />
        <label xlink:type="resource" xlink:label="label659" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element659" xlink:to="label659" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="element660" />
        <label xlink:type="resource" xlink:label="label660" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_en-US">Fair Value Assumptions, Expected Dividend Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element660" xlink:to="label660" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="element661" />
        <label xlink:type="resource" xlink:label="label661" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element661" xlink:to="label661" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="element662" />
        <label xlink:type="resource" xlink:label="label662" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_en-US">Opening Balance Available for Grant</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element662" xlink:to="label662" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="element663" />
        <label xlink:type="resource" xlink:label="label663" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_en-US">Closing Balance Available for Grant</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element663" xlink:to="label663" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="element664" />
        <label xlink:type="resource" xlink:label="label664" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_en-US">Fair Value Assumptions, Expected Volatility Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element664" xlink:to="label664" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="element665" />
        <label xlink:type="resource" xlink:label="label665" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element665" xlink:to="label665" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="element666" />
        <label xlink:type="resource" xlink:label="label666" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element666" xlink:to="label666" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="element667" />
        <label xlink:type="resource" xlink:label="label667" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_en-US">Opening Balance Stock Options Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element667" xlink:to="label667" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="element668" />
        <label xlink:type="resource" xlink:label="label668" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_en-US">Closing Balance Stock Options Outstanding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element668" xlink:to="label668" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="element669" />
        <label xlink:type="resource" xlink:label="label669" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_en-US">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element669" xlink:to="label669" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="element670" />
        <label xlink:type="resource" xlink:label="label670" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element670" xlink:to="label670" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="element671" />
        <label xlink:type="resource" xlink:label="label671" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_en-US">Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element671" xlink:to="label671" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="element672" />
        <label xlink:type="resource" xlink:label="label672" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_en-US">Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element672" xlink:to="label672" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="element673" />
        <label xlink:type="resource" xlink:label="label673" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element673" xlink:to="label673" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="element674" />
        <label xlink:type="resource" xlink:label="label674" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element674" xlink:to="label674" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="element675" />
        <label xlink:type="resource" xlink:label="label675" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_en-US">Share-based Compensation [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element675" xlink:to="label675" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="element676" />
        <label xlink:type="resource" xlink:label="label676" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_en-US">Shares Paid for Tax Withholding for Share Based Compensation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element676" xlink:to="label676" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares" xlink:label="element677" />
        <label xlink:type="resource" xlink:label="label677" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares_en-US">Shares held in Employee Stock Option Plan, Suspense Shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element677" xlink:to="label677" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="element678" />
        <label xlink:type="resource" xlink:label="label678" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_en-US">Warranty additions</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element678" xlink:to="label678" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="element679" />
        <label xlink:type="resource" xlink:label="label679" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StandardProductWarrantyAccrual_en-US">Standard Product Warranty Accrual</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element679" xlink:to="label679" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="element680" />
        <label xlink:type="resource" xlink:label="label680" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_StandardProductWarrantyAccrual_en-US">Warranty, Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element680" xlink:to="label680" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="element681" />
        <label xlink:type="resource" xlink:label="label681" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_StandardProductWarrantyAccrual_en-US">Warranty, Ending Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element681" xlink:to="label681" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="element682" />
        <label xlink:type="resource" xlink:label="label682" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StandardProductWarrantyAccrualPayments_en-US">Warranty payments</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element682" xlink:to="label682" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="element683" />
        <label xlink:type="resource" xlink:label="label683" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StandardProductWarrantyDisclosureAbstract_en-US">Product Warranty Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element683" xlink:to="label683" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="element684" />
        <label xlink:type="resource" xlink:label="label684" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StateAndLocalJurisdictionMember_en-US">State And Local Jurisdiction [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element684" xlink:to="label684" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="element685" />
        <label xlink:type="resource" xlink:label="label685" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_StateAndLocalJurisdictionMember_en-US">State</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element685" xlink:to="label685" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="element686" />
        <label xlink:type="resource" xlink:label="label686" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StatementEquityComponentsAxis_en-US">Statement, Equity Components [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element686" xlink:to="label686" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="element687" />
        <label xlink:type="resource" xlink:label="label687" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StatementOfCashFlowsAbstract_en-US">CONSOLIDATED STATEMENTS OF CASH FLOWS</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element687" xlink:to="label687" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="element688" />
        <label xlink:type="resource" xlink:label="label688" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_en-US">Consolidated Statements of Comprehensive Income [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element688" xlink:to="label688" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="element689" />
        <label xlink:type="resource" xlink:label="label689" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StatementOfFinancialPositionAbstract_en-US">CONSOLIDATED BALANCE SHEETS</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element689" xlink:to="label689" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="element690" />
        <label xlink:type="resource" xlink:label="label690" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StatementGeographicalAxis_en-US">Statement, Geographical [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element690" xlink:to="label690" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="element691" />
        <label xlink:type="resource" xlink:label="label691" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockRepurchaseProgramAuthorizedAmount1_en-US">Stock Repurchase Program, Authorized Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element691" xlink:to="label691" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="element692" />
        <label xlink:type="resource" xlink:label="label692" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockOptionPlanExpense_en-US">Stock-based compensation expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element692" xlink:to="label692" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="element693" />
        <label xlink:type="resource" xlink:label="label693" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockRepurchaseProgramPeriodInForce1_en-US">Stock Repurchase Program, Period in Force</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element693" xlink:to="label693" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="element694" />
        <label xlink:type="resource" xlink:label="label694" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_en-US">Stock issued during the year, Shares, Employee Stock Purchase Plans</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element694" xlink:to="label694" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="element695" />
        <label xlink:type="resource" xlink:label="label695" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element695" xlink:to="label695" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="element696" />
        <label xlink:type="resource" xlink:label="label696" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_en-US">Stock option exercises during the year, Shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element696" xlink:to="label696" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="element697" />
        <label xlink:type="resource" xlink:label="label697" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_en-US">Stock option exercises during the year, Shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element697" xlink:to="label697" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="element698" />
        <label xlink:type="resource" xlink:label="label698" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract_en-US">Stockholders Equity Abstract</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element698" xlink:to="label698" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="element699" />
        <label xlink:type="resource" xlink:label="label699" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteAbstract_en-US">Capital Stock Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element699" xlink:to="label699" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="element700" />
        <label xlink:type="resource" xlink:label="label700" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_en-US">Total stockholders' equity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element700" xlink:to="label700" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="element701" />
        <label xlink:type="resource" xlink:label="label701" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_StockholdersEquity_en-US">Total stockholders' equity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element701" xlink:to="label701" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="element702" />
        <label xlink:type="resource" xlink:label="label702" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_StockholdersEquity_en-US">Total stockholders' equity at begining of the year, Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element702" xlink:to="label702" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="element703" />
        <label xlink:type="resource" xlink:label="label703" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_StockholdersEquity_en-US">Total stockholders' equity at year end, Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element703" xlink:to="label703" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="element704" />
        <label xlink:type="resource" xlink:label="label704" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SubsequentEventsAbstract_en-US">Subsequent Events [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element704" xlink:to="label704" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="element705" />
        <label xlink:type="resource" xlink:label="label705" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember_en-US">Subsequent Event [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element705" xlink:to="label705" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="element706" />
        <label xlink:type="resource" xlink:label="label706" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SubsequentEventsTextBlock_en-US">Subsequent Events [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element706" xlink:to="label706" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="element707" />
        <label xlink:type="resource" xlink:label="label707" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeAxis_en-US">Subsequent Event [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element707" xlink:to="label707" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="element708" />
        <label xlink:type="resource" xlink:label="label708" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeDomain_en-US">Subsequent Event [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element708" xlink:to="label708" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="element709" />
        <label xlink:type="resource" xlink:label="label709" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_en-US">Summary of Income Tax Contingencies [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element709" xlink:to="label709" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="element710" />
        <label xlink:type="resource" xlink:label="label710" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_SupplementalCashFlowInformationAbstract_en-US">Supplemental disclosures of cash flow information [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element710" xlink:to="label710" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="element711" />
        <label xlink:type="resource" xlink:label="label711" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardAmount_en-US">Tax Credit Carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element711" xlink:to="label711" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="element712" />
        <label xlink:type="resource" xlink:label="label712" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_TaxCreditCarryforwardAmount_en-US">Tax credit carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element712" xlink:to="label712" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="element713" />
        <label xlink:type="resource" xlink:label="label713" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TradeNamesMember_en-US">Trade Names [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element713" xlink:to="label713" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="element714" />
        <label xlink:type="resource" xlink:label="label714" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TreasuryStockShares_en-US">Treasury Stock common shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element714" xlink:to="label714" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="element715" />
        <label xlink:type="resource" xlink:label="label715" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TreasuryStockValueAcquiredCostMethod_en-US">Treasury Stock, Value Acquired, Cost Method</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element715" xlink:to="label715" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="element716" />
        <label xlink:type="resource" xlink:label="label716" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_TreasuryStockValueAcquiredCostMethod_en-US">Purchases of treasury stock</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element716" xlink:to="label716" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="element717" />
        <label xlink:type="resource" xlink:label="label717" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_TreasuryStockValueAcquiredCostMethod_en-US">Purchases of treasury stock</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element717" xlink:to="label717" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="element718" />
        <label xlink:type="resource" xlink:label="label718" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TreasuryStockSharesAcquired_en-US">Treasury Stock, Shares Acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element718" xlink:to="label718" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="element719" />
        <label xlink:type="resource" xlink:label="label719" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TreasuryStockCarryingBasis_en-US">Treasury stock at cost, 7,745,507 common shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element719" xlink:to="label719" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="element720" />
        <label xlink:type="resource" xlink:label="label720" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_TreasuryStockCarryingBasis_en-US">Treasury stock at cost, 7,745,507 common shares</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element720" xlink:to="label720" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="element721" />
        <label xlink:type="resource" xlink:label="label721" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_TypeOfRestructuringDomain_en-US">Type of Restructuring [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element721" xlink:to="label721" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="element722" />
        <label xlink:type="resource" xlink:label="label722" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnamortizedDebtIssuanceExpense_en-US">Unamortized Debt Issuance Expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element722" xlink:to="label722" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="element723" />
        <label xlink:type="resource" xlink:label="label723" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_us-gaap_UnamortizedDebtIssuanceExpense_en-US">Current unamortized deferred financing costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element723" xlink:to="label723" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnpatentedTechnologyMember" xlink:label="element724" />
        <label xlink:type="resource" xlink:label="label724" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnpatentedTechnologyMember_en-US">Unpatented Technology [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element724" xlink:to="label724" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="element725" />
        <label xlink:type="resource" xlink:label="label725" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_en-US">Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element725" xlink:to="label725" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="element726" />
        <label xlink:type="resource" xlink:label="label726" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_en-US">Unrecognized Tax Benefits Increases Resulting from Current Period Tax Positions</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element726" xlink:to="label726" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="element727" />
        <label xlink:type="resource" xlink:label="label727" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_en-US">Increase (Decrease) In Income Taxes Resulting From Release Of Uncertain Tax Position Liability Due To Expiration Of Statute Of Limitations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element727" xlink:to="label727" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="element728" />
        <label xlink:type="resource" xlink:label="label728" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_en-US">Change in reserve for uncertain tax position</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element728" xlink:to="label728" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="element729" />
        <label xlink:type="resource" xlink:label="label729" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_en-US">Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element729" xlink:to="label729" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="element730" />
        <label xlink:type="resource" xlink:label="label730" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_en-US">Income tax reserve</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element730" xlink:to="label730" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="element731" />
        <label xlink:type="resource" xlink:label="label731" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_UnrecognizedTaxBenefits_en-US">Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element731" xlink:to="label731" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="element732" />
        <label xlink:type="resource" xlink:label="label732" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_UnrecognizedTaxBenefits_en-US">Ending Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element732" xlink:to="label732" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="element733" />
        <label xlink:type="resource" xlink:label="label733" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits_en-US">Unrecognized Tax Benefits</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element733" xlink:to="label733" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="element734" />
        <label xlink:type="resource" xlink:label="label734" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_UseOfEstimates_en-US">Use of Estimates [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element734" xlink:to="label734" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="element735" />
        <label xlink:type="resource" xlink:label="label735" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US" id="periodStart_us-gaap_ValuationAllowancesAndReservesBalance_en-US">Beginning Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element735" xlink:to="label735" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="element736" />
        <label xlink:type="resource" xlink:label="label736" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US" id="periodEnd_us-gaap_ValuationAllowancesAndReservesBalance_en-US">Ending Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element736" xlink:to="label736" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="element737" />
        <label xlink:type="resource" xlink:label="label737" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ValuationAllowancesAndReservesBalance_en-US">Valuation Allowances and Reserves, Balance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element737" xlink:to="label737" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:label="element738" />
        <label xlink:type="resource" xlink:label="label738" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ValuationAllowancesAndReservesAdjustments_en-US">Charged To Allowance</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element738" xlink:to="label738" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="element739" />
        <label xlink:type="resource" xlink:label="label739" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_en-US">Change In Valuation Allowances For Deferred Tax Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element739" xlink:to="label739" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="element740" />
        <label xlink:type="resource" xlink:label="label740" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_en-US">Charged To Bad Debt Expense</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element740" xlink:to="label740" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="element741" />
        <label xlink:type="resource" xlink:label="label741" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_en-US">Diluted</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element741" xlink:to="label741" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="element742" />
        <label xlink:type="resource" xlink:label="label742" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_en-US">Diluted</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element742" xlink:to="label742" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="element743" />
        <label xlink:type="resource" xlink:label="label743" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_en-US">Weighted average common shares:</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element743" xlink:to="label743" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="element744" />
        <label xlink:type="resource" xlink:label="label744" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_en-US">Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element744" xlink:to="label744" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="element745" />
        <label xlink:type="resource" xlink:label="label745" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_en-US">Basic</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element745" xlink:to="label745" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="element746" />
        <label xlink:type="resource" xlink:label="label746" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element746" xlink:to="label746" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_DE" xlink:label="element747" />
        <label xlink:type="resource" xlink:label="label747" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_country_DE_en-US">Segment, Geographical, Germany [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element747" xlink:to="label747" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_GB" xlink:label="element748" />
        <label xlink:type="resource" xlink:label="label748" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_country_GB_en-US">Segment, Geographical, United Kingdom [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element748" xlink:to="label748" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="element749" />
        <label xlink:type="resource" xlink:label="label749" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_country_US_en-US">Segment, Geographical, United States [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element749" xlink:to="label749" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AmortizationOfCatalogCosts" xlink:label="element750" />
        <label xlink:type="resource" xlink:label="label750" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AmortizationOfCatalogCosts_en-US">Amortization Of Catalog Costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element750" xlink:to="label750" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AmortizationOfCatalogCosts" xlink:label="element751" />
        <label xlink:type="resource" xlink:label="label751" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AmortizationOfCatalogCosts_en-US">Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element751" xlink:to="label751" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionsToCatalogCosts" xlink:label="element752" />
        <label xlink:type="resource" xlink:label="label752" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AdditionsToCatalogCosts_en-US">Additions to catalog costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element752" xlink:to="label752" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionsToCatalogCosts" xlink:label="element753" />
        <label xlink:type="resource" xlink:label="label753" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_hbio_AdditionsToCatalogCosts_en-US">Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element753" xlink:to="label753" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonCashRestructuringCharge" xlink:label="element754" />
        <label xlink:type="resource" xlink:label="label754" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NonCashRestructuringCharge_en-US">Non cash restructuring charge</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element754" xlink:to="label754" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonCashRestructuringCharge" xlink:label="element755" />
        <label xlink:type="resource" xlink:label="label755" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NonCashRestructuringCharge_en-US">These charges represent the non cash charges included in the restructuring charges within the Statement of Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element755" xlink:to="label755" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OrganizationDisclosureAbstract" xlink:label="element756" />
        <label xlink:type="resource" xlink:label="label756" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OrganizationDisclosureAbstract_en-US">Organization Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element756" xlink:to="label756" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OrganizationDisclosureTextBlock" xlink:label="element757" />
        <label xlink:type="resource" xlink:label="label757" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OrganizationDisclosureTextBlock_en-US">Organization Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element757" xlink:to="label757" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OrganizationDisclosureTextBlock" xlink:label="element758" />
        <label xlink:type="resource" xlink:label="label758" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OrganizationDisclosureTextBlock_en-US">The entire disclosure describing the organization</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element758" xlink:to="label758" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ConcentrationsDisclosureAbstract" xlink:label="element759" />
        <label xlink:type="resource" xlink:label="label759" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ConcentrationsDisclosureAbstract_en-US">Concentrations Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element759" xlink:to="label759" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AccruedExpensesDisclosureTextBlock" xlink:label="element760" />
        <label xlink:type="resource" xlink:label="label760" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AccruedExpensesDisclosureTextBlock_en-US">Accrued Expenses Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element760" xlink:to="label760" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AccruedExpensesDisclosureTextBlock" xlink:label="element761" />
        <label xlink:type="resource" xlink:label="label761" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AccruedExpensesDisclosureTextBlock_en-US">The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element761" xlink:to="label761" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureAbstract" xlink:label="element762" />
        <label xlink:type="resource" xlink:label="label762" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AllowanceForDoubtfulDebtsDisclosureAbstract_en-US">Allowance For Doubtful Debts Disclosure [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element762" xlink:to="label762" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock" xlink:label="element763" />
        <label xlink:type="resource" xlink:label="label763" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock_en-US">Allowance For Doubtful Debts Disclosure [Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element763" xlink:to="label763" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock" xlink:label="element764" />
        <label xlink:type="resource" xlink:label="label764" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock_en-US">The entire disclosure for the rollforward for allowance for doubtful debts for the three years ending the latest reporting date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element764" xlink:to="label764" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock" xlink:label="element765" />
        <label xlink:type="resource" xlink:label="label765" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock_en-US">Schedule Of Stock Options And Restricted Stock Units Activity Rollforward [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element765" xlink:to="label765" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock" xlink:label="element766" />
        <label xlink:type="resource" xlink:label="label766" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock_en-US">Tabular representation of the rollforward of stock options and restricted stock units at the end of the reporting period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element766" xlink:to="label766" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="element767" />
        <label xlink:type="resource" xlink:label="label767" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_en-US">Total Indefinite Lived Intangible Assets Including Goodwill</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element767" xlink:to="label767" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="element768" />
        <label xlink:type="resource" xlink:label="label768" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_en-US">Represents the sum total of the indefinite lived intangible assets and goodwill balances at the end of the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element768" xlink:to="label768" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="element769" />
        <label xlink:type="resource" xlink:label="label769" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_en-US">Total goodwill and other indefinite lived intangible assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element769" xlink:to="label769" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="element770" />
        <label xlink:type="resource" xlink:label="label770" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TotalIntangibleAssets_en-US">Total Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element770" xlink:to="label770" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="element771" />
        <label xlink:type="resource" xlink:label="label771" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TotalIntangibleAssets_en-US">Represents the sum total of all the intangible assets ie goodwill, definite lived intangible assets and indefinite lived intangible assets at the end of the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element771" xlink:to="label771" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="element772" />
        <label xlink:type="resource" xlink:label="label772" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_TotalIntangibleAssets_en-US">Total intangible assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element772" xlink:to="label772" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfStockRepurchaseProgramAuthorized" xlink:label="element773" />
        <label xlink:type="resource" xlink:label="label773" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DateOfStockRepurchaseProgramAuthorized_en-US">Date Of Stock Repurchase Program Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element773" xlink:to="label773" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfStockRepurchaseProgramAuthorized" xlink:label="element774" />
        <label xlink:type="resource" xlink:label="label774" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DateOfStockRepurchaseProgramAuthorized_en-US">Date Of Stock Repurchase Program Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element774" xlink:to="label774" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram" xlink:label="element775" />
        <label xlink:type="resource" xlink:label="label775" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_en-US">Treasury Stock Acquired Under Stock Repurchase Program</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element775" xlink:to="label775" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram" xlink:label="element776" />
        <label xlink:type="resource" xlink:label="label776" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_en-US">Enter definition here</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element776" xlink:to="label776" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" xlink:label="element777" />
        <label xlink:type="resource" xlink:label="label777" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_en-US">Treasury Stock Number Of Shares Acquired Under Stock Repurchase Program</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element777" xlink:to="label777" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" xlink:label="element778" />
        <label xlink:type="resource" xlink:label="label778" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_en-US">Enter Definition here</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element778" xlink:to="label778" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EmployeeStockPurchasePlanSharesAuthorized" xlink:label="element779" />
        <label xlink:type="resource" xlink:label="label779" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_EmployeeStockPurchasePlanSharesAuthorized_en-US">Employee Stock Purchase Plan Shares Authorized</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element779" xlink:to="label779" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EmployeeStockPurchasePlanSharesAuthorized" xlink:label="element780" />
        <label xlink:type="resource" xlink:label="label780" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_EmployeeStockPurchasePlanSharesAuthorized_en-US">Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element780" xlink:to="label780" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" xlink:label="element781" />
        <label xlink:type="resource" xlink:label="label781" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_en-US">Date Of Amendment Of Stock Option And Incentive Plan By Board Of Directors</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element781" xlink:to="label781" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" xlink:label="element782" />
        <label xlink:type="resource" xlink:label="label782" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_en-US">Represents the date when the Board of Directors approved the amendment to the 2000 Stock Option and Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element782" xlink:to="label782" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="element783" />
        <label xlink:type="resource" xlink:label="label783" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_en-US">Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element783" xlink:to="label783" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="element784" />
        <label xlink:type="resource" xlink:label="label784" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_en-US">Represents the increase in the total number of shares authorized for issuance under the Stock Option and Issuance Plan as approved by the shareholders in their Annual Shareholders Meeting.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element784" xlink:to="label784" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" xlink:label="element785" />
        <label xlink:type="resource" xlink:label="label785" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_en-US">Limitation Of Number Of Awards That Can Be Issued Under Stock Option And Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element785" xlink:to="label785" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" xlink:label="element786" />
        <label xlink:type="resource" xlink:label="label786" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_en-US">Represents the limitation on the issuance of the number of awards under the Stock Option and Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element786" xlink:to="label786" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleSharesIssuanceRatio" xlink:label="element787" />
        <label xlink:type="resource" xlink:label="label787" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FungibleSharesIssuanceRatio_en-US">Fungible Shares Issuance Ratio</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element787" xlink:to="label787" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleSharesIssuanceRatio" xlink:label="element788" />
        <label xlink:type="resource" xlink:label="label788" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FungibleSharesIssuanceRatio_en-US">Represents the ratio under the plan for each share that underlies an award granted under the 2000 Plan for deferred stock awards of restricted stock units, restricted stock awards, unrestricted stock awards, performance share awards or other awards for which the full value of such share is transferred to the award receipient.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element788" xlink:to="label788" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsIssued" xlink:label="element789" />
        <label xlink:type="resource" xlink:label="label789" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_StockOptionsAndRestrictedStockUnitsIssued_en-US">Stock Options And Restricted Stock Units Issued</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element789" xlink:to="label789" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsIssued" xlink:label="element790" />
        <label xlink:type="resource" xlink:label="label790" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_StockOptionsAndRestrictedStockUnitsIssued_en-US">Represents the total amount of stock options and restricted stock units granted during the period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element790" xlink:to="label790" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsIssued" xlink:label="element791" />
        <label xlink:type="resource" xlink:label="label791" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_hbio_StockOptionsAndRestrictedStockUnitsIssued_en-US">Stock Options And Restricted Stock Units Issued</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element791" xlink:to="label791" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted" xlink:label="element792" />
        <label xlink:type="resource" xlink:label="label792" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_en-US">Fungible Share Adjustment For Restricted Stock Units Granted</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element792" xlink:to="label792" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted" xlink:label="element793" />
        <label xlink:type="resource" xlink:label="label793" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_en-US">Represents the deduction from shares available for grant under the plan of 1.79 shares for each share that underlies an award granted under the 2000 Plan for deferred stock awards of restricted stock units, restricted stock awards, unrestricted stock awards, performance share awards or other awards under the 2000 Plan for which the full value of such share is transferred to the award recipient.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element793" xlink:to="label793" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" xlink:label="element794" />
        <label xlink:type="resource" xlink:label="label794" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_en-US">Share Options And Restricted Stock Units Forfeitures And Expirations In Period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element794" xlink:to="label794" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" xlink:label="element795" />
        <label xlink:type="resource" xlink:label="label795" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_en-US">Represents the stock options and restricted stock units cancelled during the reported period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element795" xlink:to="label795" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EstimatedRentalExpensesCurrentYear" xlink:label="element796" />
        <label xlink:type="resource" xlink:label="label796" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_EstimatedRentalExpensesCurrentYear_en-US">Estimated Rental Expenses Current Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element796" xlink:to="label796" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EstimatedRentalExpensesCurrentYear" xlink:label="element797" />
        <label xlink:type="resource" xlink:label="label797" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_EstimatedRentalExpensesCurrentYear_en-US">Represents estimated payments for the current year which includes the actual payment to date plus the estimated expense for the remainder of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element797" xlink:to="label797" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="element798" />
        <label xlink:type="resource" xlink:label="label798" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_en-US">Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element798" xlink:to="label798" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="element799" />
        <label xlink:type="resource" xlink:label="label799" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_en-US">Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element799" xlink:to="label799" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="element800" />
        <label xlink:type="resource" xlink:label="label800" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_en-US">Total valuation of intangible assets (goodwill and other intangible assets) as part of the acquisition.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element800" xlink:to="label800" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="element801" />
        <label xlink:type="resource" xlink:label="label801" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_en-US">Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element801" xlink:to="label801" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InterestRateInExcessOfLiborOnCreditFacility" xlink:label="element802" />
        <label xlink:type="resource" xlink:label="label802" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_InterestRateInExcessOfLiborOnCreditFacility_en-US">Interest Rate In Excess Of LIBOR On Credit Facility</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element802" xlink:to="label802" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InterestRateInExcessOfLiborOnCreditFacility" xlink:label="element803" />
        <label xlink:type="resource" xlink:label="label803" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_InterestRateInExcessOfLiborOnCreditFacility_en-US">Represents the interest rate to be added to LIBOR per the amended and restated revolving credit facility.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element803" xlink:to="label803" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold" xlink:label="element804" />
        <label xlink:type="resource" xlink:label="label804" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold_en-US">Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element804" xlink:to="label804" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold" xlink:label="element805" />
        <label xlink:type="resource" xlink:label="label805" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold_en-US">Represents the lender approval is required to fund acquisition with cash, promissory notes and/ or other consideration in excess of the threshold as stated in the revolving credit loan agreement with Bank of America.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element805" xlink:to="label805" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold" xlink:label="element806" />
        <label xlink:type="resource" xlink:label="label806" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold_en-US">Lender Approval To Fund Acquisition With Equity In Excess Of Threshold</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element806" xlink:to="label806" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold" xlink:label="element807" />
        <label xlink:type="resource" xlink:label="label807" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold_en-US">Represents the lender approval is required to fund acquisition with equity in excess of the threshold as stated in the revolving credit loan agreement with Bank of America.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element807" xlink:to="label807" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsCancelled" xlink:label="element808" />
        <label xlink:type="resource" xlink:label="label808" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_StockOptionsAndRestrictedStockUnitsCancelled_en-US">Stock Options And Restricted Stock Units Cancelled</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element808" xlink:to="label808" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsCancelled" xlink:label="element809" />
        <label xlink:type="resource" xlink:label="label809" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_StockOptionsAndRestrictedStockUnitsCancelled_en-US">Represents the aggregate of stock options and restricted stock units cancelled during the reported period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element809" xlink:to="label809" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled" xlink:label="element810" />
        <label xlink:type="resource" xlink:label="label810" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_en-US">Fungible Share Adjustment For Restricted Stock Units Cancelled</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element810" xlink:to="label810" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled" xlink:label="element811" />
        <label xlink:type="resource" xlink:label="label811" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_en-US">Represents the fungible share adjustment for the restricted stock awards cancelled during the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element811" xlink:to="label811" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="element812" />
        <label xlink:type="resource" xlink:label="label812" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FixedAssetsWriteOffMember_en-US">Fixed Assets Write Off [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element812" xlink:to="label812" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="element813" />
        <label xlink:type="resource" xlink:label="label813" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FixedAssetsWriteOffMember_en-US">Fixed Asset write offs associated with exit from or disposal of business activities or restructurings pursuant to a plan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element813" xlink:to="label813" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="element814" />
        <label xlink:type="resource" xlink:label="label814" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OtherCostsMember_en-US">Other Costs [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element814" xlink:to="label814" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="element815" />
        <label xlink:type="resource" xlink:label="label815" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OtherCostsMember_en-US">Other miscellaneous costs associated with exit from or disposal of business activities or restructurings pursuant to a plan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element815" xlink:to="label815" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="element816" />
        <label xlink:type="resource" xlink:label="label816" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2016ConsolidatedMember_en-US">Restructuring Plans 2016 Activty (Consolidated) [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element816" xlink:to="label816" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="element817" />
        <label xlink:type="resource" xlink:label="label817" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2016ConsolidatedMember_en-US">Consolidated rollforward of restructuring plans (2016 activity)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element817" xlink:to="label817" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="element818" />
        <label xlink:type="resource" xlink:label="label818" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2015ConsolidatedMember_en-US">Restructuring Plans 2015 Activty (Consolidated) [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element818" xlink:to="label818" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="element819" />
        <label xlink:type="resource" xlink:label="label819" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2015ConsolidatedMember_en-US">Consolidated rollforward of restructuring plans (2015 activity)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element819" xlink:to="label819" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="element820" />
        <label xlink:type="resource" xlink:label="label820" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AhnBiotechnologieGmbhAcquisitionMember_en-US">AHN Biotechnologie GmbH Acquisition [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element820" xlink:to="label820" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="element821" />
        <label xlink:type="resource" xlink:label="label821" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AhnBiotechnologieGmbhAcquisitionMember_en-US">Represents the acquisition of AHN Biotechnologie GmbH during the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element821" xlink:to="label821" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="element822" />
        <label xlink:type="resource" xlink:label="label822" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ModularSfcAcquisitionMember_en-US">Modular SFC Acquisition [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element822" xlink:to="label822" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="element823" />
        <label xlink:type="resource" xlink:label="label823" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ModularSfcAcquisitionMember_en-US">Represents the acquisition of Modular SFC during the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element823" xlink:to="label823" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" xlink:label="element824" />
        <label xlink:type="resource" xlink:label="label824" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_en-US">Business Acquisition Direct Acquisition Costs In Income Statement</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element824" xlink:to="label824" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" xlink:label="element825" />
        <label xlink:type="resource" xlink:label="label825" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_en-US">Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element825" xlink:to="label825" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ComprehensiveIncomeLossPolicyTextBlock" xlink:label="element826" />
        <label xlink:type="resource" xlink:label="label826" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ComprehensiveIncomeLossPolicyTextBlock_en-US">Comprehensive Income Loss [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element826" xlink:to="label826" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ComprehensiveIncomeLossPolicyTextBlock" xlink:label="element827" />
        <label xlink:type="resource" xlink:label="label827" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ComprehensiveIncomeLossPolicyTextBlock_en-US">Disclosure of the accounting policy for reporting changes in equity during a period resulting from net income (loss) and transactions from non owner sources, in a financial statement in the period in which they are recognized.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element827" xlink:to="label827" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock" xlink:label="element828" />
        <label xlink:type="resource" xlink:label="label828" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock_en-US">Impairment Of Long-Lived Assets [Policy Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element828" xlink:to="label828" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock" xlink:label="element829" />
        <label xlink:type="resource" xlink:label="label829" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock_en-US">Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets, and amortizable intangible assets.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element829" xlink:to="label829" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="element830" />
        <label xlink:type="resource" xlink:label="label830" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock_en-US">Schedule Of Property Plant And Equipment [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element830" xlink:to="label830" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="element831" />
        <label xlink:type="resource" xlink:label="label831" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock_en-US">Table of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This table includes the gross amount of individual categories of assets and the net amount of total fixed assets.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element831" xlink:to="label831" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetAssetsByGeographicAreaTableTextBlock" xlink:label="element832" />
        <label xlink:type="resource" xlink:label="label832" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetAssetsByGeographicAreaTableTextBlock_en-US">Net Assets By Geographic Area [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element832" xlink:to="label832" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetAssetsByGeographicAreaTableTextBlock" xlink:label="element833" />
        <label xlink:type="resource" xlink:label="label833" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetAssetsByGeographicAreaTableTextBlock_en-US">Tabular disclosure of the names of foreign countries in which net assets are located, and the amount of such net assets located in that country or foreign geographic area.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element833" xlink:to="label833" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="element834" />
        <label xlink:type="resource" xlink:label="label834" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TotalAccruedExpenses_en-US">Total Accrued Expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element834" xlink:to="label834" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="element835" />
        <label xlink:type="resource" xlink:label="label835" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TotalAccruedExpenses_en-US">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs (including employee compensation costs) for which invoices have not yet been received or will not be rendered. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element835" xlink:to="label835" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="element836" />
        <label xlink:type="resource" xlink:label="label836" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_TotalAccruedExpenses_en-US">Total Accrued Expenses</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element836" xlink:to="label836" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardFederalAndState" xlink:label="element837" />
        <label xlink:type="resource" xlink:label="label837" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetOperatingLossCarryforwardFederalAndState_en-US">Net Operating Loss Carryforward Federal And State</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element837" xlink:to="label837" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardFederalAndState" xlink:label="element838" />
        <label xlink:type="resource" xlink:label="label838" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetOperatingLossCarryforwardFederalAndState_en-US">The sum of federal, state and local operating loss carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element838" xlink:to="label838" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardForeign" xlink:label="element839" />
        <label xlink:type="resource" xlink:label="label839" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetOperatingLossCarryforwardForeign_en-US">Net Operating Loss Carryforward Foreign</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element839" xlink:to="label839" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardForeign" xlink:label="element840" />
        <label xlink:type="resource" xlink:label="label840" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetOperatingLossCarryforwardForeign_en-US">The sum of foreign operating loss carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element840" xlink:to="label840" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation" xlink:label="element841" />
        <label xlink:type="resource" xlink:label="label841" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation_en-US">Net Operating Loss Carryforwards Subject To Annual Limitation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element841" xlink:to="label841" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation" xlink:label="element842" />
        <label xlink:type="resource" xlink:label="label842" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation_en-US">The portion of net operating loss subject to annual limitation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element842" xlink:to="label842" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsAnnualLimitation" xlink:label="element843" />
        <label xlink:type="resource" xlink:label="label843" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetOperatingLossCarryforwardsAnnualLimitation_en-US">Net Operating Loss Carryforwards Annual Limitation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element843" xlink:to="label843" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsAnnualLimitation" xlink:label="element844" />
        <label xlink:type="resource" xlink:label="label844" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetOperatingLossCarryforwardsAnnualLimitation_en-US">The amount of the annual limitation of use of the Net Operating Loss carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element844" xlink:to="label844" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_UndistributedForeignEarnings" xlink:label="element845" />
        <label xlink:type="resource" xlink:label="label845" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_UndistributedForeignEarnings_en-US">Undistributed Foreign Earnings</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element845" xlink:to="label845" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_UndistributedForeignEarnings" xlink:label="element846" />
        <label xlink:type="resource" xlink:label="label846" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_UndistributedForeignEarnings_en-US">The amount as of the balance sheet date of the estimated undistributed earnings of subsidiaries and other recognized entities in countries outside the country of domicile which will increase future taxable income when such earnings are distributed into the country of domicile.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element846" xlink:to="label846" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiaries" xlink:label="element847" />
        <label xlink:type="resource" xlink:label="label847" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CashInForeignSubsidiaries_en-US">Cash In Foreign Subsidiaries</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element847" xlink:to="label847" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiaries" xlink:label="element848" />
        <label xlink:type="resource" xlink:label="label848" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CashInForeignSubsidiaries_en-US">The amount of cash and cash equivalents held in foreign subsidiaries</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element848" xlink:to="label848" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions" xlink:label="element849" />
        <label xlink:type="resource" xlink:label="label849" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_en-US">Cash Held In Foreign Subsidiaries Used For Acquisitions</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element849" xlink:to="label849" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions" xlink:label="element850" />
        <label xlink:type="resource" xlink:label="label850" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_en-US">Cash held in foreign Subsidiaries used for foreign acquisitions.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element850" xlink:to="label850" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements" xlink:label="element851" />
        <label xlink:type="resource" xlink:label="label851" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements_en-US">Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element851" xlink:to="label851" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements" xlink:label="element852" />
        <label xlink:type="resource" xlink:label="label852" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements_en-US">Cash held in foreign Subsidiaries used for capital improvements in foreign subsidiaries</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element852" xlink:to="label852" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="element853" />
        <label xlink:type="resource" xlink:label="label853" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_en-US">Current Federal And State Income Tax Expense Benefit Continuing Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element853" xlink:to="label853" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="element854" />
        <label xlink:type="resource" xlink:label="label854" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_en-US">The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted federal, state and local tax law to the relevant amounts of taxable Income or Loss from continuing operations.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element854" xlink:to="label854" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="element855" />
        <label xlink:type="resource" xlink:label="label855" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_en-US">Deferred Federal And State Income Tax Expense Benefit Continuing Operations</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element855" xlink:to="label855" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="element856" />
        <label xlink:type="resource" xlink:label="label856" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_en-US">The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the federal, state and local tax laws.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element856" xlink:to="label856" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" xlink:label="element857" />
        <label xlink:type="resource" xlink:label="label857" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences_en-US">Net Change In Income Tax Expense Benefit Resulting From Permanent Differences</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element857" xlink:to="label857" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" xlink:label="element858" />
        <label xlink:type="resource" xlink:label="label858" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences_en-US">Net Increase or decrease in income taxes resulting from permanent differences</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element858" xlink:to="label858" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" xlink:label="element859" />
        <label xlink:type="resource" xlink:label="label859" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences_en-US">Permanent differences, net</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element859" xlink:to="label859" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" xlink:label="element860" />
        <label xlink:type="resource" xlink:label="label860" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_en-US">Deferred Tax Assets Operating Loss And Credits Carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element860" xlink:to="label860" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" xlink:label="element861" />
        <label xlink:type="resource" xlink:label="label861" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_en-US">Deferred Tax Assets Operating Loss And Credits Carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element861" xlink:to="label861" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" xlink:label="element862" />
        <label xlink:type="resource" xlink:label="label862" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_en-US">Operating loss and credit carryforwards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element862" xlink:to="label862" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestOfTheWorldMember" xlink:label="element863" />
        <label xlink:type="resource" xlink:label="label863" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestOfTheWorldMember_en-US">Rest Of The World [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element863" xlink:to="label863" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestOfTheWorldMember" xlink:label="element864" />
        <label xlink:type="resource" xlink:label="label864" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestOfTheWorldMember_en-US">A third specified group of foreign countries about which segment information is provided by the entity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element864" xlink:to="label864" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="element865" />
        <label xlink:type="resource" xlink:label="label865" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CmaAcquisitionMember_en-US">CMA Acquisition [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element865" xlink:to="label865" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="element866" />
        <label xlink:type="resource" xlink:label="label866" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CmaAcquisitionMember_en-US">Represents the acquisition of CMA Microdialysis AB during the reporting period</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element866" xlink:to="label866" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" xlink:label="element867" />
        <label xlink:type="resource" xlink:label="label867" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_en-US">Two Dollars Two Cents To Two Dollars Forty Two Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element867" xlink:to="label867" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" xlink:label="element868" />
        <label xlink:type="resource" xlink:label="label868" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element868" xlink:to="label868" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" xlink:label="element869" />
        <label xlink:type="resource" xlink:label="label869" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_en-US">Two Dollars Forty Three Cents to Two Dollars Seventy Two Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element869" xlink:to="label869" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" xlink:label="element870" />
        <label xlink:type="resource" xlink:label="label870" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element870" xlink:to="label870" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" xlink:label="element871" />
        <label xlink:type="resource" xlink:label="label871" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_en-US">Two Dollars Seventy Three Cents to Three Dollars Sixty Eight Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element871" xlink:to="label871" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" xlink:label="element872" />
        <label xlink:type="resource" xlink:label="label872" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element872" xlink:to="label872" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" xlink:label="element873" />
        <label xlink:type="resource" xlink:label="label873" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_en-US">Three Dollars Sixty Nine Cents To Four Dollars Seven Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element873" xlink:to="label873" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" xlink:label="element874" />
        <label xlink:type="resource" xlink:label="label874" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element874" xlink:to="label874" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember" xlink:label="element875" />
        <label xlink:type="resource" xlink:label="label875" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_en-US">Four Dollars Eight Cents to Four Dollars Seventeen Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element875" xlink:to="label875" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember" xlink:label="element876" />
        <label xlink:type="resource" xlink:label="label876" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element876" xlink:to="label876" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" xlink:label="element877" />
        <label xlink:type="resource" xlink:label="label877" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_en-US">Four Dollars Eighteen Cents To Four Dollars Twenty Six Cents[Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element877" xlink:to="label877" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" xlink:label="element878" />
        <label xlink:type="resource" xlink:label="label878" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element878" xlink:to="label878" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" xlink:label="element879" />
        <label xlink:type="resource" xlink:label="label879" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_en-US">Four Dollars Twenty Seven Cents To Four Dollars Forty One Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element879" xlink:to="label879" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" xlink:label="element880" />
        <label xlink:type="resource" xlink:label="label880" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element880" xlink:to="label880" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" xlink:label="element881" />
        <label xlink:type="resource" xlink:label="label881" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_en-US">Four Dollars Forty Two Cents To Five Dollars Thirty Nine Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element881" xlink:to="label881" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" xlink:label="element882" />
        <label xlink:type="resource" xlink:label="label882" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element882" xlink:to="label882" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" xlink:label="element883" />
        <label xlink:type="resource" xlink:label="label883" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_en-US">Five Dollars Forty Cents To Five Dollars Fifty One Cents[Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element883" xlink:to="label883" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" xlink:label="element884" />
        <label xlink:type="resource" xlink:label="label884" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element884" xlink:to="label884" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="element885" />
        <label xlink:type="resource" xlink:label="label885" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_en-US">Five Dollars Fifty Two Cents To Five Dollars Sixty Three Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element885" xlink:to="label885" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="element886" />
        <label xlink:type="resource" xlink:label="label886" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element886" xlink:to="label886" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="element887" />
        <label xlink:type="resource" xlink:label="label887" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_InventoryImpairmentMember_en-US">Inventory Impairment [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element887" xlink:to="label887" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="element888" />
        <label xlink:type="resource" xlink:label="label888" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_InventoryImpairmentMember_en-US">Inventory impairment associated with exit from or disposal of business activities or restructurings pursuant to a plan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element888" xlink:to="label888" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="element889" />
        <label xlink:type="resource" xlink:label="label889" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2014ConsolidatedPlansAMember_en-US">Restructuring Plans 2014 Activty (Consolidated) [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element889" xlink:to="label889" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="element890" />
        <label xlink:type="resource" xlink:label="label890" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2014ConsolidatedPlansAMember_en-US">Consolidated rollforward of restructuring plans (2014 activity)</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element890" xlink:to="label890" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="element891" />
        <label xlink:type="resource" xlink:label="label891" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncomeTaxDisclosureLineItems_en-US">Income Tax Disclosure [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element891" xlink:to="label891" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="element892" />
        <label xlink:type="resource" xlink:label="label892" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncomeTaxDisclosureLineItems_en-US">Represents certain disclosures related to income taxes.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element892" xlink:to="label892" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="element893" />
        <label xlink:type="resource" xlink:label="label893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_IncomeTaxDisclosureLineItems_en-US">Income Tax Disclosure</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element893" xlink:to="label893" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="element894" />
        <label xlink:type="resource" xlink:label="label894" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_en-US">Schedule Of Cash In Foreign Subsidiaries Used For Acqusition [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element894" xlink:to="label894" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="element895" />
        <label xlink:type="resource" xlink:label="label895" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_en-US">Table represents the total cash in foreign subsidiaries used for acqusiition.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element895" xlink:to="label895" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="element896" />
        <label xlink:type="resource" xlink:label="label896" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_en-US">Cash In Foreign Subsidiaries Used For Acquisitions [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element896" xlink:to="label896" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="element897" />
        <label xlink:type="resource" xlink:label="label897" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_en-US">Represents the type of acquisitions done by foreign subsidiaries.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element897" xlink:to="label897" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="element898" />
        <label xlink:type="resource" xlink:label="label898" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TypesOfAcquisitionsDomain_en-US">Types Of Acquisitions [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element898" xlink:to="label898" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="element899" />
        <label xlink:type="resource" xlink:label="label899" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TypesOfAcquisitionsDomain_en-US">Represents the various acquisitions done by foreign subsidiaries during the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element899" xlink:to="label899" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PercentageOfOutstandingCommonStock" xlink:label="element900" />
        <label xlink:type="resource" xlink:label="label900" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_PercentageOfOutstandingCommonStock_en-US">Percentage Of Outstanding Common Stock</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element900" xlink:to="label900" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PercentageOfOutstandingCommonStock" xlink:label="element901" />
        <label xlink:type="resource" xlink:label="label901" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_PercentageOfOutstandingCommonStock_en-US">Represents the percentage of outstanding shares held by third parties.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element901" xlink:to="label901" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" xlink:label="element902" />
        <label xlink:type="resource" xlink:label="label902" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_en-US">Shares Authorized For Issuance Under 1996 Stock Option And Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element902" xlink:to="label902" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" xlink:label="element903" />
        <label xlink:type="resource" xlink:label="label903" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_en-US">Total shares authorized for issuance under the 1996 Stock Option and Incentive Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element903" xlink:to="label903" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards" xlink:label="element904" />
        <label xlink:type="resource" xlink:label="label904" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_en-US">Restricted Stock Units Outstanding For Issuance Of Awards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element904" xlink:to="label904" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards" xlink:label="element905" />
        <label xlink:type="resource" xlink:label="label905" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_en-US">Restricted Stock Units Outstanding For Issuance Of Awards</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element905" xlink:to="label905" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncentiveStockOptionsGrantedToDate" xlink:label="element906" />
        <label xlink:type="resource" xlink:label="label906" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncentiveStockOptionsGrantedToDate_en-US">Incentive Stock Options Granted To Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element906" xlink:to="label906" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncentiveStockOptionsGrantedToDate" xlink:label="element907" />
        <label xlink:type="resource" xlink:label="label907" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncentiveStockOptionsGrantedToDate_en-US">Represents the total number of Incentive Stock Options granted through the reporting date under the various Stock Options and Incentive Plans by the Company</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element907" xlink:to="label907" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonQualifiedStockOptionsGrantedToDate" xlink:label="element908" />
        <label xlink:type="resource" xlink:label="label908" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NonQualifiedStockOptionsGrantedToDate_en-US">Non Qualified Stock Options Granted To Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element908" xlink:to="label908" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonQualifiedStockOptionsGrantedToDate" xlink:label="element909" />
        <label xlink:type="resource" xlink:label="label909" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NonQualifiedStockOptionsGrantedToDate_en-US">Represents the total number of Non Qualified Stock Options granted through the reporting date under the various Stock Options and Incentive Plans by the Company</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element909" xlink:to="label909" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CommonStockMarketValuePerShareOnReportingDate" xlink:label="element910" />
        <label xlink:type="resource" xlink:label="label910" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CommonStockMarketValuePerShareOnReportingDate_en-US">Common Stock Market Value Per Share On Reporting Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element910" xlink:to="label910" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CommonStockMarketValuePerShareOnReportingDate" xlink:label="element911" />
        <label xlink:type="resource" xlink:label="label911" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CommonStockMarketValuePerShareOnReportingDate_en-US">Represents the stock price per common share on the reporting date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element911" xlink:to="label911" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate" xlink:label="element912" />
        <label xlink:type="resource" xlink:label="label912" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_en-US">In The Money Stock Options Exercisable At The Reporting Date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element912" xlink:to="label912" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate" xlink:label="element913" />
        <label xlink:type="resource" xlink:label="label913" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_en-US">Represents the total number of stock options which are in the money and exercisable at the reporting date</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element913" xlink:to="label913" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AnnualizedEstimatedForfeitureRate" xlink:label="element914" />
        <label xlink:type="resource" xlink:label="label914" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AnnualizedEstimatedForfeitureRate_en-US">Annualized Estimated Forfeiture Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element914" xlink:to="label914" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AnnualizedEstimatedForfeitureRate" xlink:label="element915" />
        <label xlink:type="resource" xlink:label="label915" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AnnualizedEstimatedForfeitureRate_en-US">Represents the estimated forfeiture rate as calculated and used in the computation of the stock compensation expense for the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element915" xlink:to="label915" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanPurchasesDuringYear" xlink:label="element916" />
        <label xlink:type="resource" xlink:label="label916" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanPurchasesDuringYear_en-US">Defined Benefit Plan Purchases During Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element916" xlink:to="label916" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanPurchasesDuringYear" xlink:label="element917" />
        <label xlink:type="resource" xlink:label="label917" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanPurchasesDuringYear_en-US">Defined Benefit Plan Level 3 Investment Purchases During The Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element917" xlink:to="label917" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanUnrealizedLossGain" xlink:label="element918" />
        <label xlink:type="resource" xlink:label="label918" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanUnrealizedLossGain_en-US">Defined Benefit Plan Unrealized Loss Gain</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element918" xlink:to="label918" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanUnrealizedLossGain" xlink:label="element919" />
        <label xlink:type="resource" xlink:label="label919" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanUnrealizedLossGain_en-US">Defined Benefit Plan Level 3 Investment Unrealized Gain (Loss) During The Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element919" xlink:to="label919" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContribution" xlink:label="element920" />
        <label xlink:type="resource" xlink:label="label920" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NumberOfCustomersWithBenchmarkContribution_en-US">Number Of Customers With Benchmark Contribution</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element920" xlink:to="label920" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContribution" xlink:label="element921" />
        <label xlink:type="resource" xlink:label="label921" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NumberOfCustomersWithBenchmarkContribution_en-US">Total number of customers with benchmark contribution</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element921" xlink:to="label921" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContribution" xlink:label="element922" />
        <label xlink:type="resource" xlink:label="label922" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_NumberOfCustomersWithBenchmarkContribution_en-US">Number Of Customers With Benchmark Contribution Of More Than 10%</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element922" xlink:to="label922" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" xlink:label="element923" />
        <label xlink:type="resource" xlink:label="label923" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_en-US">Number Of Customers With Benchmark Contribution Except One</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element923" xlink:to="label923" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" xlink:label="element924" />
        <label xlink:type="resource" xlink:label="label924" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_en-US">Number of customers with benchmark contribution</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element924" xlink:to="label924" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" xlink:label="element925" />
        <label xlink:type="resource" xlink:label="label925" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_en-US">Number Of Customers With Benchmark Contribution Of More Than 10% Except One</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element925" xlink:to="label925" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="element926" />
        <label xlink:type="resource" xlink:label="label926" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2010PlanBMember_en-US">Restructuring Plan 2010 Plan B [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element926" xlink:to="label926" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="element927" />
        <label xlink:type="resource" xlink:label="label927" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2010PlanBMember_en-US">Activity rollforward related to the 2010 restructuring plan B.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element927" xlink:to="label927" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="element928" />
        <label xlink:type="resource" xlink:label="label928" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredIncomeTaxesAmount_en-US">Deferred Income Taxes Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element928" xlink:to="label928" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="element929" />
        <label xlink:type="resource" xlink:label="label929" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_DeferredIncomeTaxesAmount_en-US">Deferred Income Taxes Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element929" xlink:to="label929" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="element930" />
        <label xlink:type="resource" xlink:label="label930" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredIncomeTaxesAmount_en-US">The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities in continuing operations.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element930" xlink:to="label930" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ServiceCostForDefinedBenefitPlan" xlink:label="element931" />
        <label xlink:type="resource" xlink:label="label931" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ServiceCostForDefinedBenefitPlan_en-US">Service Cost for Defined Benefit Plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element931" xlink:to="label931" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ServiceCostForDefinedBenefitPlan" xlink:label="element932" />
        <label xlink:type="resource" xlink:label="label932" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ServiceCostForDefinedBenefitPlan_en-US">The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element932" xlink:to="label932" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FairValueImpairmentOfPensionAssets" xlink:label="element933" />
        <label xlink:type="resource" xlink:label="label933" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FairValueImpairmentOfPensionAssets_en-US">Fair Value Impairment Of Pension Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element933" xlink:to="label933" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FairValueImpairmentOfPensionAssets" xlink:label="element934" />
        <label xlink:type="resource" xlink:label="label934" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FairValueImpairmentOfPensionAssets_en-US">Amount represents the additional write down of investment fair value included in the pension assets in the current year due to unfavorable market conditions</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element934" xlink:to="label934" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent" xlink:label="element935" />
        <label xlink:type="resource" xlink:label="label935" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent_en-US">Deferred Income Tax Reclassification From Current To Non Current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element935" xlink:to="label935" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent" xlink:label="element936" />
        <label xlink:type="resource" xlink:label="label936" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent_en-US">Represents the reclassification of the deferred tax amount related to employee stock based compensation expense for the prior year from current to non current</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element936" xlink:to="label936" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesOnPensionLiabilities" xlink:label="element937" />
        <label xlink:type="resource" xlink:label="label937" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredIncomeTaxesOnPensionLiabilities_en-US">Deferred Income Taxes On Pension Liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element937" xlink:to="label937" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesOnPensionLiabilities" xlink:label="element938" />
        <label xlink:type="resource" xlink:label="label938" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredIncomeTaxesOnPensionLiabilities_en-US">Represents the amount of deferred income taxes booked on pension liabilities</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element938" xlink:to="label938" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants" xlink:label="element939" />
        <label xlink:type="resource" xlink:label="label939" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_en-US">Weighted Average Estimated Black Scholes Value Of Option Grants</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element939" xlink:to="label939" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants" xlink:label="element940" />
        <label xlink:type="resource" xlink:label="label940" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_en-US">Represents the Black Scholes Value per share of stock option grants during the year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element940" xlink:to="label940" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" xlink:label="element941" />
        <label xlink:type="resource" xlink:label="label941" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_en-US">Business Acquisition, Contingent Consideration, at Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element941" xlink:to="label941" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" xlink:label="element942" />
        <label xlink:type="resource" xlink:label="label942" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_en-US">Business Acquisition Contingent Consideration At Fair Value 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element942" xlink:to="label942" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" xlink:label="element943" />
        <label xlink:type="resource" xlink:label="label943" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_en-US">Business Acquisition, Contingent Consideration, at Fair Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element943" xlink:to="label943" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="element944" />
        <label xlink:type="resource" xlink:label="label944" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_en-US">Business Acquisition, Cost of Acquired Entity 1 [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element944" xlink:to="label944" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="element945" />
        <label xlink:type="resource" xlink:label="label945" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_en-US">Tangible Assets Acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element945" xlink:to="label945" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="element946" />
        <label xlink:type="resource" xlink:label="label946" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_en-US">Business Acquisition Purchase Price Allocation Tangible Assets 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element946" xlink:to="label946" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="element947" />
        <label xlink:type="resource" xlink:label="label947" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_en-US">Business Acquisition Purchase Price Allocation Tangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element947" xlink:to="label947" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="element948" />
        <label xlink:type="resource" xlink:label="label948" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_en-US">Total Acquisition Purchase Price</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element948" xlink:to="label948" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="element949" />
        <label xlink:type="resource" xlink:label="label949" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_en-US">Business Acquisition Cost Of Acquired Entity Purchase Price 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element949" xlink:to="label949" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="element950" />
        <label xlink:type="resource" xlink:label="label950" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="total_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_en-US">Net Tangible Assets Acquired</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element950" xlink:to="label950" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="element951" />
        <label xlink:type="resource" xlink:label="label951" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_en-US">Business Acquisition Purchase Price Allocation Net Tangible Assets 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element951" xlink:to="label951" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="element952" />
        <label xlink:type="resource" xlink:label="label952" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_en-US">Business Acquisition Purchase Price Allocation Net Tangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element952" xlink:to="label952" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="element953" />
        <label xlink:type="resource" xlink:label="label953" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_en-US">Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element953" xlink:to="label953" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="element954" />
        <label xlink:type="resource" xlink:label="label954" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_en-US">Business Acquisition Purchase Price Allocation Amortizable Intangible Assets 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element954" xlink:to="label954" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="element955" />
        <label xlink:type="resource" xlink:label="label955" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_en-US">Purchase Price Allocation, Amortizable Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element955" xlink:to="label955" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="element956" />
        <label xlink:type="resource" xlink:label="label956" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_en-US">Business Acquisition Purchase Price Allocation Liabilities Assumed 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element956" xlink:to="label956" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="element957" />
        <label xlink:type="resource" xlink:label="label957" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_en-US">Liabilities Assumed</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element957" xlink:to="label957" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="element958" />
        <label xlink:type="resource" xlink:label="label958" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_en-US">Business Acquisition Purchase Price Allocation Liabilities Assumed</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element958" xlink:to="label958" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="element959" />
        <label xlink:type="resource" xlink:label="label959" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_en-US">Purchase Price Allocation, Goodwill Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element959" xlink:to="label959" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="element960" />
        <label xlink:type="resource" xlink:label="label960" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_en-US">Business Acquisition Purchase Price Allocation Goodwill Amount 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element960" xlink:to="label960" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="element961" />
        <label xlink:type="resource" xlink:label="label961" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_en-US">Business Acquisition Purchase Price Allocation Goodwill Amount</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element961" xlink:to="label961" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SegmentReportingInformationNetAssets1" xlink:label="element962" />
        <label xlink:type="resource" xlink:label="label962" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_SegmentReportingInformationNetAssets1_en-US">Net Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element962" xlink:to="label962" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SegmentReportingInformationNetAssets1" xlink:label="element963" />
        <label xlink:type="resource" xlink:label="label963" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_SegmentReportingInformationNetAssets1_en-US">Segment Reporting Information Net Assets 1</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element963" xlink:to="label963" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SegmentReportingInformationNetAssets1" xlink:label="element964" />
        <label xlink:type="resource" xlink:label="label964" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_SegmentReportingInformationNetAssets1_en-US">Segment Reporting Information Net Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element964" xlink:to="label964" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="element965" />
        <label xlink:type="resource" xlink:label="label965" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_en-US">Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element965" xlink:to="label965" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="element966" />
        <label xlink:type="resource" xlink:label="label966" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_en-US">Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element966" xlink:to="label966" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="element967" />
        <label xlink:type="resource" xlink:label="label967" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_en-US">Company was required to fix the rate of interest on minimum percentage of Term Loan and the DDTL</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element967" xlink:to="label967" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="element968" />
        <label xlink:type="resource" xlink:label="label968" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_LiborFixedRate_en-US">LIBOR Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element968" xlink:to="label968" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="element969" />
        <label xlink:type="resource" xlink:label="label969" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_LiborFixedRate_en-US">LIBOR Fixed Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element969" xlink:to="label969" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="element970" />
        <label xlink:type="resource" xlink:label="label970" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_LiborFixedRate_en-US">LIBOR Fixed Rate</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element970" xlink:to="label970" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="element971" />
        <label xlink:type="resource" xlink:label="label971" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DelayedDrawdownTermLoanMember_en-US">Delayed Drawdown Term Loan [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element971" xlink:to="label971" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="element972" />
        <label xlink:type="resource" xlink:label="label972" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DelayedDrawdownTermLoanMember_en-US">Represents the amount approved by the bank which can be drawn down at a later date to be used in the Company's HART business</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element972" xlink:to="label972" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="element973" />
        <label xlink:type="resource" xlink:label="label973" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DelayedDrawdownTermLoanMember_en-US">DDTL</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element973" xlink:to="label973" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="element974" />
        <label xlink:type="resource" xlink:label="label974" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2013Member_en-US">Restructuring Plan 2013 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element974" xlink:to="label974" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="element975" />
        <label xlink:type="resource" xlink:label="label975" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2013Member_en-US">Activity rollforward related to the Q3 2013 restructuring plan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element975" xlink:to="label975" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="element976" />
        <label xlink:type="resource" xlink:label="label976" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_en-US">Two Dollars Two Cents To Five Dollars Sixty Three Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element976" xlink:to="label976" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="element977" />
        <label xlink:type="resource" xlink:label="label977" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element977" xlink:to="label977" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" xlink:label="element978" />
        <label xlink:type="resource" xlink:label="label978" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_en-US">Two Dollars Twenty Eight Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element978" xlink:to="label978" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" xlink:label="element979" />
        <label xlink:type="resource" xlink:label="label979" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element979" xlink:to="label979" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFourtyFiveCentsMember" xlink:label="element980" />
        <label xlink:type="resource" xlink:label="label980" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFourtyFiveCentsMember_en-US">Two Dollars Fourty Five Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element980" xlink:to="label980" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFourtyFiveCentsMember" xlink:label="element981" />
        <label xlink:type="resource" xlink:label="label981" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFourtyFiveCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element981" xlink:to="label981" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftySixCentsMember" xlink:label="element982" />
        <label xlink:type="resource" xlink:label="label982" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFiftySixCentsMember_en-US">Two Dollars Fifty Six Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element982" xlink:to="label982" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftySixCentsMember" xlink:label="element983" />
        <label xlink:type="resource" xlink:label="label983" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFiftySixCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element983" xlink:to="label983" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" xlink:label="element984" />
        <label xlink:type="resource" xlink:label="label984" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_en-US">Two Dollars Fifty Nine Cents To Three Dollars Fifty Four Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element984" xlink:to="label984" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" xlink:label="element985" />
        <label xlink:type="resource" xlink:label="label985" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element985" xlink:to="label985" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyFourCentsMember" xlink:label="element986" />
        <label xlink:type="resource" xlink:label="label986" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ThreeDollarsSixtyFourCentsMember_en-US">Three Dollars Sixty Four Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element986" xlink:to="label986" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyFourCentsMember" xlink:label="element987" />
        <label xlink:type="resource" xlink:label="label987" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ThreeDollarsSixtyFourCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element987" xlink:to="label987" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" xlink:label="element988" />
        <label xlink:type="resource" xlink:label="label988" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_en-US">Three Dollars Sixty Eight Cents To Three Dollars Ninety Nine Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element988" xlink:to="label988" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" xlink:label="element989" />
        <label xlink:type="resource" xlink:label="label989" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element989" xlink:to="label989" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFourCentsMember" xlink:label="element990" />
        <label xlink:type="resource" xlink:label="label990" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsFourCentsMember_en-US">Four Dollars Four Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element990" xlink:to="label990" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFourCentsMember" xlink:label="element991" />
        <label xlink:type="resource" xlink:label="label991" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsFourCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element991" xlink:to="label991" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" xlink:label="element992" />
        <label xlink:type="resource" xlink:label="label992" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_en-US">Four Dollars Twenty One Cents To Four Dollars Thirty One Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element992" xlink:to="label992" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" xlink:label="element993" />
        <label xlink:type="resource" xlink:label="label993" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element993" xlink:to="label993" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="element994" />
        <label xlink:type="resource" xlink:label="label994" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_en-US">Five Dollars Seventy Three Cents To Six Dollars Fifty Seven Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element994" xlink:to="label994" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="element995" />
        <label xlink:type="resource" xlink:label="label995" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element995" xlink:to="label995" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="element996" />
        <label xlink:type="resource" xlink:label="label996" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_en-US">One Dollar Forty Three Cents To Six Dollars Fifty Seven Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element996" xlink:to="label996" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="element997" />
        <label xlink:type="resource" xlink:label="label997" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element997" xlink:to="label997" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="element998" />
        <label xlink:type="resource" xlink:label="label998" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlanDecember2013Member_en-US">Restructuring Plan December 2013 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element998" xlink:to="label998" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="element999" />
        <label xlink:type="resource" xlink:label="label999" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlanDecember2013Member_en-US">Rollforward of December 2013 restructuring plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element999" xlink:to="label999" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferOfCashAndCashEquivalentsToHART" xlink:label="element1000" />
        <label xlink:type="resource" xlink:label="label1000" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TransferOfCashAndCashEquivalentsToHART_en-US">Transfer of cash and cash equivalents to HART</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1000" xlink:to="label1000" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferOfCashAndCashEquivalentsToHART" xlink:label="element1001" />
        <label xlink:type="resource" xlink:label="label1001" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TransferOfCashAndCashEquivalentsToHART_en-US">Cash paid to HART as part of the spin-off.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1001" xlink:to="label1001" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferOfCashAndCashEquivalentsToHART" xlink:label="element1002" />
        <label xlink:type="resource" xlink:label="label1002" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_hbio_TransferOfCashAndCashEquivalentsToHART_en-US">Transfer of cash and cash equivalents to HART</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1002" xlink:to="label1002" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="element1003" />
        <label xlink:type="resource" xlink:label="label1003" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CreditAgreementLineItems_en-US">Credit Agreement [Line Items]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1003" xlink:to="label1003" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="element1004" />
        <label xlink:type="resource" xlink:label="label1004" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CreditAgreementLineItems_en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1004" xlink:to="label1004" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PreviousApprovedCreditFacility" xlink:label="element1005" />
        <label xlink:type="resource" xlink:label="label1005" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_PreviousApprovedCreditFacility_en-US">Previous Approved Credit Facility</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1005" xlink:to="label1005" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="element1006" />
        <label xlink:type="resource" xlink:label="label1006" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CreditAgreementTable_en-US">Credit Agreement [Table]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1006" xlink:to="label1006" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="element1007" />
        <label xlink:type="resource" xlink:label="label1007" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CreditAgreementTable_en-US">Represents the credit agreement approved by the lenders that includes a revolving credit facility, a term loan and a delayed draw down term loan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1007" xlink:to="label1007" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="element1008" />
        <label xlink:type="resource" xlink:label="label1008" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CreditAgreementAxis_en-US">Credit Agreement [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1008" xlink:to="label1008" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="element1009" />
        <label xlink:type="resource" xlink:label="label1009" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CreditAgreementAxis_en-US">Represents the credit agreement approved by the lenders that includes a revolving credit facility, a term loan and a delayed draw down term loan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1009" xlink:to="label1009" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="element1010" />
        <label xlink:type="resource" xlink:label="label1010" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_CreditAgreementDomain_en-US">Credit Agreement [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1010" xlink:to="label1010" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="element1011" />
        <label xlink:type="resource" xlink:label="label1011" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_CreditAgreementDomain_en-US">Represents the credit agreement approved by the lenders that includes a revolving credit facility, a term loan and a delayed draw down term loan.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1011" xlink:to="label1011" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Maturitydates" xlink:label="element1012" />
        <label xlink:type="resource" xlink:label="label1012" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_Maturitydates_en-US">Maturity Dates</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1012" xlink:to="label1012" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Maturitydates" xlink:label="element1013" />
        <label xlink:type="resource" xlink:label="label1013" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_Maturitydates_en-US">Represents the maturity dates for various types of loans included in the credit agreement.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1013" xlink:to="label1013" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SecuredDebtInterestRateAtPeriodEnd" xlink:label="element1014" />
        <label xlink:type="resource" xlink:label="label1014" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_SecuredDebtInterestRateAtPeriodEnd_en-US">Secured Debt Interest Rate At Period End</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1014" xlink:to="label1014" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SecuredDebtInterestRateAtPeriodEnd" xlink:label="element1015" />
        <label xlink:type="resource" xlink:label="label1015" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_SecuredDebtInterestRateAtPeriodEnd_en-US">Represents the interest rate on the term loan and delayed drawdown term loan at the end of the reporting period.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1015" xlink:to="label1015" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" xlink:label="element1016" />
        <label xlink:type="resource" xlink:label="label1016" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_en-US">DDTL Threshold For Dollar For Dollar Reduction In Revolving Line</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1016" xlink:to="label1016" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" xlink:label="element1017" />
        <label xlink:type="resource" xlink:label="label1017" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_en-US">Threshold amount after borrowings against the DDTL result in a dollar for dollar reduction in the Revolving Line capacity.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1017" xlink:to="label1017" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" xlink:label="element1018" />
        <label xlink:type="resource" xlink:label="label1018" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_en-US">DDTL Threshold For Dollar For Dollar Reduction In Revolving Line</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1018" xlink:to="label1018" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DiscontinuedOperationsMember" xlink:label="element1019" />
        <label xlink:type="resource" xlink:label="label1019" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DiscontinuedOperationsMember_en-US">Discontinued Operations [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1019" xlink:to="label1019" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DiscontinuedOperationsMember" xlink:label="element1020" />
        <label xlink:type="resource" xlink:label="label1020" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DiscontinuedOperationsMember_en-US">The portion of stock based compensation expense recorded in the statements of operations related to discontinued operations.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1020" xlink:to="label1020" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseInitialTerm" xlink:label="element1021" />
        <label xlink:type="resource" xlink:label="label1021" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_SubleaseInitialTerm_en-US">HART Sublease Initial Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1021" xlink:to="label1021" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseInitialTerm" xlink:label="element1022" />
        <label xlink:type="resource" xlink:label="label1022" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_SubleaseInitialTerm_en-US">This represents the months of the initial term of the HART sublease signed in the current year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1022" xlink:to="label1022" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseExtendedTerm" xlink:label="element1023" />
        <label xlink:type="resource" xlink:label="label1023" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_SubleaseExtendedTerm_en-US">HART Sublease Extended Term</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1023" xlink:to="label1023" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseExtendedTerm" xlink:label="element1024" />
        <label xlink:type="resource" xlink:label="label1024" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_SubleaseExtendedTerm_en-US">This represents the expiration date of the extended term of the HART sublease signed in the current year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1024" xlink:to="label1024" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalOptionsGrantedDueToHartSpinoff" xlink:label="element1025" />
        <label xlink:type="resource" xlink:label="label1025" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncrementalOptionsGrantedDueToHartSpinoff_en-US">Options Granted due to the Spin-off of HART</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1025" xlink:to="label1025" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalOptionsGrantedDueToHartSpinoff" xlink:label="element1026" />
        <label xlink:type="resource" xlink:label="label1026" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncrementalOptionsGrantedDueToHartSpinoff_en-US">Represents the total number of Options granted to existing option holders as part of the spin-off of HART to maintain the same intrinsic value of options held.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1026" xlink:to="label1026" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalUnitsGrantedDueToHartSpinoff" xlink:label="element1027" />
        <label xlink:type="resource" xlink:label="label1027" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncrementalUnitsGrantedDueToHartSpinoff_en-US">Restricted Stock Units Granted due to the Spin-off of HART</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1027" xlink:to="label1027" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalUnitsGrantedDueToHartSpinoff" xlink:label="element1028" />
        <label xlink:type="resource" xlink:label="label1028" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncrementalUnitsGrantedDueToHartSpinoff_en-US">Represents the total number of Restricted Stock Units granted to existing unit holders as part of the spin-off of HART to maintain the same intrinsic value of restricted stock units held.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1028" xlink:to="label1028" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" xlink:label="element1029" />
        <label xlink:type="resource" xlink:label="label1029" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_en-US">Transfer Of Delayed Draw Down Term Loan Capacity To Revolver Capacity</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1029" xlink:to="label1029" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" xlink:label="element1030" />
        <label xlink:type="resource" xlink:label="label1030" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_en-US">Transfer of borrowing capactiy for the delayed draw down term loan to the revolving line of credit.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1030" xlink:to="label1030" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DerivativeInterestRateSwapEffectivePercentage" xlink:label="element1031" />
        <label xlink:type="resource" xlink:label="label1031" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DerivativeInterestRateSwapEffectivePercentage_en-US">Derivative Interest Rate Swap Effective Percentage</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1031" xlink:to="label1031" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DerivativeInterestRateSwapEffectivePercentage" xlink:label="element1032" />
        <label xlink:type="resource" xlink:label="label1032" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DerivativeInterestRateSwapEffectivePercentage_en-US">Represents the effective percentage of all interest rate swaps the Company has entered into during 2013.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1032" xlink:to="label1032" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransitionServicesChargedToSpinnee" xlink:label="element1033" />
        <label xlink:type="resource" xlink:label="label1033" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TransitionServicesChargedToSpinnee_en-US">Transition Services Charged to HART</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1033" xlink:to="label1033" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransitionServicesChargedToSpinnee" xlink:label="element1034" />
        <label xlink:type="resource" xlink:label="label1034" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TransitionServicesChargedToSpinnee_en-US">Represents the transition services charged to HART pursuant to the Transition Services Agreement entered into as part of the HART spin-off.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1034" xlink:to="label1034" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage" xlink:label="element1035" />
        <label xlink:type="resource" xlink:label="label1035" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage_en-US">Defined Benefit Plan Increase (Decrease) In Discount Rate Percentage</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1035" xlink:to="label1035" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage" xlink:label="element1036" />
        <label xlink:type="resource" xlink:label="label1036" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage_en-US">Represents, in percentage, the increase or decrease in the discount rate percentage assumption used.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1036" xlink:to="label1036" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAveragePensionPlanLiability" xlink:label="element1037" />
        <label xlink:type="resource" xlink:label="label1037" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanAveragePensionPlanLiability_en-US">Defined Benefit Plan Average Pension Plan Liability</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1037" xlink:to="label1037" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAveragePensionPlanLiability" xlink:label="element1038" />
        <label xlink:type="resource" xlink:label="label1038" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanAveragePensionPlanLiability_en-US">Represents, in years, the average duration of the pension plan liability.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1038" xlink:to="label1038" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue" xlink:label="element1039" />
        <label xlink:type="resource" xlink:label="label1039" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue_en-US">Defined Benefit Plan Increase (Decrease) In Discount Rate Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1039" xlink:to="label1039" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue" xlink:label="element1040" />
        <label xlink:type="resource" xlink:label="label1040" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue_en-US">Represents, in value, the increase or decrease in the pension liablity due to discount rate percentage assumption used.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1040" xlink:to="label1040" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage" xlink:label="element1041" />
        <label xlink:type="resource" xlink:label="label1041" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage_en-US">Defined Benefit Plan Increase (Decrease) In Asset Return Percentage</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1041" xlink:to="label1041" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage" xlink:label="element1042" />
        <label xlink:type="resource" xlink:label="label1042" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage_en-US">Represents, in percentage, the increase or decrease in the asset return percentage assumption used.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1042" xlink:to="label1042" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAverageRemainingWorkLifetime" xlink:label="element1043" />
        <label xlink:type="resource" xlink:label="label1043" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanAverageRemainingWorkLifetime_en-US">Defined Benefit Plan Average Remaining Work Lifetime</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1043" xlink:to="label1043" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAverageRemainingWorkLifetime" xlink:label="element1044" />
        <label xlink:type="resource" xlink:label="label1044" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanAverageRemainingWorkLifetime_en-US">Represents, in years, the average duration of the remaining work lifetime of plan participants.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1044" xlink:to="label1044" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue" xlink:label="element1045" />
        <label xlink:type="resource" xlink:label="label1045" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue_en-US">Defined Benefit Plan Increase (Decrease) In Asset Return Value</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1045" xlink:to="label1045" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue" xlink:label="element1046" />
        <label xlink:type="resource" xlink:label="label1046" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue_en-US">Represents, in value, the increase or decrease in the annual pension expense due to asset return percentage assumption used.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1046" xlink:to="label1046" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" xlink:label="element1047" />
        <label xlink:type="resource" xlink:label="label1047" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_en-US">Stock Issued During Period Gross Stock Options Exercised</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1047" xlink:to="label1047" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" xlink:label="element1048" />
        <label xlink:type="resource" xlink:label="label1048" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_en-US">Represents the gross number of shares exercised during the year, and is inclusive of swap exercises (where the shares are exercised for options outstanding purposes but are not issued).</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1048" xlink:to="label1048" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" xlink:label="element1049" />
        <label xlink:type="resource" xlink:label="label1049" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US" id="Negated_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_en-US">Stock Issued During Period Gross Stock Options Exercised</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1049" xlink:to="label1049" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="element1050" />
        <label xlink:type="resource" xlink:label="label1050" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_en-US">Property Plant And Equipment Useful Life [Table Text Block]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1050" xlink:to="label1050" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="element1051" />
        <label xlink:type="resource" xlink:label="label1051" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_en-US">Represents the ranges of useful lives of all property, plant and equipment.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1051" xlink:to="label1051" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DistributionRevenuesFromSpinnee" xlink:label="element1052" />
        <label xlink:type="resource" xlink:label="label1052" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DistributionRevenuesFromSpinnee_en-US">Distribution Revenues From Spinnee</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1052" xlink:to="label1052" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DistributionRevenuesFromSpinnee" xlink:label="element1053" />
        <label xlink:type="resource" xlink:label="label1053" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DistributionRevenuesFromSpinnee_en-US">Represents the revenues recorded pursuant to the Product Distribution Agreement entered into as part of the HART spin-off.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1053" xlink:to="label1053" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ExpansionAreaOfRealEstateProperty" xlink:label="element1054" />
        <label xlink:type="resource" xlink:label="label1054" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ExpansionAreaOfRealEstateProperty_en-US">Expansion Area Of Real Estate Property</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1054" xlink:to="label1054" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="element1055" />
        <label xlink:type="resource" xlink:label="label1055" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_MultiChannelSystemsMcsGmbhMember_en-US">Multi Channel Systems MCS GmbH [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1055" xlink:to="label1055" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="element1056" />
        <label xlink:type="resource" xlink:label="label1056" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_MultiChannelSystemsMcsGmbhMember_en-US">Multi Channel Systems MCS GmbH</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1056" xlink:to="label1056" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="element1057" />
        <label xlink:type="resource" xlink:label="label1057" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TriangleBiosystemsIncMember_en-US">Triangle BioSystems, Inc. [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1057" xlink:to="label1057" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="element1058" />
        <label xlink:type="resource" xlink:label="label1058" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TriangleBiosystemsIncMember_en-US">Triangle BioSystems, Inc.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1058" xlink:to="label1058" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="element1059" />
        <label xlink:type="resource" xlink:label="label1059" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_HekaElektronikMember_en-US">HEKA Elektronik [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1059" xlink:to="label1059" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ValuationAllowancesAndReservesCurrencyTranslation" xlink:label="element1060" />
        <label xlink:type="resource" xlink:label="label1060" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ValuationAllowancesAndReservesCurrencyTranslation_en-US">Valuation Allowances And Reserves Currency Translation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1060" xlink:to="label1060" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ValuationAllowancesAndReservesCurrencyTranslation" xlink:label="element1061" />
        <label xlink:type="resource" xlink:label="label1061" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ValuationAllowancesAndReservesCurrencyTranslation_en-US">Valuation Allowances And Reserves Currency Translation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1061" xlink:to="label1061" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014Member" xlink:label="element1062" />
        <label xlink:type="resource" xlink:label="label1062" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlan2014Member_en-US">Restructuring Plan 2014 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1062" xlink:to="label1062" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014Member" xlink:label="element1063" />
        <label xlink:type="resource" xlink:label="label1063" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlan2014Member_en-US">Rollforward of December 2014 restructuring plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1063" xlink:to="label1063" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" xlink:label="element1064" />
        <label xlink:type="resource" xlink:label="label1064" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_en-US">Four Dollars Seven Cents To Four Dollars Ten Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1064" xlink:to="label1064" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" xlink:label="element1065" />
        <label xlink:type="resource" xlink:label="label1065" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1065" xlink:to="label1065" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" xlink:label="element1066" />
        <label xlink:type="resource" xlink:label="label1066" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_en-US">Four Dollars Twelve Cents To Four Dollars Eighty Nine Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1066" xlink:to="label1066" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" xlink:label="element1067" />
        <label xlink:type="resource" xlink:label="label1067" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1067" xlink:to="label1067" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" xlink:label="element1068" />
        <label xlink:type="resource" xlink:label="label1068" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_en-US">One Dollar Forty Three Cents To Four Dollars Eighty Nine Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1068" xlink:to="label1068" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" xlink:label="element1069" />
        <label xlink:type="resource" xlink:label="label1069" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1069" xlink:to="label1069" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WarrantyOther" xlink:label="element1070" />
        <label xlink:type="resource" xlink:label="label1070" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_WarrantyOther_en-US">Warranty Other</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1070" xlink:to="label1070" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WarrantyOther" xlink:label="element1071" />
        <label xlink:type="resource" xlink:label="label1071" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_WarrantyOther_en-US">Represents change in warranty accrual rollforward associated with foreign currency changes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1071" xlink:to="label1071" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ12015Member" xlink:label="element1072" />
        <label xlink:type="resource" xlink:label="label1072" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlanQ12015Member_en-US">Restructuring Plan Q1 2015 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1072" xlink:to="label1072" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ12015Member" xlink:label="element1073" />
        <label xlink:type="resource" xlink:label="label1073" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlanQ12015Member_en-US">Rollforward of Q1 2015 restructuring plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1073" xlink:to="label1073" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="element1074" />
        <label xlink:type="resource" xlink:label="label1074" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_MarketConditionRestrictedStockUnitMember_en-US">Market Condition Restricted Stock Unit [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1074" xlink:to="label1074" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="element1075" />
        <label xlink:type="resource" xlink:label="label1075" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_MarketConditionRestrictedStockUnitMember_en-US">Market Condition RSU</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1075" xlink:to="label1075" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ22015Member" xlink:label="element1076" />
        <label xlink:type="resource" xlink:label="label1076" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlanQ22015Member_en-US">Restructuring Plan Q2 2015 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1076" xlink:to="label1076" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ22015Member" xlink:label="element1077" />
        <label xlink:type="resource" xlink:label="label1077" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlanQ22015Member_en-US">Rollforward of Q2 2015 restructuring plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1077" xlink:to="label1077" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" xlink:label="element1078" />
        <label xlink:type="resource" xlink:label="label1078" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation Coefficient</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1078" xlink:to="label1078" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" xlink:label="element1079" />
        <label xlink:type="resource" xlink:label="label1079" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_en-US">Correlation Coefficient Fair Value Assumption for Market Condition RSU's</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1079" xlink:to="label1079" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" xlink:label="element1080" />
        <label xlink:type="resource" xlink:label="label1080" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_en-US">Two Dollars Forty Three Cents To Two Dollars Seventy Two Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1080" xlink:to="label1080" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" xlink:label="element1081" />
        <label xlink:type="resource" xlink:label="label1081" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1081" xlink:to="label1081" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" xlink:label="element1082" />
        <label xlink:type="resource" xlink:label="label1082" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_en-US">Two Dollars Seventy Three Cents To Three Dollars Sixty Eight Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1082" xlink:to="label1082" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" xlink:label="element1083" />
        <label xlink:type="resource" xlink:label="label1083" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1083" xlink:to="label1083" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" xlink:label="element1084" />
        <label xlink:type="resource" xlink:label="label1084" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_en-US">Three Dollars Sixty Cents To Three Dollars Sixty Eight Cents [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1084" xlink:to="label1084" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" xlink:label="element1085" />
        <label xlink:type="resource" xlink:label="label1085" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_en-US">Represents the price range for the number of options outstanding and exercisable at the end of the year.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1085" xlink:to="label1085" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ42015Member" xlink:label="element1086" />
        <label xlink:type="resource" xlink:label="label1086" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RestructuringPlanQ42015Member_en-US">Restructuring Plan Q4 2015 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1086" xlink:to="label1086" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ42015Member" xlink:label="element1087" />
        <label xlink:type="resource" xlink:label="label1087" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_RestructuringPlanQ42015Member_en-US">Rollforward of Q4 2015 restructuring plan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1087" xlink:to="label1087" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxLiabilityOnForeignEarningsRepatriated" xlink:label="element1088" />
        <label xlink:type="resource" xlink:label="label1088" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxLiabilityOnForeignEarningsRepatriated_en-US">Tax Liability On Foreign Earnings Repatriated</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1088" xlink:to="label1088" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxLiabilityOnForeignEarningsRepatriated" xlink:label="element1089" />
        <label xlink:type="resource" xlink:label="label1089" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TaxLiabilityOnForeignEarningsRepatriated_en-US">The tax liability owed on repatriated foreign earnings</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1089" xlink:to="label1089" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetImpactOfForeignRateChanges" xlink:label="element1090" />
        <label xlink:type="resource" xlink:label="label1090" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NetImpactOfForeignRateChanges_en-US">Net Impact Of Foreign Rate Changes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1090" xlink:to="label1090" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetImpactOfForeignRateChanges" xlink:label="element1091" />
        <label xlink:type="resource" xlink:label="label1091" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NetImpactOfForeignRateChanges_en-US">Net Impact Of Foreign Rate Changes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1091" xlink:to="label1091" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetImpactOfForeignRateChanges" xlink:label="element1092" />
        <label xlink:type="resource" xlink:label="label1092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_NetImpactOfForeignRateChanges_en-US">Impact of foreign rate change</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1092" xlink:to="label1092" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" xlink:label="element1093" />
        <label xlink:type="resource" xlink:label="label1093" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_en-US">Deferred Tax Assets Tax Credits On Repatriation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1093" xlink:to="label1093" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" xlink:label="element1094" />
        <label xlink:type="resource" xlink:label="label1094" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_en-US">Deferred Tax Assets Tax Credits On Repatriation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1094" xlink:to="label1094" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" xlink:label="element1095" />
        <label xlink:type="resource" xlink:label="label1095" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_en-US">Tax credits on repatriation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1095" xlink:to="label1095" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets" xlink:label="element1096" />
        <label xlink:type="resource" xlink:label="label1096" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets_en-US">Deferred Tax Liabilities Indefinite Lived Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1096" xlink:to="label1096" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets" xlink:label="element1097" />
        <label xlink:type="resource" xlink:label="label1097" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets_en-US">Deferred Tax Liabilities Indefinite Lived Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1097" xlink:to="label1097" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets" xlink:label="element1098" />
        <label xlink:type="resource" xlink:label="label1098" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets_en-US">Deferred Tax Liabilities Definite Lived Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1098" xlink:to="label1098" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets" xlink:label="element1099" />
        <label xlink:type="resource" xlink:label="label1099" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets_en-US">Deferred Tax Liabilities Definite Lived Intangible Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1099" xlink:to="label1099" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesOnRepatriation" xlink:label="element1100" />
        <label xlink:type="resource" xlink:label="label1100" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredTaxLiabilitiesOnRepatriation_en-US">Deferred Tax Liabilities On Repatriation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1100" xlink:to="label1100" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesOnRepatriation" xlink:label="element1101" />
        <label xlink:type="resource" xlink:label="label1101" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_DeferredTaxLiabilitiesOnRepatriation_en-US">Deferred Tax Liabilities On Repatriation</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1101" xlink:to="label1101" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets" xlink:label="element1102" />
        <label xlink:type="resource" xlink:label="label1102" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets_en-US">Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1102" xlink:to="label1102" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets" xlink:label="element1103" />
        <label xlink:type="resource" xlink:label="label1103" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets_en-US">APIC NOL's Impact On DTA's</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1103" xlink:to="label1103" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" xlink:label="element1104" />
        <label xlink:type="resource" xlink:label="label1104" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes_en-US">Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1104" xlink:to="label1104" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" xlink:label="element1105" />
        <label xlink:type="resource" xlink:label="label1105" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes_en-US">Income tax reconciliation foreign operations foreign withholding taxes.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1105" xlink:to="label1105" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" xlink:label="element1106" />
        <label xlink:type="resource" xlink:label="label1106" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes_en-US">Foreign withholding taxes</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1106" xlink:to="label1106" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction" xlink:label="element1107" />
        <label xlink:type="resource" xlink:label="label1107" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction_en-US">Income Tax Reconciliation Foreign Tax Credits Deduction</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1107" xlink:to="label1107" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction" xlink:label="element1108" />
        <label xlink:type="resource" xlink:label="label1108" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction_en-US">The portion of the difference, between total income tax expense (benefit) as reported in the Income Statement for the period and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to deduction for foreign tax credit.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1108" xlink:to="label1108" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction" xlink:label="element1109" />
        <label xlink:type="resource" xlink:label="label1109" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction_en-US">Conversion of U.S. foreign tax credits from credit to deduction</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1109" xlink:to="label1109" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale" xlink:label="element1110" />
        <label xlink:type="resource" xlink:label="label1110" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale_en-US">Income Tax Reconciliation Loss on Subsidiary stock sale</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1110" xlink:to="label1110" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale" xlink:label="element1111" />
        <label xlink:type="resource" xlink:label="label1111" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale_en-US">The portion of the difference, between total income tax expense (benefit) as reported in the Income Statement for the period and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to loss on subsidiary stock sales.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1111" xlink:to="label1111" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale" xlink:label="element1112" />
        <label xlink:type="resource" xlink:label="label1112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale_en-US">Loss on subsidiary stock sale without benefit</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1112" xlink:to="label1112" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxRateReconciliationDeductionsStockOptions" xlink:label="element1113" />
        <label xlink:type="resource" xlink:label="label1113" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_en-US">Income Tax Rate Reconciliation Deductions Stock Options</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1113" xlink:to="label1113" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxRateReconciliationDeductionsStockOptions" xlink:label="element1114" />
        <label xlink:type="resource" xlink:label="label1114" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for stock options.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1114" xlink:to="label1114" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxRateReconciliationDeductionsStockOptions" xlink:label="element1115" />
        <label xlink:type="resource" xlink:label="label1115" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_en-US">Income tax deduction related to stock options</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1115" xlink:to="label1115" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OperatingLossCarryforwardsExpirationYear" xlink:label="element1116" />
        <label xlink:type="resource" xlink:label="label1116" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_OperatingLossCarryforwardsExpirationYear_en-US">Operating loss carryforwards expiration year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1116" xlink:to="label1116" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OperatingLossCarryforwardsExpirationYear" xlink:label="element1117" />
        <label xlink:type="resource" xlink:label="label1117" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_OperatingLossCarryforwardsExpirationYear_en-US">Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY format.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1117" xlink:to="label1117" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditCarryforwardsExpirationYear" xlink:label="element1118" />
        <label xlink:type="resource" xlink:label="label1118" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditCarryforwardsExpirationYear_en-US">Tax Credit Carryforwards Expiration Year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1118" xlink:to="label1118" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditCarryforwardsExpirationYear" xlink:label="element1119" />
        <label xlink:type="resource" xlink:label="label1119" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TaxCreditCarryforwardsExpirationYear_en-US">Expiration date of the tax credit carryforward, in CCYY format.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1119" xlink:to="label1119" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditCarryforwardsExpirationYear" xlink:label="element1120" />
        <label xlink:type="resource" xlink:label="label1120" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_TaxCreditCarryforwardsExpirationYear_en-US">Tax credit carryforwards expiration year</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1120" xlink:to="label1120" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2017Member" xlink:label="element1121" />
        <label xlink:type="resource" xlink:label="label1121" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditExpire2017Member_en-US">Tax Credit Expire 2017 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1121" xlink:to="label1121" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2017Member" xlink:label="element1122" />
        <label xlink:type="resource" xlink:label="label1122" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_TaxCreditExpire2017Member_en-US">Expire in 2017</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1122" xlink:to="label1122" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2017Member" xlink:label="element1123" />
        <label xlink:type="resource" xlink:label="label1123" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TaxCreditExpire2017Member_en-US">Tax credit expire in 2017.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1123" xlink:to="label1123" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2020Member" xlink:label="element1124" />
        <label xlink:type="resource" xlink:label="label1124" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditExpire2020Member_en-US">Tax Credit Expire 2020 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1124" xlink:to="label1124" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2020Member" xlink:label="element1125" />
        <label xlink:type="resource" xlink:label="label1125" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TaxCreditExpire2020Member_en-US">Tax credit expire in 2020.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1125" xlink:to="label1125" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2020Member" xlink:label="element1126" />
        <label xlink:type="resource" xlink:label="label1126" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_TaxCreditExpire2020Member_en-US">Expire in 2020</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1126" xlink:to="label1126" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="element1127" />
        <label xlink:type="resource" xlink:label="label1127" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditExpirationAxis_en-US">Tax Credit Expiration [Axis]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1127" xlink:to="label1127" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="element1128" />
        <label xlink:type="resource" xlink:label="label1128" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditExpirationDomain_en-US">Tax Credit Expiration [Domain]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1128" xlink:to="label1128" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2022Member" xlink:label="element1129" />
        <label xlink:type="resource" xlink:label="label1129" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_TaxCreditExpire2022Member_en-US">Tax Credit Expire 2022 [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1129" xlink:to="label1129" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2022Member" xlink:label="element1130" />
        <label xlink:type="resource" xlink:label="label1130" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_TaxCreditExpire2022Member_en-US">Expire in 2022</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1130" xlink:to="label1130" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2022Member" xlink:label="element1131" />
        <label xlink:type="resource" xlink:label="label1131" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_TaxCreditExpire2022Member_en-US">Tax credit expire in 2022.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1131" xlink:to="label1131" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="element1132" />
        <label xlink:type="resource" xlink:label="label1132" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_Documentandentityinformationabstract_en-US">Document And Entity Information [Abstract]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1132" xlink:to="label1132" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonAffiliateShareHolding" xlink:label="element1133" />
        <label xlink:type="resource" xlink:label="label1133" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_NonAffiliateShareHolding_en-US">Non Affiliate Share Holding</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1133" xlink:to="label1133" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonAffiliateShareHolding" xlink:label="element1134" />
        <label xlink:type="resource" xlink:label="label1134" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="documentation_hbio_NonAffiliateShareHolding_en-US">State aggregate of voting and non-voting common equity held by non-affiliates as of the last business day of registrant's most recently completed second fiscal quarter.</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1134" xlink:to="label1134" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFinancingCostsMember" xlink:label="element1135" />
        <label xlink:type="resource" xlink:label="label1135" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DeferredFinancingCostsMember_en-US">Deferred Financing costs [Member]</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1135" xlink:to="label1135" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFinancingCostsMember" xlink:label="element1136" />
        <label xlink:type="resource" xlink:label="label1136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DeferredFinancingCostsMember_en-US">Deferred Financing costs</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1136" xlink:to="label1136" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoan" xlink:label="element1137" />
        <label xlink:type="resource" xlink:label="label1137" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_DelayedDrawdownTermLoan_en-US">Delayed Drawdown Term Loan</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1137" xlink:to="label1137" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoan" xlink:label="element1138" />
        <label xlink:type="resource" xlink:label="label1138" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="terse_hbio_DelayedDrawdownTermLoan_en-US">DDTL</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1138" xlink:to="label1138" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RevolvingCreditFacility" xlink:label="element1139" />
        <label xlink:type="resource" xlink:label="label1139" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_hbio_RevolvingCreditFacility_en-US">Revolving Credit Facility</label>
        <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="element1139" xlink:to="label1139" />
    </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>hbio-20170331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by IBM Cognos Disclosure Management XBRL Version: 10.2.6 Using Fujitsu -->
<!-- Validation status: Passed -->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/instance http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccruedExpenses" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccruedExpenses" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccruedExpensesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccruedExpensesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccruedExpensesTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccumulatedOtherComprehensiveIncome" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AccumulatedOtherComprehensiveIncomeDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DisclosureAccumulatedOtherComprehensiveIncomeTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Acquisitions" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Acquisitions" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AcquisitionsTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebts" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AllowanceForDoubtfulDebts" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AllowanceForDoubtfulDebtsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_AllowanceForDoubtfulDebtsTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStock" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStock" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockDetails3" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockDetails3" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CapitalStockTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CapitalStockTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/CommitmentsAndContingentLiabilities" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_CommitmentsAndContingentLiabilities" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Concentrations" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Concentrations" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/ConcentrationsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_ConcentrationsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Derivatives" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Derivatives" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DerivativeTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DerivativeTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SummaryOfSignificantAccountingPoliciesPolicies" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_DocumentAndEntityInformation" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlans" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails3" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails3" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails4" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansDetails4" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_EmployeeBenefitPlansTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_FairValueMeasurements" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_FairValueMeasurementsDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_FairValueMeasurementsTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssets" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_GoodwillAndOtherIntangibleAssetsTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxes" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxes" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxesTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_IncomeTaxNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Inventories" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Inventories" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/InventoriesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_InventoriesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/InventoriesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_InventoriesTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Leases" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Leases" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LeasesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LeasesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LeasesNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LeasesNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LeasesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LeasesTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebt" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebt" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtDetails2" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtDetails2" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_LongTermDebtTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Organiziation" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Organiziation" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipment" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_PropertyPlantAndEquipment" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_PropertyPlantAndEquipmentDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_PropertyPlantAndEquipmentTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunaudited" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_QuarterlyFinancialInformationunaudited" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_QuarterlyFinancialInformationunauditedTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RecentlyIssuedAccountingPronouncements" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RecentlyIssuedAccountingPronouncements" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RelatedPartyTransactions" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RelatedPartyTransactionsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCosts" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCosts" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCostsDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCostsTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_RestructuringAndOtherExitCotsNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SegmentAndRelatedInformationDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationNarrativesDetails" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SegmentAndRelatedInformationNarrativesDetails" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SegmentAndRelatedInformationTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SegmentReporting" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SegmentReporting" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementOfComprehensiveIncomeParentheticals" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementOfComprehensiveIncomeParentheticals" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementsOfFinancialPositionParentheticals" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfFinancialPositionParentheticals" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementsOfOperations" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfOperations" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfCashFlows" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_StatementsOfFinancialPosition" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SubsequentEvents" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SubsequentEvents" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SummaryOfSignificantAccountingPoliciesTables" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_SummaryOfSignificantAccountingPolicyDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/Warranties" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_Warranties" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/WarrantiesDetails1" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_WarrantiesDetails1" />
    <roleRef roleURI="http://www.harvardbioscience.com/role/WarrantiesTables" xlink:type="simple" xlink:href="hbio-20170331.xsd#ELRID_WarrantiesTables" />
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
    <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementsOfOperations">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_1" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="Locator_us-gaap_Revenues_2" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_1" xlink:to="Locator_us-gaap_Revenues_2" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_3" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="Locator_us-gaap_CostOfGoodsAndServicesSold_4" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_3" xlink:to="Locator_us-gaap_CostOfGoodsAndServicesSold_4" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_5" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="Locator_us-gaap_GrossProfit_6" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_5" xlink:to="Locator_us-gaap_GrossProfit_6" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_7" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="Locator_us-gaap_SellingAndMarketingExpense_8" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_7" xlink:to="Locator_us-gaap_SellingAndMarketingExpense_8" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_9" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="Locator_us-gaap_GeneralAndAdministrativeExpense_10" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_9" xlink:to="Locator_us-gaap_GeneralAndAdministrativeExpense_10" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_11" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpense_12" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_11" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpense_12" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_13" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_14" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_13" xlink:to="Locator_us-gaap_RestructuringCharges_14" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_15" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="Locator_us-gaap_AmortizationOfIntangibleAssets_16" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_15" xlink:to="Locator_us-gaap_AmortizationOfIntangibleAssets_16" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_17" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="Locator_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_18" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_17" xlink:to="Locator_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_18" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_19" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="Locator_us-gaap_AssetImpairmentCharges_20" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_19" xlink:to="Locator_us-gaap_AssetImpairmentCharges_20" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_21" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="Locator_us-gaap_GainLossOnSaleOfBusiness_22" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_21" xlink:to="Locator_us-gaap_GainLossOnSaleOfBusiness_22" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_23" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="Locator_us-gaap_OtherGeneralExpense_24" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_23" xlink:to="Locator_us-gaap_OtherGeneralExpense_24" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_25" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="Locator_us-gaap_OperatingExpenses_26" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_25" xlink:to="Locator_us-gaap_OperatingExpenses_26" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_27" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="Locator_us-gaap_OperatingIncomeLoss_28" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_27" xlink:to="Locator_us-gaap_OperatingIncomeLoss_28" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_29" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_29" xlink:to="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_43" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_44" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_43" xlink:to="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_44" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_45" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="Locator_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_46" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_45" xlink:to="Locator_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_46" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_47" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="Locator_us-gaap_InterestExpense_48" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_47" xlink:to="Locator_us-gaap_InterestExpense_48" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_49" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInterestAndDividendIncome" xlink:label="Locator_us-gaap_OtherInterestAndDividendIncome_50" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_49" xlink:to="Locator_us-gaap_OtherInterestAndDividendIncome_50" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_51" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpense_52" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpenseAbstract_51" xlink:to="Locator_us-gaap_OtherNonoperatingIncomeExpense_52" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="Locator_us-gaap_OtherNonoperatingIncomeExpense_53" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="Locator_us-gaap_NonoperatingIncomeExpense_54" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherNonoperatingIncomeExpense_53" xlink:to="Locator_us-gaap_NonoperatingIncomeExpense_54" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_31" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_31" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_33" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_34" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_33" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefit_34" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_35" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_36" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_35" xlink:to="Locator_us-gaap_NetIncomeLoss_36" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_37" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_38" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_37" xlink:to="Locator_us-gaap_EarningsPerShareAbstract_38" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_55" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_56" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_55" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_56" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_57" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="Locator_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_58" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_57" xlink:to="Locator_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_58" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_59" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="Locator_us-gaap_EarningsPerShareBasic_60" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_59" xlink:to="Locator_us-gaap_EarningsPerShareBasic_60" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_61" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_62" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_61" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_62" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_63" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="Locator_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_64" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_63" xlink:to="Locator_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_64" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="Locator_us-gaap_EarningsPerShareAbstract_65" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="Locator_us-gaap_EarningsPerShareDiluted_66" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EarningsPerShareAbstract_65" xlink:to="Locator_us-gaap_EarningsPerShareDiluted_66" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_39" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_39" xlink:to="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_67" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_68" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_67" xlink:to="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_68" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_69" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="Locator_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_69" xlink:to="Locator_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="Locator_us-gaap_IncomeStatementAbstract_41" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_42" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementAbstract_41" xlink:to="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_42" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_115" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_116" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_115" xlink:to="Locator_us-gaap_NetIncomeLoss_116" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_117" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_118" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_117" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_118" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_119" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_120" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_119" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_120" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_121" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_122" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_121" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_122" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_123" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_124" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_123" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_124" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_125" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_126" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_125" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_126" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_127" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="Locator_us-gaap_ComprehensiveIncomeNetOfTax_128" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_127" xlink:to="Locator_us-gaap_ComprehensiveIncomeNetOfTax_128" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_139" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_140" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_139" xlink:to="Locator_us-gaap_AssetsAbstract_140" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_143" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_144" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_143" xlink:to="Locator_us-gaap_AssetsCurrentAbstract_144" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_159" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_160" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_159" xlink:to="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_160" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_161" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="Locator_us-gaap_AccountsReceivableNetCurrent_162" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_161" xlink:to="Locator_us-gaap_AccountsReceivableNetCurrent_162" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_163" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_164" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_163" xlink:to="Locator_us-gaap_InventoryNet_164" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_165" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="Locator_us-gaap_DeferredTaxAssetsNetCurrent_166" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_165" xlink:to="Locator_us-gaap_DeferredTaxAssetsNetCurrent_166" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_167" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="Locator_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_168" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_167" xlink:to="Locator_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_168" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="Locator_us-gaap_AssetsCurrentAbstract_169" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="Locator_us-gaap_OtherAssetsCurrent_170" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsCurrentAbstract_169" xlink:to="Locator_us-gaap_OtherAssetsCurrent_170" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="Locator_us-gaap_OtherAssetsCurrent_171" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="Locator_us-gaap_AssetsCurrent_172" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherAssetsCurrent_171" xlink:to="Locator_us-gaap_AssetsCurrent_172" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_145" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_146" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_145" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentNet_146" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_147" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="Locator_us-gaap_DeferredTaxAssetsNetNoncurrent_148" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_147" xlink:to="Locator_us-gaap_DeferredTaxAssetsNetNoncurrent_148" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_149" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsNet_150" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_149" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsNet_150" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_151" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_152" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_151" xlink:to="Locator_us-gaap_Goodwill_152" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_153" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_154" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_153" xlink:to="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_154" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_155" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="Locator_us-gaap_OtherAssetsNoncurrent_156" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_155" xlink:to="Locator_us-gaap_OtherAssetsNoncurrent_156" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="Locator_us-gaap_AssetsAbstract_157" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Locator_us-gaap_Assets_158" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AssetsAbstract_157" xlink:to="Locator_us-gaap_Assets_158" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_141" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_142" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_141" xlink:to="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_142" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_174" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" xlink:to="Locator_us-gaap_LiabilitiesCurrentAbstract_174" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_189" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="Locator_us-gaap_SecuredDebtCurrent_190" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_189" xlink:to="Locator_us-gaap_SecuredDebtCurrent_190" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_191" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="Locator_us-gaap_AccountsPayableCurrent_192" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_191" xlink:to="Locator_us-gaap_AccountsPayableCurrent_192" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_193" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="Locator_us-gaap_NotesPayableCurrent_194" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_193" xlink:to="Locator_us-gaap_NotesPayableCurrent_194" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_195" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="Locator_us-gaap_DeferredRevenueCurrent_196" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_195" xlink:to="Locator_us-gaap_DeferredRevenueCurrent_196" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_197" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="Locator_us-gaap_AccruedIncomeTaxesCurrent_198" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_197" xlink:to="Locator_us-gaap_AccruedIncomeTaxesCurrent_198" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_199" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesCurrent" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesCurrent_200" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_199" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesCurrent_200" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_201" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrent_202" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_201" xlink:to="Locator_us-gaap_AccruedLiabilitiesCurrent_202" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_LiabilitiesCurrentAbstract_203" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="Locator_us-gaap_OtherLiabilitiesCurrent_204" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesCurrentAbstract_203" xlink:to="Locator_us-gaap_OtherLiabilitiesCurrent_204" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="Locator_us-gaap_OtherLiabilitiesCurrent_205" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="Locator_us-gaap_LiabilitiesCurrent_206" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherLiabilitiesCurrent_205" xlink:to="Locator_us-gaap_LiabilitiesCurrent_206" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_175" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_176" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_175" xlink:to="Locator_us-gaap_LongTermDebtNoncurrent_176" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_177" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesNoncurrent_178" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_177" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesNoncurrent_178" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_179" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="Locator_us-gaap_OtherAccruedLiabilitiesNoncurrent_180" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_179" xlink:to="Locator_us-gaap_OtherAccruedLiabilitiesNoncurrent_180" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_181" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Locator_us-gaap_Liabilities_182" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_181" xlink:to="Locator_us-gaap_Liabilities_182" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_183" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="Locator_us-gaap_CommitmentsAndContingencies_184" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_183" xlink:to="Locator_us-gaap_CommitmentsAndContingencies_184" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_185" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_186" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_185" xlink:to="Locator_us-gaap_StockholdersEquityAbstract_186" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_207" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="Locator_us-gaap_PreferredStockValue_208" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_207" xlink:to="Locator_us-gaap_PreferredStockValue_208" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_209" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="Locator_us-gaap_CommonStockValue_210" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_209" xlink:to="Locator_us-gaap_CommonStockValue_210" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_211" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="Locator_us-gaap_AdditionalPaidInCapitalCommonStock_212" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_211" xlink:to="Locator_us-gaap_AdditionalPaidInCapitalCommonStock_212" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_213" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="Locator_us-gaap_RetainedEarningsAccumulatedDeficit_214" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_213" xlink:to="Locator_us-gaap_RetainedEarningsAccumulatedDeficit_214" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_215" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_216" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_215" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_216" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="Locator_us-gaap_StockholdersEquityAbstract_217" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="Locator_us-gaap_TreasuryStockCarryingBasis_218" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityAbstract_217" xlink:to="Locator_us-gaap_TreasuryStockCarryingBasis_218" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="Locator_us-gaap_TreasuryStockCarryingBasis_219" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="Locator_us-gaap_StockholdersEquity_220" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TreasuryStockCarryingBasis_219" xlink:to="Locator_us-gaap_StockholdersEquity_220" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_187" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="Locator_us-gaap_LiabilitiesAndStockholdersEquity_188" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract_187" xlink:to="Locator_us-gaap_LiabilitiesAndStockholdersEquity_188" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementsOfFinancialPositionParentheticals">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_287" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="Locator_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_288" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_287" xlink:to="Locator_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_288" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_289" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="Locator_us-gaap_PreferredStockParOrStatedValuePerShare_290" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_289" xlink:to="Locator_us-gaap_PreferredStockParOrStatedValuePerShare_290" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_291" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="Locator_us-gaap_PreferredStockSharesAuthorized_292" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_291" xlink:to="Locator_us-gaap_PreferredStockSharesAuthorized_292" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_293" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="Locator_us-gaap_CommonStockParOrStatedValuePerShare_294" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_293" xlink:to="Locator_us-gaap_CommonStockParOrStatedValuePerShare_294" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_295" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="Locator_us-gaap_CommonStockSharesAuthorized_296" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_295" xlink:to="Locator_us-gaap_CommonStockSharesAuthorized_296" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_297" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="Locator_us-gaap_CommonStockSharesIssued_298" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_297" xlink:to="Locator_us-gaap_CommonStockSharesIssued_298" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_299" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="Locator_us-gaap_CommonStockSharesOutstanding_300" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_299" xlink:to="Locator_us-gaap_CommonStockSharesOutstanding_300" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="Locator_us-gaap_StatementOfFinancialPositionAbstract_301" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="Locator_us-gaap_TreasuryStockShares_302" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfFinancialPositionAbstract_301" xlink:to="Locator_us-gaap_TreasuryStockShares_302" order="8.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_303" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_304" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_303" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_304" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_319" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="Locator_us-gaap_NetIncomeLoss_320" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_319" xlink:to="Locator_us-gaap_NetIncomeLoss_320" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_321" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_322" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_321" xlink:to="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_322" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_325" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="Locator_us-gaap_StockOptionPlanExpense_326" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_325" xlink:to="Locator_us-gaap_StockOptionPlanExpense_326" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="Locator_us-gaap_AssetImpairmentCharges_328" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="Locator_us-gaap_AssetImpairmentCharges_328" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_329" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="Locator_us-gaap_Depreciation_330" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_329" xlink:to="Locator_us-gaap_Depreciation_330" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="Locator_us-gaap_GainLossOnSaleOfBusiness_332" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="Locator_us-gaap_GainLossOnSaleOfBusiness_332" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_333" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_334" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_333" xlink:to="Locator_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_334" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_335" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="Locator_us-gaap_GainLossOnDispositionOfAssets_336" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_335" xlink:to="Locator_us-gaap_GainLossOnDispositionOfAssets_336" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_337" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonCashRestructuringCharge" xlink:label="Locator_hbio_NonCashRestructuringCharge_338" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_337" xlink:to="Locator_hbio_NonCashRestructuringCharge_338" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_339" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AmortizationOfCatalogCosts" xlink:label="Locator_hbio_AmortizationOfCatalogCosts_340" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_339" xlink:to="Locator_hbio_AmortizationOfCatalogCosts_340" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_341" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="Locator_us-gaap_ProvisionForDoubtfulAccounts_342" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_341" xlink:to="Locator_us-gaap_ProvisionForDoubtfulAccounts_342" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_343" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="Locator_us-gaap_AmortizationOfIntangibleAssets_344" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_343" xlink:to="Locator_us-gaap_AmortizationOfIntangibleAssets_344" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_345" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="Locator_us-gaap_AmortizationOfFinancingCosts_346" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_345" xlink:to="Locator_us-gaap_AmortizationOfFinancingCosts_346" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_347" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_DeferredIncomeTaxExpenseBenefit_348" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_347" xlink:to="Locator_us-gaap_DeferredIncomeTaxExpenseBenefit_348" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_349" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_350" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_349" xlink:to="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_350" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_351" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccountsReceivable_352" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_351" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccountsReceivable_352" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_353" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="Locator_us-gaap_IncreaseDecreaseInInventories_354" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_353" xlink:to="Locator_us-gaap_IncreaseDecreaseInInventories_354" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_355" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="Locator_us-gaap_IncreaseDecreaseInOtherReceivables_356" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_355" xlink:to="Locator_us-gaap_IncreaseDecreaseInOtherReceivables_356" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_357" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade_358" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_357" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade_358" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_359" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_360" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_359" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_360" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_361" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="Locator_us-gaap_IncreaseDecreaseInAccruedLiabilities_362" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_361" xlink:to="Locator_us-gaap_IncreaseDecreaseInAccruedLiabilities_362" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_363" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="Locator_us-gaap_IncreaseDecreaseInDeferredRevenue_364" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_363" xlink:to="Locator_us-gaap_IncreaseDecreaseInDeferredRevenue_364" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_365" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="Locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_366" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_365" xlink:to="Locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_366" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_323" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_324" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_323" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInOperatingActivities_324" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_305" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_306" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_305" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_306" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_367" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAdditions_368" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_367" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentAdditions_368" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_369" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionsToCatalogCosts" xlink:label="Locator_hbio_AdditionsToCatalogCosts_370" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_369" xlink:to="Locator_hbio_AdditionsToCatalogCosts_370" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_371" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="Locator_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_372" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_371" xlink:to="Locator_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_372" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_373" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_374" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_373" xlink:to="Locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_374" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_375" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_376" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_375" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_376" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_377" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_378" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_377" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInInvestingActivities_378" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_307" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_308" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_307" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_308" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_379" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="Locator_us-gaap_RepaymentsOfShortTermDebt_380" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_379" xlink:to="Locator_us-gaap_RepaymentsOfShortTermDebt_380" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_381" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="Locator_us-gaap_RepaymentsOfLongTermDebt_382" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_381" xlink:to="Locator_us-gaap_RepaymentsOfLongTermDebt_382" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_383" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="Locator_us-gaap_ProceedsFromIssuanceOfSecuredDebt_384" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_383" xlink:to="Locator_us-gaap_ProceedsFromIssuanceOfSecuredDebt_384" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_385" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_386" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_385" xlink:to="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_386" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_387" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferOfCashAndCashEquivalentsToHART" xlink:label="Locator_hbio_TransferOfCashAndCashEquivalentsToHART_388" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_387" xlink:to="Locator_hbio_TransferOfCashAndCashEquivalentsToHART_388" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="Locator_us-gaap_PaymentsOfDebtIssuanceCosts_390" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389" xlink:to="Locator_us-gaap_PaymentsOfDebtIssuanceCosts_390" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_391" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="Locator_us-gaap_ProceedsFromIssuanceOfCommonStock_392" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_391" xlink:to="Locator_us-gaap_ProceedsFromIssuanceOfCommonStock_392" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_393" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_394" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_393" xlink:to="Locator_us-gaap_NetCashProvidedByUsedInFinancingActivities_394" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_309" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="Locator_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_310" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_309" xlink:to="Locator_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_310" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_311" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_312" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_311" xlink:to="Locator_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_312" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_313" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_314" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_313" xlink:to="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_314" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_315" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_316" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_315" xlink:to="Locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_316" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="Locator_us-gaap_StatementOfCashFlowsAbstract_317" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="Locator_us-gaap_SupplementalCashFlowInformationAbstract_318" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfCashFlowsAbstract_317" xlink:to="Locator_us-gaap_SupplementalCashFlowInformationAbstract_318" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="Locator_us-gaap_SupplementalCashFlowInformationAbstract_395" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="Locator_us-gaap_InterestPaid_396" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SupplementalCashFlowInformationAbstract_395" xlink:to="Locator_us-gaap_InterestPaid_396" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="Locator_us-gaap_SupplementalCashFlowInformationAbstract_397" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="Locator_us-gaap_IncomeTaxesPaid_398" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SupplementalCashFlowInformationAbstract_397" xlink:to="Locator_us-gaap_IncomeTaxesPaid_398" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCosts">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_473" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="Locator_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_474" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_473" xlink:to="Locator_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_474" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Warranties">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:label="Locator_us-gaap_ProductWarrantiesDisclosuresAbstract_475" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock" xlink:label="Locator_us-gaap_ProductWarrantyDisclosureTextBlock_476" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ProductWarrantiesDisclosuresAbstract_475" xlink:to="Locator_us-gaap_ProductWarrantyDisclosureTextBlock_476" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Inventories">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_477" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="Locator_us-gaap_InventoryDisclosureTextBlock_478" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_477" xlink:to="Locator_us-gaap_InventoryDisclosureTextBlock_478" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Acquisitions">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="Locator_us-gaap_BusinessCombinationDescriptionAbstract_479" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="Locator_us-gaap_BusinessCombinationDisclosureTextBlock_480" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessCombinationDescriptionAbstract_479" xlink:to="Locator_us-gaap_BusinessCombinationDisclosureTextBlock_480" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssets">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_481" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_482" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_481" xlink:to="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_482" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxes">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_483" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="Locator_us-gaap_IncomeTaxDisclosureTextBlock_484" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_483" xlink:to="Locator_us-gaap_IncomeTaxDisclosureTextBlock_484" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SegmentReporting">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_485" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="Locator_us-gaap_SegmentReportingDisclosureTextBlock_486" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_485" xlink:to="Locator_us-gaap_SegmentReportingDisclosureTextBlock_486" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_487" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_488" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_487" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_488" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_489" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_490" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_489" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_490" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_491" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_492" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_491" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_492" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_493" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_494" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_493" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_494" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_495" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_496" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_495" xlink:to="Locator_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_496" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_497" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="Locator_us-gaap_LongTermDebt_498" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_497" xlink:to="Locator_us-gaap_LongTermDebt_498" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStock">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_509" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="Locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_510" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_509" xlink:to="Locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_510" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlans">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_511" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="Locator_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_512" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_511" xlink:to="Locator_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_512" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Leases">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_513" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="Locator_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_514" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_513" xlink:to="Locator_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_514" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Organiziation">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OrganizationDisclosureAbstract" xlink:label="Locator_hbio_OrganizationDisclosureAbstract_515" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OrganizationDisclosureTextBlock" xlink:label="Locator_hbio_OrganizationDisclosureTextBlock_516" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_OrganizationDisclosureAbstract_515" xlink:to="Locator_hbio_OrganizationDisclosureTextBlock_516" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Concentrations">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ConcentrationsDisclosureAbstract" xlink:label="Locator_hbio_ConcentrationsDisclosureAbstract_517" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="Locator_us-gaap_ConcentrationRiskDisclosureTextBlock_518" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ConcentrationsDisclosureAbstract_517" xlink:to="Locator_us-gaap_ConcentrationRiskDisclosureTextBlock_518" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/PropertyPlantAndEquipment">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_519" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_520" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_519" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_520" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccruedExpenses">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_521" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AccruedExpensesDisclosureTextBlock" xlink:label="Locator_hbio_AccruedExpensesDisclosureTextBlock_522" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_521" xlink:to="Locator_hbio_AccruedExpensesDisclosureTextBlock_522" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CommitmentsAndContingentLiabilities">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="Locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_523" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="Locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_524" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_523" xlink:to="Locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_524" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebts">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureAbstract" xlink:label="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureAbstract_525" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock" xlink:label="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock_526" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureAbstract_525" xlink:to="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureTextBlock_526" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunaudited">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="Locator_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_527" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="Locator_us-gaap_QuarterlyFinancialInformationTextBlock_528" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_527" xlink:to="Locator_us-gaap_QuarterlyFinancialInformationTextBlock_528" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_529" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="Locator_us-gaap_ConsolidationPolicyTextBlock_530" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_529" xlink:to="Locator_us-gaap_ConsolidationPolicyTextBlock_530" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_531" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="Locator_us-gaap_UseOfEstimates_532" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_531" xlink:to="Locator_us-gaap_UseOfEstimates_532" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_533" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Reclassifications" xlink:label="Locator_us-gaap_Reclassifications_534" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_533" xlink:to="Locator_us-gaap_Reclassifications_534" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_535" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="Locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock_536" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_535" xlink:to="Locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock_536" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_537" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="Locator_us-gaap_ReceivablesPolicyTextBlock_538" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_537" xlink:to="Locator_us-gaap_ReceivablesPolicyTextBlock_538" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_539" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="Locator_us-gaap_InventoryPolicyTextBlock_540" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_539" xlink:to="Locator_us-gaap_InventoryPolicyTextBlock_540" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_541" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_542" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_541" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_542" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_543" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="Locator_us-gaap_AdvertisingCostsPolicyTextBlock_544" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_543" xlink:to="Locator_us-gaap_AdvertisingCostsPolicyTextBlock_544" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_545" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="Locator_us-gaap_IncomeTaxPolicyTextBlock_546" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_545" xlink:to="Locator_us-gaap_IncomeTaxPolicyTextBlock_546" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_547" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="Locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_548" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_547" xlink:to="Locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_548" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_549" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="Locator_us-gaap_EarningsPerSharePolicyTextBlock_550" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_549" xlink:to="Locator_us-gaap_EarningsPerSharePolicyTextBlock_550" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_551" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ComprehensiveIncomeLossPolicyTextBlock" xlink:label="Locator_hbio_ComprehensiveIncomeLossPolicyTextBlock_552" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_551" xlink:to="Locator_hbio_ComprehensiveIncomeLossPolicyTextBlock_552" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_553" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="Locator_us-gaap_RevenueRecognitionPolicyTextBlock_554" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_553" xlink:to="Locator_us-gaap_RevenueRecognitionPolicyTextBlock_554" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_555" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="Locator_us-gaap_IntangibleAssetsFiniteLivedPolicy_556" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_555" xlink:to="Locator_us-gaap_IntangibleAssetsFiniteLivedPolicy_556" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_557" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_558" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_557" xlink:to="Locator_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_558" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_559" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock" xlink:label="Locator_hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock_560" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_559" xlink:to="Locator_hbio_ImpairmentOfLongLivedAssetsPolicyTextBlock_560" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_561" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="Locator_us-gaap_DerivativesPolicyTextBlock_562" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_561" xlink:to="Locator_us-gaap_DerivativesPolicyTextBlock_562" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_563" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="Locator_us-gaap_FairValueOfFinancialInstrumentsPolicy_564" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_563" xlink:to="Locator_us-gaap_FairValueOfFinancialInstrumentsPolicy_564" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_565" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="Locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_566" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_565" xlink:to="Locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_566" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_567" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract" xlink:label="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_568" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_567" xlink:to="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_568" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract" xlink:label="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_569" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="Locator_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_570" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_569" xlink:to="Locator_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_570" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_572" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" xlink:to="Locator_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_572" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_573" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="Locator_us-gaap_ScheduleOfGoodwillTextBlock_574" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_573" xlink:to="Locator_us-gaap_ScheduleOfGoodwillTextBlock_574" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/InventoriesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_575" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_576" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_575" xlink:to="Locator_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_576" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_577" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_578" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_577" xlink:to="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_578" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="Locator_us-gaap_BusinessCombinationDescriptionAbstract_579" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_580" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessCombinationDescriptionAbstract_579" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_580" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="Locator_us-gaap_BusinessCombinationDescriptionAbstract_581" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_582" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessCombinationDescriptionAbstract_581" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_582" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/WarrantiesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:label="Locator_us-gaap_ProductWarrantiesDisclosuresAbstract_583" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_584" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ProductWarrantiesDisclosuresAbstract_583" xlink:to="Locator_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_584" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_585" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_586" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_585" xlink:to="Locator_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_586" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_587" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_588" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_587" xlink:to="Locator_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_588" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_589" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_590" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_589" xlink:to="Locator_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_590" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_591" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_592" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_591" xlink:to="Locator_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_592" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_593" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_594" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_593" xlink:to="Locator_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_594" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_595" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_596" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_595" xlink:to="Locator_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_596" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_597" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_598" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_597" xlink:to="Locator_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_598" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_599" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_600" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_599" xlink:to="Locator_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_600" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_601" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_602" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_601" xlink:to="Locator_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_602" order="9.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LeasesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_603" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_604" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_603" xlink:to="Locator_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_604" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_605" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock" xlink:label="Locator_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock_606" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_605" xlink:to="Locator_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock_606" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_607" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_608" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_607" xlink:to="Locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_608" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_609" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_610" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_609" xlink:to="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_610" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_611" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_612" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_611" xlink:to="Locator_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_612" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_613" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_614" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_613" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_614" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_615" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_616" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_615" xlink:to="Locator_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_616" order="6.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_617" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="Locator_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_618" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_617" xlink:to="Locator_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_618" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_619" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:label="Locator_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_620" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_619" xlink:to="Locator_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_620" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_621" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:label="Locator_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_622" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_621" xlink:to="Locator_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_622" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_623" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetAssetsByGeographicAreaTableTextBlock" xlink:label="Locator_hbio_NetAssetsByGeographicAreaTableTextBlock_624" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_623" xlink:to="Locator_hbio_NetAssetsByGeographicAreaTableTextBlock_624" order="4.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_625" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="Locator_us-gaap_AmortizationOfIntangibleAssets_626" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_625" xlink:to="Locator_us-gaap_AmortizationOfIntangibleAssets_626" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_627" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_628" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_627" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_628" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_629" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_630" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_629" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_630" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_631" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_632" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_631" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_632" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_633" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_634" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_633" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_634" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_635" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_636" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_635" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_636" order="6.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_649" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_650" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_649" xlink:to="Locator_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_650" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_651" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill" xlink:label="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_652" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_651" xlink:to="Locator_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill_652" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_653" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalIntangibleAssets" xlink:label="Locator_hbio_TotalIntangibleAssets_654" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_653" xlink:to="Locator_hbio_TotalIntangibleAssets_654" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_647" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_648" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_647" xlink:to="Locator_us-gaap_Goodwill_648" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_645" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_646" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_645" xlink:to="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_646" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_683" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_684" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_683" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_684" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_637" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_638" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_637" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsGross_638" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_639" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_640" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_639" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_640" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_641" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_642" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_641" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_642" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_685" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_686" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_685" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_686" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_687" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_688" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_687" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_688" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_689" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="Locator_us-gaap_DevelopedTechnologyRightsMember_690" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_689" xlink:to="Locator_us-gaap_DevelopedTechnologyRightsMember_690" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_691" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_692" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_691" xlink:to="Locator_us-gaap_TradeNamesMember_692" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_693" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_694" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_693" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_694" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_695" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember" xlink:label="Locator_us-gaap_PatentsMember_696" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_695" xlink:to="Locator_us-gaap_PatentsMember_696" order="4.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/InventoriesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_697" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="Locator_us-gaap_InventoryFinishedGoods_698" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_697" xlink:to="Locator_us-gaap_InventoryFinishedGoods_698" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_699" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="Locator_us-gaap_InventoryWorkInProcess_700" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_699" xlink:to="Locator_us-gaap_InventoryWorkInProcess_700" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_701" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="Locator_us-gaap_InventoryRawMaterials_702" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_701" xlink:to="Locator_us-gaap_InventoryRawMaterials_702" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="Locator_us-gaap_InventoryDisclosureAbstract_703" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="Locator_us-gaap_InventoryNet_704" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_InventoryDisclosureAbstract_703" xlink:to="Locator_us-gaap_InventoryNet_704" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_717" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_718" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_717" xlink:to="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_718" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_751" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_752" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_751" xlink:to="Locator_us-gaap_RestructuringCostAndReserveLineItems_752" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_711" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_712" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_711" xlink:to="Locator_us-gaap_RestructuringCharges_712" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_713" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:label="Locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_714" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_713" xlink:to="Locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_714" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_753" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_754" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_753" xlink:to="Locator_us-gaap_RestructuringCostAndReserveAxis_754" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_757" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_758" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringCostAndReserveAxis_757" xlink:to="Locator_us-gaap_TypeOfRestructuringDomain_758" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_759" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="Locator_us-gaap_EmployeeSeveranceMember_760" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_759" xlink:to="Locator_us-gaap_EmployeeSeveranceMember_760" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_761" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="Locator_hbio_FixedAssetsWriteOffMember_762" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_761" xlink:to="Locator_hbio_FixedAssetsWriteOffMember_762" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_763" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="Locator_hbio_OtherCostsMember_764" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_763" xlink:to="Locator_hbio_OtherCostsMember_764" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_765" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="Locator_hbio_InventoryImpairmentMember_766" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_765" xlink:to="Locator_hbio_InventoryImpairmentMember_766" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_755" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_756" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_755" xlink:to="Locator_us-gaap_RestructuringPlanAxis_756" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_767" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_768" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanAxis_767" xlink:to="Locator_us-gaap_RestructuringPlanDomain_768" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_769" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2016ConsolidatedMember_770" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_769" xlink:to="Locator_hbio_RestructuringPlan2016ConsolidatedMember_770" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_771" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2015ConsolidatedMember_772" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_771" xlink:to="Locator_hbio_RestructuringPlan2015ConsolidatedMember_772" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_773" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_774" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_773" xlink:to="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_774" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_775" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="Locator_hbio_RestructuringPlan2010PlanBMember_776" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_775" xlink:to="Locator_hbio_RestructuringPlan2010PlanBMember_776" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_777" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="Locator_hbio_RestructuringPlan2013Member_778" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_777" xlink:to="Locator_hbio_RestructuringPlan2013Member_778" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_779" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="Locator_hbio_RestructuringPlanDecember2013Member_780" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_779" xlink:to="Locator_hbio_RestructuringPlanDecember2013Member_780" order="6.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_797" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_798" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringAndRelatedActivitiesAbstract_797" xlink:to="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_798" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_851" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_852" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_851" xlink:to="Locator_us-gaap_RestructuringCostAndReserveLineItems_852" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="Locator_us-gaap_RestructuringCostAndReserveLineItems_781" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_782" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringCostAndReserveLineItems_781" xlink:to="Locator_us-gaap_RestructuringReserveRollForward_782" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_787" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="Locator_us-gaap_RestructuringCharges_788" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_787" xlink:to="Locator_us-gaap_RestructuringCharges_788" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_789" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="Locator_us-gaap_PaymentsForRestructuring_790" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_789" xlink:to="Locator_us-gaap_PaymentsForRestructuring_790" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_791" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1" xlink:label="Locator_us-gaap_RestructuringReserveAccrualAdjustment1_792" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_791" xlink:to="Locator_us-gaap_RestructuringReserveAccrualAdjustment1_792" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_793" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment" xlink:label="Locator_us-gaap_RestructuringReserveTranslationAdjustment_794" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_793" xlink:to="Locator_us-gaap_RestructuringReserveTranslationAdjustment_794" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_785" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="Locator_us-gaap_RestructuringReserve_786" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_785" xlink:to="Locator_us-gaap_RestructuringReserve_786" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="Locator_us-gaap_RestructuringReserveRollForward_795" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="Locator_us-gaap_RestructuringReserve_796" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringReserveRollForward_795" xlink:to="Locator_us-gaap_RestructuringReserve_796" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_853" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_854" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_853" xlink:to="Locator_us-gaap_RestructuringCostAndReserveAxis_854" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="Locator_us-gaap_RestructuringCostAndReserveAxis_857" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_858" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringCostAndReserveAxis_857" xlink:to="Locator_us-gaap_TypeOfRestructuringDomain_858" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_859" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="Locator_us-gaap_EmployeeSeveranceMember_860" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_859" xlink:to="Locator_us-gaap_EmployeeSeveranceMember_860" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_861" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FixedAssetsWriteOffMember" xlink:label="Locator_hbio_FixedAssetsWriteOffMember_862" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_861" xlink:to="Locator_hbio_FixedAssetsWriteOffMember_862" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_863" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OtherCostsMember" xlink:label="Locator_hbio_OtherCostsMember_864" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_863" xlink:to="Locator_hbio_OtherCostsMember_864" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="Locator_us-gaap_TypeOfRestructuringDomain_865" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InventoryImpairmentMember" xlink:label="Locator_hbio_InventoryImpairmentMember_866" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_TypeOfRestructuringDomain_865" xlink:to="Locator_hbio_InventoryImpairmentMember_866" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_855" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_856" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_855" xlink:to="Locator_us-gaap_RestructuringPlanAxis_856" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="Locator_us-gaap_RestructuringPlanAxis_867" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_868" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanAxis_867" xlink:to="Locator_us-gaap_RestructuringPlanDomain_868" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_869" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2016ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2016ConsolidatedMember_870" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_869" xlink:to="Locator_hbio_RestructuringPlan2016ConsolidatedMember_870" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_871" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2015ConsolidatedMember" xlink:label="Locator_hbio_RestructuringPlan2015ConsolidatedMember_872" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_871" xlink:to="Locator_hbio_RestructuringPlan2015ConsolidatedMember_872" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_873" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014ConsolidatedPlansAMember" xlink:label="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_874" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_873" xlink:to="Locator_hbio_RestructuringPlan2014ConsolidatedPlansAMember_874" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_875" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2010PlanBMember" xlink:label="Locator_hbio_RestructuringPlan2010PlanBMember_876" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_875" xlink:to="Locator_hbio_RestructuringPlan2010PlanBMember_876" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_877" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2013Member" xlink:label="Locator_hbio_RestructuringPlan2013Member_878" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_877" xlink:to="Locator_hbio_RestructuringPlan2013Member_878" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_879" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanDecember2013Member" xlink:label="Locator_hbio_RestructuringPlanDecember2013Member_880" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_879" xlink:to="Locator_hbio_RestructuringPlanDecember2013Member_880" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_881" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlan2014Member" xlink:label="Locator_hbio_RestructuringPlan2014Member_882" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_881" xlink:to="Locator_hbio_RestructuringPlan2014Member_882" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_883" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ12015Member" xlink:label="Locator_hbio_RestructuringPlanQ12015Member_884" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_883" xlink:to="Locator_hbio_RestructuringPlanQ12015Member_884" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_885" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ22015Member" xlink:label="Locator_hbio_RestructuringPlanQ22015Member_886" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_885" xlink:to="Locator_hbio_RestructuringPlanQ22015Member_886" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="Locator_us-gaap_RestructuringPlanDomain_887" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestructuringPlanQ42015Member" xlink:label="Locator_hbio_RestructuringPlanQ42015Member_888" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RestructuringPlanDomain_887" xlink:to="Locator_hbio_RestructuringPlanQ42015Member_888" order="10.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="Locator_us-gaap_BusinessCombinationsAbstract_901" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_902" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessCombinationsAbstract_901" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_902" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_923" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_924" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_923" xlink:to="Locator_us-gaap_BusinessAcquisitionLineItems_924" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_889" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="Locator_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_890" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_889" xlink:to="Locator_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_890" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_891" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesGross_892" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_891" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesGross_892" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_893" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement" xlink:label="Locator_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_894" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_893" xlink:to="Locator_hbio_BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement_894" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_895" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="Locator_us-gaap_NumberOfBusinessesAcquired_896" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_895" xlink:to="Locator_us-gaap_NumberOfBusinessesAcquired_896" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_897" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease" xlink:label="Locator_us-gaap_GoodwillOtherIncreaseDecrease_898" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_897" xlink:to="Locator_us-gaap_GoodwillOtherIncreaseDecrease_898" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_925" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_926" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_925" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_926" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_927" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_928" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_927" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_928" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_929" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_930" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_929" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_930" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_931" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="Locator_hbio_ModularSfcAcquisitionMember_932" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_931" xlink:to="Locator_hbio_ModularSfcAcquisitionMember_932" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_933" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_934" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_933" xlink:to="Locator_hbio_CmaAcquisitionMember_934" order="3.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AcquisitionsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1059" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1060" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1059" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1060" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1061" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnpatentedTechnologyMember" xlink:label="Locator_us-gaap_UnpatentedTechnologyMember_1062" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1061" xlink:to="Locator_us-gaap_UnpatentedTechnologyMember_1062" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1067" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentedTechnologyMember" xlink:label="Locator_us-gaap_PatentedTechnologyMember_1068" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1067" xlink:to="Locator_us-gaap_PatentedTechnologyMember_1068" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1069" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="Locator_us-gaap_NoncompeteAgreementsMember_1070" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1069" xlink:to="Locator_us-gaap_NoncompeteAgreementsMember_1070" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1065" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_1066" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1065" xlink:to="Locator_us-gaap_TradeNamesMember_1066" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1063" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_1064" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1063" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_1064" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="Locator_us-gaap_BusinessCombinationsAbstract_967" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_968" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessCombinationsAbstract_967" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_968" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1055" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1056" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1055" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1056" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1057" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="Locator_us-gaap_SubsequentEventTypeAxis_1058" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1057" xlink:to="Locator_us-gaap_SubsequentEventTypeAxis_1058" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="Locator_us-gaap_SubsequentEventTypeAxis_1085" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="Locator_us-gaap_SubsequentEventTypeDomain_1086" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SubsequentEventTypeAxis_1085" xlink:to="Locator_us-gaap_SubsequentEventTypeDomain_1086" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="Locator_us-gaap_SubsequentEventTypeDomain_1087" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="Locator_us-gaap_SubsequentEventMember_1088" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SubsequentEventTypeDomain_1087" xlink:to="Locator_us-gaap_SubsequentEventMember_1088" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1051" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_1052" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1051" xlink:to="Locator_us-gaap_BusinessAcquisitionLineItems_1052" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_935" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_936" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_935" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTangibleAssets1_936" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_937" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_938" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_937" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed1_938" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_939" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_940" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_939" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets1_940" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_941" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_942" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_941" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_942" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_951" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_952" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_951" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount1_952" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_953" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_954" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_953" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets1_954" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_955" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_956" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_955" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_956" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_957" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_958" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_957" xlink:to="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationTotalIntangibleAssetsAmountIncludingGoodwill_958" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract" xlink:label="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_959" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_960" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsAbstract_959" xlink:to="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_960" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_943" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_944" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_943" xlink:to="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_944" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_961" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="Locator_us-gaap_PaymentsToAcquireBusinessesGross_962" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_961" xlink:to="Locator_us-gaap_PaymentsToAcquireBusinessesGross_962" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_963" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionContingentConsiderationAtFairValue1" xlink:label="Locator_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_964" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_963" xlink:to="Locator_hbio_BusinessAcquisitionContingentConsiderationAtFairValue1_964" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_965" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1" xlink:label="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_966" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntity1Abstract_965" xlink:to="Locator_hbio_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice1_966" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_945" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="Locator_us-gaap_BusinessAcquisitionsProFormaRevenue_946" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_945" xlink:to="Locator_us-gaap_BusinessAcquisitionsProFormaRevenue_946" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_947" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="Locator_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_948" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_947" xlink:to="Locator_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_948" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1053" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_1054" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1053" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_1054" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_1071" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1072" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_1071" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1072" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1073" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1074" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1073" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1074" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1075" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ModularSfcAcquisitionMember" xlink:label="Locator_hbio_ModularSfcAcquisitionMember_1076" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1075" xlink:to="Locator_hbio_ModularSfcAcquisitionMember_1076" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1077" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_1078" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1077" xlink:to="Locator_hbio_CmaAcquisitionMember_1078" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1079" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1080" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1079" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1080" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1081" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="Locator_hbio_TriangleBiosystemsIncMember_1082" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1081" xlink:to="Locator_hbio_TriangleBiosystemsIncMember_1082" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1083" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_1084" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_1083" xlink:to="Locator_hbio_HekaElektronikMember_1084" order="6.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/WarrantiesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1091" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="Locator_us-gaap_StandardProductWarrantyAccrualPayments_1092" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1091" xlink:to="Locator_us-gaap_StandardProductWarrantyAccrualPayments_1092" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1093" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="Locator_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1094" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1093" xlink:to="Locator_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1094" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1095" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WarrantyOther" xlink:label="Locator_hbio_WarrantyOther_1096" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1095" xlink:to="Locator_hbio_WarrantyOther_1096" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1089" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="Locator_us-gaap_StandardProductWarrantyAccrual_1090" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1089" xlink:to="Locator_us-gaap_StandardProductWarrantyAccrual_1090" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:label="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1097" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="Locator_us-gaap_StandardProductWarrantyAccrual_1098" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StandardProductWarrantyDisclosureAbstract_1097" xlink:to="Locator_us-gaap_StandardProductWarrantyAccrual_1098" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1099" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1100" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1099" xlink:to="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1100" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1101" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1102" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1101" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1102" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1103" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1104" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1103" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1104" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1105" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1106" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_1105" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1106" order="3.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1123" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="Locator_us-gaap_DefinedContributionPlanCostRecognized_1124" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1123" xlink:to="Locator_us-gaap_DefinedContributionPlanCostRecognized_1124" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1125" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear" xlink:label="Locator_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear_1126" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1125" xlink:to="Locator_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear_1126" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1127" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:label="Locator_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1128" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1127" xlink:to="Locator_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1128" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1129" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear" xlink:label="Locator_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear_1130" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1129" xlink:to="Locator_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear_1130" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1131" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FairValueImpairmentOfPensionAssets" xlink:label="Locator_hbio_FairValueImpairmentOfPensionAssets_1132" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1131" xlink:to="Locator_hbio_FairValueImpairmentOfPensionAssets_1132" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1133" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData_1134" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1133" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData_1134" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1135" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage" xlink:label="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage_1136" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1135" xlink:to="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage_1136" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1137" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAveragePensionPlanLiability" xlink:label="Locator_hbio_DefinedBenefitPlanAveragePensionPlanLiability_1138" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1137" xlink:to="Locator_hbio_DefinedBenefitPlanAveragePensionPlanLiability_1138" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1139" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue" xlink:label="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue_1140" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1139" xlink:to="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue_1140" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1141" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage" xlink:label="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage_1142" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1141" xlink:to="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage_1142" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1143" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanAverageRemainingWorkLifetime" xlink:label="Locator_hbio_DefinedBenefitPlanAverageRemainingWorkLifetime_1144" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1143" xlink:to="Locator_hbio_DefinedBenefitPlanAverageRemainingWorkLifetime_1144" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1145" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue" xlink:label="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue_1146" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1145" xlink:to="Locator_hbio_DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue_1146" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1147" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="Locator_us-gaap_DefinedBenefitPlanContributionsByEmployer_1148" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1147" xlink:to="Locator_us-gaap_DefinedBenefitPlanContributionsByEmployer_1148" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1149" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="Locator_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1150" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1149" xlink:to="Locator_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1150" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1151" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1152" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1151" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1152" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1153" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1154" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1153" xlink:to="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1154" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1107" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1108" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1107" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1108" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1109" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1110" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1109" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1110" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1111" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_1112" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1111" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_1112" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1113" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1114" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1113" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1114" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1115" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_1116" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1115" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_1116" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1117" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1118" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_1117" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1118" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1155" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1156" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1155" xlink:to="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1156" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1119" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData_1120" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1119" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData_1120" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1121" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportBondIndices" xlink:label="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportBondIndices_1122" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1121" xlink:to="Locator_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportBondIndices_1122" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1157" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanServiceCost_1158" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1157" xlink:to="Locator_us-gaap_DefinedBenefitPlanServiceCost_1158" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1159" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanInterestCost_1160" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1159" xlink:to="Locator_us-gaap_DefinedBenefitPlanInterestCost_1160" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1161" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1162" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1161" xlink:to="Locator_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1162" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1163" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1164" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1163" xlink:to="Locator_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1164" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1165" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="Locator_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1166" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1165" xlink:to="Locator_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1166" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1167" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1168" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1167" xlink:to="Locator_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1168" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1169" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1170" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1169" xlink:to="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1170" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1181" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ServiceCostForDefinedBenefitPlan" xlink:label="Locator_hbio_ServiceCostForDefinedBenefitPlan_1182" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1181" xlink:to="Locator_hbio_ServiceCostForDefinedBenefitPlan_1182" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1183" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="Locator_us-gaap_DefinedBenefitPlanInterestCost_1184" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1183" xlink:to="Locator_us-gaap_DefinedBenefitPlanInterestCost_1184" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1185" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByPlanParticipants" xlink:label="Locator_us-gaap_DefinedBenefitPlanContributionsByPlanParticipants_1186" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1185" xlink:to="Locator_us-gaap_DefinedBenefitPlanContributionsByPlanParticipants_1186" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1187" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="Locator_us-gaap_DefinedBenefitPlanActuarialGainLoss_1188" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1187" xlink:to="Locator_us-gaap_DefinedBenefitPlanActuarialGainLoss_1188" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1189" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="Locator_us-gaap_DefinedBenefitPlanBenefitsPaid_1190" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1189" xlink:to="Locator_us-gaap_DefinedBenefitPlanBenefitsPaid_1190" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1191" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="Locator_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1192" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1191" xlink:to="Locator_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1192" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1179" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="Locator_us-gaap_DefinedBenefitPlanBenefitObligation_1180" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1179" xlink:to="Locator_us-gaap_DefinedBenefitPlanBenefitObligation_1180" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1193" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="Locator_us-gaap_DefinedBenefitPlanBenefitObligation_1194" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1193" xlink:to="Locator_us-gaap_DefinedBenefitPlanBenefitObligation_1194" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1171" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1172" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1171" xlink:to="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1172" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1197" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1198" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1197" xlink:to="Locator_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1198" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1199" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByPlanParticipants" xlink:label="Locator_us-gaap_DefinedBenefitPlanContributionsByPlanParticipants_1200" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1199" xlink:to="Locator_us-gaap_DefinedBenefitPlanContributionsByPlanParticipants_1200" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1201" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="Locator_us-gaap_DefinedBenefitPlanContributionsByEmployer_1202" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1201" xlink:to="Locator_us-gaap_DefinedBenefitPlanContributionsByEmployer_1202" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1203" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="Locator_us-gaap_DefinedBenefitPlanBenefitsPaid_1204" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1203" xlink:to="Locator_us-gaap_DefinedBenefitPlanBenefitsPaid_1204" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1205" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_1206" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1205" xlink:to="Locator_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_1206" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1195" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1196" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1195" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1196" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1207" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1208" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1207" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1208" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1173" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_1174" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1173" xlink:to="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_1174" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_1209" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_1210" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_1209" xlink:to="Locator_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_1210" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1175" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1176" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1175" xlink:to="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1176" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1211" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesOnPensionLiabilities" xlink:label="Locator_hbio_DeferredIncomeTaxesOnPensionLiabilities_1212" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1211" xlink:to="Locator_hbio_DeferredIncomeTaxesOnPensionLiabilities_1212" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1213" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:label="Locator_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_1214" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1213" xlink:to="Locator_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_1214" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1215" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1216" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_1215" xlink:to="Locator_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1216" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1177" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1178" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_1177" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1178" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1217" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1218" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1217" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1218" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LeasesNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1233" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EstimatedRentalExpensesCurrentYear" xlink:label="Locator_hbio_EstimatedRentalExpensesCurrentYear_1234" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1233" xlink:to="Locator_hbio_EstimatedRentalExpensesCurrentYear_1234" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1235" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="Locator_us-gaap_OperatingLeasesRentExpenseNet_1236" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1235" xlink:to="Locator_us-gaap_OperatingLeasesRentExpenseNet_1236" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1237" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="Locator_us-gaap_AreaOfRealEstateProperty_1238" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1237" xlink:to="Locator_us-gaap_AreaOfRealEstateProperty_1238" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1239" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseInitialTerm" xlink:label="Locator_hbio_SubleaseInitialTerm_1240" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1239" xlink:to="Locator_hbio_SubleaseInitialTerm_1240" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1241" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SubleaseExtendedTerm" xlink:label="Locator_hbio_SubleaseExtendedTerm_1242" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1241" xlink:to="Locator_hbio_SubleaseExtendedTerm_1242" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1243" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="Locator_us-gaap_LeaseExpirationDate1_1244" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1243" xlink:to="Locator_us-gaap_LeaseExpirationDate1_1244" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1245" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ExpansionAreaOfRealEstateProperty" xlink:label="Locator_hbio_ExpansionAreaOfRealEstateProperty_1246" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1245" xlink:to="Locator_hbio_ExpansionAreaOfRealEstateProperty_1246" order="7.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LeasesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1247" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1248" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1247" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1248" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1249" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1250" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1249" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1250" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1251" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1252" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1251" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1252" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1253" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1254" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1253" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1254" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1255" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1256" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1255" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1256" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1257" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1258" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1257" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1258" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="Locator_us-gaap_LeasesAbstract_1259" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1260" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LeasesAbstract_1259" xlink:to="Locator_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1260" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_1455" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1456" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeAxis_1455" xlink:to="Locator_us-gaap_RangeMember_1456" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1459" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="Locator_us-gaap_MaximumMember_1460" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeMember_1459" xlink:to="Locator_us-gaap_MaximumMember_1460" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_1457" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="Locator_us-gaap_MinimumMember_1458" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeMember_1457" xlink:to="Locator_us-gaap_MinimumMember_1458" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_1353" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1354" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_1353" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1354" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1451" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_1452" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1451" xlink:to="Locator_us-gaap_RangeAxis_1452" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1449" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1450" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1449" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1450" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1273" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfStockRepurchaseProgramAuthorized" xlink:label="Locator_hbio_DateOfStockRepurchaseProgramAuthorized_1274" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1273" xlink:to="Locator_hbio_DateOfStockRepurchaseProgramAuthorized_1274" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1275" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="Locator_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1276" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1275" xlink:to="Locator_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1276" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1277" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="Locator_us-gaap_StockRepurchaseProgramPeriodInForce1_1278" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1277" xlink:to="Locator_us-gaap_StockRepurchaseProgramPeriodInForce1_1278" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1279" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="Locator_us-gaap_TreasuryStockSharesAcquired_1280" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1279" xlink:to="Locator_us-gaap_TreasuryStockSharesAcquired_1280" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1281" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_1282" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1281" xlink:to="Locator_us-gaap_TreasuryStockValueAcquiredCostMethod_1282" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1283" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram" xlink:label="Locator_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_1284" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1283" xlink:to="Locator_hbio_TreasuryStockAcquiredUnderStockRepurchaseProgram_1284" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1285" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram" xlink:label="Locator_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_1286" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1285" xlink:to="Locator_hbio_TreasuryStockNumberOfSharesAcquiredUnderStockRepurchaseProgram_1286" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1287" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_1288" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1287" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_1288" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1289" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_EmployeeStockPurchasePlanSharesAuthorized" xlink:label="Locator_hbio_EmployeeStockPurchasePlanSharesAuthorized_1290" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1289" xlink:to="Locator_hbio_EmployeeStockPurchasePlanSharesAuthorized_1290" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1291" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1292" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1291" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1292" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1293" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors" xlink:label="Locator_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_1294" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1293" xlink:to="Locator_hbio_DateOfAmendmentOfStockOptionAndIncentivePlanByBoardOfDirectors_1294" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1295" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1296" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1295" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1296" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1299" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_1300" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1299" xlink:to="Locator_hbio_LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan_1300" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1301" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleSharesIssuanceRatio" xlink:label="Locator_hbio_FungibleSharesIssuanceRatio_1302" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1301" xlink:to="Locator_hbio_FungibleSharesIssuanceRatio_1302" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1305" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1306" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1305" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1306" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1307" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="Locator_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_1308" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1307" xlink:to="Locator_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_1308" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1309" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="Locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1310" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1309" xlink:to="Locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1310" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1311" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1312" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1311" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1312" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1313" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PercentageOfOutstandingCommonStock" xlink:label="Locator_hbio_PercentageOfOutstandingCommonStock_1314" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1313" xlink:to="Locator_hbio_PercentageOfOutstandingCommonStock_1314" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1315" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan" xlink:label="Locator_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_1316" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1315" xlink:to="Locator_hbio_SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan_1316" order="22.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1317" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares" xlink:label="Locator_us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares_1318" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1317" xlink:to="Locator_us-gaap_SharesHeldInEmployeeStockOptionPlanSuspenseShares_1318" order="23.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1319" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards" xlink:label="Locator_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_1320" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1319" xlink:to="Locator_hbio_RestrictedStockUnitsOutstandingForIssuanceOfAwards_1320" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1321" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncentiveStockOptionsGrantedToDate" xlink:label="Locator_hbio_IncentiveStockOptionsGrantedToDate_1322" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1321" xlink:to="Locator_hbio_IncentiveStockOptionsGrantedToDate_1322" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1323" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonQualifiedStockOptionsGrantedToDate" xlink:label="Locator_hbio_NonQualifiedStockOptionsGrantedToDate_1324" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1323" xlink:to="Locator_hbio_NonQualifiedStockOptionsGrantedToDate_1324" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1325" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CommonStockMarketValuePerShareOnReportingDate" xlink:label="Locator_hbio_CommonStockMarketValuePerShareOnReportingDate_1326" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1325" xlink:to="Locator_hbio_CommonStockMarketValuePerShareOnReportingDate_1326" order="27.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1327" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1328" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1327" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1328" order="28.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1329" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate" xlink:label="Locator_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_1330" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1329" xlink:to="Locator_hbio_InTheMoneyStockOptionsExercisableAtTheReportingDate_1330" order="29.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1331" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1332" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1331" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1332" order="30.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1333" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1334" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1333" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1334" order="31.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1335" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AnnualizedEstimatedForfeitureRate" xlink:label="Locator_hbio_AnnualizedEstimatedForfeitureRate_1336" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1335" xlink:to="Locator_hbio_AnnualizedEstimatedForfeitureRate_1336" order="32.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1337" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants" xlink:label="Locator_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_1338" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1337" xlink:to="Locator_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants_1338" order="33.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1339" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalOptionsGrantedDueToHartSpinoff" xlink:label="Locator_hbio_IncrementalOptionsGrantedDueToHartSpinoff_1340" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1339" xlink:to="Locator_hbio_IncrementalOptionsGrantedDueToHartSpinoff_1340" order="34.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1341" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncrementalUnitsGrantedDueToHartSpinoff" xlink:label="Locator_hbio_IncrementalUnitsGrantedDueToHartSpinoff_1342" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1341" xlink:to="Locator_hbio_IncrementalUnitsGrantedDueToHartSpinoff_1342" order="35.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1345" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1346" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1345" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1346" order="37.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1347" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1348" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1347" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1348" order="38.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1349" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1" xlink:label="Locator_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_1350" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1349" xlink:to="Locator_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1_1350" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1297" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1298" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1297" xlink:to="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1298" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1303" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1304" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1303" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1304" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1343" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="Locator_us-gaap_PreferredStockSharesAuthorized_1344" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1343" xlink:to="Locator_us-gaap_PreferredStockSharesAuthorized_1344" order="36.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1453" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1454" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1453" xlink:to="Locator_us-gaap_AwardTypeAxis_1454" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1461" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1462" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AwardTypeAxis_1461" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1462" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1463" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="Locator_hbio_MarketConditionRestrictedStockUnitMember_1464" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1463" xlink:to="Locator_hbio_MarketConditionRestrictedStockUnitMember_1464" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_1543" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1544" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_1543" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1544" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1617" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1618" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1617" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1618" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1471" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan" xlink:label="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1472" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1471" xlink:to="Locator_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan_1472" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1473" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsIssued" xlink:label="Locator_hbio_StockOptionsAndRestrictedStockUnitsIssued_1474" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1473" xlink:to="Locator_hbio_StockOptionsAndRestrictedStockUnitsIssued_1474" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1475" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1476" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1475" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1476" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1477" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1478" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1477" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1478" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1479" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted" xlink:label="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_1480" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1479" xlink:to="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsGranted_1480" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="Locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1482" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481" xlink:to="Locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1482" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1483" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="Locator_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1484" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1483" xlink:to="Locator_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1484" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1485" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1486" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1485" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1486" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1487" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1488" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1487" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1488" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1465" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1466" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1465" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1466" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1489" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1490" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1489" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1490" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1469" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1470" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1469" xlink:to="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1470" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1493" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1494" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1493" xlink:to="Locator_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1494" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1497" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1498" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1497" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1498" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1499" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1500" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1499" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1500" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1495" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1496" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1495" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1496" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1501" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1502" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1501" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1502" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1505" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1506" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1505" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1506" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1503" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1504" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1503" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1504" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1507" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1508" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1507" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1508" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1509" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1510" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1509" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1510" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1511" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1512" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1511" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1512" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1533" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1534" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1533" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1534" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1535" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1536" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1535" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1536" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1537" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1538" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1537" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1538" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1539" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1540" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1539" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1540" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1541" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient" xlink:label="Locator_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_1542" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1541" xlink:to="Locator_hbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficient_1542" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1513" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod" xlink:label="Locator_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_1514" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1513" xlink:to="Locator_hbio_ShareOptionsAndRestrictedStockUnitsForfeituresAndExpirationsInPeriod_1514" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1515" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1516" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1515" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1516" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1517" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1518" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1517" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1518" order="27.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1519" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockOptionsAndRestrictedStockUnitsCancelled" xlink:label="Locator_hbio_StockOptionsAndRestrictedStockUnitsCancelled_1520" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1519" xlink:to="Locator_hbio_StockOptionsAndRestrictedStockUnitsCancelled_1520" order="28.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1521" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1522" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1521" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1522" order="29.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1523" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1524" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1523" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1524" order="30.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1525" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled" xlink:label="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_1526" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1525" xlink:to="Locator_hbio_FungibleShareAdjustmentForRestrictedStockUnitsCancelled_1526" order="31.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1527" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="Locator_us-gaap_PreferredStockSharesAuthorized_1528" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1527" xlink:to="Locator_us-gaap_PreferredStockSharesAuthorized_1528" order="32.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1529" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_StockIssuedDuringPeriodGrossStockOptionsExercised" xlink:label="Locator_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_1530" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1529" xlink:to="Locator_hbio_StockIssuedDuringPeriodGrossStockOptionsExercised_1530" order="33.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1467" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1468" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1467" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1468" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1491" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1492" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1491" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1492" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1619" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1620" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1619" xlink:to="Locator_us-gaap_AwardTypeAxis_1620" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="Locator_us-gaap_AwardTypeAxis_1621" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1622" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AwardTypeAxis_1621" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1622" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1623" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MarketConditionRestrictedStockUnitMember" xlink:label="Locator_hbio_MarketConditionRestrictedStockUnitMember_1624" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1623" xlink:to="Locator_hbio_MarketConditionRestrictedStockUnitMember_1624" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1661" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold" xlink:label="Locator_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold_1662" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1661" xlink:to="Locator_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold_1662" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1663" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold" xlink:label="Locator_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold_1664" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1663" xlink:to="Locator_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold_1664" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1659" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_1660" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1659" xlink:to="Locator_hbio_CreditAgreementTable_1660" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_1709" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1710" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementTable_1709" xlink:to="Locator_hbio_CreditAgreementLineItems_1710" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1625" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PreviousApprovedCreditFacility" xlink:label="Locator_hbio_PreviousApprovedCreditFacility_1626" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1625" xlink:to="Locator_hbio_PreviousApprovedCreditFacility_1626" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1627" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_1628" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1627" xlink:to="Locator_us-gaap_SecuredDebt_1628" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1629" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="Locator_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1630" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1629" xlink:to="Locator_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1630" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1631" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Maturitydates" xlink:label="Locator_hbio_Maturitydates_1632" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1631" xlink:to="Locator_hbio_Maturitydates_1632" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1633" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1634" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1633" xlink:to="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1634" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1635" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_1636" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1635" xlink:to="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_1636" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1637" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="Locator_us-gaap_LineOfCredit_1638" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1637" xlink:to="Locator_us-gaap_LineOfCredit_1638" order="7.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1639" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="Locator_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1640" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1639" xlink:to="Locator_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1640" order="8.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1641" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_InterestRateInExcessOfLiborOnCreditFacility" xlink:label="Locator_hbio_InterestRateInExcessOfLiborOnCreditFacility_1642" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1641" xlink:to="Locator_hbio_InterestRateInExcessOfLiborOnCreditFacility_1642" order="9.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1643" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SecuredDebtInterestRateAtPeriodEnd" xlink:label="Locator_hbio_SecuredDebtInterestRateAtPeriodEnd_1644" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1643" xlink:to="Locator_hbio_SecuredDebtInterestRateAtPeriodEnd_1644" order="10.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1645" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="Locator_hbio_LiborFixedRate_1646" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1645" xlink:to="Locator_hbio_LiborFixedRate_1646" order="11.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1647" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="Locator_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_1648" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1647" xlink:to="Locator_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_1648" order="12.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1649" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="Locator_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1650" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1649" xlink:to="Locator_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1650" order="13.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1651" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine" xlink:label="Locator_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_1652" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1651" xlink:to="Locator_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine_1652" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1653" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity" xlink:label="Locator_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_1654" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1653" xlink:to="Locator_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity_1654" order="15.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementLineItems" xlink:label="Locator_hbio_CreditAgreementLineItems_1655" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="Locator_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1656" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementLineItems_1655" xlink:to="Locator_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1656" order="16.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_1711" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_1712" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementTable_1711" xlink:to="Locator_hbio_CreditAgreementAxis_1712" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_1713" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1714" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementAxis_1713" xlink:to="Locator_hbio_CreditAgreementDomain_1714" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1717" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_1718" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_1717" xlink:to="Locator_us-gaap_SecuredDebtMember_1718" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1719" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_1720" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_1719" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_1720" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_1715" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="Locator_us-gaap_RevolvingCreditFacilityMember_1716" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_1715" xlink:to="Locator_us-gaap_RevolvingCreditFacilityMember_1716" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1861" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1862" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_1861" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_1862" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1863" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1864" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1863" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1864" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1721" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="Locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1722" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1721" xlink:to="Locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1722" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1723" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1724" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1723" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1724" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1725" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="Locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1726" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1725" xlink:to="Locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1726" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1727" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="Locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1728" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1727" xlink:to="Locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1728" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1729" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardFederalAndState" xlink:label="Locator_hbio_NetOperatingLossCarryforwardFederalAndState_1730" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1729" xlink:to="Locator_hbio_NetOperatingLossCarryforwardFederalAndState_1730" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1731" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardForeign" xlink:label="Locator_hbio_NetOperatingLossCarryforwardForeign_1732" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1731" xlink:to="Locator_hbio_NetOperatingLossCarryforwardForeign_1732" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1733" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="Locator_us-gaap_TaxCreditCarryforwardAmount_1734" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1733" xlink:to="Locator_us-gaap_TaxCreditCarryforwardAmount_1734" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1735" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation" xlink:label="Locator_hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation_1736" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1735" xlink:to="Locator_hbio_NetOperatingLossCarryforwardsSubjectToAnnualLimitation_1736" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1737" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetOperatingLossCarryforwardsAnnualLimitation" xlink:label="Locator_hbio_NetOperatingLossCarryforwardsAnnualLimitation_1738" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1737" xlink:to="Locator_hbio_NetOperatingLossCarryforwardsAnnualLimitation_1738" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1739" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_UndistributedForeignEarnings" xlink:label="Locator_hbio_UndistributedForeignEarnings_1740" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1739" xlink:to="Locator_hbio_UndistributedForeignEarnings_1740" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1741" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiaries" xlink:label="Locator_hbio_CashInForeignSubsidiaries_1742" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1741" xlink:to="Locator_hbio_CashInForeignSubsidiaries_1742" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1743" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements" xlink:label="Locator_hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements_1744" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1743" xlink:to="Locator_hbio_CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements_1744" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1745" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1746" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1745" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1746" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1747" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefits_1748" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1747" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefits_1748" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1749" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1750" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1749" xlink:to="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1750" order="15.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1833" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1834" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1833" xlink:to="Locator_hbio_IncomeTaxDisclosureLineItems_1834" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1759" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions" xlink:label="Locator_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_1760" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1759" xlink:to="Locator_hbio_CashHeldInForeignSubsidiariesUsedForAcquisitions_1760" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1761" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxRateReconciliationDeductionsStockOptions" xlink:label="Locator_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_1762" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1761" xlink:to="Locator_hbio_IncomeTaxRateReconciliationDeductionsStockOptions_1762" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1763" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="Locator_us-gaap_OperatingLossCarryforwards_1764" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1763" xlink:to="Locator_us-gaap_OperatingLossCarryforwards_1764" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1765" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OperatingLossCarryforwardsExpirationYear" xlink:label="Locator_hbio_OperatingLossCarryforwardsExpirationYear_1766" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1765" xlink:to="Locator_hbio_OperatingLossCarryforwardsExpirationYear_1766" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1767" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="Locator_us-gaap_TaxCreditCarryforwardAmount_1768" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1767" xlink:to="Locator_us-gaap_TaxCreditCarryforwardAmount_1768" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1769" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditCarryforwardsExpirationYear" xlink:label="Locator_hbio_TaxCreditCarryforwardsExpirationYear_1770" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1769" xlink:to="Locator_hbio_TaxCreditCarryforwardsExpirationYear_1770" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxDisclosureLineItems" xlink:label="Locator_hbio_IncomeTaxDisclosureLineItems_1771" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_1772" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_IncomeTaxDisclosureLineItems_1771" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_1772" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1835" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="Locator_hbio_TaxCreditExpirationAxis_1836" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1835" xlink:to="Locator_hbio_TaxCreditExpirationAxis_1836" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationAxis" xlink:label="Locator_hbio_TaxCreditExpirationAxis_1865" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1866" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TaxCreditExpirationAxis_1865" xlink:to="Locator_hbio_TaxCreditExpirationDomain_1866" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1867" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2017Member" xlink:label="Locator_hbio_TaxCreditExpire2017Member_1868" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1867" xlink:to="Locator_hbio_TaxCreditExpire2017Member_1868" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1869" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2020Member" xlink:label="Locator_hbio_TaxCreditExpire2020Member_1870" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1869" xlink:to="Locator_hbio_TaxCreditExpire2020Member_1870" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpirationDomain" xlink:label="Locator_hbio_TaxCreditExpirationDomain_1871" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxCreditExpire2022Member" xlink:label="Locator_hbio_TaxCreditExpire2022Member_1872" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TaxCreditExpirationDomain_1871" xlink:to="Locator_hbio_TaxCreditExpire2022Member_1872" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1837" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1838" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1837" xlink:to="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1838" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis" xlink:label="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1843" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1844" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CashInForeignSubsidiariesUsedForAcquisitionsAxis_1843" xlink:to="Locator_hbio_TypesOfAcquisitionsDomain_1844" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1845" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CmaAcquisitionMember" xlink:label="Locator_hbio_CmaAcquisitionMember_1846" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1845" xlink:to="Locator_hbio_CmaAcquisitionMember_1846" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1847" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AhnBiotechnologieGmbhAcquisitionMember" xlink:label="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1848" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1847" xlink:to="Locator_hbio_AhnBiotechnologieGmbhAcquisitionMember_1848" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1849" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1850" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1849" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_1850" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TypesOfAcquisitionsDomain" xlink:label="Locator_hbio_TypesOfAcquisitionsDomain_1851" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_1852" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_TypesOfAcquisitionsDomain_1851" xlink:to="Locator_hbio_HekaElektronikMember_1852" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1839" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="Locator_us-gaap_IncomeTaxAuthorityAxis_1840" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1839" xlink:to="Locator_us-gaap_IncomeTaxAuthorityAxis_1840" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="Locator_us-gaap_IncomeTaxAuthorityAxis_1853" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1854" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxAuthorityAxis_1853" xlink:to="Locator_us-gaap_IncomeTaxAuthorityDomain_1854" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1855" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="Locator_us-gaap_DomesticCountryMember_1856" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1855" xlink:to="Locator_us-gaap_DomesticCountryMember_1856" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1857" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="Locator_us-gaap_StateAndLocalJurisdictionMember_1858" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1857" xlink:to="Locator_us-gaap_StateAndLocalJurisdictionMember_1858" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="Locator_us-gaap_IncomeTaxAuthorityDomain_1859" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="Locator_us-gaap_ForeignCountryMember_1860" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxAuthorityDomain_1859" xlink:to="Locator_us-gaap_ForeignCountryMember_1860" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable" xlink:label="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1841" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1842" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_ScheduleOfCashInForeignSubsidiariesUsedForAcqusitionTable_1841" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_1842" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1751" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent" xlink:label="Locator_hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent_1752" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1751" xlink:to="Locator_hbio_DeferredIncomeTaxReclassificationFromCurrentToNonCurrent_1752" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1753" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignEarningsRepatriated" xlink:label="Locator_us-gaap_ForeignEarningsRepatriated_1754" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1753" xlink:to="Locator_us-gaap_ForeignEarningsRepatriated_1754" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1755" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TaxLiabilityOnForeignEarningsRepatriated" xlink:label="Locator_hbio_TaxLiabilityOnForeignEarningsRepatriated_1756" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1755" xlink:to="Locator_hbio_TaxLiabilityOnForeignEarningsRepatriated_1756" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1757" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets" xlink:label="Locator_hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets_1758" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1757" xlink:to="Locator_hbio_AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets_1758" order="19.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingMeasurementDisclosuresAbstract" xlink:label="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_1873" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="Locator_us-gaap_Revenues_1874" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingMeasurementDisclosuresAbstract_1873" xlink:to="Locator_us-gaap_Revenues_1874" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="Locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1875" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="Locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1876" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1875" xlink:to="Locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1876" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RecentlyIssuedAccountingPronouncements">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract" xlink:label="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_1877" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="Locator_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_1878" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract_1877" xlink:to="Locator_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_1878" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebt">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1879" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="Locator_us-gaap_LongTermDebtTextBlock_1880" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1879" xlink:to="Locator_us-gaap_LongTermDebtTextBlock_1880" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1917" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1918" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_1917" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_1918" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1919" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="Locator_us-gaap_CostOfSalesMember_1920" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1919" xlink:to="Locator_us-gaap_CostOfSalesMember_1920" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1921" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1922" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1921" xlink:to="Locator_us-gaap_ResearchAndDevelopmentExpenseMember_1922" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1923" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="Locator_us-gaap_SellingAndMarketingExpenseMember_1924" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1923" xlink:to="Locator_us-gaap_SellingAndMarketingExpenseMember_1924" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1925" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="Locator_us-gaap_GeneralAndAdministrativeExpenseMember_1926" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1925" xlink:to="Locator_us-gaap_GeneralAndAdministrativeExpenseMember_1926" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_1927" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DiscontinuedOperationsMember" xlink:label="Locator_hbio_DiscontinuedOperationsMember_1928" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_1927" xlink:to="Locator_hbio_DiscontinuedOperationsMember_1928" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_1891" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1892" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_1891" xlink:to="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1892" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1913" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1914" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1913" xlink:to="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1914" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1887" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="Locator_us-gaap_ShareBasedCompensation_1888" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1887" xlink:to="Locator_us-gaap_ShareBasedCompensation_1888" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1915" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_1916" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1915" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_1916" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_1893" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1894" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_1893" xlink:to="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1894" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1881" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1882" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1881" xlink:to="Locator_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1882" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1883" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1884" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1883" xlink:to="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1884" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1885" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="Locator_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1886" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_1885" xlink:to="Locator_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1886" order="3.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1931" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="Locator_us-gaap_GoodwillAcquiredDuringPeriod_1932" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1931" xlink:to="Locator_us-gaap_GoodwillAcquiredDuringPeriod_1932" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1933" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="Locator_us-gaap_GoodwillPurchaseAccountingAdjustments_1934" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1933" xlink:to="Locator_us-gaap_GoodwillPurchaseAccountingAdjustments_1934" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1935" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease" xlink:label="Locator_us-gaap_GoodwillOtherIncreaseDecrease_1936" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1935" xlink:to="Locator_us-gaap_GoodwillOtherIncreaseDecrease_1936" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1937" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="Locator_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1938" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1937" xlink:to="Locator_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1938" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1939" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="Locator_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1940" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1939" xlink:to="Locator_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1940" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1929" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_1930" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1929" xlink:to="Locator_us-gaap_Goodwill_1930" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1941" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Locator_us-gaap_Goodwill_1942" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1941" xlink:to="Locator_us-gaap_Goodwill_1942" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_1943" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="Locator_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock_1944" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_1943" xlink:to="Locator_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock_1944" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1945" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1946" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1945" xlink:to="Locator_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1946" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_1947" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfDebtTableTextBlock_1948" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_1947" xlink:to="Locator_us-gaap_ScheduleOfDebtTableTextBlock_1948" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccruedExpensesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_1949" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1950" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_1949" xlink:to="Locator_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1950" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1951" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1952" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1951" xlink:to="Locator_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1952" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1953" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1954" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1953" xlink:to="Locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1954" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1955" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1956" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1955" xlink:to="Locator_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1956" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1957" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1958" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1957" xlink:to="Locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1958" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_1959" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="Locator_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1960" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_1959" xlink:to="Locator_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1960" order="5.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsTables">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_AllowanceForDoubtfulDebtsDisclosureAbstract" xlink:label="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureAbstract_1961" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_1962" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_AllowanceForDoubtfulDebtsDisclosureAbstract_1961" xlink:to="Locator_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_1962" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/QuarterlyFinancialInformationunauditedTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="Locator_us-gaap_QuarterlyFinancialDataAbstract_1963" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1964" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_QuarterlyFinancialDataAbstract_1963" xlink:to="Locator_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1964" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/ConcentrationsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:label="Locator_us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_1975" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="Locator_us-gaap_ConcentrationRiskTable_1976" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_1975" xlink:to="Locator_us-gaap_ConcentrationRiskTable_1976" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="Locator_us-gaap_ConcentrationRiskTable_1995" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1996" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskTable_1995" xlink:to="Locator_us-gaap_ConcentrationRiskLineItems_1996" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1965" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCustomer" xlink:label="Locator_us-gaap_ConcentrationRiskCustomer_1966" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1965" xlink:to="Locator_us-gaap_ConcentrationRiskCustomer_1966" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1967" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContribution" xlink:label="Locator_hbio_NumberOfCustomersWithBenchmarkContribution_1968" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1967" xlink:to="Locator_hbio_NumberOfCustomersWithBenchmarkContribution_1968" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1969" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="Locator_us-gaap_ConcentrationRiskPercentage1_1970" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1969" xlink:to="Locator_us-gaap_ConcentrationRiskPercentage1_1970" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="Locator_us-gaap_ConcentrationRiskLineItems_1971" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NumberOfCustomersWithBenchmarkContributionExceptOne" xlink:label="Locator_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_1972" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskLineItems_1971" xlink:to="Locator_hbio_NumberOfCustomersWithBenchmarkContributionExceptOne_1972" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="Locator_us-gaap_ConcentrationRiskTable_1997" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1998" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskTable_1997" xlink:to="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1998" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1999" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2000" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskByBenchmarkAxis_1999" xlink:to="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2000" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2001" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNetMember" xlink:label="Locator_us-gaap_SalesRevenueGoodsNetMember_2002" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2001" xlink:to="Locator_us-gaap_SalesRevenueGoodsNetMember_2002" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2003" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="Locator_us-gaap_AccountsReceivableMember_2004" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ConcentrationRiskBenchmarkDomain_2003" xlink:to="Locator_us-gaap_AccountsReceivableMember_2004" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2013" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2014" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2013" xlink:to="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2014" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2043" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2044" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2043" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2044" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2005" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentGross_2006" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2005" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentGross_2006" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2007" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2008" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2007" xlink:to="Locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2008" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2009" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentNet_2010" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2009" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentNet_2010" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2045" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2046" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2045" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2046" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2047" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2048" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2047" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2048" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2059" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:label="Locator_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2060" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2059" xlink:to="Locator_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2060" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2049" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="Locator_us-gaap_LandBuildingsAndImprovementsMember_2050" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2049" xlink:to="Locator_us-gaap_LandBuildingsAndImprovementsMember_2050" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2051" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="Locator_us-gaap_MachineryAndEquipmentMember_2052" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2051" xlink:to="Locator_us-gaap_MachineryAndEquipmentMember_2052" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2053" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="Locator_us-gaap_ComputerEquipmentMember_2054" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2053" xlink:to="Locator_us-gaap_ComputerEquipmentMember_2054" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2055" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="Locator_us-gaap_FurnitureAndFixturesMember_2056" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2055" xlink:to="Locator_us-gaap_FurnitureAndFixturesMember_2056" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2057" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="Locator_us-gaap_AutomobilesMember_2058" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2057" xlink:to="Locator_us-gaap_AutomobilesMember_2058" order="5.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccruedExpensesDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2061" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="Locator_us-gaap_EmployeeRelatedLiabilitiesCurrent_2062" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2061" xlink:to="Locator_us-gaap_EmployeeRelatedLiabilitiesCurrent_2062" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2063" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="Locator_us-gaap_AccruedProfessionalFeesCurrent_2064" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2063" xlink:to="Locator_us-gaap_AccruedProfessionalFeesCurrent_2064" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2065" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="Locator_us-gaap_RestructuringReserveCurrent_2066" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2065" xlink:to="Locator_us-gaap_RestructuringReserveCurrent_2066" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2067" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="Locator_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2068" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2067" xlink:to="Locator_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2068" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2069" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="Locator_us-gaap_OtherAccruedLiabilitiesCurrent_2070" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2069" xlink:to="Locator_us-gaap_OtherAccruedLiabilitiesCurrent_2070" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2071" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TotalAccruedExpenses" xlink:label="Locator_hbio_TotalAccruedExpenses_2072" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccruedLiabilitiesCurrentAbstract_2071" xlink:to="Locator_hbio_TotalAccruedExpenses_2072" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2083" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2084" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2083" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2084" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2089" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="Locator_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2090" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2089" xlink:to="Locator_hbio_CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2090" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2091" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentForeignTaxExpenseBenefit_2092" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2091" xlink:to="Locator_us-gaap_CurrentForeignTaxExpenseBenefit_2092" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2093" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2094" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2093" xlink:to="Locator_us-gaap_CurrentIncomeTaxExpenseBenefit_2094" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2095" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations" xlink:label="Locator_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2096" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2095" xlink:to="Locator_hbio_DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations_2096" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2097" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2098" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2097" xlink:to="Locator_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2098" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2099" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredIncomeTaxesAmount" xlink:label="Locator_hbio_DeferredIncomeTaxesAmount_2100" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2099" xlink:to="Locator_hbio_DeferredIncomeTaxesAmount_2100" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2101" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_2102" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_2101" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefit_2102" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2085" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2086" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2085" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2086" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2103" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="Locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2104" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2103" xlink:to="Locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2104" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2105" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences" xlink:label="Locator_hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences_2106" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2105" xlink:to="Locator_hbio_NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences_2106" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2107" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="Locator_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2108" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2107" xlink:to="Locator_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2108" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2109" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="Locator_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2110" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2109" xlink:to="Locator_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2110" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2111" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:label="Locator_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_2112" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2111" xlink:to="Locator_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_2112" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2113" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="Locator_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2114" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2113" xlink:to="Locator_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2114" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2115" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NetImpactOfForeignRateChanges" xlink:label="Locator_hbio_NetImpactOfForeignRateChanges_2116" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2115" xlink:to="Locator_hbio_NetImpactOfForeignRateChanges_2116" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2117" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="Locator_us-gaap_IncomeTaxReconciliationTaxCredits_2118" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2117" xlink:to="Locator_us-gaap_IncomeTaxReconciliationTaxCredits_2118" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2119" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2120" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2119" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2120" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2121" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="Locator_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2122" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2121" xlink:to="Locator_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2122" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2123" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:label="Locator_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_2124" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2123" xlink:to="Locator_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_2124" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2125" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes" xlink:label="Locator_hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes_2126" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2125" xlink:to="Locator_hbio_IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes_2126" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2127" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction" xlink:label="Locator_hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction_2128" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2127" xlink:to="Locator_hbio_IncomeTaxReconciliationForeignTaxCreditsDeduction_2128" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2129" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale" xlink:label="Locator_hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale_2130" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2129" xlink:to="Locator_hbio_IncomeTaxReconciliationLossOnSubsidiaryStockSale_2130" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2131" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="Locator_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2132" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2131" xlink:to="Locator_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2132" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2133" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="Locator_us-gaap_IncomeTaxExpenseBenefit_2134" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2133" xlink:to="Locator_us-gaap_IncomeTaxExpenseBenefit_2134" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2087" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2088" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2087" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2088" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2135" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2136" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2135" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2136" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2137" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2138" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2137" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2138" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2139" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2140" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_2139" xlink:to="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2140" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2141" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="Locator_us-gaap_IncomeTaxReconciliationOtherAdjustments_2142" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2141" xlink:to="Locator_us-gaap_IncomeTaxReconciliationOtherAdjustments_2142" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/IncomeTaxDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2159" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2160" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2159" xlink:to="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2160" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2165" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2166" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2165" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2166" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2167" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="Locator_us-gaap_DeferredTaxAssetsInventory_2168" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2167" xlink:to="Locator_us-gaap_DeferredTaxAssetsInventory_2168" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2169" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards" xlink:label="Locator_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_2170" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2169" xlink:to="Locator_hbio_DeferredTaxAssetsOperatingLossAndCreditsCarryforwards_2170" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2171" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2172" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2171" xlink:to="Locator_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2172" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2173" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_2174" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2173" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_2174" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2175" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_2176" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2175" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_2176" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2177" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_2178" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2177" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_2178" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2179" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxAssetsTaxCreditsOnRepatriation" xlink:label="Locator_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_2180" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2179" xlink:to="Locator_hbio_DeferredTaxAssetsTaxCreditsOnRepatriation_2180" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2181" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2182" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2181" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2182" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2183" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_2184" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2183" xlink:to="Locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_2184" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2185" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="Locator_us-gaap_DeferredTaxAssetsGross_2186" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2185" xlink:to="Locator_us-gaap_DeferredTaxAssetsGross_2186" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2187" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="Locator_us-gaap_DeferredTaxAssetsValuationAllowance_2188" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2187" xlink:to="Locator_us-gaap_DeferredTaxAssetsValuationAllowance_2188" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2189" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="Locator_us-gaap_DeferredTaxAssetsNet_2190" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2189" xlink:to="Locator_us-gaap_DeferredTaxAssetsNet_2190" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2161" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2162" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2161" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2162" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2191" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets" xlink:label="Locator_hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets_2192" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2191" xlink:to="Locator_hbio_DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets_2192" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2193" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets" xlink:label="Locator_hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets_2194" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2193" xlink:to="Locator_hbio_DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets_2194" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2195" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2196" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2195" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2196" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2197" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2198" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2197" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2198" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2199" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredTaxLiabilitiesOnRepatriation" xlink:label="Locator_hbio_DeferredTaxLiabilitiesOnRepatriation_2200" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2199" xlink:to="Locator_hbio_DeferredTaxLiabilitiesOnRepatriation_2200" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2201" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesOther_2202" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2201" xlink:to="Locator_us-gaap_DeferredTaxLiabilitiesOther_2202" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2203" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="Locator_us-gaap_DeferredTaxLiabilities_2204" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2203" xlink:to="Locator_us-gaap_DeferredTaxLiabilities_2204" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2205" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="Locator_us-gaap_DeferredTaxAssetsLiabilitiesNet_2206" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DeferredTaxLiabilitiesAbstract_2205" xlink:to="Locator_us-gaap_DeferredTaxAssetsLiabilitiesNet_2206" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="Locator_us-gaap_IncomeTaxDisclosureAbstract_2163" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2164" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeTaxDisclosureAbstract_2163" xlink:to="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2164" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2209" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2210" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2209" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2210" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2211" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2212" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2211" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2212" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2207" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefits_2208" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2207" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefits_2208" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2213" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="Locator_us-gaap_UnrecognizedTaxBenefits_2214" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2213" xlink:to="Locator_us-gaap_UnrecognizedTaxBenefits_2214" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails3">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2293" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2294" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2293" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2294" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2295" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="Locator_us-gaap_FairValueInputsLevel1Member_2296" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2295" xlink:to="Locator_us-gaap_FairValueInputsLevel1Member_2296" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="Locator_us-gaap_FairValueInputsLevel2Member_2298" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297" xlink:to="Locator_us-gaap_FairValueInputsLevel2Member_2298" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2299" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2300" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2299" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2300" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_2245" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2246" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_2245" xlink:to="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2246" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2279" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2280" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2279" xlink:to="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2280" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2283" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2284" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2283" xlink:to="Locator_us-gaap_PlanAssetCategoriesDomain_2284" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2285" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="Locator_us-gaap_EquitySecuritiesMember_2286" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2285" xlink:to="Locator_us-gaap_EquitySecuritiesMember_2286" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2287" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="Locator_us-gaap_DebtSecuritiesMember_2288" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2287" xlink:to="Locator_us-gaap_DebtSecuritiesMember_2288" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2289" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="Locator_us-gaap_CashAndCashEquivalentsMember_2290" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2289" xlink:to="Locator_us-gaap_CashAndCashEquivalentsMember_2290" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="Locator_us-gaap_PlanAssetCategoriesDomain_2291" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="Locator_us-gaap_OtherAssetsMember_2292" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PlanAssetCategoriesDomain_2291" xlink:to="Locator_us-gaap_OtherAssetsMember_2292" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2277" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2278" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2277" xlink:to="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2278" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2241" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2242" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2241" xlink:to="Locator_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2242" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2239" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2240" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2239" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2240" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2281" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2282" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2281" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2282" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails4">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2333" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2334" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2333" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2334" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2335" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2336" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2335" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2336" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract" xlink:label="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_2313" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2314" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract_2313" xlink:to="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2314" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2329" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2330" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2329" xlink:to="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2330" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2303" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanPurchasesDuringYear" xlink:label="Locator_hbio_DefinedBenefitPlanPurchasesDuringYear_2304" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2303" xlink:to="Locator_hbio_DefinedBenefitPlanPurchasesDuringYear_2304" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2305" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DefinedBenefitPlanUnrealizedLossGain" xlink:label="Locator_hbio_DefinedBenefitPlanUnrealizedLossGain_2306" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2305" xlink:to="Locator_hbio_DefinedBenefitPlanUnrealizedLossGain_2306" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2307" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2308" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2307" xlink:to="Locator_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2308" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2301" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2302" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2301" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2302" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2309" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2310" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DefinedBenefitPlanDisclosureLineItems_2309" xlink:to="Locator_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2310" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2331" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2332" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2331" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2332" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/CapitalStockDetails3">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2337" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2338" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2337" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2338" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2339" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2340" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2339" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2340" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2341" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2342" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2341" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2342" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2343" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2344" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2343" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2344" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2345" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2346" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2345" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2346" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2347" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2348" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2347" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2348" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2349" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2350" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2349" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2350" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2351" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2352" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2351" xlink:to="Locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2352" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="Locator_us-gaap_StockholdersEquityNoteAbstract_2355" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2356" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StockholdersEquityNoteAbstract_2355" xlink:to="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2356" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2433" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2434" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2433" xlink:to="Locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2434" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2435" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2436" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2435" xlink:to="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2436" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2437" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2438" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2437" xlink:to="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2438" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2439" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember" xlink:label="Locator_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_2440" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2439" xlink:to="Locator_hbio_TwoDollarsTwoCentsToTwoDollarsFortyTwoCentsMember_2440" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2441" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember" xlink:label="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_2442" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2441" xlink:to="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsSeventyTwoCentsMember_2442" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2443" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember" xlink:label="Locator_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_2444" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2443" xlink:to="Locator_hbio_TwoDollarsSeventyThreeCentstoThreeDollarsSixtyEightCentsMember_2444" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2445" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_2446" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2445" xlink:to="Locator_hbio_ThreeDollarsSixtyNineCentsToFourDollarsSevenCentsMember_2446" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2447" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember" xlink:label="Locator_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_2448" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2447" xlink:to="Locator_hbio_FourDollarsEightCentsToFourDollarsSeventeenCentsMember_2448" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2449" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember" xlink:label="Locator_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_2450" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2449" xlink:to="Locator_hbio_FourDollarsEighteenCentsToFourDollarsTwentySixCentsMember_2450" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2451" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember" xlink:label="Locator_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_2452" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2451" xlink:to="Locator_hbio_FourDollarsTwentySevenCentsToFourDollarsFortyOneCentsMember_2452" order="7.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2453" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember" xlink:label="Locator_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_2454" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2453" xlink:to="Locator_hbio_FourDollarsFortyTwoCentsToFiveDollarsThirtyNineCentsMember_2454" order="8.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2455" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember" xlink:label="Locator_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_2456" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2455" xlink:to="Locator_hbio_FiveDollarsFortyCentsToFiveDollarsFiftyOneCentsMember_2456" order="9.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2457" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="Locator_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_2458" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2457" xlink:to="Locator_hbio_FiveDollarsFiftyTwoCentsToFiveDollarsSixtyThreeCentsMember_2458" order="10.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2459" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember" xlink:label="Locator_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_2460" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2459" xlink:to="Locator_hbio_TwoDollarsTwoCentsToFiveDollarsSixtyThreeCentsMember_2460" order="11.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2461" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember" xlink:label="Locator_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_2462" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2461" xlink:to="Locator_hbio_OneDollarFortyThreeCentsToTwoDollarsFifteenCentsMember_2462" order="12.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2463" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFourtyFiveCentsMember" xlink:label="Locator_hbio_TwoDollarsFourtyFiveCentsMember_2464" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2463" xlink:to="Locator_hbio_TwoDollarsFourtyFiveCentsMember_2464" order="13.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2465" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftySixCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftySixCentsMember_2466" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2465" xlink:to="Locator_hbio_TwoDollarsFiftySixCentsMember_2466" order="14.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2467" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_2468" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2467" xlink:to="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyFourCentsMember_2468" order="15.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2469" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyFourCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyFourCentsMember_2470" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2469" xlink:to="Locator_hbio_ThreeDollarsSixtyFourCentsMember_2470" order="16.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2471" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_2472" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2471" xlink:to="Locator_hbio_ThreeDollarsSixtyEightCentsToThreeDollarsNinetyNineCentsMember_2472" order="17.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2473" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsFourCentsMember" xlink:label="Locator_hbio_FourDollarsFourCentsMember_2474" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2473" xlink:to="Locator_hbio_FourDollarsFourCentsMember_2474" order="18.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2475" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember" xlink:label="Locator_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_2476" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2475" xlink:to="Locator_hbio_FourDollarsTwentyOneCentsToFourDollarsThirtyOneCentsMember_2476" order="19.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2477" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="Locator_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_2478" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2477" xlink:to="Locator_hbio_FiveDollarsSeventyThreeCentsToSixDollarsFiftySevenCentsMember_2478" order="20.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2479" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember" xlink:label="Locator_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_2480" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2479" xlink:to="Locator_hbio_FourDollarsSevenCentsToFourDollarsTenCentsMemberMember_2480" order="21.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2481" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember" xlink:label="Locator_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_2482" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2481" xlink:to="Locator_hbio_FourDollarsTwelveCentsToFourDollarsEightyNineCentsMember_2482" order="22.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2483" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember" xlink:label="Locator_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_2484" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2483" xlink:to="Locator_hbio_OneDollarFortyThreeCentsToSixDollarsFiftySevenCentsMember_2484" order="23.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2485" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember" xlink:label="Locator_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_2486" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2485" xlink:to="Locator_hbio_OneDollarRortyThreeCentsToFourDollarsEightyNineCentsMember_2486" order="24.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2487" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember" xlink:label="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_2488" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2487" xlink:to="Locator_hbio_TwoDollarsFortyThreeCentsToTwoDollarsFiftyEightCentsMember_2488" order="25.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2489" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember" xlink:label="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_2490" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2489" xlink:to="Locator_hbio_TwoDollarsFiftyNineCentsToThreeDollarsFiftyNineCentsMember_2490" order="26.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2491" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember" xlink:label="Locator_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_2492" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2491" xlink:to="Locator_hbio_ThreeDollarsSixtyCentsToThreeDollarsSixtyEightCentsMember_2492" order="27.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="Locator_us-gaap_SegmentsGeographicalAreasAbstract_2501" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2502" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentsGeographicalAreasAbstract_2501" xlink:to="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2502" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2525" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2526" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2525" xlink:to="Locator_us-gaap_SegmentReportingInformationLineItems_2526" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2493" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="Locator_us-gaap_Revenues_2494" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2493" xlink:to="Locator_us-gaap_Revenues_2494" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2495" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_SegmentReportingInformationNetAssets1" xlink:label="Locator_hbio_SegmentReportingInformationNetAssets1_2496" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2495" xlink:to="Locator_hbio_SegmentReportingInformationNetAssets1_2496" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="Locator_us-gaap_SegmentReportingInformationLineItems_2497" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="Locator_us-gaap_NoncurrentAssets_2498" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentReportingInformationLineItems_2497" xlink:to="Locator_us-gaap_NoncurrentAssets_2498" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2527" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="Locator_us-gaap_StatementGeographicalAxis_2528" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2527" xlink:to="Locator_us-gaap_StatementGeographicalAxis_2528" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="Locator_us-gaap_StatementGeographicalAxis_2529" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2530" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementGeographicalAxis_2529" xlink:to="Locator_us-gaap_SegmentGeographicalDomain_2530" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2531" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="Locator_country_US_2532" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2531" xlink:to="Locator_country_US_2532" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2533" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_DE" xlink:label="Locator_country_DE_2534" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2533" xlink:to="Locator_country_DE_2534" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2535" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_GB" xlink:label="Locator_country_GB_2536" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2535" xlink:to="Locator_country_GB_2536" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2537" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RestOfTheWorldMember" xlink:label="Locator_hbio_RestOfTheWorldMember_2538" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2537" xlink:to="Locator_hbio_RestOfTheWorldMember_2538" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="Locator_us-gaap_SegmentGeographicalDomain_2539" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="Locator_us-gaap_IntersegmentEliminationMember_2540" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SegmentGeographicalDomain_2539" xlink:to="Locator_us-gaap_IntersegmentEliminationMember_2540" order="5.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AllowanceForDoubtfulDebtsDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2543" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="Locator_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2544" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2543" xlink:to="Locator_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2544" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2545" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:label="Locator_us-gaap_ValuationAllowancesAndReservesAdjustments_2546" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2545" xlink:to="Locator_us-gaap_ValuationAllowancesAndReservesAdjustments_2546" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2547" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_ValuationAllowancesAndReservesCurrencyTranslation" xlink:label="Locator_hbio_ValuationAllowancesAndReservesCurrencyTranslation_2548" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2547" xlink:to="Locator_hbio_ValuationAllowancesAndReservesCurrencyTranslation_2548" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2541" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="Locator_us-gaap_ValuationAllowancesAndReservesBalance_2542" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2541" xlink:to="Locator_us-gaap_ValuationAllowancesAndReservesBalance_2542" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2549" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="Locator_us-gaap_ValuationAllowancesAndReservesBalance_2550" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2549" xlink:to="Locator_us-gaap_ValuationAllowancesAndReservesBalance_2550" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/StatementOfComprehensiveIncomeParentheticals">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="Locator_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2551" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_2552" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2551" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_2552" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="Locator_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2553" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_2554" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2553" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_2554" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2563" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2564" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2563" xlink:to="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2564" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2615" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2616" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2615" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2616" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2555" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2556" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsLineItems_2555" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2556" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2619" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2620" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2619" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2620" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2627" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2628" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2627" xlink:to="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2628" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2629" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="Locator_us-gaap_DevelopedTechnologyRightsMember_2630" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2629" xlink:to="Locator_us-gaap_DevelopedTechnologyRightsMember_2630" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2631" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="Locator_us-gaap_TradeNamesMember_2632" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2631" xlink:to="Locator_us-gaap_TradeNamesMember_2632" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2633" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DistributionRightsMember" xlink:label="Locator_us-gaap_DistributionRightsMember_2634" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2633" xlink:to="Locator_us-gaap_DistributionRightsMember_2634" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2635" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="Locator_us-gaap_CustomerRelationshipsMember_2636" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2635" xlink:to="Locator_us-gaap_CustomerRelationshipsMember_2636" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2637" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember" xlink:label="Locator_us-gaap_PatentsMember_2638" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2637" xlink:to="Locator_us-gaap_PatentsMember_2638" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2621" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2622" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2621" xlink:to="Locator_us-gaap_RangeAxis_2622" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2639" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2640" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeAxis_2639" xlink:to="Locator_us-gaap_RangeMember_2640" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2641" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="Locator_us-gaap_MaximumMember_2642" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeMember_2641" xlink:to="Locator_us-gaap_MaximumMember_2642" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="Locator_us-gaap_RangeMember_2643" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="Locator_us-gaap_MinimumMember_2644" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RangeMember_2643" xlink:to="Locator_us-gaap_MinimumMember_2644" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2565" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2566" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2565" xlink:to="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2566" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2617" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2618" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2617" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2618" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2559" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentUsefulLife_2560" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentLineItems_2559" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentUsefulLife_2560" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2623" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2624" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2623" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2624" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2645" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2646" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2645" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2646" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2647" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="Locator_us-gaap_LandBuildingsAndImprovementsMember_2648" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2647" xlink:to="Locator_us-gaap_LandBuildingsAndImprovementsMember_2648" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2649" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="Locator_us-gaap_MachineryAndEquipmentMember_2650" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2649" xlink:to="Locator_us-gaap_MachineryAndEquipmentMember_2650" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2651" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="Locator_us-gaap_ComputerEquipmentMember_2652" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2651" xlink:to="Locator_us-gaap_ComputerEquipmentMember_2652" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2653" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="Locator_us-gaap_FurnitureAndFixturesMember_2654" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2653" xlink:to="Locator_us-gaap_FurnitureAndFixturesMember_2654" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2655" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="Locator_us-gaap_AutomobilesMember_2656" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_2655" xlink:to="Locator_us-gaap_AutomobilesMember_2656" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2625" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="Locator_us-gaap_RangeAxis_2626" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2625" xlink:to="Locator_us-gaap_RangeAxis_2626" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_2567" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2568" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_2567" xlink:to="Locator_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2568" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_2569" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2570" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_2569" xlink:to="Locator_us-gaap_PropertyPlantAndEquipmentAbstract_2570" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/Derivatives">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2657" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2658" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2657" xlink:to="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2658" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2659" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="Locator_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2660" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2659" xlink:to="Locator_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2660" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2661" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_2662" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2661" xlink:to="Locator_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_2662" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2663" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2664" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2663" xlink:to="Locator_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2664" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2665" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="Locator_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2666" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2665" xlink:to="Locator_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2666" order="4.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2681" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2682" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2681" xlink:to="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2682" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2705" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2706" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2705" xlink:to="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2706" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2667" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed" xlink:label="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_2668" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2667" xlink:to="Locator_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed_2668" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2669" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="Locator_us-gaap_DerivativeAssetNotionalAmount_2670" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2669" xlink:to="Locator_us-gaap_DerivativeAssetNotionalAmount_2670" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2671" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_LiborFixedRate" xlink:label="Locator_hbio_LiborFixedRate_2672" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2671" xlink:to="Locator_hbio_LiborFixedRate_2672" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2673" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_2674" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2673" xlink:to="Locator_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_2674" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2675" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2676" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2675" xlink:to="Locator_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2676" order="5.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2677" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DerivativeInterestRateSwapEffectivePercentage" xlink:label="Locator_hbio_DerivativeInterestRateSwapEffectivePercentage_2678" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2677" xlink:to="Locator_hbio_DerivativeInterestRateSwapEffectivePercentage_2678" order="6.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2707" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="Locator_us-gaap_DerivativeInstrumentRiskAxis_2708" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2707" xlink:to="Locator_us-gaap_DerivativeInstrumentRiskAxis_2708" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="Locator_us-gaap_DerivativeInstrumentRiskAxis_2709" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2710" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentRiskAxis_2709" xlink:to="Locator_us-gaap_DerivativeContractTypeDomain_2710" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2711" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_2712" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeContractTypeDomain_2711" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_2712" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="Locator_us-gaap_DerivativeContractTypeDomain_2713" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_2714" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeContractTypeDomain_2713" xlink:to="Locator_us-gaap_SecuredDebtMember_2714" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2721" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2722" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2721" xlink:to="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2722" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2743" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2744" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2743" xlink:to="Locator_us-gaap_DerivativesFairValueLineItems_2744" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2715" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="Locator_invest_DerivativeNotionalAmount_2716" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativesFairValueLineItems_2715" xlink:to="Locator_invest_DerivativeNotionalAmount_2716" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="Locator_us-gaap_DerivativesFairValueLineItems_2717" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="Locator_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_2718" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativesFairValueLineItems_2717" xlink:to="Locator_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_2718" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2745" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="Locator_us-gaap_BalanceSheetLocationAxis_2746" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2745" xlink:to="Locator_us-gaap_BalanceSheetLocationAxis_2746" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="Locator_us-gaap_BalanceSheetLocationAxis_2753" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="Locator_us-gaap_BalanceSheetLocationDomain_2754" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BalanceSheetLocationAxis_2753" xlink:to="Locator_us-gaap_BalanceSheetLocationDomain_2754" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="Locator_us-gaap_BalanceSheetLocationDomain_2755" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="Locator_us-gaap_OtherLiabilitiesMember_2756" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BalanceSheetLocationDomain_2755" xlink:to="Locator_us-gaap_OtherLiabilitiesMember_2756" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2747" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2748" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2747" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2748" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2749" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2750" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2749" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2750" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2751" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2752" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2751" xlink:to="Locator_us-gaap_InterestRateSwapMember_2752" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DerivativeDetails2">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2787" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2788" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2787" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2788" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2789" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2790" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2789" xlink:to="Locator_us-gaap_InterestRateSwapMember_2790" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2763" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2764" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2763" xlink:to="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2764" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2781" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2782" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2781" xlink:to="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2782" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2757" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion" xlink:label="Locator_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion_2758" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2757" xlink:to="Locator_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion_2758" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2759" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:label="Locator_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_2760" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossLineItems_2759" xlink:to="Locator_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_2760" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2783" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2784" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2783" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2784" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2785" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_2786" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2785" xlink:to="Locator_us-gaap_IncomeStatementLocationAxis_2786" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="Locator_us-gaap_IncomeStatementLocationAxis_2791" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_2792" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationAxis_2791" xlink:to="Locator_us-gaap_IncomeStatementLocationDomain_2792" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="Locator_us-gaap_IncomeStatementLocationDomain_2793" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="Locator_us-gaap_InterestExpenseMember_2794" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_IncomeStatementLocationDomain_2793" xlink:to="Locator_us-gaap_InterestExpenseMember_2794" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/FairValueMeasurements">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="Locator_us-gaap_FairValueDisclosuresAbstract_2795" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="Locator_us-gaap_FairValueDisclosuresTextBlock_2796" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueDisclosuresAbstract_2795" xlink:to="Locator_us-gaap_FairValueDisclosuresTextBlock_2796" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/FairValueMeasurementsTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="Locator_us-gaap_FairValueDisclosuresAbstract_2797" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2798" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueDisclosuresAbstract_2797" xlink:to="Locator_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2798" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/FairValueMeasurementsDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2839" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2840" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2839" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2840" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2841" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="Locator_us-gaap_InterestRateSwapMember_2842" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_2841" xlink:to="Locator_us-gaap_InterestRateSwapMember_2842" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="Locator_us-gaap_FairValueDisclosuresAbstract_2799" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="Locator_us-gaap_LiabilitiesFairValueDisclosureAbstract_2800" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueDisclosuresAbstract_2799" xlink:to="Locator_us-gaap_LiabilitiesFairValueDisclosureAbstract_2800" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="Locator_us-gaap_LiabilitiesFairValueDisclosureAbstract_2805" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2806" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LiabilitiesFairValueDisclosureAbstract_2805" xlink:to="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2806" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2825" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2826" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2825" xlink:to="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2826" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2801" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="Locator_us-gaap_DerivativeLiabilities_2802" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2801" xlink:to="Locator_us-gaap_DerivativeLiabilities_2802" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2827" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2828" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2827" xlink:to="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2828" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2831" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2832" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueByFairValueHierarchyLevelAxis_2831" xlink:to="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2832" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2833" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="Locator_us-gaap_FairValueInputsLevel1Member_2834" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2833" xlink:to="Locator_us-gaap_FairValueInputsLevel1Member_2834" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2835" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="Locator_us-gaap_FairValueInputsLevel2Member_2836" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2835" xlink:to="Locator_us-gaap_FairValueInputsLevel2Member_2836" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2837" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="Locator_us-gaap_FairValueInputsLevel3Member_2838" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2837" xlink:to="Locator_us-gaap_FairValueInputsLevel3Member_2838" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2829" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2830" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2829" xlink:to="Locator_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2830" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RelatedPartyTransactions">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="Locator_us-gaap_RelatedPartyTransactionsAbstract_2843" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="Locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2844" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RelatedPartyTransactionsAbstract_2843" xlink:to="Locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2844" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncome">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2845" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="Locator_us-gaap_ComprehensiveIncomeNoteTextBlock_2846" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2845" xlink:to="Locator_us-gaap_ComprehensiveIncomeNoteTextBlock_2846" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2847" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="Locator_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2848" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2847" xlink:to="Locator_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2848" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2849" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="Locator_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2850" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2849" xlink:to="Locator_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2850" order="2.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2863" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2864" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2863" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2864" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2889" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2890" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2889" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2890" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2853" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2854" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2853" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2854" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2855" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2856" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2855" xlink:to="Locator_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2856" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2857" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2858" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2857" xlink:to="Locator_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2858" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2851" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2852" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2851" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2852" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2859" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2860" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2859" xlink:to="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2860" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2891" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="Locator_us-gaap_StatementEquityComponentsAxis_2892" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2891" xlink:to="Locator_us-gaap_StatementEquityComponentsAxis_2892" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="Locator_us-gaap_StatementEquityComponentsAxis_2893" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2894" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_StatementEquityComponentsAxis_2893" xlink:to="Locator_us-gaap_EquityComponentDomain_2894" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2895" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="Locator_us-gaap_AccumulatedTranslationAdjustmentMember_2896" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EquityComponentDomain_2895" xlink:to="Locator_us-gaap_AccumulatedTranslationAdjustmentMember_2896" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2897" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="Locator_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2898" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EquityComponentDomain_2897" xlink:to="Locator_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2898" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="Locator_us-gaap_EquityComponentDomain_2899" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="Locator_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2900" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_EquityComponentDomain_2899" xlink:to="Locator_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2900" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/LongTermDebtDetails1">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="Locator_us-gaap_LongTermDebtAbstract_2919" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_2920" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtAbstract_2919" xlink:to="Locator_hbio_CreditAgreementTable_2920" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_2967" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2968" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementTable_2967" xlink:to="Locator_us-gaap_DebtInstrumentLineItems_2968" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2901" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="Locator_us-gaap_LongTermLoansPayable_2902" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2901" xlink:to="Locator_us-gaap_LongTermLoansPayable_2902" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2903" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoan" xlink:label="Locator_hbio_DelayedDrawdownTermLoan_2904" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2903" xlink:to="Locator_hbio_DelayedDrawdownTermLoan_2904" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2905" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_RevolvingCreditFacility" xlink:label="Locator_hbio_RevolvingCreditFacility_2906" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2905" xlink:to="Locator_hbio_RevolvingCreditFacility_2906" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2907" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsNet_2908" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2907" xlink:to="Locator_us-gaap_DeferredFinanceCostsNet_2908" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2909" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="Locator_us-gaap_SecuredDebt_2910" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2909" xlink:to="Locator_us-gaap_SecuredDebt_2910" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2911" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="Locator_us-gaap_SecuredDebtCurrent_2912" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2911" xlink:to="Locator_us-gaap_SecuredDebtCurrent_2912" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2913" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2914" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2913" xlink:to="Locator_us-gaap_DeferredFinanceCostsCurrentNet_2914" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="Locator_us-gaap_DebtInstrumentLineItems_2915" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2916" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_DebtInstrumentLineItems_2915" xlink:to="Locator_us-gaap_LongTermDebtNoncurrent_2916" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="Locator_us-gaap_LongTermDebtNoncurrent_2921" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="Locator_us-gaap_UnamortizedDebtIssuanceExpense_2922" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_LongTermDebtNoncurrent_2921" xlink:to="Locator_us-gaap_UnamortizedDebtIssuanceExpense_2922" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementTable" xlink:label="Locator_hbio_CreditAgreementTable_2969" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_2970" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementTable_2969" xlink:to="Locator_hbio_CreditAgreementAxis_2970" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementAxis" xlink:label="Locator_hbio_CreditAgreementAxis_2971" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2972" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementAxis_2971" xlink:to="Locator_hbio_CreditAgreementDomain_2972" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2973" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="Locator_us-gaap_SecuredDebtMember_2974" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_2973" xlink:to="Locator_us-gaap_SecuredDebtMember_2974" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2975" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DelayedDrawdownTermLoanMember" xlink:label="Locator_hbio_DelayedDrawdownTermLoanMember_2976" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_2975" xlink:to="Locator_hbio_DelayedDrawdownTermLoanMember_2976" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2977" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="Locator_us-gaap_RevolvingCreditFacilityMember_2978" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_2977" xlink:to="Locator_us-gaap_RevolvingCreditFacilityMember_2978" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_CreditAgreementDomain" xlink:label="Locator_hbio_CreditAgreementDomain_2979" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DeferredFinancingCostsMember" xlink:label="Locator_hbio_DeferredFinancingCostsMember_2980" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_CreditAgreementDomain_2979" xlink:to="Locator_hbio_DeferredFinancingCostsMember_2980" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3011" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_3012" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3011" xlink:to="Locator_us-gaap_BusinessAcquisitionLineItems_3012" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_2981" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="Locator_us-gaap_OperatingLeasesRentExpenseNet_2982" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_2981" xlink:to="Locator_us-gaap_OperatingLeasesRentExpenseNet_2982" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_2983" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="Locator_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_2984" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_2983" xlink:to="Locator_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_2984" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_2985" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TransitionServicesChargedToSpinnee" xlink:label="Locator_hbio_TransitionServicesChargedToSpinnee_2986" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_2985" xlink:to="Locator_hbio_TransitionServicesChargedToSpinnee_2986" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="Locator_us-gaap_BusinessAcquisitionLineItems_2987" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_DistributionRevenuesFromSpinnee" xlink:label="Locator_hbio_DistributionRevenuesFromSpinnee_2988" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionLineItems_2987" xlink:to="Locator_hbio_DistributionRevenuesFromSpinnee_2988" order="4.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3013" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_3014" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3013" xlink:to="Locator_us-gaap_BusinessAcquisitionAxis_3014" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="Locator_us-gaap_BusinessAcquisitionAxis_3015" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3016" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAxis_3015" xlink:to="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3016" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3017" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_MultiChannelSystemsMcsGmbhMember" xlink:label="Locator_hbio_MultiChannelSystemsMcsGmbhMember_3018" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3017" xlink:to="Locator_hbio_MultiChannelSystemsMcsGmbhMember_3018" order="1.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3019" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_TriangleBiosystemsIncMember" xlink:label="Locator_hbio_TriangleBiosystemsIncMember_3020" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3019" xlink:to="Locator_hbio_TriangleBiosystemsIncMember_3020" order="2.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3021" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_HekaElektronikMember" xlink:label="Locator_hbio_HekaElektronikMember_3022" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_BusinessAcquisitionAcquireeDomain_3021" xlink:to="Locator_hbio_HekaElektronikMember_3022" order="3.0" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="Locator_us-gaap_RelatedPartyTransactionsAbstract_2991" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2992" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_RelatedPartyTransactionsAbstract_2991" xlink:to="Locator_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2992" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPoliciesTables">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="Locator_us-gaap_AccountingPoliciesAbstract_3023" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="Locator_hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_3024" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_AccountingPoliciesAbstract_3023" xlink:to="Locator_hbio_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_3024" order="1.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/DocumentAndEntityInformation">
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3025" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="Locator_dei_DocumentType_3026" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3025" xlink:to="Locator_dei_DocumentType_3026" order="1.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3027" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="Locator_dei_DocumentPeriodEndDate_3028" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3027" xlink:to="Locator_dei_DocumentPeriodEndDate_3028" order="2.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3029" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="Locator_dei_AmendmentFlag_3030" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3029" xlink:to="Locator_dei_AmendmentFlag_3030" order="3.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3031" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="Locator_dei_AmendmentDescription_3032" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3031" xlink:to="Locator_dei_AmendmentDescription_3032" order="4.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3033" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="Locator_dei_DocumentFiscalPeriodFocus_3034" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3033" xlink:to="Locator_dei_DocumentFiscalPeriodFocus_3034" order="5.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3035" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="Locator_dei_DocumentFiscalYearFocus_3036" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3035" xlink:to="Locator_dei_DocumentFiscalYearFocus_3036" order="6.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3037" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="Locator_dei_CurrentFiscalYearEndDate_3038" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3037" xlink:to="Locator_dei_CurrentFiscalYearEndDate_3038" order="7.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3039" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="Locator_dei_EntityCentralIndexKey_3040" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3039" xlink:to="Locator_dei_EntityCentralIndexKey_3040" order="8.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3041" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="Locator_dei_EntityCurrentReportingStatus_3042" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3041" xlink:to="Locator_dei_EntityCurrentReportingStatus_3042" order="9.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3043" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="Locator_dei_EntityFilerCategory_3044" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3043" xlink:to="Locator_dei_EntityFilerCategory_3044" order="10.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3045" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="Locator_dei_EntityRegistrantName_3046" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3045" xlink:to="Locator_dei_EntityRegistrantName_3046" order="11.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3047" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="Locator_dei_EntityVoluntaryFilers_3048" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3047" xlink:to="Locator_dei_EntityVoluntaryFilers_3048" order="12.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3049" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="Locator_dei_EntityWellKnownSeasonedIssuer_3050" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3049" xlink:to="Locator_dei_EntityWellKnownSeasonedIssuer_3050" order="13.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3051" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="Locator_dei_EntityCommonStockSharesOutstanding_3052" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3051" xlink:to="Locator_dei_EntityCommonStockSharesOutstanding_3052" order="14.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3053" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="Locator_dei_EntityPublicFloat_3054" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3053" xlink:to="Locator_dei_EntityPublicFloat_3054" order="15.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3055" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_NonAffiliateShareHolding" xlink:label="Locator_hbio_NonAffiliateShareHolding_3056" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3055" xlink:to="Locator_hbio_NonAffiliateShareHolding_3056" order="16.0" />
        <loc xlink:type="locator" xlink:href="hbio-20170331.xsd#hbio_Documentandentityinformationabstract" xlink:label="Locator_hbio_Documentandentityinformationabstract_3057" />
        <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="Locator_dei_TradingSymbol_3058" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_hbio_Documentandentityinformationabstract_3057" xlink:to="Locator_dei_TradingSymbol_3058" order="17.0" />
    </presentationLink>
    <presentationLink xlink:type="extended" xlink:role="http://www.harvardbioscience.com/role/SubsequentEvents">
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="Locator_us-gaap_SubsequentEventsAbstract_3059" />
        <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="Locator_us-gaap_SubsequentEventsTextBlock_3060" />
        <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Locator_us-gaap_SubsequentEventsAbstract_3059" xlink:to="Locator_us-gaap_SubsequentEventsTextBlock_3060" order="1.0" />
    </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823636368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>May 02, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_Documentandentityinformationabstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document period end date</a></td>
<td class="text">Mar. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current fiscal year end date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity central index key</a></td>
<td class="text">0001123494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity current reporting status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity filer category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity registrant name</a></td>
<td class="text">HARVARD BIOSCIENCE INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity voluntary filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity well known seasoned issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,618,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HBIO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_Documentandentityinformationabstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_Documentandentityinformationabstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824177120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Financial Position - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,599<span></span>
</td>
<td class="nump">$ 5,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $559 and $611, respectively</a></td>
<td class="nump">15,479<span></span>
</td>
<td class="nump">15,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">20,282<span></span>
</td>
<td class="nump">19,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other receivables and other assets</a></td>
<td class="nump">4,761<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">45,121<span></span>
</td>
<td class="nump">45,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,268<span></span>
</td>
<td class="nump">4,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetNoncurrent', window );">Deferred income tax assets - non-current</a></td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">17,070<span></span>
</td>
<td class="nump">17,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">38,398<span></span>
</td>
<td class="nump">38,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite lived intangible assets</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">107,396<span></span>
</td>
<td class="nump">107,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion, long-term debt</a></td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,835<span></span>
</td>
<td class="nump">6,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes payable</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">4,324<span></span>
</td>
<td class="nump">4,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities - current</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">14,056<span></span>
</td>
<td class="nump">14,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">10,931<span></span>
</td>
<td class="nump">11,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income tax liabilities - non-current</a></td>
<td class="nump">6,460<span></span>
</td>
<td class="nump">6,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other liabilities- non current</a></td>
<td class="nump">3,234<span></span>
</td>
<td class="nump">3,177<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,681<span></span>
</td>
<td class="nump">35,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01 per share, 5,000,000 shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share, 80,000,000 shares authorized; 42,364,404 and 42,186,827 shares issued and 34,618,897 and 34,441,320 shares outstanding, respectively</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in-capital</a></td>
<td class="nump">215,842<span></span>
</td>
<td class="nump">215,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(117,168)<span></span>
</td>
<td class="num">(116,030)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(15,709)<span></span>
</td>
<td class="num">(16,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCarryingBasis', window );">Treasury stock at cost, 7,745,507 common shares</a></td>
<td class="num">(10,668)<span></span>
</td>
<td class="num">(10,668)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">72,715<span></span>
</td>
<td class="nump">72,196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 107,396<span></span>
</td>
<td class="nump">$ 107,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31928-109318<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCarryingBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost basis for treasury stock acquired for purposes other than retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCarryingBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823678976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Financial Position (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONSOLIDATED BALANCE SHEETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock Par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock - Shares Authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock- Shares Authorized</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock- Shares Issued</a></td>
<td class="nump">42,364,404<span></span>
</td>
<td class="nump">42,186,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock- Shares Outstanding</a></td>
<td class="nump">34,618,897<span></span>
</td>
<td class="nump">34,441,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock common shares</a></td>
<td class="nump">7,745,507<span></span>
</td>
<td class="nump">7,745,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824324944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 24,156<span></span>
</td>
<td class="nump">$ 26,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues (exclusive of items shown separately below)</a></td>
<td class="nump">12,657<span></span>
</td>
<td class="nump">14,018<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,499<span></span>
</td>
<td class="nump">12,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">5,048<span></span>
</td>
<td class="nump">5,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">5,206<span></span>
</td>
<td class="nump">5,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">1,285<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges (credits)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses, net</a></td>
<td class="nump">12,138<span></span>
</td>
<td class="nump">13,166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(639)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange</a></td>
<td class="num">(143)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInterestAndDividendIncome', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(404)<span></span>
</td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(1,043)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,066)<span></span>
</td>
<td class="num">$ (636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings Per Common Share</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">34,579,473<span></span>
</td>
<td class="nump">34,013,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">34,579,473<span></span>
</td>
<td class="nump">34,013,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,066)<span></span>
</td>
<td class="num">$ (636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Derivatives qualifying as hedges, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Gain (loss) on derivative instruments designated and qualifying as cash flow hedges</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss to net loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total Comprehensive Income (Loss), Net of Tax, total</a></td>
<td class="num">$ (117)<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32022-110900<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32157-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41638-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInterestAndDividendIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInterestAndDividendIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824082880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,066)<span></span>
</td>
<td class="num">$ (636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_AmortizationOfCatalogCosts', window );">Amortization Of Catalog Costs</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for allowance for doubtful accounts</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferrred Income Taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) decrease in accounts receivable</a></td>
<td class="nump">410<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Increase in other receivables and other assets</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Increase in trade accounts payable</a></td>
<td class="num">(320)<span></span>
</td>
<td class="num">(2,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">(Decrease) increase in accrued income taxes</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase in accrued expenses</a></td>
<td class="num">(571)<span></span>
</td>
<td class="nump">1,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">(Decrease) increase in deferred revenue</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Increase (decrease) in other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="num">(610)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows (used in) provided by investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Additions to property, plant and equipment</a></td>
<td class="num">(198)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_AdditionsToCatalogCosts', window );">Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog.</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by (used in) financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="num">(1,113)<span></span>
</td>
<td class="num">(2,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Net proceeds from issuance of debt</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(1,726)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase in cash and cash equivalents</a></td>
<td class="num">(997)<span></span>
</td>
<td class="num">(2,569)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the begining of period</a></td>
<td class="nump">5,596<span></span>
</td>
<td class="nump">6,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the end of period</a></td>
<td class="nump">4,599<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_AdditionsToCatalogCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_AdditionsToCatalogCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_AmortizationOfCatalogCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_AmortizationOfCatalogCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814591744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:center;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >HARVARD BIOSCIENCE, INC. </font></p><p style='text-align:center;margin-top:4.5pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >1.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >Basis of Presentation and Summary of Significant Accounting Policies</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:27pt;' >Basis of Presentation</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The unaudited consolidated financial statements of Harvard Bioscience, </font><font style='font-family:Times New Roman;font-size:10pt;' >Inc. and its wholly-owned subsidiaries (collectively, &#8220;Harvard Bioscience&#8221; or the &#8220;Company&#8221;) as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' > have been prepared by the Company pursuant to the rules </font><font style='font-family:Times New Roman;font-size:10pt;' >and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) have been cond</font><font style='font-family:Times New Roman;font-size:10pt;' >ensed or omitted pursuant to such rules and regulations. The December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' > consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. However, the Company believes tha</font><font style='font-family:Times New Roman;font-size:10pt;' >t the disclosures are adequate to make the information presented not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s Annu</font><font style='font-family:Times New Roman;font-size:10pt;' >al Report on Form 10-K for the fiscal year ended December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, which was filed with the SEC on </font><font style='font-family:Times New Roman;font-size:10pt;' >March 17, 2017</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >In the opinion of management, all adjustments, which include normal recurring adjustments necessary to present a fair statement o</font><font style='font-family:Times New Roman;font-size:10pt;' >f financial position as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, results of operations and comprehensive loss </font><font style='font-family:Times New Roman;font-size:10pt;' >and cash flows for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, a</font><font style='font-family:Times New Roman;font-size:10pt;' >s applicable, have been made. The results of o</font><font style='font-family:Times New Roman;font-size:10pt;' >perations for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > are not necessarily indicative of the operating results for the full fiscal year or any future periods.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:27pt;' >Summary of Significant Accounting Policies</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The accounting policies underlying the accompanying unaudited consolidated financial statements are those set forth in Note 2 to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, which was filed with the SEC on March 17, 2017</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797568944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recently Issued Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract', window );"><strong>Recently Issued Accounting Pronouncements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Recently Issued Accounting Pronouncements Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >&#8220;Revenue from Contracts with Customers,&#8221;</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in th</font><font style='font-family:Times New Roman;font-size:10pt;' >e United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or servi</font><font style='font-family:Times New Roman;font-size:10pt;' >ces. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactio</font><font style='font-family:Times New Roman;font-size:10pt;' >ns that could have implications to the timing of revenue recognition under the new guidance. The Company expects this undertaking will be complete in the second half of 2017.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In February 2016, the FASB issued ASU 2016-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, which is intended to impr</font><font style='font-family:Times New Roman;font-size:10pt;' >ove financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12&#160;months. The update is effective for fiscal year</font><font style='font-family:Times New Roman;font-size:10pt;' >s beginning after December 15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determined the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabili</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ties will increase upon adoption for right-of-use assets and lease liabilities. The Company&#8217;s future commitments under lease obligations are summarized in Note 10.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In March 2016, the FASB issued ASU 2016-09,&#160;</font><font style='font-family:Times New Roman;font-size:10pt;' >Compensation &#8211; Stock Compensation (Topic 718): </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;' >, which simplifies the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity o</font><font style='font-family:Times New Roman;font-size:10pt;' >r liabilities and classification on the statement of cash flows. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The standard requires an entity to recognize all excess tax benefits and tax deficiencies as income tax benefit or expense in the income statement as discrete items in the reporting period </font><font style='font-family:Times New Roman;font-size:10pt;' >in which they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&#8217;s annual effective tax rate, applied on a prospective basis. Further, the standard eliminates the requirement to defer the recognition of excess t</font><font style='font-family:Times New Roman;font-size:10pt;' >ax benefits until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with any valuation allowance, should be recognized on a modified retrospective basis as a cumulative adjustment to retain</font><font style='font-family:Times New Roman;font-size:10pt;' >ed earnings as of the </font><font style='font-family:Times New Roman;font-size:10pt;' >date of adoption. Under ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09, an entity that applies the treasury stock method in calculating diluted earnings per share is required to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since</font><font style='font-family:Times New Roman;font-size:10pt;' > such amounts are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner as other cash flows related to income taxes on the statement of cash flows, as such excess tax benefits no longer</font><font style='font-family:Times New Roman;font-size:10pt;' > represent financing activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods presented. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company adopted ASU 2016-09 as of January 1, 2017. The Company  recorded a cumulative</font><font style='font-family:Times New Roman;font-size:10pt;' > increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred tax assets related to the prior years&#8217; unrecognized excess tax benefits. An equal amount of valuation allowance was also </font><font style='font-family:Times New Roman;font-size:10pt;' >recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in a net impact of $0. In addition, </font><font style='font-family:Times New Roman;font-size:10pt;' >tax deficiencies related to vested restricted stock units and canceled stock options during the first quarter</font><font style='font-family:Times New Roman;font-size:10pt;' > of 2017 have been recognized in the current period&#8217;s income statement.  </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09 also allows an entity to elect as an accounting policy either to continue to estimate the total number of awards for which the requisite service period will not be rende</font><font style='font-family:Times New Roman;font-size:10pt;' >red or to account for forfeitures for service based awards as they occur. An entity that elects to account for forfeitures as they occur should apply the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earn</font><font style='font-family:Times New Roman;font-size:10pt;' >ings as of the date of adoption. The Company elected as an accounting policy to account for forfeitures for service based awards as they </font><font style='font-family:Times New Roman;font-size:10pt;' >occur, and as a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings</font><font style='font-family:Times New Roman;font-size:10pt;' > with a corresponding increase in additional paid in capital related to the prior years</font><font style='font-family:Times New Roman;font-size:10pt;' >&#8217; stock-based compensation expense</font><font style='font-family:Times New Roman;font-size:10pt;' > as required under the modified retrospective approach. </font><font style='font-family:Times New Roman;font-size:10pt;' > The tax effect of this adjustment, which included the impact of a valuation al</font><font style='font-family:Times New Roman;font-size:10pt;' >lowance was immaterial. </font></p><p style='text-align:left;line-height:12pt;' ></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e31137-122693<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814687248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >3.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Accumulated Other Comprehensive Loss</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Changes in each component of accumulated other comprehensive loss, net of tax are as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:14.4pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Foreign currency</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Derivatives</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >translation  </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >qualifying as</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Defined benefit</font></td><td style='width:14.25pt;text-align:right;vertical-align:middle;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >adjustments</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >hedges</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >pension plans</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance at December 31,  2016</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(14,200)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,458)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(16,658)</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:25.5pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other comprehensive income before reclassifications</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >942</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >946</font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Amounts reclassified from AOCI</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other comprehensive income </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >942</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >949</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:82.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(13,258)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,458)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(15,709)</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e716-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e709-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797707728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Other Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill And Other Intangible Assets Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >4</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >. </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Goodwill and Other Intangible Assets</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Intangible assets consist of the following:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Weighted </font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Average</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' >March 31, 2017</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' >December 31, 2016</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Life</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > (a)</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='11' rowspan='1' style='width:247.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:247.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:26.4pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Amortizable intangible assets:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Gross</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Accumulated Amortization</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Gross</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Accumulated Amortization</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Existing technology</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >15,287</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(12,020)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >15,082</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(11,710)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >6.8</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Trade names</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,436</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3,617)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,379</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3,479)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7.8</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Distribution agreements/customer relationships</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >23,136</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(13,228)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >22,976</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(12,862)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8.7</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Patents</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >207</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(131)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >204</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(119)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.9</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total amortizable intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >46,066</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(28,996)</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >45,641</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(28,170)</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Indefinite-lived intangible assets:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Goodwill</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,398</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,032</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other indefinite-lived intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,216</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,209</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:26.4pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total goodwill and other indefinite-lived intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >39,614</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >39,241</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total intangible assets, gross</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >85,680</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >84,882</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td colspan='15' rowspan='1' style='width:496.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:496.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(a) Weighted average life as of March 31, 2017.</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' >The change</font><font style='font-family:Times New Roman;font-size:10pt;' > in the carrying amount of goodwill for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > is as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:63.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,032</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Effect of change in currency translation</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >366</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:63.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,398</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Amortization of intangible assets</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Intangible asset amortization expense was $</font><font style='font-family:Times New Roman;font-size:10pt;' >0.6</font><font style='font-family:Times New Roman;font-size:10pt;' > million and $</font><font style='font-family:Times New Roman;font-size:10pt;' >0.7</font><font style='font-family:Times New Roman;font-size:10pt;' > million</font><font style='font-family:Times New Roman;font-size:10pt;' > for</font><font style='font-family:Times New Roman;font-size:10pt;' > the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >Amortization expense of existing amortizable intangible assets is currently estimated to be</font><font style='font-family:Times New Roman;font-size:10pt;' > $</font><font style='font-family:Times New Roman;font-size:10pt;' >2.4</font><font style='font-family:Times New Roman;font-size:10pt;' >&#160;million for the year ending December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, $</font><font style='font-family:Times New Roman;font-size:10pt;' >2.3</font><font style='font-family:Times New Roman;font-size:10pt;' > million for the year ending December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2018</font><font style='font-family:Times New Roman;font-size:10pt;' >, $</font><font style='font-family:Times New Roman;font-size:10pt;' >2.1</font><font style='font-family:Times New Roman;font-size:10pt;' > million for the year ending December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2019</font><font style='font-family:Times New Roman;font-size:10pt;' >, $</font><font style='font-family:Times New Roman;font-size:10pt;' >2.1</font><font style='font-family:Times New Roman;font-size:10pt;' > million for the year ending Dece</font><font style='font-family:Times New Roman;font-size:10pt;' >mber&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2020</font><font style='font-family:Times New Roman;font-size:10pt;' > and $</font><font style='font-family:Times New Roman;font-size:10pt;' >2.1</font><font style='font-family:Times New Roman;font-size:10pt;' > million for the year ending December&#160;31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2021</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814687248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >5</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Inventories</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Inventories consist of the following:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:153pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Finished goods</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,686</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,340</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Work in process</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >900</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >823</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Raw materials</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,696</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,792</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >20,282</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >19,955</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797720768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >6</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Property</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >, Plant and Equipment</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;margin-left:0pt;' >	</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:10pt;line-height:13.8pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, p</font><font style='font-family:Times New Roman;font-size:10pt;' >roperty, plant and equipment </font><font style='font-family:Times New Roman;font-size:10pt;' >consist of the following:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:150pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:150pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Land, buildings and leasehold improvements</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2,117</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2,095</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Machinery and equipment</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,395</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,224</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Computer equipment and software</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,345</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,115</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Furniture and fixtures</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,284</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,274</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Automobiles</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >201</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >196</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >19,342</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >18,904</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Less: accumulated depreciation</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(15,074)</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(14,608)</font></td></tr><tr style='height:13.8pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Property, plant and equipment, net</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,268</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,296</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797689616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long Term Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long Term Debt Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >12.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >Long Term Debt</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >On August&#160;7, 2009, the Company entered into an Amended and Restated Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&#160;&amp;</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > Co as lenders (as amended, the &#8220;2009 Credit Agreement&#8221;). On March 29, 2013, the Company entered into a Second Amended and Restated Revolving Credit Agreement (as amended, the &#8220;2013 Credit Agreement&#8221;) with Bank of America, as agent, and Bank of America and</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > Brown Brothers Harriman&#160;&amp; Co, as lenders that amended and restated the 2009 Credit Agreement. Between September 2011 and March 2016, the Company entered into a series of amendments that among other things did the following:</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >&#160;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on September 30, 2011, red</font><font style='font-family:Times New Roman;font-size:10pt;' >uced interest rates to the London Interbank Offered Rate plus 3.0%;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on March 29, 2013, converted existing loan advances into a term loan in the principal amount of $15.0 million (the &#8220;2013 Term Loan&#8221;), provided a revolving credit facility in the maxim</font><font style='font-family:Times New Roman;font-size:10pt;' >um principal amount of $25.0 million (the &#8220;2013 Revolving Line&#8221;) and a delayed draw term loan (the &#8220;2013 DDTL&#8221;) of up to $15.0 million (all with a maturity date of March 29, 2018);</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on October 31, 2013, reduced the 2013 DDTL from up to $15.0 million to</font><font style='font-family:Times New Roman;font-size:10pt;' > up to $10.0 million;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on April 24, 2015, extended the maturity date of the 2013 Revolving Line to March 29, 2018 and reduced the interest rates on the 2013 Revolving Line, 2013 Term Loan and 2013 DDTL;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on June 30, 2015, amended our quarterly mini</font><font style='font-family:Times New Roman;font-size:10pt;' >mum fixed charge coverage financial covenant; and</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Symbol;font-size:10pt;margin-left:0pt;' >&#61623;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >on March 9, 2016, amended the principal payment amortization of the 2013 Term Loan and 2013 DDTL to five years, as well as amended our quarterly minimum fixed charge coverage financial covenant.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The maximum amount available under the 2013 Credit Agreement is $50.0 million as borrowings against the 2013 DDTL in excess of $10.0 million results in a dollar for dollar reduction in the 2013 Revolving Line capacity. The 2013 Revolving Line, 2013 Term Lo</font><font style='font-family:Times New Roman;font-size:10pt;' >an and 2013 DDTL each have a maturity date of March&#160;29, 2018. Borrowings under the 2013 Term Loan and the 2013 DDTL accrue interest at a rate based on either the effective London Interbank Offered Rate (LIBOR) for certain interest periods selected by the C</font><font style='font-family:Times New Roman;font-size:10pt;' >ompany, or a daily floating rate based on the British Bankers&#8217; Association (BBA) LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the 2013 Revolv</font><font style='font-family:Times New Roman;font-size:10pt;' >ing Line accrues interest at a rate based on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%. The Company was required to fix the rate </font><font style='font-family:Times New Roman;font-size:10pt;' >of interest on at least 50% of the 2013 Term Loan and the 2013 DDTL through the purchase of interest rate swaps.</font><font style='font-family:Times New Roman;font-size:10pt;' >&#160;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >The loans evidenced by the 2013 Credit Agreement, or the 2013 </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Loans, are guaranteed by all of the Company&#8217;s direct and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and the guarantors.&#160;The 2013 Loans are subject to restrictive covenants under the 2013 Credit Agreement, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the 2013 Loans is all</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >owed by the 2013 Credit Agreement at any time during the terms of the 2013 Loans. The 2013 Loans also contain limitations on the Company&#8217;s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory n</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >otes and/or other consideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, the C</font><font style='font-family:Times New Roman;font-size:10pt;' >ompany had net borrowings of $</font><font style='font-family:Times New Roman;font-size:10pt;' >13.7</font><font style='font-family:Times New Roman;font-size:10pt;' > million, </font><font style='font-family:Times New Roman;font-size:10pt;' >respectively, outstanding under its </font><font style='font-family:Times New Roman;font-size:10pt;' >2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >Credit Agreement. </font><font style='font-family:Times New Roman;font-size:10pt;' >T</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >he </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >carrying value of the debt approximates fair value because the interest rate under the obligation approximates market rates of interest available to the Company for similar&#160;instruments.</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, the Company was in compliance with all financial covenants contained in the </font><font style='font-family:Times New Roman;font-size:10pt;' >2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >Credit A</font><font style='font-family:Times New Roman;font-size:10pt;' >greement,</font><font style='font-family:Times New Roman;font-size:10pt;' > was subject to </font><font style='font-family:Times New Roman;font-size:10pt;' >covenant and w</font><font style='font-family:Times New Roman;font-size:10pt;' >orking capital borrowing restriction</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > and had </font><font style='font-family:Times New Roman;font-size:10pt;' >available borrowing capacity</font><font style='font-family:Times New Roman;font-size:10pt;' > under its </font><font style='font-family:Times New Roman;font-size:10pt;' >2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >Credit </font><font style='font-family:Times New Roman;font-size:10pt;' >Agre</font><font style='font-family:Times New Roman;font-size:10pt;' >ement </font><font style='font-family:Times New Roman;font-size:10pt;' >of $</font><font style='font-family:Times New Roman;font-size:10pt;' >5.2</font><font style='font-family:Times New Roman;font-size:10pt;' > million.</font><font style='font-family:Times New Roman;font-size:10pt;' >    </font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, the weighted effective interest rates</font><font style='font-family:Times New Roman;font-size:10pt;' >, net of the impact of the Company&#8217;s interest rate swaps, </font><font style='font-family:Times New Roman;font-size:10pt;' >on </font><font style='font-family:Times New Roman;font-size:10pt;' >its 2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >Term Loan, </font><font style='font-family:Times New Roman;font-size:10pt;' >2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >DDTL and </font><font style='font-family:Times New Roman;font-size:10pt;' >2013 </font><font style='font-family:Times New Roman;font-size:10pt;' >Revolving Line borrowings were </font><font style='font-family:Times New Roman;font-size:10pt;' >3.96%</font><font style='font-family:Times New Roman;font-size:10pt;' >, </font><font style='font-family:Times New Roman;font-size:10pt;' >3.83%</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >3.23%</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, the Company&#8217;s borrowings were comprised of:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:138pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:138pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Long-term debt:</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Term loan</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,062</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,400</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     DDTL</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,125</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,400</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Revolving line</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,550</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,050</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Total unamortized deferred financing costs</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(84)</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(104)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total debt</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13,653</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13,746</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Less: current installments</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,800)</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,450)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Current unamortized deferred financing costs</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >78</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >78</font></td></tr><tr style='height:13.8pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Long-term debt</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >10,931</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >11,374</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >On May 2</font><font style='font-family:Times New Roman;font-size:10pt;' >, 2017, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >the Company entered into a Third Amended and Restated Revolving Credit Agreement (as amended, the &#8220;Credit Agreement&#8221;) with Bank of America, as agent, and Bank of America and Brown Brothers Harriman&#160;&amp;</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > Co, as lenders that amended and restated the 2013 Credit Agreement. As a result of the Credit Agreement, the amounts outstanding under the 2013 Credit Agreement with maturities subsequent to March 31, 2018 are classified as long term. The Credit Agreement</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > was entered into to, among other things, consolidate, combine and restate the outstanding indebtedness, on the date of the Credit Agreement, into a Term Loan in the principal amount of $14.0 million, and also provide for a $25.0 million revolving line of </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >credit (the &#8220;Revolving Line&#8221;).  The Term Loan and the Revolving Line each have a maturity date of May 1, 2022.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >Borrowings under the Term Loan accrue interest at a rate based on either the effective </font><font style='font-family:Times New Roman;font-size:10pt;' >LIBOR</font><font style='font-family:Times New Roman;font-size:10pt;' > for certain interest periods selected by the Company</font><font style='font-family:Times New Roman;font-size:10pt;' >, or a daily floating rate based on the </font><font style='font-family:Times New Roman;font-size:10pt;' >BBA</font><font style='font-family:Times New Roman;font-size:10pt;' > LIBOR as published by Reu</font><font style='font-family:Times New Roman;font-size:10pt;' >ters (or other commercially available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the Revolving Line accrues interest at a rate based </font><font style='font-family:Times New Roman;font-size:10pt;' >on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%.&#160;</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >The Term Loan and loans under the Revolving Line evidenced by the Credit Agreemen</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >t, or the Loans, are guaranteed by all of the Company&#8217;s direct and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and the guarantors.&#160;The Loans are subject to restrictive covenants under the Credit Agreement, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >and financial covenants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the Loans is allowed </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >by the Credit Agreement at any time during the terms of the Loans. The Loans also contain limitations on the Company&#8217;s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory notes and/or other co</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >nsideration in excess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million.</font></p><p style='text-align:left;line-height:12pt;' ></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6607372736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >13</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >Derivatives</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company uses interest</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate</font><font style='font-family:Times New Roman;font-size:10pt;' >-related derivative instruments to manage its exposure related to changes in interest rates on its variable</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate debt instruments. The Company does not enter into derivative instruments for any purpose other </font><font style='font-family:Times New Roman;font-size:10pt;' >than cash flow hedging. The Company does not speculate using derivative instruments.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >By using derivative financial instruments to hedge exposures to changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the f</font><font style='font-family:Times New Roman;font-size:10pt;' >ailure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative co</font><font style='font-family:Times New Roman;font-size:10pt;' >ntract is negative, the Company owes the counterparty and, therefore, the Company is not exposed to the counterparty&#8217;s credit risk in those circumstances. The Company minimizes counterparty credit risk in derivative instruments by entering into transaction</font><font style='font-family:Times New Roman;font-size:10pt;' >s with carefully selected major financial institutions based upon their credit profile.  </font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Market risk is the adverse effect on the value of a derivative instrument that results from a change in interest rates. The market risk associated with interest</font><font style='font-family:Times New Roman;font-size:10pt;' >-rat</font><font style='font-family:Times New Roman;font-size:10pt;' >e contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company assesses interest rate risk by continually identifying and monitoring changes in interest rate exposures th</font><font style='font-family:Times New Roman;font-size:10pt;' >at may adversely impact expected future cash flows and by evaluating hedging opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company&#8217;s outstanding or forecasted debt obligations as</font><font style='font-family:Times New Roman;font-size:10pt;' > well as the Company&#8217;s offsetting hedge positions. The risk management control systems involve the use of analytical techniques, including cash flow sensitivity analysis, to estimate the expected impact of changes in interest rates on the Company&#8217;s future </font><font style='font-family:Times New Roman;font-size:10pt;' >cash flows.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company uses variable</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate London Interbank Offered Rate (LIBOR) debt to finance its operations. The debt obligations expose the Company to variability in interest payments due to changes in interest rates. Management believes that it is p</font><font style='font-family:Times New Roman;font-size:10pt;' >rudent to limit the variability of a portion of its interest payments. To meet this objective, management enters into LIBOR based interest rate swap agreements to manage fluctuations in cash flows resulting from changes in the benchmark interest rate of LI</font><font style='font-family:Times New Roman;font-size:10pt;' >BOR. These swaps change the variable</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate cash flow exposure on the debt obligations to fixed cash flows.  Under the terms of the interest rate swaps, the Company receives LIBOR based variable interest rate payments and makes fixed interest rate payments, </font><font style='font-family:Times New Roman;font-size:10pt;' >thereby creating the equivalent of fixed-rate debt for the notional amount of its debt hedged.  In accordance with its Credit Agreement, the Company was required to fix the rate of interest on at least 50% of its Term Loan and the DDTL through the purchase</font><font style='font-family:Times New Roman;font-size:10pt;' > of interest rate swaps. On June 5, 2013, the Company entered into an interest rate swap contract with an original notional amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark inter</font><font style='font-family:Times New Roman;font-size:10pt;' >est rate (LIBOR) associated with the Company&#8217;s Term Loan. On November 29, 2013, the Company entered into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March 29, 2018 in order to hedge the risk </font><font style='font-family:Times New Roman;font-size:10pt;' >of changes in the effective benchmark interest rate (LIBOR) associated with the DDTL. </font><font style='font-family:Times New Roman;font-size:10pt;' >The notional amount of the Company&#8217;s derivative instruments as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > w</font><font style='font-family:Times New Roman;font-size:10pt;' >as $</font><font style='font-family:Times New Roman;font-size:10pt;' >4.5</font><font style='font-family:Times New Roman;font-size:10pt;' > million</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font><font style='font-family:Times New Roman;font-size:10pt;' > The Term Loan swap </font><font style='font-family:Times New Roman;font-size:10pt;' >contract </font><font style='font-family:Times New Roman;font-size:10pt;' >effectively </font><font style='font-family:Times New Roman;font-size:10pt;' >convert</font><font style='font-family:Times New Roman;font-size:10pt;' >ed specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at </font><font style='font-family:Times New Roman;font-size:10pt;' >0.96%</font><font style='font-family:Times New Roman;font-size:10pt;' > plus a ba</font><font style='font-family:Times New Roman;font-size:10pt;' >nk margin of </font><font style='font-family:Times New Roman;font-size:10pt;' >2.75%</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:Times New Roman;font-size:10pt;' >The DDTL swap contract </font><font style='font-family:Times New Roman;font-size:10pt;' >effectively </font><font style='font-family:Times New Roman;font-size:10pt;' >converted specific variable-rate debt into fixed-r</font><font style='font-family:Times New Roman;font-size:10pt;' >ate debt and fixed the LIBOR rate associated with the Term Loan at </font><font style='font-family:Times New Roman;font-size:10pt;' >0.93%</font><font style='font-family:Times New Roman;font-size:10pt;' > plus a bank margin of </font><font style='font-family:Times New Roman;font-size:10pt;' >2.75%</font><font style='font-family:Times New Roman;font-size:10pt;' >.The interest rate swap</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >were designated as </font><font style='font-family:Times New Roman;font-size:10pt;' >cash flow hedge</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > in accordance with ASC 815, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Derivatives and Hedging</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >As disclos</font><font style='font-family:Times New Roman;font-size:10pt;' >ed in Note 12, </font><font style='font-family:Times New Roman;font-size:10pt;' >on May </font><font style='font-family:Times New Roman;font-size:10pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;' >, 2017, the</font><font style='font-family:Times New Roman;font-size:10pt;' > Company entered into the Credit Agreement to amend its credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman &amp; Co. as lenders. I</font><font style='font-family:Times New Roman;font-size:10pt;' >mmediately after entering into this Credit Agreemen</font><font style='font-family:Times New Roman;font-size:10pt;' >t</font><font style='font-family:Times New Roman;font-size:10pt;' >,  the Company entered into a new interest rate swap contract with Bank of America with a notional amount of </font><font style='font-family:Times New Roman;font-size:10pt;' >$14.0 million</font><font style='font-family:Times New Roman;font-size:10pt;' > and a maturity date of March 30, 2022 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associa</font><font style='font-family:Times New Roman;font-size:10pt;' >ted with the Company&#8217;s Term Loan. The swap contract converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term </font><font style='font-family:Times New Roman;font-size:10pt;' >Loan at 1.86%. The interest</font><font style='font-family:Times New Roman;font-size:10pt;' > rate swap was designated as a cash flow hedge instrument in accorda</font><font style='font-family:Times New Roman;font-size:10pt;' >nce with ASC 815 &#8220;Derivatives and Hedging&#8221;. As a result of entering into the new interest rate swap </font><font style='font-family:Times New Roman;font-size:10pt;' >contract, the Company unwound the previous interest rate swap contracts, and received an immaterial amount in proceeds.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The following table presents </font><font style='font-family:Times New Roman;font-size:10pt;' >the</font><font style='font-family:Times New Roman;font-size:10pt;' > no</font><font style='font-family:Times New Roman;font-size:10pt;' >tional amount and </font><font style='font-family:Times New Roman;font-size:10pt;' >fair value</font><font style='font-family:Times New Roman;font-size:10pt;' > of the Company</font><font style='font-family:Times New Roman;font-size:10pt;' >&#8217;</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > derivative </font><font style='font-family:Times New Roman;font-size:10pt;' >instrument</font><font style='font-family:Times New Roman;font-size:10pt;' >s as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31, 2017</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31, 2017</font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Notional Amount</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value (a)</font></td></tr><tr style='height:27pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives designated as hedging instruments under ASC 815</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance sheet classification</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other liabilities-non current</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,500</font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td></tr><tr style='height:13.8pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31, 2016</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31, 2016</font></td></tr><tr style='height:12.75pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Notional Amount</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value (a)</font></td></tr><tr style='height:27pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives designated as hedging instruments under ASC 815</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance sheet classification</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other liabilities-non current</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,500</font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.8pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='8' rowspan='1' style='width:530.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:530.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(a) See Note 14 for the fair value measurements related to these financial instruments.</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >All of the Company&#8217;s derivative instruments are designated as hedging instruments.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company has structured its interest rate swap agreements</font><font style='font-family:Times New Roman;font-size:10pt;' > to be 100% effective and as a result, there was no impact to earnings resulting from hedge ineffectiveness.  Changes in the fair value of interest rate swaps designated as hedging instruments that effectively offset the variability of cash flows associate</font><font style='font-family:Times New Roman;font-size:10pt;' >d with variable</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate, long</font><font style='font-family:Times New Roman;font-size:10pt;' >-term debt obligations are reported in accumulated other comprehensive income (&#8220;AOCI&#8221;). These amounts subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in </font><font style='font-family:Times New Roman;font-size:10pt;' >which the related interest affects earnings.  The Company&#8217;s interest rate swap agreement was deemed to be fully effective in accordance with ASC 815, and, as such, unrealized gains and losses related to these derivatives were recorded as AOCI.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The followi</font><font style='font-family:Times New Roman;font-size:10pt;' >ng table summarizes the effect of derivatives designated as cash flow hedging instruments </font><font style='font-family:Times New Roman;font-size:10pt;' >and their classification within comprehensive loss for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:55.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives in Hedging Relationships</font></td><td colspan='5' rowspan='1' style='width:123pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Amount of gain (loss) recognized in OCI on derivative (effective portion) </font></td></tr><tr style='height:31.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended March 31,</font></td></tr><tr style='height:15pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:10.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:15pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4 </font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(36)</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The following table summarizes the reclassifications out of accumulated other comprehensive loss for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:39pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Details about AOCI Components</font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Amount reclassified from AOCI into income (effective portion)</font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Location of amount</font></td></tr><tr style='height:40.2pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended March 31,</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >reclassified from AOCI</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >into income (effective portion)</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:139.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:14.4pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest expense</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, $</font><font style='font-family:Times New Roman;font-size:10pt;' >7</font><font style='font-family:Times New Roman;font-size:10pt;' > thousand</font><font style='font-family:Times New Roman;font-size:10pt;' > of deferred</font><font style='font-family:Times New Roman;font-size:10pt;' > losses on derivative instruments accumulated in AOCI are expected to be reclassified to earnings during the next </font><font style='font-family:Times New Roman;font-size:10pt;' >twelve</font><font style='font-family:Times New Roman;font-size:10pt;' > months. Transactions and events expected to occur over the next twelve months that will necessitate reclassifying these derivatives&#8217; losses to earnings include the repricing of variable</font><font style='font-family:Times New Roman;font-size:10pt;' >-rate debt. There were no cash flow hedges discontinued during </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > or </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41620-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579240-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624177-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80784-113994<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41641-113959<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579245-113959<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624258-113959<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80748-113994<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5708775-113959<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5708773-113959<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5580258-113959<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624181-113959<br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41638-113959<br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814695536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >14</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >Fair Value Measurements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Fair value measurement is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between </font><font style='font-family:Times New Roman;font-size:10pt;' >market participants at the measurement date. A fair value hierarchy is established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Level 1&#8212;Quoted prices in active markets for identical assets or liabilities.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Level 2&#8212;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Level 3&#8212;Unobservable inputs based on the Company&#8217;s own assumptions.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >&#160;</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The following table</font><font style='font-family:Times New Roman;font-size:10pt;' >s present</font><font style='font-family:Times New Roman;font-size:10pt;' > the fair value hierarchy for those liabili</font><font style='font-family:Times New Roman;font-size:10pt;' >ties measured at fair value on a recurring basis:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.8pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Fair Value as of March 31, 2017</font></td></tr><tr style='height:14.4pt;' ><td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(In thousands)</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 1</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 2</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 3</font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Liabilities:</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swap agreements</font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Fair Value as of December 31, 2016</font></td></tr><tr style='height:14.4pt;' ><td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(In thousands)</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 1</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 2</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 3</font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Liabilities:</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swap agreements</font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company uses the market approach technique to value its financial liabilities.  The Company&#8217;s financial liabilities carried at fair value include derivative instruments used to hedge the Company&#8217;s interest rate risks. The fair value of the Company&#8217;s </font><font style='font-family:Times New Roman;font-size:10pt;' >interest rate swap agreement</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > was based on LIBOR yield curves at the reporting date.&#160;</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13504-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639519392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Leases Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >10</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Leases </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company has noncancelable operating leases for office and warehouse space expiring at various dates through </font><font style='font-family:Times New Roman;font-size:10pt;' >2022 and</font><font style='font-family:Times New Roman;font-size:10pt;' > thereafter. Rent expense, which is recorded on a straight-line basis, is estimated to </font><font style='font-family:Times New Roman;font-size:10pt;' >be </font><font style='font-family:Times New Roman;font-size:10pt;' >$</font><font style='font-family:Times New Roman;font-size:10pt;' >1.7</font><font style='font-family:Times New Roman;font-size:10pt;' > million</font><font style='font-family:Times New Roman;font-size:10pt;' > for the year</font><font style='font-family:Times New Roman;font-size:10pt;' > ended </font><font style='font-family:Times New Roman;font-size:10pt;' >December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >.  Rent expense was approximately $</font><font style='font-family:Times New Roman;font-size:10pt;' >0.4</font><font style='font-family:Times New Roman;font-size:10pt;' > million and $</font><font style='font-family:Times New Roman;font-size:10pt;' >0.5</font><font style='font-family:Times New Roman;font-size:10pt;' > million for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Future minimum lease payments for operating leases, with initial or r</font><font style='font-family:Times New Roman;font-size:10pt;' >emaining terms in excess of one year at </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, </font><font style='font-family:Times New Roman;font-size:10pt;' >are as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:67.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Operating </font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Leases</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2018</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,610</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2019</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,618</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2020</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,421</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2021</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,098</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2022</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,098</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Thereafter</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,836</font></td></tr><tr style='height:13.8pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net minimum lease payments</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:67.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,681</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.  Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6452660&amp;loc=d3e36991-112694<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814698544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >15.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Income Tax </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >Income tax was an expense of approximately $</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >23</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > thousand and $</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >0.2</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > million for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > and </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >, respectively. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The tax expense for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > reflects the expense recorded for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >associated with the actual results for the three-month period, as described below.  </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >Discrete items included in the tax expense for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > included changes to reserves for unc</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ertain tax positions and t</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ax deficiencies related to stock-based compensation. Tax expense for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > included foreign currency gains and losses and </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >the tax impact of the</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >amortiza</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >tion of </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >certain </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >indefinite-lived intangible assets</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > which are amortized for tax purposes only, against which a valuation allowance is not established</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >. </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;background-color:#FFFF00;margin-left:24.5pt;color:#000000;' >   </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >The effective income tax rate was </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2.2%)</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >, compared with </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(43.6%)</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > for the same period in </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >.  The tax rates for the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > and </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > were based on actual results for the three-month period rather than an effective tax rate estimated fo</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >r the entire year.  </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >In 2017 and 2016 t</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >he Company determined that using a year-to-date approach resulted in a better estimate of income tax expense</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >/benefit</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > based on its forecast of pre-tax income</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >/loss</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >, the mix of</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > taxable</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > income</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >/loss</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > across several jurisdict</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ions with different statutory tax rates, and the impact of the full valuation allowance against U.S. deferred tax assets.        </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >The difference between the Company&#8217;s effective tax rate period over period was primarily attributable to </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >higher pre-tax incom</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >e</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > at certain individual subsidiaries</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > in 2016 versus 2017,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > despite an overall pre-tax loss in both periods. In addition, both periods included the tax impact of amortization of certain indefinite-lived intangibles which are amortized for tax purposes only, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >against which a valuation allowance is not established.</font></p><p style='text-align:left;line-height:12pt;' ></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639711936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract', window );"><strong>Employee Benefit Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >9</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Employee Benefit Plans </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >One</font><font style='font-family:Times New Roman;font-size:10pt;' > of </font><font style='font-family:Times New Roman;font-size:10pt;' >the Company&#8217;s </font><font style='font-family:Times New Roman;font-size:10pt;' >subs</font><font style='font-family:Times New Roman;font-size:10pt;' >idiaries in the United Kingdom, </font><font style='font-family:Times New Roman;font-size:10pt;' >or UK, </font><font style='font-family:Times New Roman;font-size:10pt;' >Biochrom Limited, maintain</font><font style='font-family:Times New Roman;font-size:10pt;' >s </font><font style='font-family:Times New Roman;font-size:10pt;' >contributory, defined benefit </font><font style='font-family:Times New Roman;font-size:10pt;' >pension plans for substantially all of its</font><font style='font-family:Times New Roman;font-size:10pt;' > employees. </font><font style='font-family:Times New Roman;font-size:10pt;' >As of June 30, 2014, these defined benefit pension plans wer</font><font style='font-family:Times New Roman;font-size:10pt;' >e</font><font style='font-family:Times New Roman;font-size:10pt;' > closed to new employees,</font><font style='font-family:Times New Roman;font-size:10pt;' > as well as closed to the future accrual of benefits for existing employees. The components of the Company&#8217;s defined benefit pension expense were as follows:</font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Components of net periodic benefit cost:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest cost</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >125</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >168</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Expected return on plan assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(159)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(181)</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net amortization loss</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >87</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >80</font></td></tr><tr style='height:13.8pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net periodic benefit cost</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >53</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >67</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >For </font><font style='font-family:Times New Roman;font-size:10pt;' >the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, the Company contributed $</font><font style='font-family:Times New Roman;font-size:10pt;' >0.2</font><font style='font-family:Times New Roman;font-size:10pt;' >&#160;million</font><font style='font-family:Times New Roman;font-size:10pt;' >,</font><font style='font-family:Times New Roman;font-size:10pt;' > for both periods</font><font style='font-family:Times New Roman;font-size:10pt;' >,</font><font style='font-family:Times New Roman;font-size:10pt;' > to its defined benefit pension plans. The Company expects to contribute </font><font style='font-family:Times New Roman;font-size:10pt;' >approximately </font><font style='font-family:Times New Roman;font-size:10pt;' >$</font><font style='font-family:Times New Roman;font-size:10pt;' >0.5</font><font style='font-family:Times New Roman;font-size:10pt;' > million </font><font style='font-family:Times New Roman;font-size:10pt;' >to its defined benefit pension plans during the remainder of </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company had an underfunded pension liability of </font><font style='font-family:Times New Roman;font-size:10pt;' >approximately $</font><font style='font-family:Times New Roman;font-size:10pt;' >3.2</font><font style='font-family:Times New Roman;font-size:10pt;' > million</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >$</font><font style='font-family:Times New Roman;font-size:10pt;' >3.0</font><font style='font-family:Times New Roman;font-size:10pt;' > million, </font><font style='font-family:Times New Roman;font-size:10pt;' >a</font><font style='font-family:Times New Roman;font-size:10pt;' >s of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and December 31, </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively, </font><font style='font-family:Times New Roman;font-size:10pt;' >in</font><font style='font-family:Times New Roman;font-size:10pt;' >cluded in the other </font><font style='font-family:Times New Roman;font-size:10pt;' >long term </font><font style='font-family:Times New Roman;font-size:10pt;' >liabilities line item in the consolidated balance</font><font style='font-family:Times New Roman;font-size:10pt;' > sheets</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450702-114947<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39675-114964<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814695536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Capital Stock Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Capital Stock Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >11</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Capital Stock </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Common Stock </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >On February&#160;5, 2008, the Company&#8217;s</font><font style='font-family:Times New Roman;font-size:10pt;' > Board of Directors adopted a Shareholder Rights Plan and declared a dividend distribution of one preferred stock purchase right for each outstanding share of the Company&#8217;s common stock to shareholders of record as of the close of business on February&#160;6, 2</font><font style='font-family:Times New Roman;font-size:10pt;' >008. Initially, these rights will not be exercisable and will trade with the shares of the Company&#8217;s common stock. Under the Shareholder Rights Plan, the rights generally will become exercisable if a person becomes a</font><font style='font-family:Times New Roman;font-size:10pt;' >n &#8220;acquiring person&#8221; by acquiring 20% or</font><font style='font-family:Times New Roman;font-size:10pt;' > more of the common stock of the Company or if a person commences a tender offer that could result in that person owning 20% or more of the common stock of the Company. If a person becomes an acquiring person, each holder of a right (other than the acquiri</font><font style='font-family:Times New Roman;font-size:10pt;' >ng person) would be entitled to purchase, at the then-current exercise price, such number of shares of preferred stock which are equivalent to shares of the Company&#8217;s common stock having a value of twice the exercise price of the right.</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Unless the Board of Directors elects to extend such plan, the Shareholder Rights Plan will expire in February 2018.</font><font style='font-family:Times New Roman;font-size:10pt;' > If the Company is a</font><font style='font-family:Times New Roman;font-size:10pt;' >cquired in a merger or other business combination transaction after any such event, each holder of a right would then be entitled to purchase, at the then-current exercise price, shares of the acquiring company&#8217;s common stock having a value of twice the ex</font><font style='font-family:Times New Roman;font-size:10pt;' >ercise price of the right.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Preferred Stock</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The</font><font style='font-family:Times New Roman;font-size:10pt;' > Company&#8217;s Board of Directors </font><font style='font-family:Times New Roman;font-size:10pt;' >has the authority to issue up to 5.0 million shares of preferred stock and to determine the price privileges and other terms of the shares. The Board of Directors may exercise th</font><font style='font-family:Times New Roman;font-size:10pt;' >is authority without any further approval of stockholders. As of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, the Company had no preferred stock issued or outstanding</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Employee Stock Purchase Plan (as amended, the &#8220;ESPP&#8221;)</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In 2000, the Company approved </font><font style='font-family:Times New Roman;font-size:10pt;' >the ESPP</font><font style='font-family:Times New Roman;font-size:10pt;' >. Under thi</font><font style='font-family:Times New Roman;font-size:10pt;' >s </font><font style='font-family:Times New Roman;font-size:10pt;' >ESPP</font><font style='font-family:Times New Roman;font-size:10pt;' >, participating employees can authorize the Company to withhold a portion of their base pay during consecutive six-month payment periods for the purchase of shares of the Company&#8217;s common stock. At the conclusion of the period, participating employee</font><font style='font-family:Times New Roman;font-size:10pt;' >s can purchase shares of the Company&#8217;s common stock at 85% of the lower of the fair market value of the Company&#8217;s common stock at the beginning or end of the period. Shares are iss</font><font style='font-family:Times New Roman;font-size:10pt;' >ued under the ESPP for the six-month periods ending June&#160;30 and December&#160;31.</font><font style='font-family:Times New Roman;font-size:10pt;' > Under this plan, </font><font style='font-family:Times New Roman;font-size:10pt;' >750,000</font><font style='font-family:Times New Roman;font-size:10pt;' > shares of common stock are authorized for issuance of which </font><font style='font-family:Times New Roman;font-size:10pt;' >725,239</font><font style='font-family:Times New Roman;font-size:10pt;' > shares were issue</font><font style='font-family:Times New Roman;font-size:10pt;' >d as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:Times New Roman;font-size:10pt;' >There were no shares issued under the ESPP during the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:27pt;' >Stock Option and Equity Incentive Plans</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Third Amended and Restated 2000 Stock Option and Incentive Plan (as amended, the &#8220;Third A&amp;R Plan&#8221;)</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Second Amendment to the Third A&amp;R Plan (the &#8220;Amendment&#8221;) was adopted by the Board of </font><font style='font-family:Times New Roman;font-size:10pt;' >Directors on April&#160;3, 2015. Such Amendment was approved by the stockholders at the Company&#8217;s 2015 Annual Meeting</font><font style='font-family:Times New Roman;font-size:10pt;' > of Stockholders</font><font style='font-family:Times New Roman;font-size:10pt;' >.  Pursuant to the Amendment, the aggregate number of shares authorized for issuance under the Third A&amp;R Plan was increased by 2</font><font style='font-family:Times New Roman;font-size:10pt;' >,500,000 shares to 17,508,929.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Restricted Stock Units with a Market Condition (the &#8220;Market Condition RSU&#8217;s&#8221;)</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >On August 3, 2015, the Compensation Committee of the Board of Directors of the Company approved and granted deferred stock awards of Market Condi</font><font style='font-family:Times New Roman;font-size:10pt;' >tion RSU&#8217;s to certain members of the Company&#8217;s management team under the Third A&amp;R Plan.  The vesting of these Market Condition RSU&#8217;s is cliff-based and linked to the achievement of a relative total shareholder return of the Company&#8217;s common stock from Aug</font><font style='font-family:Times New Roman;font-size:10pt;' >ust 3, 2015 to the earlier of (i) August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average price before each such date). As </font><font style='font-family:Times New Roman;font-size:10pt;' >of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' >, t</font><font style='font-family:Times New Roman;font-size:10pt;' >he target number of thes</font><font style='font-family:Times New Roman;font-size:10pt;' >e restricted stock units that may be earned is 182,150 shares; the maximum amount is 150% of the target number.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Stock-Based Payment Awards</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The Company accounts for stock-based payment awards in accordance with the provisions of FASB ASC 718, which requir</font><font style='font-family:Times New Roman;font-size:10pt;' >es it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, Market Condition RSU&#8217;s and employee stock purchases related to the&#160;ESPP.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;color:#000000;' >The Company adopted ASU 20</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >16-09 as of January 1, 2017. As disclosed in footnote 2, as a result of this adoption, the Company has elected as an accounting policy to account for forfeitures for service based awards as they occur, with no adjustment for estimated forfeitures. The Comp</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >any recognized as of January 1, 2017, a cumulative effect adjustment of $0.1 million to reduce retained earnings as required under the modified retrospective approach. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >Stock option and restricted stock unit activity under the Company&#8217;s Third A&amp;R Plan for</font><font style='font-family:Times New Roman;font-size:10pt;' > the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > was as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock Options</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Restricted Stock Units</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:144pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:144pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Market Condition RSU&#39;s</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Weighted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Average</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Restricted</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Market</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Options</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Exercise </font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock Units</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Grant Date</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Condition RSU&#39;s</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Grant Date</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > Price</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value</font></td></tr><tr style='height:9.75pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,096,818</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.94</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,072,653</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.15</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >182,150</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4.81</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Granted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >30,000</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.25</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >445,690</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2.83</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Exercised</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(5,709)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2.56</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Vested (RSUs)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(251,570)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.28</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Cancelled / forfeited</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(152,212)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.68</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(4,190)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.05</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.8pt;' ><td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3,968,897</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.94</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,262,583</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.01</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >182,150</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4.81</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The </font><font style='font-family:Times New Roman;font-size:10pt;' >weighted average fair value of the options granted under the </font><font style='font-family:Times New Roman;font-size:10pt;' >Third A&amp;R</font><font style='font-family:Times New Roman;font-size:10pt;' > Plan during the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' > was $</font><font style='font-family:Times New Roman;font-size:10pt;' >1.27</font><font style='font-family:Times New Roman;font-size:10pt;' > and $</font><font style='font-family:Times New Roman;font-size:10pt;' >1.11</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively. </font><font style='font-family:Times New Roman;font-size:10pt;' >The following assumptions were used to esti</font><font style='font-family:Times New Roman;font-size:10pt;' >mate the fair value</font><font style='font-family:Times New Roman;font-size:10pt;' >, using the Black-Scholes option pricing model,</font><font style='font-family:Times New Roman;font-size:10pt;' > of stock options granted during the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:165pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:12.75pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:165pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:79.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:79.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:5.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:80.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:80.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Volatility</font></td><td style='width:53.25pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >41.07</font></td><td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >40.26</font></td><td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Risk-free interest rate</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.89</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.48</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Expected holding period (in years)</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5.20</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >years</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5.36</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >years</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Dividend yield</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company used historical volatility to calculate the expected volatility </font><font style='font-family:Times New Roman;font-size:10pt;' >for each grant as of the grant date</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:Times New Roman;font-size:10pt;' >Historical volatility was determined by calculating the mean reversion of the daily adjusted closing stock price. The risk-free interest rate </font><font style='font-family:Times New Roman;font-size:10pt;' >assumption is based upon observed U.S. Treasury bill interest rates (risk-free) appropriate for the term of the Company&#8217;s stock options and Market Condition RSU&#8217;s. The expected holding period of stock options represents the period of time options are expec</font><font style='font-family:Times New Roman;font-size:10pt;' >ted to be outstanding and is based on historical experience. The vesting period ranges from one to four years and the contractual life is ten years. The correlation coefficient, used to value the Market Condition RSU&#8217;s, represents the way in which entities</font><font style='font-family:Times New Roman;font-size:10pt;' > move in relation to the Russell 3000 index as a whole.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Stock-</font><font style='font-family:Times New Roman;font-size:10pt;' >based c</font><font style='font-family:Times New Roman;font-size:10pt;' >om</font><font style='font-family:Times New Roman;font-size:10pt;' >pensation expense related to</font><font style='font-family:Times New Roman;font-size:10pt;' > stock options, restricted stock units</font><font style='font-family:Times New Roman;font-size:10pt;' >, Market Condition RSU&#8217;s</font><font style='font-family:Times New Roman;font-size:10pt;' > and the </font><font style='font-family:Times New Roman;font-size:10pt;' >ESPP</font><font style='font-family:Times New Roman;font-size:10pt;' > for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' > was alloca</font><font style='font-family:Times New Roman;font-size:10pt;' >ted as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:9.75pt;' ><td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Cost of revenues</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >11</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Sales and marketing</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >133</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >101</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >General and administrative</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >688</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >622</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Research and development</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >29</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >20</font></td></tr><tr style='height:13.8pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total stock-based compensation</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >863</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >754</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company did not capitalize any stock-based compensation.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Earnings per share</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Basic earnings per share is based upon net income divided by the number of</font><font style='font-family:Times New Roman;font-size:10pt;' > weighted average common shares outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options, restricted stock units and Market Condition RSU&#8217;s into common stock using the treasury method. The weighted av</font><font style='font-family:Times New Roman;font-size:10pt;' >erage number of shares used to compute basic and diluted earnings per share consists of the following:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:129.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:129.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:9.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Basic </font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,579,473</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,013,352</font></td></tr><tr style='height:26.4pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU&#39;s</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:12.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Diluted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,579,473</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,013,352</font></td></tr></table></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Excluded from the shares used in calculating the diluted earnings per common share in the above table are options, restricted stock units and Market Condition RSU&#8217;s of approximately </font><font style='font-family:Times New Roman;font-size:10pt;' >5,413,630</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >5,461,017</font><font style='font-family:Times New Roman;font-size:10pt;' > shares of common stock for the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively, as the impact of these shares would be ant</font><font style='font-family:Times New Roman;font-size:10pt;' >i</font><font style='font-family:Times New Roman;font-size:10pt;' >-dilutive.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797689616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >7</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Related Party Transactions</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:36pt;' >As part of the acquisitions of Multi Channel Systems MCS GmbH (MCS)</font><font style='font-family:Times New Roman;font-size:10pt;' > and Triangle BioSystems, Inc. (TBSI) in 2014, the Company signed lease agreements with the former owners of the acquired companies.  The principals of such former owners of MCS and TBSI were employees of the Com</font><font style='font-family:Times New Roman;font-size:10pt;' >pany</font><font style='font-family:Times New Roman;font-size:10pt;' > as of </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >Pursuant to a lease agreement</font><font style='font-family:Times New Roman;font-size:10pt;' >, the Company incurred rent </font><font style='font-family:Times New Roman;font-size:10pt;' >expense of approximately $</font><font style='font-family:Times New Roman;font-size:10pt;' >58</font><font style='font-family:Times New Roman;font-size:10pt;' > thousand to the former owners of MCS for</font><font style='font-family:Times New Roman;font-size:10pt;' > both</font><font style='font-family:Times New Roman;font-size:10pt;' > the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font><font style='font-family:Times New Roman;font-size:10pt;' > T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company incurr</font><font style='font-family:Times New Roman;font-size:10pt;' >ed rent </font><font style='font-family:Times New Roman;font-size:10pt;' >expense of approximately $</font><font style='font-family:Times New Roman;font-size:10pt;' >11</font><font style='font-family:Times New Roman;font-size:10pt;' > thousand to the former owner of TBSI for both</font><font style='font-family:Times New Roman;font-size:10pt;' > the </font><font style='font-family:Times New Roman;font-size:10pt;' >three months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >March 31,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >2016</font><font style='font-family:Times New Roman;font-size:10pt;' >, respectively</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639595136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Warranties Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Warranties Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >8</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Warranties</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Warranties are estimated and accrued at the time revenues are recorded.  </font><font style='font-family:Times New Roman;font-size:10pt;' >A rollforward of </font><font style='font-family:Times New Roman;font-size:10pt;' >the Company&#8217;s product warranty accrual</font><font style='font-family:Times New Roman;font-size:10pt;' > is as follows:</font></p></div><p style='line-height:20pt;' /><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Beginning</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Additions/</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Ending</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Payments</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >(Credits)</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='10' rowspan='1' style='width:246pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:246pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:6.75pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Year ended December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >147</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(97)</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >143</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >193</font></td></tr><tr style='height:6.45pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Three months ended March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >193</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3)</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >16</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >206</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639796432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >1</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >6</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >Subsequent Events</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >On April 14, 2017, anticipated representatives for the estate of an individual plaintiff filed a wrongful death complaint with the Suffolk Superior Court, in the County of Suffolk, Massachusetts, against the Company and other </font><font style='font-family:Times New Roman;font-size:10pt;' >defendants, including Biostage, Inc. (f/k/a Harvard Apparatus Regenerative Technology, Inc.), its subsidiary that was spun off in 2013, as well as another third party.  The complaint seeks payment for an unspecified amount of damages and alleges that the p</font><font style='font-family:Times New Roman;font-size:10pt;' >laintiff sustained terminal injuries allegedly caused by products, including synthetic trachea scaffolds and bioreactors, provided by certain of the named defendants and utilized in connection with surgeries performed by third parties in 2012 and 2013.</font><font style='font-family:Times New Roman;font-size:10pt;' > The</font><font style='font-family:Times New Roman;font-size:10pt;' > litigation is at an early s</font><font style='font-family:Times New Roman;font-size:10pt;' >tage and the Company intends to vigorously defend this case.  While the Company believe that such claim is without merit, the Company is unable to predict the ultimate outcome of such litigation. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >On May 2</font><font style='font-family:Times New Roman;font-size:10pt;' >, 2017, the Company en</font><font style='font-family:Times New Roman;font-size:10pt;' >tered into </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >the Credit Agreement which restated the 2013 Agreement.  See Note 12 for a discussion of the Credit Agreement.</font><font style='font-family:Times New Roman;font-size:10pt;' >  Additionally, immediately after entering into the Credit Agreement, the Company entered into a new interest swap agreement with Bank </font><font style='font-family:Times New Roman;font-size:10pt;' >of America. See Note 13 for a discussion of the interest swap agreement</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814695536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract', window );"><strong>Recently Issued Accounting Pronouncements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Recently Issued Accounting Pronouncements Disclosure [Text Block]</a></td>
<td class="text"><div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >	Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >&#8220;Revenue from Contracts with Customers,&#8221;</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in th</font><font style='font-family:Times New Roman;font-size:10pt;' >e United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or servi</font><font style='font-family:Times New Roman;font-size:10pt;' >ces. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactio</font><font style='font-family:Times New Roman;font-size:10pt;' >ns that could have implications to the timing of revenue recognition under the new guidance. The Company expects this undertaking will be complete in the second half of 2017.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In February 2016, the FASB issued ASU 2016-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, which is intended to impr</font><font style='font-family:Times New Roman;font-size:10pt;' >ove financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12&#160;months. The update is effective for fiscal year</font><font style='font-family:Times New Roman;font-size:10pt;' >s beginning after December 15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determined the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabili</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ties will increase upon adoption for right-of-use assets and lease liabilities. The Company&#8217;s future commitments under lease obligations are summarized in Note 10.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In March 2016, the FASB issued ASU 2016-09,&#160;</font><font style='font-family:Times New Roman;font-size:10pt;' >Compensation &#8211; Stock Compensation (Topic 718): </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;' >, which simplifies the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity o</font><font style='font-family:Times New Roman;font-size:10pt;' >r liabilities and classification on the statement of cash flows. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The standard requires an entity to recognize all excess tax benefits and tax deficiencies as income tax benefit or expense in the income statement as discrete items in the reporting period </font><font style='font-family:Times New Roman;font-size:10pt;' >in which they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&#8217;s annual effective tax rate, applied on a prospective basis. Further, the standard eliminates the requirement to defer the recognition of excess t</font><font style='font-family:Times New Roman;font-size:10pt;' >ax benefits until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with any valuation allowance, should be recognized on a modified retrospective basis as a cumulative adjustment to retain</font><font style='font-family:Times New Roman;font-size:10pt;' >ed earnings as of the </font><font style='font-family:Times New Roman;font-size:10pt;' >date of adoption. Under ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09, an entity that applies the treasury stock method in calculating diluted earnings per share is required to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since</font><font style='font-family:Times New Roman;font-size:10pt;' > such amounts are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner as other cash flows related to income taxes on the statement of cash flows, as such excess tax benefits no longer</font><font style='font-family:Times New Roman;font-size:10pt;' > represent financing activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods presented. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company adopted ASU 2016-09 as of January 1, 2017. The Company  recorded a cumulative</font><font style='font-family:Times New Roman;font-size:10pt;' > increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred tax assets related to the prior years&#8217; unrecognized excess tax benefits. An equal amount of valuation allowance was also </font><font style='font-family:Times New Roman;font-size:10pt;' >recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in a net impact of $0. In addition, </font><font style='font-family:Times New Roman;font-size:10pt;' >tax deficiencies related to vested restricted stock units and canceled stock options during the first quarter</font><font style='font-family:Times New Roman;font-size:10pt;' > of 2017 have been recognized in the current period&#8217;s income statement.  </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09 also allows an entity to elect as an accounting policy either to continue to estimate the total number of awards for which the requisite service period will not be rende</font><font style='font-family:Times New Roman;font-size:10pt;' >red or to account for forfeitures for service based awards as they occur. An entity that elects to account for forfeitures as they occur should apply the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earn</font><font style='font-family:Times New Roman;font-size:10pt;' >ings as of the date of adoption. The Company elected as an accounting policy to account for forfeitures for service based awards as they </font><font style='font-family:Times New Roman;font-size:10pt;' >occur, and as a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings</font><font style='font-family:Times New Roman;font-size:10pt;' > with a corresponding increase in additional paid in capital related to the prior years</font><font style='font-family:Times New Roman;font-size:10pt;' >&#8217; stock-based compensation expense</font><font style='font-family:Times New Roman;font-size:10pt;' > as required under the modified retrospective approach. </font><font style='font-family:Times New Roman;font-size:10pt;' > The tax effect of this adjustment, which included the impact of a valuation al</font><font style='font-family:Times New Roman;font-size:10pt;' >lowance was immaterial. </font></p><p style='text-align:left;line-height:12pt;' ></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e31137-122693<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823662592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:14.4pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Foreign currency</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Derivatives</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >translation  </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >qualifying as</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Defined benefit</font></td><td style='width:14.25pt;text-align:right;vertical-align:middle;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >adjustments</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >hedges</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >pension plans</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Calibri;font-size:11pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:middle;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance at December 31,  2016</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(14,200)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,458)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(16,658)</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:25.5pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other comprehensive income before reclassifications</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >942</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >946</font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Amounts reclassified from AOCI</font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other comprehensive income </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >942</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >949</font></td></tr><tr style='height:9.75pt;' ><td style='width:171pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td style='width:14.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:82.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:70.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:171pt;text-align:left;vertical-align:middle;border-color:Black;min-width:171pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:82.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:82.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(13,258)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,458)</font></td><td style='width:14.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:14.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:70.5pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:70.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(15,709)</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:39pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Details about AOCI Components</font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Amount reclassified from AOCI into income (effective portion)</font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Location of amount</font></td></tr><tr style='height:40.2pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended March 31,</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >reclassified from AOCI</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >into income (effective portion)</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:139.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:14.4pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest expense</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797566976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Other Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Weighted </font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Average</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' >March 31, 2017</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:116.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:116.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' >December 31, 2016</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Life</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > (a)</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='11' rowspan='1' style='width:247.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:247.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:26.4pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Amortizable intangible assets:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Gross</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Accumulated Amortization</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Gross</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Accumulated Amortization</font></td><td style='width:1.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Existing technology</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >15,287</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(12,020)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >15,082</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(11,710)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >6.8</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Trade names</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,436</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3,617)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,379</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3,479)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7.8</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Distribution agreements/customer relationships</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >23,136</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(13,228)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >22,976</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(12,862)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8.7</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Patents</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >207</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(131)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >204</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(119)</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.9</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Years</font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total amortizable intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >46,066</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(28,996)</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >45,641</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:60pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(28,170)</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Indefinite-lived intangible assets:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Goodwill</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,398</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,032</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other indefinite-lived intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,216</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,209</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:26.4pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total goodwill and other indefinite-lived intangible assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >39,614</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >39,241</font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total intangible assets, gross</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >85,680</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >84,882</font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:192.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:192.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:double;border-top-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:60pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:60pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:1.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:1.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td colspan='15' rowspan='1' style='width:496.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:496.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(a) Weighted average life as of March 31, 2017.</font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill Rollforward [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:63.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,032</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:262.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:262.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Effect of change in currency translation</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:63.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >366</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td colspan='2' rowspan='1' style='width:269.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:269.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:63.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >38,398</font></td><td style='width:63.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:63.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824088880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:153pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Finished goods</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,686</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,340</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Work in process</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >900</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >823</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:105pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:105pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Raw materials</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,696</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >9,792</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:98.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:98.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >20,282</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >19,955</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797695536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock', window );">Schedule Of Property Plant And Equipment [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:150pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:150pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Land, buildings and leasehold improvements</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2,117</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2,095</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Machinery and equipment</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,395</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7,224</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Computer equipment and software</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,345</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,115</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Furniture and fixtures</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,284</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,274</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Automobiles</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >201</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >196</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >19,342</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >18,904</font></td></tr><tr style='height:13.2pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Less: accumulated depreciation</font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(15,074)</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:69.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(14,608)</font></td></tr><tr style='height:13.8pt;' ><td style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Property, plant and equipment, net</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,268</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:69.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:69.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,296</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This table includes the gross amount of individual categories of assets and the net amount of total fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_ScheduleOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824060864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long Term Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:138pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:138pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Long-term debt:</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Term loan</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,062</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,400</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     DDTL</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,125</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,400</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Revolving line</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,550</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,050</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Total unamortized deferred financing costs</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(84)</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(104)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total debt</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13,653</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13,746</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Less: current installments</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,800)</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(2,450)</font></td></tr><tr style='height:13.2pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >     Current unamortized deferred financing costs</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >78</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:64.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >78</font></td></tr><tr style='height:13.8pt;' ><td style='width:224.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:224.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Long-term debt</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >10,931</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:64.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:64.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >11,374</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6810154608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31, 2017</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31, 2017</font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Notional Amount</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value (a)</font></td></tr><tr style='height:27pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives designated as hedging instruments under ASC 815</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance sheet classification</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other liabilities-non current</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,500</font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td></tr><tr style='height:13.8pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31, 2016</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >December 31, 2016</font></td></tr><tr style='height:12.75pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Notional Amount</font></td><td style='width:15pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:90.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value (a)</font></td></tr><tr style='height:27pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives designated as hedging instruments under ASC 815</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance sheet classification</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:207pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:207pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:202.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:202.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Other liabilities-non current</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5,500</font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:90.75pt;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.8pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:186.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:186.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:15pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:15pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:90.75pt;border-top-style:double;border-top-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:90.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:15.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:15.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='8' rowspan='1' style='width:530.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:530.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(a) See Note 14 for the fair value measurements related to these financial instruments.</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in AOCI [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:55.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Derivatives in Hedging Relationships</font></td><td colspan='5' rowspan='1' style='width:123pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Amount of gain (loss) recognized in OCI on derivative (effective portion) </font></td></tr><tr style='height:31.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended March 31,</font></td></tr><tr style='height:15pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:10.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:56.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:56.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:15pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:123pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:123pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:140.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:140.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4 </font></td><td style='width:10.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:10.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:10.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(36)</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:39pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Details about AOCI Components</font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Amount reclassified from AOCI into income (effective portion)</font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Location of amount</font></td></tr><tr style='height:40.2pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended March 31,</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >reclassified from AOCI</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:52.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:139.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >into income (effective portion)</font></td></tr><tr style='height:15pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='6' rowspan='1' style='width:118.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:118.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td><td style='width:139.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:14.4pt;' ><td style='width:103.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:103.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swaps</font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:45.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:45.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13 </font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:139.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:139.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest expense</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in cash flow hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814614624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.8pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Fair Value as of March 31, 2017</font></td></tr><tr style='height:14.4pt;' ><td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(In thousands)</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 1</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 2</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 3</font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Liabilities:</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swap agreements</font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >7</font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160; </font></td><td colspan='9' rowspan='1' style='width:293.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:Black;min-width:293.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Fair Value as of December 31, 2016</font></td></tr><tr style='height:14.4pt;' ><td style='width:194.25pt;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(In thousands)</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 1</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 2</font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Level 3</font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:center;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total</font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;border-bottom-style:solid;border-bottom-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.8pt;' ><td style='width:194.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Liabilities:</font></td><td style='width:20.25pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:17.25pt;border-top-style:solid;border-top-width:3;text-align:right;vertical-align:bottom;border-color:#000000;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:21.75pt;border-top-style:solid;border-top-width:3;text-align:left;vertical-align:bottom;border-color:#000000;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:194.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:194.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest rate swap agreements</font></td><td style='width:20.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:20.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:17.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:17.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:21.75pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:21.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797547920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:67.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Operating </font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Leases</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:12pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2018</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,610</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2019</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,618</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2020</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,421</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2021</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,098</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2022</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,098</font></td></tr><tr style='height:13.2pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Thereafter</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:67.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,836</font></td></tr><tr style='height:13.8pt;' ><td style='width:165pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net minimum lease payments</font></td><td style='width:12pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:67.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:67.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >8,681</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797566304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract', window );"><strong>Employee Benefit Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:109.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:109.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Components of net periodic benefit cost:</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Interest cost</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >125</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >168</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Expected return on plan assets</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(159)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(181)</font></td></tr><tr style='height:13.2pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net amortization loss</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >87</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >80</font></td></tr><tr style='height:13.8pt;' ><td style='width:225pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:225pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Net periodic benefit cost</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >53</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >67</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797659104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Capital Stock Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock', window );">Schedule Of Stock Options And Restricted Stock Units Activity Rollforward [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock Options</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:127.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:127.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Restricted Stock Units</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:144pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:144pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Market Condition RSU&#39;s</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Weighted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Average</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Restricted</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Market</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Options</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Exercise </font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Stock Units</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Grant Date</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:78pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Condition RSU&#39;s</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Grant Date</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > Price</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Outstanding</font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:52.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Fair Value</font></td></tr><tr style='height:9.75pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td><td style='width:52.5pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4,096,818</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.94</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,072,653</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.15</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >182,150</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4.81</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Granted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >30,000</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.25</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >445,690</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2.83</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Exercised</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(5,709)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >2.56</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Vested (RSUs)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(251,570)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.28</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.2pt;' ><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:119.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:119.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Cancelled / forfeited</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(152,212)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.68</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(4,190)</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.05</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:13.8pt;' ><td colspan='2' rowspan='1' style='width:126pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:126pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Balance at March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3,968,897</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.94</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1,262,583</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >3.01</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:78pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:78pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >182,150</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:52.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:52.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >4.81</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Table Of Assumptions [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:165pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:12.75pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:165pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:165pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:79.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:79.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:5.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='2' rowspan='1' style='width:80.25pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:80.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Volatility</font></td><td style='width:53.25pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >41.07</font></td><td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >40.26</font></td><td style='width:26.25pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Risk-free interest rate</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.89</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >1.48</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Expected holding period (in years)</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5.20</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >years</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >5.36</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >years</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Dividend yield</font></td><td style='width:53.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:53.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td><td style='width:5.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:5.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:54pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:54pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:26.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:26.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >%</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock Based Compensation Expense Activity By Function [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='4' rowspan='1' style='width:111.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:111.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:9.75pt;' ><td style='width:153.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Cost of revenues</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >11</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Sales and marketing</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >133</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >101</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >General and administrative</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >688</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >622</font></td></tr><tr style='height:13.2pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Research and development</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >29</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >20</font></td></tr><tr style='height:13.8pt;' ><td style='width:153.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:153.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Total stock-based compensation</font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >863</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:9pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >754</font></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Basic and Diluted Shares [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Arial;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:129.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Three Months Ended</font></td></tr><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='3' rowspan='1' style='width:129.75pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:129.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >March 31,</font></td></tr><tr style='height:13.2pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2017</font></td><td style='width:6.75pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >2016</font></td></tr><tr style='height:9.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:12.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Basic </font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,579,473</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,013,352</font></td></tr><tr style='height:26.4pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU&#39;s</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >-</font></td></tr><tr style='height:12.75pt;' ><td style='width:266.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:266.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Diluted</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,579,473</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:61.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:double;border-bottom-width:3;text-align:right;vertical-align:bottom;border-color:Black;min-width:61.5pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >34,013,352</font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular representation of the rollforward of stock options and restricted stock units at the end of the reporting period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_ScheduleOfStockOptionsAndRestrictedStockUnitsActivityRollforwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814694736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Warranties Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Warranty Rollforward Disclosure [Table Text Block]</a></td>
<td class="text"><div><table style='border-collapse:collapse;' ><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Beginning</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Additions/</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Ending</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Payments</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >(Credits)</font></td><td style='width:11.25pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:center;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >Balance</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td colspan='10' rowspan='1' style='width:246pt;border-top-style:solid;border-top-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:246pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(in thousands)</font></td></tr><tr style='height:6.75pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Year ended December 31, 2016</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >147</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(97)</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >143</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >193</font></td></tr><tr style='height:6.45pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Three months ended March 31, 2017</font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >193</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >(3)</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >16</font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >$</font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >206</font></td></tr><tr style='height:13.2pt;' ><td style='width:183.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:183.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:11.25pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:11.25pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:6.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:6.75pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td><td style='width:48pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:48pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' ></font></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823832032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policy (Details 1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">1 year 10 months 25 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821863376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Opening Balance</a></td>
<td class="num">$ (16,658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss) before Reclassifications</a></td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax, total</a></td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Closing Balance</a></td>
<td class="num">(15,709)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Opening Balance</a></td>
<td class="num">(14,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss) before Reclassifications</a></td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax, total</a></td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Closing Balance</a></td>
<td class="num">(13,258)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Derivatives qualifying as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Opening Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss) before Reclassifications</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax, total</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Closing Balance</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined benefit pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Opening Balance</a></td>
<td class="num">(2,458)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss) before Reclassifications</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax, total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Closing Balance</a></td>
<td class="num">$ (2,458)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6810651152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narratives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Other Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 599<span></span>
</td>
<td class="nump">$ 680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated Amortization Expense Next Twelve Months</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated Amortization Expense Year 2</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated Amortization Expense Year 3</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated Amortization Expense Year 4</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated Amortization Expense Year 5</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825122608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 46,066<span></span>
</td>
<td class="nump">$ 45,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(28,996)<span></span>
</td>
<td class="num">(28,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">38,398<span></span>
</td>
<td class="nump">38,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite lived intangible assets</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill', window );">Total goodwill and other indefinite lived intangible assets</a></td>
<td class="nump">39,614<span></span>
</td>
<td class="nump">39,241<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_TotalIntangibleAssets', window );">Total intangible assets</a></td>
<td class="nump">85,680<span></span>
</td>
<td class="nump">84,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">15,287<span></span>
</td>
<td class="nump">15,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (12,020)<span></span>
</td>
<td class="num">(11,710)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 7,436<span></span>
</td>
<td class="nump">7,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (3,617)<span></span>
</td>
<td class="num">(3,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 23,136<span></span>
</td>
<td class="nump">22,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (13,228)<span></span>
</td>
<td class="num">(12,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (131)<span></span>
</td>
<td class="num">$ (119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">1 year 10 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the sum total of the indefinite lived intangible assets and goodwill balances at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_TotalIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the sum total of all the intangible assets ie goodwill, definite lived intangible assets and indefinite lived intangible assets at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_TotalIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6810281504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details 2)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Other Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 38,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effect of change in currency transaltion</a></td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 38,398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797673024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods</a></td>
<td class="nump">$ 9,686<span></span>
</td>
<td class="nump">$ 9,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in Process</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw Materials</a></td>
<td class="nump">9,696<span></span>
</td>
<td class="nump">9,792<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventories, Net</a></td>
<td class="nump">$ 20,282<span></span>
</td>
<td class="nump">$ 19,955<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821896528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 19,342<span></span>
</td>
<td class="nump">$ 18,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(15,074)<span></span>
</td>
<td class="num">(14,608)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,268<span></span>
</td>
<td class="nump">4,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">2,117<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">7,395<span></span>
</td>
<td class="nump">7,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">8,345<span></span>
</td>
<td class="nump">8,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797616688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Exit Cots (Narratives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges (credits)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6805718976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Exit Costs (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges (credits)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825541040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Narratives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2017</div></th>
<th class="th"><div>Apr. 24, 2015</div></th>
<th class="th"><div>Oct. 31, 2013</div></th>
<th class="th"><div>Mar. 29, 2013</div></th>
<th class="th"><div>Aug. 07, 2009</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementLineItems', window );"><strong>Credit Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_PreviousApprovedCreditFacility', window );">Previous Approved Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,653<span></span>
</td>
<td class="nump">$ 13,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed', window );">Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_InterestRateInExcessOfLiborOnCreditFacility', window );">Interest Rate In Excess Of LIBOR On Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine', window );">DDTL Threshold For Dollar For Dollar Reduction In Revolving Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity', window );">Transfer Of Delayed Draw Down Term Loan Capacity To Revolver Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold', window );">Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold', window );">Lender Approval To Fund Acquisition With Equity In Excess Of Threshold</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementLineItems', window );"><strong>Credit Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_Maturitydates', window );">Maturity Dates</a></td>
<td class="text">May  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 29,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis Spread Over LIBOR</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest Rate As Of Reporting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementLineItems', window );"><strong>Credit Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_Maturitydates', window );">Maturity Dates</a></td>
<td class="text">May  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 29,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis Spread Over LIBOR</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest Rate As Of Reporting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember', window );">Delayed Drawdown Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementLineItems', window );"><strong>Credit Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_Maturitydates', window );">Maturity Dates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 29,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis Spread Over LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Maximum Borrowings Available Under The Current Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest Rate As Of Reporting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold amount after borrowings against the DDTL result in a dollar for dollar reduction in the Revolving Line capacity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_DdtlThresholdForDollarForDollarReductionInRevolvingLine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_InterestRateInExcessOfLiborOnCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the interest rate to be added to LIBOR per the amended and restated revolving credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_InterestRateInExcessOfLiborOnCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the lender approval is required to fund acquisition with cash, promissory notes and/ or other consideration in excess of the threshold as stated in the revolving credit loan agreement with Bank of America.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the lender approval is required to fund acquisition with equity in excess of the threshold as stated in the revolving credit loan agreement with Bank of America.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_Maturitydates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maturity dates for various types of loans included in the credit agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_Maturitydates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company was required to fix the rate of interest on minimum percentage of Term Loan and the DDTL</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_PreviousApprovedCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_PreviousApprovedCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer of borrowing capactiy for the delayed draw down term loan to the revolving line of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813365936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 02, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Mar. 29, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,062<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_DelayedDrawdownTermLoan', window );">DDTL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,125<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_RevolvingCreditFacility', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,550<span></span>
</td>
<td class="nump">4,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Total unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Total Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,653<span></span>
</td>
<td class="nump">13,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Less: current installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,722)<span></span>
</td>
<td class="num">(2,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,931<span></span>
</td>
<td class="nump">$ 11,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Total Debt</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember', window );">DDTL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Total Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Total Debt</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_DelayedDrawdownTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_DelayedDrawdownTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_RevolvingCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_RevolvingCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=hbio_DelayedDrawdownTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_CreditAgreementAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825611424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative (Narratives) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Nov. 30, 2013</div></th>
<th class="th"><div>Jun. 05, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments And Hedging Activities Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed', window );">Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Deferred losses on derivative instruments accumulated in AOCI expected to be reclassified to earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_DerivativeInterestRateSwapEffectivePercentage', window );">Derivative Interest Rate Swap Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hbio_DelayedDrawdownTermLoanMember', window );">Delayed Drawdown Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments And Hedging Activities Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount of Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_LiborFixedRate', window );">LIBOR Fixed Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_SecuredDebtMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments And Hedging Activities Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount of Interest Rate Swaps</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_LiborFixedRate', window );">LIBOR Fixed Rate</a></td>
<td class="nump">1.86%<span></span>
</td>
<td class="nump">0.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_DerivativeInterestRateSwapEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effective percentage of all interest rate swaps the Company has entered into during 2013.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_DerivativeInterestRateSwapEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_LiborFixedRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LIBOR Fixed Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_LiborFixedRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company was required to fix the rate of interest on minimum percentage of Term Loan and the DDTL</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Notional Amount<br> -URI http://asc.fasb.org/extlink&amp;oid=6519104<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hbio_DelayedDrawdownTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hbio_DelayedDrawdownTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6805593968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative (Details 1) - Other liabilities-non current [Member] - Derivatives qualifying as hedges [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional Amount of Interest Rate Derivatives</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Derivative Liability, Fair Value, Net</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41678-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226006-175313<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797686672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative (Details 2) - Derivatives qualifying as hedges [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion', window );">Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember', window );">Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of losses on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813081728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Derivatives qualifying as hedges [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823623760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">$ 1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">1,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">1,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">1,836<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating Leases, Total Future Minimum Payments Due</a></td>
<td class="nump">$ 8,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6805404384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narratives) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_EstimatedRentalExpensesCurrentYear', window );">Estimated Rental Expenses Current Year</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_EstimatedRentalExpensesCurrentYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents estimated payments for the current year which includes the actual payment to date plus the estimated expense for the remainder of the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_EstimatedRentalExpensesCurrentYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814537312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Narratives) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate</a></td>
<td class="num">(2.20%)<span></span>
</td>
<td class="num">(43.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6627305024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Income Tax Expense (benefit) Attributable To Income From Continuing Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense, Total</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Tax Rate Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense, Total</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Operating Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">$ (1,043)<span></span>
</td>
<td class="num">$ (443)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6696767888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Narratives) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract', window );"><strong>Employee Benefit Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear', window );">Expected employer contribution in current remaining fiscal year</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan Payments In Current Fiscal Year</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Defined Benefit Plans Liabilities Noncurrent</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by the employer to defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 35<br> -Paragraph 123<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937487&amp;loc=d3e36068-114959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 63<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12551-114930<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of employer's best estimate of contributions expected to be paid to the plan in the current remaining fiscal period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813033328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract', window );"><strong>Employee Benefit Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest Cost</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected Return on Plan Assets</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net Amortization Loss</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net Periodic Benefit Cost, Total</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest Cost</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan Payments In Current Fiscal Year</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of gains or losses recognized in net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by the employer to defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 35<br> -Paragraph 123<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937487&amp;loc=d3e36068-114959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 63<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12551-114930<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512171<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821855104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narratives) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Apr. 03, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_EmployeeStockPurchasePlanSharesAuthorized', window );">Employee Stock Purchase Plan Shares Authorized</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock issued during the year, Shares, Employee Stock Purchase Plans</a></td>
<td class="nump">725,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,508,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan', window );">Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">445,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">5,413,630<span></span>
</td>
<td class="nump">5,461,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_PercentageOfOutstandingCommonStock', window );">Percentage Of Outstanding Common Stock</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants', window );">Weighted Average Estimated Black Scholes Value Of Option Grants</a></td>
<td class="nump">$ 1.27<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock - Shares Authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1', window );">Cumulative effect adjustment to retained earnings</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember', window );">Market Condition Restricted Stock Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_EmployeeStockPurchasePlanSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_EmployeeStockPurchasePlanSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase in the total number of shares authorized for issuance under the Stock Option and Issuance Plan as approved by the shareholders in their Annual Shareholders Meeting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_PercentageOfOutstandingCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of outstanding shares held by third parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_PercentageOfOutstandingCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Black Scholes Value per share of stock option grants during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_WeightedAverageEstimatedBlackScholesValueOfOptionGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cumulative effect on retained earnings before related income tax effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64853466&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824431536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Apr. 03, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Opening Balance Stock Options Outstanding</a></td>
<td class="nump">4,096,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Begining Balance Weighted Average Exercise Price</a></td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan', window );">Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, Grants in Period, Gross</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises during the year, Shares</a></td>
<td class="nump">5,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options, Forfeitures and Expirations in Period</a></td>
<td class="nump">152,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Closing Balance Stock Options Outstanding</a></td>
<td class="nump">3,968,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Closing Balance Weighted Average Exercise Price</a></td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Begining Balance Restricted Stock Units Outstanding</a></td>
<td class="nump">1,072,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">445,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">251,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Closing Balance Restricted Stock Units Outstanding</a></td>
<td class="nump">1,262,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Begining Balance Grant Date Fair Value Of Restricted Stock Units</a></td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">2.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Closing Balance Grant Date Fair Value Of Restricted Stock Units</a></td>
<td class="nump">3.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value of Vested Restricted Stock</a></td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">41.07%<span></span>
</td>
<td class="nump">40.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">1.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 3.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="nump">4,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock - Shares Authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember', window );">Market Condition Restricted Stock Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Begining Balance Restricted Stock Units Outstanding</a></td>
<td class="nump">182,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Closing Balance Restricted Stock Units Outstanding</a></td>
<td class="nump">182,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Begining Balance Grant Date Fair Value Of Restricted Stock Units</a></td>
<td class="nump">$ 4.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Closing Balance Grant Date Fair Value Of Restricted Stock Units</a></td>
<td class="nump">4.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase in the total number of shares authorized for issuance under the Stock Option and Issuance Plan as approved by the shareholders in their Annual Shareholders Meeting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hbio_IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hbio_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hbio_MarketConditionRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813732528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">34,579,473<span></span>
</td>
<td class="nump">34,013,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">34,579,473<span></span>
</td>
<td class="nump">34,013,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 688<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814667040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Stock (Details 3) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">3,968,897<span></span>
</td>
<td class="nump">4,096,818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6650935280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Narratives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hbio_MultiChannelSystemsMcsGmbhMember', window );">Multi Channel Systems MCS GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hbio_TriangleBiosystemsIncMember', window );">Triangle BioSystems, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hbio_MultiChannelSystemsMcsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hbio_MultiChannelSystemsMcsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hbio_TriangleBiosystemsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hbio_TriangleBiosystemsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814538400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranties (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDisclosureAbstract', window );"><strong>Product Warranty Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Warranty, Beginning Balance</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Warranty payments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Warranty additions</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Warranty, Ending Balance</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797593136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information (Narratives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingMeasurementDisclosuresAbstract', window );"><strong>Segment and Related Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 24,156<span></span>
</td>
<td class="nump">$ 26,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingMeasurementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingMeasurementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6643574736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 24,156<span></span>
</td>
<td class="nump">$ 26,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W%;9>FYWYQ\87P:Z%7_^B^P)02P,$%     @ )YRE2IE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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ME8,8LT#&)W!^&LI/X&RT_+L41"I2P8 ,4. $-92@P.G(2A!!@ZAE*R@#%#E
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M%3&8)8',/T-$3HA(^^,E1.KVQTY_K/UPZ<^,(D9)IB6=EB3)VBC#UJ1AZ.:
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MD%1C$AKB!"7"J!*3*-Y+S'J)J1>#O(R29-8*R"1.D1=&I05DO)>$]9(0+YE
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MG\TT9I/AL)]_$%N^<?$74$L#!!0    ( "><I4IGE 4+N $  -(#   8
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M'T]IB(\!/R6,=G4FH9(+XG,POE0YW86$0$'I H/PVQ4>0*E Y-/X-7/213(
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MM/,O&_O?:.W 2TDN_ AU_H,MAH#&A>.U/YMIS";#Z7[^063YQN5_4$L#!!0
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M?-G8_]H8#R@EN<,1:O&#+8:"VH?C!SS;:<PFPYM^_D%L^<;%7U!+ P04
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M2964!FPJT9TMN+%/Q6)PJ(S;WMN]F@9F,HSLY[> + ]2_@=02P,$%     @
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M5%)#9R5VQ$"=T_O=\90&? 2\2!CMZDQ")1?$UV!\K7*:A(1 0>F"@O#;%1Y
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MS5[.4SD'6@S+@X/75Z_X U!+ P04    "  GG*5*XJN'G+8!  #2 P  &0
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M(P7.!_@ 'P#G \SA ]A\@-#<CF#C <+(80:G \RA R!T()28;C 5<; !<#;
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M;6ZJNT^U$!I,,O&=*;DU#\9B,*BUW>[-7OJQ\886P_PBX.59*OX 4$L#!!0
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MS?GT#DR%9,/\Q*'EG2W^ %!+ P04    "  GG*5*E@!*?9X"  !+"@  &0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;'U4;6^;,!#^*\@_H"9
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M-#,N>&ULE5AK;YLP%/TKB!]0L,VK51)I31^9M$G5IFV?:>(DJ( S<)ONW\^
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M((A!@M@1) ,"S\BJQ60.4SL,1:GO%@ E",%2$E!* DCQ=[W%I!>K))A03PH
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M'_].",T-);HQ.WTPK\U^4/*=MMW,]&7[Y&H'6C3=<S+JW[3+?U!+ P04
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M    >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;(U476^;,!3]*XCWU0D0Z")
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MWO>FXK_"'9B6FTPTH^1,VJ]7WJ3B[>2B4VGIV]@VG6V'<65/IC!W )D"R!Q
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M\8B .,EL,8G%U&VL)-0_6(> .@30<1*V)5,=3'"4PSH)J), .JF3]62B@W1
M68YGE%)0*064,D<IG2AAF[F9U&6@4 8(Y4[JLHE0'),DG]')09U\JH.< [O-
M)SHD1E'B'NP=A$M0B%+8(13"7WH(N(3<3QT"X1F=F8J" (K(U6E!V?#8++!S
MMG8@"LT4'P16GSN$)^XD[H9WF%&&P_'1:JO0)X!CG^!"@R(@1;'K5 O*!UKA
M8BYVN!XAH" A,D,!EQI$/E\4$5Q%$%1&)ELPK2-N3H/!G58Q<;(-AO3V_%(K
M4_<'JWT3<X?-G>BL;]%RU[8B[S1M9_2#BE-12^^9*WWCVGOQR+EBVL-PH3-Q
MULU8/RG949EAJL>B[4C:B>)-UVT%?<NW^0]02P,$%     @ )YRE2O[X_4HS
M!   HA0  !D   !X;"]W;W)K<VAE971S+W-H965T-38N>&ULE5C;CMLV$/T5
M01]@B3/4Q0O;P-K9H@$28)&B[;/6IB^(+JXDKY._KV[K6.2AJ^[#2J+/S.%0
M,X<C+JY%^;TZ*E4[/[(TKY;NL:[/3YY7;8\J2ZI9<59Y\\N^*+.D;A[+@U>=
M2Y7L.J,L]<CW0R]+3KF[6G1CK^5J45SJ])2KU]*I+EF6E#_7*BVN2U>X'P/?
M3H=CW0YXJ\4Y.:@_5/WG^;5LGKR;E]TI4WEU*G*G5/NE^RR>7B2U!AWBKY.Z
M5G?W3AO*6U%\;Q\^[Y:NW\Y(I6I;MRZ2YO*N-BI-6T_-//X9G+HWSM;P_O[#
M^V]=\$TP;TFE-D7Z]VE7'Y=N[#H[M4\N:?VMN/ZNAH "UQFB_Z+>5=K VYDT
M'-LBK;K_SO92U44V>&FFDB4_^NLI[Z[7P?^'&3:@P8!N!A0\-.#!@'\9R(<&
M<C"0-P/QV" 8# +-P.MC[Q;S4U(GJT597)VRSX=STJ:=> J:U[5M![NWT_W6
MK&?5C+ZOI @7WGOK:,"L>PS=8<0-X37>;Q2$*-9DF-.88&,B(FT.GTP(^V/(
MBPF1/N.),EP+[ASPR('$#B1T(#L'<K28D;:8/2;L,/E ,@]C$6.B !(%@"C6
MB'I,?$?$L[DEG!"RA":+K[&\A$8X%/CM'R:*(%$$PIEKX40&$=MI8D@3FS2D
M)=$Z-FB"R)]CECEDF0,6H;',#181$ G"/,+'I>L#)M)KUP=I$%J235@T0@ B
MUHF$^8*:O([GD84+BL6S(, E=2[Z'[DM<+$+!D2!3L3FB_(C"@.+K@BL"P((
M@Z\GN #*((-P;DEQ@95! &D@0] #4+6B270+%98' ?2!=+D3ID ("BF(;2N(
M%4( B2!=\0;0."U$8"'"&B&02!BOJ@<)<;^ ,VM(6"<$$ I]3UL/H!$3SWS;
M_HN%@H!0L"Y)A(2"+$)!6"A(F#LH6T2-</T3J'_6M0:"-)'80) E&0AK! &-
M8+V8("C2)X- ML7%(D) 1%C/3 22OCX9!+*E%)89 C(C];T'@EB?S&/0>#)8
MB @(D=3WC $4CTHV""U$6(4(J)#4]XP!I)4LV3(/RQ !&9)&YL6@9'T;$58A
M BHD=1$GLU]I&C3+;L%8A-@4H5#/W@$SZK[\<3?9?PU, ([GA/6*06-CVR\8
MZQ73](\&MGQV3.E$&'0B,8G %C#6$)[2B+#9B-A8L#CPE!Z$S1[$QH*KGJ>T
M'PS:CT?+ANN>IW0?;'8?<A9;9)5QV?.4[H/-;Q1;.+CF>4KGP:#SL,<C<=%+
M?WI#('&-2E"CAA(.H.B_ET3B,I:@63!D<  ]6GCO[MPE4^6A.P2KG&UQR>OV
M;.)N]';0]MR=LVGC:_&TZ8_+?KGI3^^^)N7AE%?.6U'71=:=W>R+HE;-#/U9
M4U1'E>QN#ZG:U^UMU-R7_:E9_U 7Y^%$T+L=2Z[^!5!+ P04    "  GG*5*
M:3'FRL$"  "5"@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6R55NV.
MFS 0?!7$ QS8?.:41$JHJE9JI>BJ7G\[B1/0 ::VDUS?OK8A'#%+E/MS8&=V
M/#NW:W9^8?Q-Y)1*Y[TJ:[%P<RF;9\\3NYQ61#RQAM;JEP/C%9%JR8^>:#@E
M>Q-4E1[V_=BK2%&[R[G9V_#EG)UD6=1TPQUQJBK"_ZUIR2X+%[G7C9?BF$N]
MX2WG#3G27U3^;C9<K;R>95]4M!8%JQU.#PMWA9XS[.L @W@MZ$4,WAV=RI:Q
M-[WXOE^XOE9$2[J3FH*HQYEFM"PUD]+QMR-U^S-UX/#]RO[5)*^2V1)!,U;^
M*?8R7[BIZ^SI@9Q*^<(NWVB74.0Z7?8_Z)F6"JZ5J#-VK!3FK[,["<FJCD5)
MJ<A[^RQJ\[QT_-<P. !W ;@/4&??"PBZ@. C(#3)M\I,JE^(),LY9Q>'M_^M
MANBB0,^!,G.G-XUWYC>5K5"[YV48IG/OK(DZS+K%X $&]0A/L?='8.B(-1Z%
MX]L#LC$BB>$3 C")P,0'-TG,8((0) @-03@DB'S+A1:3&$QM,&D<6(F,,4D4
MPD(B4$@TSB2:,#L&">)1)LA'5B8M)AZH#,(HF86)G0X$]%$01!B6E("2$L!<
MJP+6R>@DR_[L'N)&1 J*2 %?;!'IH[Y P'N^S$!),\"7 "9 /MR\_N.%CR;Z
M'SU0^AUH6-?(]@3"3%0N N^)%<* E(GN0?!%@#YQ$R#X*D"/W 4=:%@!>&8;
M F F2A;!EP&* "G1! 5\':#X$X; [8N@_AT9,FY/U0^V(P#(GZH1N(W1N(_#
M:.);@>"V0[/'+<%PWV'_ 4LZT+ AXM3ZM&80"-NWB#?XF%>4'\W<(YP=.]52
M?S8'N_ULM<)Z&+#VUVKF:B>D#YIV8/M)^+&HA;-E4HT:9B X,":ITN@_J3+,
MU8S8+TIZD/HU4>^\'93:A61--P1Z_22Z_ ]02P,$%     @ )YRE2DQ8RIRW
M 0  V ,  !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL?5/M;ILP%'T5
MY >H^6I*(T!:F:9-VJ2HT]K?#EP"JHV9[83V[7MM'$33J'^P[_4YQ^<8.Y^D
M>M$=@ E>!1]T03ICQBVENNY ,'TC1QAPI95*,(.E.E ]*F"-(PE.XS#<4,'Z
M@92YZ^U4F<NCX?T .Q7HHQ!,O3T EU-!(G)N//:'SM@&+?.1'> OF'_C3F%%
M%Y6F%S#H7@Z!@K8@WZ)ME5B\ SSU,.G5/+!)]E*^V.)74Y#0&@(.M;$*#(<3
M5,"Y%4(;_[TF6;:TQ/7\K/[#9<<L>Z:ADORY;TQ7D(P$#;3LR,VCG'Z"SW-+
M A_^-YR (]PZP3UJR;7[!O51&RF\"EH1['4>^\&-D]<_TZX38D^(%T*4?DE(
M/"&Y(-#9F8OZG1E6YDI.@9I_ULCLG8BV"1YF;9ON[-P:IM78/97I[5U.3U;(
M8QYF3+S"Q!\1U6=$$BX0B@86%_%5%['C)VL787I=(+DJD#B!]$.,["+&C-DX
MS#";O-]DV?U%W.HS+@T1&&47ANCJC.V=_\/4H1]TL)<&?Y<[U%9* Z@9WN!%
MZO"9+06'UMCI'<[5?-GFPLC1OR.Z/.;R'5!+ P04    "  GG*5*(8N%S"@"
M  !Y!@  &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6R-5=N.FS 0_16+
M#UASST4$:9.J:J56BK;J]MDADX#6QM1VPO;OZPO+LHDWR@O&PYDSYPQX*'HN
M7F0-H- KHZU<!;52W1)C6=7 B'S@';3ZR8$+1I3>BB.6G0"RMTF,XC@,<\Q(
MTP9E86-;41;\I&C3PE8@>6*,B']KH+Q?!5'P%GAJCK4R 5P6'3G"+U"_NZW0
M.SRR[!L&K6QXBP0<5L%CM-Q$H4FPB.<&>CFY1\;*CO,7L_F^7P6A4004*F4H
MB%[.L %*#9/6\7<@#<::)G%Z_\;^U9K79G9$PH;3/\U>U:M@'J ]',B)JB?>
M?X/!4!:@P?T/. /5<*-$UZ@XE?:*JI-4G TL6@HCKVYM6KOV[LDL&]+\"?&0
M$(\)T>V$9$A(WA-2:]XILU:_$$7*0O >"?>V.F(^BFB9Z&96)FA[9Y]IMU)'
MSV6:+0I\-D0#9NTP\003C0BLV<<2L:_$.KY*CS\6V%PC9KF_0N(UD=C\9&HB
M#_T$J9<@M03IA""91Q==<)B9Q;2N2!A>&+G&9.$G0C*OD.Q*2)I_TNS<2Y#?
MWXJ9EV!V1RL<)I_:G%]TXB;D@XRY5\;<TXC83[#P$BSN;X0>0]ZC$=[1B@$T
M?>71!69S&^.DX,F!92".=K9)5/%3J\S1F$3'^?D8FP-_$5^;N6H'P3N-&\H_
MB3@VK40[KO0XL8?^P+D"+3%\T!]>K?\#XX;"09E;/;:0<,/0;13OAD&/Q[]-
M^1]02P,$%     @ )YRE2I  ^ T; @  !08  !D   !X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL?91M;YLP$,>_"N(#U 0()!$@-533)FU2U&G=:X=< JJ-
MF>V$[MO/#Y02\/HFML__N_O=$5_6,_XJ:@#IO5'2BMROI>QV"(FJ!HK% ^N@
M53=GQBF6ZL@O2'0<\,DX48+"($@0Q4WK%YFQ'7B1L:LD30L'[HDKI9C_W0-A
M?>ZO_'?#<W.II3:@(NOP!7Z"_-4=N#JA,<JIH="*AK4>AW/N/ZYV9:KU1O#2
M0"\F>T]7<F3L51^^G7(_T$! H)(Z E;+#4H@1 =2&'^&F/Z84CM.]^_1OYC:
M52U'+*!DY'=SDG7N;WSO!&=\)?*9]5]AJ&?M>T/QW^$&1,DUB<I1,2+,KU==
MA61TB*)0*'ZS:].:M;<W\69P<SN$@T,X.JC<GSE$@T/TX9"8XBV9*?4)2UQD
MG/4>MQ^KP_H_L=I%JIF5-IK>F3M5K5#66Q$G489N.M"@V5M-.-&L[A7E4A$G
M\:A!BF#$"%T8^W 1()RE6"JBP)TA<A8:&?_H#G'M#A [ \0F0'P7()EURFI2
MHVEMI[:S;I8.39RZ0=9.D+4#))V!6$TR23+'6"JV_Z%(G!2)@V(SHT@6.5:S
MCI4.21RY.5(G1^K@V,XXTD7+PV .LM1,/YT%09-718%?S  27L6NK1E^$^LX
MXQY#\RH_Y'9 _L#\TK3".S*IWK9Y@6?&)"B4X$%]FUK-Y/% X"SU-E5[;B>3
M/4C6#4,7C9._^ =02P,$%     @ )YRE2A)S0)W> 0  900  !D   !X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL?539;MLP$/P50A\0ZHJ<&I* V$71 BU@
MI&C[3$NK ^&ADI25_GUYR(KBJ'TQR=7,[ ZYZWP2\EEU !J],,I5$71:#WN,
M5=4!(^I.#,#-ET9(1K0YRA:K00*I'8E1'(=AAAGI>5#F+G:292Y&37L.)XG4
MR!B1?PY Q50$47 -//5MIVT E_E 6O@.^L=PDN:$%Y6Z9\!5+SB2T!3!8[0_
MIA;O #][F-1JCZR3LQ#/]O"E+H+0%@04*FT5B%DN< 1*K9 IX_>L&2PI+7&]
MOZI_<MZ-ES-1<!3T5U_KK@@> E1#0T:JG\3T&68_]P&:S7^%"U #MY68')6@
MROVB:E1:L%G%E,+(BU][[M9IUK_2M@GQ3(@7@LG]/T(R$Y)7@KM-["MS5C\2
M3<I<B@E)_U@#L3T1[1-SF94-NKMSWXQ;9:*7,MV%.;Y8H1ES\)AXA8D6!#;J
M2XIX*\4A?D>/WR8XOD?LLNT,R::)Q/&3-R;^46*Z*9 Z@71=P,/-)7C(SD&X
M=Y%&]]F-DPU4]B%+;FK!J]=A(%O7R I58N3:WL,JNLS*8VQ?]R9^,#/D6_Y5
MQ@_@-R+;GBMT%MKTCGOA1@@-ILCPSG1U9V9^.5!HM-WNS%[ZSO<'+89YJ/'R
MSU+^!5!+ P04    "  GG*5**J<OC]X!  !E!   &0   'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q]5-MNG# 0_17D#XB72]AD!4C9C:I6:J55JJ;/7A@N
MBB_4-DOZ]_6%$$I07K ]/N?,''M,-@KYHEH ';PRRE6.6JW[ \:J;($1=2-Z
MX&:G%I(1;9:RP:J70"I'8A1'NUV*&>DX*C(7.\LB$X.F'8>S#-3 &)%_CT#%
MF*,0O06>NJ;5-H"+K"<-_ 3]JS]+L\*S2M4QX*H3/)!0Y^@A/)P2BW> YPY&
MM9@'ULE%B!>[^%;E:&<+ @JEM@K$#%<X :56R)3Q9])$<TI+7,[?U+\X[\;+
MA2@X"?J[JW2;HSL45%"3@>HG,7Z%R<\M"B;SW^$*U,!M)29'*:ARWZ <E!9L
M4C&E,/+JQXZ[<?0[Z?U$VR9$$R&:"2;W9X1X(L3O!'>:V%?FK#X238I,BC&0
M_K)Z8GLB/,3F,$L;=&?G]HQ;9:+7(ME'&;Y:H0ES])AH@0EG!#;J<XIH*\4Q
M^D!?)3A]1.S3[0SQIHG8\>/_3,3; LFF0.($DF4!=ZM#\)"]@W#O(@EOTY63
M#51ZGZYKP8O;82 ;U\@J*,7 M3V'171^*P^1O=U5_&C>D&_Y=QG_ '\0V71<
M!1>A3>^X&ZZ%T&"*W-V8KF[-FY\7%&IMIWLSE[[S_4*+?GK4>/ZS%/\ 4$L#
M!!0    ( "><I4KC[4PME40  .D< 0 4    >&PO<VAA<F5D4W1R:6YG<RYX
M;6SM?6MSVTAVZ.?-K^C:>!*I"J))\.W9;!7U\(P2VU(D>:=26_<#1((2UB3
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M'"C[+2K SK,4?I_'7DO=P1U;)+C#QSA,3,.8L'?%)IK'__9[NM'Y4_S[/X9
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MK$;:84# M,S\_#?%@G3$S]X)^)V:#B;!E#%R/G4<(-M19F,0F2W#!*><99Z
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M*+."'#P55ZF*4$<K%Z:;H(02:;P2MS(GY\>S6_'3^OYG<02_<176.Y!_T@?
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MX9XX/M5NH-I-O<WVKD''8_MMG1Z&>F7&4.3Y]43Q)5>L?:3O@,8'4H/W^GG
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MZEYAW/F"E<5,$__3;N.GF=^A6]5E.7'G'N2]8LU';/X9W?=WUS\ 4$L#!!0
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MG,_&/SLMW@!02P$"% ,4    "  GG*5*'R// \     3 @  "P
M    @ $     7W)E;',O+G)E;'-02P$"% ,4    "  GG*5*9O,+8((   "Q
M    $               @ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( "><I4HXP5?([P   "L"   1              "  9D!  !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( "><I4J97)PC$ 8  )PG   3
M      "  ;<"  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ )YRE
M2IV;K/J* @  1PD  !@              ( !^ @  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( "><I4KC>ZGA0 0  /L4   8
M      "  ;@+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M"  GG*5*-,\-7E<"  "\!P  &               @ $N$   >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ )YRE2CHM$V4P!   #!0  !@
M             ( !NQ(  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( "><I4KF+ZOP7@0  *P5   8              "  2$7  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  GG*5*Y4SH#;(!  #2
M P  &               @ &U&P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ )YRE2G070JRV 0  T@,  !@              ( !G1T
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( "><I4IRXJPB
MM@$  -(#   8              "  8D?  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    "  GG*5*9Y0%"[@!  #2 P  &
M@ %U(0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ )YRE
M2M_OLX.V 0  T0,  !D              ( !8R,  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    "  GG*5*_";\7+8!  #2 P  &0
M        @ %0)0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( "><I4J\LQ2YMP$  -(#   9              "  3TG  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ )YRE2C-Q1@*U 0  T@,
M !D              ( !*RD  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    "  GG*5*LVD4C[<!  #2 P  &0              @ $7*P
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( "><I4HV_3A8
MM@$  -(#   9              "  04M  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ )YRE2@/&9IJW 0  T@,  !D
M ( !\BX  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  G
MG*5*^AGH-;<!  #2 P  &0              @ '@,   >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "><I4J&KPX%M@$  -(#   9
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M970R,BYX;6Q02P$"% ,4    "  GG*5*%>SV3,$!   W!   &0
M    @ %P/   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M "><I4KI^M?+Q0$  #<$   9              "  6@^  !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ )YRE2BP29(2V 0  T@,  !D
M             ( !9$   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    "  GG*5*LCS*=K8!  #2 P  &0              @ %10@  >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( "><I4H58&>@N $
M -(#   9              "  3Y$  !X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ )YRE2N<P&*_1 0  G 0  !D              ( !
M+48  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  GG*5*
M[V\>CK,!  #2 P  &0              @ $U2   >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "><I4KI*1,!M $  -(#   9
M      "  1]*  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ )YRE2A7;=^JW 0  T@,  !D              ( !"DP  'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  GG*5*J.0ZSMP!   !!0
M&0              @ 'X30  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( "><I4KBJX><M@$  -(#   9              "  0M0  !X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ )YRE2FK:A2 9
M @  U08  !D              ( !^%$  'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    "  GG*5*-+Q*,/T"   -#0  &0
M@ %(5   >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( "><
MI4J9"$'O*P(  %\&   9              "  7Q7  !X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ )YRE2KS00IUL P  2@\  !D
M         ( !WED  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
M    "  GG*5*GD8.:>(!  "B!   &0              @ &!70  >&PO=V]R
M:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( "><I4H8V5N=^P$  ',%
M   9              "  9I?  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL
M4$L! A0#%     @ )YRE2I8 2GV> @  2PH  !D              ( !S&$
M 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  GG*5*EK,8
M!M@!  !>!   &0              @ &A9   >&PO=V]R:W-H965T<R]S:&5E
M=#0Q+GAM;%!+ 0(4 Q0    ( "><I4H<&R6QV0$  %X$   9
M  "  ;!F  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
M)YRE2D/NXNE^ P  +A$  !D              ( !P&@  'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    "  GG*5*J1!OX;X"  #?"@  &0
M            @ %U;   >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( "><I4JX G>U30(  !L(   9              "  6IO  !X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ )YRE2CVBTE/$ 0
M5P0  !D              ( ![G$  'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    "  GG*5*)OG.-@ "  !H!0  &0              @ 'I
M<P  >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( "><I4J"
ME^(M^P$  " &   9              "  2!V  !X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ )YRE2F%2Y*W_ 0  Q 4  !D
M     ( !4G@  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
M"  GG*5*?4V'INX!  #1!   &0              @ &(>@  >&PO=V]R:W-H
M965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( "><I4K_Q2X4U0$  &($   9
M              "  :U\  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L!
M A0#%     @ )YRE2IIX9HL6 @  ]@4  !D              ( !N7X  'AL
M+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  GG*5*B)HO@Q "
M  "C!0  &0              @ $&@0  >&PO=V]R:W-H965T<R]S:&5E=#4S
M+GAM;%!+ 0(4 Q0    ( "><I4JK,Z]*7 (  )8'   9              "
M 4V#  !X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ )YRE
M2@!J*E7% @  _@D  !D              ( !X(4  'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6Q02P$"% ,4    "  GG*5*_OC]2C,$  "B%   &0
M        @ '<B   >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0
M   ( "><I4II,>;*P0(  )4*   9              "  4:-  !X;"]W;W)K
M<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ )YRE2DQ8RIRW 0  V ,
M !D              ( !/I   'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q0
M2P$"% ,4    "  GG*5*(8N%S"@"  !Y!@  &0              @ $LD@
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( "><I4J0 /@-
M&P(   4&   9              "  8N4  !X;"]W;W)K<VAE971S+W-H965T
M-C N>&UL4$L! A0#%     @ )YRE2A)S0)W> 0  900  !D
M ( !W98  'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  G
MG*5**J<OC]X!  !E!   &0              @ 'RF   >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( "><I4KC[4PME40  .D< 0 4
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !' $< 8Q,  &?K      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>94</ContextCount>
  <ElementCount>234</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>30</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000200 - Statement - Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/StatementStatementsOfFinancialPosition</Role>
      <ShortName>Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000300 - Statement - Statements of Financial Position (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/StatementsOfFinancialPositionParentheticals</Role>
      <ShortName>Statements of Financial Position (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000400 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/StatementsOfOperations</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000600 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/StatementStatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>010010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>010020 - Disclosure - Recently Issued Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/RecentlyIssuedAccountingPronouncements</Role>
      <ShortName>Recently Issued Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>010040 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>010045 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>010050 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010060 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>010110 - Disclosure - Long Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LongTermDebt</Role>
      <ShortName>Long Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>010120 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>010130 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>010140 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>010160 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>010170 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>010190 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>010200 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>010230 - Disclosure - Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/Warranties</Role>
      <ShortName>Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>010250 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>200000 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>300010 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>300015 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>300020 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/Inventories</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>300030 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>300080 - Disclosure - Long Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LongTermDebtTables</Role>
      <ShortName>Long Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/LongTermDebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>300090 - Disclosure - Derivative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DerivativeTables</Role>
      <ShortName>Derivative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/Derivatives</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>300100 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>300110 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>300140 - Disclosure - Employee Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables</Role>
      <ShortName>Employee Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/EmployeeBenefitPlans</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>300150 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/CapitalStock</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>300180 - Disclosure - Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/WarrantiesTables</Role>
      <ShortName>Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/Warranties</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>400000 - Disclosure - Summary of Significant Accounting Policy (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/SummaryOfSignificantAccountingPolicyDetails1</Role>
      <ShortName>Summary of Significant Accounting Policy (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>400020 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>400031 - Disclosure - Goodwill and Other Intangible Assets (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsNarrativesDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>400032 - Disclosure - Goodwill and Other Intangible Assets (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails1</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>400033 - Disclosure - Goodwill and Other Intangible Assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsDetails2</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>400040 - Disclosure - Inventories (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/InventoriesDetails1</Role>
      <ShortName>Inventories (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/InventoriesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>400050 - Disclosure - Property, Plant and Equipment (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentDetails1</Role>
      <ShortName>Property, Plant and Equipment (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>400120 - Disclosure - Restructuring and Other Exit Cots (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/RestructuringAndOtherExitCotsNarrativesDetails</Role>
      <ShortName>Restructuring and Other Exit Cots (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>400130 - Disclosure - Restructuring and Other Exit Costs (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/RestructuringAndOtherExitCostsDetails1</Role>
      <ShortName>Restructuring and Other Exit Costs (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>400140 - Disclosure - Long Term Debt (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LongTermDebtNarrativesDetails</Role>
      <ShortName>Long Term Debt (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/LongTermDebtTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>400150 - Disclosure - Long Term Debt (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LongTermDebtDetails1</Role>
      <ShortName>Long Term Debt (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/LongTermDebtTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>400170 - Disclosure - Derivative (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DerivativeNarrativesDetails</Role>
      <ShortName>Derivative (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/DerivativeTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>400180 - Disclosure - Derivative (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DerivativeDetails1</Role>
      <ShortName>Derivative (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/DerivativeTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>400190 - Disclosure - Derivative (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/DerivativeDetails2</Role>
      <ShortName>Derivative (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/DerivativeTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>400200 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>400210 - Disclosure - Leases (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LeasesDetails1</Role>
      <ShortName>Leases (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/LeasesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>400210 - Disclosure - Leases (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/LeasesNarrativesDetails</Role>
      <ShortName>Leases (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/LeasesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>400240 - Disclosure - Income Tax (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/IncomeTaxNarrativesDetails</Role>
      <ShortName>Income Tax (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/IncomeTaxes</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>400250 - Disclosure - Income Tax (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/IncomeTaxDetails1</Role>
      <ShortName>Income Tax (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/IncomeTaxes</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>400270 - Disclosure - Employee Benefit Plans (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/EmployeeBenefitPlansNarrativesDetails</Role>
      <ShortName>Employee Benefit Plans (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>400280 - Disclosure - Employee Benefit Plans (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/EmployeeBenefitPlansDetails1</Role>
      <ShortName>Employee Benefit Plans (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>400320 - Disclosure - Capital Stock (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStockNarrativesDetails</Role>
      <ShortName>Capital Stock (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/CapitalStockTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>400330 - Disclosure - Capital Stock (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStockDetails1</Role>
      <ShortName>Capital Stock (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/CapitalStockTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>400340 - Disclosure - Capital Stock (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStockDetails2</Role>
      <ShortName>Capital Stock (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/CapitalStockTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>400350 - Disclosure - Capital Stock (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/CapitalStockDetails3</Role>
      <ShortName>Capital Stock (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/CapitalStockTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>400360 - Disclosure - Related Party Transactions (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/RelatedPartyTransactionsNarrativesDetails</Role>
      <ShortName>Related Party Transactions (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/RelatedPartyTransactions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>400400 - Disclosure - Warranties (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/WarrantiesDetails1</Role>
      <ShortName>Warranties (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harvardbioscience.com/role/WarrantiesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>500000 - Disclosure - Segment and Related Information (Narratives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/SegmentAndRelatedInformationNarrativesDetails</Role>
      <ShortName>Segment and Related Information (Narratives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hbio-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>500010 - Disclosure - Segment and Related Information (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harvardbioscience.com/role/SegmentAndRelatedInformationDetails1</Role>
      <ShortName>Segment and Related Information (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>hbio-20170331.xml</File>
    <File>hbio-20170331.xsd</File>
    <File>hbio-20170331_cal.xml</File>
    <File>hbio-20170331_def.xml</File>
    <File>hbio-20170331_lab.xml</File>
    <File>hbio-20170331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001171843-17-002748-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-17-002748-xbrl.zip
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M2K6U@"M(D5X9FB:;P3\>@>HHF)NW>E#]BM\4X+7/S2^)5T+$2D*74/)AI5T
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M*0)9?&^[%Q(&T*;Z:%G5^]F;3> GD_$HMN/<%\:!N-557.6Y[[I$%)YH#C;
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M[]F,#F)^-C^I-BM.C#JPL\=QMR$!1$X(ZS2LPEC*#R')Y/E/8,U/+@?4O2:
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MXI"K&$;@:36,\K6IU!NH0VL%5'(#7=_G5Z:DLLL7J-"*=]*PF@W&TXH= &P
M.I._"O(WE K-1$VJ^09._V.N1O?,=!=PZ(RK\8=A_H4;&S:FH8 NSLKNIJKG
M"REZYFBT :.V"-]4'#(O@WD9# ?F9>3=8(_R&[>6;8#IPGR,T_5+UIS^F+'T
M!Q/7UHCK9%9H D2W_9CLF>(MM9\,AP;BT#T=V9;: W)-6O=852J;W_1.ZCI-
MG\@/Q&)7ZC!7C<EV.V1;F UFHU$__;HB$VJSNL[CO>K!LWY5 NYMMX+.] D?
M[TR?/WV_O\EN1N<<';H/?WNZ>L>I0(%K6;-^>W<V?/=I-IZ.T;,AU.GOWP,C
M/LZXU1_<PXP01H$RC(0Y*2#&7K\'Q$?Y[:N?"@DA%&E3<;:'BM'7NQ"N7J 1
MD0T$_08)__9!DW5[KJO7_W3@9KU_-,%DV+;1!")/;P 9WY !OH) S0?UESHY
M3BUN8BW5?BWP2;&L4-S*TY'+7-CVA*EY.Y,K'1DQY=0NY=2/OJU"S8F]TF/]
MX'_FP0[3=]W4=\'Q\S"S=8<OE'*@U+I3V^53^5MW>B'V7Q 9!MR+ S45ZDN+
M0W]R&I ML$+:@H/KC6F\ AP=%CK63]D@I=,NM>Z0;E:*BP.AJD4O7V12GZQV
ME5G\+#.AV0L]]%565E 'YI9H(.#GI'IHE=LIQ9/!,%N*#ZN<\A:B1IW346:)
MHM1[E7-IK#<.<E!#;4-TCV4L[#?9!$SUM$2:IX.AQ%1/:Y@E",S;N7%,'=J.
M"8C&6< ?^-]5(RRF<8Y6A# 0IYGVDVF<1C%KPIR=N8/>;[Q C:F9SI:\B[S
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M(@,)^B+P/9"5PEERO!M?#,?F-(0:T0_!KM,M5YP=U\\P 8IJ4,""-C\R018
M&$J\)9#",5SY?9$U8LZL%0"N&7 O^T ;7N4T*+_@!C'H663\-2E\<;\VPL&C
M'!YJADW1RY: !7R=L$":RP1X]^J<(+J.A3#F?UD;N.$\!BVB)E@L/,6&7[>
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M#1@^>I&A%W)M<*HSRT>@"F34XR &R\M5*M'DKI=0HET$% D;PT/Y@Q4.E*'
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MO7\AEGLI-_Z5]YL[$#I(0FVYII2P-Q.D4M!GYI8JQGE2W="+U=)'@8:[P'4
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M:HWBAHDI[:"=(71Q+I24%+30&-'DEQ_#T*)TOV2-7D$XPXS++_9V%NH<*0H
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M&,63,GFLR)D9^G)@_#" ]T0R,'T-Y9RE]8+BG1>#.YJ=YP-B$XPENEF0(:B
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MUHT71]N>8I/M8JA<QD1#V: ;'G96(K4(C"]S[MI_A"P7UDS] ,Y<84O9PJB
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M'\2-;&#K*5,411E&@@3$5$"N9SX3@0OR.+<!1;[4I1+]*!G2)P#=7Q@C__
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M/CYP<.!2CP3SCP=?IU>'_SKX]\___5\?_N?PT+EE>(48]IS[M7-]_MD9T7E
M0^>"A*Y/PYAAYS,*T!PO<1 Y_SF?W#B_)8+?.X/CUR>OWSI?0Y#K7,5_D"B,
MG</#3/)OR"<>BH#4"2,4Q>%[YQ:%(7PJH0G=!5XB)T)LCJ,O:(G#%7+QQX-%
M%*W>'QT]/CZ^7B#V@)AW3VCH$E !OW;I\NCD>/#3\>GI +3R1;FN*%M>X!F*
M_>CCP9\Q?'=&L'?@@!F","?P\?0U97.0<#PX^L_GFSM1A)3P_0*^T^CS"=N3
M3X+ONJ\,WKU[=R3>9J0*Y=,]\[,2G1[QU_<HQ!O)\)94T), # O%RN@#&@3Q
M4L_@1>PH6J_P$1 = A5FQ,WX2/" PVC#)WA"[+Z>TX>CY!U7^O3P>'"X5=O@
M2_FO< *O\)54E3='R<L#J!<._/<!!0&-1-U)GR1/5RL2S*CT2#SF9GN?V6Z"
M9XZP^7M>AH\'(5FN?&XA\6S!\ Q* (@>9C#^OF+X-90P(V'4QQ4VYZ^/@"6$
M>B<*>+/]<"8",5>1HM0)$$)7F$4$AQ+P1QTKYR*_J7+ XL;^'NCFX5E3W8"%
M!,1^U7QTWU0U8,'^2VC%I4U!#X?_^#JY-N@R10'OH+V([CH<S\;P,5'#P@.'
M>!\/+F\FUQ>_EU 42K$MR1;-GX^/C\^.CYU#9R-#_ATZ=.9L)7XX*K*7?2&&
MX6H<_"Q^%QM]*B4E,9%0:%G-!>2K;Q5_^B[#ZGF E/&Z(@$,103YMS04)2P#
M5B4TQ/>D!M^-8">3W./<68-54+L%IS&(%C@BH&UI*ZYC,X3^M#'TSJO\E_[1
MUX7NV_P(A8LKGSZ6PK\E, 3Z;0W07* C)/9X[H3G!)QZ%KM1S&#R-@R\,;04
M=OE$HA$-HQR>-91&P [@?PZL-*L\='*"'11XCA#M<-F.$-YCO!/&WQ!C*. ^
MG8RG]-00NY-3!;NMD!ZCG3"ZANEU$%%6 $E^;(C2\1L%)4E*#]-., W=/V.2
M>!8YG'+/38'Z20%*%M,CM1-2GRCU'HGO9R/5-1@EF)-['P_#$.>'MEI:4T3/
MWA01S41+X]I6NI.([Y'>L>N$GWB*GHI=Y_:QJ7/R5M-U<BF.$-/CM-O4 <^Y
M_S[!*\HB</5RDX7B.U.79* @EHIR-K)ZV':"[88&\RGF&ROWT06.$/'#$QDZ
M[7L3^,Z.=0V.BW.X/(<+=%ZE(IV3?N:^&XXCM"(1\N\BZGZ7\<L]-^THWRFX
MI6(<(:>':B>H+I<KGZXQ/L<!E">Z]5'>V]2^-X5.]3HS<4XJSQ$">PQWZS8Q
M"O,.2?K$%*<SM6L4 GI<=L)ES.8H('\15-R;R+\P]?C5Y:R<G!ZLW<8L"G\&
MD6:+L/#&%"YU!2LOJ,=K)[QND]WC-1] (IA-7_X9DQ7WQF7HRHE,452]QDSF
M/\78%8G9]D9N#^I.H Y=E\78NWQ:X: PI!5?F8YMZA)E*LG)1/68[=AQ+I<D
M$MMET,*@C^,38?CKAJ![XI/B7H )N2FV_])TL1OIHF%NY3O2!WK$=VNEOD\?
M>1#@%647-+Z/9K'/9]#Y]EI*9+K><J*VW$RF,Z/,R:2*V7N/Z6Z8_AHC%F'F
MKS=Q#=<!&'DI%(L#%'LDXO&M6X -.4S15N<@FP](L1;2)YQ7FX_TZS6[@;\U
M^UV\7"*V'L_NR#P@,^)RO\EU:2RZT5OJ$^ -LW]SRZK-.$VJQ<FQ;M*3?HB'
M9DB?<K;?<K*/.*^R7WT%>=X=KBF"GXWVN5(.DVIP"I5@T&JWRWF5?*:'O[.(
M 15I]:4IJ.H +\GJL>L&N^I8*A5.(WI3A-4%X/H(K![X;H"7 SQ4F#5O34%5
M/3596 ]?-_!MP]U4\)1WAM!I)LQ;43UPW0"GVS%3(:R@,@53;8?ZW;4>V&Z
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M]4!V Z1T0+4N@;_XTA1 M5^5S[#NP>L&O-*3E#3ML8;4%%A-%%W%T4L]T-T
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M4N0PNA52+H/<H><&Q"^Z]%<;&.)%_N9(>G$U:.ID)#\FV(/!EU?L8((?J/_
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MH.NB?/MTB>CO2_TD'AE0VI2\V) @XJ1'DFFZ!R$>;"Z!SBY*EIM8 IV]II;
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MELGC,'['IO"/E/3S\#KHBU:US!1/1YU-B/.M*$4'T*L\5P5(?OVV7 M@N4)
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M_PJRX3 .IS<#5[,G(Q/%*:D4CML5?SD2'X70DU&97=Q>Z"+4P?$&AV/F5QM
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MV4%<QSYUW%C>-^F1)".]/DLF7@P2W?SHI#*"+(0J9$6]T4V2-FVS<!W0-&W
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M4O4\T(0DF" 0&P,>'*:L]-[ %T=P>-!@EH"?7AJ2C:6KRE8'P29@=Y]J,(K
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M;:H' 2=XLHL">;-1R&6NM1!TF#,\)\^9(@"KA@ 7>+*$ EGS+%0F:QC"%%;
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M^;(?)+7-DG_E7ACTQT$T.//2X648O\'A6\F>LR9> 5)"4V+'TZ,4Q.N* 4-
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MSX.0/SIOI0,2&M6JZFM!Q@ZF;8[>RNJDB?+9K1BGI-4VYS,G%:76US$.*$C
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MQM&(T. P3(> QCMY)E'@EW7I?2)=WM>43()N<&7;F18J'D9J''((X0ZC\RU
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M4^5EYZ/ZHPPU\9IM*K$_9#7CK4L'X7YA**P"T7D@%VR4P8A(!W<TT<&-[?H
MD)**YJ&$L,@P'&U"22T7J^Z:B.1Q1U-2A:UW?[_^VY:120<AC*%#6PRXZ]<'
MG,@$=S0QP5OOG@<\^=&>@"-4+G1HBP%/\\E=^7)WMLHH=N)YP5='6"*S ]SS
MB(>O8A(9>-YE$'YUPI+UU_T.D<CM:")R/V!A#IZTJISVYI79IK;J3;+Z3-Z
MI7>P9SE,P:\%Q!FD>#<:7G*Z6AF<B.QM1Q-[^_[UMX3(Y&C!Y#S!(^8;SPA?
M\$(A^ 99V!L>RZ.5[L+@U9WQV>GZ2R2/<LR/ SV9QNYK12JO?H?(S78T<;/-
M#<L (VJPJ3IF*JW#GM;%0[OS"L8QA#"Z, R'A"$B?=O1N>3V6P82PM'"6!@'
MTJ7KB]Y]R]75*WG['2)UV]%$W>YNX-;Y=W,QSHFV4/7]*E)'Y_[ YMD]"O@R
MG:FAX,<"P SRO"7^E_G HT8M59=(^W8U+0=N;AAHI%($B?^?EK6H@>HB=# ,
MP2'AA\@(=YLQPMM'[#[6=7@WA7+?/*00<AA&Q49(U?1Y72)+W-7$$N]N(-+G
M;?JY8N^'X<MXG]=%*&,8&^, 0\:O=0 C\LI=3;SR[@8B ),Q1,?HYO&$,-(P
M%*WBZ<J?!@M^'92=_-/O$AGIKLXTO5L&%/LN+S!^W$_!\D*T#=+1C:)-))J[
MFHCFTD"[ZE?VO0SX#\8CCM#!T*.619S(!7=WXH)W7/UB]_>-\+_0F\9'!P@C
M408%(O_;;9?_10P#TQ=\L(D1+,;1A##!,""'A"8B$]PUP 1_8Y!".&$8E7;5
MR6"QY#'/D_Y5GC37[Q*YWZXN[K?4D!PM@<_2(IL,A]:<*U=P3 $9)LG<P,\G
M;$F'?_&VY'Y4MHND1^1N>[JXVS([,ES<QB\\9#SYT0H5NX?PLM"]%D.!2,/V
M=EJ8NVLW<X!X0$A5Z.,V\1#S;$-69:K^?H_(FO9TL:;0@DTW(2ZQ97+->.01
MMA/ZM,7(KV1?>3L_746NSR-Y;N/TKY4;\K)5<CTBJ]G3Q6J6&I+C0)60"ZF?
M\C)B()D4,HX+A+6$KFX/%SD;G!S;>;F*5R%/UZ+>I3OKSE>E_061S^QI6F';
MT*J\X\CY[:3\$4N._$CJL6QI;E:3B:K&<83PH3 :!X,C(E/:VXDIW7'<\4\
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M.3E[;GPH,4+$&AB^ED'["_=YZ'C5J?%'1*%EI&M+$;1@*T53O$$7FP:1!1!
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M6#.K,'05*C!9PT8,(?H1C(01#-6?>-B\,R9*/B--VXJ(UF(;T@[J+,<1HL[
M6)D9',ZY&'W+4^?$5\SCZ,2?%0Z1:X8ZHI RTK1KZ8-68BU<=@/59R:W4%NU
MM\[;LP]VB/(!@V5D^/8B><SHRL^9R-NY2@ZE7-L,=40A8Z1+R/B0D>B@+:DO
M)A3OZ%B5*"M%H86H0U0&&"P3J+MT?3?FUZ*KF%WYL7"N*UQ7B$89THA"P4A3
M_JSFAF'H2NI\4I78IE:&JZ<U^^S\/1!=K#P<-X69>6PAC#\,CYF.]*G9C'-,
M)/O'NLC^"E/P+O$IMK#U&2,</W2YT3[O+@S^KM:VIG/NVR?/?4XXH&8((JH
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MLHU(((HNW6:BRR1!@L^?Y7CMN@(0-TF1!I"XYE'T,YNFP)!' #N>IUH6XVA
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M9T]+=J\DSTN&*T<L>Z1JD(U#'9&^8.P/ .IH7_M+&$1ERGN?J)GU=6EF^_=
M ^Y1E3,-QCXBN,$P'0 8KVM6??2)DEQ?ER1'-GB[#46Z^&(;>IJUH:?8OOUK
M>]:-]!%Q#\;P6P F40CL[R0$+E7C\Q [87Q=@=%",0U(O16UD].6TS.&"AF<
MHN*F?.,@1&1%&*]O 81$M;"_DUJ8H.O"K]R*E1?2 , S+X@. X"(  AC=0
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M._[4%7/,(%)4=QVFB!SN6!^'6VL2VB2=GER?W)Q=L(=?+RX>S3=$"(<+76X
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MQCW\^KGYX75Y@4?B#/P8(&34'-<^3<\],<WN)'@^EF=P.B!"T4%'4!3I02$
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MKKH(-1SI1J::K$BV9,QG4UG*NJ&1\( YTOT:FLC^K_I@_S4,?^ N9&Z*D@<
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MXQ@0X&X.:@^&)(+S01_@_+AAUWX"\[T7\F@K9G]IYC?@"1!(;1J3(*"OY2&
M(URBR.1&/#U&@0];B1?'=47DT8,N>'3-+A4KTE)Q>8HM85!#W7V<[MB[<MT?
MW/$M"&PV[6%/&D2N/.B#*S>42OF=PTN)]WR)=!X)>R=UI'W.[@?KBD&HKFFF
MEA4SKJ\8(M == %T:W;IA#,9.^],$*)KVL.>-(@P=] 'S&THE7.<R=@A9X+
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M9!#Z;IJ.$JY:>W6OUI@0>?JD"YZ.??\\:OG+M9/7IDP0W&T.;D]&)0+L21\
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M'G>H([+O<Q!^:UJ,<J)-U$CNE^4!O(W6XD&A2BY$?CMKQ&]K.I?*3N3S$!2
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MB2\>(E@MA[Q:7U08/NH"AI_NS]Y\)DNRK"C399W)[C'"$+DY\';L3P7FHSZ
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M[*ZB$\5-D?KMC-]E!>S;%V-VY3'6W_"S*")>$?\2?SQZ"?^__Q]02P,$%
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MD@)?4U51EMK9T68;NU&' Y<]Y,Q++0XHM8A3YK-JX<7!P6FCVM&?2'M==DS
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MWH7KQP$<0DDC&=N%&[$(((7CF':4T6$<4CFUWR91O99A>^P(U*<C2BF,3A1
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MCJ4P=$Z@EB, 0M?"KB-Q1P<NR+I+]"Z3T-5L-+X'?1U$/RCDG3]HT;>4K:'
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M3<A%I6T/4NP46B^14(13A\E*(!36K?0=V_RDPW""#W$M4!'*YY852L0E$P!
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M:P&FT/UBQW(^<]KJ)66@5>F]Y\M.<:L_!:(IK<HZG.;KZ3; :MW:SZ*,;CN
MKOKV*>CCVJ^!=$KKI0Z_12I9@[&N <3??ZN"_0KSE?^P^?=K7&!O*0LGJUM#
M6WQX\>)7+YX\^U$R]EDX9G\%@I:NQMI3H.#8Y&V-KM[\='G0YZQ2<9VJ!Q;@
MV9=VOEUYGM&QRUN24C(O_60<1$D6LR<0]GD@/V8RF1*80"@XU90=W_S,65&W
M<SBPT3\\?*$^/V5Q=^@Y 0ZN"%FQ3-445:8 KKN\H+E&X;N^S<DG ("$/"YU
MD0A/<Y4P$S&EZBL5SORC)0D57BEWGN2.!"8[=?FV"%.U&=%0 $7(&91R7^0
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MNN:T =XX\)(DWW*6ATYB'%N_!_()!<0R-O,UC@.,PM6+=I2.7/=SS?U790Z
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MO7V-$L6U5&,&(+LCH=,)OW14!VJI?_T[,#IQ>F#TRL*,/;!Q- M]_7-SZ7B
MUY'0Z41RH*0$M-32_ITPG;A]EW&M__FU#R)@7V'1F"RE( VC).,!7D?BJ1/9
MHXTJ0$LM[=^QTHG#R$K0L%]O456?" !W)'8Z$<9.NHA+!>[?.=2)6;!4[XS>
MS!>>'R\?*L:N5/E"H*.1FK.,3DX[$A"=U 9$1G!+7>S?2=2IPY.H2Q;[KZ U
MK[IG]/R! *@C(=.I\+1)AK!4R/X=,)TZC)2N85'XEQ=D[&Y:*4G'%U'GJ^H=
M68Y490Z V9&(Z508,6F +36V?V=.IRY?.?GH>X=Y%A8FN?[<+1^'0T<+.T?
M*I(WFE/27X,9@04=B:Q.Q2^>F$(O=;M_IUBG#F.M^SA*%@Q?GF;#291+X6YZ
MRWY4Z(VC$/XX9LLKL,K-/(RF!69T) X[%<9AS?"7)?U.C[#H:8;#XZ_*<Z!"
M:F^C]-\LS8&M[KYQ'6R#.4<GGPE%ALV$*?+,C5E#Y ZC[&75I[PT^.=[7_7D
ML\-8^''\PB99 ([T)J5 ?(DCEXQRCVC]&8$%A*)G ^D)?#M3;E"X+^G2)AR&
MXRN9?0A(6_>W1@(D0J&W@314=)R#NNX^II.G@Y=%_^"TNMUK/FX?&#P@S!T)
MK':9$*BL<P6)1:,OX\U#- V )13Z2Z6BMC_( 1/QY!X8IMK&^/9-."O=N:LW
M/\TKO]W:UB9M#RSPP!,>HD>>=V!3M#3E>4 R#I,5*_WA$+P4B;;Y*<T&T FE
M)C0EIF*3&EP@8IK#\7\S/\F+B!P;XGF6^"%+DHMH_NR'RU8]JQA6T0K5)@$)
MN'QCYT-=2FJK0CA_K_R7OAVJ3SDZ&1!*@^@(3L42=?E (7S:J04,2"01I&):
M-47%ED'^A,5:W<LL?@E81BCIH"-F*_:BQAXBD=L?7AQ[8>H\<+N/HPFX RMR
M5@Z_1K)?.@7PGD3Z8YW6][*-\;MA2*<V'8 GE"A1%Y>*5>IP@(A#6?=RG.-,
M/?7WXP8D\C!YD((A3$GH2G3ZIJLR&0 GE).Q(T85HU;G#06GE+[UD,BF7+QX
MX!PE-R$LV?]A8PCZ"TKOG@-_YJWB:P-;TIX:F$(HSV)'Q$J69<@I"OT?Z=L9
MB93)AX@K)9VX?E9* AI8F,*DHY,S0FD3.V+5LBUE'E%H<$G>JLY(I&%N67J=
MH<?_"%J<F9J1<!: 2BA]8D=P*G:CP!0*C37I&PJ)#,=PCD5T27'U^D\VN0G/
MO0!?[7A\8<ST[%IK5F %H7R''<&J&)(!DRAT"*5O6"2R#S72S:GGM.6P9VCJ
M7P%6]2I?<::8K[# - H-4ND;(HE$!OCSV3P_1$I^3]C$U-!$LP#47J4GSA33
M$PI,H="/E;ZAD,A$X'MMX^7-N^89")7)1J>?>I5Y.%/,/*CSAD*[6.K6<_J)
M1,;A:CIEXW3M5;+?P^@Y87'>\?\F7&1ILLKG-K4O.Y\#YO4IAY&K@HH%VN1>
M72-=!\?47YF7N*X.6=*@:/CK/P9>DLB'7&=I%K-O?NC/L_D#2BJX]][SBX77
M47RWR*N$PEF%V_JVV^ ;P"9"N9(Z$:J87V,&$"D-N? 6/M#^F )A;BTO)^$E
M"H M"3Z0D+[?1JGJG1KQ8."XS<>55UJ0?W;9Y"')2\OA>SZ><>;_\'N(*_NR
M=/W](0J":13_ #DHV5P+7P(V$$J6J(ALVQ);8PN%NHYV38!$*F/5)Z58+H<H
MD*H8\1QSJ8^KT-QPE[+Q,6 <H<2(BI!5MB][G*%0I]&NW9#(;)0EG(_@W_MX
MO%+7;J@:E:]2P_<L]B/3.V26OSLZ/2"4+U$1O5(LU@:3*)1JM&I8!R22'G\P
M?_:"5PQ?P66?L=ML_LSB8H$TW7<TY@0V$$I?J(A,Q2"T&4"AW*)=92>1&JA?
MF99B&6;I2Q3CFO0[!)-QQ1?(:Z'/WZ_>6#SV$W8/'C9[P,12$X_,+@' 8$))
M!15ET//2VN 6A4J,=FV.1!7%;12^0E@*(2G*K8Q&3<OY%"8#X!T*\P\4*Q[4
MD=<5-CC(K#VR61Y8?70<N FG43Q?WM!TFVE;4O; %E&,2<IOS,.[</AW^G<A
M]28#"=%(0VQ079'-^7OQCP:[F\ZLP I*B04#,2IM8?HL(9&)<VHB)#(.Q8M&
MUZ N5[ ,QJ$77&1)&LUA(1^F:>P_9["H/47ENX98D(9MN<[?O[!H%GN+%W\\
MC)EGTK?&\I='IX>4L@X&ZJ!B:BVQC42"SZ4Y'I+(4UR%*?@[?_@3MB+R+ER7
M7++Q'LE->!-.P$^:9%ZP+?7E'Y4?SM@E*<!T2ED1 X512AONB(\D,HE.+=@L
M^5)_^GO+TJ4HMM9-Y6-=Q2F <$I)#0.F<\YOM?#7I08)=KZ^Q7X@^:,[ERSU
M_. G;()]>N@PX3*<HUK^61RP;%(KP2D>#, ()50,9,+?C%2 4XC'7"JUPX1%
MY7W.K=;C%<E=O6%RF-W"^O;T@P6O[%L4IB\RI6\V.3"&4/K"0*9\H[#!& I1
MDTNC<9C"T!/?OYD7/_V(K-I*,>?H](A0VL% @K9,9(T?%*(1AY9QY#";8" U
M^#RS;QLX*[""4(QO($6KUK'B"(52")?VX?(-3VVY74=9;-T\<%)@!*'8WT"&
M-JUCQ1 *-0LNC<-A@&T@-OBM?>. WP(CNAN0'PD#\B8,(5+X(,N4%?FQ@Y\P
M07;L,"RZ 7E.^=IU]38.LHD?SDI($N2ZTXU.3[H;#!T+@R$S5OSD<=")61Q4
M?R;S%*7X>+A0##>AFH*;3PB@NAO1G-1&-$V940UF@!=3%L=L\G7)<"[6'&B*
M'\U_^7.:A\TCRT* 2D<B_ % 5'=#DA/^::0 ;#7<V*NOSH;I\-!$T8%9+53'
MW3W(.!8>9*Q#_,F/)(Y)W 80Q'=Y\8-R$99L(@#<W1CY6/%2@!H3*!Q@.]$
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M*8KFP #A]B0 E.HVSY.*W@[/@TPNL]N""E.YI%,0]Q1[8;)LB+<2AP'(VGD
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M=\^!/\L57M\K%DR&R D=IUD2I)8S*^<.A:*=#E@0J0,JQ47S%N*%]C>U]:\
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M<JBPD+.]A8B8;_7!6!5QY0'OLE[(GF]5.RFBZU>.0?"(;%,NE0>YG_;F(I2
MS:X=W'W_@6&#"X@Q_XCB[U_]*5 TU[01T4R(HU]1O>#)&"/6E-:PKVL0LWW7
MD7EE!;/B76W.AYCZ%8W7]XQORJ#2/O85!F+FDZHP6#MJ.W\O3^"T4\V<>1!O
MOT)V<<MZ7<:4-K.O*1 SW6%-@9#6FC/MRB._MU$X7E9C25ADY1O IY-^)0&.
MA?4$-IE6VN&^G$ HD!.'MT]S"O'R0,Q>D.Q7MGH 1 5'K@/#R7^R),6_O67I
MW?3)>Y,PK:6O(B_[E88X$5XZ;9>-I?7N:R3$(B)5([%1^U7^2]$DT/A"G=JT
MR(U^93O$C\TTY%-I8$Z+$NBIT"=2H5QY_[:6:JRA?/K!@E?V#0*2%_V+UUJS
M(V\(A7T-1:QE5@9LHG!?BJ!QD:HC%\H5RY*??D1V;:J8%#AQ0"BJ:RA0:Z:T
MSAT*=YOH6= !J5Y!<G'"]_7O^JM-B]P@%&\U%*I=*ZKPA\(-)X)V1"MND@GT
M.LKT\_=*LR(O"$5-#45JU8HJ[*%P,XF@$9&Z[BZ7I__:PEZ$LR(O"!TG-Q2I
M72-:L8?"K2>"1M2=A /*<G5I,WEZ83'SIJG!T;+99Y!;_4A!'-A,0<CXM;]]
MI)1L);69:?0 *T:M[J?MHG$=]Z/(24);H27%T+%5BUPLLXA.[T'U2SD/2*4@
M^WZI^)!TFM.B2NDL$*URF^;!0Y=7C$-2*==FRG,>A0!\XH^9S3;-FE]&GI).
MW%I4G-VM"]L,KCM!(=)ZU?5+J!T(1TBE!1Y9_ J:A:U!M=>-REC$12B MR0F
M'1O?9@:%#;L#YD#*;;\)4P9JFQK90W4P(#LEY");$I2.0=1P@\+)/WV+."7E
MEI8)RO*!B,*?,7D.A#\5HB;D.%H2HDD>F,N;ZFF_XBN"9TLW+60SS%P[?DZS
M W9'JG)@. ?7W_\S5_^[Z1?/#Q.LOS<)[W@S(69"%0*61*@5F$E84ZT.V!M=
M*Q(C=3BS>AWAEJ6H#J@-EQE[BBZR& /;_%A.VP+5ID5N].N Y53S@$6+3P;/
MZNYM4T]\I#(5]<\4:=MB_32(ME_YBU/-_(60+]5" [TGK-,H]8*]I<F$12H)
M<O'BA3-V$VXEIQ^B(+B.XA]>K/@LD^:DP(G/_4J:G&HF332X1*&3*BW=&=CL
MA%?)Y\(7MFGB@% :B[022G<T8OBV=NNP@$)&D)@2D\I"V,R'#PCE&AJ)IT$6
M?'!,]=Z.4YTGE038: *%?W7OQ:D_]A>>2?0OF0_Q$PK[&PE1R]518@O-^SE.
MC8545#X<IYD7^UY0IFOTT].;,R!&0K%X(T%I):,YC*!YN\:I"9 *E\NP[][S
M]1%7!P.R,T+A;R/QZ"A^#0\HW&RAI?-GI*H"@"[FSXKG:\?O5V_C' 56+2[Q
M)%MPM!EC\ WD4Q\"ZS/-Z@%S5NVS2%NY-8J;2P,SJI/\H _;S&>S;6:+$=4Z
M3;W#C45^8/*80MCB^(B#E@F=D<IAM6-"9WW(9IUI9K-XC*B^965B0E?A_C1>
M=I3TF90#6"K8Q\NX .BC9-'&$B.;&#E"R-6S)&"3LT)%3E%X;XZF'IW1RZ@%
M%LJM>1,AXD[DUQ1%IYUCX_.$]G&D4QLA%17M_(@&=+LO%J-;D:+$&MIGF@X-
M!V@EQ9&V7Q Z_$3(*6LLN :&LL$2VN>83@V$8K+ QF'.X:=.I @4161^H)/S
M@?8AIE/])U7\(C]):!"1Z$R.G.E$68RBB.T>YVSQB?:!J=/(A99]U1&L;TAU
MLR#6GEA,+C0MBQ$PI-_G.TZW+E*)LU9-ZY#V$SF:0K-@6H>5QW ^[\]]6CSW
M(14?76?8+0R6Q#1+"H4P[>+'GPI1$XJ=+ E1R^ADO"DL[XR6O[<C[3BD]=S4
M-JD6T )*VD])20743-\+_/LF:DK+"ZD89SC'#I;)JIO#37CNP=^/V>,+8ZGQ
MDJ X+_*#4!QD2;Q:IYQ:C"I-[!.MO<2Y%AT:/LE6?Y_XLO".ET\I/WEO++D+
M"T6H/';.@:,S!5).^A!&3P+;BF_ # K;"$D5IQ-<+$67![-YWC.%Y?$V"L?+
M_Y";2--ID1N$@HZF4E7>+W095*V1Z6+?)9)FV"7_S38?$#\A?ZVI'"TZ:@5G
M#%I_[KLOZ;C7#M/8.847T1SD^H)DO[*E0X/W?V]9>C<%S^8>FU0"GG197^(]
M!^PINL\56I%)EKZ"O"*4!K<D>K[!VF5;Z8,Z=4([IF^'+A]1;(BB71XA;PC9
MHEV)MV:2!=?JPD$'#ZA\95["DELOCF'N5U8^GN+J[90E.8HFOOYCX.N162A9
MGRWY>&_S 1D?8'?T$#Y71"CX&J8H42(?C?02"O9JF<E)?"B#HY#S:*A2#L.B
MNP6+\R>:EE0ALPM6WTI#(.%8Q$4HW*EENF#]58!&X19-0\5SZ'4,8^;=31\8
MF'8"&L'NXPAXGKY+,/"&(1I"?D(MJ_GJ)D%%X=I)0TTS.\GF]"S-P-6!#]R$
M?NI[P1.+YZ)MLN;G0-$QH5/G6G9Q]D4^&@IW+YIIR;'5SK8%HZX*SU553:J_
M1YH(G3'5,DRB)S5P*%Q2:*@H#L]SOBZYNO#CY4N6L%P?J-"_,0114';-CX6'
M*P)$%$KT&VJ7F3_."?'>%MXR6:?G\*@-1FHI>]G'M5ZV%K:ZUEW.DABNWWUM
MJ-@NLXSK$=5UEF8Q^^:'_CR;WWOO^9,WEQDKXGN]R%,R&2*G'!L<BU.!)EB[
MGQ0Y=EC[JLCRF_#I1X29*%FMAO9\@/^$<GQR+*Q[-87;_83*B<,N".I<AZ\R
MNVK[,2/R@'+ ="+L=F .N/L9FA.'(94RWZ^C++:JN1\3(@<HAV,GPG#,&&_W
M<T8G= Y/!&SW7^VNN!\3(@<H!X G.L<LZGB[G\(ZH1^+/;TP",VGJ;1QDO9\
MB)]R1'9B(R+;@MO]S-@)_:#,CJH"UE/* =B)C0"L &E^N[VN[M9!:N["6_A
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MXJ$&"<CEOD7TA^U<T=7G:FGJ^_H&N<QL)@'PJ4OV+0K9>]4[*02'S7:'*?Q
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MD-G:% K/7=9G36D-^\8+4L8?=K'43EH(7HF?Z-X1T"$2)=6'O-6FZKFX)6#
M]W)!.=LO*%*I=K$B3U5G"/1PVJ($>=ZW[-FAH[N,/.:6I^+[U['DHC/+L]EX
M,%7)TS:<$I'U+8]U6)O'LL"ETERZ6;BZ6W-QF(VZ+Z\OY9+,::VTU96@%P]&
M9'W+^1P*<SY*_"@-HYO5F+LU#.MIFNW':K_$4:+U0+#99%B8T[>$S:$D86/
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M01<Q@UUV.(M9OI>+XGGN[Y'+A.); =LX*B8 U= G;Y/IGPU;R2K1),OI"L<
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M$#&YM5HD&[[F:X.FLW"WH,8.%^W?PYB-HUF(_:J!OG,6LJF?)A\G4?"G) M
M*K-K4(*OWB)A=]/A8A'X8TRZX<J7I0PKUN9^JJ3O+7P1>4AN4Q!)FV\8[7&'
M0C.3UBS(81A;OY0]@!1#C-J6"IA>,^"^%RSE$\7O:S\VVB&TOH \(A 2JTM3
M=^LPX0:%7BFM683#C#$^HK440Q!$/_"9D,O"8P5JATG"THL7[*AV$R[+OR1
M=:=#] 3RS>IRXNNZ(?2&]UEI*[;-K/8M2PM/,YQ]C9+DPHOC]VD48S>_8@6!
MV"P/[T3958UI  &%^_7JO.:DOO4A-[SA2EHIK=[,%[(VBID_$Z;Z%88CQ9T)
M) 5W^=6A5F^B]D[Y'(:/0-/RB*+*>J5=73 2,74FG!-W 9"C;'AUE;9FVKS)
M(S+VY#%[_@]$!4_1, PS+UA%OZ8K)7]&Q-694$IP\;\1^H9W6VEKK5GH9*"U
MUI2U3DJ="8'J;_L;@VYX/Y:V:MH,?GX/)SZV&W_.4E:Z2U=>C%?:A<6*HG%
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M-.?=-MYWE&U'=QKD,XV8&98V/\5J'98 V<63*N$,WR'Q7W,VE\^G&H;.AA]
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MQ[&!8DOS80@'+A+V*H(C_LYN(]&$/>;">&499%!2;\<'EC3.R!(BJ2$6>YC
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M7Z,XC$?3)[A227VY%;*WP$;IH)B=9.0:CT._TW#!!X][-;TD&#"@!J?2U>9
M/:&]#3O>RW58 I=" :9WI?681KSB:9;PEPEHF,E\+.D&: BE".UDH9B(U;")
M)TPVH\P>TRC%K0'Y%8A"1.DK?\/ILZ(G8.I&TD0A$;E*ZY%3*)3TKM4>X\C'
M(&.Z2V!KVP+=W8@!%5R7:VX=UKJS69\CQ;?OT?/-;]M%Y&X6[8!>0KZN,:/E
M2EF%2,&_M1&/SV.J.1VHZ:[44M!,Z0AJE9<:C5G!0"&0MY:!QVGH>_"+CR=C
M%-4K;8%N0M/1.D?EVE.'H]/ZXS$6_BXF?[3^E-L"W82BWG6.*O2G!@>%->LQ
MB=]8DDVA@BX_MOOWA+_E-]SC2KFT_:&*Q^<EUPN70TJIF8NH'@;0$@IBL=*1
MZZTA< I3XL9%?KSG,VJ5$7>'+-O1#P ("<6WAH)1!+98Y!3RC1N1\]&1QW!$
M2B"Z-@LQ LQ3A,(7M% LM'@-].><G/<]>KI2XBZF/?%M1*X ,0)@).05&XK&
M0K'7H%-0[$V)VN?M,7*!BB^C=@00(P#&+KC0:U*QT.0UU*0UV;64/7K-=T$T
MN)@(X?-H!$?/;\=OR?R<.VX#2#\ ("3D->-E(M=C-.A/I<8>7>;O@9!\Q))I
MF3ID7E;:4V"B=/\$7@JJ[*T.+>E<G&.-]7G1 ASEG60L,=-622_ 0F@_ <]]
MN::JD9).1+C64H]QV\TDB7@&QUJCP0W_!7_AW )Y1T!$*$K#RT"NJUJP%"J:
M-J:N'N.R\TD6C^,7'B*U=*T]T-^%F&N-XW+EE&&D5;FTL2281^VTJEHBI(V&
M;):K9!4@!9^S<LT(9]C'PN4=(=OL,;3W>E$)H8!?*R"YHMK IA#RMZ3,%/?$
M')9GG! *]K6"L$BR5J 2N?/IBB7\70S[SKQ=^+@DX382+)KD>3S!N=_98"0D
M<-X7_\0S(0/C>;/!R."F>5P]+"CO"36X$"3]=,^4Q=# %4)K2W/YRNW8 9OJ
MUB*O)I[[ASL[K^J!SS=4%TY]+8;;J'21X0V/@JC/@_ Q3CEHR4W $[C"&&WZ
MCK\F>$>IB*6Y%LAG@W8X1\%9I6J5QQYW!S32OAX.63][B%3W]^93K2.[-/\>
M\(_0CD1S3;"V3&O>4<B*D+5-$A>A7@;IZTT8?P#-3$S!_7 R@'-\(GB;C">A
MF(\'+5BHTZ\"+PGMQC37"HR=ML%!"CN29*W59]*]<HW]PT0X2 A!&QFGFX\
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M$(/]M7]&Z2)!E710!H&';+&GH%!]#T5@=W$TZK%D#">EYM5>>[[*O<JT8"]
MK.DB1+-G9X>"04#;R=>#.67PRU^70J0\.Q\E+'>259&XM+V@:9^0A2C8MFX@
M.E -G?Q6F7[L]<W7EVSYMA,V)RKI!5@(^!PZ7LNG5S6N;KL0KB7M\X*Y8FJX
MB\6J]QA,$7G'NBZ @E >3LUKN=8JH%'(;3A7/+OL6OT4?L7"8"J<J23X&,0?
M4<%&U2PNZ0*4$<J7J?DG64#5T';SWPH;[=)L]6KXQ-[C\!TBV'S9N@GZ<.O
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M4$L! A0#%     @ )YRE2IQ"!(#+&P  +68! !$              ( !G;P
M &AB:6\M,C Q-S S,S$N>'-D4$L! A0#%     @ )YRE2O]^P.L^'0  Y=L!
M !4              ( !E]@  &AB:6\M,C Q-S S,S%?8V%L+GAM;%!+ 0(4
M Q0    ( "><I4I@XR<%<T@  ,$Z!0 5              "  0CV  !H8FEO
M+3(P,3<P,S,Q7V1E9BYX;6Q02P$"% ,4    "  GG*5*5(U0H=;$   [, H
M%0              @ &N/@$ :&)I;RTR,#$W,#,S,5]L86(N>&UL4$L! A0#
M%     @ )YRE2N^+I&K@E0  1@\+ !4              ( !MP," &AB:6\M
F,C Q-S S,S%?<')E+GAM;%!+!08     !@ & (H!  #*F0(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
